Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Cervical Cancer, January 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 3856 articles:
HTML format


 

Single Articles

  1. RATHOD S, Potdar J, Gupta A, Sethi N, et al
    Empowering Women's Health: Insights Into HPV Vaccination and the Prevention of Invasive Cervical Cancer.
    Cureus. 2023;15:e49523.
    Abstract

  2. FU B, Fang L, Wang R, Zhang X, et al
    Inhibition of Wnt/beta-catenin signaling by monensin in cervical cancer.
    Korean J Physiol Pharmacol. 2024;28:21-30.
    Abstract

  3. XU Y, Lai H, Pan S, Pan L, et al
    Selenium promotes immunogenic radiotherapy against cervical cancer metastasis through evoking P53 activation.
    Biomaterials. 2023;305:122452.
    Abstract

  4. RUAN X
    Chinese Expert Consensus on ovarian function and fertility preservation of cervical cancer in pregnancy (2023).
    Front Endocrinol (Lausanne). 2023;14:1280631.
    Abstract

  5. SHEN T, Zhao J, Li W, Wang X, et al
    Hypertension and hyperglycaemia are positively correlated with local invasion of early cervical cancer.
    Front Endocrinol (Lausanne). 2023;14:1280060.
    Abstract

  6. MA X, Zheng J, He K, Wang L, et al
    TGFA expression is associated with poor prognosis and promotes the development of cervical cancer.
    J Cell Mol Med. 2023 Dec 28. doi: 10.1111/jcmm.18086.
    Abstract

  7. QIN Q, Yu Z, Tang Y
    Embryonal rhabdomyosarcoma of the uterine cervix.
    Med Ultrason. 2023;25:475-476.
    Abstract

  8. KANG C, Duo Y, Zheng L, Zhao N, et al
    CAFs-derived exosomes promote the development of cervical cancer by regulating miR-18a-5p-TMEM170B signaling axis.
    Biochem Biophys Res Commun. 2023;694:149403.
    Abstract

  9. BENCIC D, Barbaric M, Mornar A, Klaric DA, et al
    Oleuropein in olive leaf, branch, and stem extracts: stability and biological activity in human cervical carcinoma and melanoma cells.
    Acta Pharm. 2023;73:601-616.
    Abstract

  10. YANG T, Tian S, Zhao J, Pei M, et al
    LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
    Cell Cycle. 2023 Dec 26:1-14. doi: 10.1080/15384101.2023.2297591.
    Abstract

  11. LUVIAN-MORALES J, Delgadillo-Gonzalez M, Castro-Eguiluz D, Onate-Ocana LF, et al
    Quality of life but not cachexia definitions are associated with overall survival in women with cervical cancer: a STROBE-compliant cohort study.
    Jpn J Clin Oncol. 2023 Dec 23:hyad182. doi: 10.1093.
    Abstract

  12. HIBINO Y, Okazawa-Sakai M, Yokoyama T, Fujimoto E, et al
    Abnormal Vaginal Cytology after Total Laparoscopic Hysterectomy in Patients with Cervical Intraepithelial Neoplasia.
    Acta Med Okayama. 2023;77:627-634.
    Abstract

  13. SAMARE-NAJAF M, Samareh A, Savardashtaki A, Khajehyar N, et al
    Non-Apoptotic Cell Death Programs in Cervical Cancer with an Emphasis on Ferroptosis.
    Crit Rev Oncol Hematol. 2023 Dec 23:104249.
    Abstract

  14. GUAN MM, Rao QX, Huang ML, Wang LJ, et al
    Retracted: Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines.
    Med Sci Monit. 2023;29:e943586.
    Abstract

  15. DU Y, Ye H, Lin M, Cao L, et al
    KLF14 activates the JNK-signaling pathway to induce S-phase arrest in cervical cancer cells.
    Front Immunol. 2023;14:1267950.
    Abstract

  16. ALKHAMIS FH, Alabbas ZAS, Al Mulhim JE, Alabdulmohsin FF, et al
    Prevalence and Predictive Factors of Cervical Cancer Screening in Saudi Arabia: A Nationwide Study.
    Cureus. 2023;15:e49331.
    Abstract

  17. BOVO AC, Pedrao PG, Guimaraes YM, Godoy LR, et al
    Combined Oral Contraceptive Use and the Risk of Cervical Cancer: Literature Review.
    Rev Bras Ginecol Obstet. 2023;45:e818-e824.
    Abstract

  18. ZAGO RA, Camilo-Junior DJ, D'Avilla SCGP, Xavier-Junior JCC, et al
    Underestimated Cervical Cancer among Women over 65 Years Old: Is It Time to Revise the Screening Target Age Group?
    Rev Bras Ginecol Obstet. 2023;45:e790-e795.
    Abstract

  19. HUANG L, Liu F, Liu X, Niu L, et al
    Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3beta pathway.
    Cancer Chemother Pharmacol. 2023 Dec 23. doi: 10.1007/s00280-023-04621.
    Abstract

  20. SANTOS KVGD, da Silva RLM, Sarmento ACA, Medeiros KS, et al
    Effect of Zingiber Officinale in the Management of Nausea and Vomiting Induced by Treatment With Cisplatin Associated With Radiotherapy: A Randomized Controlled Trial.
    Integr Cancer Ther. 2023;22:15347354231220608.
    Abstract

  21. GAMEIRO SF, Salnikov MY, Zeng PYF, Barrett JW, et al
    HPV16 Intratypic Variants in Head and Neck Cancers: A North American Perspective.
    Viruses. 2023;15:2411.
    Abstract

  22. LOZAR T, Wang W, Gavrielatou N, Christensen L, et al
    Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review.
    Viruses. 2023;15:2320.
    Abstract

  23. WU PJ, Tsai SC, Huang JY, Lee MS, et al
    From Infection to Malignancy: Tracing the Impact of Human Papillomavirus on Uterine Endometrial Cancer in a Nationwide Population-Based Cohort Study.
    Viruses. 2023;15:2314.
    Abstract

  24. CAKIR MO, Bilge U, Ghanbari A, Ashrafi GH, et al
    Regulatory Effect of Ficus carica Latex on Cell Cycle Progression in Human Papillomavirus-Positive Cervical Cancer Cell Lines: Insights from Gene Expression Analysis.
    Pharmaceuticals (Basel). 2023;16:1723.
    Abstract

  25. CHOOWONGKOMON K, Choengpanya K, Pientong C, Ekalaksananan T, et al
    The Inhibitory Effect of Kerra(TM), KS(TM), and Minoza(TM) on Human Papillomavirus Infection and Cervical Cancer.
    Medicina (Kaunas). 2023;59:2169.
    Abstract

  26. DICU-ANDREESCU IG, Marincas MA, Prunoiu VM, Dicu-Andreescu I, et al
    The Impact of Patient Characteristics, Risk Factors, and Surgical Intervention on Survival in a Cohort of Patients Undergoing Neoadjuvant Treatment for Cervical Cancer.
    Medicina (Kaunas). 2023;59:2147.
    Abstract

  27. CHOI Y, Ando Y, Lee D, Kim NY, et al
    Profiling of Lymphovascular Space Invasion in Cervical Cancer Revealed PI3K/Akt Signaling Pathway Overactivation and Heterogenic Tumor-Immune Microenvironments.
    Life (Basel). 2023;13:2342.
    Abstract

  28. KOURI MA, Spyratou E, Kalkou ME, Patatoukas G, et al
    Nanoparticle-Mediated Radiotherapy: Unraveling Dose Enhancement and Apoptotic Responses in Cancer and Normal Cell Lines.
    Biomolecules. 2023;13:1720.
    Abstract

  29. DI DONNA MC, Cucinella G, Giallombardo V, Sozzi G, et al
    Urinary, Gastrointestinal, and Sexual Dysfunctions after Chemotherapy, Radiotherapy, Radical Surgery or Multimodal Treatment in Women with Locally Advanced Cervical Cancer: A Multicenter Retrospective Study.
    Cancers (Basel). 2023;15:5734.
    Abstract

  30. ABD RASHID N, Mohamad Najib NH, Abdul Jalil NA, Teoh SL, et al
    Essential Oils in Cervical Cancer: Narrative Review on Current Insights and Future Prospects.
    Antioxidants (Basel). 2023;12:2109.
    Abstract

  31. THE LANCET INFECTIOUS DISEASES
    A blueprint for elimination of cervical cancer.
    Lancet Infect Dis. 2024;24:1.
    Abstract

  32. RAHANGDALE L, Teodoro N, Chinula L, Brewer NT, et al
    Eliminating cervical cancer as a global public health problem requires equitable action.
    BMJ. 2023;383:2978.
    Abstract

  33. CORONADO PJ, Gracia M
    Robotic radical hysterectomy after conization for patients with small volume early-stage cervical cancer.
    Best Pract Res Clin Obstet Gynaecol. 2023;92:102434.
    Abstract

  34. SON YJ, Nam KH, Shim J
    Factors influencing the supportive care needs of female patients with genital cancer in South Korea.
    Medicine (Baltimore). 2023;102:e36650.
    Abstract

  35. LIU X, Hou X, Hu K, Zhang F, et al
    Risk Factors for Nodal Failure in Patients with FIGO IIIC Cervical Cancer Receiving Definitive Image-Guided Radiotherapy.
    Curr Oncol. 2023;30:10385-10395.
    Abstract

  36. PURI SUDHIR K, Kagenaar E, Meijer M, Hesselink AT, et al
    Comparing the Costs and Diagnostic Outcomes of Replacing Cytology with the QIAsure DNA Methylation Test as a Triage within HPV Primary Cervical Cancer Screening in The Netherlands.
    Diagnostics (Basel). 2023;13:3612.
    Abstract

  37. SEVILLA-SANCHEZ MJ, Montoya-Gomez A, Osorno-Valencia D, Montealegre-Sanchez L, et al
    Exploring the Safety of Pllans-II and Antitumoral Potential of Its Recombinant Isoform in Cervical Cancer Therapy.
    Cells. 2023;12:2812.
    Abstract

  38. CUI HX, Lou XL, Xia W, Zhang YS, et al
    [Expression of ProEXC and PRMT5 in cervical adenocarcinoma and their clinical significance].
    Zhonghua Yi Xue Za Zhi. 2023;103:3967-3971.
    Abstract

  39. UGURLUER G, Zoto Mustafayev T, Gungor G, Abacioglu U, et al
    Online Adaptive Magnetic Resonance-guided Radiation Therapy for Gynaecological Cancers: Preliminary Results of Feasibility and Outcome.
    Clin Oncol (R Coll Radiol). 2024;36:12-20.
    Abstract

  40. KAWANA K, Kobayashi O, Ikeda Y, Yahata H, et al
    Phase I and II randomized clinical trial of an oral therapeutic vaccine targeting human papillomavirus for treatment of cervical intraepithelial neoplasia 2 and 3.
    JNCI Cancer Spectr. 2023;7:pkad101.
    Abstract

  41. RATNAM S, Jang D, Alaghehbandan R, Gilbert L, et al
    HPV genotype-specific distribution and attributable risk in cervical intraepithelial neoplasia in a referral population with a history of LSIL.
    Cancer Biomark. 2023;38:433-442.
    Abstract

  42. TAGHIZADEH PIRPOSHTEH R, Arefian E, Arashkia A, Mohajel N, et al
    Nona-Arginine Mediated Anti-E6 ShRNA Delivery Suppresses the Growth of Hela Cells in vitro.
    Iran Biomed J. 2023;27:349-56.
    Abstract

  43. PENG S, Tu H-F, Cheng M, Hu M-H, et al
    Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojector.
    mBio. 2023;14:e0212123.
    Abstract

  44. LEE SS, Dinicu A, Arthurs L, Shileds D, et al
    Demographic reporting and language exclusion in gynecologic oncology clinical trials.
    Am J Obstet Gynecol. 2023 Sep 24:S0002-9378(23)00639.
    Abstract

  45. GUO Q, Qu L, Zhu J, Li H, et al
    Predicting Lymph Node Metastasis From Primary Cervical Squamous Cell Carcinoma Based on Deep Learning in Histopathologic Images.
    Mod Pathol. 2023;36:100316.
    Abstract

  46. DOORBAR J
    The human Papillomavirus twilight zone - Latency, immune control and subclinical infection.
    Tumour Virus Res. 2023;16:200268.
    Abstract

  47. STERN PL
    Is immunotherapy a potential game changer in managing human papillomavirus (HPV) infection and intraepithelial neoplasia?
    Tumour Virus Res. 2023;16:200263.
    Abstract

  48. WEARN A, Shepherd L
    Determinants of routine cervical screening participation in underserved women: a qualitative systematic review.
    Psychol Health. 2024;39:145-170.
    Abstract

  49. KANNO M, Yunokawa M, Fusegi A, Abe A, et al
    Cerebral infarction caused by Trousseau syndrome associated with cervical cancer.
    J Gynecol Oncol. 2024 Jan 1. doi: 10.3802/jgo.2024.
    Abstract

  50. M PARVATH ES, John NO, Sathyamurthy A, Ramireddy JK, et al
    Development and validation of a novel scoring system to predict the risk of uterine perforation during intracavitary brachytherapy for cervical cancer.
    J Gynecol Oncol. 2023 Dec 29. doi: 10.3802/jgo.2024.
    Abstract

  51. WANG G, Wang Z, Guo Y, Zhang Y, et al
    Evaluation of PTV margins with daily iterative online adaptive radiotherapy for postoperative treatment of endometrial and cervical cancer: a prospective single-arm phase 2 study.
    Radiat Oncol. 2024;19:2.
    Abstract

  52. KOK HP, Herrera TD, Crezee J
    Biological treatment evaluation in thermoradiotherapy: application in cervical cancer patients.
    Strahlenther Onkol. 2024 Jan 4. doi: 10.1007/s00066-023-02185.
    Abstract

  53. HUNG TM, Son HX, Bang LVN, Van Duyet L, et al
    Characteristics of cervical cancer caused by the human papillomavirus 18 and its genetic variations in Vietnamese women.
    Infect Genet Evol. 2024 Jan 2:105546. doi: 10.1016/j.meegid.2023.105546.
    Abstract

  54. WANG Y, Lou C, Zhao S, Li B, et al
    Preparation of polypeptide-metal complexes-coated Hosenkoside A and its inhibitory effect in cervical cancer.
    Int J Biol Macromol. 2024 Jan 2:129177. doi: 10.1016/j.ijbiomac.2023.129177.
    Abstract

  55. HERBST J, Vohl V, Krajina M, Leffers M, et al
    Detection of Multiple HPV Types in Liquid Biopsies of Cervical Neoplasia.
    Clin Chem. 2024;70:285-296.
    Abstract

  56. PISANI T, Cenci M
    Prevalence of Multiple High Risk Human Papilloma Virus (HR-HPV) Infections in Cervical Cancer Screening in Lazio Region, Italy.
    Cancer Diagn Progn. 2024;4:42-45.
    Abstract

  57. ADDO-LARTEY AA, Bonful HA, Sefenu RS, Abagre TA, et al
    Effectiveness of a culturally tailored text messaging program for promoting cervical cancer screening in accra, Ghana: a quasi-experimental trial.
    BMC Womens Health. 2024;24:22.
    Abstract

  58. YAN H, Wang Q, Qiao Y
    Cervical cancer prevention in China: where are we now, and what's next?
    Cancer Biol Med. 2024 Jan 2:j.issn.2095-3941.2023.0432.
    Abstract

  59. YAO H, Li J, Zhou D, Pan X, et al
    FOXM1 transcriptional regulation of RacGAP1 activates the PI3K/AKT signaling pathway to promote the proliferation, migration, and invasion of cervical cancer cells.
    Int J Clin Oncol. 2024 Jan 3. doi: 10.1007/s10147-023-02452.
    Abstract

  60. WANG M, Huang K, Wong MCS, Huang J, et al
    Global Cervical Cancer Incidence by Histological Subtype and Implications for Screening Methods.
    J Epidemiol Glob Health. 2024 Jan 3. doi: 10.1007/s44197-023-00172.
    Abstract

  61. LI G, Chen Q, Hong S, Yang X, et al
    CNKSR2 expression is correlated with immune infiltrates in Cervical Cancer as a favorable prognostic factor.
    J Cancer. 2024;15:444-455.
    Abstract

  62. YUN Z, Li X, Zhu D, Li L, et al
    A meta-analysis examining the impact of open surgical therapy versus minimally invasive surgery on wound infection in females with cervical cancer.
    Int Wound J. 2024 Jan 2. doi: 10.1111/iwj.14535.
    Abstract

  63. WANG S, Zhang Y, Ma X, Feng Y, et al
    Function and mechanism of GBP1 in the development and progression of cervical cancer.
    J Transl Med. 2024;22:11.
    Abstract

  64. HUSSEIN K, Kokwaro G, Wafula F, Kassie GM, et al
    Factors influencing the uptake and utilization of cervical cancer screening services among women attending public health centers in Addis Ababa, Ethiopia: mixed methods study.
    BMC Womens Health. 2024;24:3.
    Abstract

  65. CHEN X, Lu D, Mu Y, Kong L, et al
    The clinical significance of intraoperative adverse events in laparoscopic radical hysterectomies for early-stage cervical cancer.
    BMC Womens Health. 2024;24:1.
    Abstract

  66. LI J, Jin H, Sun Y, Wang C, et al
    Reconnoitering correlation between human papillomavirus infection-induced vaginal microecological abnormality and squamous intraepithelial lesion (SIL) progression.
    BMC Womens Health. 2024;24:5.
    Abstract

  67. SONG Y, Xia L, Ju X, Wang W, et al
    Development of a supportive care needs eHealth application for patients with cervical cancer undergoing surgery: a feasibility study.
    BMC Health Serv Res. 2024;24:3.
    Abstract

  68. ENDEN MR, Moen K, Igland J, Diaz E, et al
    Trends in cervical cancer screening in Norway 2012-2017: a comparison study of non-immigrant and immigrant women.
    Scand J Public Health. 2024 Jan 2:14034948231217636.
    Abstract

  69. KOUSSOURI A, Baraquin A, Desmarets M, Diallo K, et al
    Comparison of high-risk HPV detection by the AmpFire(R) HPV Screening 16/18/HR technique (Atila Biosystems) and the hybrid capture 2 test (Qiagen).
    Mol Biol Rep. 2024;51:52.
    Abstract

  70. WU KC, Chen SW, Hsieh TC, Yen KY, et al
    Early prediction of distant metastasis in patients with uterine cervical cancer treated with definitive chemoradiotherapy by deep learning using pretreatment [18F]fluorodeoxyglucose positron emission tomography/computed tomography.
    Nucl Med Commun. 2023 Dec 27. doi: 10.1097/MNM.0000000000001799.
    Abstract

  71. ONAL C, Guler OC, Torun N, Reyhan M, et al
    Long-term assessment of clinical parameters and positron emission tomography parameters in predicting recurrence in uterine cervical cancer patients receiving definitive chemoradiotherapy.
    Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001800.
    Abstract

  72. JAHAN S, Begum F, Nigar K, Sarkar S, et al
    Primary Tuberculosis of Cervix Which Simulated Endocervical Polyp: A Case Study.
    Mymensingh Med J. 2024;33:307-310.
    Abstract

  73. CHOUDHOURY S, Latif T, Dhar S, Sarker K, et al
    Analysis of Socio Demographic Risk Factors of Cervical Intraepithelial Neoplasia at Colposcopic Clinic in Mymensingh Medical College Hospital.
    Mymensingh Med J. 2024;33:62-67.
    Abstract

  74. LUTHERA NGOMBE MOUABATA DF, Magloire Boumba AL, Bienvenu Massengo NR, Saturnin Pouki F, et al
    Prevalence of co-infection with human papillomavirus and Chlamydia trachomatis and risk factors associated with cervical cancer in Congolese women.
    Microbes Infect. 2023 Dec 30:105287. doi: 10.1016/j.micinf.2023.105287.
    Abstract

  75. XU C, Liu W, Zhao Q, Zhang L, et al
    CT-based radiomics nomogram for overall survival prediction in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Front Oncol. 2023;13:1287121.
    Abstract

  76. OU Q, Chen Z, Tang J, Chen M, et al
    [Listeria Balanced Lethal Systems Expressing Cervical Cancer Antigen Genes: Construction and Basic Biological Characteristics].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2023;54:1159-1166.
    Abstract

  77. NICHOLS M, Kesaria A, Spencer HJ, Williams HR, et al
    Opioid Use in Patients With Cervical Cancer at a Tertiary Academic Medical Center.
    Anticancer Res. 2024;44:151-155.
    Abstract

  78. D'ORIA O, Bogani G, Cuccu I, D'Auge TG, et al
    Pharmacotherapy for the treatment of recurrent cervical cancer: an update of the literature.
    Expert Opin Pharmacother. 2023 Dec 30:1-11. doi: 10.1080/14656566.2023.2298329.
    Abstract

  79. LATHROP E, Chissano M, Tevir G, Chongo Y, et al
    Self-sampling for human papilloma virus DNA as a strategy to increase access to cervical cancer screening: patients' and providers' perspectives on facilitators and barriers to scale.
    Afr J Reprod Health. 2023;27:106-111.
    Abstract

  80. KIMONI GB, Martin R, Mukengere DM, de Kerchove C, et al
    Screening and risk factors for cervical cancer among survivors of sexual violence in conflict settings, in Eastern Democratic Republic of Congo.
    Afr J Reprod Health. 2023;27:79-85.
    Abstract

  81. YAGI A, Nakagawa S, Ueda Y, Oka E, et al
    Effectiveness of catch-up and routine program of the 9-valent vaccine on cervical cancer risk reduction in Japan.
    Cancer Sci. 2023 Dec 30. doi: 10.1111/cas.16055.
    Abstract

  82. FANG M, Zhou Y, Li Z, Li X, et al
    Transcriptional factor CCAAT enhancer binding protein beta inhibits epithelial-mesenchymal transition in cervical cancer via regulating attractin-like 1.
    Cell Mol Biol (Noisy-le-grand). 2023;69:1-7.
    Abstract

  83. ILAHI NE, Siddique N, Rashid MI, Noreen M, et al
    Decoding the Genetic and Structural Features of HPV16 E5 Oncogene in Cervical Cancer Isolates from Pakistan: A Pilot Study.
    Iran Biomed J. 2023;27:388-96.
    Abstract

  84. CHEN X, Tian J, Zhao C, Wu Y, et al
    Resveratrol, a novel inhibitor of FABP5, inhibits cervical cancer metastasis by suppressing fatty acid transport into nucleus and downstream pathways.
    Br J Pharmacol. 2023 Dec 29. doi: 10.1111/bph.16308.
    Abstract

  85. JIANG W, Huang G, Pan S, Chen X, et al
    TRAIL-driven targeting and reversing cervical cancer radioresistance by seleno-nanotherapeutics through regulating cell metabolism.
    Drug Resist Updat. 2023;72:101033.
    Abstract

  86. WEN S, Lv X, Li P, Li J, et al
    Analysis of cancer-associated fibroblasts in cervical cancer by single-cell RNA sequencing.
    Aging (Albany NY). 2023;15.
    Abstract

  87. LAZNIAK S, Sowinska A, Roszak A, Lianeri M, et al
    Role of rs2366152 single-nucleotide variant located in the long noncoding RNA HOTAIR gene in the cervical cancer susceptibility in a Polish population.
    J Appl Genet. 2023 Dec 29. doi: 10.1007/s13353-023-00822.
    Abstract

  88. YASIN YS, Jumaa AH, Jabbar S, Abdulkareem AH, et al
    Effect of Laetrile Vinblastine Combination on the Proliferation of the Hela Cancer Cell Line.
    Asian Pac J Cancer Prev. 2023;24:4329-4337.
    Abstract

  89. RAI R, Sehgal R, Singhal S, Suri V, et al
    Cervical Cancer Screening Coverage at Tertiary Care Institutes Across India.
    Asian Pac J Cancer Prev. 2023;24:4269-4275.
    Abstract

  90. DAVIES P, Aluloski I, Aluloski D, Dizdarevic Maksumic A, et al
    Update on HPV Vaccination Policies and Practices in 17 Eastern European and Central Asian Countries and Territories.
    Asian Pac J Cancer Prev. 2023;24:4227-4235.
    Abstract

  91. TEKKESIN N, Goktas S, Alkis V, Tekkesin E, et al
    Male Human Papillomavirus Infection and Genotyping in Turkey.
    Asian Pac J Cancer Prev. 2023;24:4187-4193.
    Abstract

  92. RAYA I, Kartina D, Wijaya RI, Irfandi R, et al
    Novel Complex of Zinc (II) Dichloroethylenediamine: Synthesis, Characterization, In-silico, and In-vitro Evaluation against Cervical Cancer Cells.
    Asian Pac J Cancer Prev. 2023;24:4155-4165.
    Abstract

  93. OKONOFUA F, Edouard L, Isikhuemen M
    Human papilloma virus (HPV) vaccine and cervical cancer prevention in Africa.
    Afr J Reprod Health. 2023;27:9-14.
    Abstract

  94. KOMATSU H, Ikeda Y, Kawana K, Nagase S, et al
    Impact of COVID-19 on gynecological cancer incidence: a large cohort study in Japan.
    Int J Clin Oncol. 2024;29:72-77.
    Abstract

  95. NAKOWONG P, Chatchawal P, Chaibun T, Boonapatcharoen N, et al
    Detection of high-risk HPV 16 genotypes in cervical cancers using isothermal DNA amplification with electrochemical genosensor.
    Talanta. 2024;269:125495.
    Abstract

  96. SHARMA S, Chauhan D, Kumar S, Kumar R, et al
    Impact of HPV strains on molecular mechanisms of cervix cancer.
    Microb Pathog. 2024;186:106465.
    Abstract

  97. DISIPIO T, Pearse E, Jordan S
    Survivorship research in advanced gynecological cancer: A scoping review of cohort studies.
    Cancer Med. 2023;12:21779-21797.
    Abstract

  98. KELLY MK, Katzenellenbogen RA, Fiks AG
    What Health Systems Can Do Now to Improve Human Papillomavirus Vaccination.
    JAMA Pediatr. 2024;178:13-14.
    Abstract

  99. SUN Y, Zhou X, Lucas E, Chen L, et al
    Expression of B7-H3 and TIM-3 in gastric-type endocervical adenocarcinoma: prevalence, association with PD-L1 expression, and prognostic significance.
    J Pathol Clin Res. 2024;10:e345.
    Abstract

  100. GARG A, Galvin AM, Griner SB, Rosberger Z, et al
    HPV self-sampling among women in the United States: preferences for implementation.
    Cancer Causes Control. 2024;35:167-176.
    Abstract

  101. NITKOWSKI J, Fernandez ME, Ridolfi T, Chiao E, et al
    The impact of body mass index and physical disability on home-based anal self-sampling.
    Cancer Causes Control. 2024;35:161-166.
    Abstract

  102. LI F, Wang Y, Wen M, Aizezi G, et al
    NPHS2-6 drives cervical squamous cell carcinoma (CSCC) progression via hsa-miR-1323/SMC1B axis to activate PI3K-Akt pathway.
    Clin Transl Oncol. 2024;26:245-259.
    Abstract

  103. GOYAL A, Booth CN, Souers RJ, Tabbara SO, et al
    Navigating Practice Issues Related to the Unsatisfactory Cervicovaginal Papanicolaou Test: Survey Results of Laboratories Participating in the 2020 College of American Pathologists PAP Education Program.
    Arch Pathol Lab Med. 2024;148:48-54.
    Abstract

  104. CHIU HC, Lau CH, Tan SJ, Huang SC, et al
    Successful pregnancy with in vitro fertilization after vaginal radical trachelectomy and pelvic lymphadenectomy in stage IB1 cervical cancer.
    Taiwan J Obstet Gynecol. 2024;63:95-97.
    Abstract

  105. KOBAYASHI O, Taguchi A, Nakajima T, Ikeda Y, et al
    Immunotherapy that leverages HPV-specific immune responses for precancer lesions of cervical cancer.
    Taiwan J Obstet Gynecol. 2024;63:22-28.
    Abstract

  106. WANG Y, Lyu Y, Che X, Li J, et al
    Can surgery boost the survival benefit of chemoradiotherapy in T1b1-T2a1 stage cervical cancer with lymph node metastasis? A population-based study.
    J Gynecol Oncol. 2023 Dec 29. doi: 10.3802/jgo.2024.
    Abstract

  107. JEONG S, Yu H, Park SH, Woo D, et al
    Comparing deep learning and handcrafted radiomics to predict chemoradiotherapy response for locally advanced cervical cancer using pretreatment MRI.
    Sci Rep. 2024;14:1180.
    Abstract

  108. ANJAM MAJOUMERD A, Hosseini S, Hosseini SMH, Roshandel G, et al
    Epidemiology of cervical cancer in Iran in 2016: A nationwide study of incidence and regional variation.
    Cancer Rep (Hoboken). 2024 Jan 12:e1973. doi: 10.1002/cnr2.1973.
    Abstract

  109. ZHANG Y, Wang G, Chang Y, Wang Z, et al
    Prospects for daily online adaptive radiotherapy for cervical cancer: Auto-contouring evaluation and dosimetric outcomes.
    Radiat Oncol. 2024;19:6.
    Abstract

  110. YAO Y, Yan Z, Li C, Zhang S, et al
    Association of HLA class I and II genes with cervical cancer susceptibility in a Han Chinese population.
    HLA. 2024;103:e15340.
    Abstract

  111. DAVIDOVIC M, Asangbeh SL, Taghavi K, Dhokotera T, et al
    Facility-Based Indicators to Manage and Scale Up Cervical Cancer Prevention and Care Services for Women Living With HIV in Sub-Saharan Africa: a Three-Round Online Delphi Consensus Method.
    J Acquir Immune Defic Syndr. 2024;95:170-178.
    Abstract

  112. MEI X, Xiong J, Liu J, Huang A, et al
    DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4/PI3K/AKT axis and VEGF-C secretion.
    Cancer Lett. 2024 Jan 9:216609. doi: 10.1016/j.canlet.2024.216609.
    Abstract

  113. HEINERT SW, Ahmed M, Guzman-Baez K, Penugonda A, et al
    Characteristics and Barriers of Emergency Department Patients Overdue for Cancer Screening.
    West J Emerg Med. 2024;25:101-110.
    Abstract

  114. ZHANG J, Yu X, Guo Y, Wang D, et al
    HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
    Cancer Med. 2024 Jan 11. doi: 10.1002/cam4.6875.
    Abstract

  115. DHANDE B, Khandeparkar SGS, Gogate BP, Joshi AR, et al
    Immunohistopathological Study of Papillary Squamotransitional Carcinoma of Uterine Cervix.
    Gulf J Oncolog. 2024;1:16-24.
    Abstract

  116. ACOSTA LH, Pino MTL, Rocca MV, Cabilla JP, et al
    Soluble guanylyl cyclase beta1 subunit targets epithelial-to-mesenchymal transition and downregulates Akt pathway in human endometrial and cervical cancer cells.
    Heliyon. 2023;10:e23927.
    Abstract

  117. HIGGASON N, Nguyen L, Le YC, Juliet Ezeigwe O, et al
    Facilitators to cervical cancer screening in a minority, urban, underserved population.
    Gynecol Oncol Rep. 2023;51:101315.
    Abstract

  118. CHEN H, Zhao X, Hu S, You T, et al
    Estimation of economic burden throughout course of cervical squamous intraepithelial lesion and cervical cancer in China: A nationwide multicenter cross-sectional study.
    Chin J Cancer Res. 2023;35:675-685.
    Abstract

  119. SONG B, Choi SY
    Factors influencing the intention to engage in cervical cancer preventive behavior in human papillomavirus-infected women: a cross-sectional survey.
    Korean J Women Health Nurs. 2023;29:317-327.
    Abstract

  120. ALIMUJIANG Y, Maimaiti A, Ablise M, Yang Z, et al
    Design, Synthesis, and In vitro Anti-cervical Cancer Activity of a Novel MDM2-p53 Inhibitor Based on a Chalcone Scaffold.
    Anticancer Agents Med Chem. 2024.
    Abstract

  121. NI BQ, Pan MM, He LX, Li T, et al
    Zimberelimab combined with systemic therapy extended tumor control in post-radiotherapy cervical cancer with brain metastases: A case report.
    J Obstet Gynaecol Res. 2024 Jan 10. doi: 10.1111/jog.15887.
    Abstract

  122. CHO O
    Post-Radiotherapy Exosomal Non-Coding RNA and Hemograms for Early Death Prediction in Patients with Cervical Cancer.
    Int J Mol Sci. 2023;25:126.
    Abstract

  123. MARGIOULA-SIARKOU C, Almperis A, Gullo G, Almperi EA, et al
    Sentinel Lymph Node Staging in Early-Stage Cervical Cancer: A Comprehensive Review.
    J Clin Med. 2023;13:27.
    Abstract

  124. BRAMMALL BR, Garad RM, Teede HJ, Harrison CL, et al
    Evaluating Preconception Health and Behaviour Change in Australian Women Planning a Pregnancy: The OptimalMe Program, a Digital Healthy Lifestyle Intervention with Remotely Delivered Coaching.
    Nutrients. 2024;16:155.
    Abstract

  125. VAN KOL K, Ebisch R, Beugeling M, Cnossen J, et al
    Comparing Methods to Determine Complete Response to Chemoradiation in Patients with Locally Advanced Cervical Cancer.
    Cancers (Basel). 2023;16:198.
    Abstract

  126. NADILE M, Kornel A, Sze NSK, Tsiani E, et al
    A Comprehensive Review of Genistein's Effects in Preclinical Models of Cervical Cancer.
    Cancers (Basel). 2023;16:35.
    Abstract

  127. YANG H, Xu Y, Dong M, Zhang Y, et al
    Automated Prediction of Neoadjuvant Chemoradiotherapy Response in Locally Advanced Cervical Cancer Using Hybrid Model-Based MRI Radiomics.
    Diagnostics (Basel). 2023;14:5.
    Abstract

  128. GUO F, Lu R, Kong W, Anwar M, et al
    DNA mismatch repair system regulates the expression of PD-L1 through DNMTs in cervical cancer.
    Cancer Cell Int. 2024;24:25.
    Abstract

  129. KANG J, Jiang J, Xiang X, Zhang Y, et al
    Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysis.
    Cancer Cell Int. 2024;24:23.
    Abstract

  130. ZHANG Z, Liu J, Zhang Y, Qu F, et al
    T1 mapping as a quantitative imaging biomarker for diagnosing cervical cancer: a comparison with diffusion kurtosis imaging.
    BMC Med Imaging. 2024;24:16.
    Abstract

  131. LI J, Cao Y, Liu Y, Yu L, et al
    Multiomics profiling reveals the benefits of gamma-delta (gammadelta) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer.
    J Immunother Cancer. 2024;12:e008355.
    Abstract

  132. ZHANG Q, Wang Z, Tang H, Zhang B, et al
    Serum CYFRA21-1 and SCC-Ag levels in women during pregnancy and their diagnostic value for cervical cancer.
    Cancer Treat Res Commun. 2023;38:100786.
    Abstract

  133. WANG B, Mao Z, Ye J, Jiao X, et al
    Glycolysis Induced by METTL14 Is Essential for Macrophage Phagocytosis and Phenotype in Cervical Cancer.
    J Immunol. 2024 Jan 10:ji2300339. doi: 10.4049/jimmunol.2300339.
    Abstract

  134. JIANG Z, Zhang G, Sun T, Zhang G, et al
    Advantages of IMRT optimization with MCO compared to IMRT optimization without MCO in reducing small bowel high dose index for cervical cancer patients-individualized treatment options.
    Transl Cancer Res. 2023;12:3255-3265.
    Abstract

  135. TAN F, Xia R, Zeng L, Xie H, et al
    Value of preoperative controlling nutritional status score in prognosis of patients with high-risk factors for early-stage cervical cancer.
    Pak J Med Sci. 2024;40.
    Abstract

  136. WANG X, Ye Z, Li S, Yan Z, et al
    A multicenter study of cervical cancer using quantitative diffusion-weighted imaging.
    Acta Radiol. 2024 Jan 9:2841851231222360. doi: 10.1177/02841851231222360.
    Abstract

  137. PASSARELLI A, Pisano C, Coppola E, Ventriglia J, et al
    Complete and early response to cemiplimab associated to severe immune toxicity in advanced cervical cancer: a case report.
    Front Immunol. 2023;14:1303893.
    Abstract

  138. WANG S, Liu S, Tan S, Yin J, et al
    Characteristics of human papillomavirus prevalence and infection patterns among women aged 25-64 according to age groups and cytology results in Ordos City, China.
    Virol J. 2024;21:12.
    Abstract

  139. ZHAI C, Jin X, You L, Yan N, et al
    Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review.
    BMC Geriatr. 2024;24:32.
    Abstract

  140. SHARIATI-SARCHESHME M, Mahdizdeh M, Tehrani H, Jamali J, et al
    Women's perception of barriers and facilitators of cervical cancer Pap smear screening: a qualitative study.
    BMJ Open. 2024;14:e072954.
    Abstract

  141. KASSA RN, Shifti DM, Alemu K, Omigbodun AO, et al
    Integration of cervical cancer screening into healthcare facilities in low- and middle-income countries: a scoping review protocol.
    BMJ Open. 2024;14:e078466.
    Abstract

  142. WASIHUN GA, Addise M, Nega A, Kifle A, et al
    Gap analysis of service quality and associated factors at the oncology center of Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia, 2022: a cross-sectional study.
    BMJ Open. 2024;14:e078239.
    Abstract

  143. HONDA R, Nakao Y, Masuda Y, Ohshima K, et al
    Isolated Massive Metastatic Tumor of the Right Ventricle and Pulmonary Artery With Disseminated Intravascular Coagulation in the Distant Period of Cervical Cancer.
    Circ J. 2024 Jan 6. doi: 10.1253/circj.CJ-23-0844.
    Abstract

  144. VURAL TOPUZ O, Bagbudar S
    Cervical Cancer Metastasis to the Stomach Masquerading as Primary Gastric Cancer: A Case Report of a Rare Metastasis Detected via 18F-FDG PET/CT.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9673.
    Abstract

  145. ZHI S, Gu W, Miao R, Zhang L, et al
    Associations between dyadic communication and dyadic coping of patients with cervical cancer and their spouses: a study utilizing the actor-partner interdependence model.
    Support Care Cancer. 2024;32:90.
    Abstract

  146. FU B, Wei L, Wang C, Xiong B, et al
    Nomograms combining computed tomography-based body composition changes with clinical prognostic factors to predict survival in locally advanced cervical cancer patients.
    J Xray Sci Technol. 2024 Jan 5. doi: 10.3233/XST-230212.
    Abstract

  147. FAN L, Ma L, Ling R, Guo X, et al
    Clinical value of conventional magnetic resonance imaging combined with diffusion-weighted imaging in predicting pelvic lymph node metastasis of cervical cancer.
    Front Oncol. 2023;13:1267598.
    Abstract

  148. WELP AM, Crawford M, O'Brien R, Sullivan SA, et al
    Presence of low volume metastases does not alter management in node-negative, early-stage cervical cancer patients who underwent postoperative adjuvant therapy: A retrospective cohort study.
    Gynecol Oncol Rep. 2023;51:101320.
    Abstract

  149. LI X, Zhang Y, Wu H, Li S, et al
    A case of neoadjuvant chemotherapy in pregnancy with cervical cancer (IB3).
    Cancer Treat Res Commun. 2023;38:100749.
    Abstract

  150. MWANGI GF, Niyonzima N, Atwine R, Tusubira D, et al
    Dyslipidemia: prevalence and association with precancerous and cancerous lesions of the cervix; a pilot study.
    Lipids Health Dis. 2024;23:3.
    Abstract

  151. CHEN XJ, Guo CH, Wang ZC, Yang Y, et al
    Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRPalpha axis.
    Cell Commun Signal. 2024;22:15.
    Abstract

  152. DOVER L, Dulaney C
    Neoadjuvant Chemotherapy and Surgery for Cervical Cancer, Timing of Surgery for Esophageal Cancer, Endometrial Cancer Molecular Classification, Vestibular Schwannoma, and Breast Boost Techniques.
    Pract Radiat Oncol. 2024;14:1-5.
    Abstract

  153. ZHANG Z, Yang Y, Zhang L, Wu Y, et al
    Relationship between Cervicovaginal Microecological Changes and HPV16/18 Infection and Cervical Cancer in Women of Childbearing Age.
    Ann Clin Lab Sci. 2023;53:825-834.
    Abstract

  154. SUI H, Shi C, Yan Z, Chen J, et al
    LRRC75A-AS1 drives the epithelial-mesenchymal transition in cervical cancer by binding IGF2BP1 and inhibiting SYVN1-mediated NLRP3 ubiquitination.
    Mol Cancer Res. 2024 Jan 5. doi: 10.1158/1541-7786.MCR-23-0478.
    Abstract

  155. SUI X, Xi X
    MCT1 gene silencing enhances the immune effect of dendritic cells on cervical cancer cells.
    Adv Clin Exp Med. 2024 Jan 5. doi: 10.17219/acem/171446.
    Abstract

  156. GE WS, Geng W, Shen Y, Bao L, et al
    [The screening of HPV-independent adenocarcinoma in situ of the uterine cervix by cell block: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:98-100.
    Abstract

  157. ZHENG L, Zheng L, Chen S, Liu W, et al
    Human papillomavirus prevalence and genotype distribution in Liaocheng men between 2016 and 2022.
    J Med Virol. 2024;96:e29360.
    Abstract

  158. DAI L, Wilson LG, Nakagawa M, Qin Z, et al
    Coinfections with additional oncoviruses in HPV+ individuals: Status, function and potential clinical implications.
    J Med Virol. 2024;96:e29363.
    Abstract

  159. RAJKHOWA P, Pundir P, Dsouza SM, Patil DS, et al
    Factors influencing HPV vaccine implementation in South Asia: a scoping review protocol.
    Syst Rev. 2024;13:14.
    Abstract

  160. MIYAMA Y, Kato T, Sato M, Yabuno A, et al
    Cervical lymphoepithelioma-like carcinoma with deficient mismatch repair and loss of SMARCA4/BRG1: a case report and five related cases.
    Diagn Pathol. 2024;19:6.
    Abstract

  161. FISHER H, Denford S, Audrey S, Finn A, et al
    Information needs of ethnically diverse, vaccine-hesitant parents during decision-making about the HPV vaccine for their adolescent child: a qualitative study.
    BMC Public Health. 2024;24:91.
    Abstract

  162. MOSS JL, Entenman J, Stoltzfus K, Liao J, et al
    Self-sampling tools to increase cancer screening among underserved patients: a pilot randomized controlled trial.
    JNCI Cancer Spectr. 2024;8:pkad103.
    Abstract

  163. WEN KY, Dayaratna S, Slamon R, Granda-Cameron C, et al
    Chatbot-interfaced and cognitive-affective barrier-driven messages to improve colposcopy adherence after abnormal Pap test results in underserved urban women: A feasibility pilot study.
    Transl Behav Med. 2024;14:1-12.
    Abstract

  164. NA DH, Seo AN, Park SY
    Laparoscopic Salvage Surgery for Infrarenal Para-aortic Lymph Node Recurrence of Rectal Cancer.
    Dis Colon Rectum. 2024;67:e119-e120.
    Abstract

  165. CHOI W, Shim E
    Evaluating the cost-effectiveness of HPV vaccination for adolescent girls in Japan: A comparison of 2-valent, 4-valent, and 9-valent HPV vaccines with consideration of cross-protection.
    Prev Med. 2024;178:107743.
    Abstract

  166. WAITE F, Marlow LAV, Nemec M, Waller J, et al
    The impact of age-relevant and generic infographics on knowledge, attitudes and intention to attend cervical screening: A randomized controlled trial.
    Br J Health Psychol. 2024;29:204-220.
    Abstract

  167. SHEN Y, Tang X, Lin S, Jin X, et al
    Automatic dose prediction using deep learning and plan optimization with finite-element control for intensity modulated radiation therapy.
    Med Phys. 2024;51:545-555.
    Abstract

  168. CURY-MARTINS J, Giannotti MA, Miyashiro D, Pereira J, et al
    A unique case of a lymphoproliferative disorder affecting the skin and uterine cervix on a male transgender.
    An Bras Dermatol. 2024;99:135-139.
    Abstract

  169. O'DONNELL N, Waller J, Marlow L, Anderson NC, et al
    "Knowing that I had HPV, I literally just shut down": A qualitative exploration of the psychosocial impact of human papillomavirus (HPV) in women living with mental health conditions.
    Br J Health Psychol. 2024;29:80-94.
    Abstract

  170. METZ CK, Skof AS, Henrich W, Sehouli J, et al
    Human papillomavirus prevalence in pregnant women living with human immunodeficiency virus infection: a scoping review of the literature.
    J Perinat Med. 2023;52:1-13.
    Abstract

  171. CHEBLI P, Strayhorn SM, Hanneke R, Muramatsu N, et al
    A Scoping Review of Cancer Interventions with Arab Americans.
    J Immigr Minor Health. 2024;26:200-226.
    Abstract

  172. WALKER L, Burke S, McGeechan GJ
    Understanding perceptions of the public and key stakeholders toward a localised cancer screening promotion campaign.
    Psychol Health Med. 2024;29:317-333.
    Abstract

  173. ZHANG L, Li M, Yuan F, Jiang J, et al
    The difference of transcriptome of HPV-infected patients contributes more to the occurrence of cervical cancer than the mutations of E6 and E7 genes in HPV16.
    Medicine (Baltimore). 2024;103:e36822.
    Abstract

  174. KAJABWANGU R, Bajunirwe F, Izudi J, Bazira J, et al
    Magnitude and trends in cervical cancer at Mbarara Regional Referral Hospital in South Western Uganda: Retrospective analysis of data from 2017-2022.
    PLOS Glob Public Health. 2024;4:e0002848.
    Abstract

  175. CHEN X, Cao R, Liu H, Zhang T, et al
    [Retracted] MicroRNA?15a?5p?targeting oncogene YAP1 inhibits cell viability and induces cell apoptosis in cervical cancer cells.
    Int J Mol Med. 2024;53:24.
    Abstract

  176. LUO X, Wei J, Yang FL, Pang XX, et al
    Retraction Note: Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b/TUFT1 axis.
    Cancer Cell Int. 2024;24:39.
    Abstract

  177. GUPTA S, Kumar P, Das BC
    Challenges and opportunities to making Indian women cervical cancer free.
    Indian J Med Res. 2024 Jan 13. doi: 10.4103/ijmr.ijmr_1052.
    Abstract

  178. MEZEI A, Trawin J, Payne B, Rawat A, et al
    Acceptability of Integrated Community-Based HIV and Cervical Cancer Screening in Mayuge District, Uganda.
    JCO Glob Oncol. 2024;10:e2200324.
    Abstract

  179. DANGAL G, Dhital R, Dwa YP, Poudel S, et al
    Implementation of cervical cancer prevention and screening across five tertiary hospitals in Nepal and its policy implications: A mixed-methods study.
    PLOS Glob Public Health. 2024;4:e0002832.
    Abstract

  180. DILLNER J
    Nobel calling Harald zur Hausen.
    J Med Virol. 2024;96:e29414.
    Abstract

  181. LIU X, Yu B, Gao F, Jing P, et al
    Chemical immune conization of precancerous cervical lesions awakens immune cells and restores normal HPV negative and abnormal proliferation.
    Front Immunol. 2024;14:1259723.
    Abstract

  182. KUE J, Tate J, Szalacha LA, Menon U, et al
    A randomized controlled trial of a tailored navigation intervention to promote breast and cervical cancer screening among intergenerational Southeast Asian women.
    Contemp Clin Trials Commun. 2023;37:101248.
    Abstract

  183. ABUGHAZALEH S, Tarawneh M, Alzghoul H, Alsakarneh S, et al
    A case report of lung metastasis in a cervical cancer presenting as a consolidation.
    Radiol Case Rep. 2024;19:1144-1148.
    Abstract

  184. NYMAN MH, Lillsunde Larsson G, Blomberg K, Schroder A, et al
    Older women's perceptions of HPV self-sampling and HPV-sampling performed by a midwife - a phenomenographic study.
    BMC Public Health. 2024;24:211.
    Abstract

  185. HARRIS E
    HPV Screening Could Cut Cervical Cancer Deaths by Up to Two-Thirds.
    JAMA. 2024 Jan 17. doi: 10.1001/jama.2023.27430.
    Abstract

  186. TIAN P, Feng Y, Tao L
    LINC00460 knockdown sensitizes cervical cancer to cisplatin by downregulating TGFBI.
    Chem Biol Drug Des. 2024;103:e14424.
    Abstract

  187. SAKURAMACHI M, Murakami N, Nagao A, Kojima K, et al
    Hydrogel spacer injection to the meso-sigmoid to protect the sigmoid colon in cervical cancer brachytherapy: A technical report.
    J Contemp Brachytherapy. 2023;15:465-469.
    Abstract

  188. JI L, Zhang W, Hao S, Wang Z, et al
    Clinical efficacy analysis of radioactive (125)I particle implantation for the treatment of pelvic local recurrence of cervical cancer after radiotherapy.
    J Contemp Brachytherapy. 2023;15:432-441.
    Abstract

  189. YAP ET, Dumago MP, Jainar CJ, Bojador M, et al
    Clinical outcomes of single application multi-fractionated CT-guided interstitial high-dose-rate brachytherapy for locally advanced cervical cancer: A multi-institution initial experience.
    J Contemp Brachytherapy. 2023;15:399-404.
    Abstract

  190. TU Y, Wang J, Chen Y, Chen Y, et al
    Clinical implementation of three-dimensional standardized template-guided brachytherapy for patients with locally advanced cervical cancer.
    J Contemp Brachytherapy. 2023;15:405-413.
    Abstract

  191. PARIKH AA, Hanna J, Shah AP
    Acute keratoconjunctivitis associated with tisotumab vedotin-tftv for metastatic cervical cancer.
    Am J Ophthalmol Case Rep. 2023;33:101979.
    Abstract

  192. DONG H, Chen S, Liang X, Cai Q, et al
    Vitamin D and Its Receptors in Cervical Cancer.
    J Cancer. 2024;15:926-938.
    Abstract

  193. WANG Q, Lin B, Wei H, Wang X, et al
    AQP3 Promotes the Invasion and Metastasis in Cervical Cancer by Regulating NOX4-derived H(2)O(2) Activation of Syk/PI3K/Akt Signaling Axis.
    J Cancer. 2024;15:1124-1137.
    Abstract

  194. INTERNATIONAL BR
    Retracted: Ant Colony Optimization-Enabled CNN Deep Learning Technique for Accurate Detection of Cervical Cancer.
    Biomed Res Int. 2024;2024:9878397.
    Abstract

  195. WANG J, Li H, Zhang J, Wang H, et al
    Epidemiology and genotypes analysis of human papillomavirus infection in Beijing, China.
    Virol J. 2024;21:19.
    Abstract

  196. MAGAJI FA, Mashor MI, Anzaku SA, Hinjari AR, et al
    Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
    BMC Public Health. 2024;24:193.
    Abstract

  197. ELSHAMI M, Abukmail H, Thalji M, Al-Slaibi I, et al
    Myths and common misbeliefs about cervical cancer causation among Palestinian women: a national cross-sectional study.
    BMC Public Health. 2024;24:189.
    Abstract

  198. KWAK K, Hwang SS
    Predicted Cervical Cancer Prevention: Impact of National HPV Vaccination Program on Young Women in South Korea.
    Cancer Res Treat. 2024 Jan 15. doi: 10.4143/crt.2023.
    Abstract

  199. HARPER DM, Bettcher CM, Young AP
    It Is Time to Switch to Primary HPV Screening for Cervical Cancer.
    Am Fam Physician. 2024;109:8-9.
    Abstract

  200. STRAATHOF R, Meijaard JP, van Vliet-Perez SM, Kolkman-Deurloo IK, et al
    Multibody dynamic modeling of the behavior of flexible instruments used in cervical cancer brachytherapy.
    Med Phys. 2024 Jan 16. doi: 10.1002/mp.16934.
    Abstract

  201. ZHOU YY, Chang M, Li CP, Han XL, et al
    Causal effect of age first had sexual intercourse and lifetime number of sexual partners on cervical cancer.
    Heliyon. 2023;10:e23758.
    Abstract

  202. YIM VW, Wang Q, Li Y, Qin C, et al
    Between now and later: a mixed methods study of HPV vaccination delay among Chinese caregivers in urban Chengdu, China.
    BMC Public Health. 2024;24:183.
    Abstract

  203. DE SANJOSE S, Perkins RB, Campos N, Inturrisi F, et al
    Design of the HPV-automated visual evaluation (PAVE) study: Validating a novel cervical screening strategy.
    Elife. 2024;12:RP91469.
    Abstract

  204. JI HZ, Liu B, Ren M, Li S, et al
    The CXCLs-CXCR2 axis modulates the cross-communication between tumor-associated neutrophils and tumor cells in cervical cancer.
    Expert Rev Clin Immunol. 2024 Jan 15. doi: 10.1080/1744666X.2024.2305808.
    Abstract

  205. LI S, Wang L, Shi J, Chen Y, et al
    Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer.
    PeerJ. 2024;12:e16752.
    Abstract

  206. MELESE A, Bekele G, Molla E, Banga D, et al
    Utilization of cervical cancer screening service among female health workforces in public health institutions in south east Ethiopia, a cross-sectional study.
    Heliyon. 2023;10:e23086.
    Abstract

  207. WANG Q, Qin W, Gao W, Zhao K, et al
    Correlation between vaginal flora and cervical immune function of human papilloma virus-infected patients with cervical cancer.
    Afr Health Sci. 2023;23:179-185.
    Abstract

  208. WU J, Chi X, Yang Q, Li J, et al
    Expression of miR-152 in cervical cancer and its influence on cisplatin resistance.
    Afr Health Sci. 2023;23:246-255.
    Abstract

  209. LI F, Wang Y, Yan J, Wu H, et al
    Autologous Tumor-Infiltrating Lymphocyte Mono-Therapy Can Rapidly Shrank Tumor in Asian Patient with Stage III/IV Cervical Cancer: Two Cases Report.
    Int J Womens Health. 2024;16:31-39.
    Abstract

  210. SINGH N, Chanco M, Wen V, Mishra N, et al
    Synoptic Operative Reporting in Cervical Cancer Surgeries: Experience From a Single Oncology Center.
    Cureus. 2023;15:e50462.
    Abstract

  211. LUO L, Qiao F, Zhou K, Tu Q, et al
    Constructed competitive endogenous RNA network and patterns of immune infiltration revealing the prognostic signature for cervical cancer.
    Epigenomics. 2024;16:23-39.
    Abstract

  212. SUN H, Zhao X, Wang X, Ma J, et al
    Correlation analysis of risk factors for cervical lymphatic metastasis in papillary thyroid carcinoma.
    Diagn Pathol. 2024;19:13.
    Abstract

  213. M AL KINDI R, H Al Sumri H, M Al Muhdhoori T, Al Mamari K, et al
    Knowledge of cervical cancer screening among Omani women attending a university teaching hospital: a cross-sectional study.
    BMC Womens Health. 2024;24:40.
    Abstract

  214. CHOI Y, Ibrahim S, Park LP, Bukusi EA, et al
    The impact of text message reminders on cryotherapy uptake among women testing positive for HPV in western Kenya: a prospective cohort study.
    BMC Womens Health. 2024;24:32.
    Abstract

  215. QU X, Xu C, Yang W, Li Q, et al
    KLF5 inhibits the migration and invasion in cervical cancer cell lines by regulating SNAI1.
    Cancer Biomark. 2023 Dec 28. doi: 10.3233/CBM-230175.
    Abstract

  216. CHANG KL, Chao WR, Lee YJ, Lin YH, et al
    Mutational analysis of PDGFRA oncogene in high-grade neuroendocrine carcinoma of the uterine cervix in twelve Taiwanese women.
    Taiwan J Obstet Gynecol. 2024;63:125-126.
    Abstract

  217. OOI KM, Saniasiaya J, Kulasegarah J, Ong DL, et al
    Cervical bronchogenic cyst in a toddler.
    BMJ Case Rep. 2024;17:e256699.
    Abstract

  218. CHEN J, Pang L, He L, Li T, et al
    Whether specific genetic feature predicted immunotherapy efficacy: A case report.
    Medicine (Baltimore). 2024;103:e36922.
    Abstract

  219. PULIDO E, Gonzalez M, Gamboa O, Bonilla J, et al
    Effectiveness of cryotherapy delivered by nurses for treatment of cervical preneoplasic lesions.
    Biomedica. 2023;43.
    Abstract

  220. PENG Q, Wang L, Zuo L, Gao S, et al
    HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor.
    Cancer Gene Ther. 2024;31:9-17.
    Abstract

  221. MOSSERI J, Benoit L, Koual M, Nguyen-Xuan HT, et al
    Margin status after loop electrosurgical excision procedure (LEEP) and laser excision in patients with high-grade cervical neoplasia.
    J Gynecol Obstet Hum Reprod. 2024;53:102707.
    Abstract

  222. SEINO M, Nagase S, Tokunaga H, Yamagami W, et al
    Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment.
    J Gynecol Oncol. 2024;35:e15.
    Abstract

  223. HARADA N, Sakaeyama Y, Fuchinoue Y, Abe M, et al
    Differentiation between Anterior and Posterior Roots Using Compound Muscle Action Potential in Intradural Extramedullary Spinal Tumor Surgery.
    Neurol Med Chir (Tokyo). 2024;64:36-42.
    Abstract

  224. LI Y, Jiang L, Yu Z, Jiang C, et al
    SPRi/SERS dual-mode biosensor based on ployA-DNA/ miRNA/AuNPs-enhanced probe sandwich structure for the detection of multiple miRNA biomarkers.
    Spectrochim Acta A Mol Biomol Spectrosc. 2024;308:123664.
    Abstract

  225. ZHANG Y, Wu C, Du J, Xiao Z, et al
    Prediction of recurrence risk factors in patients with early-stage cervical cancers by nomogram based on MRI handcrafted radiomics features and deep learning features: a dual-center study.
    Abdom Radiol (NY). 2024;49:258-270.
    Abstract

  226. HAYNES D, Hughes KD, Borrero M, Haas M, et al
    Estimating uninsured and underinsured women eligible for Minnesota's Breast Cancer Screening Program.
    Cancer Causes Control. 2024;35:359-366.
    Abstract

  227. HANG S, Haruyama R, Uy K, Fujita N, et al
    Feasibility, accuracy and acceptability of self-sampled human papillomavirus testing using careHPV in Cambodia: a cross-sectional study.
    J Gynecol Oncol. 2024;35:e6.
    Abstract

  228. GHARBARAN R, Sayibou Z, Atamturktur S, Ofosu-Mensah JJ, et al
    Diminazene aceturate-induced cytotoxicity is associated with the deregulation of cell cycle signaling and downregulation of oncogenes Furin, c-MYC, and FOXM1 in human cervical carcinoma Hela cells.
    J Biochem Mol Toxicol. 2024;38:e23527.
    Abstract

  229. HANCIOGLU T, Pekcevik Y, Akdogan AI, Kucuk U, et al
    Imaging Characteristics Predictive of Cervical Extranodal Tumor Extension in Patients With Head and Neck Squamous Cell Carcinoma.
    J Comput Assist Tomogr. 2024;48:129-136.
    Abstract

  230. HU T, Li K, He L, Huang F, et al
    Testing for viral DNA integration among HPV-positive women to detect cervical precancer: An observational cohort study.
    BJOG. 2024;131:309-318.
    Abstract

  231. FATTORINI C, Rocca BJ, Giusti A, Arganini M, et al
    Mixed mucinous adenocarcinoma/large cell neuroendocrine carcinoma of the uterine cervix: case report and molecular characterization of a rare entity.
    Virchows Arch. 2024;484:141-146.
    Abstract

  232. MALVOLTI S, Soble A, Bloem P, LaMontagne DS, et al
    The Global Demand and Supply Balance of the Human Papillomavirus Vaccine: Implications for the Global Strategy for the Elimination of Cervical Cancer.
    Vaccines (Basel). 2023;12:4.
    Abstract

  233. VOINEA SC, Bordea CI, Chitoran E, Rotaru V, et al
    Why Is Surgery Still Done after Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer in Romania?
    Cancers (Basel). 2024;16:425.
    Abstract

  234. WANG K, Wang J, Jiang P
    High-Dose-Rate Three-Dimensional Image-Guided Adaptive Brachytherapy (3D IGABT) for Locally Advanced Cervical Cancer (LACC): A Narrative Review on Imaging Modality and Clinical Evidence.
    Curr Oncol. 2023;31:50-65.
    Abstract

  235. LIN YT, Wang C, He XY, Yao QM, et al
    Comparative cost-effectiveness of first-line pembrolizumab plus chemotherapy vs. chemotherapy alone in persistent, recurrent, or metastatic cervical cancer.
    Front Immunol. 2024;14:1345942.
    Abstract

  236. SZAMRETA EA, Mulvihill E, Aguinaga K, Amos K, et al
    Information needs during cancer care: Qualitative research with locally advanced cervical cancer patients in Brazil, China, Germany, & the US.
    Gynecol Oncol Rep. 2023;51:101321.
    Abstract

  237. YADAV G, Srinivasan G, Jain A
    Cervical cancer: Novel treatment strategies offer renewed optimism.
    Pathol Res Pract. 2024;254:155136.
    Abstract

  238. AHMAD M, Asrar R, Ahmed I, Bule MH, et al
    HPV vaccination: A key strategy for preventing cervical cancer.
    J Infect Public Health. 2024;17:474-475.
    Abstract

  239. ROLLE LD, Chery MJ, Larson M, Lopez-Pentecost M, et al
    The Effect of Disability and Social Determinants of Health on Breast and Cervical Cancer Screenings During the COVID-19 Pandemic.
    Prev Chronic Dis. 2024;21:E05.
    Abstract

  240. WANG Y, Xie Y, Wang X, Yang N, et al
    Tumor cells-derived extracellular vesicles carry circ_0064516 competitively inhibit microRNA-6805-3p and promote cervical cancer angiogenesis and tumor growth.
    Expert Opin Ther Targets. 2024 Jan 25. doi: 10.1080/14728222.2024.2306353.
    Abstract

  241. WANG Y, Yang J, Wang Y
    Serum miRNA Combined With Transvaginal Color Doppler Ultrasound Diagnosis Clinical Research on Cervical Cancer.
    J Ultrasound Med. 2024 Jan 25. doi: 10.1002/jum.16413.
    Abstract

  242. BEKALU YE, Wudu MA, Workie Gashu A
    Uptake of cervical cancer screening and associated factors among human immune virus positive women attending antiretroviral therapy clinic in public health facilities, Northeast Ethiopia, 2022: A cross-sectional study.
    SAGE Open Med. 2024;12:20503121231225935.
    Abstract

  243. MWALWANDA A, Chavura E, Chisale MRO, Mbakaya BC, et al
    Cervical cancer screening among female health workers: Evidence from a secondary health facility in Northern Malawi.
    Prev Med Rep. 2023;37:102581.
    Abstract

  244. LI Y, Zhou Z, Qu J, Gong P, et al
    Role of microRNA-4739 in enhancing cisplatin chemosensitivity by negative regulation of RHBDD2 in human cervical cancer cells.
    Cell Mol Biol Lett. 2024;29:20.
    Abstract

  245. LOU J, Zhang X, Liu J, Dong L, et al
    The prognostic value of radiological and pathological lymph node status in patients with cervical cancer who underwent neoadjuvant chemotherapy and followed hysterectomy.
    Sci Rep. 2024;14:2045.
    Abstract

  246. BUCK DISILVESTRO J, Ulmer KK, Hedges M, Kardonsky K, et al
    Cervical Cancer: Preventable Deaths Among American Indian/Alaska Native Communities.
    Obstet Gynecol Clin North Am. 2024;51:125-141.
    Abstract

  247. XU Z, Guo Y, Wang L, Cui J, et al
    HECW1 restrains cervical cancer cell growth by promoting DVL1 ubiquitination and downregulating the activation of Wnt/beta-catenin signaling.
    Exp Cell Res. 2024 Jan 22:113949. doi: 10.1016/j.yexcr.2024.113949.
    Abstract

  248. DUJARDIN C, Balcaen T, Vanoost A, Chatelain D, et al
    [Risk factors for high-grade squamous intraepithelial lesions or cervical cancer in chronic inflammatory bowel disease].
    Gynecol Obstet Fertil Senol. 2024 Jan 22:S2468-7189(24)00012.
    Abstract

  249. SONG L, Liang X, Zhu M, Su Q, et al
    Knowledge mapping of immunotherapy in cervical carcinoma: a bibliometric analysis (2000-2023).
    Front Immunol. 2024;14:1328103.
    Abstract

  250. HE S, Wang A, Wang J, Tang Z, et al
    Human papillomavirus E7 protein induces homologous recombination defects and PARPi sensitivity.
    J Cancer Res Clin Oncol. 2024;150:27.
    Abstract

  251. XU M, Chen H, Tan T, Xie K, et al
    Exploring the causal association between rheumatoid arthritis and the risk of cervical cancer: a two-sample Mendelian randomization study.
    Arthritis Res Ther. 2024;26:35.
    Abstract

  252. OUH YT, Kim TJ, Ju W, Kim SW, et al
    Development and validation of artificial intelligence-based analysis software to support screening system of cervical intraepithelial neoplasia.
    Sci Rep. 2024;14:1957.
    Abstract

  253. NESSA A, Hossain MS, Uddin SMN, Islam MR, et al
    Electronic aggregated data collection on cervical cancer screening in Bangladesh since 2014: what the data tells us?
    BMC Public Health. 2024;24:270.
    Abstract

  254. VAN ERP MAJM, Slaats FMA, Emmen JMA, van Hamont D, et al
    Paraneoplastic anti-TIF1-gamma-positive dermatomyositis as expression of cervical squamous cell carcinoma recurrence.
    BMJ Case Rep. 2024;17:e253636.
    Abstract

  255. MASEKO T, Tsoka-Gwegweni JM, Ndirangu J, Okello V, et al
    Knowledge and Perceptions of Cervical Cancer Screening in Nhlambeni, Eswatini: Understanding Facilitators and Barriers for Prevention Interventions.
    West Afr J Med. 2023;40:1325-1331.
    Abstract

  256. MASEKO T, Dlamini X, Okello V, Tsoka-Gwegweni JM, et al
    Eswatini Women s Knowledge about Cervical Cancer, Data from a Prevention and Awareness Campaign 2021: A Community Based Cross-sectional Campaign.
    West Afr J Med. 2023;40:1311-1316.
    Abstract

  257. WANG Y, Jian W, Zhu L, Cai C, et al
    Attention-Gated Deep-Learning-Based Automatic Digitization of Interstitial Needles in High-Dose-Rate Brachytherapy for Cervical Cancer.
    Adv Radiat Oncol. 2023;9:101340.
    Abstract

  258. KONSTANTOPOULOS G, Leventakou D, Saltiel DR, Zervoudi E, et al
    HPV16 E6 Oncogene Contributes to Cancer Immune Evasion by Regulating PD-L1 Expression through a miR-143/HIF-1a Pathway.
    Viruses. 2024;16:113.
    Abstract

  259. CASTRO JI, Payan-Valero A, Valencia-Llano CH, Insuasty D, et al
    Evaluation of the Antibacterial, Anti-Cervical Cancer Capacity, and Biocompatibility of Different Graphene Oxides.
    Molecules. 2024;29:281.
    Abstract

  260. HUANG Y, Zhang D, Yin L, Zhao J, et al
    Modeling the Health Impact and Cost-Effectiveness of a Combined Schoolgirl HPV Vaccination and Cervical Cancer Screening Program in Guangdong Province, China.
    Children (Basel). 2024;11:103.
    Abstract

  261. MULATO-BRIONES IB, Rodriguez-Ildefonso IO, Jimenez-Tenorio JA, Cauich-Sanchez PI, et al
    Cultivable Microbiome Approach Applied to Cervical Cancer Exploration.
    Cancers (Basel). 2024;16:314.
    Abstract

  262. MANGA SM, Ye Y, Nulah KL, Manjuh F, et al
    Human Papillomavirus Types and Cervical Cancer Screening among Female Sex Workers in Cameroon.
    Cancers (Basel). 2024;16:243.
    Abstract

  263. GU L, Hu Y, Wei Y, Hong Z, et al
    Optimising Cervical Cancer Screening During Pregnancy: A Study of Liquid-Based Cytology and HPV DNA Co-Test.
    Epidemiol Infect. 2024 Jan 23:1-22. doi: 10.1017/S095026882400013.
    Abstract

  264. ZHOU J, Li H, Wu B, Zhu L, et al
    Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer.
    Sci Rep. 2024;14:1860.
    Abstract

  265. LIAO H, Barra C, Zhou Z, Peng X, et al
    MARS an improved de novo peptide candidate selection method for non-canonical antigen target discovery in cancer.
    Nat Commun. 2024;15:661.
    Abstract

  266. AN JM, Jeong M, Jung J, Yeo SG, et al
    Next-Generation Femtech: Urine-Based Cervical Cancer Diagnosis Using a Fluorescent Biothiol Probe with Controlled Smiles Rearrangement.
    ACS Appl Mater Interfaces. 2024 Jan 22. doi: 10.1021/acsami.3c17050.
    Abstract

  267. AO K, Yin M, Lyu X, Xiao Y, et al
    METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer.
    Cancer Lett. 2024 Jan 20:216658. doi: 10.1016/j.canlet.2024.216658.
    Abstract

  268. GONG H, Zhao L, Liu J
    Protective effect of tretinoin on cervical cancer growth and proliferation through downregulation of pFAK2 expression.
    Environ Toxicol. 2024 Jan 22. doi: 10.1002/tox.24144.
    Abstract

  269. BAXTER L, Wright C
    The importance of rhythms for maintaining consent in diagnostic encounters to detect cervical cancer.
    Sociol Health Illn. 2024 Jan 22. doi: 10.1111/1467-9566.13752.
    Abstract

  270. P E, S K, Sagayam KM, J A, et al
    An automated cervical cancer diagnosis using genetic algorithm and CANFIS approaches.
    Technol Health Care. 2024 Jan 4. doi: 10.3233/THC-230926.
    Abstract

  271. ZHONG S, Guo Q, Chen X, Luo X, et al
    The inhibition of YTHDF3/m(6)A/LRP6 reprograms fatty acid metabolism and suppresses lymph node metastasis in cervical cancer.
    Int J Biol Sci. 2024;20:916-936.
    Abstract

  272. DJORDJEVIC S, Boricic K, Radovanovic S, Simic Vukomanovic I, et al
    Demographic and socioeconomic factors associated with cervical cancer screening among women in Serbia.
    Front Public Health. 2024;11:1275354.
    Abstract

  273. ZAMUDIO CANAS R, Jaramillo Flores ME, Vallejo Ruiz V, Delgado Macuil RJ, et al
    Detection of Sialic Acid to Differentiate Cervical Cancer Cell Lines Using a Sambucus nigra Lectin Biosensor.
    Biosensors (Basel). 2024;14:34.
    Abstract

  274. AL-BADAWI IA, Abu-Zaid A, Alomar O, Alsabban M, et al
    Association between Endometriosis and the Risk of Ovarian, Endometrial, Cervical, and Breast Cancer: A Population-Based Study from the U.S. National Inpatient Sample 2016-2019.
    Curr Oncol. 2024;31:472-481.
    Abstract

  275. SALMAN L, Covens A
    Fertility Preservation in Cervical Cancer-Treatment Strategies and Indications.
    Curr Oncol. 2024;31:296-306.
    Abstract

  276. PALMER TJ, Kavanagh K, Cuschieri K, Cameron R, et al
    Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation.
    J Natl Cancer Inst. 2024 Jan 22:djad263. doi: 10.1093.
    Abstract

  277. YEN A, Zhong X, Lin MH, Nwachukwu C, et al
    Improved Dosimetry with Daily Online Adaptive Radiotherapy for Cervical Cancer: Waltzing the Pear.
    Clin Oncol (R Coll Radiol). 2024 Jan 17:S0936-6555(24)00021.
    Abstract

  278. ZHANG T, Zhou C, Lv M, Yu J, et al
    Trifluoromethyl quinoline derivative targets inhibiting HDAC1 for promoting the acetylation of histone in cervical cancer cells.
    Eur J Pharm Sci. 2024 Jan 18:106706. doi: 10.1016/j.ejps.2024.106706.
    Abstract

  279. MADDAH SAFAEI A, Esmati E, Gomar M, Akhavan S, et al
    Hypofractionated versus standard chemoradiotherapy in the definitive treatment of uterine cervix cancer: interim results of a randomized controlled clinical trial.
    J Cancer Res Clin Oncol. 2024;150:20.
    Abstract

  280. JOHNSTON CD, Bullman S
    Bacteria-derived L-lactate fuels cervical cancer chemoradiotherapy resistance.
    Trends Cancer. 2024 Jan 18:S2405-8033(24)00001.
    Abstract

  281. FAY M, Hu M, Hajizadeh M
    Socioeconomic inequalities in cervical cancer mortality in Canada, 1990 and 2019: a trend analysis.
    Public Health. 2024;227:210-218.
    Abstract

  282. LI M, Zheng W
    Sigmoid colonic metastasis from a squamous cell carcinoma of the cervix: A rare case report with literature review.
    Medicine (Baltimore). 2024;103:e37001.
    Abstract

  283. ZHOU Z, Feng Y, Xie L, Ma S, et al
    Alterations in gut and genital microbiota associated with gynecological diseases: a systematic review and meta-analysis.
    Reprod Biol Endocrinol. 2024;22:13.
    Abstract

  284. BABI A, Issa T, Gusmanov A, Akilzhanova A, et al
    Prevalence of high-risk human papillomavirus infection and genotype distribution among Kazakhstani women with abnormal cervical cytology.
    Ann Med. 2024;56:2304649.
    Abstract

  285. GUPTA R, Gupta S
    Point-of-care tests for human papillomavirus detection in uterine cervical samples: A review of advances in resource-constrained settings.
    Indian J Med Res. 2023;158.
    Abstract

  286. LIU B, Xu Y, Hu B, Song X, et al
    Immune landscape and heterogeneity of cervical squamous cell carcinoma and adenocarcinoma.
    Aging (Albany NY). 2024;16:568-592.
    Abstract

  287. MINHAS S, Kashif M, Nisar H, Idrees M, et al
    Whole-genome analysis and evolutionary characterization of cervical and oral human papillomavirus 16.
    Exp Biol Med (Maywood). 2023;248:2332-2340.
    Abstract

  288. HU Y, Liu L, Wang C, Zhou J, et al
    CRISPR-Cas12a-enhanced mass spectrometric DNA nanomachine for HPV-16 detection in human serum.
    Chem Commun (Camb). 2024;60:976-979.
    Abstract

  289. BARQUIN GARCIA A, Palacios-Zambrano S, Lozano Alarcon F, Paumard-Hernandez B, et al
    Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary.
    J Natl Compr Canc Netw. 2023;22.
    Abstract

  290. KAHRAMAN A, Dirilenoglu F
    Assessing the diagnostic value of CAIX and ProEx-C in cervical squamous intraepithelial lesions.
    Pathol Res Pract. 2024;253:155029.
    Abstract

  291. ZHAO S, Li Y, Xu J, Shen L, et al
    APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Neurol Res. 2023 Nov 26:1-16. doi: 10.1080/01616412.2023.2287340.
    Abstract

  292. WANG H, Wang WH, Wang W, Ma JH, et al
    Folate deficiency promotes cervical squamous carcinoma SiHa cells progression by targeting miR-375/FZD4/beta-catenin signaling.
    J Nutr Biochem. 2024;124:109489.
    Abstract

  293. NITKOWSKI J, Giuliano AR, Ridolfi T, Chiao E, et al
    Acceptability of Anal Human Papillomavirus Home Self-Sampling and Clinician Sampling Among Sexual and Gender Minority Individuals in Milwaukee, Wisconsin: The Prevent Anal Cancer Self-Swab Study.
    LGBT Health. 2024;11:47-56.
    Abstract

  294. CROCE S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, et al
    [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
    Bull Cancer. 2024;111:97-116.
    Abstract

  295. CELIKKOL O, Gulseren V, Gungorduk K, Ozdemir IA, et al
    Effects of human papillomavirus and LEEP on sexual function.
    Ir J Med Sci. 2024;193:285-288.
    Abstract

  296. ASSEFA AA, Feleke T, G/Tsadik SA, Degela F, et al
    Utilization and associated factors of cervical cancer screening service among eligible women attending maternal health services at Adare General Hospital, Hawassa city, Southern Ethiopia.
    Sci Rep. 2024;14:2774.
    Abstract

  297. GORI S, Frayle H, Pagan A, Solda M, et al
    Exploring conservative management for cervical intraepithelial neoplasia grade 2 in organised cervical cancer screening programmes: a multicentre study in Italy.
    Fam Med Community Health. 2024;12.
    Abstract

  298. BRAUTIGAM K, Schmidt T, Baur M, Tauber N, et al
    Prevalence of PD-L1 in Cervical Cancer Patients and the Potential for Combining an Immune Checkpoint Inhibitor With Lenvatinib.
    Anticancer Res. 2024;44:503-510.
    Abstract

  299. JIA C, Wu Y, Gao F, Liu W, et al
    The opposite role of lactate dehydrogenase a (LDHA) in cervical cancer under energy stress conditions.
    Free Radic Biol Med. 2024 Jan 31:S0891-5849(24)00051.
    Abstract

  300. RODRIGUEZ I, Rossi NM, Keskus AG, Xie Y, et al
    Insights into the mechanisms and structure of breakage-fusion-bridge cycles in cervical cancer using long-read sequencing.
    Am J Hum Genet. 2024 Jan 25:S0002-9297(24)00002.
    Abstract

  301. GU LN, Yu JW, Jiang L, Liu TB, et al
    Serum squamous cell carcinoma antigen level and magnetic resonance imaging for the prognosis of locally advanced cervical cancer.
    Eur Rev Med Pharmacol Sci. 2024;28:668-678.
    Abstract

  302. LIN S, Chen Z, Li S, Chen B, et al
    Anti-tumor effect and mechanism of the total biflavonoid extract from S doederleinii on human cervical cancer cells in vitro and in vivo.
    Heliyon. 2024;10:e24778.
    Abstract

  303. ALSHEHRI HD, Alqudah O, Almadani FB, Aldalbahi AM, et al
    Factors Associated With the Uptake of Cervical Cancer Screening Among Family Medicine Physicians, Compared With Women of the Community in Riyadh, Saudi Arabia.
    Cureus. 2024;16:e53283.
    Abstract

  304. JUNG BC, Woo SH, Kim SH, Kim YS, et al
    Gefitinib induces anoikis in cervical cancer cells.
    BMB Rep. 2024 Feb 5:6127.
    Abstract

  305. SONG J, Pang W, Yi H, Ji J, et al
    Tumor and metastatic lymph nodes metabolic activity on (18)F-FDG-PET/CT to predict progression-free survival in locally advanced cervical cancer.
    Abdom Radiol (NY). 2024 Feb 1. doi: 10.1007/s00261-023-04158.
    Abstract

  306. LA SPINA S, Scollo P, Pecorino B, Lombardo V, et al
    Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy.
    Oncology (Williston Park). 2024;38:15-19.
    Abstract

  307. SARASWAT I, Goel A
    Cervical Cancer Therapeutics: An In-depth Significance of Herbal and Chemical Approaches of Nanoparticles.
    Anticancer Agents Med Chem. 2024.
    Abstract

  308. FOKOM DOMGUE J, Dille I, Kapambwe S, Yu R, et al
    HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providers' knowledge, training, and recommendation practices.
    Front Public Health. 2024;12:1343064.
    Abstract

  309. INTERNATIONAL EM
    Retracted: Analysis of the Clinical Value of MAGE-A9 Expressions in Cervical Cancer Tissues and PBMC.
    Emerg Med Int. 2024;2024:9758570.
    Abstract

  310. LI Z, Wei R, Yao S, Meng F, et al
    HIF-1A as a prognostic biomarker related to invasion, migration and immunosuppression of cervical cancer.
    Heliyon. 2024;10:e24664.
    Abstract

  311. HUANG Z, Yao W, Zhong Z, Yang G, et al
    Chemotherapy alone versus chemotherapy plus (125)I brachytherapy for the second-line treatment of locally recurrent cervical cancer after/with radical treatment: A propensity score analysis.
    Heliyon. 2024;10:e24666.
    Abstract

  312. WANG X, Wang K, Wang X
    NUPR1 contributes to activate TFE3-dependent autophagy leading to cervical cancer proliferation.
    Heliyon. 2024;10:e24408.
    Abstract

  313. MA GF, Lin GL, Wang ST, Huang YY, et al
    Prediction of recurrence-related factors for patients with early-stage cervical cancer following radical hysterectomy and adjuvant radiotherapy.
    BMC Womens Health. 2024;24:81.
    Abstract

  314. ALFRINK J, Aigner T, Zoche H, Distel L, et al
    Radiochemotherapy and interstitial brachytherapy for cervical cancer: clinical results and patient-reported outcome measures.
    Strahlenther Onkol. 2024 Jan 31. doi: 10.1007/s00066-023-02196.
    Abstract

  315. LI Z, Zhang J, You S, Zhang J, et al
    Pterostilbene upregulates MICA/B via the PI3K/AKT signaling pathway to enhance the capability of natural killer cells to kill cervical cancer cells.
    Exp Cell Res. 2024;435:113933.
    Abstract

  316. ZHANG YT, Xu LJ, Li L
    EGLN1: A Biomarker of Poor Prognosis of Cervical Cancer and a Target of Treatment.
    Genet Test Mol Biomarkers. 2024;28:10-21.
    Abstract

  317. BARTOSIK M, Moranova L, Izadi N, Strmiskova J, et al
    Advanced technologies towards improved HPV diagnostics.
    J Med Virol. 2024;96:e29409.
    Abstract


  318. Retraction: LINC00636 promotes lymph node metastasis and of cervical cancer through target NM23.
    Biosci Rep. 2024;44:BSR-2020-0367.
    Abstract

  319. PATTERSON MR, Meijers AS, Ryder EL, Scarth JA, et al
    E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer.
    bioRxiv. 2024 Jan 15:2024.01.08.574687. doi: 10.1101/2024.01.08.574687.
    Abstract

  320. BHATTACHARYA K, Chandra Nath B, Ahmed E, Khanal P, et al
    Integration of network pharmacology, molecular docking, and simulations to evaluate phytochemicals from Drymaria cordata against cervical cancer.
    RSC Adv. 2024;14:4188-4200.
    Abstract

  321. PRATT R, Barsness CB, Lin J, Desai J, et al
    Integrating HPV self-collect into primary care to address cervical cancer screening disparities.
    Prev Med Rep. 2024;38:102599.
    Abstract

  322. MENG Q, Sun H, Zhang Y, Yang X, et al
    Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression.
    J Exp Clin Cancer Res. 2024;43:36.
    Abstract

  323. DENNY L, Kataria I, Huang L, Schmeler KM, et al
    Cervical cancer kills 300,000 people a year - here's how to speed up its elimination.
    Nature. 2024;626:30-32.
    Abstract

  324. VOVK CAPITAL O, CYRILLICY, Holovanova IA, Podvin A, Popovuch IU, et al
    CONTEXTUAL FACTORS ASSOCIATED WITH CERVICAL CANCER.
    Wiad Lek. 2023;76:2687-2693.
    Abstract

  325. AMATYA VAIDYA S, Roka Magar L, Magar SB
    Knowledge of Cervical Cancer Screening and Prevention by Human Papillomavirus Deoxyribonucleic Acid and Human Papillomavirus Vaccination among Women Attending a Tertiary Care Centre.
    JNMA J Nepal Med Assoc. 2023;61:658-661.
    Abstract

  326. SAPKOTA RP, Pokhrel S, Bhandari A, Adhikari P, et al
    Cervical Papanicolaou Smear Test Screening among Patients Visiting the Outpatient Department of Gynaecology of a Tertiary Care Centre.
    JNMA J Nepal Med Assoc. 2023;61:699-702.
    Abstract

  327. WANG J, Wang X, Ma T, Lu Y, et al
    A visualization analysis of hotspots and global trends on pelvic floor dysfunction in cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:54.
    Abstract

  328. TRIPATHI T, Yadav J, Janjua D, Chaudhary A, et al
    Targeting Cervical Cancer Stem Cells by Phytochemicals.
    Curr Med Chem. 2024 Jan 29. doi: 10.2174/0109298673281823231222065616.
    Abstract

  329. VARGAS-SIERRA O, Hernandez-Juarez J, Uc-Uc PY, Herrera LA, et al
    Role of SLC5A8 as a Tumor Suppressor in Cervical Cancer.
    Front Biosci (Landmark Ed). 2024;29:16.
    Abstract

  330. BIKORIMANA JP, Abusarah J, Goncalves M, Farah R, et al
    An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer activity.
    Cancer Sci. 2024 Jan 29. doi: 10.1111/cas.16096.
    Abstract

  331. DESAI KT, Hansen N, Rodriguez AC, Befano B, et al
    Squamocolumnar junction visibility, age, and implications for cervical cancer screening programs.
    Prev Med. 2024;180:107881.
    Abstract

  332. GONG Y, Luo G, Zhang S, Chen Y, et al
    Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3/KRAS axis.
    Cell Signal. 2024 Jan 27:111068. doi: 10.1016/j.cellsig.2024.111068.
    Abstract

  333. KITTISIAM T, Chanpanitkitchot S, Tangjitgamol S, Srijaipracharoen S, et al
    Clinical Performance of Self-collected Specimen HPV-DNA vs Clinician- collected Specimen HPV-mRNA to Detect High-risk HPV and High-grade Cervical Lesions and Cancer.
    Asian Pac J Cancer Prev. 2024;25:211-217.
    Abstract

  334. THAKUR N, Kaur H, Kaur S, Lehal P, et al
    Comparative Analysis of VMAT and IMRT Techniques: Evaluation of Dose Constraints and Bone Marrow Sparing in Cervical Cancer Patients Undergoing Chemoradiotherapy.
    Asian Pac J Cancer Prev. 2024;25:139-144.
    Abstract

  335. SINGARAM NK, Hulikal N, Manthri R, Chowhan AK, et al
    Predictive Role of Preoperative Whole-Body 18F-FDG PET/CT for Risk Stratification of Early-Stage (FIGO I-IIA) Cervical Cancer Patients Treated by Surgery.
    Cureus. 2024;16:e53107.
    Abstract

  336. ALBAYAT SS, Mundodan JM, Elmardi K, Hasnain S, et al
    Knowledge, attitude, and practices regarding human papilloma virus vaccination among physicians in Qatar.
    Womens Health (Lond). 2024;20:17455057241227360.
    Abstract

  337. ANG DJM, Chan JJ
    Evolving standards and future directions for systemic therapies in cervical cancer.
    J Gynecol Oncol. 2024 Jan 15. doi: 10.3802/jgo.2024.
    Abstract

  338. AL-ANI A, Hammouri M, Sultan H, Al-Huneidy L, et al
    Factors affecting cervical screening using the health belief model during the last decade: A systematic review and meta-analysis.
    Psychooncology. 2024;33:e6275.
    Abstract

  339. EVINA BOLO S, Kenfack B, Wisniak A, Tankeu G, et al
    Factors influencing cervical cancer re-screening in a semi-rural health district of Cameroon: a cohort study.
    BMC Womens Health. 2024;24:76.
    Abstract

  340. CHEN Q, Zhao J, Xue X, Xie X, et al
    Effect of marital status on the survival outcomes of cervical cancer: a retrospective cohort study based on SEER database.
    BMC Womens Health. 2024;24:75.
    Abstract

  341. HA JL, Kaser E, Guan T, Mayberry TG, et al
    Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1.
    Med Oncol. 2024;41:65.
    Abstract

  342. LE-TRUNG N, Kanaori K, Waku T, Dang TTP, et al
    Acetylmelodorinol isolated from Sphaerocoryne affinis seeds inhibits cell proliferation and activates apoptosis on HeLa cells.
    BMC Complement Med Ther. 2024;24:59.
    Abstract

  343. QUAN Y, Zhou M, Li J, Yang Y, et al
    The m6A methyltransferase RBM15 affects tumor cell stemness and progression of cervical cancer by regulating the stability of lncRNA HEIH.
    Exp Cell Res. 2024 Jan 25:113924. doi: 10.1016/j.yexcr.2024.113924.
    Abstract

  344. BERZANSKY I, Reynolds CA, Charlton BM
    Breast and cervical cancer screenings across gender identity: results from the Behavioral Risk Factor Surveillance System before and during the COVID-19 pandemic.
    Cancer Causes Control. 2024 Jan 27. doi: 10.1007/s10552-023-01847.
    Abstract

  345. JARAMILLO L, Camussi E, Dotti M, Ferrante G, et al
    EuroMed Cancer Network contributions to eliminating cervical cancer in low- and middle-income Mediterranean countries.
    East Mediterr Health J. 2023;26:894-902.
    Abstract

  346. OKAYAMA K, Kakinuma M, Teruya K, Oda M, et al
    Predictive Value of Various Atypical Cells for the Detection of Human Papillomavirus in Cervical Smears.
    Int J Mol Sci. 2024;25:1212.
    Abstract

  347. QIN Y, Deng J, Ling Y, Chen T, et al
    Our experience diagnosing 225 patients with cervical glandular lesions: current technologies, lessons learned, and areas for improvement.
    Diagn Pathol. 2024;19:22.
    Abstract

  348. WU Q, Lou J, Liu J, Dong L, et al
    Performance of node reporting and data system (node-RADS): a preliminary study in cervical cancer.
    BMC Med Imaging. 2024;24:28.
    Abstract

  349. MURAHWA AT, Mudzviti T, Mandishora RSD, Chatindo T, et al
    Vaccine and Non-Vaccine HPV Types Presence in Adolescents with Vertically Acquired HIV Five Years Post Gardasil Quadrivalent Vaccination: The ZIMGARD Cohort.
    Viruses. 2024;16:162.
    Abstract

  350. LI J, Xi J
    Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Genes (Basel). 2024;15:121.
    Abstract

  351. AZANGOU-KHYAVY M, Ghasemi E, Rezaei N, Khanali J, et al
    Global, regional, and national quality of care index of cervical and ovarian cancer: a systematic analysis for the global burden of disease study 1990-2019.
    BMC Womens Health. 2024;24:69.
    Abstract

  352. CASANOVA C, Madeira JIM, Pereira da Silva N, Antunes C, et al
    Post-radiation uterine rhabdomyosarcoma.
    BMJ Case Rep. 2024;17:e258853.
    Abstract

  353. KELLEN E, Meers Z, Pil L, Goossens MC, et al
    Impact of altering the invitation package on screening participation among never-screeners in the Flemish population-based cancer screening programs.
    Eur J Cancer Prev. 2024;33:181-184.
    Abstract

  354. NIE L, Qin H, Li S, Yu Z, et al
    The establishment of a multiplex fluorescent polymerase chain reaction coupled with capillary electrophoresis analysis technology enables the simultaneous detection of 16 genotypes of human papillomavirus.
    J Clin Lab Anal. 2024;38.
    Abstract

  355. YU Y, Yu J, Cui X, Sun X, et al
    TNF-alpha-induced down-regulation of type I interferon receptor contributes to acquired resistance of cervical squamous cancer to Cisplatin.
    J Antibiot (Tokyo). 2024;77:102-110.
    Abstract

  356. TOYOHARA Y, Taguchi A, Ishii Y, Yoshimoto D, et al
    Identification of target cells of human papillomavirus 18 using squamocolumnar junction organoids.
    Cancer Sci. 2024;115:125-138.
    Abstract

  357. DARVISHI M, Nouri M, Zahir M, Asli M, et al
    Overview of Human Papillomavirus Infection.
    Infect Disord Drug Targets. 2024;24:e031123223107.
    Abstract

  358. JIBOC NM, Pasca A, Taut D, Baban AS, et al
    Factors influencing human papillomavirus vaccination uptake in European women and adolescents: A systematic review and meta-analysis.
    Psychooncology. 2024;33:e6242.
    Abstract

  359. WHEELER CM, Torrez-Martinez NE, Torres-Chavolla E, Parvu V, et al
    Comparing the performance of two HPV assays for a new use indication: a real-world evidence-based evaluation in the United States.
    Am J Obstet Gynecol. 2023 Oct 6:S0002-9378(23)00730.
    Abstract

  360. SLAMA J, Dvorak V, Trnkova M, Skrivanek A, et al
    Is phased implementation of HPV testing and triage with dual staining the way to transform organized cytology screening?
    Eur J Cancer Prev. 2024;33:168-176.
    Abstract

  361. WANG S, Zhang S
    A Novel Eight-Gene Signature for Lipid Metabolism Predicts the Progression of Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
    Reprod Sci. 2024;31:514-531.
    Abstract

  362. MONDRAGON MARQUEZ LI, Dominguez Bueso DL, Gonzalez Ruiz LM, Liu JJ, et al
    Associations between sociodemographic factors and breast, cervical, and colorectal cancer screening in the United States.
    Cancer Causes Control. 2023;34:1073-1084.
    Abstract

  363. RIVERS G, Hinchliff S, Thompson J
    Transgender and non-binary peoples experiences of cervical cancer screening: A scoping review.
    J Clin Nurs. 2024 Feb 9. doi: 10.1111/jocn.17023.
    Abstract

  364. MA F, Wang Q, Zhang D, Wang Z, et al
    Comparative efficacy and safety of Chinese medicine injections as an adjunctive therapy for cervical cancer in Chinese patients: a network meta-analysis.
    Pharm Biol. 2024;62:170-182.
    Abstract

  365. YANG S, Zhang W, Liu C, Li C, et al
    Predictive value and potential association of PET/CT radiomics on lymph node metastasis of cervical cancer.
    Ann Med Surg (Lond). 2023;86:805-810.
    Abstract

  366. PIRANI N, Jafari M, Motlagh AG, Pourasghari H, et al
    Policy analysis of cervical cancer prevention in Iran based on the policy triangle model.
    J Educ Health Promot. 2023;12:381.
    Abstract

  367. ZHANG Z, Ma Q, Zhang L, Ma L, et al
    Human papillomavirus and cervical cancer in the microbial world: exploring the vaginal microecology.
    Front Cell Infect Microbiol. 2024;14:1325500.
    Abstract

  368. FERNANDEZ-DEAZA G, Serrano B, Roura E, Castillo JS, et al
    Cervical cancer screening coverage in the Americas region: a synthetic analysis.
    Lancet Reg Health Am. 2024;30:100689.
    Abstract

  369. OLTHOF EP, Bergink-Voorthuis BJ, Wenzel HHB, Mongula J, et al
    Diagnostic accuracy of MRI, CT, and [(18)F]FDG-PET-CT in detecting lymph node metastases in clinically early-stage cervical cancer - a nationwide Dutch cohort study.
    Insights Imaging. 2024;15:36.
    Abstract

  370. ATNAFU DD, Khatri R, Assefa Y
    Drivers of cervical cancer prevention and management in sub-Saharan Africa: a qualitative synthesis of mixed studies.
    Health Res Policy Syst. 2024;22:21.
    Abstract

  371. FIGUEIREDO D, Ribeiro I, Penedones A, Mendes D, et al
    Correction: Performance of Aptima-HPV in the cervical cancer screening program of Portugal: a cost-analysis.
    BMC Womens Health. 2024;24:102.
    Abstract

  372. ZHANG C, Yuan L, Zou Q, Shao C, et al
    CircMAST1 inhibits cervical cancer progression by hindering the N4-acetylcytidine modification of YAP mRNA.
    Cell Mol Biol Lett. 2024;29:25.
    Abstract

  373. YANG X, Wang W, Li SH, Yang Z, et al
    A case of cervical cancer which metastasized to axillary lymph node and breast skin was documented.
    Asian J Surg. 2024 Feb 7:S1015-9584(24)00156.
    Abstract

  374. PENG C, Li X, Tang W, Zhu W, et al
    Real-world outcomes of first-line maintenance therapy for recurrent or metastatic cervical cancer: A multi-center retrospective study.
    Int Immunopharmacol. 2024;129:111578.
    Abstract

  375. HUO G, Liu W, Chen P
    Cost-effectiveness of tisotumab vedotin as a second- or third-line therapy for cervical cancer.
    J Gynecol Oncol. 2024 Jan 24. doi: 10.3802/jgo.2024.
    Abstract

  376. YUN BS, Lee KB, Lee KH, Chang HK, et al
    Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial).
    J Gynecol Oncol. 2024 Jan 22. doi: 10.3802/jgo.2024.
    Abstract

  377. SCOTT AA, Vanderpuye V, Dadzie MA, Yarney J, et al
    Expanding Access to Computed Tomographic Staging and Three-Dimensional Intensity Modulated Radiotherapy for Cervical Cancer in Ghana.
    JCO Glob Oncol. 2024;10:e2300266.
    Abstract

  378. KAMIL SHAREEF NA, Zandsalimi F, Tavoosidana G
    Gold nanoparticles (AuNPs) decrease the viability of cervical cancer cells by inducing the BAX gene and activating antioxidant enzymes.
    Mol Biol Rep. 2024;51:287.
    Abstract

  379. FENG X, Meng X, Tang D, Guo S, et al
    Reversal of the immunosuppressive tumor microenvironment via platinum-based neoadjuvant chemotherapy in cervical cancer.
    Cancer Pathog Ther. 2023;2:38-49.
    Abstract

  380. JAFARI A, Farahani M, Abdollahpour-Alitappeh M, Manzari-Tavakoli A, et al
    Unveiling diagnostic and therapeutic strategies for cervical cancer: biomarker discovery through proteomics approaches and exploring the role of cervical cancer stem cells.
    Front Oncol. 2024;13:1277772.
    Abstract

  381. WANG J, Mou X, Lu H, Jiang H, et al
    Exploring a novel seven-gene marker and mitochondrial gene TMEM38A for predicting cervical cancer radiotherapy sensitivity using machine learning algorithms.
    Front Endocrinol (Lausanne). 2024;14:1302074.
    Abstract

  382. WANG YZ, Wang JS, Du J, Tang XL, et al
    Clinical benefit analysis of PD-1 inhibitors in patients with advanced, recurrent or metastatic cervical cancer: a meta-analysis and systematic review.
    Front Immunol. 2024;15:1305810.
    Abstract

  383. DAMSGAARD S, Allergodt K, Handberg C
    Women's experiences with opting out of cervical cancer screening and the role of the nurse in the women's decision-making process.
    J Clin Nurs. 2024 Feb 7. doi: 10.1111/jocn.17067.
    Abstract

  384. SONG Y, Zhang A, Zhou J, Luo Y, et al
    Overlapping cytoplasms segmentation via constrained multi-shape evolution for cervical cancer screening.
    Artif Intell Med. 2024;148:102756.
    Abstract

  385. PEDERSEN BT, Pedersen H, Serizawa R, Sonne SB, et al
    Cervical cancer screening activity in the Capital Region of Denmark before, during and after the COVID-19 pandemic.
    Prev Med. 2024 Feb 5:107888. doi: 10.1016/j.ypmed.2024.107888.
    Abstract

  386. UMUTLU L, Nensa F, Demircioglu A, Antoch G, et al
    Radiomics Analysis of Multiparametric PET/MRI for N- and M-Staging in Patients with Primary Cervical Cancer.
    Nuklearmedizin. 2024;63:34-42.
    Abstract

  387. NODE J, Dor F, Puget L, Ramanah R, et al
    Prevalence and significance of HPV DNA detection below the clinical threshold of the commercial kit Alinity m HR-HPV assay (Abbott).
    J Med Virol. 2024;96:e29465.
    Abstract

  388. SPRINGER R, Erroba J, O'Malley JP, Huguet N, et al
    Differences in up-to-date colorectal and cervical cancer screening rates by ethnicity and preferred language: An analysis across patient-, clinic-, and area-level data sources.
    SSM Popul Health. 2024;25:101612.
    Abstract

  389. XIAO J, Wang L, Zhuang Y, Zhu Q, et al
    The deubiquitinase OTUB2 promotes cervical cancer growth through stabilizing FOXM1.
    Am J Transl Res. 2024;16:75-84.
    Abstract

  390. OKEKE SU
    Fighting cervical cancer in Africa: Taking a closer look at human papillomavirus 35.
    Afr J Lab Med. 2024;13:2243.
    Abstract

  391. WANG P, An M, Zhang M, Yan X, et al
    Acute retinal necrosis in a patient with cervical malignant tumor treated with sintilimab: a case report and literature review.
    Front Immunol. 2024;15:1301329.
    Abstract

  392. AKANDE OW, Akande TM
    Human Papillomavirus Vaccination amongst Students in a Tertiary Institution in North Central Nigeria: A Cross-sectional Study on Sociodemographic Factors Associated with Its Awareness, Uptake and Willingness to Pay.
    Niger Postgrad Med J. 2024;31:14-24.
    Abstract

  393. LURGAIN JG, Ouaarab-Essadek H, Mellouki K, Malik-Hameed S, et al
    Exploring self-care and cervical cancer prevention attitudes and practices among Moroccan and Pakistani immigrant women in Catalonia, Spain: a comparative qualitative study.
    BMC Public Health. 2024;24:388.
    Abstract

  394. PEERENBOOM R, Ackroyd S, Lee N
    The burden of cervical cancer survivorship: Understanding morbidity and survivorship needs through hospital admissions.
    Gynecol Oncol Rep. 2024;51:101328.
    Abstract

  395. EL RHABORI S, El Aissouq A, Daoui O, Elkhattabi S, et al
    Design of new molecules against cervical cancer using DFT, theoretical spectroscopy, 2D/3D-QSAR, molecular docking, pharmacophore and ADMET investigations.
    Heliyon. 2024;10:e24551.
    Abstract

  396. ENDALE HT, Mariye YF, Negash HK, Hassen FS, et al
    MiRNA in cervical cancer: Diagnosis to therapy: Systematic review.
    Heliyon. 2024;10:e24398.
    Abstract

  397. CAO D, Yang Z, Dong S, Li Y, et al
    PCDHGB7 hypermethylation-based Cervical cancer Methylation (CerMe) detection for the triage of high-risk human papillomavirus-positive women: a prospective cohort study.
    BMC Med. 2024;22:55.
    Abstract

  398. SAEKI Y, Saito M, Irie T, Itoh F, et al
    Effectiveness of prophylactic HPV vaccines against cervical abnormalities and HPV infection in Japan: The J-HERS 2021 multicenter study.
    J Med Virol. 2024;96:e29413.
    Abstract

  399. TJOKROPRAWIRO BA, Novitasari K, Saraswati W, Yuliati I, et al
    The challenging journey of cervical cancer diagnosis and treatment at the second largest hospital in Indonesia.
    Gynecol Oncol Rep. 2024;51:101325.
    Abstract

  400. KARENA ZV, Faldu PS
    A Cross-Sectional Study on Knowledge, Attitude, and Practices Related to Cervical Cancer Screening Among the Nursing Staff in a Tertiary Care Hospital in the Western Region of India.
    Cureus. 2024;16:e51566.
    Abstract

  401. BARMON D, Tak A, Baruah U, Begum D, et al
    Pattern of Care of Recurrent Cervical Cancer in Low-resource Settings: Challenges and Patient-initiated Follow-up as a Novel Opportunity.
    J Midlife Health. 2023;14:205-211.
    Abstract

  402. PETRIC HOWE N, Gardiner J
    Cervical cancer could be eliminated: here's how.
    Nature. 2024 Feb 4. doi: 10.1038/d41586-024-00302.
    Abstract

  403. CHEKRINE T, Bellefkih FZ, Hatim G, Bouchbika Z, et al
    Patterns of practice survey for cervical cancer brachytherapy in Morocco.
    Brachytherapy. 2024 Feb 3:S1538-4721(24)00008.
    Abstract

  404. LIU J, Li S, Cao Q, Zhang Y, et al
    ASO Visual Abstract: Prediction of Recurrent Cervical Cancer in 2 Years Follow-Up After Treatment Based on Quantitative and Qualitative Magnetic Resonance Imaging Parameters-A Preliminary Study.
    Ann Surg Oncol. 2024 Feb 3. doi: 10.1245/s10434-024-14891.
    Abstract

  405. GRIMES DR
    Impact of human papillomavirus age-related prevalence and vaccination levels on interpretation of cervical screening modalities: a modelling study.
    BMJ Open. 2024;14:e078551.
    Abstract

  406. HE X, Sun J, Zhang J, Zhu B, et al
    circ_0039787 promotes cervical cancer cell tumorigenesis by regulation of the miR-877-5p-KRAS axis.
    Aging (Albany NY). 2024;16.
    Abstract

  407. LI Y, Maimaitirexiati G, Wang J, Zhang J, et al
    Long non-coding RNA Linc00657 up-regulates Skp2 to promote the progression of cervical cancer through lipid reprogramming and regulation of immune microenvironment.
    Cytokine. 2024;176:156510.
    Abstract

  408. ROMELUS J, McLaughlin C, Ruggieri D, Morgan S, et al
    A Narrative Review of Cervical Cancer Screening Utilization Among Haitian Immigrant Women in the U.S.: Health Beliefs, Perceptions, and Societal Barriers and Facilitators.
    J Immigr Minor Health. 2024 Feb 3. doi: 10.1007/s10903-024-01581.
    Abstract

  409. BRIDGE F, Brotherton J, Stankovich J, Sanfilippo PG, et al
    Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying Therapies.
    Neurology. 2024;102:e208059.
    Abstract

  410. WANG X, Wang T, Jiang X, Ruan Y, et al
    The potential mechanism of Guizhi Fuling Wan effect in the treatment of cervical squamous cell carcinoma: A bioinformatics analysis investigation.
    Medicine (Baltimore). 2024;103:e37153.
    Abstract

  411. ALBA C, Zheng Z, Wadhera RK
    Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity.
    JAMA Health Forum. 2024;5:e235058.
    Abstract

  412. ZHANG N, Chen Z, Huang M, Lu Q, et al
    Cervicovaginal microbiota long-term dynamics and prediction of different outcomes in persistent human papillomavirus infection.
    J Med Virol. 2024;96:e29451.
    Abstract

  413. ZHOU YX, Ma XH, Wang TT, Qu XL, et al
    Analysis of age-specified and genotype distribution of HPV multiple infections in the Chinese population.
    Sci Rep. 2024;14:2678.
    Abstract

  414. MITANI T, Kukimoto I, Tsukamoto T, Nomura H, et al
    A prospective clinical trial of diathermy ablation for patients with high-grade cervical intraepithelial neoplasia from a single institution in Japan.
    Sci Rep. 2024;14:2632.
    Abstract

  415. BAKHSHANI A, Ganjali R, Tabatabaeizadeh SE
    Prevalence of Human Papillomavirus (HPV) Genotypes among Women During 2015-2020 in Mashhad, Iran.
    Arch Iran Med. 2023;26:419-426.
    Abstract

  416. LIU L, Fan X, Liu H, Zhang C, et al
    QUIZ: An arbitrary volumetric point matching method for medical image registration.
    Comput Med Imaging Graph. 2024;112:102336.
    Abstract

  417. FILIPAS DK, Labban M, Beatrici E, Stone BV, et al
    Exploring preventive care practices among unvaccinated individuals in the United States during the COVID-19 pandemic.
    Vaccine. 2024;42:441-447.
    Abstract

  418. STEGMULLER T, Abbet C, Bozorgtabar B, Clarke H, et al
    Self-supervised learning-based cervical cytology for the triage of HPV-positive women in resource-limited settings and low-data regime.
    Comput Biol Med. 2024;169:107809.
    Abstract

  419. LIU S, Liu Y, Zhang H
    Minimal deviation adenocarcinoma of the cervix with lymphatic metastasis: A case report.
    Asian J Surg. 2024;47:1099-1100.
    Abstract

  420. YABUKI A, Muraoka A, Tamauchi S, Seki T, et al
    The influence of radical trachelectomy on endometrial thickness in in vitro fertilization-embryo transfer.
    J Obstet Gynaecol Res. 2024;50:218-224.
    Abstract

  421. ZHOU X, Lin W, Qin Y, Zhang J, et al
    Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with atypical glandular cells cytology: A retrospective analysis of 369 cases.
    Cancer Cytopathol. 2024;132:119-128.
    Abstract

  422. PENG K, Tu K, Li Z, Hallinan CM, et al
    Global impacts of COVID-19 pandemic on sexual and reproductive health services: An international comparative study on primary care from the INTRePID Consortium.
    BJOG. 2024;131:508-517.
    Abstract

  423. GARCIA-ALCARAZ C, Binda A, Gordon JR, Alpert EN, et al
    Intervention recommendations to improve uptake of breast, cervical, and colorectal cancer screening among individuals living with serious mental illness.
    Cancer Causes Control. 2024;35:451-463.
    Abstract

  424. ZHANG S, Cao Y, Hu Y, Li G, et al
    Correlation Between Persistent HPV Infection and Vaginal Microecological Imbalance After Treatment of Cervical High-Grade Squamous Intraepithelial Lesion.
    Altern Ther Health Med. 2024;30:414-418.
    Abstract

  425. XIAO ML, Fu L, Wei Y, Liu AE, et al
    Intratumoral and peritumoral MRI radiomics nomogram for predicting parametrial invasion in patients with early-stage cervical adenocarcinoma and adenosquamous carcinoma.
    Eur Radiol. 2024;34:852-862.
    Abstract

  426. ESCANDE A, Leblanc J, Hannoun-Levi JM, Renard S, et al
    Place of radiotherapy for treatment of metastatic cervical, vaginal and endometrial uterine cancer.
    Cancer Radiother. 2024;28:15-21.
    Abstract

  427. LUO X, Qu L, Guo Q, Song Z, et al
    Negative Instance Guided Self-Distillation Framework for Whole Slide Image Analysis.
    IEEE J Biomed Health Inform. 2024;28:964-975.
    Abstract

  428. DENIZOT A, Rousseau A
    [Intraoperative diagnosis of a tumor of the cervical spine].
    Ann Pathol. 2024;44:82-83.
    Abstract

  429. ZHANG Q, Zhang W, Xu T, Song J, et al
    Analysis of the current state of cervical cancer prevention awareness and its influencing factors among rural women in Luohe City.
    Medicine (Baltimore). 2024;103:e35136.
    Abstract

  430. CHANUDOM I, Tharavichitkul E, Laosiritaworn W
    Prediction of Cervical Cancer Patients' Survival Period with Machine Learning Techniques.
    Healthc Inform Res. 2024;30:60-72.
    Abstract

  431. MUNGO C, Orang'o O, Ofner S, Musick B, et al
    Real-World Cervical Cancer Screening Uptake and Predictors of Visual Inspection With Acetic Acid Positivity Among Women Living With HIV in Care Programs in Western Kenya.
    JCO Glob Oncol. 2024;10:e2300311.
    Abstract

  432. GUO Q, Gao Y, Lin Y, Li W, et al
    A nomogram of preoperative indicators predicting lymph vascular space invasion in cervical cancer.
    Arch Gynecol Obstet. 2024 Feb 15. doi: 10.1007/s00404-024-07385.
    Abstract

  433. WANG M, Meng J, Wang H, Hu H, et al
    Atractylodes macrocephala III suppresses EMT in cervical cancer by regulating IGF2BP3 through ETV5.
    J Cell Mol Med. 2024;28:e18081.
    Abstract

  434. OLUBODUN T, Ogundele OO, Salisu ZA, Odusolu YO, et al
    Cervical cancer awareness and risk factors among women residing in an urban slum in Lagos, Southwest Nigeria.
    Afr Health Sci. 2023;23:269-279.
    Abstract

  435. SAMAILA A, Biambo AA, Usman N, Aliyu UM, et al
    Health-related quality of life associated with different cervical cancer therapies received by patients in two Nigerian tertiary hospitals.
    Afr Health Sci. 2023;23:261-268.
    Abstract

  436. WANG W, Chen P, Yuan S
    Programmed cell death-index (PCDi) as a prognostic biomarker and predictor of drug sensitivity in cervical cancer: a machine learning-based analysis of mRNA signatures.
    J Cancer. 2024;15:1378-1396.
    Abstract

  437. HAN C, Hu C, Liu T, Sun Y, et al
    IGF2BP3 enhances lipid metabolism in cervical cancer by upregulating the expression of SCD.
    Cell Death Dis. 2024;15:138.
    Abstract

  438. SAFARI-FARAMANI B, Safari-Faramani R, Najafi F, Zavareh DK, et al
    Socioeconomic disparities in Papanicolaou test utilization in Western Iran.
    BMC Public Health. 2024;24:471.
    Abstract

  439. GONETE TZ, Asseffa NA, Gashu KD, Tilahun B, et al
    Communicable and Non-communicable Diseases Diagnosis and Treatment Service Availability at Primary Health Care Units During COVID-19 Outbreak in Ethiopia.
    Ethiop J Health Sci. 2023;33.
    Abstract

  440. OLKHOV IG, Grishina NK, Timurzieva AB
    [The experience of organization of combined screening of uterine neck cancer in the Republic of Bashkortostan].
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2024;32:75-82.
    Abstract

  441. ZHANG X, Cao J, Li X, Zhang Y, et al
    Comprehensive Analysis of the SUMO-related Signature: Implication for Diagnosis, Prognosis, and Immune Therapeutic Approaches in Cervical Cancer.
    Biochem Genet. 2024 Feb 13. doi: 10.1007/s10528-024-10728.
    Abstract

  442. CHEN Y, Sun L, Li L
    Human papillomavirus type 16 E7 promotes cell viability and migration in cervical cancer by regulating the miR-23a/HOXC8 axis.
    J Obstet Gynaecol. 2024;44:2311658.
    Abstract

  443. BIAN Y, Zhang Z, Deng X, Wen Q, et al
    Case report: Giant lymph node metastases: a new opportunity for cancer radioimmunotherapy?
    Front Immunol. 2024;15:1357601.
    Abstract

  444. RAMLI Z, Farizan A, Tamchek N, Haron Z, et al
    Impact of Image Enhancement on the Radiomics Stability of Diffusion-Weighted MRI Images of Cervical Cancer.
    Cureus. 2024;16:e52132.
    Abstract

  445. CHO A, Kim MY, Park IS, Park CM, et al
    A retrospective study for long-term oncologic and obstetric outcomes in cervical intraepithelial neoplasia treated with loop electrosurgical excision procedure: focus on surgical margin and human papillomavirus.
    BMC Womens Health. 2024;24:116.
    Abstract

  446. ENYAN NIE, Ken-Amoah S, Tuoyire DA, Akakpo KP, et al
    HIV status and knowledge of cervical cancer among women in Ghana.
    BMC Womens Health. 2024;24:112.
    Abstract

  447. LAYET F, Murungi T, Ashaba N, Kigongo E, et al
    Factors associated with utilization of cervical cancer screening services among HIV-positive women aged 18 to 49 years at Lira regional referral hospital, Northern Uganda.
    BMC Womens Health. 2024;24:114.
    Abstract

  448. SHENG B, Pan S, Ye M, Liu H, et al
    Single-cell RNA sequencing of cervical exfoliated cells reveals potential biomarkers and cellular pathogenesis in cervical carcinogenesis.
    Cell Death Dis. 2024;15:130.
    Abstract

  449. SETYAWATY D, Mariya S, Prabandari SA, Boilessen DR, et al
    Immunohistochemical characterization of integrin alfa 6 in uterus and cervix of the cynomolgus monkeys (Macaca fascicularis) with MfPV3 infection.
    J Med Primatol. 2024;53:e12690.
    Abstract

  450. SUN Y, Wang Y, Gan K, Wang Y, et al
    Reliable Delineation of Clinical Target Volumes for Cervical Cancer Radiotherapy on CT/MR Dual-Modality Images.
    J Imaging Inform Med. 2024 Jan 10. doi: 10.1007/s10278-023-00951.
    Abstract

  451. YAN H, Huang G, Yang Z, Chen Y, et al
    Machine Learning-Based Multiparametric Magnetic Resonance Imaging Radiomics Model for Preoperative Predicting the Deep Stromal Invasion in Patients with Early Cervical Cancer.
    J Imaging Inform Med. 2024 Jan 10. doi: 10.1007/s10278-023-00906.
    Abstract

  452. K A, B S
    A Deep Learning-Based Approach for Cervical Cancer Classification Using 3D CNN and Vision Transformer.
    J Imaging Inform Med. 2024 Jan 10. doi: 10.1007/s10278-023-00911.
    Abstract

  453. DEHGHANI A, Khajepour F, Dehghani M, Razmara E, et al
    Hsa-miR-194-5p and hsa-miR-195-5p are down-regulated expressed in high dysplasia HPV-positive Pap smear samples compared to normal cytology HPV-positive Pap smear samples.
    BMC Infect Dis. 2024;24:182.
    Abstract

  454. COTTRELL-DANIELS C, Hoogland CE, Fennell BS, Simmons VN, et al
    Smoking Cessation by Cancer Treatment Status among Cervical Cancer Survivors.
    Am J Prev Med. 2024 Feb 9:S0749-3797(24)00043.
    Abstract

  455. HEYDARNIA E, Dorostgou Z, Hedayati N, Mousavi V, et al
    Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms.
    Cell Commun Signal. 2024;22:107.
    Abstract

  456. WANG Q, Zhou FY, Ding JX
    Factors associated with the persistence of human papillomavirus after surgery in patients with cervical cancer.
    Diagn Microbiol Infect Dis. 2024;108:116201.
    Abstract

  457. SERVAYGE J, Olthof EP, Mom CH, van der Aa MA, et al
    Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus Chemoradiotherapy.
    Cancers (Basel). 2024;16:635.
    Abstract

  458. VOGELSANG TLR, Schmoeckel E, Topalov NE, Ganster F, et al
    Prognostic Impact of Heat Shock Protein 90 Expression in Women Diagnosed with Cervical Cancer.
    Int J Mol Sci. 2024;25:1571.
    Abstract

  459. SUCULARLI C, Simay Demir YD, Ozdemir A, Ark M, et al
    Temporal regulation of gene expression and pathways in chemotherapy-induced senescence in HeLa cervical cancer cell line.
    Biosystems. 2024;237:105140.
    Abstract

  460. ZHOU X, Li Z, Li M
    LncRNA WWTR1-AS1 upregulates Notch3 through miR-136 to increase cancer cell stemness in cervical squamous cell carcinoma.
    BMC Womens Health. 2024;24:104.
    Abstract

  461. LIU Y, Li Z
    Vaginal pH value can affect the susceptibility to human papillomavirus infection.
    BMC Infect Dis. 2024;24:176.
    Abstract

  462. BARRE-PIERREL S, Fillol F, Derhy S, Taleb S, et al
    [News in French cancer screenings].
    Rev Prat. 2024;74:40-43.
    Abstract

  463. SUN S, Yang Z, Majdaeen M, Agbele AT, et al
    Functions of Sialyltransferases in gynecological malignancies: A systematic review.
    Pathol Res Pract. 2024;254:155159.
    Abstract

  464. ZANNONI GF, Santoro A, Addante F, Cianfrini F, et al
    Endometrioid type adenocarcinoma in situ as a potential precursor lesion for extremely rare invasive endometrioid type adenocarcinoma of the cervix.
    Pathol Res Pract. 2024;254:155062.
    Abstract

  465. NILYANIMIT P, Chaithongwongwatthana S, Oranratanaphan S, Poudyal N, et al
    Comparable detection of HPV using real-time PCR in paired cervical samples and concentrated first-stream urine collected with Colli-Pee device.
    Diagn Microbiol Infect Dis. 2024;108:116160.
    Abstract

  466. ZHOU M, Su Y, Tong Y, Zhang C, et al
    Comparative study of topical 5-aminolevulinic acid photodynamic therapy and surgery for the treatment of vulvar squamous intraepithelial lesion.
    Photodiagnosis Photodyn Ther. 2023;44:103868.
    Abstract

  467. PAPOUTSIS D, Underwood M, Parry-Smith W, Tzavara C, et al
    Endocervical crypt involvement by high-grade cervical intraepithelial neoplasia and its association with high-grade histopathological recurrence after cervical excision in women with negative excision margins: a systematic review and meta-analysis.
    Arch Gynecol Obstet. 2024;309:939-948.
    Abstract

  468. EL-LATEEF AEA, El-Shemi AGA, Hassanein RAM, Iqbal MS, et al
    Analysis of Correlation Between LncRNA TDRG1 Expression and its Prognosis in Cervical Carcinoma Tissues.
    Appl Biochem Biotechnol. 2024;196:1079-1088.
    Abstract

  469. ROSENDO-CHALMA P, Antonio-Vejar V, Ortiz Tejedor JG, Ortiz Segarra J, et al
    The Hallmarks of Cervical Cancer: Molecular Mechanisms Induced by Human Papillomavirus.
    Biology (Basel). 2024;13:77.
    Abstract

  470. GREENMAN M, McNamara B, Mutlu L, Santin AD, et al
    Targeting cervical cancer with anti-PD-1 antibodies: what's new?
    Expert Opin Biol Ther. 2024 Feb 23. doi: 10.1080/14712598.2024.2323596.
    Abstract

  471. FONG AMARIS WM, de Assumpcao PP, Valadares LJ, Moreira FC, et al
    Microbiota changes: the unseen players in cervical cancer progression.
    Front Microbiol. 2024;15:1352778.
    Abstract

  472. YOO JG, Lee SJ, Nam EJ, No JH, et al
    Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines.
    J Gynecol Oncol. 2024 Feb 13. doi: 10.3802/jgo.2024.
    Abstract

  473. GAO F, Qian T, Sun M, Lu Y, et al
    MRI Plain Scan: A Tool in the Management of Cervical Cancer during Pregnancy.
    Curr Med Imaging. 2024;20:1-8.
    Abstract

  474. LIU Q, Sun YX, Liu KJ, Li PQ, et al
    [Oncological outcomes of laparoscopic radical trachelectomy for early stage cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:135-142.
    Abstract

  475. NDARUKWA S, Flores JA, Rosenblatt E, Berger D, et al
    Brachytherapy Workflow Practices: Analysis of Different Workflow Scenarios in Patients With Cervical Cancer and Impact on IGBT Implementation-An IAEA Study.
    JCO Glob Oncol. 2024;10:e2300336.
    Abstract

  476. INGAMELLS S, Bell R, Nip J, Innes C, et al
    Perceived barriers to self-collected HPV testing for cervical cancer screening, and knowledge of HPV: a survey of primary healthcare smear-takers across Aotearoa New Zealand.
    N Z Med J. 2024;137:57-76.
    Abstract


  477. News Brief: A quarter of U.S. women are not up to date on cervical cancer screening.
    Am J Nurs. 2024;124:11.
    Abstract

  478. GE J, Weng C, Zhao J, Yuan D, et al
    Upper extremity phlegmasia cerulea dolens complicating supra vena cava embolism in a cervical cancer patient: case report.
    Front Cardiovasc Med. 2024;11:1351358.
    Abstract

  479. ZHANG H, Zhang R, Zhang G, Liu W, et al
    [Retracted] Clinical significance of miR?1298 in cervical cancer and its biological function in vitro.
    Oncol Lett. 2024;27:150.
    Abstract

  480. YADAV R, Chauhan MB, Yadav C, Ranga S, et al
    Awareness data on cervical cancer among females of rural and urban areas of Haryana, India.
    Data Brief. 2024;53:110168.
    Abstract

  481. ZHENG H, Liu M, Shi S, Huang H, et al
    MAP4K4 and WT1 mediate SOX6-induced cellular senescence by synergistically activating the ATF2-TGFbeta2-Smad2/3 signaling pathway in cervical cancer.
    Mol Oncol. 2024 Feb 21. doi: 10.1002/1878-0261.13613.
    Abstract

  482. CHEN X, Dong X, Li H, Wu T, et al
    RNA-binding proteins signature is a favorable biomarker of prognosis, immunotherapy and chemotherapy response for cervical cancer.
    Cancer Cell Int. 2024;24:80.
    Abstract

  483. PERKINS RB, Fuzzell L, Lake P, Brownstein NC, et al
    Factors Associated With Guideline-concordant and Excessive Cervical Cancer Screening: A Mixed Methods Study.
    Womens Health Issues. 2024 Feb 20:S1049-3867(24)00001.
    Abstract

  484. FOGH JORGENSEN S, Kellen E, Haelens A, Herck KV, et al
    How follow-up rates in cervical cancer screening depend on organizational factors: A comparison of two population-based organized screening programmes.
    J Med Screen. 2024 Feb 21:9691413241231440. doi: 10.1177/09691413241231440.
    Abstract

  485. ZOU Q, Wu Y, Zhang S, Li S, et al
    Escherichia coli and HPV16 coinfection may contribute to the development of cervical cancer.
    Virulence. 2024;15:2319962.
    Abstract

  486. SHAFFI AF, Odongo EB, Itsura PM, Tonui PK, et al
    Cervical cancer management in a low resource setting: A 10-year review in a tertiary care hospital in Kenya.
    Gynecol Oncol Rep. 2024;51:101331.
    Abstract

  487. HAMID HA, Lin X, Qin YK, Akim AM, et al
    Best practices for managing malodorous and infected wounds in advanced cervical cancer.
    Int Wound J. 2024;21:e14574.
    Abstract

  488. MANTULA F, Toefy Y, Sewram V
    Barriers to cervical cancer screening in Africa: a systematic review.
    BMC Public Health. 2024;24:525.
    Abstract

  489. LU Y, Wu Q, Wang L, Ji L, et al
    Chlamydia trachomatis enhances HPV persistence through immune modulation.
    BMC Infect Dis. 2024;24:229.
    Abstract

  490. WANG Z, Liu C, Liu W, Lv X, et al
    Long-read sequencing reveals the structural complexity of genomic integration of HPV DNA in cervical cancer cell lines.
    BMC Genomics. 2024;25:198.
    Abstract

  491. ZHANG J, Qiu H, Qing Y, Hu Y, et al
    A commentary on "Local excision as a viable alternative to c-stage cervical cancer in women of reproductive age: a population-based cohort study".
    Int J Surg. 2024 Feb 21. doi: 10.1097/JS9.0000000000001218.
    Abstract

  492. MINGOLA P, Alshomrani A, Greiner T
    Anaplastic large cell lymphoma presenting as a mass in the uterine cervix: a case report.
    J Hematop. 2024;17:23-26.
    Abstract

  493. PAUL A, Dutta P, Basu K
    Assessment and clinicopathological correlation of p16 expression in cervical squamous cell carcinoma of Indian population: Diagnostic implications.
    J Cancer Res Ther. 2023;19:2012-2017.
    Abstract

  494. DATKHILE KD, Patil SR, Patil MN, Durgawale PP, et al
    Genetic polymorphisms of CYP1A, CYP1B, CYP2C and risk of cervical cancer among rural population of Maharashtra: Findings from a hospital-based case-control study.
    J Cancer Res Ther. 2023;19:1925-1930.
    Abstract

  495. AZAK C, Kavak G, Ertan F, Alioglu F, et al
    The effect of lower urinary tract substructure doses on side effects of cervical cancer image-guided adaptive brachytherapy.
    J Cancer Res Ther. 2023;19:1825-1830.
    Abstract

  496. PURI I, Sharma R, Dewan D, Angurana S, et al
    Sexual function status after adjuvant radiation including vaginal cuff brachytherapy in survivors of cancer cervix.
    J Cancer Res Ther. 2023;19:1721-1724.
    Abstract

  497. ASHOK G, Basu S, Priyamvada P, Anbarasu A, et al
    Coinfections in human papillomavirus associated cancers and prophylactic recommendations.
    Rev Med Virol. 2024;34:e2524.
    Abstract

  498. CHEN Y, Chen S, Chen K, Ji L, et al
    Magnolol and 5-fluorouracil synergy inhibition of metastasis of cervical cancer cells by targeting PI3K/AKT/mTOR and EMT pathways.
    Chin Herb Med. 2023;16:94-105.
    Abstract

  499. DURA MC, Akturk H, Aslan O, Yildiz S, et al
    Human Papillomavirus Infection (HPV) Prevalence in the Black Sea Region of Turkey: Primary HPV Screening for Cervical Cancer.
    Cureus. 2024;16:e52615.
    Abstract

  500. G SN, Sssn R, Chaturvedula L, Adole P, et al
    Deoxyribose Nucleic Acid Damage and Its Association With Plasma Malondialdehyde Levels Among Patients With Cervical Cancer: A Case-Control Study.
    Cureus. 2024;16:e52600.
    Abstract

  501. CAO Y, Xiong J, Du Y, Tang Y, et al
    Raman spectroscopy combined with multivariate statistical algorithms for the simultaneous screening of cervical and breast cancers.
    Lasers Med Sci. 2024;39:68.
    Abstract

  502. TESFAYE E, Kumbi B, Mandefro B, Hemba Y, et al
    Prevalence of human papillomavirus infection and associated factors among women attending cervical cancer screening in setting of Addis Ababa, Ethiopia.
    Sci Rep. 2024;14:4053.
    Abstract

  503. OKO-OBOH GA, Auvinen A, Obaseki DE, Pitkaniemi J, et al
    Improving cancer incidence evaluation through local government area matching: a study of the Edo-Benin cancer registry in Nigeria.
    BMC Public Health. 2024;24:514.
    Abstract

  504. SUKRONG M, Prapaisilp P, Juntamongkol T, Siranart N, et al
    Knowledge regarding human papillomavirus and cervical cancer prevention among medical students from Chulalongkorn University in Thailand.
    BMC Womens Health. 2024;24:129.
    Abstract

  505. PRETI M, Boldorini R, Gallio N, Cavagnetto C, et al
    Human papillomavirus genotyping in high-grade vaginal intraepithelial neoplasia: A multicentric Italian study.
    J Med Virol. 2024;96:e29474.
    Abstract

  506. ZHOU X, Wang Y, Bao M, Chu Y, et al
    Advanced detection of cervical cancer biomarkers using engineered filamentous phage nanofibers.
    Appl Microbiol Biotechnol. 2024;108:221.
    Abstract

  507. WANG YY, Ye LH, Zhao AQ, Gao WR, et al
    M6A modification regulates tumor suppressor DIRAS1 expression in cervical cancer cells.
    Cancer Biol Ther. 2024;25:2306674.
    Abstract

  508. BAEKER BISPO JA, Goo I, Ashad-Bishop K, Kobetz E, et al
    Does Neighborhood Social Cohesion Influence Participation in Routine Cancer Screening? Findings From a Representative Sample of Adults in South Florida.
    Fam Community Health. 2024;47:130-140.
    Abstract

  509. STEFANOS R, Lewis RM, Querec TD, Gargano JW, et al
    High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018.
    Hum Vaccin Immunother. 2024;20:2308378.
    Abstract

  510. MITOMA T, Maki J, Ooba H, Ogawa C, et al
    Association of Regular Cervical Cancer Screening with Socioeconomic, COVID-19 Infection and Vaccine Status Among Japanese Population: Cohort Observational Study.
    Int J Gen Med. 2024;17:541-551.
    Abstract

  511. WU F, Zhang R, Li F, Qin X, et al
    Radiomics analysis based on multiparametric magnetic resonance imaging for differentiating early stage of cervical cancer.
    Front Med (Lausanne). 2024;11:1336640.
    Abstract

  512. AKINNIBOSUN O, Abakpa OG, Ujoh AJ, Oche DA, et al
    Knowledge, Attitudes and Practices among Women of Reproductive Age on Human Papillomavirus Infection, Cervical Cancer and Vaccination in Otukpo, Nigeria.
    Ethiop J Health Sci. 2024;34:15-26.
    Abstract

  513. CARMACK C, Roncancio A, Coleman TM, McKay S, et al
    Concept mapping sociocultural aspects of cervical cancer prevention among African American women.
    Front Public Health. 2024;11:1311286.
    Abstract

  514. GUO S, Chen P, Yang Y, Wei W, et al
    Tumor-to-stroma cd8(+) t cells ratio combined with cancer-associated fibroblasts: an innovative approach to predicting lymph node metastases of cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:93.
    Abstract

  515. LUO L, Wang M, Li X, Luo C, et al
    Correction: A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression.
    Cancer Cell Int. 2024;24:76.
    Abstract


  516. Correction to: Quality of life but not cachexia definitions are associated with overall survival in women with cervical cancer: a STROBE-compliant cohort study.
    Jpn J Clin Oncol. 2024 Feb 15:hyae023. doi: 10.1093.
    Abstract

  517. MICHA JP, Rettenmaier MA, Bohart RD, Goldstein BH, et al
    Current analysis of the survival implications for minimally invasive surgery in the treatment of early-stage cervix cancer.
    J Robot Surg. 2024;18:80.
    Abstract

  518. WANG T, Li YY, Ma NN, Wang PA, et al
    A MRI radiomics-based model for prediction of pelvic lymph node metastasis in cervical cancer.
    World J Surg Oncol. 2024;22:55.
    Abstract

  519. EKAWATI FM, Listiani P, Idaiani S, Thobari JA, et al
    Cervical cancer screening program in Indonesia: is it time for HPV-DNA tests? Results of a qualitative study exploring the stakeholders' perspectives.
    BMC Womens Health. 2024;24:125.
    Abstract

  520. FOKOM-DEFO V, Dille I, Fokom-Domgue J
    Single dose HPV vaccine in achieving global cervical cancer elimination.
    Lancet Glob Health. 2024;12:e360-e361.
    Abstract

  521. JORGENSEN KA, Agusti N, Wu CF, Kanbergs A, et al
    Fertility-sparing surgery versus standard surgery for early-stage cervical cancer: difference in 5-year life expectancy by tumor size.
    Am J Obstet Gynecol. 2024 Feb 14:S0002-9378(24)00084.
    Abstract

  522. KUZUCULAR E, Ozden F, Muezzinoglu B
    Comparison of liquid-based cytology and cell blocks prepared from cell remnants for diagnosis of cervical pathology.
    Ann Diagn Pathol. 2024;69:152265.
    Abstract

  523. KAUR JAWANDA I, Soni T, Kumari S, Prabha V, et al
    Deciphering the potential of proteomic-based biomarkers in women's reproductive diseases: empowering precision medicine in gynecology.
    Biomarkers. 2024;29:7-17.
    Abstract

  524. PEITZ JG, Adebamowo CA, Adebamowo SN
    Association between Serum Folate and Vaginal High-Risk Human Papillomavirus Infections in United States Women.
    J Nutr. 2024;154:583-589.
    Abstract

  525. MASUDA M, Iida K, Iwabuchi S, Tanaka M, et al
    Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine Cervix.
    Am J Pathol. 2024;194:415-429.
    Abstract

  526. OLTHOF EMG, Aitken CA, Siebers AG, van Kemenade FJ, et al
    Resilience of the Dutch HPV-based cervical screening programme during the COVID-19 pandemic.
    Public Health. 2024;227:42-48.
    Abstract

  527. PARKER SL, Amboree TL, Bulsara S, Daheri M, et al
    Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System.
    Am J Prev Med. 2024;66:540-547.
    Abstract

  528. YUILL S, Egger S, Smith MA, Velentzis L, et al
    Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up study.
    J Med Screen. 2024;31:35-45.
    Abstract

  529. GIRIJA NS, Neethi B, Sakthimanipriya L, Sinekha MA, et al
    In-Vitro Cytotoxic, Antiproliferative and Apoptotic Activity of Siddha Formulation Nandhi Mezhugu (NM) Against Hela Cell Line.
    Appl Biochem Biotechnol. 2024;196:1612-1622.
    Abstract

  530. SOOKAROMDEE P, Wiwanitkit V
    Coverage rate of cervical cytology and HPV DNA test for cervix cancer screening: Reappraisal on impact of COVID-19 outbreak.
    J Cancer Res Ther. 2023;19.
    Abstract

  531. AKRAM M, Khazir M, Khan M, Afrose R, et al
    Age-wise cancer incidence in western Uttar Pradesh in India: An observational study.
    J Cancer Res Ther. 2023;19.
    Abstract

  532. FANG C, Zhu Y, Zhang P, Zhu T, et al
    The impact of different clinicopathologic factors and salvage therapies on cervical cancer patients with isolated para-aortic lymph node recurrence.
    Discov Oncol. 2024;15:54.
    Abstract

  533. WANG C, Wacharasin C, Hengudomsub P
    Self-efficacy as mediators of the association between dyadic coping and quality of life among spousal caregiver of patients with cervical cancer.
    Asia Pac J Oncol Nurs. 2023;11:100354.
    Abstract

  534. PANAHI MEYMANDI AR, Akbari B, Soltantoyeh T, Shahosseini Z, et al
    PX-478, an HIF-1alpha inhibitor, impairs mesoCAR T cell antitumor function in cervical cancer.
    Front Oncol. 2024;14:1357801.
    Abstract

  535. CHANG SH, Huang KG, Yang LY, Pan YB, et al
    Comparison of outcomes of laparotomic and minimally invasive radical hysterectomy in women with early-stage cervical cancer.
    J Gynecol Oncol. 2024 Feb 23. doi: 10.3802/jgo.2024.
    Abstract

  536. BENSELER A, Covens A
    Simple hysterectomy SHAPE-ing up to be the treatment of choice for early cervical cancer under 2 cm.
    J Gynecol Oncol. 2024 Jan 12. doi: 10.3802/jgo.2024.
    Abstract

  537. PARK JY
    Is it time to change surgery for early-stage low-risk cervical cancer to simple hysterectomy?
    J Gynecol Oncol. 2024 Jan 23. doi: 10.3802/jgo.2024.
    Abstract

  538. WU H, Fan Y, Bao Y, Zhou Q, et al
    Construction of a ferroptosis and hypoxia-related gene signature in cervical cancer to assess tumour immune microenvironment and predict prognosis.
    J Obstet Gynaecol. 2024;44:2321323.
    Abstract

  539. MONK BJ, Mayadev J
    CALLA trial: immunotherapy in locally advanced cervical cancer - Authors' reply.
    Lancet Oncol. 2024;25:e96.
    Abstract

  540. YANG X, Zhang Y, Jia S, An J, et al
    CALLA trial: immunotherapy in locally advanced cervical cancer.
    Lancet Oncol. 2024;25:e95.
    Abstract

  541. KOUHEN F, Sqali Houssaini M
    CALLA trial: immunotherapy in locally advanced cervical cancer.
    Lancet Oncol. 2024;25:e94.
    Abstract

  542. FENG J, He L, Hui JQ, Kavithaa K, et al
    Synthesis of Bimetallic Palladium/Zinc Oxide Nanocomposites Using Crocus sativus and Its Anticancer Activity via the Induction of Apoptosis in Cervical Cancer.
    Appl Biochem Biotechnol. 2024 Feb 29. doi: 10.1007/s12010-024-04877.
    Abstract

  543. CHOU HH, Yang CY, Chao A, Lin H, et al
    Consistency in human papillomavirus type detection between self-collected vaginal specimens and physician-sampled cervical specimens.
    J Med Virol. 2024;96:e29426.
    Abstract

  544. ASOUDEH-FARD A, Salehi M, Ilghari D, Parsaei A, et al
    Isolated Lactobacillus fermentum Ab.RS22 from traditional dairy products inhibits HeLa cervical cancer cell proliferation and modulates apoptosis by the PTEN-Akt pathway.
    Iran J Basic Med Sci. 2024;27:447-452.
    Abstract

  545. WANG L, McQuaid D, Blackledge M, McNair H, et al
    Predicting cervical cancer target motion using a multivariate regression model to enable patient selection for adaptive external beam radiotherapy.
    Phys Imaging Radiat Oncol. 2024;29:100554.
    Abstract

  546. YANG H
    The causal correlation between gut microbiota abundance and pathogenesis of cervical cancer: a bidirectional mendelian randomization study.
    Front Microbiol. 2024;15:1336101.
    Abstract

  547. WU Z, Chen J, Yang L, Sun K, et al
    Elevated INHBA Promotes Tumor Progression of Cervical Cancer.
    Technol Cancer Res Treat. 2024;23:15330338241234798.
    Abstract

  548. VAN VLIET-PEREZ SM, van Paassen R, Wauben LSGL, Straathof R, et al
    Time-action and patient experience analyses of locally advanced cervical cancer brachytherapy.
    Brachytherapy. 2024 Feb 27:S1538-4721(24)00011.
    Abstract

  549. WANG GL, Guo N, Zhang JW
    The intact gestational sac of a pregnant patient with cervical cancer: A case report.
    Asian J Surg. 2024 Feb 27:S1015-9584(24)00365.
    Abstract

  550. MELONI P, Simari T, Roberta L, Cassella I, et al
    Occult invasive cervical cancer, FIGO stage III, with a negative Pap smear test - clinical presentation and brief review of the literature.
    Ceska Gynekol. 2024;89:34-39.
    Abstract

  551. STUEBS FA, Behrens AS, Seibold A, Adler W, et al
    Impact of the Corona Pandemic on Cervical Cancer Screening Assessment.
    In Vivo. 2024;38:734-740.
    Abstract

  552. PLANTE M, Kwon JS, Ferguson S, Samouelian V, et al
    Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer.
    N Engl J Med. 2024;390:819-829.
    Abstract

  553. SATANOVA A, Bolatbekova R, Kukubassov Y, Ossikbayeva S, et al
    Vaccination Effectiveness against Human Papillomavirus in Kazakhstan.
    Asian Pac J Cancer Prev. 2024;25:681-688.
    Abstract

  554. MOTAMEDINASAB M, Karimi-Zarchi M, Marzbanrad Z, Mirmohammadi SR, et al
    Lack of Association between TP73 G4C14-A4T14 Polymorphism and Cervical Cancer Risk in Overall and Asian Women: A Meta-Analysis.
    Asian Pac J Cancer Prev. 2024;25:661-670.
    Abstract

  555. PANTA S, Rajaram S, Heda A, Bhadoria AS, et al
    Community Screening for High-Risk Human Papilloma Virus Infection using Self-Sampling and 'Point-Of-Care' Test.
    Asian Pac J Cancer Prev. 2024;25:653-659.
    Abstract

  556. THIMMAIAH N, Malavade V, A S UK, S S, et al
    Dosimetric Comparison of Isodose Surface Volume and Total Reference Air Kerma (TRAK) based Volume in Cervical Cancer Brachytherapy.
    Asian Pac J Cancer Prev. 2024;25:587-594.
    Abstract

  557. SHARMA V, Sinha ES, Singh J
    Investigation of in-vitro Anti-Cancer and Apoptotic Potential of Garlic-Derived Nanovesicles against Prostate and Cervical Cancer Cell Lines.
    Asian Pac J Cancer Prev. 2024;25:575-585.
    Abstract

  558. SABRI NA, Shamsuddin SH, Mat Zin AA
    Evaluation of HPV 16 and HPV 18 Oncoprotein Expression as Alternative Diagnostic Tools in Cervical Lesion.
    Asian Pac J Cancer Prev. 2024;25:521-527.
    Abstract

  559. THASNEEM P, Sudhager A, Nalini C, J SSR, et al
    Out-reach Colposcopy Clinics and HPV Self-Sampling Decreases Loss to Follow up in a Community based Cervical Cancer Screening Programme.
    Asian Pac J Cancer Prev. 2024;25:419-424.
    Abstract

  560. CHEN M, Ye Z, Wang H, Cui X, et al
    Genotype, cervical intraepithelial neoplasia, and type-specific cervical intraepithelial neoplasia distributions in hrHPV+ cases referred to colposcopy: A multicenter study of Chinese mainland women.
    J Med Virol. 2024;96:e29475.
    Abstract

  561. DIALLO AA, Codjoe NNA, Ken-Amoah S, Agbeno EK, et al
    Cervical cancer prevention methods: awareness and use among urban Ghanaian women in Cape Coast, West Africa.
    Ecancermedicalscience. 2023;17:1626.
    Abstract

  562. OREKOYA AA, Abdus-Salam AA, Oyesegun AR, Ntekim AI, et al
    EGFR and HER2 expression in cervical cancer patients in Ibadan, Nigeria.
    Ecancermedicalscience. 2023;17:1607.
    Abstract

  563. AYTENEW TM, Kassie YT, Kebede SD
    Uptake of Cervical Cancer Screening and Its Barriers Using Health Belief Model Among Health Professionals Working in Public Hospitals in South Gondar Zone, Northcentral Ethiopia: Multicenter Cross-Sectional Study.
    Womens Health Rep (New Rochelle). 2024;5:152-160.
    Abstract

  564. LI W, Huang Y, Xiao M, Zhao J, et al
    PBRM1 presents a potential ctDNA marker to monitor response to neoadjuvant chemotherapy in cervical cancer.
    iScience. 2024;27:109160.
    Abstract

  565. ZHANG J, Niu S, Lu X, Hu R, et al
    Overall survival and short-term efficacy analysis of cervical squamous cell carcinoma with skeletal muscle and (18)F-FDG PET/CT parameters.
    Sci Rep. 2024;14:4809.
    Abstract

  566. QIN F, Sun X, Tian M, Jin S, et al
    Prediction of lymph node metastasis in operable cervical cancer using clinical parameters and deep learning with MRI data: a multicentre study.
    Insights Imaging. 2024;15:56.
    Abstract

  567. CHEN X, Zhang Z, Wang L, Zhang J, et al
    Homodimeric peptide radiotracer [(68)Ga]Ga-NOTA-(TMVP1)(2) for VEGFR-3 imaging of cervical cancer patients.
    Eur J Nucl Med Mol Imaging. 2024 Feb 27. doi: 10.1007/s00259-024-06661.
    Abstract

  568. ZHENG J, Huang B, Xiao L, Wu M, et al
    Effects of BRD4 inhibitor JQ1 on the expression profile of super-enhancer related lncRNAs and mRNAs in cervical cancer HeLa cells.
    PeerJ. 2024;12:e17035.
    Abstract

  569. GUAN W, Wang Y, Zhao H, Lu H, et al
    Prediction models for lymph node metastasis in cervical cancer based on preoperative heart rate variability.
    Front Neurosci. 2024;18:1275487.
    Abstract

  570. KNOTH J, Sturdza A, Zaharie A, Dick V, et al
    Transrectal ultrasound for intraoperative interstitial needle guidance in cervical cancer brachytherapy.
    Strahlenther Onkol. 2024 Feb 26. doi: 10.1007/s00066-024-02207.
    Abstract

  571. CHIGBU CO, Onyebuchi AK, Odugu BU, Ifebi CO, et al
    Pregnancy Outcome Following Treatment of Premalignant Lesion of the Cervix in Southeast Nigeria; A Retrospective Case-Control Study.
    Niger J Clin Pract. 2024;27:215-220.
    Abstract

  572. DING F, Liu J, Zhang X
    Retraction Note: MicroRNA-375 released from extracellular vesicles of bone marrow mesenchymal stem cells exerts anti-oncogenic effects against cervical cancer.
    Stem Cell Res Ther. 2024;15:51.
    Abstract

  573. ALLANSON ER, Zafar SN, Anakwenze CP, Schmeler KM, et al
    The global burden of cervical cancer requiring surgery: database estimates.
    Infect Agent Cancer. 2024;19:5.
    Abstract

  574. FAN X, He W, Zhang Q, Zhang B, et al
    Evaluation and Prediction Analysis of 3- and 5-Year Relative Survival Rates of Patients with Cervical Cancer: A Model-Based Period Analysis.
    Cancer Control. 2024;31:10732748241232324.
    Abstract

  575. EMERSON A, Dogan M, Hawes E, Wilson K, et al
    Cervical cancer screening barriers and facilitators from the perspectives of women with a history of criminal-legal system involvement and substance use.
    Health Justice. 2024;12:9.
    Abstract

  576. ZHANG S, Lin X, Xiao L, Wang Y, et al
    Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity.
    J Vis Exp. 2024;.
    Abstract

  577. YU C, Xu J, Xu S, Tang L, et al
    Exploring genetic associations of Crohn's disease and ulcerative colitis with extraintestinal cancers in European and East Asian populations.
    Front Immunol. 2024;15:1339207.
    Abstract

  578. CHAKRABARTI D, Qayoom S, Srivastava K, Resu AV, et al
    Cancer stem cell biomarkers SOX2 and Oct4 in cervical cancer patients undergoing chemoradiotherapy.
    Asia Pac J Clin Oncol. 2024 Feb 25. doi: 10.1111/ajco.14049.
    Abstract

  579. SHAN Y, Ding Z, Chen A, Cui Z, et al
    Incidence, prognostic factors, and a nomogram of cervical cancer with lung metastasis: A SEER-based study.
    J Gynecol Obstet Hum Reprod. 2024;53:102757.
    Abstract

  580. ZHANG L, Ju Y, Hu H, Ma C, et al
    Analytical evaluation of the automated genotyping system (GenPlex) compared to a traditional real-time PCR assay for the detection of high-risk human papillomaviruses.
    J Med Virol. 2024;96:e29496.
    Abstract

  581. OU-YANG X, Cao Y, Leng Q, Wang Y, et al
    Eliminating cervical cancer in China: Opportunities come and challenges remain.
    J Med Virol. 2024;96:e29480.
    Abstract

  582. HONDA KI, Miyama M, Nishii Y, Tasaka R, et al
    Metastasis of cervical cancer indicated by elevation of serum CA125 produced by mediastinal lymph nodes: a case report.
    J Med Case Rep. 2024;18:112.
    Abstract

  583. BIZZARRI N, Di Berardino S, Benkortbi K, Balaya V, et al
    External beam radiotherapy boost versus surgical debulking followed by radiotherapy for the treatment of metastatic lymph nodes in cervical cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108013.
    Abstract

  584. JIANG P, Jiang W, Li X, Zhu Q, et al
    Combination of Formononetin and Sulforaphane Natural Drug Repress the Proliferation of Cervical Cancer Cells via Impeding PI3K/AKT/mTOR Pathway.
    Appl Biochem Biotechnol. 2024 Feb 24. doi: 10.1007/s12010-024-04873.
    Abstract

  585. SRINATH S, Jishnu PV, Varghese VK, Shukla V, et al
    Regulation and tumor-suppressive function of the miR-379/miR-656 (C14MC) cluster in cervical cancer.
    Mol Oncol. 2024 Feb 23. doi: 10.1002/1878-0261.13611.
    Abstract

  586. ZHITKEVICH A, Bayurova E, Avdoshina D, Zakirova N, et al
    HIV-1 Reverse Transcriptase Expression in HPV16-Infected Epidermoid Carcinoma Cells Alters E6 Expression and Cellular Metabolism, and Induces a Hybrid Epithelial/Mesenchymal Cell Phenotype.
    Viruses. 2024;16:193.
    Abstract

  587. WEYKAMP F, Meixner E, Arians N, Hoegen-Sassmannshausen P, et al
    Daily AI-Based Treatment Adaptation under Weekly Offline MR Guidance in Chemoradiotherapy for Cervical Cancer 1: The AIM-C1 Trial.
    J Clin Med. 2024;13:957.
    Abstract

  588. UBINHA ACF, Pedrao PG, Tadini AC, Schmidt RL, et al
    The Role of Pelvic Exenteration in Cervical Cancer: A Review of the Literature.
    Cancers (Basel). 2024;16:817.
    Abstract

  589. FISCHEROVA D, Fruhauf F, Burgetova A, Haldorsen IS, et al
    The Role of Imaging in Cervical Cancer Staging: ESGO/ESTRO/ESP Guidelines (Update 2023).
    Cancers (Basel). 2024;16:775.
    Abstract

  590. OLTHOF EP, Wenzel HHB, van der Velden J, Stalpers LJA, et al
    Treatment Strategies Guided by [18F]FDG-PET/CT in Patients with Locally Advanced Cervical Cancer and [18F]FDG-Positive Lymph Nodes.
    Cancers (Basel). 2024;16:717.
    Abstract

  591. SAITO T, Imahashi K, Yamaki C
    Use of General Health Examination and Cancer Screening among People with Disability Who Need Support from Others: Analysis of the 2016 Comprehensive Survey of Living Conditions in Japan.
    Int J Environ Res Public Health. 2024;21:219.
    Abstract

  592. BERMUDEZ Y, Scott L, Miller J, DeGroff A, et al
    Are National Breast and Cervical Cancer Early Detection Program Recipients Providing Services in Counties Heavily Burdened by Breast and Cervical Cancer?
    Int J Environ Res Public Health. 2024;21:188.
    Abstract

  593. TAYLOR EV, Dugdale S, Connors CM, Garvey G, et al
    "A Huge Gap": Health Care Provider Perspectives on Cancer Screening for Aboriginal and Torres Strait Islander People in the Northern Territory.
    Int J Environ Res Public Health. 2024;21:141.
    Abstract

  594. OUH YT, Kim HY, Yi KW, Lee NW, et al
    Enhancing Cervical Cancer Screening: Review of p16/Ki-67 Dual Staining as a Promising Triage Strategy.
    Diagnostics (Basel). 2024;14:451.
    Abstract

  595. NAERT E, Van Hulle H, De Jaeghere EA, Orije MRP, et al
    Sexual health in Belgian cervical cancer survivors: an exploratory qualitative study.
    Qual Life Res. 2024 Feb 24. doi: 10.1007/s11136-024-03603.
    Abstract

  596. PARVEZ R, Vijayachari P, Thiruvengadam K, Roy A, et al
    A population based study on human papillomavirus infection and associated risk factors among women of the remote South Andaman Island, India.
    BMC Womens Health. 2024;24:139.
    Abstract

  597. LI M, Chen J, Zhang H, Zhang Y, et al
    LOC644656 promotes cisplatin resistance in cervical cancer by recruiting ZNF143 and activating the transcription of E6-AP.
    Cell Signal. 2024 Feb 21:111115. doi: 10.1016/j.cellsig.2024.111115.
    Abstract

  598. MIZUNO H, Nakaji T, Fukuda S, Kato S, et al
    End-to-end dosimetry audit for three-dimensional image-guided brachytherapy for cervical cancer.
    Phys Med. 2024;119:103321.
    Abstract

  599. WASHINGTON A, Smith L, Randall J, Anderson G, et al
    A Systematic Review of the Effectiveness of Cervical Cancer Screening and Prevention Interventions for African American Women: Implications for Promoting Health Equity.
    J Womens Health (Larchmt). 2024 Feb 23. doi: 10.1089/jwh.2023.0635.
    Abstract

  600. KILINC ISLEYEN E, Korkmaz Aslan G, Kartal A
    Knowledge and Perceptions About Cervical Cancer and Human Papillomavirus, and Relationship with E-health Literacy, and Affecting Factors Among Female University Students.
    J Adolesc Young Adult Oncol. 2024 Feb 23. doi: 10.1089/jayao.2023.0173.
    Abstract

  601. SONDER GJB, Grey C, Ryan D, Cumming J, et al
    Selective under-representation of Pacific peoples in population estimates for health indicator measurements in Aotearoa New Zealand misinforms policy making.
    BMC Public Health. 2024;24:564.
    Abstract

  602. MU J, Cao Y, Zhong X, Diao W, et al
    Prediction of cervical lymph node metastasis in differentiated thyroid cancer based on radiomics models.
    Br J Radiol. 2024;97:526-534.
    Abstract

  603. BARRA M, Chang M, Salcedo MP, Schmeler K, et al
    Single-tube four-target lateral flow assay detects human papillomavirus types associated with majority of cervical cancers.
    Anal Biochem. 2024;688:115480.
    Abstract

  604. GUERRA S, Roope LS, Tsiachristas A
    Assessing the relationship between coverage of essential health services and poverty levels in low- and middle-income countries.
    Health Policy Plan. 2024;39:156-167.
    Abstract

  605. ANDERSON LE, Collins KE, Myers L, Ireland MJ, et al
    Decisions and prompts to screen for cervical, bowel, and breast cancer.
    Patient Educ Couns. 2024;122:108174.
    Abstract

  606. YUCEL E, Koca Yildirim HE, Sahin Duran F, Cakir C, et al
    The role of cervical elastography in the differential diagnosis of preinvasive and invasive lesions of the cervix.
    Arch Gynecol Obstet. 2024;309:1585-1595.
    Abstract

  607. RENAUD J, Buissonniere P, Dulau C, Deloire M, et al
    Gynaecological follow-up for women of reproductive age with multiple sclerosis: The GYNESEP study.
    Mult Scler Relat Disord. 2024;83:105448.
    Abstract

  608. AHADINEZHAD B, Maleki A, Amerzadeh M, Mohtashamzadeh B, et al
    What rate of Iranian women perform Pap smear test? Results from a meta-analysis.
    Prev Med. 2024;180:107871.
    Abstract

  609. BAEK SU, Lee YM, Yoon JH
    Association between long working hours and engagement in preventive healthcare services in Korean workers: Findings from the Korean National Health and Nutrition Examination Survey.
    Prev Med. 2024;180:107849.
    Abstract

  610. URWIN S, Gillibrand S, Davies JC, Crosbie EJ, et al
    Factors associated with cervical screening coverage: a longitudinal analysis of English general practices from 2013 to 2022.
    J Public Health (Oxf). 2024;46:e43-e50.
    Abstract

  611. NAEGELE S, Ruiz-Torres DA, Zhao Y, Goss D, et al
    Comparing the Diagnostic Performance of Quantitative PCR, Digital Droplet PCR, and Next-Generation Sequencing Liquid Biopsies for Human Papillomavirus-Associated Cancers.
    J Mol Diagn. 2024;26:179-190.
    Abstract

  612. KUENKEL E, Jaeger A, Bohlmann I, Bergauer F, et al
    The use of colposcopy for triage in HPV-positive women aged 65 years and older.
    Arch Gynecol Obstet. 2024;309:1561-1567.
    Abstract

  613. YADAV R, Bhawale R, Kapoor DN, Singh SB, et al
    Experimental design approach for development of carboplatin loaded chitosan modified liposomal formulation with improved topical vaginal therapeutic potential.
    Pharm Dev Technol. 2024;29:1-12.
    Abstract

  614. BAO Y, Zhang H, Huang W, Luo X, et al
    Novel predictors for identifying cervical minimal deviation adenocarcinoma patients with poor prognosis: a long-term observational study in a tertiary centre.
    Arch Gynecol Obstet. 2024;309:1483-1490.
    Abstract

  615. REYNOSO-NOVERON N, Torres-Dominguez JA, Morales-Juarez L, Mohar-Betancourt A, et al
    Analysis of cancer mortality in Mexico using the results of the Global Burden of Disease 2021 study.
    Gac Med Mex. 2023;159:574-581.
    Abstract

  616. SONG YL, Li RZ, Feng BJ, Lu YH, et al
    Survival after minimally invasive radical hysterectomy with protective colpotomy for early-stage cervical cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108240.
    Abstract

  617. YOON HJ, Kwon BS, Rho HJ, Lee TH, et al
    Comparison of survival outcome of open, total laparoscopic, and laparoscopy-assisted radical vaginal hysterectomy for stage IB2 cervical cancer patients: A multicenter retrospective study.
    Medicine (Baltimore). 2024;103:e37426.
    Abstract

  618. ZHANG Z, Sun B, Lu J, Bai P, et al
    Norcantharidin inhibits the malignant progression of cervical cancer by inducing endoplasmic reticulum stress.
    Mol Med Rep. 2024;29:71.
    Abstract

  619. NITTALA MR, Yang J, Velazquez AE, Salvemini JD, et al
    Precision Population Cancer Medicine in Cancer of the Uterine Cervix: A Potential Roadmap to Eradicate Cervical Cancer.
    Cureus. 2024;16:e53733.
    Abstract

  620. LI X, Ning R, Xiao B, Meng S, et al
    A multi-variable predictive warning model for cervical cancer using clinical and SNPs data.
    Front Med (Lausanne). 2024;11:1294230.
    Abstract

  621. LIU L, Huang L, Deng L, Li F, et al
    Bioinformatics identification of characteristic genes of cervical cancer via an artificial neural network.
    Chin Clin Oncol. 2024;13:4.
    Abstract

  622. SHI R, Chang L, Shi L, Zhang Z, et al
    Development and validation of a prognostic model for cervical cancer by combination of machine learning and high-throughput sequencing.
    Eur J Surg Oncol. 2024;50:108241.
    Abstract

  623. WANG C, Zhang M, Peng J, Zhang M, et al
    Combining cisplatin with Pinellia pedatisecta Schott lipid-soluble extract induces tumor immunogenic cell death in cervical cancer.
    Phytomedicine. 2024;128:155504.
    Abstract

  624. LUO PH, Mo DC, Wang HL, Liang XJ, et al
    Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab.
    J Clin Oncol. 2024 Mar 7:JCO2302479. doi: 10.1200/JCO.23.02479.
    Abstract

  625. FENNELL BS, Jones SR, Sutton SK, Hoogland CE, et al
    In-Clinic vs. Online Recruitment of Women with a History of Cervical Intraepithelial Neoplasia or Cervical Cancer to a Smoking Cessation Trial: A Post-hoc Comparison of Participant Characteristics, Study Retention, and Cessation Outcomes.
    Nicotine Tob Res. 2024 Mar 7:ntae049. doi: 10.1093.
    Abstract

  626. LUIZ ODC, Nisida V, Silva Filho AMD, Souza ASP, et al
    Racial iniquity in mortality from cervical cancer in Brazil: a time trend study from 2002 to 2021.
    Cien Saude Colet. 2024;29:e05202023.
    Abstract

  627. XU X, Ping P, Zhang Z, Zou L, et al
    Plasma free fatty acid levels in cervical cancer: concurrent chemoradiotherapy improves abnormal profile.
    Front Pharmacol. 2024;15:1352101.
    Abstract

  628. WANG Y, Xu M, Yao Y, Li Y, et al
    Extracellular cancer?associated fibroblasts: A novel subgroup in the cervical cancer microenvironment that exhibits tumor?promoting roles and prognosis biomarker functions.
    Oncol Lett. 2024;27:167.
    Abstract

  629. IWATA T, Matsui T, Matsuda R, Katoh Y, et al
    [?. Immunotherapy in Cervical Cancer-Current Approaches and Future Horizons].
    Gan To Kagaku Ryoho. 2024;51:134-137.
    Abstract

  630. AHN SY
    Mitofusin-2 enhances cervical cancer progression through Wnt/beta-catenin signaling.
    BMB Rep. 2024 Mar 7:6097.
    Abstract

  631. OLALEYE OO, Kim DH, Spriggs KA
    Antiproliferative activities of some selected Nigerian medicinal plants against breast, liver, and cervical cancer cells.
    BMC Complement Med Ther. 2024;24:110.
    Abstract

  632. ROMERO D
    Non-inferiority of simple versus radical hysterectomy in low-risk cervical cancer.
    Nat Rev Clin Oncol. 2024 Mar 6. doi: 10.1038/s41571-024-00879.
    Abstract

  633. LI X, He S, Zhao X, Sun D, et al
    High-grade cervical lesions diagnosed by JAM3/PAX1 methylation in high-risk human papillomavirus-infected patients.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48:1820-1829.
    Abstract

  634. WENTZENSEN N, Garcia F, Clarke MA, Massad LS, et al
    Enduring Consensus Guidelines for Cervical Cancer Screening and Management: Introduction to the Scope and Process.
    J Low Genit Tract Dis. 2024 Mar 6. doi: 10.1097/LGT.0000000000000804.
    Abstract

  635. SINHA A, Ghosh S, Ghosh A, Ghosh A, et al
    Unfurling the functional association between long intergenic noncoding RNAs (lincRNAs) and HPV16-related cervical cancer pathogenesis through weighted gene co-expression network analysis of differentially expressed lincRNAs and coding genes.
    Carcinogenesis. 2024 Mar 6:bgae019. doi: 10.1093.
    Abstract

  636. SOLEIMANI-JELODAR R, Arashkia A, Shoja Z, Akhavan S, et al
    The expression analysis of human endogenous retrovirus-K Env, Np9, and Rec transcripts in cervical cancer.
    J Med Virol. 2024;96:e29501.
    Abstract

  637. VILASBOAS-RIBEIRO I, Sumser K, Nouwens S, Feddersen T, et al
    Adapting Temperature Predictions to MR Imaging in Treatment Position to Improve Simulation-Guided Hyperthermia for Cervical Cancer.
    IEEE Open J Eng Med Biol. 2023;5:99-106.
    Abstract

  638. ANYOLO E, Amakali K, Amukugo HJ
    Attitudes of women towards screening, prevention and treatment of cervical cancer in Namibia.
    Health SA. 2024;29:2433.
    Abstract

  639. SONG X, Li X, Tan Z, Zhang L, et al
    Recent status and trends of nanotechnology in cervical cancer: a systematic review and bibliometric analysis.
    Front Oncol. 2024;14:1327851.
    Abstract

  640. JIANG M, Wu R, Liu D, Wang X, et al
    Utilizing Ni(II) complex for metal drug-gel particles in cervical cancer treatment and designing novel drugs through machine learning methods.
    Sci Rep. 2024;14:5421.
    Abstract

  641. SAITSU Y, Yoneda S, Fukuta K
    Management of a pregnant woman with a large cervical polyp and moderate genital bleeding in the first trimester.
    BMJ Case Rep. 2024;17:e258163.
    Abstract

  642. SHARMA V, Sinha ES, Singh J
    Investigation of In Vitro Anti-cancer and Apoptotic Potential of Onion-Derived Nanovesicles Against Prostate and Cervical Cancer Cell Lines.
    Appl Biochem Biotechnol. 2024 Mar 5. doi: 10.1007/s12010-024-04872.
    Abstract

  643. MAZUREC K, Trzeszcz M, Mazurec M, Streb J, et al
    Should we use risk selection tests for HPV 16 and/or 18 positive cases: Comparison of p16/Ki67 and cytology.
    J Med Virol. 2024;96:e29500.
    Abstract

  644. SHANAZAROV NA, Zare A, Mussin NM, Albayev RK, et al
    Photodynamic therapy of cervical cancer: a scoping review on the efficacy of various molecules.
    Ther Adv Chronic Dis. 2024;15:20406223241233206.
    Abstract

  645. DANIELS J, Asante K, Tackie JNO, Kyei KA, et al
    Survival rate of cervical cancer: a five year review at a Major Teaching Hospital in Ghana, West Africa.
    Ecancermedicalscience. 2024;18:1663.
    Abstract

  646. CHEN W, Wang R, Wu J, Wu Y, et al
    Comparison of surgical and oncological outcomes between different surgical approaches for overweight or obese cervical cancer patients.
    J Robot Surg. 2024;18:107.
    Abstract

  647. YE D, Duan X, Guan B, Yuan J, et al
    Biomarker cystatin B expression correlates with pathogenesis in cervical cancer.
    J Int Med Res. 2024;52:3000605241233959.
    Abstract

  648. KAIKSOW FA, Burns M, Krebsbach J, Lasarev MR, et al
    Cervical Cancer and a History of Incarceration: Examining a Social Determinant of Health.
    J Correct Health Care. 2024 Mar 1. doi: 10.1089/jchc.23.05.0047.
    Abstract

  649. ROMLI R, Mohd Hashim S, Abd Rahman R, Chew KT, et al
    Understanding cervical cancer screening motivations from women and health practitioners' perspectives: A qualitative exploration.
    Gynecol Oncol Rep. 2024;52:101349.
    Abstract

  650. HEIDARI-EZZATI S, Moeinian P, Ahmadian-Nejad B, Maghbbouli F, et al
    The role of long non-coding RNAs and circular RNAs in cervical cancer: modulating miRNA function.
    Front Cell Dev Biol. 2024;12:1308730.
    Abstract

  651. ZHENG N, Tang J, Ren XM
    [Common Malignant Tumors in the Reproductive System of Chinese Women: Disease Burden During 1990-2019 and Prediction of Future Trend].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024;46:25-32.
    Abstract

  652. PAL A, Sengupta S, Kundu R
    Corrigendum to "Tiliacora racemosa leaves induce oxidative stress mediated DNA damage leading to G2/M phase arrest and apoptosis in cervical cancer cells SiHa" [J. Ethnopharmacol. 269 (2021) 113686].
    J Ethnopharmacol. 2024 Mar 2:117916. doi: 10.1016/j.jep.2024.117916.
    Abstract

  653. ZHAO J, Liu Q, Jiang D, Chen T, et al
    Comparative study of tumor-free laparoscopic and open surgery in the treatment of early-stage cervical cancer.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48:1686-1695.
    Abstract

  654. ZAROCOSTAS J
    Renewed calls to scale-up cervical cancer screening.
    Lancet. 2024;403:797.
    Abstract

  655. LU Z, Fan P, Huo W, Feng Y, et al
    Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer.
    Transl Oncol. 2024;44:101923.
    Abstract

  656. REN J, Chen X, Li J, Zan Y, et al
    TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy.
    Epigenetics. 2024;19:2323751.
    Abstract

  657. XU H, Ding H, Ge Q, Shi C, et al
    The effects of laparoscopic and laparotomy extensive hysterectomy on the safety of ureterovaginal fistula infection in patients with cervical cancer.
    Cell Mol Biol (Noisy-le-grand). 2024;70:281-284.
    Abstract

  658. HOLLINGTON M
    Cox proportional hazard-model application: time to cervical cancer screening among women living with HIV in South Africa.
    Infect Agent Cancer. 2024;19:6.
    Abstract

  659. WU J, Tang J, Luo Y, Li W, et al
    Intraoperative implantation of 125I seeds improves prognosis in refractory stage IIIB cervical cancer: a case report and literature review.
    BMC Womens Health. 2024;24:153.
    Abstract

  660. COUTINHO F, Gokhale M, Doran C, Monberg M, et al
    Characteristics, treatment patterns, and outcomes in patients with high-risk locally advanced cervical cancer.
    Cancer Treat Res Commun. 2024;39:100800.
    Abstract

  661. BIAN Z, Wu X, Chen Q, Gao Q, et al
    Oct4 activates IL-17A to orchestrate M2 macrophage polarization and cervical cancer metastasis.
    Cancer Immunol Immunother. 2024;73:73.
    Abstract

  662. ZHANG J, Zha T, Wang X, He W, et al
    Prevalence and genotype distribution of HPV infections among women in Chengdu,China.
    Virol J. 2024;21:52.
    Abstract

  663. TEKPOR E, Effah K, Sifa J, Amuah JE, et al
    Prevalence of high-risk human papillomavirus infection and cervical lesions among female migrant head porters (kayayei) in Accra, Ghana: a pilot cross-sectional study.
    BMC Public Health. 2024;24:659.
    Abstract

  664. WANG H, Li C, Wei Q, Zhang E, et al
    RBM15 Knockdown Impairs the Malignancy of Cervical Cancer by Mediating m6A Modification of Decorin.
    Biochem Genet. 2024 Mar 1. doi: 10.1007/s10528-024-10757.
    Abstract

  665. PIAO L, Xiang P, Zhou Y, Zhao W, et al
    Thermo-sensitive PLGA-PEG-PLGA hydrogel for sustained release of EGF to inhibit cervical cancer recurrence.
    Colloids Surf B Biointerfaces. 2024;236:113795.
    Abstract

  666. PALMER C, Dolk C, Sabale U, Wang W, et al
    Cost-effectiveness of nonavalent HPV vaccination in the Netherlands.
    Expert Rev Vaccines. 2024;23:312-323.
    Abstract

  667. MARTINELLI M, Latsuzbaia A, Bonde J, Pedersen H, et al
    Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples.
    Microbiol Spectr. 2024;12:e0287223.
    Abstract

  668. ZHAO X, Singhal A, Park S, Kong J, et al
    Cancer Mutations Converge on a Collection of Protein Assemblies to Predict Resistance to Replication Stress.
    Cancer Discov. 2024;14:508-523.
    Abstract

  669. AGGARWAL S, Agarwal P, Gupta N
    A comprehensive narrative review of challenges and facilitators in the implementation of various HPV vaccination program worldwide.
    Cancer Med. 2024;13:e6862.
    Abstract

  670. HUANG Y, Kang Y, Li Y, Cai L, et al
    HPV positivity status in males is related to the acquisition of HPV infection in females in heterosexual couples.
    Eur J Clin Microbiol Infect Dis. 2024 Jan 4. doi: 10.1007/s10096-023-04722.
    Abstract

  671. DE JONG A, Baeten IGT, Jansen A, Hoogendam JP, et al
    Symptomatic Lymphocele After Robot-Assisted Pelvic Lymphadenectomy as Part of the Primary Surgical Treatment for Cervical and Endometrial Cancer: A Retrospective Cohort Study.
    J Minim Invasive Gynecol. 2024;31:243-249.
    Abstract

  672. WANG B, Zhang C, Su Y, Yuan S, et al
    Comparative study of topical 5-aminolevulinic acid photodynamic therapy and surgery in treating vaginal high-grade squamous intraepithelial lesions following hysterectomy.
    Photodiagnosis Photodyn Ther. 2024;45:103921.
    Abstract

  673. OREN EDT, Kiziltas S
    Sexual quality of life between healthy women and women with gynecological cancer: Results of a hospital-based case-control study in Turkiye.
    J Obstet Gynaecol Res. 2024;50:456-466.
    Abstract

  674. SHANAZAROV N, Bariyeva G, Avdeyev A, Albayev R, et al
    Evaluation of the effectiveness and safety of photodynamic therapy in the treatment of precancerous diseases of the cervix (neoplasia) associated with the human papillomavirus: A systematic review.
    Photodiagnosis Photodyn Ther. 2024;45:103925.
    Abstract

  675. DAVARO E, Tinnirello AA, Bevers TB, Milbourne A, et al
    Efficacy of Cobas HPV testing for predicting grade 2+ cervical intraepithelial neoplasia in a cancer prevention center and a gynecologic oncology clinic: A single-institution experience.
    Cancer Cytopathol. 2024;132:152-160.
    Abstract

  676. WHITTAKER M, Davies JC, Sargent A, Sawyer M, et al
    A comparison of the carbon footprint of alternative sampling approaches for cervical screening in the UK: A descriptive study.
    BJOG. 2024;131:699-708.
    Abstract

  677. RAY S, Mulchandani R, Patel P
    Demand and willingness to pay for human papilloma virus vaccine for their daughters among mothers in Haryana, India: A contingent valuation study.
    J Health Serv Res Policy. 2024;29:76-83.
    Abstract

  678. RUBAGUMYA F, Wilson B, Manirakiza A, Mutabazi E, et al
    Financial Toxicity: Unveiling the Burden of Cancer Care on Patients in Rwanda.
    Oncologist. 2024;29:e345-e350.
    Abstract

  679. LI X, Ren C, Huang A, Zhao Y, et al
    PIBF1 regulates multiple gene expression via impeding long-range chromatin interaction to drive the malignant transformation of HPV16 integration epithelial cells.
    J Adv Res. 2024;57:163-180.
    Abstract

  680. DAU H, Nankya E, Naguti P, Basemera M, et al
    The economic burden of cervical cancer on women in Uganda: Findings from a cross-sectional study conducted at two public cervical cancer clinics.
    PLOS Glob Public Health. 2024;4:e0002554.
    Abstract

  681. CHEN F, Gong X, Zhang K, Yu Y, et al
    Nomogram Predicting Grade >/=2 Acute Radiation Enteritis in Patients With Cervical Cancer Receiving Concurrent Chemoradiotherapy.
    Am J Clin Oncol. 2024 Mar 15. doi: 10.1097/COC.0000000000001096.
    Abstract

  682. LIU CK, Huang KG, Chen MJ, Lu CH, et al
    The Current Trend of Fertility Preservation in Patients with Cervical Cancer.
    Gynecol Minim Invasive Ther. 2023;13:4-9.
    Abstract


  683. Erratum: A Comparison of Conventional Pap Smear and Liquid-Based Cytology for Cervical Cancer Screening.
    Gynecol Minim Invasive Ther. 2024;13:68.
    Abstract

  684. PALAGUDI M, Para S, Golla N, Meduri KC, et al
    Adverse Effects of Cancer Treatment in Patients With Cervical Cancer.
    Cureus. 2024;16:e54106.
    Abstract

  685. OTSUKA I
    Peritoneal Recurrence of Squamous Cell Carcinoma in a Young Woman After Conization for Microinvasive Cervical Cancer.
    Cureus. 2024;16:e54091.
    Abstract

  686. TSEGAYE AT, Lin J, Cole A, Szpiro AA, et al
    Association of Maternal Cervical Cancer Screening Adherence with Adolescent HPV Vaccination Among Adolescent-Mother Pairs.
    J Community Health. 2024 Mar 14. doi: 10.1007/s10900-024-01333.
    Abstract

  687. XIAO Y, Chen W, Long X, Li M, et al
    3D MR elastography-based stiffness as a marker for predicting tumor grade and subtype in cervical cancer.
    Magn Reson Imaging. 2024 Mar 12:S0730-725X(24)00062.
    Abstract

  688. HWANG WY, Choi CH, Kim K, Kim MH, et al
    Determination of ovarian transposition through prediction of postoperative adjuvant therapy in young patients with early stage cervical cancer undergoing surgery: a Korean multicenter retrospective study (KGOG 1042).
    Obstet Gynecol Sci. 2024 Mar 14. doi: 10.5468/ogs.23291.
    Abstract

  689. DONG Y, Jiang G, Qu H, Zhuang H, et al
    Effectiveness of a narrative nursing intervention on reproductive concerns in women of childbearing age undergoing cervical cancer surgery: A randomized controlled trial.
    Eur J Oncol Nurs. 2024;70:102537.
    Abstract

  690. KE Y, Zhang Z, Li Y, Qin Y, et al
    Prognostic value of lymph node ratio in patients with non-metastatic cervical cancer treated with radical hysterectomy: A population-based study.
    Eur J Surg Oncol. 2024;50:108258.
    Abstract

  691. CHAPMAN HL, Dholakia JJ, Marcrom S, Liang M, et al
    Treatment of Cervical Cancer Complicated by Advanced Pelvic Organ Prolapse: A Case Report.
    Urogynecology (Phila). 2024;30:309-313.
    Abstract


  692. Retraction: miR-212/132 downregulates SMAD2 expression to suppress the G1/S phase transition of the cell cycle and the epithelial to mesenchymal transition in cervical cancer cells.
    IUBMB Life. 2024 Mar 14. doi: 10.1002/iub.2815.
    Abstract

  693. SHALABY NA, Tudorescu-Morjan C, Manole CG, Iacata AA, et al
    Correlation between high-risk HPV infection and p16/Ki-67 abnormalities in Pap samples in a South Eastern Europe cohort.
    J Med Virol. 2024;96:e29524.
    Abstract

  694. YADAV P, Gaurav A, Ravi AK, Khoiwal K, et al
    Cervical cancer awareness, knowledge, behavioural patterns, and practice of screening and vaccination in females of hilly regions of North India - A hospital-based observational study.
    J Family Med Prim Care. 2024;13:43-47.
    Abstract

  695. ZHAO M, Gao MZ, Gu RY, Luo L, et al
    The Risk of Cervical Cancer in Women Among Han, Bai, Dai and Hani Ethnic Minorities in Yunnan Province of China.
    Int J Womens Health. 2024;16:373-384.
    Abstract

  696. LIN Z, Li X, Shi H, Cao R, et al
    Decoding the tumor microenvironment and molecular mechanism: unraveling cervical cancer subpopulations and prognostic signatures through scRNA-Seq and bulk RNA-seq analyses.
    Front Immunol. 2024;15:1351287.
    Abstract

  697. MA C, Zou M, Xu N, Liu Y, et al
    Portable, and ultrasensitive HR-HPV tests based on nucleic acid biosensors.
    Front Cell Infect Microbiol. 2024;14:1357090.
    Abstract

  698. DONG EE, Xu J, Kim JW, Bryan J, et al
    Apparent diffusion coefficient values predict response to brachytherapy in bulky cervical cancer.
    Radiat Oncol. 2024;19:35.
    Abstract

  699. DONG X, Zhan Y, Li S, Yang M, et al
    MKRN1 regulates the expression profiles and transcription factor activity in HeLa cells inhibition suppresses cervical cancer cell progression.
    Sci Rep. 2024;14:6129.
    Abstract

  700. LONG J, Chen X, He M, Ou S, et al
    HLA-class II restricted TCR targeting human papillomavirus type 18 E7 induces solid tumor remission in mice.
    Nat Commun. 2024;15:2271.
    Abstract

  701. KURATSUNE K, Ueda T, Tajiri R, Tohyama A, et al
    [A Case of Adenocarcinoma, HPV-independent, Mesonephric Type with Significant Response to Neoadjuvant Chemotherapy].
    J UOEH. 2024;46:45-51.
    Abstract

  702. SHELTON J, Zotow E, Smith L, Johnson SA, et al
    25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis.
    BMJ. 2024;384:e076962.
    Abstract

  703. GOCIMAN S, Florell SR, Clarke JT
    Cutaneous metastasis as a first sign of adenocarcinoma of the cervix.
    Dermatol Online J. 2023;29.
    Abstract

  704. JIN S, Wang W, Xu X, Yu Z, et al
    miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer.
    Acta Biochim Biophys Sin (Shanghai). 2024 Mar 13. doi: 10.3724/abbs.2024009.
    Abstract

  705. FENG J, Wang T
    [Retracted] MicroRNA?873 serves a critical role in human cervical cancer proliferation and metastasis via regulating glioma?associated oncogene homolog 1.
    Exp Ther Med. 2024;27:163.
    Abstract

  706. LEE F, McGue S, Chapola J, Dunda W, et al
    Experiences of women participating in a human papillomavirus-based screen-triage-and treat strategy for cervical cancer prevention in Malawi.
    Front Oncol. 2024;14:1356654.
    Abstract

  707. WANG P, Gao D, Yu X, Zhu G, et al
    Value of high?risk human papillomavirus detection combined with colposcopy in the diagnosis of cervical cancer and precancerous lesions.
    Oncol Lett. 2024;27:185.
    Abstract

  708. FELIX MM, Tavares MV, Santos IP, Batista de Carvalho ALM, et al
    Cervical Squamous Cell Carcinoma Diagnosis by FTIR Microspectroscopy.
    Molecules. 2024;29:922.
    Abstract

  709. WATTANATHAVORN W, Seki M, Suzuki Y, Buranapraditkun S, et al
    Downregulation of LAMB3 Altered the Carcinogenic Properties of Human Papillomavirus 16-Positive Cervical Cancer Cells.
    Int J Mol Sci. 2024;25:2535.
    Abstract

  710. EUSTACE N, Liu J, Ladbury C, Tam A, et al
    Current Status and Future Directions of Image-Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer.
    Cancers (Basel). 2024;16:1031.
    Abstract

  711. HALD SR, Tatari CR, Kirkegaard P, Tranberg M, et al
    "Well, that Was Pretty Clever!"-Ethnic Minority Women's Views on HPV Self-Sampling Devices for Cervical Cancer Screening: Attitudes to Brushes, First-Void Urine, and Menstrual Blood Devices.
    J Racial Ethn Health Disparities. 2024 Mar 12. doi: 10.1007/s40615-024-01963.
    Abstract

  712. CAO C, Xu Q, Zhu Z, Xu M, et al
    Three-dimensional chromatin analysis reveals Sp1 as a mediator to program and reprogram HPV-host epigenetic architecture in cervical cancer.
    Cancer Lett. 2024 Mar 10:216809. doi: 10.1016/j.canlet.2024.216809.
    Abstract

  713. TALIENTO C, Scutiero G, Arcieri M, Pellecchia G, et al
    Simple hysterectomy versus radical hysterectomy in early-stage cervical cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2024;50:108252.
    Abstract

  714. PEREIRA MTM, Charret TS, Wermelinger GF, Nogueira TSR, et al
    Evaluation of the Antiproliferative Potential of yellow Jaboticaba (Myrciaria glazioviana) extracts against Human Cervical Cancer (HeLa cells line) and the Analysis of their Chemical Composition by HPLC-HRESIMS.
    Chem Biodivers. 2024 Mar 12:e202301467. doi: 10.1002/cbdv.202301467.
    Abstract

  715. PATEL D, Tayade S, Singh Thakur A, Singh S, et al
    Revolutionizing Early-Stage Cervical Cancer Treatment: A Comprehensive Review of Radical Trachelectomy as a Minimally Invasive Approach.
    Cureus. 2024;16:e53958.
    Abstract

  716. OLAKUNDE BO, Itanyi IU, Olawepo JO, Liu L, et al
    Comparative effectiveness of implementation strategies for Accelerating Cervical Cancer Elimination through the integration of Screen-and-treat Services (ACCESS study): protocol for a cluster randomized hybrid type III trial in Nigeria.
    Implement Sci. 2024;19:25.
    Abstract

  717. LUO Y, Liu Z, Hu X
    ceRNA Network and WGCNA Analyses of Differentially Expressed Genes in Cervical Cancer Tissues for Association with Survival of Patients.
    Reprod Sci. 2024 Mar 11. doi: 10.1007/s43032-024-01477.
    Abstract

  718. LAMICHHANE B, Adhikari B, Poudel L, Pandey AR, et al
    Factors associated with uptake of breast and cervical cancer screening among Nepalese women: Evidence from Nepal Demographic and Health Survey 2022.
    PLOS Glob Public Health. 2024;4:e0002971.
    Abstract

  719. MBWANJI G, Mazigo HD, Maganga JK, Downs JA, et al
    Female genital schistosomiasis is a neglected public health problem in Tanzania: Evidence from a scoping review.
    PLoS Negl Trop Dis. 2024;18:e0011954.
    Abstract

  720. SETAYESHI S, Hasanzadeh A, Yahyapour Y, Alizadeh A, et al
    Evaluation of human papillomavirus type 16 viral load and genome physical status in Iranian women with cervical disease.
    Mol Biol Rep. 2024;51:411.
    Abstract

  721. LIN YX, Zhao FF, Kong WM
    Effects of vaginal dilation therapy on vaginal length, vaginal stenosis, vaginal elasticity and sexual function of cervical cancer survivors.
    J Obstet Gynaecol. 2024;44:2317387.
    Abstract

  722. LU D, Chen X, Mu Y, Guo J, et al
    Clinical Efficacy of Sodium Cantharidate Vitamin B6 Combined with Concurrent Chemoradiotherapy in the Treatment of Local Advanced Cervical Cancer and its Influence on Tumor Markers.
    Altern Ther Health Med. 2024 Mar 8:AT10236.
    Abstract

  723. ALTINOK P, Ergen SA, Guzeloz Capar Z, Canyilmaz E, et al
    Awareness Level of Cervical Cancer Patients Referred to Radiation Oncology Outpatient Clinics-A Multicenter Study.
    J Low Genit Tract Dis. 2024 Mar 5. doi: 10.1097/LGT.0000000000000798.
    Abstract

  724. HAN L, Liu J, Shataer M, Wu C, et al
    The relationship between long non-coding gene CASC21 polymorphisms and cervical cancer.
    Cancer Biol Ther. 2024;25:2322207.
    Abstract

  725. MINGO BARBA S, Ademaj A, Marder D, Riesterer O, et al
    Theoretical evaluation of the impact of diverse treatment conditions by calculation of the tumor control probability (TCP) of simulated cervical cancer Hyperthermia-Radiotherapy (HT-RT) treatments in-silico.
    Int J Hyperthermia. 2024;41:2320852.
    Abstract

  726. LI C, Hua K
    Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes.
    Front Immunol. 2024;15:1386072.
    Abstract

  727. HU H, Wang Z, Xue L, Zhang T, et al
    Effects of neoadjuvant chemotherapy combined with radical laparoscopic surgery with quality nursing care on clinical efficacy and sex hormones in patients with cervical cancer.
    Am J Transl Res. 2024;16:477-486.
    Abstract

  728. SHIMELS T, Gashawbeza B, Gedif Fenta T
    Access to advanced healthcare services and its associated factors among patients with cervical cancer in Addis Ababa, Ethiopia.
    Front Oncol. 2024;14:1342236.
    Abstract

  729. IQBAL L, Jehan M, Azam S
    Advancements in mRNA Vaccines: A Promising Approach for Combating Human Papillomavirus-Related Cancers.
    Cancer Control. 2024;31:10732748241238629.
    Abstract

  730. MATSUDA Y, Nagamine Y, Irie T, Goto T, et al
    Effects of pain management using nonsteroidal anti-inflammatory drug suppositories during brachytherapy for cervical cancer: A single-center prospective observational study.
    Brachytherapy. 2024 Mar 9:S1538-4721(24)00003.
    Abstract

  731. BIZZARRI N, Fedele C, Teodorico E, Certelli C, et al
    Survival associated with the use of one-step nucleic acid amplification (OSNA) to detect sentinel lymph node metastasis in cervical cancer.
    Eur J Surg Oncol. 2024;50:108250.
    Abstract

  732. SINHA A, Ghosh A, Ghosh A, Mathai S, et al
    MAL expression downregulation through suppressive H3K27me3 marks at the promoter in HPV16-related cervical cancers is prognostically relevant and manifested by the interplay of novel MAL antisense long noncoding RNA AC103563.8, E7 oncoprotein and EZH2
    Clin Epigenetics. 2024;16:40.
    Abstract

  733. MEI J, Pan L, Huang M, Bao D, et al
    DDOST is associated with tumor immunosuppressive microenvironment in cervical cancer.
    Discov Oncol. 2024;15:69.
    Abstract

  734. GEBREEGZIABHER ZA, Semagn BE, Kifelew Y, Abebaw WA, et al
    Cervical cancer screening and its associated factors among women of reproductive age in Kenya: further analysis of Kenyan demographic and health survey 2022.
    BMC Public Health. 2024;24:741.
    Abstract

  735. FAROOQI HA, Nabi R
    Enhancing cervical cancer surveillance: Utilizing inflammatory markers for improved recurrence detection in low-resource settings and a call for prospective multi-centric studies.
    Eur J Surg Oncol. 2024 Mar 1:108239. doi: 10.1016/j.ejso.2024.108239.
    Abstract

  736. MENG Q, Zhang Y, Sun H, Yang X, et al
    Human papillomavirus-16 E6 activates the pentose phosphate pathway to promote cervical cancer cell proliferation by inhibiting G6PD lactylation.
    Redox Biol. 2024;71:103108.
    Abstract

  737. ROBLE JG, Ligon SE, Langan KL
    Leukocytoclastic Vasculitis Localized to the Uterine Cervix.
    Hawaii J Health Soc Welf. 2024;83:81-84.
    Abstract

  738. CHOI CI, Lee SJ, Choi JB, Kim TH, et al
    2023 Korean sexually transmitted infections guidelines by the Korean Association of Urogenital Tract Infection and Inflammation: Human papillomavirus vaccination.
    Investig Clin Urol. 2024;65:108-114.
    Abstract

  739. ZHAO F, Zhou W, Xin R, Miao X, et al
    Expression and clinical diagnostic value of CCHE1 in breast cancer.
    Mutagenesis. 2024;39:141-145.
    Abstract

  740. LI Z, Qiu W, Dong J, Ying X, et al
    Colon metastasis from malignant mullerian tumor of uterine cervix: A case report.
    Asian J Surg. 2024;47:1393-1394.
    Abstract

  741. BRENTNALL AR, Cuschieri K, Sargent A, Berkhof J, et al
    Staged design recommendations for validating relative sensitivity of self-sample human papillomavirus tests for cervical screening.
    J Clin Epidemiol. 2024;166:111227.
    Abstract

  742. ARTHUR AW, El-Zein M, Burchell AN, Tellier PP, et al
    Detection and Clearance of Type-Specific and Phylogenetically Related Genital Human Papillomavirus Infections in Young Women in New Heterosexual Relationships.
    J Infect Dis. 2024;229:691-706.
    Abstract

  743. MOHAMED AA, Shah V, Njeru JW, Wieland ML, et al
    Interventions to Increase Cancer Screening Adherence Among Somali Immigrants in the US and Europe: A Systematic Review.
    J Immigr Minor Health. 2024;26:385-394.
    Abstract

  744. ARKOUDIS NA, Kelekis NL
    Editorial for "Deep Learning Nomogram for the Identification of Deep Stromal Invasion in Patients With Early-Stage Cervical Adenocarcinoma and Adenosquamous Carcinoma: A Multicenter Study".
    J Magn Reson Imaging. 2024;59:1407-1408.
    Abstract

  745. XIAO ML, Qian T, Fu L, Wei Y, et al
    Deep Learning Nomogram for the Identification of Deep Stromal Invasion in Patients With Early-Stage Cervical Adenocarcinoma and Adenosquamous Carcinoma: A Multicenter Study.
    J Magn Reson Imaging. 2024;59:1394-1406.
    Abstract

  746. HAKAMI MA, Hazazi A, Alsulami MO, Alsaiari AA, et al
    Mitoxantrone 2HCl's adroit activity against cervical cancer replication and maintenance proteins: a multitargeted approach.
    J Biomol Struct Dyn. 2024 Mar 22:1-14. doi: 10.1080/07391102.2024.2329796.
    Abstract

  747. VAN ANH DT, Thang VH, Dung TA, Huyen TT, et al
    Outcome and toxicity of chemoradiation using volumetric modulated arc therapy followed by 3D image-guided brachytherapy for cervical cancer: Vietnam National Cancer Hospital experience.
    Rep Pract Oncol Radiother. 2024;28:784-793.
    Abstract

  748. GUO Y, Tao M, Jiang M
    [Retracted] MicroRNA?454?3p inhibits cervical cancer cell invasion and migration by targeting c?Met.
    Exp Ther Med. 2024;27:179.
    Abstract

  749. ZHI Y, Du P, Li Y, Liu H, et al
    SOX21-AS1 Augmented Cervical Cancer Growth by Triggering FZD3 to Activate the Wnt/beta-Catenin Signaling Pathway.
    Biochem Genet. 2024 Mar 21. doi: 10.1007/s10528-024-10770.
    Abstract

  750. SRIHARIKRISHNAA S, John FE, Bairy M, Shetty S, et al
    A comprehensive review on the functional role of miRNA clusters in cervical cancer.
    Epigenomics. 2024;16:493-511.
    Abstract

  751. XU B, Qian M, Zhu L, Lu Z, et al
    Study on the Relationship Between Uncertainty Tolerance and Positive Acceptance in Postoperative Patients With Cervical Cancer.
    Cureus. 2024;16:e54414.
    Abstract

  752. WU S, Jiao J, Yue X, Wang Y, et al
    Cervical cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with England and India based on the global burden of disease study 2019.
    Front Public Health. 2024;12:1358433.
    Abstract

  753. BARRISON L, Hoskins E
    Cervical cancer in a transgender man: lessons learnt to improve care.
    BMJ Case Rep. 2024;17:e258903.
    Abstract

  754. HAN M, Wang N, Han W, Liu X, et al
    Specific vaginal and gut microbiome and the anti-tumor effect of butyrate in cervical cancer women.
    Transl Oncol. 2024;44:101902.
    Abstract

  755. CIVIT-MASOT J, Luna-Perejon F, Munoz-Saavedra L, Dominguez-Morales M, et al
    A lightweight xAI approach to cervical cancer classification.
    Med Biol Eng Comput. 2024 Mar 20. doi: 10.1007/s11517-024-03063.
    Abstract

  756. ASGEDOM YS, Kebede TM, Seifu BL, Mare KU, et al
    Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis.
    Hum Vaccin Immunother. 2024;20:2326295.
    Abstract

  757. XIE N, Mei S, Dai C, Chen W, et al
    HDAC1-Mediated Downregulation of NEU1 Exacerbates the Aggressiveness of Cervical Cancer.
    Crit Rev Eukaryot Gene Expr. 2024;34:45-54.
    Abstract

  758. SALINGAROS S, Shieh Y, Finkel ML, Polaneczky M, et al
    Public cervical cancer screening recommendations from US cancer centers: Assessing adherence to national guidelines.
    J Med Screen. 2024 Mar 20:9691413241238960. doi: 10.1177/09691413241238960.
    Abstract

  759. ZHANG XF, Wu HY, Liang XW, Chen JL, et al
    Deep-learning-based radiomics of intratumoral and peritumoral MRI images to predict the pathological features of adjuvant radiotherapy in early-stage cervical squamous cell carcinoma.
    BMC Womens Health. 2024;24:182.
    Abstract

  760. HAMBISA HD, Asfaha BT, Ambisa B, Gudeta Beyisho A, et al
    Common predictors of cervical cancer related mortality in Ethiopia. A systematic review and meta-analysis.
    BMC Public Health. 2024;24:852.
    Abstract

  761. HOLT HK, Martinez G, Reyes MF, Saraiya M, et al
    Tubal Sterilization and Cervical Cancer Underscreening in the United States.
    J Womens Health (Larchmt). 2024 Mar 19. doi: 10.1089/jwh.2023.0610.
    Abstract

  762. GARCIA-VIELMA C, Cortes-Gutierrez EI, Fernandez JL, Davila-Rodriguez MI, et al
    DBD-FISH Using Specific Chromosomal Region Probes for the Study of Cervical Carcinoma Progression.
    Methods Mol Biol. 2024;2784:271-284.
    Abstract

  763. ARBYN M, Rousta P, Bruni L, Schollin Ask L, et al
    Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer.
    J Natl Cancer Inst. 2024 Mar 19:djae042. doi: 10.1093.
    Abstract

  764. MWENDA V, Mwangi M, Gathecha G, Kibachio J, et al
    Factors associated with late diagnosis of cervical cancer at two national referral hospitals, Kenya 2017: A case control study.
    Gynecol Oncol Rep. 2024;52:101355.
    Abstract

  765. AGIMAS MC, Adugna DG, Derseh NM, Kassaw A, et al
    Uptake of human papilloma virus vaccine and its determinants among females in East Africa: a systematic review and meta-analysis.
    BMC Public Health. 2024;24:842.
    Abstract

  766. DANTONY E, Uhry Z, Fauvernier M, Coureau G, et al
    Multidimensional penalized splines for survival models: illustration for net survival trend analyses.
    Int J Epidemiol. 2024;53:dyae033.
    Abstract

  767. TAKEKUMA M
    Challenges and perspectives on less invasive surgery for early-stage cervical cancer: a critical analysis of the SHAPE trial and its implications.
    J Gynecol Oncol. 2024;35:e48.
    Abstract

  768. LARSON S, McAnany B, Ladd I, Gogoi R, et al
    What do cervical cancer patients know, how do they learn, and who do they tell? A pilot study.
    J Eval Clin Pract. 2024 Mar 18. doi: 10.1111/jep.13964.
    Abstract

  769. WU S, Yue X, Wang Y
    A commentary on 'Effect of preoperative radiotherapy on stage IB2 and IIA2 cervical cancer: A retrospective cohort study'.
    Int J Surg. 2024 Mar 18. doi: 10.1097/JS9.0000000000001314.
    Abstract

  770. ALHARBI B, Alessa M, Alsayid H, Alareek L, et al
    Magnetic resonance imaging accuracy in assessing depth of invasion in tongue squamous cell carcinomas and predicting cervical nodal metastasis.
    Eur Rev Med Pharmacol Sci. 2024;28:1783-1790.
    Abstract

  771. ZHAO W, Wen S, Wang X, Wang J, et al
    Targeted regulation of miR-154-5p/Cullin2 pathway by hsa_circ_TRIM22 in promoting human papillomavirus 16 positive cervical cancer progression.
    J Cancer. 2024;15:2137-2146.
    Abstract

  772. ZHANG YM, Wang GC, Liu YJ, Wang YC, et al
    [Exploration of the method and efficacy of treatments for intractable pelvic pain caused by rectal or bladder fistula].
    Zhonghua Zhong Liu Za Zhi. 2024;46:263-268.
    Abstract

  773. LI ZM, Liang ZH, Liu N, Wei KR, et al
    [Net survival analysis of cancer in Zhongshan City of Guangdong Province in China, 1970 to 2014].
    Zhonghua Zhong Liu Za Zhi. 2024;46:232-238.
    Abstract

  774. BRUNO M, Bizzarri N, Scambia G, Ferrandina G, et al
    Reply to: 'Enhancing cervical cancer surveillance: Utilizing inflammatory markers for improved recurrence detection in low-resource settings and a call for prospective multi-centric studies'.
    Eur J Surg Oncol. 2024 Mar 12:108238. doi: 10.1016/j.ejso.2024.108238.
    Abstract

  775. ZHANG T, Ji T, Duan Z, Xue Y, et al
    Long non-coding RNA MLLT4 antisense RNA 1 induces autophagy to inhibit tumorigenesis of cervical cancer through modulating the myosin-9/ATG14 axis.
    Sci Rep. 2024;14:6379.
    Abstract

  776. JIN T, Yin T, Xu R, Liu H, et al
    Exploring the role of disulfidptosis-related signatures in immune microenvironment, prognosis and therapeutic strategies of cervical cancer.
    Transl Oncol. 2024;44:101938.
    Abstract

  777. KOMATSU H, Matsumoto K, Morita M, Nagasawa T, et al
    A survey of carboplatin desensitization therapy in Japan: A multicenter retrospective study.
    Cancer Med. 2024;13:e6968.
    Abstract

  778. ALATTAS M, Gordon S, Sabin LL, El-Jardali F, et al
    Equity and unmet need of non-communicable diseases services in Saudi Arabia using a National Household Survey (2019).
    BMC Health Serv Res. 2024;24:346.
    Abstract

  779. SRISUTTAYASATHIEN M, Kantathavorn N, Luasiripanthu T, Petchjorm S, et al
    Correlation between P16/Ki67 in cervical cytology and diagnosis of cervical intraepithelial neoplasia 2-3 in Thai women infected with high-risk types of human papillomavirus.
    Taiwan J Obstet Gynecol. 2024;63:192-198.
    Abstract

  780. HANDE V, Ranjan N, Chopra S, Sinha S, et al
    Longitudinal Costs of Image-Guided Intensity-Modulated Radiation Therapy Versus Three-Dimensional Conformal Radiation: Lessons From Phase III PARCER Trial for Shaping Resource-Stratified Guidelines in Low- and Middle-Income Countries.
    JCO Glob Oncol. 2024;10:e2300478.
    Abstract

  781. COURT LE, Aggarwal A, Jhingran A, Naidoo K, et al
    Artificial Intelligence-Based Radiotherapy Contouring and Planning to Improve Global Access to Cancer Care.
    JCO Glob Oncol. 2024;10:e2300376.
    Abstract

  782. YANG X, Ding B, Qin J, Guo L, et al
    HVS-Unsup: Unsupervised cervical cell instance segmentation method based on human visual simulation.
    Comput Biol Med. 2024;171:108147.
    Abstract

  783. FANG M, Fu M, Liao B, Lei X, et al
    Deep integrated fusion of local and global features for cervical cell classification.
    Comput Biol Med. 2024;171:108153.
    Abstract

  784. GHOUNEIMY A, Ali Z, Aman R, Jiang W, et al
    CRISPR-Based Multiplex Detection of Human Papillomaviruses for One-Pot Point-of-Care Diagnostics.
    ACS Synth Biol. 2024;13:837-850.
    Abstract

  785. SHIM SH, Lee JY, Lee YY, Park JY, et al
    Major clinical research advances in gynecologic cancer in 2023: a tumultuous year for endometrial cancer.
    J Gynecol Oncol. 2024;35:e66.
    Abstract

  786. YANG D, Lu X, Zhang X, Zhang X, et al
    RACK1 promotes the occurrence and progression of cervical carcinoma.
    J Clin Lab Anal. 2024;38:e25012.
    Abstract

  787. ZHAO D, Sun S, Yang Z, Wang P, et al
    The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
    Neoplasma. 2024;71:70-76.
    Abstract

  788. JONES KF, Osazuwa-Peters OL, Des Marais A, Merlin JS, et al
    Substance Use Disorders Among US Adult Cancer Survivors.
    JAMA Oncol. 2024;10:384-389.
    Abstract

  789. CHOI HC, Leung K, Wu JT
    Cervical screening among Chinese females in the era of HPV vaccination: a population-based survey on screening uptake and regular screening following an 18-year organized screening program.
    J Gynecol Oncol. 2024;35:e20.
    Abstract

  790. KEFALE B, Engidaw MT, Tesfa D, Molla M, et al
    Medication-related problems among patients with cervical cancers at oncology centers of University of Gondar comprehensive specialized hospital: A hospital-based retrospective study.
    J Oncol Pharm Pract. 2024;30:270-277.
    Abstract

  791. LI T, Zhang W, Niu M, Wu Y, et al
    STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.
    Front Immunol. 2024;15:1342647.
    Abstract

  792. INTERNATIONAL BR
    Retracted: LINC00707 Promotes Cell Proliferation in Cervical Cancer via the miR-374c-5p/SDC4 Axis.
    Biomed Res Int. 2024;2024:9769120.
    Abstract

  793. CAROBELI LR, Santos ABC, Martins LBM, Damke E, et al
    Recent advances in photodynamic therapy combined with chemotherapy for cervical cancer: a systematic review.
    Expert Rev Anticancer Ther. 2024 Mar 28. doi: 10.1080/14737140.2024.2337259.
    Abstract

  794. COLLARINO A, Feudo V, Pasciuto T, Florit A, et al
    Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?
    J Nucl Med. 2024 Mar 28:jnumed.123.267044. doi: 10.2967/jnumed.123.267044.
    Abstract

  795. KAMBLE A, Naik S, Talathi M, Jadhav D, et al
    Exploring the diversity of vaginal microbiota between healthy women and cervical cancer patients in India.
    J Med Microbiol. 2024;73.
    Abstract

  796. KROON KR, Bogaards JA, Heideman DA, Meijer CJ, et al
    Colposcopy referral and CIN3+ risk of human papillomavirus genotyping strategies in cervical cancer screening.
    Cancer Epidemiol Biomarkers Prev. 2024.
    Abstract

  797. WANG X, Chang Y, Pei X, Xu XG, et al
    A prior-information-based automatic segmentation method for the clinical target volume in adaptive radiotherapy of cervical cancer.
    J Appl Clin Med Phys. 2024 Mar 28:e14350. doi: 10.1002/acm2.14350.
    Abstract

  798. CHANGADE JV, Thanvi H, Raut C, Chavan M, et al
    In vitro Evaluation of Anti-Cancer Potential of Different Solvent Extracts Derived from Clerodendrum Infortunatum Linn against Cervical Cancer.
    Asian Pac J Cancer Prev. 2024;25:1065-1075.
    Abstract

  799. SHAMSI U, Zahid F, Abdul Jabbar AB, Musharraf MD, et al
    Human Papillomavirus Vaccine Awareness and Acceptability for Primary Prevention of Cervical Cancer in Pakistan: A Cross-Sectional Study.
    Asian Pac J Cancer Prev. 2024;25:813-820.
    Abstract

  800. PAL D, Sahoo BK, Taywade M, Maji S, et al
    Evidence of Knowledge, Attitude, and Practice Regarding Human Papilloma Virus Vaccination at the Community Level in India: A Systematic Review and Meta-analysis.
    Asian Pac J Cancer Prev. 2024;25:793-800.
    Abstract

  801. PATIL-TAKBHATE BR
    Cervical Cancer Screening Revolution: Advancements with Confocal Endomicroscopy.
    Asian Pac J Cancer Prev. 2024;25:723-724.
    Abstract

  802. WARLI SM, Tala MRZ, Wijaya WS
    Predictive Factors of Successful Double J Stent Insertion Among Advanced Cervical Cancer Patients.
    World J Oncol. 2024;15:239-245.
    Abstract

  803. LOONEN AJM, Verhagen F, Luijten-de Vrije I, Lentjes-Beer M, et al
    Vaginal dysbiosis seems associated with hrHPV infection in women attending the Dutch Cervical Cancer Screening Program.
    Front Cell Infect Microbiol. 2024;14:1330844.
    Abstract

  804. HERNANDEZ-SILVA CD, Ramirez de Arellano A, Pereira-Suarez AL, Ramirez-Lopez IG, et al
    HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and Effect of Vaccination in Latin American Women.
    Viruses. 2024;16:327.
    Abstract

  805. GARCIA-ROCHA R, Monroy-Garcia A, Vazquez-Cruz AL, Marin-Aquino LA, et al
    Adenosine Increases the Immunosuppressive Capacity of Cervical Cancer Cells by Increasing PD-L1 Expression and TGF-beta Production through Its Interaction with A(2A)R/A(2B)R.
    Pharmaceuticals (Basel). 2024;17:397.
    Abstract

  806. LEE WT, Wu PY, Cheng YM, Huang YF, et al
    Tissue Inhibitor of Metalloproteinase 3: Unravelling Its Biological Function and Significance in Oncology.
    Int J Mol Sci. 2024;25:3191.
    Abstract

  807. JUNG L, Klamminger GG, Bier B, Eltze E, et al
    From Satirical Poems and Invisible Poisons to Radical Surgery and Organized Cervical Cancer Screening-A Historical Outline of Cervical Carcinoma and Its Relation to HPV Infection.
    Life (Basel). 2024;14:307.
    Abstract

  808. LOCKWOOD L, Ju X, Sethi S, Hedges J, et al
    Knowledge and Awareness of HPV, the HPV Vaccine and Cancer-Related HPV Types among Indigenous Australians.
    Int J Environ Res Public Health. 2024;21:307.
    Abstract

  809. COSTA AS, Baracat EC, Junior JMS, Sorpreso ICE, et al
    Pap Smear Cancer Coverage in Brazilian Capitals including the Pandemic Period Caused by the SARS-CoV-2 Virus: Ecological Study.
    Int J Environ Res Public Health. 2024;21:303.
    Abstract

  810. SCHETTINO MT, Preti EP, Vietri V, Agrillo N, et al
    The Role of beta1 Integrin/CD29 as a Potential Prognostic Factor for the Risk of Progression to Cervical Carcinoma in HPV-Associated Lesions.
    Medicina (Kaunas). 2024;60:364.
    Abstract

  811. VITKAUSKAITE A, Urboniene D, Celiesiute J, Jariene K, et al
    Expression of Inflammation Depending on the Stage of Cervical Cancer.
    Medicina (Kaunas). 2024;60:349.
    Abstract

  812. ALMOROX L, Antequera L, Rojas I, Herrera LJ, et al
    Gene Expression Analysis for Uterine Cervix and Corpus Cancer Characterization.
    Genes (Basel). 2024;15:312.
    Abstract

  813. MOREAU M, Keno LS, China D, Mao S, et al
    Investigating the Use of a Liquid Immunogenic Fiducial Eluter Biomaterial in Cervical Cancer Treatment.
    Cancers (Basel). 2024;16:1212.
    Abstract

  814. PHILLIPS V, Franco Montoya D, Adams EK
    Evaluation of the Cost-Effectiveness of Evidence-Based Interventions to Increase Female Breast and Cervical Cancer Screens: A Systematic Review.
    Cancers (Basel). 2024;16:1134.
    Abstract

  815. BIANCHI T, Grassi T, Di Martino G, Negri S, et al
    Low-Volume Metastases in Cervical Cancer: Does Size Matter?
    Cancers (Basel). 2024;16:1107.
    Abstract

  816. ELISSA N, Charbel H, Marly A, Ingrid N, et al
    Knowledge and perception of HPV vaccination among Lebanese mothers of children between nine and 17 years old.
    Reprod Health. 2024;21:40.
    Abstract

  817. HINKES S, Ciraldo K, Kobetz E, Bartholomew TS, et al
    Opportunities for cancer prevention at syringe services programs: acceptability of HPV self-sampling and vaccination among people who inject drugs.
    Harm Reduct J. 2024;21:70.
    Abstract

  818. AKAKPO PK, Imbeah EG, Ulzen-Appiah K, Darkwa-Abrahams A, et al
    The distribution of hrHPV genotypes among cervical cancer cases diagnosed across Ghana: a cross-sectional study.
    BMC Infect Dis. 2024;24:356.
    Abstract

  819. LI C, Li Q, Li L, Sun S, et al
    The Prognostic and Immune Significance of BZW2 in Pan-Cancer and its Relationship with Proliferation and Apoptosis of Cervical Cancer.
    Front Biosci (Landmark Ed). 2024;29:97.
    Abstract

  820. AOSHIKA T, Noda SE, Abe T, Kumazaki YU, et al
    Results of Definitive (Chemo)radiotherapy Using Computed Tomography-based Brachytherapy for Cervical Cancer.
    Anticancer Res. 2024;44:1583-1589.
    Abstract

  821. TANIM MTH, Nath SD, Khan SF, Khan A, et al
    Transcriptomes of cervical cancer provide novel insights into dysregulated pathways, potential therapeutic targets, and repurposed drugs.
    Cancer Treat Res Commun. 2024;39:100808.
    Abstract

  822. GAO Y, Gonzalez Y, Nwachukwu C, Albuquerque K, et al
    Predicting treatment plan approval probability for high-dose-rate brachytherapy of cervical cancer using adversarial deep learning.
    Phys Med Biol. 2024 Mar 27. doi: 10.1088/1361-6560/ad3880.
    Abstract

  823. YAN K, Hu C, Cheng Y, Zheng L, et al
    Circ_0020460 drives tumorigenesis in cervical cancer through miR-485-3p sponging.
    Discov Oncol. 2024;15:88.
    Abstract

  824. TANG XH, Zhao TN, Guo L, Liu XY, et al
    Cell-Cycle-related Protein Centromere Protein F Deficiency Inhibits Cervical Cancer Cell Growth by Inducing Ferroptosis Via Nrf2 Inactivation.
    Cell Biochem Biophys. 2024 Mar 27. doi: 10.1007/s12013-024-01251.
    Abstract

  825. ZHENG X, Shen F, Chen W, Ren W, et al
    Integrated pretreatment diffusion kurtosis imaging and serum squamous cell carcinoma antigen levels: a biomarker strategy for early assessment of radiotherapy outcomes in cervical cancer.
    Abdom Radiol (NY). 2024 Mar 27. doi: 10.1007/s00261-024-04270.
    Abstract

  826. KAYA TERZI N, Yulek O
    Assessment of Cervicovaginal Smear and HPV DNA Co-Test for Cervical Cancer Screening: Implications for Diagnosis and Follow-Up Strategies.
    Diagnostics (Basel). 2024;14:611.
    Abstract

  827. YING L, Kong L, Qiu X, Cheng A, et al
    A novel mitochondria-related core gene signature to predict the prognosis and evaluate tumour microenvironment in CESC single-cell validation.
    J Cell Mol Med. 2024;28:e18265.
    Abstract

  828. KIM M, Kim E
    Effective vaccination strategies for human papillomavirus (HPV) infection and cervical cancer based on the mathematical model with a stochastic process.
    J Med Virol. 2024;96:e29558.
    Abstract

  829. HARPER DM, Yu TM, Fendrick AM
    Lives Saved Through Increasing Adherence to Follow-Up After Abnormal Cervical Cancer Screening Results.
    O G Open. 2024;1:e001.
    Abstract

  830. POPOVIC A, Bojic MD, Bojic M, Vukmirovic F, et al
    Cutaneous metastases of cervical cancer: a rare entity and possible mechanisms of dissemination.
    Postepy Dermatol Alergol. 2024;41:136-138.
    Abstract

  831. ZHAO W, Li Q, Wen S, Li Y, et al
    Novel biomarkers of inflammation-associated immunity in cervical cancer.
    Front Oncol. 2024;14:1351736.
    Abstract

  832. GONCALVES-NOBRE JG, Matos A, Carreira M, Santos AC, et al
    The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).
    Front Cell Infect Microbiol. 2024;13:1251913.
    Abstract

  833. KANG HB, Kim SH, Lee JH, Lee HC, et al
    MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial.
    Int J Clin Oncol. 2024 Mar 26. doi: 10.1007/s10147-024-02490.
    Abstract

  834. ALBANO C, Biolatti M, Mazibrada J, Pasquero S, et al
    PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer.
    Front Cell Infect Microbiol. 2024;14:1359367.
    Abstract

  835. KOUSAR K, Naseer F, Abduh MS, Anjum S, et al
    Corrigendum: CD44 targeted delivery of oncolytic Newcastle disease virus encapsulated in thiolated chitosan for sustained release in cervical cancer: a targeted immunotherapy approach.
    Front Immunol. 2024;15:1391710.
    Abstract

  836. WONGPRATATE M, Bumrungthai S
    Cervical cancer in Thailand: 2023 update.
    Obstet Gynecol Sci. 2024 Mar 25. doi: 10.5468/ogs.23277.
    Abstract

  837. CHENG S, Gao H, Li Y, Shi X, et al
    Analysis of Risk Factors of Postoperative Lower Extremity Deep Venous Thrombosis in Patients With Cervical Cancer.
    Clin Appl Thromb Hemost. 2024;30:10760296241240747.
    Abstract

  838. VOIDAZAN TS, Budianu MA, Cotoi OS, Turdean SG, et al
    The importance of combined HPV and CINtec(R) PLUS genotyping testing for p16 in women with cervical squamous cell carcinoma.
    Rom J Morphol Embryol. 2024;65:99-105.
    Abstract

  839. SNIADECKI M, Guani B, Jaworek P, Klasa-Mazurkiewicz D, et al
    Tertiary prevention strategies for micrometastatic lymph node cervical cancer: A systematic review and a prototype of an adapted model of care.
    Crit Rev Oncol Hematol. 2024 Mar 23:104329.
    Abstract

  840. ZHANG Y, Hu Y, Zhao S, Xu S, et al
    Validation of the 2018 FIGO staging system for stage IIIC cervical cancer by determining the metabolic and radiomic heterogeneity of primary tumors based on (18)F-FDG PET/CT.
    Abdom Radiol (NY). 2024 Mar 25. doi: 10.1007/s00261-024-04226.
    Abstract

  841. OOKO F
    Ensuring access to palliative care for cervical cancer patients.
    S Afr Med J. 2023;114:3-4.
    Abstract

  842. GUAN P, Han X, Li D, Liao B, et al
    Effect of nurse-physician collaboration on the incidence of complications, negative emotions and quality of life in cervical cancer patients: a randomized controlled study.
    J Interprof Care. 2024 Mar 25:1-9. doi: 10.1080/13561820.2024.2327621.
    Abstract

  843. BELLOTTI JA, Gutierres IG, Furtado YL, Patury P, et al
    Surgical, oncologic, and obstetric outcomes of radical trachelectomy in early-stage cervical cancer: results from a retrospective cohort study at Brazil National Cancer Institute.
    Front Oncol. 2024;14:1267625.
    Abstract

  844. GHASEMI-GUJANI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
    Development of mobile application for cervical cancer screening in women: Protocol of a multi-phase study.
    J Educ Health Promot. 2024;13:5.
    Abstract

  845. CHAUHAN R, Goel A, Alankar B, Kaur H, et al
    Predictive modeling and web-based tool for cervical cancer risk assessment: A comparative study of machine learning models.
    MethodsX. 2024;12:102653.
    Abstract

  846. BURDIER FR, Waheed DE, Nedjai B, Steenbergen RDM, et al
    DNA methylation as a triage tool for cervical cancer screening - A meeting report.
    Prev Med Rep. 2024;41:102678.
    Abstract

  847. BALUWA PC, Moyo RC, Baluwa MA, Nyirenda L, et al
    Barriers Associated with Adherence to Cervical Cancer Screening Among Women Living with HIV in Nkhatabay District, Malawi: A Mixed-Methods Study.
    Int J Womens Health. 2024;16:491-507.
    Abstract

  848. ZRAIDI M, Ibriz M
    [The timeline of the screening and treatment strategy of intraepithelial neoplasia of the uterine cervix adopted in Morocco].
    Pan Afr Med J. 2024;47:13.
    Abstract

  849. AMORHA KC, Ozota GO, Ndunwere MO, Anyaji UL, et al
    Knowledge, attitudes, and practices of adolescent girls regarding cervical cancer: a cross-sectional study in Enugu State, Nigeria.
    Pan Afr Med J. 2024;47:17.
    Abstract

  850. ZHANG N, Guo MF
    Granulocyte-Macrophage Colony-Stimulating Factor in Combination With Chemoradiation for Recurrent or Metastatic Cervical Cancer.
    Cureus. 2024;16:e54573.
    Abstract

  851. FADL J, Aljuhani RA, Albog YH, Khraisat AF, et al
    Role of microRNA in Sex Steroid Hormones Signaling and Its Effect in Regulation of Endometrial, Ovarian, and Cervical Cancer: A Literature Review.
    Cureus. 2024;16:e54773.
    Abstract

  852. BABAYAN LM, Bouts C, Guntupalli S, Marjon NA, et al
    Exploring tisotumab vedotin in recurrent cervical cancer: A case series including an HPV-independent gastric type adenocarcinoma.
    Gynecol Oncol Rep. 2024;52:101356.
    Abstract

  853. PEREIRA IOA, Silva NNT, Lima AA, da Silva GN, et al
    Qualitative and quantitative changes in mitochondrial DNA associated with cervical cancer: A comprehensive review.
    Environ Mol Mutagen. 2024 Mar 24. doi: 10.1002/em.22591.
    Abstract

  854. LIU Y, Xin W, Wang P, Ji M, et al
    Intraoperative frozen section pathology of vaginal margin in radical hysterectomy on the prognosis and quality of life for patients with IB2-IIA2 cervical cancer: study protocol for a multicenter randomized controlled trial.
    J Gynecol Oncol. 2024 Mar 11. doi: 10.3802/jgo.2024.
    Abstract

  855. CHO EH, Park MS, Woo HY, Park H, et al
    Evaluation of clinical usefulness of HPV-16 and HPV-18 genotyping for cervical cancer screening.
    J Gynecol Oncol. 2024 Mar 15. doi: 10.3802/jgo.2024.
    Abstract

  856. GILYADOVA AV, Ishchenko AA, Samoilova SV, Shiryaev AA, et al
    Comparative study of treatment efficacy in severe intraepithelial squamous cell lesions and preinvasive cervical cancer by conization and chlorin e6-mediated fluorescence-assisted systemic photodynamic therapy.
    Photodiagnosis Photodyn Ther. 2024;46:104060.
    Abstract

  857. LORUSSO D, Xiang Y, Hasegawa K, Scambia G, et al
    Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.
    Lancet. 2024 Mar 20:S0140-6736(24)00317-9. doi: 10.1016/S0140-6736(24)00317.
    Abstract

  858. TEWARI KS, Monk BJ
    Immunotherapy plus chemoradiotherapy in cervical cancer management.
    Lancet. 2024 Mar 20:S0140-6736(24)00468-9. doi: 10.1016/S0140-6736(24)00468.
    Abstract

  859. LE VN, Le VNB, Hoang XS, Le VD, et al
    Distribution of human papillomavirus among Vietnamese women with cervical cancer and unusual genetic variability of HPV16.
    Virology. 2024;594:110058.
    Abstract

  860. ALHERZ FA, Alamri AA, Aljbreen A, Alwallan N, et al
    Knowledge of cervical cancer, human papillomavirus (HPV), and acceptance of the HPV vaccine among parents of daughters in Riyadh, Saudi Arabia.
    J Infect Public Health. 2024;17:789-794.
    Abstract

  861. YUAN L, Jiang H, Jia Y, Liao Y, et al
    Fatty Acid Oxidation Supports Lymph Node Metastasis of Cervical Cancer via Acetyl-CoA-Mediated Stemness.
    Adv Sci (Weinh). 2024 Mar 23:e2308422. doi: 10.1002/advs.202308422.
    Abstract

  862. KRISHNAMOORTHY S, Sabanayagam R, Periyasamy L, Muruganantham B, et al
    Plumbagin as a preferential lead molecule to combat EGFR-driven matrix abundance and migration of cervical carcinoma cells.
    Med Oncol. 2024;41:89.
    Abstract

  863. ROMANO KD, Petroni G, Ward K, Zheng W, et al
    A randomized trial evaluating a novel hydrogel packing system compared to standard packing during image-guided high-dose rate brachytherapy boost for cervical cancer.
    Brachytherapy. 2024 Mar 21:S1538-4721(24)00035.
    Abstract

  864. LALANDE E, Clarke H, Undurraga M, Nguyen VQH, et al
    Knowledge of cytology results affects the performance of colposcopy: a crossover study.
    BMC Womens Health. 2024;24:189.
    Abstract

  865. GOSECKA M, Gosecki M, Ziemczonek P, Urbaniak M, et al
    Selective Anticervical Cancer Injectable and Self-Healable Hydrogel Platforms Constructed of Drug-Loaded Cross-Linkable Unimolecular Micelles in a Single and Combination Therapy.
    ACS Appl Mater Interfaces. 2024;16:14605-14625.
    Abstract

  866. GRACA J, Preti M, Pollano B, Vieira-Baptista P, et al
    Performance of Different Follow-Up Strategies and Genotype-Based Recurrence Risk After Treatment of Cervical High-Grade Squamous Intraepithelial Lesion.
    J Low Genit Tract Dis. 2024;28:131-136.
    Abstract

  867. CLARKE MA, Wentzensen N, Perkins RB, Garcia F, et al
    Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus.
    J Low Genit Tract Dis. 2024;28:124-130.
    Abstract

  868. NAKAI H, Higashi T, Kakuwa T, Matsumura N, et al
    Trends in gynecologic cancer in Japan: incidence from 1980 to 2019 and mortality from 1981 to 2021.
    Int J Clin Oncol. 2024;29:363-371.
    Abstract

  869. WANG S, Ren W, Zhang B, Chen M, et al
    Knowledge, Attitude, and Uptake of Human Papillomavirus (HPV) Vaccination among Chinese Female Adults: A National Cross-sectional Web-Based Survey Based on a Large E-commerce Platform.
    Matern Child Health J. 2024;28:746-757.
    Abstract

  870. PARIKH S, Zhang Y, Sherwani Z, Kumar R, et al
    Impact of the COVID-19 pandemic on brachytherapy and cancer patient outcomes: A systematic review.
    Brachytherapy. 2024;23:141-148.
    Abstract

  871. SOEGAARD-ANDERSEN E, Frandsen AP, Sandahl P
    Adenocarcinoma In Situ of the Uterine Cervix (AIS) Treated by Loop Electrosurgical Excision Procedure Strategy: An Observational Study.
    J Low Genit Tract Dis. 2024;28:149-152.
    Abstract

  872. OWRANGI A, Medrano A, Gao Y, Kazemifar S, et al
    Definitive radiation for advanced cervix cancer is not associated with vaginal shortening-a prospective vaginal length and dose correlation.
    Brachytherapy. 2024;23:136-140.
    Abstract

  873. TAAVELA K, Eriksson T, Huhtala H, Bly A, et al
    The quality of life of frequently vs. infrequently screened HPV vaccinated women.
    Qual Life Res. 2024;33:941-949.
    Abstract

  874. HU B, Wang R, Wu D, Long R, et al
    A Promising New Model: Establishment of Patient-Derived Organoid Models Covering HPV-Related Cervical Pre-Cancerous Lesions and Their Cancers.
    Adv Sci (Weinh). 2024;11:e2302340.
    Abstract

  875. IKUSHIMA H, Ii N, Noda SE, Masui K, et al
    Patterns of care for brachytherapy in Japan.
    J Radiat Res. 2024;65:168-176.
    Abstract

  876. MANZAR GS, Alam MBE, Lynn EJ, Karpinets TV, et al
    Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapy.
    Brachytherapy. 2024;23:123-135.
    Abstract

  877. TAKATSU J, Murakami N, Muramoto Y, Karino T, et al
    Safe dose escalation and reduction of the fraction number of uterine cervical brachytherapy using a gel spacer in the rectovaginal and vesicouterine septum: A planning study.
    Brachytherapy. 2024;23:115-122.
    Abstract

  878. DUTTA P, Pal D, Sultana F, Mandal RK, et al
    Down-regulation of FA-BRCA Pathway in Cervical Carcinoma Gradually Reversed During the Development of Chemo-tolerance: Clinical Implications.
    Reprod Sci. 2024;31:1122-1138.
    Abstract

  879. DEO BS, Sah AN, Shukla S, Pandey K, et al
    Cervical pre-cancer classification using entropic features and CNN: In vivo validation with a handheld fluorescence probe.
    J Biophotonics. 2024;17:e202300363.
    Abstract

  880. DOMBROWSKI C, Bourgain C, Ma Y, Meiwald A, et al
    An economic evaluation of two cervical screening algorithms in Belgium: HR-HPV primary compared to HR-HPV and liquid-based cytology co-testing.
    Eur J Cancer Prev. 2024;33:262-270.
    Abstract

  881. ROURKE M, Fitzpatrick P, Popoola O, Boms R, et al
    The effect of HPV vaccination on the rate of high-grade cytology in 25-year-old women attending cervical screening in Ireland.
    Ir J Med Sci. 2024;193:665-668.
    Abstract

  882. GILMAN SD, Gravitt PE, Paz-Soldan VA
    Implementation of new technologies designed to improve cervical cancer screening and completion of care in low-resource settings: a case study from the Proyecto Precancer.
    Implement Sci Commun. 2024;5:35.
    Abstract

  883. TERGAS A, Byron S, Zhang G, Izatt T, et al
    YIA24-007: Genetic Ancestry and Genomic Alterations of Cervical Cancer in a Diverse Patient Population.
    J Natl Compr Canc Netw. 2024;22.
    Abstract

  884. CHEN X, Duan H, Zhao H, He F, et al
    Perineural invasion in cervical cancer: A multicenter retrospective study.
    Eur J Surg Oncol. 2024;50:108313.
    Abstract

  885. WANG J, Guo H, Yang J, Mao J, et al
    Efficacy and safety of consolidation chemotherapy after adjuvant therapy in stage IB-IIA cervical cancer patients with risk factors: a retrospective single-center study.
    Front Oncol. 2024;14:1374195.
    Abstract

  886. SONG X, Li X, Tan Z, Zhang L, et al
    Corrigendum: Recent status and trends of nanotechnology in cervical cancer: a systematic review and bibliometric analysis.
    Front Oncol. 2024;14:1395166.
    Abstract

  887. NAIK D, Kalle AM
    MicroRNA-mediated epigenetic regulation of HDAC8 and HDAC6: Functional significance in cervical cancer.
    Noncoding RNA Res. 2024;9:732-743.
    Abstract

  888. CHEN D, Cai B, Zhu Y, Ma Y, et al
    Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer.
    Clin Epigenetics. 2024;16:51.
    Abstract

  889. ESPINOSA K
    ASCCP Management Guidelines for Abnormal Cervical Cancer Screening.
    Am Fam Physician. 2024;109:275-276.
    Abstract

  890. ASWATHY R, Sumathi S
    The Evolving Landscape of Cervical Cancer: Breakthroughs in Screening and Therapy Through Integrating Biotechnology and Artificial Intelligence.
    Mol Biotechnol. 2024 Apr 4. doi: 10.1007/s12033-024-01124.
    Abstract

  891. OKYERE J, Ayebeng C, Dickson KS
    Early age at menarche and history of sexually transmitted infections significantly predict cervical cancer screening uptake among women aged 25-49 years: evidence from the 2021 Cote d'Ivoire demographic and health survey.
    BMC Health Serv Res. 2024;24:423.
    Abstract

  892. KROG L, Lycke KD, Kahlert J, Randrup TH, et al
    Risk of progression of cervical intraepithelial neoplasia grade 2 in human papillomavirus-vaccinated and unvaccinated women: a population-based cohort study.
    Am J Obstet Gynecol. 2024;230:430.
    Abstract

  893. BAHADUR A, Mundhra R, Gill P, Singh A, et al
    Aggressive precursor B cell ALL of cervix with obstructive uropathy.
    BMJ Case Rep. 2024;17:e258313.
    Abstract

  894. ZHENG S, Zhang X, Greuter MJW, de Bock GH, et al
    Willingness of healthcare providers to perform population-based cancer screening: a cross-sectional study in primary healthcare institutions in Tianjin, China.
    BMJ Open. 2024;14:e075604.
    Abstract

  895. VALLEJO-RUIZ V, Gutierrez-Xicotencatl L, Medina-Contreras O, Lizano M, et al
    Molecular aspects of cervical cancer: a pathogenesis update.
    Front Oncol. 2024;14:1356581.
    Abstract

  896. CORDOBA A, Gesta E, Escande A, Noeuveglise A, et al
    Interstitial needles versus intracavitary applicators only for locally advanced cervical cancer: results from real-life dosimetric comparisons.
    Front Oncol. 2024;14:1347727.
    Abstract

  897. ROCHA NSS, Clara BM, Luz LMM, do Rosario Oliveira Martins M, et al
    Knowledge, attitudes and practices of cervical cancer screening among female students enrolled in higher education institutions in Cabo Verde.
    Ecancermedicalscience. 2024;18:1689.
    Abstract

  898. HUSEINOVIC A, Xu M, Jaspers A, Bais B, et al
    miR-129-5p inhibits anchorage-independent growth through silencing of ACTN1 and the ELK4/c-FOS axis in HPV-transformed keratinocytes.
    J Med Virol. 2024;96:e29580.
    Abstract

  899. LIU P, Yang X, Zhao H, Liang L, et al
    High burden of human papillomavirus infection among men in Guangzhou, South China: Implications for HPV vaccination strategies.
    Hum Vaccin Immunother. 2024;20:2337161.
    Abstract

  900. SEYFU DT, Abebe SN, Haile S, Ayana BA, et al
    Health related quality of life and its predictive factors on cervical cancer patients in two teaching hospitals, Addis Ababa, Ethiopia.
    BMC Womens Health. 2024;24:209.
    Abstract

  901. SIMUYEMBA MC, Chama-Chiliba CM, Chompolola A, Sinyangwe A, et al
    An evaluation of the cost of human papilloma virus (HPV) vaccine delivery in Zambia.
    BMC Infect Dis. 2024;24:369.
    Abstract

  902. SIDAWAY P
    Pembrolizumab plus chemoradiotherapy effective in locally advanced cervical cancer.
    Nat Rev Clin Oncol. 2024 Apr 2. doi: 10.1038/s41571-024-00889.
    Abstract

  903. YIN Q, Zhou Q, Hu J, Weng J, et al
    Fabrication of bimetallic Ag@ZnO nanocomposite and its anti-cancer activity on cervical cancer via impeding PI3K/AKT/mTOR pathway.
    J Trace Elem Med Biol. 2024;84:127437.
    Abstract

  904. MA Y, Zhu W
    Development of gene panel for predicting recurrence in early-stage cervical cancer patients.
    Environ Toxicol. 2024 Apr 2. doi: 10.1002/tox.24270.
    Abstract

  905. ARVIZU-HERNANDEZ E, Hernandez-Guerrero CJ, Alvarez-Rios E, Gariglio P, et al
    Laurencia johnstonii extract reverses early lesions in the K14E7HPV16 murine cervical carcinogenesis model.
    J Med Virol. 2024;96:e29571.
    Abstract

  906. EFFAH K, Anthony R, Tekpor E, Amuah JE, et al
    HPV DNA Testing and Mobile Colposcopy for Cervical Precancer Screening in HIV Positive Women: A Comparison Between Two Settings in Ghana and Recommendation for Screening.
    Cancer Control. 2024;31:10732748241244678.
    Abstract

  907. LIANG KW, Chen LJ, Wang CH, Ma KS, et al
    Impact of programmed cell death protein 1 inhibitor therapy on the survival of patients with advanced or recurrent uterine cancers: a meta-analysis.
    Front Immunol. 2024;15:1331994.
    Abstract

  908. ANYAKA CU, Alero BJ, Olukoya B, Envuladu EA, et al
    Parental Knowledge of HPV Infection, Cervical Cancer and the Acceptance of HPV Vaccination for their Children in Jos, Nigeria.
    J West Afr Coll Surg. 2024;14:146-153.
    Abstract

  909. GOSSE RA, Msengi EA, Chona EZ, Ambikile JS, et al
    Experiences of caring for women with cervical cancer: A qualitative study among male partners in Dar es Salaam, Tanzania.
    Health Expect. 2024;27:e14038.
    Abstract

  910. ZENG S, Yang P, Xiao S, Liu L, et al
    Development and validation of prognostic nomographs for patients with cervical cancer: SEER-based Asian population study.
    Sci Rep. 2024;14:7681.
    Abstract

  911. WANG Q, Wang B, Zhang W, Zhang T, et al
    APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway.
    Arch Biochem Biophys. 2024;755:109983.
    Abstract

  912. BATUR P
    For due or overdue cervical cancer screening, direct or opt-in mailing of HPV self-sampling increased screening at 6 mo vs. education.
    Ann Intern Med. 2024 Apr 2. doi: 10.7326/J24-0019.
    Abstract

  913. RODRIGUES IO, Duarte I, Costa CG, Pimentel AL, et al
    Knowledge about cervical cancer in young Portuguese women: a cross-sectional study.
    Front Public Health. 2024;12:1357606.
    Abstract

  914. GAZZETTA S, Valent F, Sala A, Driul L, et al
    Sexually transmitted infections and the HPV-related burden: evolution of Italian epidemiology and policy.
    Front Public Health. 2024;12:1336250.
    Abstract

  915. NAGAI H
    Immunoradiation Therapy for End-Stage Undifferentiated Cervical Cancer That Restored Sensitivity to Chemotherapy and Resulted in the Disappearance of the Cancer.
    Cureus. 2024;16:e57144.
    Abstract

  916. DIVYA KT, Chidrawar VR, Bhupalam PK, Shiromwar S, et al
    Assessment of knowledge and attitude of cervical cancer among the youths in the Rayalaseema region of Andhra Pradesh - India.
    J Educ Health Promot. 2024;13:73.
    Abstract

  917. YAMADA S, Fukugawa Y, Otsuka T, Saito T, et al
    Radiation-Induced Myonecrosis: A Case Report of a Cervical Cancer Patient With a History of Systemic Lupus Erythematosus.
    Cureus. 2024;16:e55134.
    Abstract

  918. LI N, Wang XL, Ge R, Wang Y, et al
    FNDC5 inhibits malignant growth of human cervical cancer cells via restraining PI3K/AKT pathway.
    J Cell Physiol. 2024 Apr 1. doi: 10.1002/jcp.31267.
    Abstract

  919. SAUVAGE LM, Bentahila R, Tran Y, Guenegou-Arnoux A, et al
    Radiation Proctitis in Patients With Locally Advanced Cervical Cancer Treated by Chemoradiation: Analysis and Predictive Factors From a Retrospective Cohort.
    Am J Clin Oncol. 2024 Apr 1. doi: 10.1097/COC.0000000000001092.
    Abstract

  920. YOSHIMOTO M, Tokuda A, Eguchi A, Nozawa Y, et al
    Alterations of UHRF family Expression and was regulated by High Risk Type HPV16 in Uterine Cervical Cancer.
    Exp Cell Res. 2024;437:114018.
    Abstract

  921. KHAN NG, Adiga D, Rai PS, Kabekkodu SP, et al
    Integrated In-Silico and In Vitro analysis to Decipher the contribution of bisphenol-A in cervical cancer.
    Toxicology. 2024;504:153791.
    Abstract

  922. NGABONZIZA E, Ghebre R, DeBoer RJ, Ntasumbumuyange D, et al
    Outcomes of neoadjuvant chemotherapy and radical hysterectomy for locally advanced cervical cancer at Kigali University Teaching Hospital, Rwanda: a retrospective descriptive study.
    BMC Womens Health. 2024;24:204.
    Abstract

  923. ZOU T, Gao Y, Qie M
    Promotive actions of lncRNA EBLN3P involved in cervical cancer progression via interacting with miR-29c-3p and TAF15 to modify RCC2.
    Arch Biochem Biophys. 2024 Mar 28:109980. doi: 10.1016/j.abb.2024.109980.
    Abstract

  924. DITTO A, Longo M, Chiarello G, Mariani L, et al
    Are biomarkers expression and clinical-pathological factors predictive markers of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer?
    Eur J Surg Oncol. 2024;50:108311.
    Abstract

  925. ANAND A, Raju K
    Significance of platelet parameters in invasive squamous cell carcinoma of uterine cervix.
    J Cancer Res Ther. 2024;20:139-143.
    Abstract

  926. LADBURY C, Eustace N, Kassardjian A, Amini A, et al
    Explainable artificial intelligence analysis of brachytherapy boost receipt in cervical cancer during the COVID-19 era.
    Brachytherapy. 2024 Mar 28:S1538-4721(24)00010.
    Abstract

  927. GUO X, Zhao E, Guan Z, Li W, et al
    A retrospective study of the effects of uterine manipulators on prognosis in patients with cervical cancer.
    J Int Med Res. 2024;52:3000605241233966.
    Abstract

  928. SU D, Song X, Wu F, Fan S, et al
    Cervical clear cell carcinoma: Case report and literature review.
    Medicine (Baltimore). 2024;103:e37449.
    Abstract

  929. KONG Y, Liu S, Wang X, Qie R, et al
    Associations between gut microbiota and gynecological cancers: A bi-directional two-sample Mendelian randomization study.
    Medicine (Baltimore). 2024;103:e37628.
    Abstract

  930. LI M, Zheng W
    Mature solid teratoma of the uterine cervix: A rare case report and review of the literature.
    Medicine (Baltimore). 2024;103:e37451.
    Abstract

  931. LI X, Zhang L, Huang X, Peng Q, et al
    High-throughput metabolomics identifies new biomarkers for cervical cancer.
    Discov Oncol. 2024;15:90.
    Abstract

  932. WANG S, Dang L, Liu S, Rezhake R, et al
    Cervical Cancer Screening via Visual Inspection With Acetic Acid and Lugol Iodine for Triage of HPV-Positive Women.
    JAMA Netw Open. 2024;7:e244090.
    Abstract

  933. XIAO H, Chen W, Lin M, Jiang S, et al
    Rapid immunoassay for dual-mode detection of HPV16 and HPV18 DNA based on Au@PdPt nanoparticles.
    Anal Methods. 2024;16:1862-1869.
    Abstract

  934. YANG L, Bu G, Zhao J, La X, et al
    Comparison of 3D and 2D laparoscopy: Initial experience of perioperative outcomes and clinical assessment.
    J Gynecol Obstet Hum Reprod. 2024;53:102754.
    Abstract

  935. TIAN X, Liu P, Kang S, Cui Z, et al
    Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
    Eur J Surg Oncol. 2024;50:107977.
    Abstract

  936. SAKURAI A, Yamanoi K, Yamaguchi K, Hamanishi J, et al
    Neuroendocrine carcinoma of the uterine cervix with extensive pagetoid spread pattern.
    J Obstet Gynaecol Res. 2024;50:758-763.
    Abstract

  937. PARTANEN VM, Dillner J, Trope A, Agustsson AI, et al
    Divergent effects of switching from cytology to HPV-based screening in the Nordic countries.
    Eur J Public Health. 2024;34:354-360.
    Abstract

  938. AKSOY C, Reimold P, Schumann A, Schneidewind L, et al
    Enhancing Human Papillomavirus Vaccination Rates through Better Knowledge? Insights from a Survey among German Medical Students.
    Urol Int. 2024;108:153-158.
    Abstract

  939. NGO O, Chloupkova R, Cibula D, Slama J, et al
    Direct mailing of HPV self-sampling kits to women aged 50-65 non-participating in cervical screening in the Czech Republic.
    Eur J Public Health. 2024;34:361-367.
    Abstract

  940. LI F, Chen A, Shan Y, Yao Y, et al
    Factors associated with human papillomavirus persistence after loop electrosurgical excision procedure in patients with cervical squamous intraepithelial lesion.
    J Obstet Gynaecol Res. 2024;50:639-646.
    Abstract

  941. ALQABBANI R, Chan J, Goldberg A
    Presence of 10 transformation zone cells in endocervical curettage should not be required for adequacy.
    Am J Clin Pathol. 2024;161:369-373.
    Abstract

  942. PARISI S, Sciacca M, Ferrantelli G, Chillari F, et al
    Locally advanced squamous cervical carcinoma (M0): management and emerging therapeutic options in the precision radiotherapy era.
    Jpn J Radiol. 2024;42:354-366.
    Abstract

  943. YAHIA A, Cole E, Rayford A, Fava J, et al
    A community-based, interdisciplinary approach to improving HPV vaccine uptake at a large urban public university.
    J Am Coll Health. 2024;72:500-508.
    Abstract

  944. ROSENBLUM HG, Gargano JW, Cleveland AA, Dahl RM, et al
    U.S. Women with Invasive Cervical Cancer: Characteristics and Potential Barriers to Prevention.
    J Womens Health (Larchmt). 2024 Apr 12. doi: 10.1089/jwh.2023.0462.
    Abstract

  945. ZHAO X, Fan X, Lin X, Guo B, et al
    Deciphering age-specific molecular features in cervical cancer and constructing an angio-immune prognostic model.
    Medicine (Baltimore). 2024;103:e37717.
    Abstract

  946. LI C, Li J, Lu Y, Hou J, et al
    Observations of the effectiveness, dosage, and prognosis of intensity-modulated radiation therapy under ultrasonic guidance for cervical cancer patients.
    Technol Health Care. 2024 Feb 29. doi: 10.3233/THC-231977.
    Abstract

  947. COCHRANE AC, Bullington BW, Prokopowicz C, Rahangdale L, et al
    Comparing Cervical Cancer Screening Strategies in an Incarcerated Population.
    J Womens Health (Larchmt). 2024 Apr 12. doi: 10.1089/jwh.2023.0513.
    Abstract

  948. BUENO-URQUIZA LJ, Godinez-Rubi M, Villegas-Pineda JC, Vega-Magana AN, et al
    Phenotypic Heterogeneity of Cancer Associated Fibroblasts in Cervical Cancer Progression: FAP as a Central Activation Marker.
    Cells. 2024;13:560.
    Abstract

  949. FANG C, Zhou Y, Feng Y, He L, et al
    QL1604 plus paclitaxel-cisplatin/carboplatin in patients with recurrent or metastatic cervical cancer: an open-label, single-arm, phase II trial.
    J Gynecol Oncol. 2024 Mar 29. doi: 10.3802/jgo.2024.
    Abstract

  950. LIZANO M, Carrillo-Garcia A, De La Cruz-Hernandez E, Castro-Munoz LJ, et al
    Promising predictive molecular biomarkers for cervical cancer (Review).
    Int J Mol Med. 2024;53:50.
    Abstract

  951. BARQUET-MUNOZ SA, Arteaga-Gomez C, Diaz-Lopez E, Rodriguez-Trejo A, et al
    Current status and challenges in timely detection of cervical cancer in Mexico: expert consensus.
    Front Oncol. 2024;14:1383105.
    Abstract

  952. FINCH LA, Levy MS, Thiele A, Jeudin P, et al
    Barriers to cervical cancer prevention in a safety net clinic: gaps in HPV vaccine provider recommendation and series completion among Ob/Gyn patients.
    Front Oncol. 2024;14:1359160.
    Abstract

  953. GUTIERREZ SALMEAN G, Delgadillo Gonzalez M, Rueda Escalona AA, Leyva Islas JA, et al
    Effects of prebiotics, probiotics, and synbiotics on the prevention and treatment of cervical cancer: Mexican consensus and recommendations.
    Front Oncol. 2024;14:1383258.
    Abstract

  954. SAHA I, Halder J, Rajwar TK, Mahanty R, et al
    Novel Drug Delivery Approaches for the Localized Treatment of Cervical Cancer.
    AAPS PharmSciTech. 2024;25:85.
    Abstract

  955. KIM H, Yoo SK, Kim JS, Kim YT, et al
    Clinical feasibility of deep learning-based synthetic CT images from T2-weighted MR images for cervical cancer patients compared to MRCAT.
    Sci Rep. 2024;14:8504.
    Abstract

  956. ZHANG Y, Li L, Han Q, Wen L, et al
    The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis.
    J Obstet Gynaecol. 2024;44:2333784.
    Abstract

  957. JIBAT N, Ali R, Adissu W, Buruh G, et al
    Less known but greatly feared: Cervical cancer in Ethiopia community awareness.
    Heliyon. 2024;10:e28328.
    Abstract

  958. CHEN J, Zhang R, Xu W, Bai L, et al
    Knowledge and Practices Regarding Human Papillomavirus and Cervical Cancer Screening Among Women in Low-Income Areas of China: A Cross-Sectional Study.
    Cureus. 2024;16:e55930.
    Abstract

  959. KHOSHNAZAR MS, Tarrahi MJ, Shahnazi H
    Impact of virtual education based on health belief model on cervical cancer screening behavior in middle-aged women: A quasi-experimental study.
    Cancer Rep (Hoboken). 2024;7:e2058.
    Abstract

  960. YIN J, Zhang S, Li Z, Li Y, et al
    Impact of high-performance HPV testing to improve cervical cancer screening in China: A prospective population-based multicenter cohort study.
    Clin Microbiol Infect. 2024 Apr 8:S1198-743X(24)00166.
    Abstract

  961. SONKER P, Tamang R, Mehata AK, Nidhar M, et al
    PTSA-induced synthesis, in silico and nano study of novel ethylquinolin-thiazolo-triazole in cervical cancer.
    Future Med Chem. 2024 Apr 10. doi: 10.4155/fmc-2023-0344.
    Abstract

  962. NAAMALA A, Eriksson LE, Orem J, Nalwadda GK, et al
    Health-related quality of life among adult patients with cancer in Uganda - a cross-sectional study.
    Glob Health Action. 2024;17:2325728.
    Abstract

  963. WANG D, Zou F, Li Y, Hu J, et al
    Targeting MELK improves PD-1 blockade efficiency in cervical cancer via enhancing antitumor immunity.
    Mol Ther Oncol. 2024;32:200759.
    Abstract

  964. JIANG R, Li X, Cao S, Wu Y, et al
    Nodal staging score for adequacy of nodal staging in cervical cancer.
    Heliyon. 2024;10:e26116.
    Abstract

  965. NUZHATH FJ, Patil NJ, Sheela SR, Manjunath GN, et al
    A Randomized Controlled Trial on Pranayama and Yoga Nidra for Anxiety and Depression in Patients With Cervical Cancer Undergoing Standard of Care.
    Cureus. 2024;16:e55871.
    Abstract

  966. LIN G, Ma C, Wu C, Si Y, et al
    [Application of microchannel technique in minimally invasive resection of cervical intraspinal tumors].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2024;56:318-321.
    Abstract

  967. LI W, Ma L, Li F, Li K, et al
    Effects of bone marrow sparing radiotherapy on acute hematologic toxicity for patients with locoregionally advanced cervical cancer: a prospective phase II randomized controlled study.
    Radiat Oncol. 2024;19:46.
    Abstract

  968. LIN G, Hsieh CY, Lai YC, Wang CC, et al
    Hyperpolarized [1-(13)C]-pyruvate MRS evaluates immune potential and predicts response to radiotherapy in cervical cancer.
    Eur Radiol Exp. 2024;8:46.
    Abstract

  969. ADAMS RA, Botha MH
    Cervical cancer prevention in Southern Africa: a review of national cervical cancer screening guidelines in the Southern African Development Community.
    J Cancer Policy. 2024 Apr 7:100477. doi: 10.1016/j.jcpo.2024.100477.
    Abstract

  970. LI J
    Relationships among health-related social media use, knowledge, worry, and cervical cancer screening: A cross-sectional study of US females.
    Patient Educ Couns. 2024;124:108283.
    Abstract


  971. Retraction: "Downregulation of microRNA-205 inhibits cell invasion and angiogenesis of cervical cancer through TSLC1-mediated Akt signaling pathway".
    J Cell Physiol. 2024 Apr 9. doi: 10.1002/jcp.31239.
    Abstract

  972. SSEDYABANE F, Ngonzi J, Tusubira D, Nambi Najjuma J, et al
    Association between serum P16ink4A concentration and CIN and cervical cancer among women attending a cervical cancer clinic in western Uganda: A case control study.
    Gynecol Oncol Rep. 2024;53:101388.
    Abstract

  973. YAO X, Li Q, Chen Y, Du Z, et al
    Epidemiology of human papillomavirus infection in women from Xiamen, China, 2013 to 2023.
    Front Public Health. 2024;12:1332696.
    Abstract

  974. MAITRA S, Mukerjee N, Alharbi HM, Ghosh A, et al
    Targeted therapies for HPV-associated cervical cancer: Harnessing the potential of exosome-based chipsets in combating leukemia and HPV-mediated cervical cancer.
    J Med Virol. 2024;96:e29596.
    Abstract

  975. UEDA Y
    Epidemiology of cervical cancer and HPV infection in Asia and Oceania.
    J Obstet Gynaecol Res. 2024 Apr 8. doi: 10.1111/jog.15943.
    Abstract

  976. CHOI SY, Kim S, Jeon JY, Kim MG, et al
    Metabolomic Profiles in Patients with Cervical Cancer Undergoing Cisplatin and Radiation Therapy.
    Biomol Ther (Seoul). 2024 Apr 9. doi: 10.4062/biomolther.2023.
    Abstract

  977. MUNGO C, Ellis GK, Rop M, Zou Y, et al
    Perceived acceptability of self-administered topical therapy for cervical precancer treatment among women undergoing cervical cancer screening in Kenya.
    medRxiv [Preprint]. 2024 Mar 6:2024.03.05.24303779.
    Abstract

  978. LI Y, Man X, Zhang Q, Wang X, et al
    Apigenin 7-glucoside impedes hypoxia-induced malignant phenotypes of cervical cancer cells in a p16-dependent manner.
    Open Life Sci. 2024;19:20220819.
    Abstract

  979. JAMADAGNI S, Ponni Tr A, P R
    Dosimetric comparison of intra-cavitary brachytherapy technique with free-hand (intra-cavitary + interstitial) technique in cervical cancer.
    J Contemp Brachytherapy. 2024;16:28-34.
    Abstract

  980. SONG C, Chen L
    Circ_0051428 targeting miR-885-3p/MMP2 axis enhances the malignancy of cervical cancer.
    Open Med (Wars). 2024;19:20230858.
    Abstract

  981. WANG SF, Du CY, Li M, Wen B, et al
    Endometrial Cancer Detection by DNA Methylation Analysis in Cervical Papanicolaou Brush Samples.
    Technol Cancer Res Treat. 2024;23:15330338241242637.
    Abstract

  982. WU Z, Liu M, Pang Y, Deng L, et al
    A Comparative Study of Deep Learning Dose Prediction Models for Cervical Cancer Volumetric Modulated Arc Therapy.
    Technol Cancer Res Treat. 2024;23:15330338241242654.
    Abstract

  983. BAI Y, Miao Y, Wang J, Gan J, et al
    Predictive Value and Immunological Role of the HSPA5 Gene in Cervical Cancer.
    Biochem Genet. 2024 Apr 8. doi: 10.1007/s10528-024-10782.
    Abstract

  984. GOPALANI SV, Sawaya GF, Rositch AF, Dasari S, et al
    The Impact of Adjusting for Hysterectomy Prevalence on Cervical Cancer Incidence Rates and Trends Among Women Aged 30 Years and Older - United States, 2001-2019.
    Am J Epidemiol. 2024 Apr 6:kwae041. doi: 10.1093.
    Abstract

  985. LIU Z, Yang Z, Ablise M
    Design and synthesis of novel imidazole-chalcone derivatives as microtubule protein polymerization inhibitors to treat cervical cancer and reverse cisplatin resistance.
    Bioorg Chem. 2024;147:107310.
    Abstract

  986. LIU B, Gao H, Zhou F, Zhao W, et al
    Dynamic contrast-enhanced magnetic resonance imaging in cervical cancer: correlation between quantitative parameters and molecular markers hypoxia-inducible factors-1-alpha, vascular endothelial growth factor, and Ki-67.
    Clin Radiol. 2024 Mar 15:S0009-9260(24)00128-4. doi: 10.1016/j.crad.2024.
    Abstract

  987. EL-NASHAR HAS, Al-Azzawi MA, Al-Kazzaz HH, Alghanimi YK, et al
    HPLC-ESI/MS-MS metabolic profiling of white pitaya fruit and cytotoxic potential against cervical cancer: Comparative studies, synergistic effects, and molecular mechanistic approaches.
    J Pharm Biomed Anal. 2024;244:116121.
    Abstract

  988. WELSH A, Matshitse R, Khan SF, Nyokong T, et al
    Trinuclear ruthenium(II) polypyridyl complexes: Evaluation as photosensitizers for enhanced cervical cancer treatment.
    J Inorg Biochem. 2024;256:112545.
    Abstract

  989. LI X, Ou C, He A
    Construction of artificial neural network (ANN) based on predictive value of prognostic nutritional index (PNI) and neutrophil-to-lymphocyte ratio (NLR) in patients with cervical squamous cell carcinoma.
    Medicine (Baltimore). 2024;103:e37680.
    Abstract

  990. XU M, Wang Y
    Clinical characteristics, HPV involvement, and demographic risk factors in women with cervical intraepithelial neoplasia complicated by vaginal intraepithelial neoplasia.
    BMC Womens Health. 2024;24:220.
    Abstract

  991. ABATE A, Munshea A, Nibret E, Alemayehu DH, et al
    Characterization of human papillomavirus genotypes and their coverage in vaccine delivered to Ethiopian women.
    Sci Rep. 2024;14:7976.
    Abstract

  992. ZHAO C, Zhao Y, Li J, Li M, et al
    Opportunities and challenges for human papillomavirus vaccination in China.
    Hum Vaccin Immunother. 2024;20:2329450.
    Abstract

  993. MALDONADO I, Rodriguez Nino N, Valencia CF, Ortiz D, et al
    Evaluation of the safety profile of the quadrivalent vaccine against human papillomavirus in the risk of developing autoimmune, neurological, and hematological diseases in adolescent women in Colombia.
    Vaccine. 2024 Mar 7:S0264-410X(24)00263-9. doi: 10.1016/j.vaccine.2024.
    Abstract

  994. TOTZKAY D
    The potential influence of patient-centered communication, online provider communication, and social determinants of health on cancer screening.
    Patient Educ Couns. 2024;123:108238.
    Abstract

  995. LIU Y, Yan Q, Zeng Z, Fan C, et al
    Advances and prospects of mRNA vaccines in cancer immunotherapy.
    Biochim Biophys Acta Rev Cancer. 2024;1879:189068.
    Abstract

  996. LOHR AM, Capetillo GP, Molina L, Goodson M, et al
    Development of a Digital Storytelling Intervention to Increase Breast, Cervical, and Colorectal Cancer Screening in the Hispanic/Latino Community: a Qualitative Evaluation.
    J Cancer Educ. 2024;39:160-167.
    Abstract

  997. ZHANG Y, Lei Y, Ou Q, Chen M, et al
    Listeria-vectored cervical cancer vaccine candidate strains reduce MDSCs via the JAK-STAT signaling pathway.
    BMC Biol. 2024;22:88.
    Abstract

  998. SHEN J, Sun H, Chu J, Gong X, et al
    Cervicovaginal microbiota: a promising direction for prevention and treatment in cervical cancer.
    Infect Agent Cancer. 2024;19:13.
    Abstract

  999. OKYERE J, Ayebeng C, Dosoo AK, Dickson KS, et al
    Cervical cancer screening among women with comorbidities: evidence from the 2022 Tanzania demographic and health survey.
    BMC Public Health. 2024;24:1093.
    Abstract

  1000. KASHID SR, Gurram L, Pullan S, Chopra S, et al
    Clinical outcomes of adaptive intracavitary and interstitial brachytherapy technique in locally advanced cervical cancer: A real-world data.
    Brachytherapy. 2024 Apr 18:S1538-4721(24)00047.
    Abstract

  1001. XIAO Y, Yu R, Gu J
    Diagnosis and rescue of malignant hyperthermia induced by anesthesia during radical surgery in a cervical cancer patient using the National Remote Emergency System: A case report.
    Medicine (Baltimore). 2024;103:e37699.
    Abstract

  1002. CHEN XX, Nie C, Rao DF, Chen XX, et al
    The effect of refined psychological pain nursing combined with IMB nursing on the pain, sleep and quality of life of patients after cervical cancer surgery.
    Medicine (Baltimore). 2024;103:e37816.
    Abstract

  1003. ZHOU L, Bi Y, Wu X, He H, et al
    High keratin 15 expression reflects favorable prognosis in early cervical cancer patients.
    Ir J Med Sci. 2024 Apr 19. doi: 10.1007/s11845-024-03686.
    Abstract

  1004. HU J, Wang S, Li X
    A comprehensive review of m(6)A research in cervical cancer.
    Epigenomics. 2024 Apr 19. doi: 10.2217/epi-2024-0002.
    Abstract

  1005. ZHANG G, Su G
    Efficacy and Safety of Recombinant Human p53 Adenovirus Injection Combined with Radiotherapy or Concurrent Chemoradiotherapy in the Treatment of Cervical Cancer: A Systematic Review and Meta-analysis.
    Altern Ther Health Med. 2024 Apr 18:AT10189.
    Abstract

  1006. LI E, Ni H
    Prognostic nomogram for early-stage cervical cancer in the elderly: A SEER database analysis.
    Prev Med Rep. 2024;41:102700.
    Abstract

  1007. TAKAGAWA Y, Izumi S, Takahashi E, Kita M, et al
    Interstitial round needles should not be used for cervical cancer patient treated with intracavitary/ interstitial brachytherapy using a Venezia applicator : a case report.
    BMC Womens Health. 2024;24:249.
    Abstract

  1008. LIU K, Yang W, Tian H, Li Y, et al
    Association between programmed cell death ligand-1 expression in patients with cervical cancer and apparent diffusion coefficient values: a promising tool for patient s immunotherapy selection.
    Eur Radiol. 2024 Apr 18. doi: 10.1007/s00330-024-10759.
    Abstract

  1009. DEO BS, Nayak S, Pal M, Panigrahi PK, et al
    Wavelet scattering transform and entropy features in fluorescence spectral signal analysis for cervical cancer diagnosis.
    Biomed Phys Eng Express. 2024 Apr 18. doi: 10.1088/2057-1976.
    Abstract

  1010. BUCHALET C, Loap P, Losa S, Laas E, et al
    Long-term clinical outcomes of preoperative brachytherapy in early-stage cervical cancer.
    Eur J Surg Oncol. 2024;50:108342.
    Abstract

  1011. LI SS, Chen JJ, Zhang MM, Wang WX, et al
    Design, synthesis, and biological evaluation of novel benzimidazole derivatives as anti-cervical cancer agents through PI3K/Akt/mTOR pathway and tubulin inhibition.
    Eur J Med Chem. 2024;271:116425.
    Abstract

  1012. CHEN YC, Chen YY, Su SY, Jhuang JR, et al
    Projected Time for the Elimination of Cervical Cancer Under Various Intervention Scenarios: Age-Period-Cohort Macrosimulation Study.
    JMIR Public Health Surveill. 2024;10:e46360.
    Abstract

  1013. LIU XQ, Wang L, Gu X, Shan X, et al
    The Experience of Cervical Cancer Patients Undergoing Hysterectomy: A Qualitative Study.
    J Transcult Nurs. 2024 Apr 18:10436596241246976. doi: 10.1177/10436596241246976.
    Abstract

  1014. MA Y, Zhao X, Chen X
    Contrast-enhanced ultrasound combined with elastic imaging for predicting the efficacy of concurrent chemoradiotherapy in cervical cancer: a feasibility study.
    Front Oncol. 2024;14:1301900.
    Abstract

  1015. LIU C, Yuan Z, Liu Q, Song K, et al
    Siamese deep learning video flow cytometry for automatic and label-free clinical cervical cancer cell analysis.
    Biomed Opt Express. 2024;15:2063-2077.
    Abstract

  1016. WU Z, Jia X, Lu L, Xu C, et al
    Multi-center Dose Prediction Using Attention-aware Deep learning Algorithm Based on Transformers for Cervical Cancer Radiotherapy.
    Clin Oncol (R Coll Radiol). 2024 Mar 26:S0936-6555(24)00119.
    Abstract

  1017. HERNANDEZ-PADILLA L, Duran-Maldonado MX, Martinez-Alcantar L, Rodriguez-Zavala JS, et al
    The HGF/Met Receptor Mediates Cytotoxic Effect of Bacterial Cyclodipeptides in Human Cervical Cancer Cells.
    Curr Cancer Drug Targets. 2024 Apr 15. doi: 10.2174/0115680096285034240323035013
    Abstract

  1018. YIFAN M, Rui X, Yuan L, Feiyun J, et al
    Allicin inhibits the biological activities of cervical cancer cells by suppressing circEIF4G2.
    Food Sci Nutr. 2024;12:2523-2536.
    Abstract

  1019. WANG Y, Lv B, Wang H, Ren T, et al
    Ultrasound-Triggered Azo Free Radicals for Cervical Cancer Immunotherapy.
    ACS Nano. 2024 Apr 16. doi: 10.1021/acsnano.3c10625.
    Abstract

  1020. GRINCEVICIENE S, Vaitkiene D, Kanopiene D, Vanseviciute Petkeviciene R, et al
    Aerobic vaginitis is associated with carbonic anhydrase IX in cervical intraepithelial neoplasia.
    Sci Rep. 2024;14:8789.
    Abstract

  1021. SPENCER JC, Charlton BM, Pretsch PK, Schnarrs PW, et al
    Barriers to Cervical Cancer Screening by Sexual Orientation Among Low-Income Women in North Carolina.
    Arch Sex Behav. 2024 Apr 16. doi: 10.1007/s10508-024-02844.
    Abstract

  1022. MAPAONA R, Williams V, Musarapasi N, Kibwana S, et al
    Cervical cancer screening outcomes for HIV-positive women in the Lubombo and Manzini regions of Eswatini-Prevalence and predictors of a positive visual inspection with acetic acid (VIA) screen.
    PLOS Glob Public Health. 2024;4:e0002760.
    Abstract

  1023. WANG N, Xu J, Wang Y, Zhang X, et al
    USP7 promotes cervical cancer progression by stabilizing MTDH expression through deubiquitination.
    J Cancer Res Clin Oncol. 2024;150:196.
    Abstract

  1024. WANG Z, Cho H, Choyke P, Levy D, et al
    A Mathematical Model of TCR-T Cell Therapy for Cervical Cancer.
    Bull Math Biol. 2024;86:57.
    Abstract

  1025. ITO K, Nakajima Y, Ogawa H, Furusawa A, et al
    Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy.
    Jpn J Radiol. 2024 Apr 16. doi: 10.1007/s11604-024-01566.
    Abstract

  1026. YU L, Majerciak V, Lobanov A, Mirza S, et al
    HPV oncogenes expressed from only one of multiple integrated HPV DNA copies drive clonal cell expansion in cervical cancer.
    mBio. 2024 Apr 16:e0072924. doi: 10.1128/mbio.00729.
    Abstract

  1027. SHARIATI SARCHESHME M, Mahdizadeh M, Tehrani H, Vahedian-Shahroodi M, et al
    Exploring the barriers to Pap smear test compliance: A qualitative study for improving cervical cancer screening in the primary health care.
    Health Promot Perspect. 2024;14:80-88.
    Abstract

  1028. SHA S, R J Goyette E, West LA, Bentz JL, et al
    Recurrent pembrolizumab-induced mechanical small bowel obstruction in a patient with metastatic cervical cancer.
    Gynecol Oncol Rep. 2024;53:101382.
    Abstract

  1029. ZENG Z, Zhu J, Wang Z, Wang G, et al
    Pelvic target volume inter-fractional motion during radiotherapy for cervical cancer with daily iterative cone beam computed tomography.
    Radiat Oncol. 2024;19:48.
    Abstract

  1030. XU M, Lin MC, Li ZH
    Interferon-gamma-induced GBP1 is an inhibitor of human papillomavirus 18.
    BMC Womens Health. 2024;24:240.
    Abstract

  1031. CHO O, Chun M, Chang SJ
    Average log change rate of pretreatment squamous cell carcinoma antigen after concurrent chemoradiotherapy in stage IIIC1 cervical squamous cell carcinoma.
    Sci Rep. 2024;14:8710.
    Abstract

  1032. SONG L, Gao Y, Wang Z, Shi Y, et al
    Serum Levels of Intercellular Adhesion Molecule 1 and Vascular Cell Adhesion Molecule 1 as Biomarkers to Predict Radiotherapy Sensitivity in Cervical Cancer.
    Geburtshilfe Frauenheilkd. 2024;84:370-377.
    Abstract

  1033. LIU P, Xie L, Wu Q, Huang L, et al
    TIE1 promotes cervical cancer progression via Basigin-matrix metalloproteinase axis.
    Int J Biol Sci. 2024;20:2297-2309.
    Abstract

  1034. JIN L, Cao F, Zhang Y, Dang Y, et al
    Nomograms for predicting prognostic value of combined neutrophil-to-lymphocyte ratio and SCC-Ag in locally advanced cervical cancer.
    Transl Cancer Res. 2024;13:1323-1335.
    Abstract

  1035. ZHANG R, Xu W, Yang S, Hu D, et al
    Prevalence of High-Risk Human Papillomavirus Infection, Associated Risk Factors, and Relationship With Cervical Precancerous Lesions in Perimenopausal and Older Women in an Area With High Cervical Cancer Incidence in China.
    Cureus. 2024;16:e58081.
    Abstract

  1036. TIAN W, Tan S, Wang J, Shen P, et al
    Immune-related LncRNAs scores predicts chemotherapeutic responses and prognosis in cervical cancer patients.
    Discov Oncol. 2024;15:119.
    Abstract

  1037. MARIN-AQUINO LA, Mora-Garcia ML, Moreno-Lafont MC, Garcia-Rocha R, et al
    Adenosine increases PD-L1 expression in mesenchymal stromal cells derived from cervical cancer through its interaction with A(2A)R/A(2B)R and the production of TGF-beta1.
    Cell Biochem Funct. 2024;42:e4010.
    Abstract

  1038. AGUILAR-MARTINEZ SY, Campos-Viguri GE, Medina-Garcia SE, Garcia-Flores RJ, et al
    MiR-21 Regulates Growth and Migration of Cervical Cancer Cells by RECK Signaling Pathway.
    Int J Mol Sci. 2024;25:4086.
    Abstract

  1039. PANTE GC, Castro JC, Lini RS, Romoli JCZ, et al
    Inclusion Complexes of Litsea cubeba (Lour.) Pers Essential Oil into beta-Cyclodextrin: Preparation, Physicochemical Characterization, Cytotoxicity and Antifungal Activity.
    Molecules. 2024;29:1626.
    Abstract

  1040. BEBIA V, Diaz-Feijoo B, Tejerizo A, Torne A, et al
    Patterns of First Recurrence and Oncological Outcomes in Locally Advanced Cervical Cancer Patients: Does Surgical Staging Play a Role?
    Cancers (Basel). 2024;16:1423.
    Abstract

  1041. JACQUES C, Marchand F, Chatelais M, Albinet V, et al
    The Micro-Immunotherapy Medicine 2LPAPI((R)) Displays Immune-Modulatory Effects in a Model of Human Papillomavirus Type-16 L1-Protein Capsid-Treated Human Peripheral Blood Mononuclear Cells and Antiproliferative Effects in a Model of Cervical Cancer C
    Cancers (Basel). 2024;16:1421.
    Abstract

  1042. LE GUEVELOU J, Selleret L, Laas E, Lecuru F, et al
    Cervical Cancer Associated with Pregnancy: Current Challenges and Future Strategies.
    Cancers (Basel). 2024;16:1341.
    Abstract

  1043. BELLOSILLO B, Ibanez R, Roura E, Monfil L, et al
    Clinical Validation of the Vitro HPV Screening Assay for Its Use in Primary Cervical Cancer Screening.
    Cancers (Basel). 2024;16:1322.
    Abstract

  1044. BALCIUNIENE E, Inciura A, Juozaityte E, Ugenskiene R, et al
    Impact of RRP1B Variants on the Phenotype, Progression, and Metastasis of Cervical Cancer.
    Cancers (Basel). 2024;16:1250.
    Abstract

  1045. OZTURK NY, Hossain SZ, Mackey M, Adam S, et al
    HPV and Cervical Cancer Awareness and Screening Practices among Migrant Women: A Narrative Review.
    Healthcare (Basel). 2024;12:709.
    Abstract

  1046. DOUGLAS R, Olanrewaju A, Mumme R, Zhang L, et al
    Evaluating automatically generated normal tissue contours for safe use in head and neck and cervical cancer treatment planning.
    J Appl Clin Med Phys. 2024 Apr 12:e14338. doi: 10.1002/acm2.14338.
    Abstract

  1047. LIN W, Yao B, He J, Lin S, et al
    The effect of physical therapy and mechanical stimulation on dysfunction of lower extremities after total pelvic exenteration in cervical carcinoma patient with rectovesicovaginal fistula induced by radiotherapy: a case report.
    J Med Case Rep. 2024;18:207.
    Abstract

  1048. HUANG Y, Pan C, Wu S, Ye F, et al
    A combination of cuproptosis and lncRNAs predicts the prognosis and tumor immune microenvironment in cervical cancer.
    Discov Oncol. 2024;15:116.
    Abstract

  1049. VOVK V, Duda I, Vovk A
    THE EFFECT OF A MULTIMODAL APPROACH ON THE RESULTS OF TREATMENT IN SURGERY: INTEGRATION OF CHEMOTHERAPY, SURGERY, AND RADIOTHERAPY.
    Georgian Med News. 2024;:41-46.
    Abstract

  1050. YAN Z, Chang C, Kang Z, Chen C, et al
    Application of one-dimensional hierarchical network assisted screening for cervical cancer based on Raman spectroscopy combined with attention mechanism.
    Photodiagnosis Photodyn Ther. 2024 Apr 10:104086.
    Abstract

  1051. OAKNIN A, Moore K, Meyer T, Lopez-Picazo Gonzalez J, et al
    Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): a phase 1-2, open-label, multicohort trial.
    Lancet Oncol. 2024 Apr 9:S1470-2045(24)00088.
    Abstract

  1052. LAURIE C, El-Zein M, Tota JE, Tellier PP, et al
    Impact of a carrageenan gel on viral load of genital human papillomavirus infections in sexually active women: Findings from the Carrageenan-gel Against Transmission of Cervical Human papillomavirus (CATCH) trial.
    J Med Virol. 2024;96:e29604.
    Abstract

  1053. CHOI CH, Lee JW, Bae DS, Kang ES, et al
    Efficacy and safety of BVAC-C in HPV type 16- or 18-positive cervical carcinoma who failed 1st platinum-based chemotherapy: a phase I/IIa study.
    Front Immunol. 2024;15:1371353.
    Abstract

  1054. WAMUTI B, Jamil MS, Siegfried N, Ford N, et al
    Understanding effective post-test linkage strategies for HIV prevention and care: a scoping review.
    J Int AIDS Soc. 2024;27:e26229.
    Abstract

  1055. LUO Y, Liu T, Yang X, Lu M, et al
    Human papillomavirus vaccination and contributing factors of vaccination intention among adolescents and young adults in China from a socio-ecological perspective: A cross-sectional study.
    Public Health Nurs. 2024;41:602-616.
    Abstract

  1056. KNISELY A, Hinchcliff E, Fellman B, Mosley A, et al
    Phase 1b study of intraperitoneal ipilimumab and nivolumab in patients with recurrent gynecologic malignancies with peritoneal carcinomatosis.
    Med. 2024;5:311-320.
    Abstract

  1057. PERGIALIOTIS V, Papageorgiou D, Douligeris A, Mortaki A, et al
    Awareness, knowledge and attitudes of human papillomavirus infection, screening and vaccination: a survey study in Greece.
    Arch Gynecol Obstet. 2024;309:2031-2040.
    Abstract

  1058. GARDELLA B, Dominoni M, Pasquali MF, Gotti M, et al
    Retrospective Investigation of Human Papillomavirus Cervical Infection and Lymphoma Incidence: A Clinical and Pathological Evaluation.
    Gynecol Obstet Invest. 2024;89:95-102.
    Abstract

  1059. HAWKINS KE, Gourlay K, Cuschieri K
    Challenges for cervical screening in people experiencing homelessness.
    BMJ Sex Reprod Health. 2024;50:150-151.
    Abstract

  1060. SZALAI L, Vereczkey I, Szemes M, Rokusz A, et al
    NTRK-rearranged spindle cell sarcoma of the uterine cervix with a novel NUMA1::NTRK1 fusion.
    Virchows Arch. 2024;484:527-531.
    Abstract

  1061. TRAN TXM, Kim S, Cha C, Park B, et al
    Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer.
    Cancer Res Treat. 2024;56:522-530.
    Abstract

  1062. BRITO MJ, Sequeira P, Quintas A, Silva I, et al
    Programmed death-ligand 1 (PD-L1) expression in cervical intraepithelial neoplasia and cervical squamous cell carcinoma of HIV-infected and non-infected patients.
    Virchows Arch. 2024;484:507-516.
    Abstract

  1063. TEMMINGHOFF L, Russell C, Andersson T, Broun K, et al
    Barriers and enablers to participation in the National Cervical Screening Program experienced by young women and people with a cervix aged between 25 and 35.
    Health Promot J Austr. 2024;35:376-384.
    Abstract

  1064. FLORENCE AM, Fogel J, Mozey M, Dave S, et al
    Therapeutic human papilloma virus vaccination in patients at risk for cervical dysplasia.
    Minerva Obstet Gynecol. 2024;76:127-134.
    Abstract

  1065. FLEMING J, Grasso C, Mayer KH, Reisner SL, et al
    Gender-Affirming Hormone Therapy and Cervical Cancer Screening Rates in Transgender Men and Nonbinary People: A Cross-Sectional Study from a Boston Community Health Center.
    LGBT Health. 2024 Apr 26. doi: 10.1089/lgbt.2023.0418.
    Abstract

  1066. PETRE I, Vernic C, Petre I, Vlad CS, et al
    Systematic Review on the Effectiveness and Outcomes of Nivolumab Treatment Schemes in Advanced and Metastatic Cervical Cancer.
    Diseases. 2024;12:77.
    Abstract

  1067. MEHTA H, Ambele MA, Mokgautsi N, Moela P, et al
    Probing the Effects of Retinoblastoma Binding Protein 6 (RBBP6) Knockdown on the Sensitivity of Cisplatin in Cervical Cancer Cells.
    Cells. 2024;13:700.
    Abstract

  1068. HUANG L, Zhang J, Songyang Z, Xiong Y, et al
    Identification and Validation of eRNA as a Prognostic Indicator for Cervical Cancer.
    Biology (Basel). 2024;13:227.
    Abstract

  1069. ATIASE Y, Effah K, Mawusi Wormenor C, Tekpor E, et al
    Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
    BMC Womens Health. 2024;24:260.
    Abstract

  1070. ZHANG Y, Du H, Wang C, Huang X, et al
    Feasibility and applicability of self-sampling based online cervical cancer screening: findings from the China online cervical cancer screening trial.
    Infect Agent Cancer. 2024;19:16.
    Abstract

  1071. AGARWAL M, Kumar M, Pathak R, Bala K, et al
    Exploring TLR signaling pathways as promising targets in cervical cancer: The road less traveled.
    Int Rev Cell Mol Biol. 2024;385:227-261.
    Abstract

  1072. VAN DER HOEF C, Bawuah Dsane L, Schuur N, Louwers YV, et al
    Hormone replacement therapy in women with iatrogenic premature ovarian insufficiency after radiotherapy for cervical cancer: A retrospective cohort and survey study.
    Maturitas. 2024;185:108004.
    Abstract

  1073. HOSSEINI MS, Shafizadeh F, Bahremani MH, Farzaneh F, et al
    Comparison of programmed death-ligand 1 expression in adenocarcinoma and squamous cell carcinoma of the cervix in paraffin blocks of patients with cervical cancer.
    Cancer Rep (Hoboken). 2024;7:e2057.
    Abstract

  1074. CHO WK, Park W, Kim SW, Lee KK, et al
    Postoperative Hypofractionated Intensity-Modulated Radiotherapy With Concurrent Chemotherapy in Cervical Cancer: The POHIM-CCRT Nonrandomized Controlled Trial.
    JAMA Oncol. 2024 Apr 25. doi: 10.1001/jamaoncol.2024.0565.
    Abstract

  1075. MOHAMMAD H, Espensen AS, Arnardottir MB, Bergholdt SH, et al
    The Incidence of Cervical Intraepithelial Neoplasia or Cervical Cancer in Women Referred With Postcoital Bleeding.
    J Low Genit Tract Dis. 2024 Apr 23. doi: 10.1097/LGT.0000000000000808.
    Abstract

  1076. SKERLEV M, Ljubojevic Hadzavdic S, Sirotkovic-Skerlev M
    Not all bad with HPV is the cervical cancer only!
    J Eur Acad Dermatol Venereol. 2024;38:796-797.
    Abstract

  1077. THOMAS-PURCELL K, Bailey A, Sealy DA, Song G, et al
    Cervical Cancer Stigma Among Caribbean Population: A Descriptive Paper.
    Int J Public Health. 2024;69:1606725.
    Abstract

  1078. ALZIBDEH A, Mohamad I, Wahbeh L, Abuhijlih R, et al
    Can we triumph over locally advanced cervical cancer with colossal para-aortic lymph nodes? A case report.
    World J Clin Cases. 2024;12:1851-1856.
    Abstract

  1079. BONGAERTS THG, Buchner FL, Nierkens V, Crone MR, et al
    Perceptions and beliefs of general practitioners on their role in the cancer screening programmes in the Netherlands: a mixed-methods study.
    BMC Prim Care. 2024;25:129.
    Abstract

  1080. BALOGUN FM, Omotade O
    Pursuance of a Yoruba name for cervical cancer in Southwest Nigeria: a case study.
    BMJ Open. 2024;14:e074020.
    Abstract


  1081. What factors contribute to differences in cervical cancer screening in rural and urban community health centers?
    Saudi Med J. 2024;45:447.
    Abstract

  1082. LI C, Xue Y, Wu J, Zhang L, et al
    MTH1 inhibition synergizes with ROS-inducing agents to trigger cervical cancer cells undergoing parthanatos.
    Biochim Biophys Acta Mol Basis Dis. 2024 Apr 22:167190.
    Abstract

  1083. WANG Y, Wang H
    CCT6A regulates cervical cancer cell glycolysis and proliferation under hypoxic conditions via the TCAB1/TERT.
    Gynecol Obstet Invest. 2024 Apr 24. doi: 10.1159/000539042.
    Abstract

  1084. KHOJA L, Wang Y, Haque SE, Ahsan H, et al
    Understanding of cervical cancer, acceptability of HPV self-collection, and prevalence of HPV in a semi-urban setting in Bangladesh.
    PLOS Glob Public Health. 2024;4:e0003157.
    Abstract

  1085. LEUNG SN, Chandra SS, Lim K, Young T, et al
    Automatic segmentation of tumour and organs at risk in 3D MRI for cervical cancer radiation therapy with anatomical variations.
    Phys Eng Sci Med. 2024 Apr 24. doi: 10.1007/s13246-024-01415.
    Abstract

  1086. FIRNHABER C, Simoncini G, Mayer C, Armon C, et al
    Mammogram and Pap Smear Uptake Among Women in the HIV Outpatient Study USA, 2010-2021.
    AIDS Patient Care STDS. 2024;38:151-154.
    Abstract

  1087. MA CY, Zhao J, Zhou JY
    Microbiome profiling and Co-metabolism pathway analysis in cervical cancer patients with acute radiation enteritis.
    Heliyon. 2024;10:e29598.
    Abstract

  1088. MA B, Zhou J, Zhou W, Ma Z, et al
    Nonlinear relationship between viral load and TCT in single/multiple HPV52 infection.
    Virol J. 2024;21:90.
    Abstract

  1089. HUANG K, Huang X, Zeng C, Wang S, et al
    Radiomics signature for dynamic changes of tumor-infiltrating CD8+ T cells and macrophages in cervical cancer during chemoradiotherapy.
    Cancer Imaging. 2024;24:54.
    Abstract

  1090. HOUPERT R, Bendiane MK, Huiart L, Bouhnik AD, et al
    Socioeconomic and cultural factors associated with pap smear screening among French women living in Reunion Island.
    BMC Public Health. 2024;24:1125.
    Abstract

  1091. YIN C, Yu J, Liu G, He J, et al
    Riddle of the Sphinx: Emerging role of circular RNAs in cervical cancer.
    Pathol Res Pract. 2024;257:155315.
    Abstract

  1092. GRIEGER P, Eisemann N, Hammersen F, Rudolph C, et al
    Initial Evidence of a Possible Effect of HPV Vaccination on Cancer Incidence in Germany-Focus on Cervical Cancer.
    Dtsch Arztebl Int. 2024;.
    Abstract

  1093. CHENG D, Rieu-Werden ML, Lykken JM, Werner CL, et al
    Assessing Management of Abnormal Cervical Cancer Screening Results and Concordance with Guideline Recommendations in Three US Healthcare Settings.
    Cancer Epidemiol Biomarkers Prev. 2024.
    Abstract

  1094. SCHMITT F, Najjari L, Kupec T, Stickeler E, et al
    Predictors of significant distress in cervical cancer patients: a cross sectional study.
    Arch Gynecol Obstet. 2024 Apr 23. doi: 10.1007/s00404-024-07505.
    Abstract

  1095. DATTA S, Verma P, Dhara B, Kundu R, et al
    Interplay of precision therapeutics and MD study: Calocybe indica's potentials against cervical cancer and its interaction with VEGF via octadecanoic acid.
    J Cell Mol Med. 2024;28:e18302.
    Abstract

  1096. LIANG M, Sheng L, Ke Y, Wu Z, et al
    The research progress on radiation resistance of cervical cancer.
    Front Oncol. 2024;14:1380448.
    Abstract

  1097. ZHENG L, Ren Q, Zhu W, Tao X, et al
    MiR-4319 targets tuftelin 1 to reduce malignancy of cervical cancer cells.
    Cell Mol Biol (Noisy-le-grand). 2024;70:54-60.
    Abstract

  1098. NGU SF, Lau LS, Chan CY, Ngan HY, et al
    Acceptability of self-collected vaginal samples for human papillomavirus testing for primary cervical cancer screening: comparison of face-to-face and online recruitment modes.
    BMC Public Health. 2024;24:1104.
    Abstract

  1099. MCDOWELL A, Rieu-Werden ML, Atlas SJ, Fields CD, et al
    Characteristics of Clinicians Caring for Transgender Men and Nonbinary Individuals and Guideline Concordance of Clinicians' Cervical Cancer Screening Counseling for Cisgender Individuals Versus Transgender Men and Nonbinary Individuals with a Cervix.
    LGBT Health. 2024 Apr 22. doi: 10.1089/lgbt.2023.0067.
    Abstract

  1100. TESHOME R, Yang I, Woldetsadik E, Girma E, et al
    Pre- and Post-Treatment Quality of Life Among Patients with Advanced Stage Cervical Cancer at Tikur Anbessa Specialized Hospital, Ethiopia.
    Cancer Manag Res. 2024;16:311-323.
    Abstract

  1101. MAYERI DG, Kahasha PM, Kibalama IB, Mongane J, et al
    Cervical precancerous and cancerous lesions screening using Pap smear test at Provincial Referral Hospital of Bukavu, Eastern DR Congo: profile and recommendations to stakeholders.
    Pan Afr Med J. 2024;47:57.
    Abstract

  1102. TESHOME R, Yang I, Woldetsadik E, Girma E, et al
    Survival Status and Predictors Among Women with Advanced Stage of Cervical Cancer.
    Int J Womens Health. 2024;16:605-617.
    Abstract

  1103. SCHLUETER D, Bermudez Y, Debrot KF, Ross LW, et al
    Breast and cervical cancer programs' success in maintaining screening during periods of high COVID-19: A qualitative multi-case study analysis.
    Heliyon. 2024;10:e29223.
    Abstract

  1104. LEE J, Lapuz C, Khor R, Lau E, et al
    Narrative review of the utility of magnetic resonance imaging in radiotherapy for cervical cancer.
    Chin Clin Oncol. 2024 Apr 13:cco-23-91. doi: 10.21037.
    Abstract

  1105. LI X, Gao YH, Yang Z, Ma Y, et al
    [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:307-319.
    Abstract

  1106. ZHANG W, Cao YS, Wei MC, Xu J, et al
    [Application of optical coherence tomography in the evaluation of cervical lesions: a multicenter study].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:299-306.
    Abstract


  1107. [Specification for quality control of cervical cancer screening (DB11/T 2137-2023)].
    Zhonghua Zhong Liu Za Zhi. 2024;46:269-273.
    Abstract

  1108. NETO BV, Tavares V, da Silva JB, Liz-Pimenta J, et al
    Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies.
    J Thromb Thrombolysis. 2024 Apr 20. doi: 10.1007/s11239-024-02983.
    Abstract

  1109. FACKLER MJ, Pleas M, Li Y, Soni A, et al
    Discovery and technical validation of high-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries.
    Clin Epigenetics. 2024;16:56.
    Abstract

  1110. SARWAR A, Eminowicz G
    Radiotherapy induced ureteric stenosis in locally advanced cervical cancer: A review of current evidence.
    Brachytherapy. 2024 Apr 19:S1538-4721(24)00044.
    Abstract

  1111. BAEKELANDT J
    vNOTES Radical Hysterectomy: A New Approach To Cervical Cancer.
    J Minim Invasive Gynecol. 2024 Apr 18:S1553-4650(24)00173.
    Abstract

  1112. SABAH J, Menoux I, Eberst L, Lodi M, et al
    Variability of treatment of locally advanced cervical cancer: How French multidisciplinary teams follow European guidelines?
    Eur J Surg Oncol. 2024;50:108281.
    Abstract

  1113. DENG S, Yuan P, Sun J
    The role of NF-kappaB in carcinogenesis of cervical cancer: opportunities and challenges.
    Mol Biol Rep. 2024;51:538.
    Abstract

  1114. ZHANG J, Shao SY, Ma YJ, Qin W, et al
    [Cognition of human papillomavirus and its influencing factors among college students in Shandong province].
    Zhonghua Nan Ke Xue. 2023;29:826-830.
    Abstract

  1115. YUAN H, Li L, Li N, Yao H, et al
    Sarcoma of the uterine cervix: experience of a single center.
    World J Surg Oncol. 2024;22:104.
    Abstract

  1116. ABDUL-LATIF M, Chowdhury A, Tharmalingam H, Taylor NJ, et al
    Exploratory study of using Magnetic resonance Prognostic Imaging markers for Radiotherapy In Cervix cancer (EMPIRIC): a prospective cohort study protocol.
    BMJ Open. 2024;14:e077390.
    Abstract

  1117. BOLDINOVA EO, Baranovskiy AG, Filina YV, Miftakhova RR, et al
    PrimPol Variant V102A with Altered Primase and Polymerase Activities.
    J Mol Biol. 2024;436:168542.
    Abstract

  1118. YASUTAKE N, Yamamoto H, Kuga R, Jiromaru R, et al
    Immunohistochemical p16 overexpression and Rb loss correlate with high-risk human papillomavirus infection in endocervical adenocarcinomas.
    Histopathology. 2024;84:1178-1191.
    Abstract

  1119. PATODI V, Soni TP, Singh DK, Patni N, et al
    Dosimetric comparison of O-ring versus conventional C-arm linear accelerator for volumetric modulated arc therapy (VMAT) of head and neck cancer and carcinoma cervix patients.
    Radiat Prot Dosimetry. 2024;200:538-543.
    Abstract

  1120. LIU Q, Zhang X, Jiang X, Zhang C, et al
    A Histopathologic Image Analysis for the Classification of Endocervical Adenocarcinoma Silva Patterns Depend on Weakly Supervised Deep Learning.
    Am J Pathol. 2024;194:735-746.
    Abstract

  1121. ZHONG F, Wang T, Li W, Zhang H, et al
    Associations of Single Versus Multiple Human Papillomavirus Infections With the Prevalence of Cervical Intraepithelial Neoplasia 2/3 and Squamous Cell Carcinoma Lesions: Human Papillomavirus Type-Specific Attribution.
    Lab Invest. 2024;104:100328.
    Abstract

  1122. CALVEZ J, Neirynck V, Marcelin AG, Jary A, et al
    Extending vaccination periods against human papillomavirus: Lessons from the SARS-CoV-2 pandemic.
    BJOG. 2024;131:877-879.
    Abstract

  1123. STOLNICU S, Praiss AM, Allison D, Tessier-Cloutier B, et al
    Proposal of Novel Binary Grading Systems for Cervical Squamous Cell Carcinoma.
    Int J Gynecol Pathol. 2024;43:203-214.
    Abstract

  1124. HE H, Lin C, Lu Y, Wu H, et al
    Knockdown of miR-24 Suppressed the Tumor Growth of Cervical Carcinoma Through Regulating PTEN/PI3K/AKT Signaling Pathway.
    Biochem Genet. 2024;62:1277-1290.
    Abstract

  1125. YAMAN M, Ozcan HEA, Bakir A
    High-Risk Human Papilloma Virus Genotype Distribution and Correlation with Cervical Cytomorphological Data in Turkish and Immigrant Women in Mersin Province.
    New Microbiol. 2024;47:88-97.
    Abstract

  1126. XUE X, Pan Y, Li C
    Circ_TMCO3 Inhibits the Progression of Cervical Cancer by Activating FRMD6 Expression by Restraining miR-1291.
    Reprod Sci. 2024 May 3. doi: 10.1007/s43032-024-01549.
    Abstract

  1127. ALREFAI EA, Alhejaili RT, Haddad SA
    Human Papillomavirus and Its Association With Cervical Cancer: A Review.
    Cureus. 2024;16:e57432.
    Abstract

  1128. LEFEUVRE C, De Pauw H, Le Duc Banaszuk AS, Pivert A, et al
    Corrigendum: Study Protocol: Randomised Controlled Trial Assessing the Efficacy of Strategies Involving Self-Sampling in Cervical Cancer Screening.
    Int J Public Health. 2024;69:1607299.
    Abstract

  1129. KHURANA S, Smolar I, Warren L, Velasquez J, et al
    Time Differences From Abnormal Cervical Cancer Screening to Colposcopy Between Insurance Statuses.
    J Low Genit Tract Dis. 2024 May 2. doi: 10.1097/LGT.0000000000000812.
    Abstract

  1130. VUKOMANOVIC IS, Kocic S, Vukomanovic V, Janicijevic K, et al
    Assessment of Sexual Health and Use of Cervical Cancer Screening among the Female Working Population.
    Iran J Public Health. 2024;53:198-207.
    Abstract

  1131. BALAN L, Cimpean AM, Secosan C, Sorop VB, et al
    Heterogeneity of Cervical Cancer-Associated Tertiary Lymphoid Structures (TLSs) and Their Specific Interrelation With Clinicopathological Parameters.
    Cureus. 2024;16:e59077.
    Abstract

  1132. ZHANG R, Xu W, Yang S, Hu D, et al
    Correction: Prevalence of High-Risk Human Papillomavirus Infection, Associated Risk Factors, and Relationship With Cervical Precancerous Lesions in Perimenopausal and Older Women in an Area With High Cervical Cancer Incidence in China.
    Cureus. 2024;16:c171.
    Abstract

  1133. SHANKAR A, Sehra D, Roy S
    Cervical cancer advocacy: needs more than faking death.
    Lancet Reg Health Southeast Asia. 2024;25:100411.
    Abstract

  1134. SHRATEH ON, Habib A, Jalamneh B, Omar BMM, et al
    The level of medical students' knowledge regarding the prevention of cervical cancer.
    Ann Med Surg (Lond). 2024;86:2591-2597.
    Abstract

  1135. MUKSIMOVA S, Umirzakova S, Kang S, Cho YI, et al
    CerviLearnNet: Advancing cervical cancer diagnosis with reinforcement learning-enhanced convolutional networks.
    Heliyon. 2024;10:e29913.
    Abstract

  1136. ARROYO MUHR LS, Gini A, Yilmaz E, Hassan SS, et al
    Concomitant human papillomavirus (HPV) vaccination and screening for elimination of HPV and cervical cancer.
    Nat Commun. 2024;15:3679.
    Abstract

  1137. LIU H, Liu Y, Zhou Y, Chen X, et al
    TM7SF2-induced lipid reprogramming promotes cell proliferation and migration via CPT1A/Wnt/beta-Catenin axis in cervical cancer cells.
    Cell Death Discov. 2024;10:207.
    Abstract

  1138. TSONEVA E, Dimitrova P, Metodiev M, Shivarov V, et al
    Utility of expression of 4-hydroxynonenal tested by immunohistochemistry for cervical cancer.
    Prz Menopauzalny. 2024;23:6-13.
    Abstract

  1139. ABBAS K, Yoo KJ, Prem K, Jit M, et al
    Equity impact of HPV vaccination on lifetime projections of cervical cancer burden among cohorts in 84 countries by global, regional, and income levels, 2010-22: a modelling study.
    EClinicalMedicine. 2024;70:102524.
    Abstract

  1140. CHEN W, Xie X, Liu C, Liao J, et al
    IRAK1 deficiency potentiates the efficacy of radiotherapy in repressing cervical cancer development.
    Cell Signal. 2024;119:111192.
    Abstract

  1141. ZHANG W, Yin Y, Jiang Y, Yang Y, et al
    Relationship between vaginal and oral microbiome in patients of human papillomavirus (HPV) infection and cervical cancer.
    J Transl Med. 2024;22:396.
    Abstract

  1142. LIU S, Gu Y, Shi Y, Yu S, et al
    AEBP1 upregulation contributes to cervical cancer progression by facilitating cell proliferation, migration, and invasion.
    J Obstet Gynaecol Res. 2024 Apr 29. doi: 10.1111/jog.15959.
    Abstract

  1143. ARROSSI S, Binder F, Ituarte C, Martiarena N, et al
    [Effect of COVID-19 pandemics in treatment of cervical cancer: pre/post study].
    Medicina (B Aires). 2024;84:236-248.
    Abstract

  1144. BRUERA S, Bowman S, Huang Y, Suarez-Almazor ME, et al
    Factors associated with adherence of cervical cancer screening in women with Systemic Lupus Erythematosus.
    Arthritis Care Res (Hoboken). 2024 Apr 29. doi: 10.1002/acr.25355.
    Abstract

  1145. NGWIBETE A, Ogunbode O, Swende LT, Agbada MM, et al
    Prevalence of precancerous lesions and other cervical abnormalities among internally displaced women in Benue State Nigeria.
    Pan Afr Med J. 2024;47:50.
    Abstract

  1146. SHEASHEA AA, Ahmed FA, El Zayat E, Ebeed BW, et al
    In Vitro Antiviral and Anticancer Effects of Tanacetum sinaicum Essential Oil on Human Cervical and Breast Cancer.
    Asian Pac J Cancer Prev. 2024;25:1457-1471.
    Abstract

  1147. ALIM S, Siddiqui SA, Akram M, Hakim S, et al
    A Comparative Study of Clinical Outcomes in Locally Advanced Cervical Cancer: External Beam Radiotherapy (EBRT) and Sequential High Dose Rate Intracavitary Brachytherapy (HDRICBT) with or without Concurrent Cisplatin on the Day of ICBT Insertion - A T
    Asian Pac J Cancer Prev. 2024;25:1333-1338.
    Abstract

  1148. DEWI SM, Bennett LR, Barrett A
    Exploring Indonesian Primary Schoolgirls' Experiences of School-based HPV Vaccination, Knowledge of HPV Risks and Prevention, and Preferences for Cervical Cancer Education.
    Asian Pac J Cancer Prev. 2024;25:1285-1292.
    Abstract

  1149. CHAOPOTONG P, Laiwejpithya S, Areeswate C
    Prevalence of High-Risk HPV Detection and HPV Vaccination in Cervical Cancer Screening During the HPV Vaccination Era at Siriraj Hospital - Thailand's Largest National Tertiary Referral Center.
    Asian Pac J Cancer Prev. 2024;25:1241-1245.
    Abstract

  1150. MARZBANRAD Z, Karimi-Zarchi M, Noei-Teymoordash S, Motamedinasab M, et al
    A Comprehensive Integration of Data Regarding the Correlation of TNF-alpha rs1800629 Polymorphism with Susceptibility to Cervical Cancer.
    Asian Pac J Cancer Prev. 2024;25:1155-1167.
    Abstract

  1151. TIAN Q, Huang J, Zhang Q, Zhao J, et al
    N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
    Clin Exp Pharmacol Physiol. 2024;51:e13864.
    Abstract

  1152. RIGBY S, Greenley R, Uuskula A, Tisler A, et al
    Expanding eligibility and improving quality of cervical cancer screening in Estonia: The 2021 reforms.
    Health Policy. 2024;144:105077.
    Abstract

  1153. TAKAC I, Kavalar R, Lovrec MR, Lovrec VG, et al
    Concomitant ectopic Enterobius vermicularis infection in uterine cervical cancer.
    BMC Womens Health. 2024;24:265.
    Abstract

  1154. KIRABIRA J, Kayondo M, Bawakanya SM, Nsubuga EJ, et al
    Association between HIV Serostatus and premalignant cervical lesions among women attending a cervical cancer screening clinic at a tertiary care facility in southwestern Uganda: a comparative cross-sectional study.
    BMC Womens Health. 2024;24:266.
    Abstract

  1155. YAMAOKA Y, Tamura S, Yamanoi K, Taki M, et al
    Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced Cervical Squamous Cell Carcinoma.
    Anticancer Res. 2024;44:2009-2019.
    Abstract

  1156. JUNG BC, Woo SH, Kim SH, Kim YS, et al
    Parkin Enhances Gefitinib-induced Anoikis in HeLa Cervical Cancer Cells.
    Anticancer Res. 2024;44:1853-1862.
    Abstract

  1157. WILLSON CM, Lequio M, Zhu Z, Wakefield MR, et al
    The Role of SARS-CoV-2 Spike Protein in the Growth of Cervical Cancer Cells.
    Anticancer Res. 2024;44:1807-1815.
    Abstract

  1158. KUM SJ, Jung YY, Kim HS
    Comparison of Clinicopathological and Prognostic Characteristics Between Minimal Deviation Adenocarcinoma and Gastric-type Endocervical Adenocarcinoma.
    Anticancer Res. 2024;44:2193-2204.
    Abstract

  1159. WANG J, Liu S, Wei B, Liu Y, et al
    Frequency shift Raman-based sensing of serum MicroRNA for ultrasensitive cervical cancer diagnosis.
    Photodiagnosis Photodyn Ther. 2024;46:104105.
    Abstract

  1160. PESUT E, Simic I, Fures R, Milutin Gasperov N, et al
    Monitoring HPV Prevalence and Risk Cofactors for Abnormal Cytology in the Post-Vaccination Period among Croatian Women.
    Viruses. 2024;16:642.
    Abstract

  1161. D'AMATO A, Riemma G, Agrifoglio V, Chiantera V, et al
    Reproductive Outcomes in Young Women with Early-Stage Cervical Cancer Greater than 2 cm Undergoing Fertility-Sparing Treatment: A Systematic Review.
    Medicina (Kaunas). 2024;60:608.
    Abstract

  1162. LEE SM, Seol A, Cho HW, Min KJ, et al
    Optimal Dietary Intake of Riboflavin Associated with Lower Risk of Cervical Cancer in Korea: Korean National Health and Nutrition Examination Survey 2010-2021.
    Life (Basel). 2024;14:529.
    Abstract

  1163. CHOI Y, Lee D, Kim NY, Seo I, et al
    Role of Tumor-Associated Macrophages in Cervical Cancer: Integrating Classical Perspectives with Recent Technological Advances.
    Life (Basel). 2024;14:443.
    Abstract

  1164. STANIEWSKA E, Grudzien K, Stankiewicz M, Raczek-Zwierzycka K, et al
    The Prognostic Value of the Systemic Immune-Inflammation Index (SII) and Red Cell Distribution Width (RDW) in Patients with Cervical Cancer Treated Using Radiotherapy.
    Cancers (Basel). 2024;16:1542.
    Abstract

  1165. NIU J, Chen Y, Chai HC, Sasidharan S, et al
    Exploring MiR-484 Regulation by Polyalthia longifolia: A Promising Biomarker and Therapeutic Target in Cervical Cancer through Integrated Bioinformatics and an In Vitro Analysis.
    Biomedicines. 2024;12:909.
    Abstract

  1166. CHIZYUKA NA, Crawford E, Hebert KS, Gaju S, et al
    Lessons From the Design and Rollout of an Electronic Medical Record System for Cervical Cancer Screening in Rwanda.
    Glob Health Sci Pract. 2024 Apr 26. doi: 10.9745/GHSP-D-23-00469.
    Abstract

  1167. YIN X, Liu X, Gong H, Chu Z, et al
    LncRNA STARD7-AS1 suppresses cervical cancer cell proliferation while promoting autophagy by regulating miR-31-5p/TXNIP axis to inactivate the mTOR signaling.
    J Gynecol Oncol. 2024 Apr 19. doi: 10.3802/jgo.2024.
    Abstract

  1168. WANG H, Wang D, Xu Y
    Exonuclease-iii -propelled DNAzyme cascade for sensitive and reliable cervical cancer related miRNA analysis.
    Anal Biochem. 2024;691:115547.
    Abstract

  1169. JANJUA D, Thakur K, Aggarwal N, Chaudhary A, et al
    Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis.
    Crit Rev Oncol Hematol. 2024;197:104346.
    Abstract

  1170. KINSLOW CJ, DeStephano DM, Neugut AI, Taparra K, et al
    Site-specific patterns of early-stage cancer diagnosis during the COVID-19 pandemic.
    JNCI Cancer Spectr. 2024;8:pkae022.
    Abstract

  1171. STROETMANN CY, Gizaw M, Alemayehu R, Wondimagegnehu A, et al
    Adherence to Treatment and Follow-Up of Precancerous Cervical Lesions in Ethiopia.
    Oncologist. 2024;29:e655-e664.
    Abstract

  1172. HUR CE, Goldberg JM
    Laparoscopic transfundal approach to cervical dilation: a novel treatment for cervical stenosis and cervical factor infertility.
    Fertil Steril. 2024;121:890-891.
    Abstract

  1173. BOGANI G, Sopracordevole F, Ciavattini A, Vizza E, et al
    HPV persistence after cervical surgical excision of high-grade cervical lesions.
    Cancer Cytopathol. 2024;132:268-269.
    Abstract

  1174. ZHU Z, Lu J
    Development and assessment of an RNA editing-based risk model for the prognosis of cervical cancer patients.
    Medicine (Baltimore). 2024;103:e38116.
    Abstract

  1175. XIONG J, Chen P, He L, Chai X, et al
    Functional mechanism of hypoxia-like conditions mediating resistance to ferroptosis in cervical cancer cells by regulating KDM4A SUMOylation and the SLC7A11/GPX4 pathway.
    Environ Toxicol. 2024 May 10. doi: 10.1002/tox.24304.
    Abstract

  1176. PASQUIER C, Raymond S, Carcenac R, Demmou S, et al
    HPV genotyping in clinical samples using long-read single-molecule real-time sequencing.
    J Med Virol. 2024;96:e29652.
    Abstract

  1177. FAN C, Hu J, Luo T, Dong B, et al
    Analysis of the diagnostic performance of PAX1/SOX1 gene methylation in cervical precancerous lesions and its role in triage diagnosis.
    J Med Virol. 2024;96:e29521.
    Abstract

  1178. EHMAN KM, Jenkins GD, Grimm JA, Cammack TL, et al
    Primary Human Papillomavirus Test Uptake and Cervical Cancer Screening Trends in the Midwest, United States.
    J Prim Care Community Health. 2024;15:21501319241251934.
    Abstract

  1179. MA Z, Zhang H, Wang Y, Zhao H, et al
    Circular RNA circIL21R promotes cervical cancer cells proliferation and migration by sponging the miR-1205/PTBP1 axis.
    Am J Cancer Res. 2024;14:1730-1746.
    Abstract

  1180. VANINOV A, Ibraimova D, Sharshenbaeva A, Zhumabekova A, et al
    Trends in the Prevalence and Mortality of Cervical Cancer in the Kyrgyz Republic.
    Cureus. 2024;16:e57863.
    Abstract

  1181. AGUIAR-ROSAS S, Plancarte-Sanchez R, Hernandez-Porras BC, Garcia-Andreu J, et al
    Pain management in cervical cancer.
    Front Oncol. 2024;14:1371779.
    Abstract

  1182. GAO T, Yang Z, Wei L, Tang X, et al
    Prognostic analysis of stage IIIC1p cervical cancer patients.
    Front Oncol. 2024;14:1362281.
    Abstract

  1183. NISHIMURA H, Amano T, Yoneoka Y, Tsuji S, et al
    Comparison of postoperative adjuvant platinum-based chemotherapy and no further therapy after radical surgery in intermediate-risk early-stage cervical cancer.
    J Gynecol Oncol. 2024 May 1. doi: 10.3802/jgo.2025.
    Abstract

  1184. DVORAK V, Petras M, Dvorak V, Lomozova D, et al
    Reduced risk of CIN2+ recurrence in women immunized with a 9-valent HPV vaccine post-excision: Retrospective cohort study.
    Hum Vaccin Immunother. 2024;20:2343552.
    Abstract

  1185. DAI D, Pei Y, Zhu B, Wang D, et al
    Chemoradiotherapy-induced ACKR2(+) tumor cells drive CD8(+) T cell senescence and cervical cancer recurrence.
    Cell Rep Med. 2024 Apr 30:101550. doi: 10.1016/j.xcrm.2024.101550.
    Abstract

  1186. LIU Q, Chen X, Tan Y, Liu J, et al
    Natural products as glycolytic inhibitors for cervical cancer treatment: A comprehensive review.
    Biomed Pharmacother. 2024;175:116708.
    Abstract

  1187. SHASTRI SS, McNeill LH, Shete S
    Culturally Competent Education and Human Papillomavirus Self-Sampling Achieves Healthy People 2030 Cervical Screening Target Among Low-Income Non-Hispanic Black and Hispanic Women.
    JCO Glob Oncol. 2024;10:e2400005.
    Abstract

  1188. MISHRA R, Singh S, Patel G, Mandal A, et al
    Comparative analysis of simultaneous integrated boost and sequential boost radiotherapy in node-positive cervical cancer: dosimetric and radiobiological considerations.
    Radiat Environ Biophys. 2024 May 9. doi: 10.1007/s00411-024-01069.
    Abstract

  1189. LU X, Zhang W, Zhang J, Ren D, et al
    EPAS1, a hypoxia- and ferroptosis-related gene, promotes malignant behaviour of cervical cancer by ceRNA and super-enhancer.
    J Cell Mol Med. 2024;28:e18361.
    Abstract

  1190. PICKERING AN, Zhao X, Sileanu FE, Lovelace EZ, et al
    Care cascades following low-value cervical cancer screening in dually enrolled Veterans.
    J Am Geriatr Soc. 2024 May 9. doi: 10.1111/jgs.18956.
    Abstract

  1191. NESSA A, Islam T, Noor-E-Ferdousi NE, Sultana A, et al
    Staging and Management of Cervical Cancer at the Colposcopy Clinic of Bangabandhu Sheikh Sheikh Mujib Medical University (BSMMU), Bangladesh.
    South Asian J Cancer. 2024;13:17-26.
    Abstract

  1192. TRAN J, Hathaway CL, Broshkevitch CJ, Palanee-Phillips T, et al
    Cost-effectiveness of single-visit cervical cancer screening in KwaZulu-Natal, South Africa: a model-based analysis accounting for the HIV epidemic.
    Front Oncol. 2024;14:1382599.
    Abstract

  1193. ZHANG W, Yu H, Xiu Y, Meng F, et al
    Clinical Outcomes and Prognostic Factors in Stage III C Cervical Cancer Patients Treated with Radical Radiotherapy or Radiochemotherapy.
    Technol Cancer Res Treat. 2024;23:15330338241254075.
    Abstract

  1194. KOBAYASHI N, Oike T, Ando K, Murata K, et al
    Carbon ion radiotherapy for mesonephric adenocarcinoma of the uterine cervix: a case report.
    J Med Case Rep. 2024;18:228.
    Abstract

  1195. WEI Y, Yu P, Zouyu Zhao, Sun C, et al
    Cervical Cancer Cell-derived Tie1 Expression Via PI3K/AKT Signaling Pathway Promotes Tumour Progression.
    Exp Cell Res. 2024 May 6:114060. doi: 10.1016/j.yexcr.2024.114060.
    Abstract

  1196. LIU S, Wang Z, Hu L, Ye C, et al
    Pan-cancer analysis of super-enhancer-induced LINC00862 and validation as a SIRT1-promoting factor in cervical cancer and gastric cancer.
    Transl Oncol. 2024;45:101982.
    Abstract

  1197. RAJKHOWA P, Kalyanpur C, K R, Dsouza VS, et al
    Geospatial mapping of public sentiment and infodemic on human papillomavirus vaccination in India: An indication to formulation of strategies for effective implementation.
    Glob Public Health. 2024;19:2348646.
    Abstract

  1198. LEE CY, Chen PN, Kao SH, Wu HH, et al
    Deoxyshikonin triggers apoptosis in cervical cancer cells through p38 MAPK-mediated caspase activation.
    Environ Toxicol. 2024 May 8. doi: 10.1002/tox.24323.
    Abstract

  1199. GONZALEZ-RODRIGUEZ JC, Cruz-Valdez A, Madrid-Marina V
    Cervical cancer prevention by vaccination: review.
    Front Oncol. 2024;14:1386167.
    Abstract


  1200. [Expert recommendation for real-world study on the application of human papillomavirus vaccine in the Yangtze River Delta region].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2024;58:577-587.
    Abstract

  1201. PRESTON M, McBain R, Rajadevan N, Jones A, et al
    Sentinel lymph node detection with indocyanine green and patent blue dye in cervical cancer: A single-centre feasibility study.
    Aust N Z J Obstet Gynaecol. 2024 May 7. doi: 10.1111/ajo.13834.
    Abstract

  1202. CHEN H, Zhou L, Fong D, Cun Y, et al
    Quality of life and its related-influencing factors in patients with cervical cancer based on the scale QLICP-CE(V2.0).
    BMC Womens Health. 2024;24:277.
    Abstract

  1203. VEMULA VENKATA VL, Hulikal N, Chowhan AK
    Effectiveness of sentinel lymph node biopsy and bilateral pelvic nodal dissection using methylene blue dye in early-stage operable cervical cancer-A prospective study.
    Cancer Treat Res Commun. 2024;39:100816.
    Abstract

  1204. ZHANG W, Wang H, Chen S, Fan X, et al
    Reactivation of methylation-silenced PAX1 inhibits cervical cancer proliferation and migration via the WNT/TIMELESS pathway.
    Mol Carcinog. 2024 May 7. doi: 10.1002/mc.23728.
    Abstract

  1205. NARCISSE MR, McElfish PA, Hallgren E, Pierre-Joseph N, et al
    Non-use and inadequate use of cervical cancer screening among a representative sample of women in the United States.
    Front Public Health. 2024;12:1321253.
    Abstract

  1206. ZENG F, Guo P, Xia M, He M, et al
    Total hysterectomy versus radical hysterectomy in neuroendocrine cervical cancer: a SEER-database analysis.
    J Cancer Res Clin Oncol. 2024;150:236.
    Abstract

  1207. HE H, He M, Zhou Q, Tang Y, et al
    Genetic analysis of cervical cancer with lymph node metastasis.
    J Gynecol Oncol. 2024 Apr 29. doi: 10.3802/jgo.2024.
    Abstract

  1208. PENG Q, Li Y, Li J, Yao X, et al
    [Research progress on the differences between T and B cell responses to three different forms of human papilloma virus (HPV) vaccination].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024;40:378-382.
    Abstract

  1209. XU Y, Gao L, Yang J, Wang J, et al
    [Knockdown mitochondrial transcription factor A (TFAM) inhibits autophagy, proliferation, invasion and migration in human cervical cancer and osteosarcoma cells].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024;40:311-318.
    Abstract

  1210. ZHANG A, Zheng X, Chen S, Duan G, et al
    In vitro study of HPV18-positive cervical cancer HeLa cells based on CRISPR/Cas13a system.
    Gene. 2024;921:148527.
    Abstract

  1211. FISHER A, Long JR, Chor J
    Closing the Cervical Cancer Screening Gap-Reaching Sexual and Gender Diverse Populations.
    JAMA Netw Open. 2024;7:e248855.
    Abstract

  1212. BAUMANN K, Matzke H, Peterson CE, Geller S, et al
    Sexual Orientation and Cervical Cancer Screening Among Cisgender Women.
    JAMA Netw Open. 2024;7:e248886.
    Abstract

  1213. ZHAO N, Li Y, Chen X, Ma J, et al
    Evaluating the clinical efficacy and safety of concurrent chemoradiotherapy with cisplatin and nab-paclitaxel in postoperative early-stage cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:233.
    Abstract

  1214. LIU L, Lei H, Hou G, Zhang L, et al
    Gas-Amplified Metalloimmunotherapy with Dual Activation of Pyroptosis and the STING Pathway for Remodeling the Immunosuppressive Cervical Cancer Microenvironment.
    ACS Nano. 2024 May 6. doi: 10.1021/acsnano.4c00017.
    Abstract

  1215. XIONG G, Shan J, Chong Q, Cui Y, et al
    Tertiary lymphoid structures associated with enhanced anti-tumor immunity and favorable prognosis in cervical squamous carcinoma.
    Aging (Albany NY). 2024;16:6898-6920.
    Abstract

  1216. COSTANZI JM, Stosic MS, Lovestad AH, Ambur OH, et al
    Changes in intrahost genetic diversity according to lesion severity in longitudinal HPV16 samples.
    J Med Virol. 2024;96:e29641.
    Abstract

  1217. NEWTON C, Graham R, Liberale V, Burnell M, et al
    Outcomes of minimal access retroperitoneal para-aortic lymphadenectomy in patients with locally advanced cervical cancer.
    J Obstet Gynaecol. 2024;44:2344529.
    Abstract

  1218. ADAMS RA, Visser C, Dreyer G, Snyman L, et al
    Sociodemographics, behaviour and knowledge of first South African HPV-vaccine recipients.
    S Afr Fam Pract (2004). 2024;66:e1-e6.
    Abstract

  1219. SAHIN G, Duran T, Afsar S, Kebapcilar A, et al
    The antitumoral effect of the esculetin in HeLa cells through endoplasmic reticulum stress.
    Eur Rev Med Pharmacol Sci. 2024;28:3048-3055.
    Abstract

  1220. KUNATOGA A, Mohammadnezhad M, Khan S, Naeem P, et al
    Prevalence and trends of cervical cancer screening among women in Fiji from 2014 to 2018.
    Heliyon. 2024;10:e30220.
    Abstract

  1221. CHEN W, Zhang N, He Z, Li Q, et al
    The efficacy of immune checkpoint inhibitors on low PD-L1 cervical cancer: A meta-analysis.
    Health Sci Rep. 2024;7:e2069.
    Abstract

  1222. YU X, Dong S, Wang W, Sun X, et al
    Case report: A case of recurrent cervical cancer with bronchial and esophageal metastases presenting with hemoptysis and dysphagia.
    Front Oncol. 2024;14:1375035.
    Abstract

  1223. SALTA S, Sequeira JP, Lobo J, Sousa A, et al
    Preliminary outcomes of the Cervical Cancer Screening Program of Northern Portugal: A snapshot.
    J Infect Public Health. 2024;17:1057-1064.
    Abstract

  1224. SANTANA OTANO S, Mendes Melo A, Ferreira Souza B, Souto Morlin J, et al
    Peritumoral stroma and systemic inflammatory response in cervical cancer.
    Ceska Gynekol. 2024;89:95-101.
    Abstract

  1225. PROWSE SR, Brazzelli M, Treweek S
    What factors influence the uptake of bowel, breast and cervical cancer screening? An overview of international research.
    Eur J Public Health. 2024 May 3:ckae073. doi: 10.1093.
    Abstract

  1226. TEKLEHAIMANOT DA, Mekuria AD, Dadi AF, Derseh BT, et al
    Precancerous lesion determinants in women attending cervical cancer screening at public health facilities in North Shoa Zone, Amhara, Ethiopia: an unmatched case-control study.
    BMC Womens Health. 2024;24:271.
    Abstract

  1227. MOOSES K, Savrova A, Pajusalu M, Oja M, et al
    Using electronic health records to evaluate the adherence to cervical cancer prevention guidelines: A cross-sectional study.
    Prev Med. 2024;183:107982.
    Abstract

  1228. GARG P, Krishna M, Subbalakshmi AR, Ramisetty S, et al
    Emerging biomarkers and molecular targets for precision medicine in cervical cancer.
    Biochim Biophys Acta Rev Cancer. 2024;1879:189106.
    Abstract

  1229. LIU HT, Zhao Y, Wang HC, Liu QL, et al
    METTL3-mediated m(6)A methylation of SLC38A1 stimulates cervical cancer growth.
    Biochem Biophys Res Commun. 2024;716:150039.
    Abstract

  1230. WANG Y, Han Y, Jin L, Ji L, et al
    A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Aging (Albany NY). 2024;16:7293-7310.
    Abstract

  1231. FELICELLI C, Smith SH, Griffin B, Grubs A, et al
    The Silva pattern-based classification for HPV-associated endocervical adenocarcinoma: A single institution concordance study of trainees and gynecologic pathologists.
    Pathol Res Pract. 2024;257:155311.
    Abstract

  1232. LORENSET LC, Percicote AP, Munhos SHO, Zanine RM, et al
    Reevaluation of negative cervical conizations: Frequency, diagnostic errors, risk factors and management.
    Pathol Res Pract. 2024;257:155283.
    Abstract

  1233. LIN LH, Howitt BE, Kolin DL
    From morphology to methylome: epigenetic studies of Mullerian mesonephric-like adenocarcinoma reveal similarities to cervical mesonephric adenocarcinoma(dagger).
    J Pathol. 2024;263:135-138.
    Abstract

  1234. KASHYAP A, Kumari M, Singh A, Mukherjee K, et al
    Current development of theragnostic nanoparticles for women's cancer treatment.
    Biomed Mater. 2024;19.
    Abstract

  1235. PENG X, Wang B, Li X, Li Y, et al
    Correlates of sexual and reproductive health service utilization among older adults in China: Findings from the sexual well-being (SWELL) study.
    Maturitas. 2024;184:107965.
    Abstract

  1236. KIZILTAS S, Topaloglu Oren ED
    Levels of depression and self-esteem in women with cancer of the endometrium and cervix receiving chemotherapy treatment in Turkiye.
    Enferm Clin (Engl Ed). 2024;34:96-107.
    Abstract

  1237. HA K, Sheets K, Kedar R, Gooden C, et al
    Primary Cervical Lymphoma Mimicking Deep Endometriosis.
    J Minim Invasive Gynecol. 2024;31:357-359.
    Abstract

  1238. AUGUSTOVSKI F, Argento F, Alcaraz A, Garcia Marti S, et al
    Toward the Implementation of a Value Framework for Diagnostic Technologies: Operationalization, Piloting, and Validation in Latin America.
    Value Health. 2024;27:570-577.
    Abstract

  1239. NISHIO H, Matsuda R, Iwata T, Yamagami W, et al
    Gastric-type adenocarcinoma of the uterine cervix: clinical features and future directions.
    Jpn J Clin Oncol. 2024;54:516-520.
    Abstract

  1240. TAN CY, Yang QL, Xu N, Wang HJ, et al
    Small-cell neuroendocrine carcinoma of the cervix: An analysis of 5 cases and literature review.
    Asian J Surg. 2024;47:2508-2509.
    Abstract

  1241. SINGH AK, Walavalkar K, Tavernari D, Ciriello G, et al
    Cis-regulatory effect of HPV integration is constrained by host chromatin architecture in cervical cancers.
    Mol Oncol. 2024;18:1189-1208.
    Abstract

  1242. WALLER J, Waite F, Marlow L
    Awareness and knowledge about HPV and primary HPV screening among women in Great Britain: An online population-based survey.
    J Med Screen. 2024;31:91-98.
    Abstract

  1243. PENG J, Chen Y, Yin A
    JAM3 promotes cervical cancer metastasis by activating the HIF-1alpha/VEGFA pathway.
    BMC Womens Health. 2024;24:293.
    Abstract

  1244. HALLE MK, Hodneland E, Wagner-Larsen KS, Lura NG, et al
    Radiomic profiles improve prognostication and reveal targets for therapy in cervical cancer.
    Sci Rep. 2024;14:11339.
    Abstract

  1245. SAHASRABUDDHE VV
    Cervical Cancer: Precursors and Prevention.
    Hematol Oncol Clin North Am. 2024 May 16:S0889-8588(24)00032.
    Abstract

  1246. BOJE RB, Bardou M, Mensah K, Rico Berrocal R, et al
    What are the barriers towards cervical cancer screening for vulnerable women? A qualitative comparative analysis of stakeholder perspectives in seven European countries.
    BMJ Open. 2024;14:e079921.
    Abstract

  1247. REICH O, Regauer S
    Understanding the age-related epithelial shifts at the uterine cervix and the area of risk for squamous cell cervical cancer.
    Prev Med. 2024 May 15:108006. doi: 10.1016/j.ypmed.2024.108006.
    Abstract

  1248. QIN J, Chen Y, Zhao X, Yu J, et al
    circCUL3 drives malignant progression of cervical cancer by activating autophagy through sponge miR-223-3p upregulation of ATG7.
    Gene. 2024 May 15:148572. doi: 10.1016/j.gene.2024.148572.
    Abstract

  1249. DEVI S, Gangarde R, Deokar S, Muqeemuddin SF, et al
    Public health nurse perspectives on predicting nonattendance for cervical cancer screening through classification, ensemble, and deep learning models.
    Public Health Nurs. 2024 May 17. doi: 10.1111/phn.13334.
    Abstract

  1250. PARLAK B, Ugurlucan FG, Gokcay EG
    Actions speak louder than words; pediatricians, gynecologists, nurses, and other mothers' perspectives on the human papillomavirus vaccine: an Istanbul multicenter study.
    Front Public Health. 2024;12:1361509.
    Abstract

  1251. ZHU X, Feng Y, Fan P, Dong D, et al
    Increased co-expression of 4-1BB with PD-1 on CD8+ tumor-infiltrating lymphocytes is associated with improved prognosis and immunotherapy response in cervical cancer.
    Front Oncol. 2024;14:1381381.
    Abstract

  1252. SATHISHKUMAR K, Sankarapillai J, Mathew A, Nair RA, et al
    Survival of patients with cervical cancer in India - findings from 11 population based cancer registries under National Cancer Registry Programme.
    Lancet Reg Health Southeast Asia. 2023;24:100296.
    Abstract

  1253. ZHANG M, Chen J, Cui M, Jia J, et al
    Analysis of the global burden of cervical cancer in young women aged 15-44 years old.
    Eur J Public Health. 2024 May 16:ckae084. doi: 10.1093.
    Abstract

  1254. ZHANG Z, Zhou X, Li J, Meng Q, et al
    LncRNA HOTAIR promotes the migration and invasion of cervical cancer through DNMT3B/LATS1/ YAP1 pS127 axis.
    Reprod Biol. 2024;24:100893.
    Abstract

  1255. BACORRO W, Short M, Baldivia K, Mariano J, et al
    Shared Decision Making in Oncology and Its Implementation in Cervical Cancer Management in the Philippines: A Narrative Review.
    JCO Glob Oncol. 2024;10:e2300486.
    Abstract

  1256. LI XX, Liu B, Cui Y, Zhao YF, et al
    Intravoxel incoherent motion diffusion-weighted imaging and dynamic contrast-enhanced MRI for predicting parametrial invasion in cervical cancer.
    Abdom Radiol (NY). 2024 May 16. doi: 10.1007/s00261-024-04339.
    Abstract

  1257. FARIA PCL, Resende RS, Cardoso AM
    Metastasis and angiogenesis in cervical cancer: key aspects of purinergic signaling in platelets and possible therapeutic targets.
    Purinergic Signal. 2024 May 16. doi: 10.1007/s11302-024-10020.
    Abstract

  1258. CHENG Q, Fan S, Xu J, Zhou H, et al
    Analysis of the impact of introspective therapy on the psychological state and family functioning of cervical cancer patients with anxiety.
    Minerva Med. 2024 May 15. doi: 10.23736/S0026-4806.24.09256.
    Abstract

  1259. CHOWDHURY MZI, Mubin N, Mohib T, Chowdhury N, et al
    Cancer screening research in Bangladesh: Insights from a scoping review.
    Glob Public Health. 2024;19:2351186.
    Abstract

  1260. SHANMUGAM A, Kvn K, Radhabai PR, Natarajan S, et al
    HO-SsNF: heap optimizer-based self-systematized neural fuzzy approach for cervical cancer classification using pap smear images.
    Front Oncol. 2024;14:1264611.
    Abstract

  1261. IDRAK S, Zaki S, Rasheed F, Javed M, et al
    Cervical cancer screening practices in HIV positive females - a missing link in health care delivery in Pakistan.
    J Pak Med Assoc. 2024;74:631-640.
    Abstract

  1262. RIZZO A, Dalu D, Moschese D, Giacomelli A, et al
    Eliminating cervical cancer: Don't forget HPV test and vaccination in men.
    J Med Virol. 2024;96:e29677.
    Abstract

  1263. WANG Y, Wang X, Liu Y, He Y, et al
    HPV16-miRNAs exert oncogenic effects through enhancers in human cervical cancer.
    Cancer Cell Int. 2024;24:172.
    Abstract

  1264. FUJII T, Nishio E, Tsukamoto T, Kukimoto I, et al
    Performance of an ancillary test for cervical cancer that measures miRNAs and cytokines in serum and cervical mucus.
    Cancer Sci. 2024 May 15. doi: 10.1111/cas.16214.
    Abstract

  1265. AMBOREE TL, Paguio J, Sonawane K
    HPV vaccine: the key to eliminating cervical cancer inequities.
    BMJ. 2024;385:q996.
    Abstract

  1266. FALCARO M, Soldan K, Ndlela B, Sasieni P, et al
    Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: population based observational study.
    BMJ. 2024;385:e077341.
    Abstract

  1267. CHENG J, Zhao B, Liu Z, Huang D, et al
    DMGM: deformable-mechanism based cervical cancer staging via MRI multi-sequence.
    Phys Med Biol. 2024 May 15. doi: 10.1088/1361-6560.
    Abstract

  1268. ZHANG R, Bai J, Wang R, Yan J, et al
    Quantified difference of the collapsed cone convolution (CCC) and Monte Carlo (MC) algorithms based on DVH and gamma analysis for cervical cancer radiation therapy.
    Appl Radiat Isot. 2024;210:111340.
    Abstract

  1269. PLANTE M, Mahner S, Ferron G
    Simple versus Radical Hysterectomy for Low-Risk Cervical Cancer. Reply.
    N Engl J Med. 2024;390:1833.
    Abstract

  1270. CIBULA D, Falconer H, Kohler C
    Simple versus Radical Hysterectomy for Low-Risk Cervical Cancer.
    N Engl J Med. 2024;390:1832-1833.
    Abstract

  1271. SONG H, Jiang H, Hu W, Hai Y, et al
    Cervical extracellular matrix hydrogel optimizes tumor heterogeneity of cervical squamous cell carcinoma organoids.
    Sci Adv. 2024;10:eadl3511.
    Abstract

  1272. ZHOU W, Song W, Lu M
    circ_0006789 promotes cervical cancer development via the miR-615-5p/HSF1 axis.
    Discov Oncol. 2024;15:165.
    Abstract

  1273. ZENG S, Xiao S, Xu Y, Yang P, et al
    Efficacy and safety analysis of non-radical surgery for early-stage cervical cancer (IA2 ~ IB1): a systematic review and meta-analysis.
    Front Med (Lausanne). 2024;11:1337752.
    Abstract

  1274. WANG M, Liang H, Yan Y, Bian R, et al
    Distribution of HPV types among women with HPV-related diseases and exploration of lineages and variants of HPV 52 and 58 among HPV-infected patients in China: A systematic literature review.
    Hum Vaccin Immunother. 2024;20:2343192.
    Abstract

  1275. HOU PX, Fan Q, Zhang Q, Liu JJ, et al
    M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C.
    Clin Exp Pharmacol Physiol. 2024;51:e13868.
    Abstract

  1276. LAMI A, Alvisi S, Siconolfi A, Seracchioli R, et al
    Primary and secondary prevention of cervical cancer among Italian AFAB transgender people.
    Curr Probl Cancer. 2024;50:101103.
    Abstract

  1277. JIN R, Li H, Nan S, Wang H, et al
    FOXA1 co-activates circODC1 and ODC1 in HPV-positive cervical cancer cell growth.
    Syst Biol Reprod Med. 2024;70:113-123.
    Abstract

  1278. KASSA RN, Shifti DM, Alemu K, Omigbodun AO, et al
    Integration of cervical cancer screening into healthcare facilities in low- and middle-income countries: A scoping review.
    PLOS Glob Public Health. 2024;4:e0003183.
    Abstract

  1279. MATHOMA A, Sartorius B, Mahomed S
    Evaluation of cancer screening services provided for people living with HIV in Botswana, 2022-2023.
    Health Promot Int. 2024;39:daae042.
    Abstract

  1280. PIOTROWSKI PG, Jelen MT
    Retrospective analysis of negative cytology results correlated with a positive high-risk in the human papillomavirus result and subsequent results of patients over a period of three years.
    Pol J Pathol. 2024;75:36-39.
    Abstract

  1281. LAN C, Lu H, Zhou L, Liao K, et al
    Long-term survival outcomes and immune checkpoint inhibitor retreatment in patients with advanced cervical cancer treated with camrelizumab plus apatinib in the phase II CLAP study.
    Cancer Commun (Lond). 2024 May 13. doi: 10.1002/cac2.12547.
    Abstract

  1282. GUILLEN-MELENDEZ GA, Perez-Hernandez RA, Chavez-Montes A, Castillo-Velazquez U, et al
    Nanoencapsulation of Extracts and Isolated Compounds of Plant Origin and Their Cytotoxic Effects on Breast and Cervical Cancer Treatments: Advantages and New Challenges.
    Toxicon. 2024 May 11:107753. doi: 10.1016/j.toxicon.2024.107753.
    Abstract

  1283. MIYATA Y, Ogo E, Murotani K, Tsuda N, et al
    Effective timing of hyaluronate gel injection in image-guided adaptive brachytherapy for uterine cervical cancer: a proposal of the 'adjusted dose score'.
    J Radiat Res. 2024 May 13:rrae031. doi: 10.1093.
    Abstract

  1284. LI L, Zeng J, He S, Yang Y, et al
    METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer.
    Cancer Biol Ther. 2024;25:2349429.
    Abstract

  1285. HE JY, Li ZM, Chen YT, Zhao BH, et al
    Development and validation of a prognostic prediction model for cervical cancer patients treated with radical radiotherapy: a study based on TCGA database.
    Transl Cancer Res. 2024;13:1721-1736.
    Abstract

  1286. ZOU J, Li Y, Chen T, Zhu C, et al
    An E7-retinoblastoma protein pathway mechanism may account for the higher carcinogenic ability of HPV16 over HPV58 in cervical cancer.
    Transl Cancer Res. 2024;13:1876-1886.
    Abstract

  1287. CHEN X, Sun Y, Li F, Xi L, et al
    (68)Ga-labeled TMTP1 radiotracer for PET imaging of cervical cancer.
    Am J Nucl Med Mol Imaging. 2024;14:110-121.
    Abstract

  1288. CHEN J, Zhang R, Xu W, Bai L, et al
    Correction: Knowledge and Practices Regarding Human Papillomavirus and Cervical Cancer Screening Among Women in Low-Income Areas of China: A Cross-Sectional Study.
    Cureus. 2024;16:c174.
    Abstract

  1289. KURDOGLU M, Kurdoglu Z, Kucukaydin Z, Erten R, et al
    Laminin receptor 1 expression in premalignant and malignant squamous lesions of the cervix.
    Biotech Histochem. 2024;99:174-181.
    Abstract

  1290. LI J, Adobo SD, Shi H, Judicael KAW, et al
    Screening Methods for Cervical Cancer.
    ChemMedChem. 2024 May 12:e202400021. doi: 10.1002/cmdc.202400021.
    Abstract

  1291. HUANG M, Hu J, Chen Y, Xun Y, et al
    Mesencephalic astrocyte-derived neurotrophic factor inhibits cervical cancer progression via regulating macrophage phenotype.
    Mol Biol Rep. 2024;51:654.
    Abstract

  1292. MATHIVANAN SK, Francis D, Srinivasan S, Khatavkar V, et al
    Enhancing cervical cancer detection and robust classification through a fusion of deep learning models.
    Sci Rep. 2024;14:10812.
    Abstract

  1293. SPORT C, Yarden N, Bale C, Mukhodpadhyay N, et al
    To who and by who: Discussions of sexual health, fertility, and premature menopause with women with locally advanced cervical cancer.
    Brachytherapy. 2024 May 10:S1538-4721(24)00066.
    Abstract

  1294. KONG X, Xiong Y, Li L
    LINC01605 promotes malignant phenotypes of cervical cancer via miR-149-3p/WNT7B axis.
    Gene. 2024;921:148518.
    Abstract

  1295. TESFAYE W, Ashine B, Yimer Y, Yismaw Y, et al
    Utilization of cervical cancer screening and determinant factors among female nurses in selected public hospitals in Addis Ababa, Ethiopia.
    Cancer Treat Res Commun. 2024;40:100815.
    Abstract

  1296. SU M, Liang Z, Shan S, Gao Y, et al
    Long non-coding RNA NEAT1 promotes aerobic glycolysis and progression of cervical cancer through WNT/beta-catenin/PDK1 axis.
    Cancer Med. 2024;13:e7221.
    Abstract

  1297. ZHANG L, Liu W, Li Y, Fu Y, et al
    Polyphyllin I Sensitizes Cisplatin-Resistant Human Cervical Cancer Cells to Cisplatin Treatment.
    Nutr Cancer. 2024 May 10:1-10. doi: 10.1080/01635581.2024.2350107.
    Abstract

  1298. MARK ZA, Yu L, Castro L, Gao X, et al
    Tobacco Smoke Condensate Induces Morphologic Changes in Human Papillomavirus-Positive Cervical Epithelial Cells Consistent with Epithelial to Mesenchymal Transition (EMT) with Activation of Receptor Tyrosine Kinases and Regulation of TGFB.
    Int J Mol Sci. 2024;25:4902.
    Abstract

  1299. MALLMANN MR, Tamir S, Alfter K, Ratiu D, et al
    Expression of Potential Antibody-Drug Conjugate Targets in Cervical Cancer.
    Cancers (Basel). 2024;16:1787.
    Abstract

  1300. WEAVER C, Nam A, Settle C, Overton M, et al
    Serum Proteomic Signatures in Cervical Cancer: Current Status and Future Directions.
    Cancers (Basel). 2024;16:1629.
    Abstract

  1301. FAN Q, Ding H, Mo H, Tang Y, et al
    Cervical cancer biomarker screening based on Raman spectroscopy and multivariate statistical analysis.
    Spectrochim Acta A Mol Biomol Spectrosc. 2024;317:124402.
    Abstract

  1302. ZHANG X, Yan W, Chen X, Li X, et al
    Long-term 4-nonylphenol exposure drives cervical cell malignancy through MAPK-mediated ferroptosis inhibition.
    J Hazard Mater. 2024;471:134371.
    Abstract

  1303. CHEN Z, Liu W, Liu K, Wang S, et al
    Double-layer hollow mesoporous silica nanoparticles for ultrasound-guided photodynamic treatment.
    Biomed Mater. 2024;19.
    Abstract

  1304. STENHOUSE K, Roumeliotis M, Ciunkiewicz P, Martell K, et al
    Prospective validation of a machine learning model for applicator and hybrid interstitial needle selection in high-dose-rate (HDR) cervical brachytherapy.
    Brachytherapy. 2024;23:368-376.
    Abstract

  1305. LAI TS, Francoeur A, Manrriquez E, Venkat P, et al
    Percutaneous interstitial brachytherapy ablation for targeting oligometastatic gynecologic cancers.
    Brachytherapy. 2024;23:266-273.
    Abstract

  1306. JIAO XF, Li H, Zeng L, Yang H, et al
    Use of statins and risks of ovarian, uterine, and cervical diseases: a cohort study in the UK Biobank.
    Eur J Clin Pharmacol. 2024;80:855-867.
    Abstract

  1307. CHEN P, Zhang X, Fang Q, Zhao Z, et al
    Betulinic acid induces apoptosis of HeLa cells via ROS-dependent ER stress and autophagy in vitro and in vivo.
    J Nat Med. 2024;78:677-692.
    Abstract

  1308. EWONGWO A, Niedermayr T, Kidd EA
    Design approach and benefits of the 3D-printed vaginal individualized applicator (VIA).
    Brachytherapy. 2024;23:282-289.
    Abstract

  1309. GOETZ LH, Evans HL, Armylagos D, Zhou H, et al
    Atypical glandular cells in Pap tests: cytology-histology correlation and risk assessment with human papillopmavirus (HPV) testing.
    J Am Soc Cytopathol. 2024;13:227-232.
    Abstract

  1310. ROACH E, Hutten R, Johnson S, Suneja G, et al
    The impact of a positive COVID-19 test on timeliness of radiation in patients receiving brachytherapy.
    Brachytherapy. 2024;23:360-367.
    Abstract

  1311. NASU H, Nishio S, Park J, Tasaki K, et al
    Comprehensive Molecular Profiling and Clinicopathological Characteristics of Gastric-Type Mucinous Carcinoma of the Uterine Cervix in Japanese Women.
    Kurume Med J. 2024;69.
    Abstract

  1312. HUANG J, Zhao Y
    Effect of GLIS1 on the Lymph Node Metastasis of Cervical Squamous Carcinoma Based on Transcriptome Analysis.
    Reprod Sci. 2024;31:1332-1344.
    Abstract

  1313. LIU Y, Dong TF, Li PJ, Chen LB, et al
    MRI-based radiomics features for the non-invasive prediction of FIGO stage in cervical carcinoma: A multi-center study.
    Magn Reson Imaging. 2023 Nov 28:S0730-725X(23)00198.
    Abstract

  1314. JARA FERNANDEZ L, Ferrer JA, Perez Calle JL, Lopez Serrano P, et al
    Is cervical dysplasia a major concern in females with inflammatory bowel disease? A Spanish retrospective study.
    Rev Esp Enferm Dig. 2024;116:292-293.
    Abstract

  1315. CHAN DNS, Lee PPK, So WKW
    Exploring the Barriers and Facilitators Influencing Human Papillomavirus Vaccination Decisions Among South Asian and Chinese Mothers: a Qualitative Study.
    J Racial Ethn Health Disparities. 2024;11:1465-1477.
    Abstract

  1316. ADEBOLA A, Adaeze A, Adeyimika D, Lovoria WB, et al
    Experiences and Challenges of African American and Sub-Saharan African Immigrant Black Women in Completing Pap Screening: a Mixed Methods Study.
    J Racial Ethn Health Disparities. 2024;11:1405-1417.
    Abstract

  1317. PATTERSON MR, Meijers AS, Ryder EL, Wootton LM, et al
    E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in HPV-positive cervical cancer.
    Oncogene. 2024 May 24. doi: 10.1038/s41388-024-03067.
    Abstract

  1318. IFTEKHARUL FERDOUS AHM, Islam MS, Noor KS, Bani MM, et al
    Harnessing THz Technology: Biosensor for Highly Accurate Cervical Cancer Cell Detection via Refractive Index.
    Cell Biochem Biophys. 2024 May 24. doi: 10.1007/s12013-024-01318.
    Abstract

  1319. BOSE CK, Basu N
    Bispecific immunotherapy MEDI5752 or volrustomig and cervical cancer.
    J Gynecol Oncol. 2024 May 17. doi: 10.3802/jgo.2024.
    Abstract

  1320. XU S, Li Z, Xin X, An F, et al
    Curdepsidone A Induces Intrinsic Apoptosis and Inhibits Protective Autophagy via the ROS/PI3K/AKT Signaling Pathway in HeLa Cells.
    Mar Drugs. 2024;22:227.
    Abstract

  1321. HUANG Y, Wan XW, Du YT, Feng Y, et al
    Norcantharidin Enhances the Antitumor Effect of 5-Fluorouracil by Inducing Apoptosis of Cervical Cancer Cells: Network Pharmacology, Molecular Docking, and Experimental Validation.
    Curr Issues Mol Biol. 2024;46:3906-3918.
    Abstract

  1322. WOLF J, Wu Y, Hayek J, Zhang Q, et al
    Trends in Early-Stage Cervical Cancer Management in the US: A National Cancer Database Analysis.
    Curr Oncol. 2024;31:2836-2845.
    Abstract

  1323. FAN KY, Chehade R, Wang AY, Sachdeva A, et al
    Pan-Canadian Analysis of Practice Patterns in Small Cell Carcinoma of the Cervix: Insights from a Multidisciplinary Survey.
    Curr Oncol. 2024;31:2610-2619.
    Abstract

  1324. MOLNAR O, Straciuc OM, Mihutiu S, Lazar L, et al
    Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma-A Literature Review.
    Curr Oncol. 2024;31:2508-2526.
    Abstract

  1325. CREAGH NS, Saunders T, Brotherton J, Hocking J, et al
    Practitioners support and intention to adopt universal access to self-collection in Australia's National Cervical Screening Program.
    Cancer Med. 2024;13:e7254.
    Abstract

  1326. LIN J, Lin J, Liu L, Xie N, et al
    A novel nomogram based on inflammation biomarkers for predicting radiation cystitis in patients with local advanced cervical cancer.
    Cancer Med. 2024;13:e7245.
    Abstract

  1327. MAKHDOOM H
    Merkel Cell Polyomavirus and their Association with the Pathogenesis of Cervical Squamous Cell Carcinomas and Adenocarcinomas: A Review Article.
    Ethiop J Health Sci. 2023;33:711-720.
    Abstract

  1328. LEE H, Mtengezo JT, Makin MS, Shi L, et al
    Mobile health-delivered narrative intervention to increase cervical cancer screening among Malawian women living with HIV: A pilot randomized controlled trial.
    Asia Pac J Oncol Nurs. 2024;11:100448.
    Abstract

  1329. JIANG S, Lin X, Wu Q, Zheng J, et al
    Transient receptor potential channels' genes forecast cervical cancer outcomes and illuminate its impact on tumor cells.
    Front Genet. 2024;15:1391842.
    Abstract

  1330. GAO Y, Zhang M, Zheng Y, Huang H, et al
    Human Papilloma Virus Infection and Gene Subtypes Analysis in Women Undergoing Physical Examinations: A 2015-2020 Study in Wenzhou, China.
    Cancer Control. 2024;31:10732748241257902.
    Abstract

  1331. CHEN JW, Huang YJ, Wang LL, Liu JJ, et al
    Mullerian adenosarcoma of the uterus with MASO: a case report of cervical adenosarcoma in a young female that never had sexual behavior.
    BMC Womens Health. 2024;24:308.
    Abstract

  1332. HAQUE M, Hossen MS
    Insights into pelvic insufficiency fracture following pelvic radiotherapy for cervical cancer: a comparative review.
    BMC Womens Health. 2024;24:306.
    Abstract

  1333. SHANG X, Kong LH, Xiao XP, Wan R, et al
    [A multicenter study on the accuracy of PAX1/JAM3 dual genes methylation testing for screening cervical cancer].
    Zhonghua Yi Xue Za Zhi. 2024;104:1852-1859.
    Abstract

  1334. LIU X, Xie X, Li Q, Xie X, et al
    KIF23 promotes cervical cancer progression via inhibiting NLRP3-mediated pyroptosis.
    FASEB J. 2024;38:e23685.
    Abstract

  1335. ZHU L, Cui X, Yan Z, Tao Y, et al
    Design and evaluation of a multi-epitope DNA vaccine against HPV16.
    Hum Vaccin Immunother. 2024;20:2352908.
    Abstract

  1336. FERNANDES SPM, Vilarinho AS, Frutuoso A, Teixeira C, et al
    Application of CytoPath(R)Easy Vials in Cervical Cancer Screening: Self-Sampling Approach.
    J Cytol. 2024;41:67-74.
    Abstract

  1337. CHENG L, Li Z, Zheng Q, Yao Q, et al
    Correlation study of serum lipid levels and lipid metabolism-related genes in cervical cancer.
    Front Oncol. 2024;14:1384778.
    Abstract

  1338. CHANG L, Zhao K
    Construction and validation of an innovative prognostic nomogram for overall survival in cervical cancer patients with lung metastasis: an analysis utilizing the SEER database.
    Front Oncol. 2024;14:1397454.
    Abstract

  1339. LIU J, Dong L, Zhang X, Wu Q, et al
    Radiomics analysis for prediction of lymph node metastasis after neoadjuvant chemotherapy based on pretreatment MRI in patients with locally advanced cervical cancer.
    Front Oncol. 2024;14:1376640.
    Abstract

  1340. GABRIELLI L, Alvim Matos SM, Luisa Patrao A, Goes EF, et al
    Do social protection programmes affect the burden of breast and cervical cancer? A systematic review.
    Health Policy Open. 2024;6:100122.
    Abstract

  1341. HAIDAR A, Andour H, Essaber H, Abdallah H, et al
    Imaging of an exceptional urinoma complicating a cervical cancer and leading to death: A case report.
    SAGE Open Med Case Rep. 2024;12:2050313X241253748.
    Abstract

  1342. NOGUEIRA-RODRIGUES A, Cetina Perez L, Maza M
    Editorial: Cervical cancer control in Latin America and the Caribbean.
    Front Oncol. 2024;13:1226915.
    Abstract

  1343. PLEYERS C
    [Brachytherapy : a crucial part of locally advanced cervical cancer treatment].
    Rev Med Liege. 2024;79.
    Abstract

  1344. WANG J, Yu Y, Tan Y, Wan H, et al
    Artificial intelligence enables precision diagnosis of cervical cytology grades and cervical cancer.
    Nat Commun. 2024;15:4369.
    Abstract

  1345. WAN F, Qiu F, Deng Y, Hu H, et al
    Knockdown of YTHDF2 initiates ERS-induced apoptosis and cancer stemness suppression by sustaining GLI2 stability in cervical cancer.
    Transl Oncol. 2024;46:101994.
    Abstract

  1346. V VN, Dharmarajan A, Jones J, Yahiya EKN, et al
    Clinical Outcomes and Dosimetric Evaluationof Interstitial Brachytherapyin Gynecological Malignancies.
    Gulf J Oncolog. 2024;1:69-74.
    Abstract

  1347. DAVIDSON SJ, El-Rayes D, Khalifa M, Fok CS, et al
    HPV-independent cervical cancer associated with non-reducible pelvic organ prolapse: A case report.
    Gynecol Oncol Rep. 2024;53:101408.
    Abstract

  1348. OHTAKA T, Ando K, Oike T, Noda SE, et al
    The prognostic effect of tumor volume, reduction ratio, and cumulative doses on external beam radiotherapy with central-shielding method and image-guided adaptive brachytherapy for cervical cancer.
    Front Oncol. 2024;14:1366777.
    Abstract

  1349. XU G, Chai S, Zhang R, Chen M, et al
    The Contribution and Mechanism of Hypoxia /USP19/Beclin-1 Feed-Forward Loop in Cervical Cancer.
    Biophys J. 2024 May 20:S0006-3495(24)00328-X. doi: 10.1016/j.bpj.2024.
    Abstract

  1350. LI X, Xiang F, Liu T, Chen Z, et al
    Leveraging existing 16S rRNA gene surveys to decipher microbial signatures and dysbiosis in cervical carcinogenesis.
    Sci Rep. 2024;14:11532.
    Abstract

  1351. LIN Y, Gao Y, Weng T
    Construction and Validation of a MRI?Based Radiomic Nomogram to Predict Overall Survival in Patients with Local Advanced Cervical Cancer: A Multicenter Study.
    Acad Radiol. 2024 May 20:S1076-6332(24)00289-7. doi: 10.1016/j.acra.2024.
    Abstract

  1352. AFSAR S, Hossain M, Islam M, Simmonds H, et al
    Human papillomavirus and occupational exposure: The need for vaccine provision for healthcare providers.
    Hum Vaccin Immunother. 2024;20:2342622.
    Abstract

  1353. CHIEREGHIN A, Squillace L, Pizzi L, Sanna T, et al
    Scelte gestionali per sostenere e migliorare i programmi di screening oncologico.
    Epidemiol Prev. 2024;48:158-164.
    Abstract

  1354. GIRARDI D, Vecchio R, Tanious M, Cacitti S, et al
    Le disuguaglianze di accesso ai programmi di screening dei tumori della mammella, del colon retto e della cervice uterina sono aumentate durante il periodo pandemico. Risultati di un health equity audit condotto dall'Agenzia di Tutela della Salute d.
    Epidemiol Prev. 2024;48:130-139.
    Abstract

  1355. KUMAR M, Baruah U, Begum D, Barmon D, et al
    To study the survival outcomes of uncommon recurrences among patients with cervical cancer compared with loco-regional and nodal recurrences at a tertiary care center in North East India - Bridging the knowledge gap in the existing literature.
    Eur J Obstet Gynecol Reprod Biol X. 2024;22:100314.
    Abstract

  1356. XIAO Y, Zhi Y, Cao G, Ma H, et al
    Primary Ewing's sarcoma of the uterine cervix: a case report and review of the literature.
    J Cancer Res Clin Oncol. 2024;150:267.
    Abstract

  1357. VERIT FF, Bese T, Demirkiran F
    Correspondence on: The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter by Nicolai et al.
    J Gynecol Oncol. 2024 May 10. doi: 10.3802/jgo.2024.
    Abstract

  1358. WU G, Gu M, Zhu J, Gu R, et al
    Prognostic prediction of oxidative stress related hematological biomarkers in locally advanced cervical cancer patients undergoing chemoradiotherapy.
    Biomarkers. 2024 May 20:1-28. doi: 10.1080/1354750X.2024.2358300.
    Abstract

  1359. LI FH, Xiang L, Ran L, Zhou S, et al
    Retraction Note: BNIP1 inhibits cell proliferation, migration and invasion, and promotes apoptosis by mTOR in cervical cancer cells.
    Eur Rev Med Pharmacol Sci. 2024;28:3294.
    Abstract


  1360. The path to elimination: FEBRASGO 2023's targeted strategies against cervical cancer in Brazil.
    Rev Bras Ginecol Obstet. 2024;46:e-rbgoedt2.
    Abstract

  1361. DI DONATO V, Bogani G, Lagana AS, Giannini A, et al
    Editorial: Early cervical cancer: laparotomic vs minimally invasive surgery and fertility-sparing possible strategies.
    Front Med (Lausanne). 2024;11:1415558.
    Abstract

  1362. WIRYANTI W, Fikri E
    Survival Status and Predictors Among Women with Advanced Stage of Cervical Cancer [Letter].
    Int J Womens Health. 2024;16:829-830.
    Abstract

  1363. CHEN Y, Cui R, Xiong D, Zhao Y, et al
    Cervical cancer subtype identification and model building based on lipid metabolism and post-infection microenvironment immune landscape.
    Heliyon. 2024;10:e30746.
    Abstract

  1364. SSEDYABANE F, Niyonzima N, Nambi Najjuma J, Birungi A, et al
    Prevalence of cervical intraepithelial lesions and associated factors among women attending a cervical cancer clinic in Western Uganda; results based on Pap smear cytology.
    SAGE Open Med. 2024;12:20503121241252265.
    Abstract

  1365. LIU Y, Shi W, Mubarik S, Wang F, et al
    Assessment of secular trends of three major gynecologic cancers burden and attributable risk factors from 1990 to 2019: an age period cohort analysis.
    BMC Public Health. 2024;24:1349.
    Abstract

  1366. DESAI KT, Doorbar J, de Sanjose S, Schiffman M, et al
    Response letter to "Understanding the age-related epithelial shifts at the uterine cervix and the area of risk for squamous cell cervical cancer".
    Prev Med. 2024;184:108005.
    Abstract

  1367. KABANDA R, Kiconco A, Ronald A, Beyer KMM, et al
    Correlates of intention to screen for cervical cancer among adult women in Kyotera District, Central Uganda: a community based cross-sectional study.
    BMC Womens Health. 2024;24:296.
    Abstract

  1368. DONG B, Zhou SF
    Efficacy and safety of chemotherapy as monotherapy in patients with recurrent intermediate/high-risk factors following radical hysterectomy for stage IB-IIA cervical cancer: a single-center retrospective analysis.
    BMC Womens Health. 2024;24:297.
    Abstract

  1369. LI X, Yu D, Wang Q, Chen Y, et al
    Elucidating the molecular mechanisms of pterostilbene against cervical cancer through an integrated bioinformatics and network pharmacology approach.
    Chem Biol Interact. 2024;396:111058.
    Abstract

  1370. YANG H, Huang SG, Dong M, Wang X, et al
    Efficacy and safety of bevacizumab in neoadjuvant and concurrent chemoradiotherapy for refractory cervical cancer patients.
    Biomol Biomed. 2024 May 16. doi: 10.17305/bb.2024.10528.
    Abstract

  1371. JANS L, Brynhildsen J, Cherif E, Tenerz L, et al
    Prevalence of high-risk HPV and cervical dysplasia in IUD users and controls: a cross sectional study.
    Eur J Contracept Reprod Health Care. 2024;29:109-114.
    Abstract

  1372. OKONOGI N, Murakami N, Takatsu J, Iijima K, et al
    Hands-on-training tailored in response to pre-questionnaire-based survey on image-guided brachytherapy effectively reduces anxiety about its implementation.
    J Radiat Res. 2024;65:323-327.
    Abstract

  1373. QI M, Naranjo AR, Duque AJ, Lorey TS, et al
    Evaluation of Pre-Analytical Variables for Human Papillomavirus Primary Screening from Self-Collected Vaginal Swabs.
    J Mol Diagn. 2024;26:487-497.
    Abstract

  1374. FANG Y, Wang K, Xiao M, Cheng J, et al
    Multiparametric MRI-based radiomics nomogram for identifying cervix-corpus junction cervical adenocarcinoma from endometrioid adenocarcinoma.
    Abdom Radiol (NY). 2024;49:1557-1568.
    Abstract

  1375. GARCIA K, Iacob E, Dean-Smith M, Royce E, et al
    Low Levels of Lifetime Pap Test Receipt Among Vulnerable Guatemalans.
    J Cancer Educ. 2024;39:264-270.
    Abstract

  1376. ISHIBASHI M, Niikura H, Ishida M, Iwama N, et al
    Long-Term and Short-Interval Assessment of Self-Reported Urinary and Sexual Functions after Nerve-Sparing Radical Hysterectomy: A Prospective Cohort Study.
    Tohoku J Exp Med. 2024;263:1-9.
    Abstract

  1377. CHIKAZAWA K, Imai K, Kuwata T, Konno R, et al
    Improved bladder function in radical hysterectomy without worsening oncologic outcome: resection of the posterior layer of the vesicouterine ligament with the procedure limited to the vesical veins.
    J Gynecol Oncol. 2024;35:e28.
    Abstract

  1378. KIM H, Kim KY, Kim D, Hwang JH, et al
    Implementation rate and related factors of confirmatory tests following an abnormal Pap smear: a nationwide study from the National Health Insurance.
    J Gynecol Oncol. 2024;35:e26.
    Abstract

  1379. KUMARI S, Chandra R
    Complete double ureter in a case of carcinoma cervix: incidental intraoperative diagnosis and implications.
    BMJ Case Rep. 2023;16:e255971.
    Abstract

  1380. ATRI Y, Bharti H, Sahani N, Sarkar DP, et al
    CUL4A silencing attenuates cervical carcinogenesis and improves Cisplatin sensitivity.
    Mol Cell Biochem. 2024;479:1041-1058.
    Abstract

  1381. RAHMAN MS, Rahman MM, Acharya K, Haruyama R, et al
    Disparities and determinants of testing for early detection of cervical cancer among Nepalese women: evidence from a population-based survey.
    Cancer Epidemiol Biomarkers Prev. 2024.
    Abstract

  1382. CHEN X, Fan Y
    Analysis of Factors Influencing the Stigma Associated with Postoperative Cervical Cancer Patients and the Impact of Integrated Nursing Interventions on Stigma.
    Altern Ther Health Med. 2024 May 31:AT9398.
    Abstract

  1383. HU Y, Hu C
    Enhancement of Chemotherapy Efficacy in Cervical Cancer via MAPK Pathway Inhibition by Osimertinib.
    Cancer Invest. 2024 May 31:1-10. doi: 10.1080/07357907.2024.2359987.
    Abstract

  1384. HARO E, Butcher EA, Alves ML, El Khoury C, et al
    Barriers to Cervical Cancer Screening and Satisfaction with Self-Sampling among Black Women in Michigan: a Mixed Methods Study.
    Med Res Arch. 2024;12.
    Abstract

  1385. MA Y, Chen S, Dong H, Guo R, et al
    Relationship Between Resilience, Social Support, Existential Well-Being and Negative Emotions in Cervical Cancer Patients: a Mediation Analysis.
    J Cancer. 2024;15:3418-3426.
    Abstract

  1386. WANG L, Li Y, Zhang YJ, Peng LH, et al
    Intestinal microecological transplantation for a patient with chronic radiation enteritis: A case report.
    World J Gastroenterol. 2024;30:2603-2611.
    Abstract

  1387. YU YQ, Jiang MY, Zhang X, Pan QJ, et al
    Effectiveness of high-risk human papillomavirus genotyping for cervical cancer screening. A multicentre screening cohort study in rural China.
    An Sist Sanit Navar. 2024;47:e1065.
    Abstract

  1388. DE SOUSA C, Eksteen C, Riedemann J, Engelbrecht AM, et al
    Highlighting the role of CD44 in cervical cancer progression: immunotherapy's potential in inhibiting metastasis and chemoresistance.
    Immunol Res. 2024 May 31. doi: 10.1007/s12026-024-09493.
    Abstract

  1389. MANSOOR M, Manzoor I
    Enhancing cervical cancer prognosis: Integrating machine learning and clinical insights for personalized patient care and improved outcomes.
    Eur J Surg Oncol. 2024;50:108439.
    Abstract

  1390. COSMA S, Borella F, Grimaudo I, Seminara Y, et al
    Comedo-like growth pattern in invasive early-stage cervical cancer: A new feature related to parametrial involvement.
    Eur J Surg Oncol. 2024;50:108438.
    Abstract

  1391. ZHANG H, Ao M, Wu Y, Mao W, et al
    Lymph node dissection before initial treatment for locally advanced cervical cancer: A systematic review and meta-analysis.
    Biomol Biomed. 2024 May 29. doi: 10.17305/bb.2024.10591.
    Abstract

  1392. BENOIT L, Azais H, Koual M, Bentivegna E, et al
    [Cervical tumors, tumors of the uterine body].
    Rev Prat. 2024;74:433-440.
    Abstract

  1393. HOLY O, Machaczka O, Schovankova T, Navratilova D, et al
    Trends of cervical tumours amongst women from perspectives of demographic, socioeconomic and geographic indicators: retrospective ecological study in Czechia.
    Front Public Health. 2024;12:1347800.
    Abstract

  1394. GIUBBI C, Martinelli M, Di Meo ML, Njoku RC, et al
    Evaluation of two alternative non-alcohol-based media for the suspension of self-collected vaginal swabs for HPV testing in cervical cancer screening.
    Heliyon. 2024;10:e31032.
    Abstract

  1395. OUCHANE K, Bellefkih FZ, Benchakroun N, Bourhafour M, et al
    Reversible posterior leukoencephalopathy syndrome following carboplatin and paclitaxel in cervical cancer: Case report.
    SAGE Open Med Case Rep. 2024;12:2050313X241257444.
    Abstract

  1396. KALAMYA JN, DeCuir J, Alger SX, Ninsiima J, et al
    Provision of cervical cancer services for women living with HIV, Uganda.
    Bull World Health Organ. 2024;102:382-388.
    Abstract

  1397. DAI Z, Qin F, Yang Y, Liang W, et al
    Efficacy and safety of robotic radical hysterectomy in cervical cancer compared with laparoscopic radical hysterectomy: a meta-analysis.
    Front Oncol. 2024;14:1303165.
    Abstract

  1398. QI SY, Yang MM, Li CY, Yu K, et al
    The HPV viral regulatory mechanism of TLRs and the related treatments for HPV-associated cancers.
    Front Immunol. 2024;15:1407649.
    Abstract

  1399. ARTEAGA-PAUTT H, Bru-Cordero OE, Ricardo-Caldera D, Espitia-Perez L, et al
    High frequency of alpha7-HPV in Colombian Caribbean coast women: cervical cancer screening analysis.
    BMC Infect Dis. 2024;24:539.
    Abstract

  1400. RAMEZANI F, Takhshid MA, Abuei H, Farhadi A, et al
    Combined Effects of Annexin A5 Overexpression, 5-Fluorouracil Treatment, and Irradiation on Cell Viability of Caski Cervical Cancer Cell Line.
    Reprod Sci. 2024 May 29. doi: 10.1007/s43032-024-01575.
    Abstract

  1401. YAN J, Cheng D, Gu X, Song CW, et al
    Efficacy of para-aortic lymphadenectomy in radical resection of cervical cancer: A systematic review and meta-analysis.
    Asian J Surg. 2024 May 28:S1015-9584(24)00854.
    Abstract

  1402. DE WAARD J, Bhattacharya A, de Boer MT, van Hemel BM, et al
    Methylation analysis to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening program.
    Mod Pathol. 2024 May 27:100528. doi: 10.1016/j.modpat.2024.100528.
    Abstract

  1403. RAMIREZ PT, Robledo KP, Frumovitz M, Pareja R, et al
    LACC Trial: Final Analysis on Overall Survival Comparing Open Versus Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer.
    J Clin Oncol. 2024 May 29:JCO2302335. doi: 10.1200/JCO.23.02335.
    Abstract

  1404. LIU Y, Li C, Deng Q, Ren X, et al
    METTL3's role in cervical cancer development through m(6)A modification.
    FASEB J. 2024;38:e23693.
    Abstract

  1405. SRIPAN P, Tangmunkongvorakul A, Aurpibul L, Thongkiao H, et al
    Knowledge and Behaviors toward Human Papillomavirus and Cervical Cancer in the Women of Reproductive Age in Thailand-Myanmar Border Areas.
    Asian Pac J Cancer Prev. 2024;25:1841-1849.
    Abstract

  1406. BATMUNKH T, Surenjav U, Namjil N, Dorj G, et al
    Acceptance of Self-Sampling and Knowledge about Human Papillomavirus among Women in Mongolia.
    Asian Pac J Cancer Prev. 2024;25:1823-1829.
    Abstract

  1407. BAHADUR A, Mahamood Mm M, Heda A, Heda S, et al
    Comparison of Sexual Function after Thermal Ablation Versus Loop Electrosurgical Excision Procedure (LEEP) for Cervical Intraepithelial Neoplasia (CIN 2 and 3): A Randomized Controlled Trial.
    Asian Pac J Cancer Prev. 2024;25:1699-1705.
    Abstract

  1408. YABUSAKI H, Ono M, Shiina N, Shiina Y, et al
    Human Papillomavirus Genotype Detection and Cytology Using a New Self-Sampling Method.
    Asian Pac J Cancer Prev. 2024;25:1673-1679.
    Abstract

  1409. BUNPREENANT S, Onwatanasrikul W, Kim J, Pariyawateekul P, et al
    Inflammatory Markers in Prior Loop Electrosurgical Excision Procedure (LEEP) as a Prognosis Factor in the Recurrence of Cervical Intraepithelial Neoplasia.
    Asian Pac J Cancer Prev. 2024;25:1635-1641.
    Abstract

  1410. MINAMITANI M, Morishima K, Katano A, Ohira S, et al
    Exploring the Correlation Between Health Literacy and Knowledge of Cervical Cancer and Radiotherapy Among Japanese Women: A Web-Based Survey.
    J Cancer Educ. 2024 May 29. doi: 10.1007/s13187-024-02432.
    Abstract

  1411. MUSLIN C
    Addressing the burden of cervical cancer for Indigenous women in Latin America and the Caribbean: a call for action.
    Front Public Health. 2024;12:1376748.
    Abstract

  1412. SEKIMATA M, Kinjo Y, Tohyama A, Murakami M, et al
    Cytokine release syndrome induced by immune checkpoint inhibitor treatment for uterine cervical cancer recurrence: A case report.
    Oncol Lett. 2024;28:331.
    Abstract

  1413. ZHANG Q, Li X, He C, Zhou R, et al
    Artesunate promotes cervical cancer cell apoptosis by regulating Bcl2 family molecules and reducing the mitochondrial membrane potential.
    Oncol Lett. 2024;28:315.
    Abstract

  1414. LIN S, Chen Z, Li S, Chen B, et al
    Corrigendum to "Anti-tumor effect and mechanism of the total biflavonoid extract from S doederleinii on human cervical cancer cells in vitro and in vivo" [Heliyon 10(2) January 2024 e24778].
    Heliyon. 2024;10:e30202.
    Abstract

  1415. MALLIKARJUNA T, Thummadi NB, Vindal V, Manimaran P, et al
    Prioritizing cervical cancer candidate genes using chaos game and fractal-based time series approach.
    Theory Biosci. 2024 May 28. doi: 10.1007/s12064-024-00418.
    Abstract

  1416. LEE MS, Day AD, Bassford TL, Lininger MR, et al
    Primary Care Providers' Experiences Recommending and Performing Cervical Cancer Screening for Women with Intellectual Disabilities: A Qualitative Study.
    J Cancer Educ. 2024 May 28. doi: 10.1007/s13187-024-02454.
    Abstract

  1417. MINAMITANI M, Katano A, Mukai T, Ohira S, et al
    Comparative analysis of treatment decision-making in patients with localized prostate and cervical cancer: what influences receiving surgery or radiotherapy?
    Support Care Cancer. 2024;32:391.
    Abstract

  1418. YANG Z, Wang Y, Ablise M, Maimaiti A, et al
    Design, synthesis, and ex vivo anti-drug resistant cervical cancer activity of novel molecularly targeted chalcone derivatives.
    Bioorg Chem. 2024;149:107498.
    Abstract

  1419. ALTOVA A, Kulhanova I, Reisser K, Netrdova P, et al
    Educational inequalities in cervical cancer screening participation in 24 European countries.
    Public Health. 2024;233:1-7.
    Abstract

  1420. DHAKAL K, Chen C, Wang P, Mboineki JF, et al
    Existing psychological supportive care interventions for cervical cancer patients: a systematic review and meta-analysis.
    BMC Public Health. 2024;24:1419.
    Abstract

  1421. WANG YW, Chen M, Shen WT, Xu HP, et al
    The clinical practice and dosimetric outcome of the manual adaptive planning during definitive radiotherapy for cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:280.
    Abstract

  1422. ALLOGMANI AS, Mohamed RM, Al-Shibly NM, Ragab M, et al
    Enhanced cervical precancerous lesions detection and classification using Archimedes Optimization Algorithm with transfer learning.
    Sci Rep. 2024;14:12076.
    Abstract

  1423. LI YT, Lee NR, Chang WH
    Is it practical to add the p16/Ki67 immunohistochemical dual staining into liquid-based cytology for cervical cancer screening?
    Taiwan J Obstet Gynecol. 2024;63:437-438.
    Abstract

  1424. YANG ST, Wang PH, Liu HH, Chang WH, et al
    Cervical cancer: Part I human papilloma virus vaccination in Taiwan.
    Taiwan J Obstet Gynecol. 2024;63:320-328.
    Abstract

  1425. CHANG WH, Chou FW, Wang PH
    Immunohistochemical staining for cytology-based cervical cancer screening.
    Taiwan J Obstet Gynecol. 2024;63:285-287.
    Abstract

  1426. PARK CH, Kim CW, Lee HW, Kwon MJ, et al
    Evaluation of YD MolecuTech Real HPV Assay in Comparison with Roche Cobas HPV Assay and BD Onclarity HPV Assay for Detection of HPV Infection.
    Ann Clin Lab Sci. 2024;54:239-245.
    Abstract

  1427. GAO M, Pang X, Ni S, Wei Z, et al
    Long Non-Coding RNA FLG-AS1 Inhibits Cervical Cancer Progression through Negatively Modulating miR-147b.
    Ann Clin Lab Sci. 2024;54:149-155.
    Abstract

  1428. XIN W, Rixin S, Linrui L, Zhihui Q, et al
    Machine learning-based radiomics for predicting outcomes in cervical cancer patients undergoing concurrent chemoradiotherapy.
    Comput Biol Med. 2024;177:108593.
    Abstract

  1429. LI Y, Zhu L, Zhu C, Chen Y, et al
    Circulating micrornas as potential diagnostic biomarkers for cervical intraepithelial neoplasia and cervical cancer: a systematic review and meta-analysis.
    Discov Oncol. 2024;15:189.
    Abstract

  1430. ZHANG MJ, Shi M, Yu Y, Ou R, et al
    Curcuminoid PBPD induces cuproptosis and endoplasmic reticulum stress in cervical cancer via the Notch1/RBP-J/NRF2/FDX1 pathway.
    Mol Carcinog. 2024 May 27. doi: 10.1002/mc.23735.
    Abstract

  1431. JENA L, Behera SK, Dash S, Sethy PK, et al
    Deep feature extraction and fine kappa-nearest neighbour for enhanced human papillomavirus detection in cervical cancer - a comprehensive analysis of colposcopy images.
    Contemp Oncol (Pozn). 2024;28:37-44.
    Abstract

  1432. OUEDRAOGO S, Bamogo A, Tiendrebeogo G, Kabore S, et al
    Cervical cancer prevention in Burkina Faso: a stakeholder's collaboration for the development of awareness messaging.
    Front Oncol. 2024;14:1383133.
    Abstract

  1433. LIANG Y, Li C, Hou X, Lin Y, et al
    MicroRNA-875-5p inhibits the growth and metastasis of cervical cancer cells by promoting autophagy and apoptosis and inhibiting the epithelial-mesenchymal transition.
    Front Oncol. 2024;14:1361721.
    Abstract

  1434. LI S, Gao K, Yao D
    Comprehensive analysis of autophagy associated genes and immune infiltrates in cervical cancer.
    Iran J Basic Med Sci. 2024;27:813-824.
    Abstract

  1435. DUAN Y, Yang L, Wang W, Zhang P, et al
    A comprehensive bibliometric analysis (2000-2022) on the mapping of knowledge regarding immunotherapeutic treatments for advanced, recurrent, or metastatic cervical cancer.
    Front Pharmacol. 2024;15:1351363.
    Abstract

  1436. VAN DAMME A, Tummers P, De Visschere P, Van Dorpe J, et al
    Exclusion of non-Involved uterus from the target volume (EXIT-trial): An individualized treatment for locally advanced cervical cancer using modern radiotherapy and imaging techniques followed by completion surgery.
    Clin Transl Radiat Oncol. 2024;47:100793.
    Abstract

  1437. PASHA A, Kumar K, Heena SK, Arnold Emerson I, et al
    Inhibition of NF-kB and COX-2 by andrographolide regulates the progression of cervical cancer by promoting PTEN expression and suppressing PI3K/AKT signalling pathway.
    Sci Rep. 2024;14:12020.
    Abstract

  1438. CHEN F, Qiu LH, Sui L, Hao M, et al
    [Topical immunomodulators for persistent high?risk human papillomavirus infection: experts consensus in China].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:337-342.
    Abstract

  1439. HAN S, Na J, Li Y, Wang J, et al
    Surgical procedures and techniques in robot-assisted uterine artery-preserving radical trachelectomy.
    J Robot Surg. 2024;18:222.
    Abstract

  1440. JENSEN JE, Becker GL, Jackson JB, Rysavy MB, et al
    Human Papillomavirus and Associated Cancers: A Review.
    Viruses. 2024;16:680.
    Abstract

  1441. WANG Y, Qiu H, Lin R, Hong W, et al
    Advancements in the Understanding of Small-Cell Neuroendocrine Cervical Cancer: Where We Stand and What Lies Ahead.
    J Pers Med. 2024;14:462.
    Abstract

  1442. KONNERTH D, Gaasch A, Zinn A, Rogowski P, et al
    Hematologic Toxicity and Bone Marrow-Sparing Strategies in Chemoradiation for Locally Advanced Cervical Cancer: A Systematic Review.
    Cancers (Basel). 2024;16:1842.
    Abstract

  1443. CABIBI D, Giannone AG, Quattrocchi A, Lo Coco R, et al
    High-Risk HPV CISH Detection in Cervical Biopsies with Weak and/or Focal p16 Immunohistochemical Positivity.
    Int J Mol Sci. 2024;25:5354.
    Abstract

  1444. BALAN L, Cimpean AM, Nandarge PS, Sorop B, et al
    Clinical Outcomes and Molecular Predictors of Pembrolizumab (Keytruda) as a PD-1 Immune Checkpoint Inhibitor in Advanced and Metastatic Cervical Cancer: A Systematic Review and Meta-Analysis.
    Biomedicines. 2024;12:1109.
    Abstract

  1445. HONG Z, Xiong J, Yang H, Mo YK, et al
    Lightweight Low-Rank Adaptation Vision Transformer Framework for Cervical Cancer Detection and Cervix Type Classification.
    Bioengineering (Basel). 2024;11:468.
    Abstract

  1446. FUDULU A, Diaconu CC, Iancu IV, Plesa A, et al
    Exploring the Role of E6 and E7 Oncoproteins in Cervical Oncogenesis through MBD2/3-NuRD Complex Chromatin Remodeling.
    Genes (Basel). 2024;15:560.
    Abstract

  1447. LI D, Lu Y
    [Research progress of tumor-associated macrophages in cervical cancer].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024;40:472-478.
    Abstract

  1448. WU D, Zhou R, Chen H, Pan Y, et al
    The Role of Traditional Chinese Medicine in the Management of Cervical Cancer.
    Am J Chin Med. 2024 May 25:1-13. doi: 10.1142/S0192415X24500411.
    Abstract

  1449. YANG T, Hu H, Li X, Meng Q, et al
    An efficient Fusion-Purification Network for Cervical pap-smear image classification.
    Comput Methods Programs Biomed. 2024;251:108199.
    Abstract

  1450. BISWAL SS, Sarkar B, Goyal M
    Determining the library size for the optimal output plan in the RapidPlan knowledge-based planning system using multicriteria optimization.
    Br J Radiol. 2024;97:1153-1161.
    Abstract

  1451. LIU Y, Wu R, Li C, Wei L, et al
    Successful pregnancy and delivery after HiPorfin photodynamic therapy for cervical high-grade squamous intraepithelial lesion.
    Photodiagnosis Photodyn Ther. 2024;46:104062.
    Abstract

  1452. WANG L, Liu X, Zhang J, Song M, et al
    Comparison of 5-ALA-PDT and LEEP of cervical squamous intraepithelial neoplasia (CIN2) with high-risk human papillomavirus infection in childbearing age women: A non-randomized controlled polit study.
    Photodiagnosis Photodyn Ther. 2024;46:104044.
    Abstract

  1453. WU Y, Sun X, Yan Y, Zhou Z, et al
    Successful treatment by a chlorin e6 derivative mediated photodynamic therapy combined holmium laser for cervical and vaginal giant condyloma acuminata and low-grade intraepithelial neoplasia:A case report.
    Photodiagnosis Photodyn Ther. 2024;46:104022.
    Abstract

  1454. LIU Y, Wu R, Li C, Wei L, et al
    Photodynamic therapy with HiPorfin for cervical squamous intraepithelial lesion at childbearing age.
    Photodiagnosis Photodyn Ther. 2024;46:104018.
    Abstract

  1455. WANG B, Yuan S, Su Y, Zhang C, et al
    Comparative study of topical 5-aminolevulinic acid photodynamic therapy and surgery for recurrent cervical high-grade squamous intraepithelial lesions following surgery.
    Photodiagnosis Photodyn Ther. 2024;46:103974.
    Abstract

  1456. MENESES-LEON J, Hernandez-Salazar S, Torres-Ibarra L, Hernandez-Lopez R, et al
    Performance of urine samples compared to cervical samples for detection of precancer lesions among HPV-positive women attending colposcopy clinic in Mexico City.
    Cancer Causes Control. 2024;35:935-942.
    Abstract

  1457. DAMGAARD R, Jenkins D, Stoler MH, de Koning MC, et al
    HPV genotypes and risk of persistence and progression in women undergoing active surveillance for cervical intraepithelial neoplasia grade 2.
    Am J Obstet Gynecol. 2024 Feb 7:S0002-9378(24)00072.
    Abstract

  1458. SHIH YW, Chang CW, Chang HR, Tsai JR, et al
    Mediating Effect of White Blood Cells and Tobacco Exposure on Cervical Neoplasm Risk Among Taiwanese Women.
    Biol Res Nurs. 2024;26:380-389.
    Abstract

  1459. WANG Y, Liu Y, Bai Y, Zhou Q, et al
    A generalization performance study on the boosting radiotherapy dose calculation engine based on super-resolution.
    Z Med Phys. 2024;34:208-217.
    Abstract

  1460. MOYCE S, Claudio D, Aghbashian E, Keenan K, et al
    Barriers and Facilitators to Breast and Cervical Cancer Screenings for Hispanic Women in a Rural State.
    J Racial Ethn Health Disparities. 2024 Jun 7. doi: 10.1007/s40615-024-02037.
    Abstract

  1461. CHUNG PYJ, Dhillon SK, Baraquin A, Tkachenka Y, et al
    Intra- and interlaboratory reproducibility evaluation toward international validation status of the AmpFire assay.
    J Med Virol. 2024;96:e29688.
    Abstract

  1462. YANG X, Gao C, Sun N, Qin X, et al
    An interpretable clinical ultrasound-radiomics combined model for diagnosis of stage I cervical cancer.
    Front Oncol. 2024;14:1353780.
    Abstract

  1463. LUVIAN-MORALES J, Gutierrez-Enriquez SO, Granados-Garcia V, Torres-Poveda K, et al
    Risk factors for the development of cervical cancer: analysis of the evidence.
    Front Oncol. 2024;14:1378549.
    Abstract

  1464. WANG L, Dong Y
    Peripheral blood immune cell parameters in patients with high-grade squamous intraepithelial lesion (HSIL) and cervical cancer and their clinical value: a retrospective study.
    PeerJ. 2024;12:e17499.
    Abstract

  1465. BATESON D, Ussher J, Strnadova I, Loblinzk J, et al
    Working together with people with intellectual disability to make a difference: a protocol for a mixed-method co-production study to address inequities in cervical screening participation.
    Front Public Health. 2024;12:1360447.
    Abstract

  1466. ZHANG K, Yu B, Tang M, Li Y, et al
    Endovaginal coil for pelvic high-resolution magnetic resonance imaging of cervical cancer: a preliminary parameter optimization study.
    Quant Imaging Med Surg. 2024;14:3851-3862.
    Abstract

  1467. LI L, Gopinath SCB, Lakshmipriya T, Subramaniam S, et al
    Zeolite-iron oxide integrated interdigitated electrode sensor for diagnosing cervical cancer.
    Heliyon. 2024;10:e31851.
    Abstract

  1468. KABANDA R, Kiconco A, Ronald A, Beyer KMM, et al
    Correction: Correlates of intention to screen for cervical cancer among adult women in Kyotera District, Central Uganda: a community based cross-sectional study.
    BMC Womens Health. 2024;24:328.
    Abstract

  1469. BI D, Wei S, Luo X, Luo X, et al
    Management for persistent HPV infection and cervical lesions among women infected with HIV: a retrospective observational cohort study.
    Virol J. 2024;21:133.
    Abstract

  1470. PATERSON H, Macfarlane E, Slater T, Stanton JL, et al
    Preliminary assessment of using mobile point-of-care human papillomavirus (HPV) testing with the option of immediate colposcopy in a rural area in a high-income country: a case study.
    N Z Med J. 2024;137:43-51.
    Abstract

  1471. MARTINEZ ME, Schmeler KM, Lajous M, Newman LA, et al
    Cancer Screening in Low- and Middle-Income Countries.
    Am Soc Clin Oncol Educ Book. 2024;44:e431272.
    Abstract

  1472. HWONG AR, Murphy KA, Vittinghoff E, Alonso-Fraire P, et al
    Cervical Cancer Screening Among Female Medicaid Beneficiaries With and Without Schizophrenia.
    Schizophr Bull. 2024 Jun 6:sbae096. doi: 10.1093.
    Abstract

  1473. LI J, Hou F, Teng Z, Xia W, et al
    LncRNA HOXC-AS3 accelerates malignant proliferation of cervical cancer cells via stabilizing KDM5B.
    J Cancer Res Clin Oncol. 2024;150:294.
    Abstract

  1474. WANG R, Tan W
    RBM15-Mediated N6-Methyl Adenosine (m6A) Modification of EZH2 Drives the Epithelial-Mesenchymal Transition of Cervical Cancer.
    Crit Rev Eukaryot Gene Expr. 2024;34:15-29.
    Abstract

  1475. YU H, He H, Liang X, Lin H, et al
    Robotic-assisted laparoscopic radical hysterectomy for early-stage cervical cancer: The more experienced the bedside assistant, the better?
    Heliyon. 2024;10:e31741.
    Abstract

  1476. MA B, Ren C, Yin Y, Zhao S, et al
    Immune cell infiltration and prognostic index in cervical cancer: insights from metabolism-related differential genes.
    Front Immunol. 2024;15:1411132.
    Abstract

  1477. LIU G, Ye H, Chen W, Zhao W, et al
    Effect of Pelvic Floor Function Exercises Based on the ERAS Concept on Lower Urinary Tract Symptoms after Radical Hysterectomy for Cervical Cancer: A Retrospective Cohort Study.
    Arch Esp Urol. 2024;77:426-432.
    Abstract

  1478. WANG J, Lv N, Yang L, Zhu Y, et al
    Family Resilience and Its Influencing Factors in Patients with Stress Urinary Incontinence after Cervical Cancer Surgery: A Retrospective Study.
    Arch Esp Urol. 2024;77:397-404.
    Abstract

  1479. ONYANGO OE, Masinde D, Ouma C
    Enhancing cervical cancer knowledge among women of reproductive age: a dialogue-based community health education intervention in rural Kisumu County, Kenya.
    BMC Womens Health. 2024;24:327.
    Abstract

  1480. LOVANE L, Tulsidas S, Carrilho C, Karlsson C, et al
    PD-L1 expression in squamous cervical carcinomas of Mozambican women living with or without HIV.
    Sci Rep. 2024;14:12974.
    Abstract

  1481. KOBAYASHI O, Kamata S, Okuma Y, Nakajima T, et al
    Carcinogenesis and epidemiology of cervical cancer: The hallmark of human papillomavirus-associated cancer.
    J Obstet Gynaecol Res. 2024 Jun 5. doi: 10.1111/jog.15997.
    Abstract

  1482. KAWASE K, Taguchi A, Ishizaka A, Lin J, et al
    Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasia.
    HLA. 2024;103:e15509.
    Abstract

  1483. YU J, Huang L, Cao L
    M2 macrophages regulate KDM6B/PFKFB2 metabolic reprogramming of cervical squamous cell carcinoma through CXCL1.
    Cell Mol Biol (Noisy-le-grand). 2024;70:78-84.
    Abstract

  1484. LI J, Niu C, Zhang L, Mu Y, et al
    Association of body composition and systemic inflammation for patients with locally advanced cervical cancer following concurrent chemoradiotherapy.
    Diagn Interv Radiol. 2024 Jun 3. doi: 10.4274/dir.2024.242751.
    Abstract

  1485. ZHANG X, Li J, Yang L, Zhu Y, et al
    Targeted proteomics-determined multi-biomarker profiles developed classifier for prognosis and immunotherapy responses of advanced cervical cancer.
    Front Immunol. 2024;15:1391524.
    Abstract

  1486. YUE H, Li X, You J, Feng P, et al
    Acute hematologic toxicity prediction using dosimetric and radiomics features in patients with cervical cancer: does the treatment regimen matter?
    Front Oncol. 2024;14:1365897.
    Abstract

  1487. WORKU E, Yigizaw G, Admassu R, Mekonnen D, et al
    Prevalence and risk factors associated with precancerous and cancerous cervical lesions among HIV-infected women in University of Gondar specialized comprehensive referral hospital, Northwest Ethiopia: cross-sectional study design.
    BMC Womens Health. 2024;24:322.
    Abstract

  1488. KIPP B, Ulrich E, van Meegen C, Schwenzer T, et al
    Risk of cervical high-grade squamous intraepithelial neoplasia in cytologic negative and persistently high-risk human papillomavirus positive patients according to genotypes: a retrospective single center analysis.
    BMC Infect Dis. 2024;24:558.
    Abstract

  1489. SCHREIBERHUBER L, Barrett JE, Wang J, Redl E, et al
    Cervical cancer screening using DNA methylation triage in a real-world population.
    Nat Med. 2024 Jun 4. doi: 10.1038/s41591-024-03014.
    Abstract

  1490. LI W, Yu KN, Bao L, Shen J, et al
    Retraction Note: Non-thermal plasma inhibits human cervical cancer HeLa cells invasiveness by suppressing the MAPK pathway and decreasing matrix metalloproteinase-9 expression.
    Sci Rep. 2024;14:12785.
    Abstract

  1491. ZAMMIT CM, Brooks A, Brotherton JML, Nightingale CE, et al
    What young women (aged 24-29 years) in Australia think about self-collection for cervical screening: a brief report.
    Sex Health. 2024;21:SH24033.
    Abstract

  1492. NIMANI TD, Bayisa FS, Jimma SD, Assefa AT, et al
    Knowledge and attitude toward cervical cancer screening among women aged 30-49 years attending selected health facilities in Ethiopia: Using structural equation model.
    Heliyon. 2024;10:e31596.
    Abstract

  1493. WEI X, Li L
    Cytological diagnosis of patients with embryonal rhabdomyosarcoma of the cervix: case report and literature review.
    Diagn Pathol. 2024;19:73.
    Abstract

  1494. PAN B, Liu C, Su J, Xia C, et al
    Activation of AMPK inhibits cervical cancer growth by hyperacetylation of H3K9 through PCAF.
    Cell Commun Signal. 2024;22:306.
    Abstract

  1495. MOLINA MA, Leenders WPJ, Huynen MA, Melchers WJG, et al
    Temporal composition of the cervicovaginal microbiome associates with hrHPV infection outcomes in a longitudinal study.
    BMC Infect Dis. 2024;24:552.
    Abstract

  1496. GUO M, Guo D, Liao L, Zhang X, et al
    Ethanolic extract from Sophora moorcroftiana inhibit cell proliferation and alter the mechanical properties of human cervical cancer.
    BMC Complement Med Ther. 2024;24:212.
    Abstract

  1497. PATAKY RE, Izadi-Najafabadi S, Smith LW, Gottschlich A, et al
    Strategies to accelerate the elimination of cervical cancer in British Columbia, Canada: a modelling study.
    CMAJ. 2024;196:E716-E723.
    Abstract

  1498. CHARLEBOIS S, Kean S
    To eliminate cervical cancer in Canada, nationwide funding of self-sampling for human papillomavirus is needed.
    CMAJ. 2024;196:E729-E730.
    Abstract

  1499. GAUTAM S, Osman AFI, Richeson D, Gholami S, et al
    Attention 3D U-NET for dose distribution prediction of high-dose-rate brachytherapy of cervical cancer: Direction modulated brachytherapy tandem applicator.
    Med Phys. 2024 Jun 3. doi: 10.1002/mp.17238.
    Abstract

  1500. HANDLER A, Pham TND, Rankin K
    Women's Preventive Services Utilization in Illinois in the Aftermath of the ACA and the COVID-19 Pandemic.
    J Health Care Poor Underserved. 2024;35:672-691.
    Abstract

  1501. DUN C, Yuan M, Zhao X, Hu S, et al
    Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population-based cervical cancer screening studies from China.
    Cancer Med. 2024;13:e7316.
    Abstract

  1502. HUA L, Wei M, Feng C, Li S, et al
    Nomogram for Predicting Survival in Locally Advanced Cervical Cancer with Concurrent Chemoradiotherapy plus or Not Adjuvant Chemotherapy: A Retrospective Analysis Based on 2018 FIGO Staging.
    Cancer Biother Radiopharm. 2024 Jun 3. doi: 10.1089/cbr.2023.0199.
    Abstract

  1503. JIANG X, Feng C, Sun W, Zhang T, et al
    The top 100 most cited articles on fertility-sparing treatments for cervical cancer: A bibliometric analysis.
    Heliyon. 2024;10:e31738.
    Abstract

  1504. LIANG M, Sheng L, Ke Y, Wu Z, et al
    Corrigendum: The research progress on radiation resistance of cervical cancer.
    Front Oncol. 2024;14:1430862.
    Abstract

  1505. TSIGE AW, Beyene DA
    Cervical cancer: Challenges and prevention strategies: A narrative review.
    Health Sci Rep. 2024;7:e2149.
    Abstract

  1506. WANG G, Wang Z, Zhang Y, Sun X, et al
    Daily Online Adaptive Radiation Therapy of Postoperative Endometrial and Cervical Cancer With PTV Margin Reduction to 5 mm: Dosimetric Outcomes, Acute Toxicity, and First Clinical Experience.
    Adv Radiat Oncol. 2024;9:101510.
    Abstract

  1507. MWENDA V, McGrath CJ
    Choosing the Appropriate HPV Testing and Treatment Algorithm: What Works for Different Contexts?
    Cancer Epidemiol Biomarkers Prev. 2024;33:763-765.
    Abstract

  1508. ZHAO LN, Yuan JP, Huang AL, Wang CH, et al
    [Colorectal metastasis from female genital system neoplasm in colonoscopy biopsy specimen mimicking primary colorectum cancer: a clinicopathological analysis of ten cases].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:610-612.
    Abstract

  1509. WEI X, Zheng Z, Shi QY, Wang CS, et al
    [Application of PRAME immunohistochemistry in the differential diagnosis of primary endometrial and endocervical adenocarcinomas].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:552-556.
    Abstract

  1510. ANDRING LM, Corrigan KL, Reeve B, Meyer L, et al
    The value of patient-reported outcomes to predict for symptom burden and health-related quality of life after chemoradiation for cervical cancer: A prospective study.
    Pract Radiat Oncol. 2024 May 31:S1879-8500(24)00135.
    Abstract

  1511. SHINAGARE AB, Burk KS, Kilcoyne A, Akin EA, et al
    ACR Appropriateness Criteria(R) Pretreatment Evaluation and Follow-Up of Invasive Cancer of the Cervix: 2023 Update.
    J Am Coll Radiol. 2024;21.
    Abstract

  1512. BERZA N, Zodzika J, Kivite-Urtane A, Baltzer N, et al
    Understanding the high-risk human papillomavirus prevalence and associated factors in the European country with a high incidence of cervical cancer.
    Eur J Public Health. 2024 May 31:ckae075. doi: 10.1093.
    Abstract

  1513. LEWIS AGC, Hernandez DM, Garces-Palacio IC, Soliman AS, et al
    Impact of the universal health insurance benefits on cervical cancer mortality in Colombia.
    BMC Health Serv Res. 2024;24:693.
    Abstract

  1514. MOVAHED F, Darzi S, Mahdavi P, Salih Mahdi M, et al
    The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV).
    Virol J. 2024;21:124.
    Abstract

  1515. AYANTO SY, Belachew T, Wordofa MA
    Effectiveness of couple education and counseling on uptake of cervical cancer screening among women in Southern Ethiopia: a cluster randomized trial.
    Sci Rep. 2024;14:12557.
    Abstract

  1516. SUN HN, Ma DY, Guo XY, Hao YY, et al
    Peroxiredoxin I and II as novel therapeutic molecular targets in cervical cancer treatment through regulation of endoplasmic reticulum stress induced by bleomycin.
    Cell Death Discov. 2024;10:267.
    Abstract

  1517. YANG H, Zhang Y, Heng F, Li W, et al
    Risk Prediction Model for Radiation-induced Dermatitis in Patients with Cervical Carcinoma Undergoing Chemoradiotherapy.
    Asian Nurs Res (Korean Soc Nurs Sci). 2024;18:178-187.
    Abstract

  1518. AMBOREE TL, Montealegre JR, Parker SL, Garg A, et al
    National Breast, Cervical, and Colorectal Cancer Screening Use in Federally Qualified Health Centers.
    JAMA Intern Med. 2024;184:671-679.
    Abstract

  1519. WANG Y, Lu J, Qiu H, Yang C, et al
    Post-surgery rapid metastasis in stage IB2 mixed adenoneuroendocrine cervical carcinoma: An insightful reflective case study.
    Asian J Surg. 2024;47:2967-2968.
    Abstract

  1520. KHAN I, Khare BK
    Exploring the potential of machine learning in gynecological care: a review.
    Arch Gynecol Obstet. 2024;309:2347-2365.
    Abstract

  1521. SHI Y, Dong XY, Yimingjiang MWLD, Ma WM, et al
    The association between human papillomavirus infection, vaginal microecology, and cervical intraepithelial neoplasia in women from Xinjiang, China.
    J Obstet Gynaecol Res. 2024;50:982-990.
    Abstract

  1522. ZHANG Z, Yao P, Chen M, Zeng L, et al
    SCAC: A Semi-Supervised Learning Approach for Cervical Abnormal Cell Detection.
    IEEE J Biomed Health Inform. 2024;28:3501-3512.
    Abstract

  1523. BIST R, Mohi MK, Garg R
    Colposcopic findings to study cervical changes in reproductive age group women using various contraceptives.
    Arch Gynecol Obstet. 2024;309:2799-2809.
    Abstract

  1524. LIU J, Li S, Zhang Y, Cheng J, et al
    Gastric-type adenocarcinoma of the uterine cervix: A case report.
    Asian J Surg. 2024;47:2952-2953.
    Abstract

  1525. YE L, Gan M, Yao Y, Lu B, et al
    Retrospective analysis of cytology and high-risk HPV testing in 1067 endocervical adenocarcinomas and precursor lesions.
    Cancer Cytopathol. 2024;132:340-347.
    Abstract

  1526. HOU J, Belinson JL, Du H, Li C, et al
    AmpFire HPV and ScreenFire RS HPV validation trial.
    Am J Clin Pathol. 2024;161:535-542.
    Abstract

  1527. ADEBAMOWO SN, Adeyemo A, Adebayo A, Achara P, et al
    Genome, HLA and polygenic risk score analyses for prevalent and persistent cervical human papillomavirus (HPV) infections.
    Eur J Hum Genet. 2024;32:708-716.
    Abstract

  1528. LIU J, Lyu Y, He Y, Ge J, et al
    Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study.
    J Endocrinol Invest. 2024;47:1545-1557.
    Abstract

  1529. NIKAS IP, Souza da Silva R, Sousa-Pinto B, Schmitt F, et al
    Challenging the concept of "risk of malignancy" in cytology.
    Cancer Cytopathol. 2024;132:335-339.
    Abstract

  1530. TROJNARSKA D, Jach R
    Primary prevention of HPV-related diseases from the patients' perspective in Poland.
    Eur J Cancer Prev. 2024;33:299-308.
    Abstract

  1531. AL-AWADHI R, Alwehaidah MS, AlRoomy M, Kapila K, et al
    Relative Telomere Length in Cervical Exfoliated Cells among Women with High-Risk Human Papillomavirus.
    Pathobiology. 2024;91:180-186.
    Abstract

  1532. FAN W, Sun S, Wang J, Lv Y, et al
    Development and validation of nomograms to predict survival of primary cervical lymphoma: A surveillance, epidemiology, and end results (SEER) database analysis.
    Medicine (Baltimore). 2024;103:e38528.
    Abstract

  1533. BORDERS TF, Thaxton Wiggins A
    Cervical Cancer Screening Rates Among Rural and Urban Females, From 2019 to 2022.
    JAMA Netw Open. 2024;7:e2417094.
    Abstract

  1534. BALHARA N, Yadav R, Ranga S, Ahuja P, et al
    Understanding the HPV associated cancers: A comprehensive review.
    Mol Biol Rep. 2024;51:743.
    Abstract

  1535. ALGHAMDI YS, Mashraqi MM, Alsalmi O, Alharthi AA, et al
    Multitargeted Docking, DFT-Based Optimisation, Pharmacokinetics, and MD Simulation Reveal 6-Oxidopamine HBr as a Multitargeted Inhibitor of Cervical Cancer Proteins.
    Curr Med Chem. 2024 Jun 13. doi: 10.2174/0109298673289824240529063416.
    Abstract

  1536. ROBLES C, Monfil L, Ibanez R, Roura E, et al
    Impact of the COVID-19 pandemic on cervical cancer screening participation, abnormal cytology prevalence and screening interval in Catalonia.
    Front Oncol. 2024;14:1338859.
    Abstract

  1537. RAJU KVVN, Kumar Jonnada P, Badude M, Nekkanti S, et al
    Open total mesometrial resection for cervical cancer.
    Gynecol Oncol Rep. 2024;54:101410.
    Abstract

  1538. HU L, Mwanahamuntu MH, Sahasrabuddhe VV, Barrett C, et al
    Internal validation of Automated Visual Evaluation (AVE) on smartphone images for cervical cancer screening in a prospective study in Zambia.
    Cancer Med. 2024;13:e7355.
    Abstract

  1539. PAN B, Liu C, Su J, Xia C, et al
    Correction: Activation of AMPK inhibits cervical cancer growth by hyperacetylation of H3K9 through PCAF.
    Cell Commun Signal. 2024;22:327.
    Abstract

  1540. CHEN X, Yang N, Wang Y, Yang S, et al
    PCK1-mediated glycogenolysis facilitates ROS clearance and chemotherapy resistance in cervical cancer stem cells.
    Sci Rep. 2024;14:13670.
    Abstract

  1541. KHOJA L, Torres HG, Hak L, Aljebori M, et al
    Cervical cancer screening and vaccination acceptability and attitudes among Arab American women in Southeastern Michigan: a qualitative study.
    Sci Rep. 2024;14:13624.
    Abstract

  1542. ZHU Y, Liu L, Li D, Feng Z, et al
    Impact of Perioperative Empathic Care on Postoperative Psychological Status in Patients with Cervical Cancer.
    Altern Ther Health Med. 2024 Jun 14:AT10495.
    Abstract

  1543. ZHANG Y, Yi F, Zhang X, Song J, et al
    IRTKS contributes to the malignant progression of cervical cancer cells.
    Med Oncol. 2024;41:174.
    Abstract

  1544. CHANG J, Quan S, Tian S, Wang S, et al
    Niraparib enhances antitumor immunity and contributes to the efficacy of PD-L1 blockade in cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:304.
    Abstract

  1545. MACLAUGHLIN KL, Jenkins GD, St Sauver J, Fan C, et al
    Primary human papillomavirus testing by clinician- versus self-collection: Awareness and acceptance among cervical cancer screening-eligible women.
    J Med Screen. 2024 Jun 13:9691413241260019. doi: 10.1177/09691413241260019.
    Abstract

  1546. ZHAO X, Huang Y, Lv Q, Wang L, et al
    Knowledge, awareness, and correlates of HPV vaccine acceptability among male junior high school students in Zhejiang Province, China.
    Hum Vaccin Immunother. 2024;20:2357238.
    Abstract

  1547. SONG Q, Wang X
    Prevalence and Genotype Distribution of HPV in Hangzhou, China.
    Clin Lab. 2024;70.
    Abstract

  1548. WANG L, Chen J, Ma C, Zhang C, et al
    Targeted nanotherapy platform mediated tumor-infiltrating CD8(+) T cell immune function effects for collaborative anti-tumor photothermal immunotherapy for cervical cancer.
    Nanoscale Adv. 2024;6:3052-3063.
    Abstract

  1549. TOKALIOGLU AA, Alci A, Oktar O, Unsal M, et al
    Do HPV 16 positive/ASC-H cervical cancer screening results predict CIN 2+ better than other high-risk HPV subtypes?
    J Turk Ger Gynecol Assoc. 2024;25:90-95.
    Abstract

  1550. CHANG R, Li T, Ma X
    Application value of artificial intelligence algorithm-based magnetic resonance multi-sequence imaging in staging diagnosis of cervical cancer.
    Open Life Sci. 2024;19:20220733.
    Abstract

  1551. KUMARI S, Solomi C
    Late and unusual recurrences after minimally invasive cervical cancer surgery.
    BMJ Case Rep. 2024;17:e258831.
    Abstract

  1552. CHEN C, Liao J, Sun X
    Keratinocyte differentiation factor 1 enhances cervical cancer cell viability and migration by activating the PI3K/AKT pathway.
    J Obstet Gynaecol. 2024;44:2362420.
    Abstract

  1553. WANG B, Wang W, Zhou W, Zhao Y, et al
    Cervical cancer-specific long non-coding RNA landscape reveals the favorable prognosis predictive performance of an ion-channel-related signature model.
    Cancer Med. 2024;13:e7389.
    Abstract

  1554. YU J, Huang L, Dong T, Cao L, et al
    Prediction of outcomes after chemoradiotherapy for cervical cancer by neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio.
    J Obstet Gynaecol. 2024;44:2361858.
    Abstract

  1555. QIN J, Scarinci I, Lu E, Senkomago V, et al
    Building Capacity for Cervical Cancer Prevention in U.S.-Affiliated Pacific Islands: The Pacific Against Cervical Cancer Project.
    J Womens Health (Larchmt). 2024 Jun 12. doi: 10.1089/jwh.2024.0284.
    Abstract

  1556. LIU L, Yin P, Yang R, Zhang G, et al
    Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma.
    Front Immunol. 2024;15:1351908.
    Abstract

  1557. SU X, Huang J, Wang N
    Effect of different treatment modalities on the prognosis of patients with stage IIIC cervical cancer.
    Front Oncol. 2024;14:1405778.
    Abstract

  1558. HU M, Yang W, Yan R, Chi J, et al
    Co-evolution of vaginal microbiome and cervical cancer.
    J Transl Med. 2024;22:559.
    Abstract

  1559. LIANG J, Wang D, Zhao Y, Wu Y, et al
    Novel Hsp90-Targeting PROTACs: Enhanced synergy with cisplatin in combination therapy of cervical cancer.
    Eur J Med Chem. 2024;275:116572.
    Abstract

  1560. WANG C, Liu L, Li X, Lei J, et al
    PD-1 inhibitor plus concurrent chemoradiotherapy for high-risk locally advanced cervical cancer.
    Future Oncol. 2024 Jun 3:1-12. doi: 10.1080/14796694.2024.2342241.
    Abstract

  1561. JIN S, Chen J
    Exploring the prognostic significance of immunogenic cell death-related genes as risk biomarkers in cervical cancer.
    Immun Inflamm Dis. 2024;12:e1260.
    Abstract

  1562. MATOS AGM, Silva GEB, Barbosa EDS, de Andrade MS, et al
    What is the role of circRNAs in the pathogenesis of cervical cancer? A systematic literature review.
    Front Genet. 2024;15:1287869.
    Abstract

  1563. NAYARISSERI A, Abdalla M, Joshi I, Yadav M, et al
    Potential inhibitors of VEGFR1, VEGFR2, and VEGFR3 developed through Deep Learning for the treatment of Cervical Cancer.
    Sci Rep. 2024;14:13251.
    Abstract

  1564. SHEN T, Sun S, Li W, Wang X, et al
    Association between body mass index and lymph node metastasis among women with cervical cancer: a systematic review and network meta-analysis.
    Arch Gynecol Obstet. 2024 Jun 10. doi: 10.1007/s00404-024-07528.
    Abstract

  1565. SHANAUBE K, Ndubani R, Kelly H, Webb E, et al
    Zipime-Weka-Schista study protocol: a longitudinal cohort study and economic evaluation of an integrated home-based approach for genital multipathogen screening in women, including female genital schistosomiasis, human papillomavirus, Trichomonas and
    BMJ Open. 2024;14:e080395.
    Abstract

  1566. BAEK MH, Chen L, Tekin C, Cristescu R, et al
    Prevalence and prognostic value of PD-L1 expression and tumor mutational burden in persistent, recurrent, or metastatic cervical cancer.
    J Gynecol Oncol. 2024 May 23. doi: 10.3802/jgo.2024.
    Abstract

  1567. PRUSTY S, Patnaik S, Dash SK, Prusty SGP, et al
    Predicting cervical cancer risk probabilities using advanced H20 AutoML and local interpretable model-agnostic explanation techniques.
    PeerJ Comput Sci. 2024;10:e1916.
    Abstract

  1568. SOLTANTOYEH T, Akbari B, Shahosseini Z, Mirzaei HR, et al
    Simultaneous targeting of Tim3 and A2a receptors modulates MSLN-CAR T cell antitumor function in a human cervical tumor xenograft model.
    Front Immunol. 2024;15:1362904.
    Abstract

  1569. DEMAS T, Biku T, Getinet T, Fantahun B, et al
    Women's willingness for cervical cancer screening and associated factors among women attending health services in Addis Ababa, Ethiopia.
    Ther Adv Reprod Health. 2024;18:26334941241253181.
    Abstract

  1570. VERMA I, Bajpai R, Arjaria V, Garg L, et al
    A Study to Assess the Impact of Education on the Knowledge and Attitude Toward Cervical Cancer and HPV (Human Papillomavirus) Vaccination Among Female Healthcare Students.
    Cureus. 2024;16:e59856.
    Abstract

  1571. MOLINA MA, Steenbergen RDM, Pumpe A, Kenyon AN, et al
    HPV integration and cervical cancer: a failed evolutionary viral trait.
    Trends Mol Med. 2024 Jun 8:S1471-4914(24)00131.
    Abstract

  1572. IAVAZZO C, Trihia HJ, Gkegkes ID
    Perineural invasion: An independent risk factor for cervical cancer prognosis and a possible pathway for a future targeted treatment?
    Eur J Surg Oncol. 2024;50:108449.
    Abstract

  1573. GUI Z, Ye Y, Li Y, Ren Z, et al
    Construction of a novel cancer-associated fibroblast-related signature to predict clinical outcome and immune response in cervical cancer.
    Transl Oncol. 2024;46:102001.
    Abstract

  1574. MA Q, Yu W, Li Z, Zhang X, et al
    Circ_0081723 enhances cervical cancer progression and modulates CREBRF via sponging miR-545-3p.
    Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun 8. doi: 10.1007/s00210-024-03175.
    Abstract

  1575. HAO C, Han J, Xiang K, Wang Y, et al
    CircVIRMA enhances cell malignant behavior by governing the miR-452-5p/CREBRF pathway in cervical cancer.
    Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun 8. doi: 10.1007/s00210-024-03159.
    Abstract

  1576. LU Y, Wu H, Fu K, Shen Y, et al
    PAX1 methylation as a robust predictor: developing and validating a nomogram for assessing endocervical curettage (ECC) necessity in human papillomavirus16/18-positive women undergoing colposcopy.
    Clin Epigenetics. 2024;16:77.
    Abstract

  1577. DI X, Gao Z, Yu H, Liu X, et al
    (125)I seed brachytherapy for non-central pelvic recurrence of cervical cancer after external beam radiotherapy.
    Radiat Oncol. 2024;19:70.
    Abstract

  1578. ZHANG L, Zheng Y, Lei L, Zhang X, et al
    Development of a machine learning-based model for predicting positive margins in high-grade squamous intraepithelial lesion (HSIL) treatment by Cold Knife Conization(CKC): a single-center retrospective study.
    BMC Womens Health. 2024;24:332.
    Abstract

  1579. RAHIMI-MOGHADDAM A, Ghorbanmehr N, Gharbi S, Nili F, et al
    Interplay of miR-542, miR-126, miR-143 and miR-26b with PI3K-Akt is a Diagnostic Signal and Putative Regulatory Target in HPV-Positive Cervical Cancer.
    Biochem Genet. 2024 Jun 7. doi: 10.1007/s10528-024-10837.
    Abstract

  1580. TSEGAYE AT, Lin J, Cole AM, Szpiro A, et al
    Adherence and Correlates of Cervical Cancer Screening Among East African Immigrant Women in Washington State.
    J Racial Ethn Health Disparities. 2024 Jun 7. doi: 10.1007/s40615-024-02038.
    Abstract

  1581. GHOBADI M, Salehi S, Ardestani MTS, Mousavi-Khattat M, et al
    Amine-functionalized mesoporous silica nanoparticles decorated by silver nanoparticles for delivery of doxorubicin in breast and cervical cancer cells.
    Eur J Pharm Biopharm. 2024 Jun 5:114349. doi: 10.1016/j.ejpb.2024.114349.
    Abstract

  1582. GAO F, Wang Y, Li H, Yin J, et al
    Study on serum miR-182 as a marker for diagnosis and prognosis of cervical cancer.
    Technol Health Care. 2024 May 16. doi: 10.3233/THC-231681.
    Abstract

  1583. AOUADI S, Torfeh T, Bouhali O, Yoganathan SA, et al
    Prediction of cervix cancer stage and grade from diffusion weighted imaging using EfficientNet.
    Biomed Phys Eng Express. 2024;10.
    Abstract

  1584. PACKET B, Goyens J, Weynand B, Poppe W, et al
    Association between p16/Ki-67 dual stain cytology results prior to and 6 months after LLETZ treatment for CIN and the follow-up regimen three years after treatment: a retrospective cohort study.
    Arch Gynecol Obstet. 2024;310:493-499.
    Abstract

  1585. LI J, Hu P, Gao H, Shen N, et al
    Classification of cervical lesions based on multimodal features fusion.
    Comput Biol Med. 2024;177:108589.
    Abstract

  1586. JI L, Zhang X, Zhou Y, Guo W, et al
    Clinical vaginal-microecology testing using double-fluorescence staining in patients with high-risk human papillomavirus infection.
    Diagn Microbiol Infect Dis. 2024;109:116342.
    Abstract

  1587. CAI H, Che Y, Chen Y, Sun H, et al
    Long-term follow-up of photodynamic therapy of cervical intraepithelial neoplasia grade 2 (CIN2).
    Photodiagnosis Photodyn Ther. 2024;47:104219.
    Abstract

  1588. PAN B, Yan S, Yuan L, Xiang H, et al
    Multiomics sequencing and immune microenvironment characteristics define three subtypes of small cell neuroendocrine carcinoma of the cervix.
    J Pathol. 2024;263:372-385.
    Abstract

  1589. CAI H, Yang C, Ding Z, Lou Y, et al
    Effect of 5-aminolevulinic acid photodynamic therapy versus loop electrosurgical excision procedure for cervical intraepithelial neoplasia grade 2 treatment.
    Photodiagnosis Photodyn Ther. 2024;47:104107.
    Abstract

  1590. CHAVOSHPOUR-MAMAGHANI S, Shoja Z, Jalilvand S
    The Prevalence of Epstein-Barr Virus in Normal, Premalignant, and Malignant Uterine Cervical Samples in Iran.
    Intervirology. 2024;67:64-71.
    Abstract

  1591. DONG X, Zheng H, Luo Y, Guo T, et al
    A Rare Case of Typical and Unforgettable Cervical Malignant Melanoma.
    J Minim Invasive Gynecol. 2024;31:472-473.
    Abstract

  1592. SHUKLA S, Deo BS, Vishwakarma C, Mishra S, et al
    A smartphone-based standalone fluorescence spectroscopy tool for cervical precancer diagnosis in clinical conditions.
    J Biophotonics. 2024;17:e202300468.
    Abstract

  1593. MANCILLA V, Jimenez NR, Bishop NS, Flores M, et al
    The Vaginal Microbiota, Human Papillomavirus Infection, and Cervical Carcinogenesis: A Systematic Review in the Latina Population.
    J Epidemiol Glob Health. 2024;14:480-497.
    Abstract

  1594. DIETL AK, Beckmann MW, Stuebs FA, Gass P, et al
    PD-L1 Expression and Silva Invasion Pattern in Villoglandular Adenocarcinoma of the Uterine Cervix.
    Int J Gynecol Pathol. 2024;43:397-404.
    Abstract

  1595. PRUSKI D, Millert-Kalinska S, Klemenska P, Jach R, et al
    Clinical use of the Onclarity test with extended HPV genotyping and phenotyping in patients with suspected squamous intraepithelial lesions.
    Ginekol Pol. 2024;95:328-334.
    Abstract

  1596. ONEGA T, Garcia M, Beaber EF, Haas JS, et al
    Screening Beyond the Evidence: Patterns of Age and Comorbidity for Breast, Cervical, and Colorectal Cancer Screening.
    J Gen Intern Med. 2024;39:1324-1331.
    Abstract

  1597. SAND FL, Thomsen LT, Oernskov D, Munk C, et al
    Cervical human papillomavirus prevalence according to socioeconomic and demographic characteristics in a large Danish screening population.
    Scand J Public Health. 2024;52:502-510.
    Abstract

  1598. ABILA DB, Wasukira SB, Ainembabazi P, Kiyingi EN, et al
    Coverage and Socioeconomic Inequalities in Cervical Cancer Screening in Low- and Middle-Income Countries Between 2010 and 2019.
    JCO Glob Oncol. 2024;10:e2300385.
    Abstract


  1599. Tisotumab vedotin (Tivdak) for cervical cancer.
    Med Lett Drugs Ther. 2024;66:e109-e110.
    Abstract

  1600. ZHAO X, Zhang R, Song S, Wang Y, et al
    Analysis of the clinical characteristics and surgical methods of high-grade squamous intraepithelial lesions of the cervix in postmenopausal women: A retrospective case study.
    Medicine (Baltimore). 2024;103:e38657.
    Abstract

  1601. ANG JX, Lee WY, Tay SK
    Clinical efficacy of primary human papillomavirus (HPV) screening with partial genotyping for HPV-16 and HPV-18 subtypes in women from 25 years old.
    Ann Acad Med Singap. 2023;52:259-267.
    Abstract

  1602. MOLANO M, Machalek DA, Tan G, Garland S, et al
    Performance of CADM1, MAL and miR124-2 methylation as triage markers for early detection of cervical cancer in self-collected and clinician-collected samples: an exploratory observational study in Papua New Guinea.
    BMJ Open. 2024;14:e081282.
    Abstract

  1603. SUN YH, Wang CM, Shen HP, Lee CY, et al
    Impact of CD44 genetic variants on clinicopathological characteristics of uterine cervical cancer patients.
    Int J Med Sci. 2024;21:1428-1437.
    Abstract

  1604. GUO Y, Pan H, Chen S, Tian M, et al
    Effectiveness of acupuncture on urinary retention after radical hysterectomy for cervical cancer in China: a systematic review and meta-analysis.
    Front Med (Lausanne). 2024;11:1375963.
    Abstract

  1605. DING L, Zheng Z, Cao Y, Wang Z, et al
    Case report: Cervical brachytherapy technique for locally advanced cervical cancer in a patient with complete bicorporeal uterus.
    Front Oncol. 2024;14:1361562.
    Abstract

  1606. ZHAI C, Cui Y, Guo L, Chen C, et al
    Progress in the study of antibody-drug conjugates for the treatment of cervical cancer.
    Front Oncol. 2024;14:1395784.
    Abstract

  1607. WANG L, Wang F, Qin H, Hou L, et al
    Intermittent Catheterization Continuity Care on Bladder Function Recovery and Quality of Life in Patients After Radical Hysterectomy for Cervical Cancer: A Quasi-Experimental Study.
    Int J Gen Med. 2024;17:2781-2789.
    Abstract

  1608. ZHANG Y, Li H, You Q, Chen Y, et al
    Decoding Fujian's cervical HPV landscape: unmasking dominance of non-16/18 HR-HPV and tailoring prevention strategies at a large scale.
    Front Public Health. 2024;12:1357073.
    Abstract

  1609. CHATTERJEE PB, Hingway SR, Hiwale KM
    Evolution of Pathological Techniques for the Screening of Cervical Cancer: A Comprehensive Review.
    Cureus. 2024;16:e60769.
    Abstract

  1610. WU Z, Zhuang X, Liang M, Sheng L, et al
    Identification of an inflammatory response-related gene prognostic signature and immune microenvironment for cervical cancer.
    Front Mol Biosci. 2024;11:1394902.
    Abstract

  1611. KPOKIRI EE, Wapmuk AE, Obiezu-Umeh C, Nwaozuru U, et al
    A designathon to co-create HPV screening and vaccination approaches for mothers and daughters in Nigeria: findings from a community-led participatory event.
    BMC Infect Dis. 2024;24:606.
    Abstract

  1612. LIU J, Yang K, Lin X, Xu J, et al
    IL-32/NFkappaB/miR-205 loop sustains the high expression of IL-32 and enhances the motility of cervical cancer cells.
    Hum Cell. 2024 Jun 20. doi: 10.1007/s13577-024-01094.
    Abstract

  1613. ZHANG B, Wang W, Zhao W, Jiang X, et al
    An improved approach for automated cervical cell segmentation with PointRend.
    Sci Rep. 2024;14:14210.
    Abstract

  1614. WANG Y, Zhang F, Hu K, Yu L, et al
    CT-guided hydrogel injection for brachytherapy in cervical cancer: A case report.
    Med Dosim. 2024 Jun 19:S0958-3947(24)00024-4. doi: 10.1016/j.meddos.2024.
    Abstract

  1615. MORSE IM, Amiry J
    A 'smear campaign' against patient-excluded policy changes: a reflection on the language used in cervical screening programmes.
    Br J Gen Pract. 2024;74.
    Abstract

  1616. CHU WL, Rajasekar T, Ahamed M, Ibraheim M, et al
    Conundrum in primary care: should all cervical polyps be removed?
    Br J Gen Pract. 2024;74.
    Abstract

  1617. BOGANI G, Scambia G, Fagotti A, Fanfani F, et al
    Sentinel node mapping, sentinel node mapping plus back-up lymphadenectomy, and lymphadenectomy in Early-sTage cERvical caNcer scheduled for fertilItY-sparing approach: The ETERNITY project.
    Eur J Surg Oncol. 2024;50:108467.
    Abstract

  1618. WARDEN CD, Cholli P, Qin H, Guo C, et al
    Correction: HPV genotyping by L1 amplicon sequencing of archived invasive cervical cancer samples: a pilot study.
    Infect Agent Cancer. 2024;19:28.
    Abstract

  1619. FENG L, Hao Q, Wang S, Zhao Y, et al
    Effects of Electrical Stimulation, Pelvic Floor Muscle Exercise, and Biofeedback Program on Improving Pelvic Floor Function and Quality of Life in Postoperative Patients with Early-Stage Cervical Cancer.
    Tohoku J Exp Med. 2024 Jun 20. doi: 10.1620/tjem.2024.
    Abstract

  1620. OLIVEIRA NPD, Cancela MC, Martins LFL, Castro JL, et al
    [Social inequalities in the diagnosis of cervical cancer in Brazil: a hospital-based study].
    Cien Saude Colet. 2024;29:e03872023.
    Abstract

  1621. ARSLAN S, Vehvilainen-Julkunen K, Parviainen A
    How does robotic surgery affect gynecology patient care?
    J Robot Surg. 2024;18:256.
    Abstract


  1622. Retraction: MicroRNA-612 inhibits cervical cancer progression by targeting NOB1.
    J Cell Mol Med. 2024;28:e18498.
    Abstract

  1623. IQBAL Z, Albuquerque K, Chan KL
    Magnetic Resonance Spectroscopy for Cervical Cancer: Review and Potential Prognostic Applications.
    Cancers (Basel). 2024;16:2141.
    Abstract

  1624. LE GOFF J, Le Duc-Banaszuk AS, Lefeuvre C, Pivert A, et al
    Acceptance of Self-Sampling by Women Not Regularly Participating in Cervical Cancer Screening in Areas with Low Medical Density: A Qualitative Study within the French CapU4 Trial.
    Cancers (Basel). 2024;16:2066.
    Abstract

  1625. CHEN J, Kitzing YX, Lo G
    Systematic Review-Role of MRI in Cervical Cancer Staging.
    Cancers (Basel). 2024;16:1983.
    Abstract

  1626. SALARZAEI M, van de Laar RLO, Ewing-Graham PC, Najjary S, et al
    Unraveling Differences in Molecular Mechanisms and Immunological Contrasts between Squamous Cell Carcinoma and Adenocarcinoma of the Cervix.
    Int J Mol Sci. 2024;25:6205.
    Abstract

  1627. MILLAN-CATALAN O, Perez-Yepez EA, Martinez-Gutierrez AD, Rodriguez-Morales M, et al
    A microRNA Profile Regulates Inflammation-Related Signaling Pathways in Young Women with Locally Advanced Cervical Cancer.
    Cells. 2024;13:896.
    Abstract

  1628. QIU B, Jiang N, Jiang J, Mao X, et al
    The prevalence and genotype distribution of high-risk human papillomaviruses among women in Xianning, China.
    Virol J. 2024;21:140.
    Abstract

  1629. HONG Y, Sun X, Lu L
    Loureirin B inhibits Cervical Cancer Development by Blocking PI3K/AKT Signaling Pathway: Network Pharmacology Analysis and Experimental Validation.
    Appl Biochem Biotechnol. 2024 Jun 18. doi: 10.1007/s12010-024-04975.
    Abstract

  1630. ZIYAD YA, Jemal E, Dheresa M, Usso AA, et al
    Determinants of Cervical Cancer Screening among Female Health Professionals in Harar Town, Eastern Ethiopia: A Cross-Sectional Study.
    Infect Dis Obstet Gynecol. 2024;2024:1430978.
    Abstract

  1631. WANG Y, Xu Y, Song J, Liu X, et al
    Tumor Cell-Targeting and Tumor Microenvironment-Responsive Nanoplatforms for the Multimodal Imaging-Guided Photodynamic/Photothermal/Chemodynamic Treatment of Cervical Cancer.
    Int J Nanomedicine. 2024;19:5837-5858.
    Abstract

  1632. GUIGO M, Dauda MS, Lequesne J, Blache A, et al
    Simultaneous integrated boost on pathologic lymph nodes safely improves clinical outcomes compared to sequential boost in locally advanced cervical cancer: a multicenter retrospective study.
    Front Oncol. 2024;14:1353813.
    Abstract

  1633. WU M, Morganti AG, Du H
    Editorial: Advances in imaging of cervical cancer.
    Front Oncol. 2024;14:1421476.
    Abstract

  1634. WANG Y, Wang T, Yan D, Zhao H, et al
    Vaginal microbial profile of cervical cancer patients receiving chemoradiotherapy: the potential involvement of Lactobacillus iners in recurrence.
    J Transl Med. 2024;22:575.
    Abstract

  1635. YAMADA T, Kawamura M, Oie Y, Kozai Y, et al
    The current state and future perspectives of radiotherapy for cervical cancer.
    J Obstet Gynaecol Res. 2024 Jun 17. doi: 10.1111/jog.15998.
    Abstract

  1636. MU Y, Wang H, Xu L, Shi L, et al
    Analysis of the therapeutic effect of synchronous integrated intensity modulated radiotherapy combined with chemotherapy in stage IIIc of cervical cancer.
    Front Oncol. 2024;14:1283991.
    Abstract

  1637. TEMPFER C, Fehm T, Vordermark D, Marnitz-Schulze S, et al
    Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical Cancer.
    Geburtshilfe Frauenheilkd. 2024;84:523-528.
    Abstract

  1638. HOUDOU L, Meynard C, Guillerm S, Mimoun C, et al
    Monocentric Retrospective Study: Efficacy, Feasibility, and Prognostic Factors of Single-Insertion High-Dose-Rate Brachytherapy With 4 Sessions for Locally Advanced Cervical Cancer.
    Adv Radiat Oncol. 2024;9:101512.
    Abstract

  1639. BORATYN VM, Pocobelli G, Atlas SJ, Clark CR, et al
    Clinician-perceived barriers to cervical cancer screening before and during the COVID-19 pandemic at three US healthcare systems.
    Prev Med Rep. 2024;43:102783.
    Abstract

  1640. XIANG S, Wang M, Li Q, Yang Z, et al
    Unveiling the role of HACE1 in cervical cancer: implications for human papillomavirus infection and prognosis.
    Transl Cancer Res. 2024;13:2175-2186.
    Abstract

  1641. YANG Y, Zhu J, Feng R, Han M, et al
    Altered vaginal cervical microbiota diversity contributes to HPV-induced cervical cancer via inflammation regulation.
    PeerJ. 2024;12:e17415.
    Abstract

  1642. VAUGHAN L, Gary D, Shah M, Lewellen L, et al
    Variables that impact HPV test accuracy during vaginal self collection workflow for cervical cancer screening.
    Gynecol Oncol Rep. 2024;54:101421.
    Abstract

  1643. ERGOZ AKSOY SZ, Bilgic D
    Psychometric properties of the Turkish version of the Cervical Cancer Knowledge Scale.
    J Obstet Gynaecol Res. 2024 Jun 17. doi: 10.1111/jog.16001.
    Abstract

  1644. EKSTEEN C, Riedemann J, Rass AM, Plessis MD, et al
    A Review: Genetic Mutations as a Key to Unlocking Drug Resistance in Cervical Cancer.
    Cancer Control. 2024;31:10732748241261539.
    Abstract

  1645. HOW JA, Jazaeri AA
    Immunotherapy in locally advanced cervical cancer: Integrating KEYNOTE-A18 into management strategies.
    Med. 2024;5:487-489.
    Abstract

  1646. WHITMER A, Fuzzell LN, Lowery S, Arevalo M, et al
    "A great step in treating cervical cancer": Patient and provider perceptions about cervical cancer therapeutic vaccines.
    Patient Educ Couns. 2024;127:108338.
    Abstract

  1647. LI X, Chen S, Hirose N, Shimpuku Y, et al
    Association between multiple dimensions of access to care and cervical cancer screening among Kenyan women: a cross-sectional analysis of the Demographic Health Survey.
    BMC Health Serv Res. 2024;24:731.
    Abstract

  1648. SONG J, Ni YH, Fang J, Qu SX, et al
    The levels of women's awareness, experience, acceptability and preference for Vaginal Human Papillomavirus (HPV) self-sampling in three provinces of China: a cross-sectional study.
    BMC Womens Health. 2024;24:343.
    Abstract

  1649. ZHETPISBAYEVA I, Rommel A, Kassymbekova F, Semenova Y, et al
    Cervical cancer trend in the Republic of Kazakhstan and attitudes towards cervical cancer screening in urban and rural areas.
    Sci Rep. 2024;14:13731.
    Abstract

  1650. LAN XB, Huang W
    Correlation analysis of high-risk pathological factors after surgery for early-stage cervical cancer-A real-world study.
    Asian J Surg. 2024 Jun 14:S1015-9584(24)01175.
    Abstract

  1651. CHATTOPADHYAY SK, Pillai A, Reynolds J, Jacob V, et al
    Breast and Cervical Cancer Screenings: A Systematic Economic Review of Patient Navigation Services.
    Am J Prev Med. 2024 Jun 12:S0749-3797(24)00196.
    Abstract

  1652. BENEVOLO M, Ronco G, Mancuso P, Carozzi F, et al
    Comparison of HPV-positive triage strategies combining extended genotyping with cytology or p16/ki67 dual staining in the Italian NTCC2 study.
    EBioMedicine. 2024;104:105149.
    Abstract

  1653. SOUAYEH N, Manel BG, Rouis H, Bettaieb H, et al
    Non-surgical Fertility Sparing Management of Cervical Embryonal Rhabdomyosarcoma.
    J Obstet Gynaecol Can. 2024;46:102462.
    Abstract

  1654. VIEIRA R, Montezuma D, Barbosa C, Macedo Pinto I, et al
    Cervical cytology and HPV distribution in Cape Verde: A snapshot of a country taken during its first HPV nation-wide vaccination campaign.
    Tumour Virus Res. 2024;17:200280.
    Abstract

  1655. AKDAM A, Van Mil L, Tzur Y, Laskov I, et al
    Human Papilloma Virus Typing as a Triage Tool for Women with Postcoital Bleeding: A Retrospective Cohort Study.
    J Womens Health (Larchmt). 2024;33:734-740.
    Abstract

  1656. WONG RW, Talia KL, McCluggage WG
    Gastric-type glandular lesions of the female genital tract excluding the cervix: emerging pathological entities.
    Histopathology. 2024;85:20-39.
    Abstract

  1657. AO L, Shi J, Gan J, Yu W, et al
    Effects of dexmedetomidine and ketorolac applied for patient?controlled analgesia on the balance of Th1/Th2 and level of VEGF in patients undergoing laparoscopic surgery for cervical cancer: A randomized controlled trial.
    Oncol Lett. 2024;28:379.
    Abstract

  1658. SSEDYABANE F, Obuku EA, Namisango E, Ngonzi J, et al
    The diagnostic accuracy of serum and plasma microRNAs in detection of cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol Rep. 2024;54:101424.
    Abstract

  1659. CAO D, Dong Q
    Predictive value of prognostic nutritional index for outcomes of cervical cancer: A systematic review and meta?analysis.
    Exp Ther Med. 2024;28:316.
    Abstract

  1660. ZHOU Y, Wang X, Li Y, Zhang W, et al
    When synchronous mucinous metaplasia and neoplasia of the female genital tract and peutz-jeghers syndrome meet: a case report and literature reviews.
    BMC Womens Health. 2024;24:375.
    Abstract

  1661. SACHDEVA M, Datchoua AM, Yakam VF, Kenfack B, et al
    Acceptability of artificial intelligence for cervical cancer screening in Dschang, Cameroon: a qualitative study on patient perspectives.
    Reprod Health. 2024;21:92.
    Abstract

  1662. ZHAO Z, Yan P, Zhang X, Yu X, et al
    Causal role of immune cells on cervical cancer onset revealed by two-sample Mendelian randomization study.
    Sci Rep. 2024;14:14890.
    Abstract

  1663. CHO YA, Park CK, Kim HS
    Ovarian Metastasis from Human Papillomavirus-associated Usual-type Endocervical Adenocarcinoma: Clinicopathological Characteristics for Distinguishing from Primary Ovarian Mucinous or Endometrioid Tumor.
    In Vivo. 2024;38:1973-1983.
    Abstract

  1664. PENG C, Wang Y, Guo Y, Li J, et al
    A literature review on signaling pathways of cervical cancer cell death-apoptosis induced by Traditional Chinese Medicine.
    J Ethnopharmacol. 2024 Jun 25:118491. doi: 10.1016/j.jep.2024.118491.
    Abstract

  1665. SHINKAFI-BAGUDU Z
    Renewed Commitments to Eliminate Cervical Cancer: What This Means for Low- and Middle-Income Countries.
    JCO Glob Oncol. 2024;10:e2400147.
    Abstract

  1666. AGGARWAL A, Gupta N, Barua M, Jani KK, et al
    Gay and Bisexual Men too should not be Left Out/Deprived of Human Papilloma Virus Vaccination in "Cervical Cancer Elimination Programme" in Countries with a High Prevalence of HIV.
    Indian J Public Health. 2023;67:686.
    Abstract

  1667. KAUSHAL R, Patel M, Bhardwaj P, Gupta M, et al
    Comparison of Knowledge, Attitude, and Practices of Nursing Staff Regarding Cervical Cancer Screening at Various Levels of Health Care Facilities in Western India.
    Indian J Community Med. 2024;49:529-531.
    Abstract

  1668. ZHAO Q, Yang S, Hao S, Chen Z, et al
    Identification of transcriptionally-active human papillomavirus integrants through nanopore sequencing reveals viable targets for gene therapy against cervical cancer.
    J Med Virol. 2024;96:e29769.
    Abstract

  1669. MOSHI JM, Sohaili A, Moafa HN, Hakami AMS, et al
    Short Communication: Understanding the Barriers to Cervical Cancer Prevention and HPV Vaccination in Saudi Arabia.
    Viruses. 2024;16:974.
    Abstract

  1670. GALATI L, Di Bonito P, Marinaro M, Chiantore MV, et al
    HPV16 Phylogenetic Variants in Anogenital and Head and Neck Cancers: State of the Art and Perspectives.
    Viruses. 2024;16:904.
    Abstract

  1671. CASTRILLO-DIEZ JL, Rivera-Santiago C, Avila-Flores SM, Barrera-Barrera SA, et al
    Findings and Challenges in Replacing Traditional Uterine Cervical Cancer Diagnosis with Molecular Tools in Private Gynecological Practice in Mexico.
    Viruses. 2024;16:887.
    Abstract

  1672. PERGIALIOTIS V, Rodolakis I, Rodolakis A, Thomakos N, et al
    Controversies and Advances in the Personalized Surgical Treatment of Cervical Cancer.
    J Pers Med. 2024;14:606.
    Abstract

  1673. DICU-ANDREESCU IG, Marincas MA, Simionescu AA, Dicu-Andreescu I, et al
    Abdominal Parietal Metastasis from Cervical Cancer: A Review of One of the Most Uncommon Sites of Recurrence Including a Report of a New Case.
    Life (Basel). 2024;14:667.
    Abstract

  1674. NIKOLIC N, Basica B, Strbac M, Terzic L, et al
    Prevalence of Carcinogenic Genotypes of HPV-Infected Women in a Ten-Year Period (2014-2023) in Vojvodina, Serbia.
    Medicina (Kaunas). 2024;60:922.
    Abstract

  1675. BALAN L, Secosan C, Sorop VB, Pirtea M, et al
    Impact of SARS-CoV-2 Pandemic on the Diagnosis of Cervical Cancer and Precursor Lesions-A Single-Center Retrospective Study.
    Medicina (Kaunas). 2024;60:909.
    Abstract

  1676. DICU-ANDREESCU IG, Marincas MA, Simionescu AA, Dicu-Andreescu I, et al
    The Role of Lymph Node Downstaging Following Neoadjuvant Treatment in a Group of Patients with Advanced Stage Cervical Cancer.
    Medicina (Kaunas). 2024;60:871.
    Abstract

  1677. KIRSCH-MANGU AT, Pop DC, Tipcu A, Andries AI, et al
    CT Angiography-Guided Needle Insertion for Interstitial Brachytherapy in Locally Advanced Cervical Cancer.
    Diagnostics (Basel). 2024;14:1267.
    Abstract

  1678. MIAZGA W, Tatara T, Wnuk K, Gujski M, et al
    The Impact of Urine-Sample HPV Testing on the Effectiveness of Screening for Cervical Cancer: An Umbrella Review.
    Cancers (Basel). 2024;16:2244.
    Abstract

  1679. CATALAN-CASTORENA O, Garibay-Cerdenares OL, Illades-Aguiar B, Castillo-Sanchez R, et al
    Bioinformatics Analysis of Human Papillomavirus 16 Integration in Cervical Cancer: Changes in MAGI-1 Expression in Premalignant Lesions and Invasive Carcinoma.
    Cancers (Basel). 2024;16:2225.
    Abstract

  1680. CARDOSO-CARNEIRO D, Pinheiro J, Fontao P, Nogueira R, et al
    Unveiling the RKIP and EGFR Inverse Relationship in Solid Tumors: A Case Study in Cervical Cancer.
    Cancers (Basel). 2024;16:2182.
    Abstract

  1681. ANDO Y, Cho J, Park NJ, Ko S, et al
    Toward Interpretable Cell Image Representation and Abnormality Scoring for Cervical Cancer Screening Using Pap Smears.
    Bioengineering (Basel). 2024;11:567.
    Abstract

  1682. VELIMIROVICI MD, Feier CVI, Vonica RC, Faur AM, et al
    Efficacy and Safety of Atezolizumab as a PD-L1 Inhibitor in the Treatment of Cervical Cancer: A Systematic Review.
    Biomedicines. 2024;12:1291.
    Abstract

  1683. AHMADI M, Abdollahi R, Otogara M, Taherkhani A, et al
    Exploring molecular targets: herbal isolates in cervical cancer therapy.
    Genomics Inform. 2024;22:9.
    Abstract

  1684. DILLNER J, Muhr LSA, Kleppe SN, Wang J, et al
    The Swedish Cervical Screening Cohort.
    Sci Data. 2024;11:697.
    Abstract

  1685. CHOI EY, Han EJ, Jeon SJ, Lee SW, et al
    Kaempferol Inhibits Cervical Cancer Cells by Inducing Apoptosis and Autophagy via Inactivation of the PI3K/AKT/mTOR Signaling Pathway.
    Anticancer Res. 2024;44:2961-2972.
    Abstract

  1686. MAFUNE S, Someya M, Hasegawa T, Tsuchiya T, et al
    Analysis of Treatment Response With Proteins Related to Tumor Immunity in Postoperative Irradiated Cervical Cancer Patients.
    Anticancer Res. 2024;44:3077-3086.
    Abstract

  1687. ZHANG Y, Niu X, Wang Y, Bao S, et al
    SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism via the MEK/ERK/C-Myc Axis.
    Anticancer Res. 2024;44:2861-2870.
    Abstract

  1688. LOGEL M, El-Zein M, Franco EL, Gonzalez E, et al
    Species-level characterization of the cervicovaginal microbiota and its role in human papillomavirus-associated cervical carcinogenesis.
    J Med Virol. 2024;96:e29764.
    Abstract

  1689. FOBIAN SF, Mei X, Crezee J, Snoek BC, et al
    Increased human papillomavirus viral load is correlated to higher severity of cervical disease and poorer clinical outcome: A systematic review.
    J Med Virol. 2024;96:e29741.
    Abstract

  1690. ZHOU D, Chen D, Wu J, Feng T, et al
    Dicerandrol C Suppresses Proliferation and Induces Apoptosis of HepG2 and Hela Cancer Cells by Inhibiting Wnt/beta-Catenin Signaling Pathway.
    Mar Drugs. 2024;22:278.
    Abstract

  1691. MATHIS A, Smith UD, Crowther V, Lee T, et al
    An Epidemiological Study of Cervical Cancer Trends among Women with Human Immunodeficiency Virus.
    Healthcare (Basel). 2024;12:1178.
    Abstract

  1692. ARIZMENDI-IZAZAGA A, Navarro-Tito N, Jimenez-Wences H, Evaristo-Priego A, et al
    Bioinformatics Analysis Reveals E6 and E7 of HPV 16 Regulate Metabolic Reprogramming in Cervical Cancer, Head and Neck Cancer, and Colorectal Cancer through the PHD2-VHL-CUL2-ELOC-HIF-1alpha Axis.
    Curr Issues Mol Biol. 2024;46:6199-6222.
    Abstract

  1693. ELIT L, Manjuh F, Kila L, Suika B, et al
    Mother-Child Approach to Cervical Cancer Prevention in a Low Resource Setting: The Cameroon Baptist Convention Health Services Story.
    Curr Oncol. 2024;31:3227-3238.
    Abstract

  1694. YU JH, Yuan HB, Yan ZY, Zhang X, et al
    The complement regulatory protein CD46 serves as a novel biomarker for cervical cancer diagnosis and prognosis evaluation.
    Front Immunol. 2024;15:1421778.
    Abstract

  1695. MUHAMMAD ZB, Ezenkwa US, Imoudu IA, Katagum DA, et al
    Cervical cancer awareness, perception, and attitude among tertiary health institution students in northeastern Nigeria.
    Front Oncol. 2024;14:1415627.
    Abstract

  1696. DEGAREGE A, Madhivanan P
    Methodological Assessment of a Review of Knowledge, Attitude and Practice about Human Papilloma Virus Vaccination in India.
    Asian Pac J Cancer Prev. 2024;25:1857-1859.
    Abstract

  1697. SHANKAR A, Brixey-Watts K, Roy S, Saini D, et al
    Faking Death for Cervical Cancer Awareness: Is It Justified?
    Asian Pac J Cancer Prev. 2024;25:1851-1853.
    Abstract

  1698. BASU P, Mwanahamuntu M, Pinder LF, Muwonge R, et al
    A portable thermal ablation device for cervical cancer prevention in a screen-and-treat setting: a randomized, noninferiority trial.
    Nat Med. 2024 Jun 25. doi: 10.1038/s41591-024-03080.
    Abstract

  1699. LEE J, Kim DJ, Lee HJ
    Assessment of malignant potential for HPV types 16, 52, and 58 in the uterine cervix within a Korean cohort.
    Sci Rep. 2024;14:14619.
    Abstract

  1700. YU C, Wang J, Li Y
    TRIM8 Promotes Proliferation, Invasion, and Migration of Cervical Cancer Cells by Ubiquitinating and Degrading SOCS1.
    Biochem Genet. 2024 Jun 25. doi: 10.1007/s10528-024-10865.
    Abstract

  1701. CHUNG PYJ, Dhillon SK, Cortoos S, Hamerlinck H, et al
    Evaluation of the Allplex HPV assay's adherence to international guidelines for cervical cancer screening in clinician-collected samples.
    Microbiol Spectr. 2024 Jun 25:e0033224. doi: 10.1128/spectrum.00332.
    Abstract

  1702. FONTENOT VE, Francoeur A, Tewari K
    Review of emerging biological therapies for recurrent and advanced metastatic cervical cancer.
    Expert Opin Biol Ther. 2024 Jun 25. doi: 10.1080/14712598.2024.2373320.
    Abstract

  1703. QIN HE, Peng L, Xu YC, Zhang ZX, et al
    GuiErBai: a potent inhibitor, exhibiting broadly antitumor effect against cervical cancer in vitro and in vivo.
    Front Pharmacol. 2024;15:1296588.
    Abstract

  1704. REZA S, Dewan SMR, Islam MS, Shahriar M, et al
    Response of Bangladesh to the World Health Organization call to eliminate cervical cancer as a public health issue: An observational report.
    Health Sci Rep. 2024;7:e2178.
    Abstract

  1705. WANG J, Wang C, Su T
    Risk factors for residual lesions after total hysterectomy in patients with high-grade cervical intraepithelial neoplasia.
    BMC Womens Health. 2024;24:369.
    Abstract

  1706. LIU Y, Fang SS, Zhao RS, Liu B, et al
    Nab-paclitaxel plus platinum versus paclitaxel plus platinum as first-line therapy in patients with metastatic or recurrent cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:321.
    Abstract

  1707. YAZAKI S, Chiba Y, Kojima Y, Yoshida H, et al
    Folate Receptor Alpha Expression and the Tumor Immune Microenvironment in Patients with Cervical Cancer.
    Int J Gynecol Pathol. 2024 Jun 12. doi: 10.1097/PGP.0000000000001051.
    Abstract

  1708. WU Q, Zhang L, Sun Y, Ying J, et al
    Vitamin D-Regulated miR-589-3p in Patients with Cervical Cancer Predicts Patient Prognosis and is Involved in Tumor Progression.
    Nutr Cancer. 2024 Jun 24:1-9. doi: 10.1080/01635581.2024.2365473.
    Abstract

  1709. CHARGARI C, Maury P, Texier M, Genestie C, et al
    Theragnostic Gadolinium-Based Nanoparticles Safely Augment X-ray Radiation Effects in Patients with Cervical Cancer.
    ACS Nano. 2024 Jun 24. doi: 10.1021/acsnano.3c12537.
    Abstract

  1710. ROUHI R, Niyoteka S, Carre A, Achkar S, et al
    Automatic gross tumor volume segmentation with failure detection for safe implementation in locally advanced cervical cancer.
    Phys Imaging Radiat Oncol. 2024;30:100578.
    Abstract

  1711. ANDREW-BASSEY UI, Oke DO, Okunlola MA, Morhason-Bello IO, et al
    Scoping review protocol on the perception and attitude of women on methods for collecting cervicovaginal samples for human papillomavirus testing in sub-Saharan Africa.
    BMJ Open. 2024;14:e085408.
    Abstract

  1712. BERTELSEN VM, Tranberg M, Petersen LK, Booth B, et al
    Improving diagnostic of cervical dysplasia among postmenopausal women aged >/=50 years using local vaginal oestrogen treatment prior to colposcopy: study protocol for a multicentre randomised controlled trial (the IDEAL study).
    BMJ Open. 2024;14:e082833.
    Abstract

  1713. YANG T, Zhao T, Ji Z, Lei R, et al
    The safety and efficacy of volumetric modulated Arc therapy combined with computer tomography-guided adaptive brachytherapy for locally advanced cervical cancer: a single institution experience.
    Radiat Oncol. 2024;19:77.
    Abstract

  1714. ALCI A, Aytekin O, Ersak B, Kilic F, et al
    The role of neoadjuvant chemotherapy before radical surgery in stage IB2/IIA2 squamous cell cervical cancers.
    BMC Womens Health. 2024;24:365.
    Abstract

  1715. LIAO W, Li Y, Liu T, Deng J, et al
    The activation of Piezo1 channel promotes invasion and migration via the release of extracellular ATP in cervical cancer.
    Pathol Res Pract. 2024;260:155426.
    Abstract

  1716. BECERRA-CANALES B, Campos-Sobrino M, Campos-Sobrino M, Martinez-Munante RD, et al
    [Visual inspection with acetic acid and the control of cervical cancer in primary care].
    Medicina (B Aires). 2024;84:526-533.
    Abstract

  1717. MEDINA RUIZ L, Chahla RE, Vega IM, Ortega ES, et al
    [Artificial Intelligence: accuracy for the diagnosis of precancerous lesions of the cervix].
    Medicina (B Aires). 2024;84:459-467.
    Abstract

  1718. AGENOR M, Noh M, Eiduson R, LeBlanc M, et al
    Barriers to and opportunities for advancing racial equity in cervical cancer screening in the United States.
    BMC Womens Health. 2024;24:362.
    Abstract

  1719. TUERXUN G, Li W, Abudurexiti G, Zhuo Q, et al
    EPB41L3 Inhibits the Progression of Cervical Cancer Via the ERK/p38 MAPK Signaling Pathway.
    Mol Biotechnol. 2024 Jun 21. doi: 10.1007/s12033-024-01172.
    Abstract

  1720. LI H, Du Z, Zhu L, Zhang C, et al
    Ultrabright NIR-IIb Fluorescence Quantum Dots for Targeted Imaging-Guided Surgery.
    ACS Appl Mater Interfaces. 2024;16:32045-32057.
    Abstract

  1721. DOUBOVA SV, McClellan SP, Martinez-Vega IP, Urena-Bogarin EL, et al
    HPV Self-Sampling in the Workplace: A Qualitative Study of Benefits, Barriers, and Opportunities for Improvement Perceived by Health Professionals and Managers.
    Arch Med Res. 2024;55:103009.
    Abstract

  1722. MALAGON T, Franco EL, Tejada R, Vaccarella S, et al
    Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination.
    Nat Rev Clin Oncol. 2024;21:522-538.
    Abstract

  1723. MORGAN EL
    mSphere of Influence: Retreading old ground-the beauty in multi-omic data sets.
    mSphere. 2024;9:e0013124.
    Abstract

  1724. BAI X, Wei J, Starr D, Zhang X, et al
    Assessment of Efficacy and Accuracy of Cervical Cytology Screening With Artificial Intelligence Assistive System.
    Mod Pathol. 2024;37:100486.
    Abstract

  1725. CALAGNA G, Granese R, Giallombardo V, Capra G, et al
    Attitudes of mothers of preadolescent girls on HPV vaccine in Italy: do we need a turning point?
    Minerva Obstet Gynecol. 2024;76:222-230.
    Abstract

  1726. OSEI EA, Garti I, Ani-Amponsah M, Frimpong E, et al
    Adjustment and coping in spousal caregivers of cervical cancer patients in Ghana: A qualitative phenomenological study.
    Medicine (Baltimore). 2024;103:e38807.
    Abstract

  1727. WANG Z, Ren C, Yang L, Zhang X, et al
    Retraction of: Silencing of circular RNA_0000326 inhibits cervical cancer cell proliferation, migration and invasion by boosting microRNA-338-3p-dependent down-regulation of CDK4.
    Aging (Albany NY). 2024;16:10668-10669.
    Abstract

  1728. MOORE S, Kulkarni V, Moore A, Landes JR, et al
    Tirbanibulin decreases cell proliferation and downregulates protein expression of oncogenic pathways in human papillomavirus containing HeLa cells.
    Arch Dermatol Res. 2024;316:455.
    Abstract

  1729. VAN DER HOEVEN NMA, van den Brule AJC, van Beekhuizen HJ, de Kok IMCM, et al
    Perspective of obstetric care-providers on being involved in cervical cancer screening during antenatal care in the Netherlands.
    Cancer Med. 2024;13:e7380.
    Abstract

  1730. KUMAR KORE R, Shirbhate E, Singh V, Mishra A, et al
    New Investigational Drug's Targeting Various Molecular Pathways for Treatment of Cervical Cancer: Current Status and Future Prospects.
    Cancer Invest. 2024 Jul 5:1-16. doi: 10.1080/07357907.2024.2373841.
    Abstract

  1731. SOOKAROMDEE P, Wiwanitkit V
    Assessing the Accuracy of Self-Specimen Collection in HPV Testing: Implications for Clinical Laboratory Practice.
    Clin Lab. 2024;70.
    Abstract


  1732. Correction to "Clinical evaluation of primary human papillomavirus (HPV) testing with extended HPV genotyping triage for cervical cancer screening: A pooled analysis of individual patient data from nine population-based cervical cancer screening studi
    Cancer Med. 2024;13:e7451.
    Abstract

  1733. CHENG H, Dong Y, Wang L, Zhao X, et al
    Analysis of human papillomavirus type 16 E4, E5 and L2 gene variations among women with cervical infection in Xinjiang, China.
    BMC Med Genomics. 2024;17:179.
    Abstract

  1734. LIU Y, Medlege HB, Kang Y, Wu L, et al
    Clinical efficacy of a new therapeutic option for lower genital tract lesions: 5-ALA photodynamic therapy.
    Lasers Med Sci. 2024;39:172.
    Abstract

  1735. BHATTACHARJEE R, Dey T, Kumar L, Kar S, et al
    Corrigendum to "Cellular landscaping of cisplatin resistance in cervical cancer" Biomed. Pharmacother. 153(2022) 113345.
    Biomed Pharmacother. 2024 Jul 4:117097. doi: 10.1016/j.biopha.2024.117097.
    Abstract

  1736. JACKSON SS, O'Callaghan S, Ward E, Orkin CM, et al
    Rationale and design of the Self-TI Study protocol: a cross-sectional human papillomavirus self-testing pilot study among transgender adults in England.
    BMJ Open. 2024;14:e086099.
    Abstract

  1737. LIAO W, Liu T, Li Y, Liang H, et al
    The bioinfomatics analysis of the M1 macrophage-related gene CXCL9 signature in cervical cancer.
    J Obstet Gynaecol. 2024;44:2373951.
    Abstract

  1738. WONG CL, So WKW, Chan DNS
    Community health worker-led multimedia intervention to increase cervical cancer screening uptake among South Asians: a randomised controlled trial (abridged secondary publication).
    Hong Kong Med J. 2024;30 Suppl 3:39-42.
    Abstract

  1739. SANCHEZ-RODRIGUEZ IE, Medina-Gomez YG, Balderrama-Ibarra RI, Ramos-Vega JC, et al
    Cervical Cancer in Mexico: From a Renowned Vaccination Program to Unfulfilled Needs in Treatment Access.
    Cureus. 2024;16:e61553.
    Abstract

  1740. BEDI M, Kieft A, Joiner M, Miller S, et al
    Dramatic Radiographic Response of Pelvis-Filling Locally Advanced Cervical Cancer Treated With Radiation and Chemotherapy.
    Cureus. 2024;16:e61544.
    Abstract

  1741. OLUMODEJI AM, Adefemi AK, Adedeji MO, Ogunyemi AA, et al
    Attitude to cervical cancer screening and human papillomavirus testing experience in self-sampled Nigerian women.
    Afr Health Sci. 2024;24:127-134.
    Abstract

  1742. CHAUHAN R, Malhotra L, Gupta A, Dagar G, et al
    Bergenin inhibits growth of human cervical cancer cells by decreasing Galectin-3 and MMP-9 expression.
    Sci Rep. 2024;14:15287.
    Abstract

  1743. LING L, Chen J, Zhan L, Fu J, et al
    NLRC5 promotes tumorigenesis by regulating the PI3K/AKT signaling pathway in cervical cancer.
    Sci Rep. 2024;14:15353.
    Abstract

  1744. SHEN J, Chen M, Qiu H, Yang C, et al
    Evaluation and improvement of the safety of 3D-printed template assisted intracavitary/interstitial brachytherapy for cervical cancer using repeat FMEA.
    Brachytherapy. 2024 Jul 2:S1538-4721(24)00073.
    Abstract

  1745. WEI W, Fu P, Ju L, Chen L, et al
    Reminiscence Therapy-Engaged Care Exhibits a Pleasing Effect on Attenuating Psychological Burden and Bolstering Quality of Life in Elderly Postoperative Cervical Cancer Patients with Anxiety or Depression.
    Tohoku J Exp Med. 2024 Jul 4. doi: 10.1620/tjem.2024.
    Abstract

  1746. VERGOTE I, Gonzalez-Martin A, Fujiwara K, Kalbacher E, et al
    Tisotumab Vedotin as Second- or Third-Line Therapy for Recurrent Cervical Cancer.
    N Engl J Med. 2024;391:44-55.
    Abstract

  1747. GEDA YF, Lamiso YY, Berhe TM, Mohammed SJ, et al
    Visual Inspection with Acetic Acid Positivity in Screening and Early Detection of Cervical Dysplasia in Africa, 2023: A Meta-Analysis.
    Ethiop J Health Sci. 2024;34:3-14.
    Abstract

  1748. ZHONG PP, Tian C, He Y, Chen TB, et al
    [Clinicopathological analysis of atypical endocervical cells in cervical cytology].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:728-730.
    Abstract

  1749. LI Q, Zhou X, Xiao J, Gong Y, et al
    Role of ZNF334 in cervical cancer: implications for EMT reversal and tumor suppression.
    Med Oncol. 2024;41:191.
    Abstract

  1750. DRYSDALE H, Marlow LAV, Lim A, Waller J, et al
    Experiences of Self-Sampling and Future Screening Preferences in Non-Attenders Who Returned an HPV Vaginal Self-Sample in the YouScreen Study: Findings From a Cross-Sectional Questionnaire.
    Health Expect. 2024;27:e14118.
    Abstract

  1751. XIA C, Cai X, Li X, Chen Q, et al
    The impact of multidimensional nursing interventions on self-efficacy and quality of life in patients with cervical cancer.
    Minerva Surg. 2024 Jul 2. doi: 10.23736/S2724-5691.24.10415.
    Abstract

  1752. GUO YP, Yang Q, Wang SR, Li SM, et al
    [Value of SOX1 and PAX1 Gene Methylation Detection in Secondary Triage of High-Grade Cervical Lesions].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2024;46:329-333.
    Abstract

  1753. BAI H, Zheng H
    Labeled-free quantitative proteomic analysis of cervical squamous cell carcinoma identifies potential protein biomarkers.
    PeerJ. 2024;12:e17444.
    Abstract

  1754. FENG Q, Shen Z, Wang F, Shi C, et al
    Mediation of circ_0007142 on miR-128-3p/S100A14 pathway to stimulate the progression of cervical cancer.
    Naunyn Schmiedebergs Arch Pharmacol. 2024.
    Abstract

  1755. LIU LY, Guo CR, Sun Y
    [Research progress of radioresistance mechanism and common sensitization methods in cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:492-496.
    Abstract

  1756. WU YZ, Ren Y, Zhong YF, Tang PP, et al
    [Analysis of adverse late-term pregnancy outcomes after cervical cold knife conization].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:447-453.
    Abstract

  1757. FERGUSON S
    HPV: Cameroon fights back against one of the world's lowest vaccination rates.
    BMJ. 2024;386:q607.
    Abstract

  1758. PAVONE M, Bizzarri N, Goglia M, Lecointre L, et al
    Laparoscopic transabdominal cerclage in a pregnant woman after fertility-sparing treatment for early-stage cervical cancer: an operative technique in ten steps.
    Facts Views Vis Obgyn. 2024;16:217-223.
    Abstract

  1759. GRAM EJPN, Moseholm E, Norlov AB, Wilken-Jensen C, et al
    Cervical cancer screening integrated in routine clinical care of women living with HIV.
    AIDS. 2024 Jun 28. doi: 10.1097/QAD.0000000000003972.
    Abstract

  1760. SHI M, Zhang Y
    Efficacy of nimotuzumab in combination with immunotherapy for a young recurrent cervical cancer patient: a case report and literature review.
    Anticancer Drugs. 2024 May 20. doi: 10.1097/CAD.0000000000001611.
    Abstract

  1761. KHOKHAR M, Kartha P, Hassan S, Pandey RK, et al
    Decoding dysregulated genes, molecular pathways and microRNAs involved in cervical cancer.
    J Gene Med. 2024;26:e3713.
    Abstract

  1762. SONG LM, Yao DJ, Xia L, Wang XM, et al
    DSG2 and c-MYC Interact to Regulate the Expression of ADAM17 and Promote the Development of Cervical Cancer.
    Cancer Manag Res. 2024;16:703-710.
    Abstract

  1763. LIU Y, Liu Y, Wang Y, Wang Q, et al
    LncRNA PCGEM1 facilitates cervical cancer progression via miR-642a-5p/KIF5B axis.
    Oncol Res. 2024;32:1221-1229.
    Abstract

  1764. JIANG CZ, Zheng K, Zhang YY, Yang J, et al
    (18)F-FDG PET/CT semi-quantitative parameters combined with SCC-Ag in predicting lymph node metastasis in stage I-II cervical cancer.
    Front Oncol. 2024;14:1278464.
    Abstract

  1765. AFTAB T, Khyzer E, Suhail N, Abdullah Alanzy H, et al
    Knowledge About Cervical Cancer and Awareness About Human Papillomavirus Vaccination Among Medical Students at the Northern Border University, Arar, Kingdom of Saudi Arabia.
    Cureus. 2024;16:e61313.
    Abstract

  1766. BALAN L, Rusu EL, Ciurescu S, Larisa TV, et al
    Feasibility and Diagnostic Accuracy of Ultrastaging in the Detection of Micrometastases in Sentinel and Non-sentinel Lymph Nodes in Cervical Cancer: A Single-Center Retrospective Study With a Five-Year Follow-Up Period.
    Cureus. 2024;16:e61336.
    Abstract

  1767. YUAN L, Wang Y, Yu M, Feng Z, et al
    Oncogenic HPV-induced high expression of ESM1 predicts poor prognosis and regulates aerobic glycolysis in cervical cancer.
    iScience. 2024;27:110112.
    Abstract

  1768. ALARID-ESCUDERO F, Gracia V, Wolf M, Zhao R, et al
    State-level disparities in cervical cancer prevention and impact on outcomes in the U.S.: A modeling study.
    medRxiv [Preprint]. 2024 Jun 12:2024.06.11.24308795.
    Abstract

  1769. KULAEVA ED, Muzlaeva ES, Mashkina EV
    mRNA-lncRNA gene expression signature in HPV-associated neoplasia and cervical cancer.
    Vavilovskii Zhurnal Genet Selektsii. 2024;28:342-350.
    Abstract

  1770. MISZCZYK M, Wu T, Kuna K, Stankiewicz M, et al
    Clinical outcomes of pelvic bone marrow sparing radiotherapy for cervical cancer: A systematic review and meta-analysis of randomised controlled trials.
    Clin Transl Radiat Oncol. 2024;47:100801.
    Abstract

  1771. WASSIE M, Zegeye AF, Mekonen EG, Tekeba B, et al
    Human papillomavirus vaccination coverage among young women in the three sub-Saharan African countries using Demographic and Health Surveys data.
    Hum Vaccin Immunother. 2024;20:2370111.
    Abstract

  1772. JOMAH A, Albokhary A
    The impact of the human papillomavirus vaccine on women's health: a systematic review.
    Eur Rev Med Pharmacol Sci. 2024;28:3871-3879.
    Abstract

  1773. LIU ZL, Chen N, Li R, Ma YJ, et al
    WGCNA reveals a biomarker for cancer-associated fibroblasts to predict prognosis in cervical cancer.
    J Chin Med Assoc. 2024 Jul 1. doi: 10.1097/JCMA.0000000000001129.
    Abstract

  1774. SUPRIYA Y, Sivamalar S, Nallusamy D, Sureka V, et al
    Application of Probiotics in Cervical Cancer Infections to Enhance the Immune Response.
    Microb Pathog. 2024 Jun 27:106764. doi: 10.1016/j.micpath.2024.106764.
    Abstract

  1775. PEREIRA D, Alves N, Sousa A, Valente JFA, et al
    Metal-based approaches to fight cervical cancer.
    Drug Discov Today. 2024 Jun 27:104073. doi: 10.1016/j.drudis.2024.104073.
    Abstract

  1776. MULCAHY SYMMONS S, Drury A, De Brun A
    Stakeholder perceptions of cervical screening accessibility and attendance in Ireland: a qualitative study.
    Health Promot Int. 2024;39:daae072.
    Abstract

  1777. CHEN Y, Li L, Shi Y, Rong X, et al
    Evaluating the effectiveness of early urethral catheter removal combined with intermittent catheterization for promoting early recovery of bladder function after laparoscopic radical hysterectomy: a study protocol for a randomized controlled trial.
    Trials. 2024;25:422.
    Abstract

  1778. ZEGEYE FR, Legasu TD, Bayou FD, Ali MA, et al
    Uptake of cervical cancer screening and associated factors among HIV positive women attending adult art clinic at public hospitals in Addis Ababa, Ethiopia, 2022.
    BMC Womens Health. 2024;24:377.
    Abstract

  1779. NAGAO A, Murakami N, Sakuramachi M, Kashihara T, et al
    Role of the gel spacer in safely delivering whole pelvic radiation therapy without central shielding in computed tomography-based image-guided adaptive brachytherapy for uterine cervical cancer patients.
    Brachytherapy. 2024 Jun 27:S1538-4721(24)00075.
    Abstract

  1780. XU H, Dong C, Yu Z, Ozaki Y, et al
    Detection and analysis of microplastics in tissues and blood of human cervical cancer patients.
    Environ Res. 2024;259:119498.
    Abstract


  1781. Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus: Erratum.
    J Low Genit Tract Dis. 2024;28:316.
    Abstract

  1782. DAY T, Stuart L, Ius Y, Haqshenas G, et al
    Fanconi Anemia Complicated by Cervical Precancer, Vulvar, and Oral Squamous Cell Cancer.
    J Low Genit Tract Dis. 2024;28:310-313.
    Abstract

  1783. ENGELBRECHT K, Ovcinnikova O, Ntais D, Shoel H, et al
    Productivity costs due to human papillomavirus-related cancer mortality in the United Kingdom.
    J Med Econ. 2024;27.
    Abstract

  1784. SCHOLES-ROBERTSON N, Barday Z, Davidson B, Krishnan A, et al
    Access to Cancer Care: Prevention and Screening for Females Post Kidney Transplantation Around the World.
    Semin Nephrol. 2024;44:151502.
    Abstract

  1785. GOTTSCHLICH A, Hong Q, Gondara L, Alam MS, et al
    Evidence of Decreased Long-term Risk of Cervical Precancer after Negative Primary HPV Screens Compared with Negative Cytology Screens in a Longitudinal Cohort Study.
    Cancer Epidemiol Biomarkers Prev. 2024;33:904-911.
    Abstract

  1786. FURUGORI K, Suzuki H, Abe R, Horiuchi K, et al
    Chimera RNA transcribed from integrated HPV18 genome with adjacent host genomic region promotes oncogenic gene expression through condensate formation.
    Genes Cells. 2024;29:532-548.
    Abstract

  1787. AQUILINA A, Papagiannakis E
    Deep Learning Diagnostic Classification of Cervical Images to Augment Colposcopic Impression.
    J Low Genit Tract Dis. 2024;28:224-230.
    Abstract

  1788. WEI X, Zhou YH, Chen P
    Distribution and Severity of Cervical Intraepithelial Neoplasia in Women With Different Human Papillomavirus: An Analysis From Liaoning Province of Northeastern China.
    J Low Genit Tract Dis. 2024;28:231-239.
    Abstract

  1789. TAN CY, Li TT, Xu N, Guo HH, et al
    Mesonephric adenocarcinoma of the cervix: An analysis for 3 cases and literature review.
    Asian J Surg. 2024;47:3233-3234.
    Abstract

  1790. GOPALANI SV, Saraiya M, Huang B, Tucker TC, et al
    Population-level incidence of HPV-positive oropharyngeal, cervical, and anal cancers by smoking status.
    J Natl Cancer Inst. 2024 Mar 1:djae054. doi: 10.1093.
    Abstract

  1791. KRANKOWSKA D, Mazzitelli M, Ucak HA, Orviz E, et al
    Screening and prevention of HPV-related anogenital cancers in women living with HIV in Europe: Results from a systematic review.
    HIV Med. 2024 Jan 18. doi: 10.1111/hiv.13602.
    Abstract

  1792. TAGLIAFERRI L, Mancini S, Lancellotta V, Dinapoli L, et al
    The Impact of HAPPY (Humanity Assurance Protocol in Interventional Radiotherapy) on the Psychological Well-being of Gynecological Cancer Patients.
    Curr Radiopharm. 2024;17:168-173.
    Abstract

  1793. FACHARZTMAGAZINE R
    [Not Available].
    MMW Fortschr Med. 2024;166:66.
    Abstract

  1794. YANG L, Hu H, Yang X, Yan Z, et al
    Whole-tumor histogram analysis of multiple non-Gaussian diffusion models at high b values for assessing cervical cancer.
    Abdom Radiol (NY). 2024 Jul 12. doi: 10.1007/s00261-024-04486.
    Abstract

  1795. ENDO Y, Soeda S, Yoshimoto Y, Todate Y, et al
    Successful management of locally advanced cervical cancer via total pelvic exenteration following neoadjuvant chemotherapy.
    J Surg Case Rep. 2024;2024:rjae452.
    Abstract

  1796. GONG X, Xu J, He Y, Zou G, et al
    Socioeconomic inequalities in human papillomavirus knowledge and vaccine uptake: evidence from a cross-sectional study in China.
    Front Public Health. 2024;12:1399192.
    Abstract

  1797. DATIR SG, Jaiswal A
    Cervical Cancer and Its Association With Pregnancy.
    Cureus. 2024;16:e62144.
    Abstract

  1798. ZHAO X, Liu Y, Niu J, Shi Y, et al
    A phase III randomized clinical trial comparing laparoscopic radical hysterectomy based on open state with abdominal radical hysterectomy in patients with early-stage cervical cancer.
    Trials. 2024;25:471.
    Abstract

  1799. QIU S, Wang Q, Jiang H, Feng L, et al
    Immunohistochemistry staining of Eag1 and p16/Ki-67 can help improve the management of patients with cervical intraepithelial Neoplasia after cold knife conversion.
    Diagn Pathol. 2024;19:97.
    Abstract

  1800. HU J, Wang S, Zhang X, Yan W, et al
    A genetic variant in the TAPBP gene enhances cervical cancer susceptibility by increasing m(6)A modification.
    Arch Toxicol. 2024 Jul 12. doi: 10.1007/s00204-024-03820.
    Abstract

  1801. WANG K, Qu A, Deng X, Jiang W, et al
    Efficacy and safety of 3-dimensional printing noncoplanar template (3D-PNCT)-assisted high-dose-rate interstitial brachytherapy (HDR-ISBT) for reirradiation of recurrent cervical cancer: a prospective cohort.
    J Gynecol Oncol. 2024 Jul 4. doi: 10.3802/jgo.2025.
    Abstract

  1802. CAO Y, Peng Y, Tang Y
    ATF1 regulates MAL2 expression through inhibition of miR-630 to mediate the EMT process that promotes cervical cancer cell development and metastasis.
    J Gynecol Oncol. 2024 Jul 2. doi: 10.3802/jgo.2025.
    Abstract

  1803. CUI Y, Zhao Y, Shen G, Lv Q, et al
    CDYL loss promotes cervical cancer aggression by increasing PD-L1 expression via the suppression of IRF2BP2 transcription.
    Transl Oncol. 2024;47:102038.
    Abstract

  1804. ZHONG S, Ai C, Ding Y, Tan J, et al
    Combining multimodal diffusion-weighted imaging and morphological parameters for detecting lymph node metastasis in cervical cancer.
    Abdom Radiol (NY). 2024 Jul 11. doi: 10.1007/s00261-024-04494.
    Abstract

  1805. HSU CD, Yu X, Guo F, Adekanmbi V, et al
    Cervical cancer screening utilization among kidney transplant recipients, 2001-2018.
    Cancer Epidemiol Biomarkers Prev. 2024.
    Abstract

  1806. MENG X, Gao B, Li N
    Mitochondrial protein isoleucyl-tRNA synthetase 2 in tumor cells as a potential therapeutic target for cervical cancer.
    Cytojournal. 2024;21:22.
    Abstract

  1807. NODA T, Fukuda T, Uchikura E, Awazu Y, et al
    Predicting recurrence in intermediate? and high?risk stage IB?IIB cervical cancer treated with adjuvant cisplatin and paclitaxel chemotherapy post?radical hysterectomy: The role of TBX2 expression.
    Oncol Lett. 2024;28:414.
    Abstract

  1808. WU M, Zhou JL, Zhang Z, Meng YG, et al
    Identifying Comprehensive Genomic Alterations and Potential Neoantigens for Cervical Cancer Immunotherapy in a Cohort of Chinese Squamous Cell Carcinoma of the Cervix.
    Biomed Environ Sci. 2024;37:565-580.
    Abstract

  1809. PATTERSON MR, Cogan JA, Cassidy R, Theobald DA, et al
    The Hippo pathway transcription factors YAP and TAZ play HPV-type dependent roles in cervical cancer.
    Nat Commun. 2024;15:5809.
    Abstract

  1810. LIBERACKA-DWOJAK M, Wilkosc-Debczynska M, Perkowski R
    Breaking the silence: the role of sexual communication on quality of life in women with cervical cancer.
    Support Care Cancer. 2024;32:503.
    Abstract

  1811. SARWAR F, Ashhad S, Vimal A, Vishvakarma R, et al
    Small molecule inhibitors of the VEGF and tyrosine kinase for the treatment of cervical cancer.
    Med Oncol. 2024;41:199.
    Abstract

  1812. SANTOS BMD, Araujo Junior E, Zanine RM
    Is the colposcopic lesion size a predictor of high-grade lesions in young patients?
    Einstein (Sao Paulo). 2024;22:eAO0462.
    Abstract

  1813. GOKCAY G, Akar N, Bagis KO, Ugurlu A, et al
    The relationship between individuals' knowledge of human papillomavirus, attitudes towards HPV vaccination, and vaccine hesitancy: A cross-sectional study.
    Afr J Reprod Health. 2024;28:103-116.
    Abstract

  1814. SHEN Y, Jin X, Zhu Y, He C, et al
    Clinical analysis of patients with skin metastasis of cervical squamous cell carcinoma.
    Chin Clin Oncol. 2024;13:35.
    Abstract

  1815. WANG R, Huang H, Yu C, Li X, et al
    Current status and future directions for the development of human papillomavirus vaccines.
    Front Immunol. 2024;15:1362770.
    Abstract

  1816. FANG J, Wang Y, Li C, Liu W, et al
    A hypoxia-derived gene signature to suggest cisplatin-based therapeutic responses in patients with cervical cancer.
    Comput Struct Biotechnol J. 2024;23:2565-2579.
    Abstract

  1817. RAMPHUL R, Zamorano AS, Upadhyay S, Desai M, et al
    Spatiotemporal analysis of HPV vaccination and associated neighborhood-level disparities in Texas-an ecological study.
    Front Public Health. 2024;12:1418526.
    Abstract

  1818. KORALAHALLI KP, Hussain S, D DW, Siddikuzzaman, et al
    Molecular Actions of Enicostemma hyssopifolium Whole Plant Extract on HPV18-Infected Human Cervical Cancer (HeLa) Cells.
    Anticancer Agents Med Chem. 2024.
    Abstract

  1819. RASMUSSEN PW, Hoffman RM, Phiri S, Makwaya A, et al
    Cost-effectiveness of approaches to cervical cancer screening in Malawi: comparison of frequencies, lesion treatment techniques, and risk-stratified approaches.
    BMC Health Serv Res. 2024;24:792.
    Abstract

  1820. STUART RM, Cohen JA, Abeysuriya RG, Sanz-Leon P, et al
    Inferring the natural history of HPV from global cancer registries: insights from a multi-country calibration.
    Sci Rep. 2024;14:15875.
    Abstract

  1821. ALMEIDA TAG, Dos Santos OP, Saddi VA, Pereira JX, et al
    Association of CD133, ALDH1, CD117 and OCT4 expression with prognosis of patients with cervical cancer.
    Virchows Arch. 2024 Jul 9. doi: 10.1007/s00428-024-03862.
    Abstract

  1822. TAY SK
    Improving the effectiveness of cervical cancer screening: Managing positive high-risk human papillomavirus results.
    Ann Acad Med Singap. 2024;53:342-351.
    Abstract

  1823. CHIN FHX
    Evaluating the effectiveness of cervical cancer screening and prevention in Singapore.
    Ann Acad Med Singap. 2024;53:338-339.
    Abstract

  1824. ASANGBEH-KERMAN SL, Davidovic M, Taghavi K, Dhokotera T, et al
    Cervical cancer prevention and care in HIV clinics across sub-Saharan Africa: results of a facility-based survey.
    J Int AIDS Soc. 2024;27:e26303.
    Abstract

  1825. GAO Y, Wang H, Jiang M
    Comparative effectiveness of neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stages IB2 to IIB of cervical cancer: a meta-analysis.
    Front Oncol. 2024;14:1426002.
    Abstract

  1826. YANG H, Chen Z, Lou H, Ying W, et al
    Effects of Sintilimab Plus Radiotherapy on Levels of Spondin-2 and Glucose Transporter-1 in Patients with Cervical Cancer.
    Int J Gen Med. 2024;17:2931-2937.
    Abstract

  1827. ZHAO F, Yan H, Liu Y, Mu X, et al
    Knowledge, attitudes and practices toward cervical cancer screening among ethnic minorities in inner Mongolia, China.
    J Eval Clin Pract. 2024 Jul 8. doi: 10.1111/jep.14074.
    Abstract

  1828. HAN F, Xue Y, Huang S, Lu T, et al
    Development and validation of an automated Tomotherapy planning method for cervical cancer.
    Radiat Oncol. 2024;19:88.
    Abstract

  1829. AGABA CD, Namuli A, Ainomugisha B, Tibaijuka L, et al
    Providers and women's perspectives on opportunities, challenges and recommendations to improve cervical cancer screening in women living with HIV at Mbarara Regional Referral Hospital: a qualitative study.
    BMC Womens Health. 2024;24:392.
    Abstract

  1830. NAMALINZI F, Galadima KR, Nalwanga R, Sekitoleko I, et al
    Prediction of precancerous cervical cancer lesions among women living with HIV on antiretroviral therapy in Uganda: a comparison of supervised machine learning algorithms.
    BMC Womens Health. 2024;24:393.
    Abstract

  1831. LI J, Qi J, Zhang J, Zhang Y, et al
    Relationships between nine neuropsychiatric disorders and cervical cancer: insights from genetics, causality and shared gene expression patterns.
    BMC Womens Health. 2024;24:394.
    Abstract

  1832. AJAKAIYE A, Watson D, Abdelsalam H, Alalade A, et al
    Extranodal diffuse large B-cell lymphoma involving the uterine cervix.
    BMJ Case Rep. 2024;17:e244315.
    Abstract

  1833. GEZELS E, Van Roy K, Arbyn M, Coursier P, et al
    The ESSAG-trial protocol: A randomized controlled trial evaluating the efficacy of offering a self-sampling kit by the GP to reach women underscreened in the routine cervical cancer screening program.
    Contemp Clin Trials. 2024 Jul 6:107617. doi: 10.1016/j.cct.2024.107617.
    Abstract

  1834. LIN X, Zhan J, Guan Z, Zhang J, et al
    Clinicopathologic and prognostic significance of tumor-associated macrophages in cervical cancer: a systematic review and meta-analysis.
    Clin Transl Oncol. 2024 Jul 8. doi: 10.1007/s12094-024-03587.
    Abstract

  1835. JIA Y, Li Y, Du N, Zhao W, et al
    LIMK1 promotes the development of cervical cancer by up-regulating the ROS/Src-FAK/cofilin signaling pathway.
    Aging (Albany NY). 2024;16.
    Abstract

  1836. ORINGTHO S, Mwaka AD, Garimoi Orach C, Wabinga H, et al
    Awareness of cervical cancer risk factors and preventive approaches, and perceived causes of cervical cancer among secondary school girls: a cross-sectional study in Northern Uganda.
    Ann Med. 2024;56:2374860.
    Abstract

  1837. SEBI EP, Tejanaik P, Narendiran V
    Healthcare Provider-Related Factors in the Diagnostic Delay of Cervical Cancer: A Cross-Sectional Study.
    Cureus. 2024;16:e61865.
    Abstract

  1838. DIOP A, Mvundura M, Dieng Y, Anne M, et al
    Cervical cancer screening and treatment costing in Senegal.
    Pan Afr Med J. 2024;47:151.
    Abstract

  1839. ALMONTE M, Ilbawi AM, Maza M, Saville M, et al
    From commitments to action: the first global cervical cancer elimination forum.
    Lancet Reg Health Am. 2024;36:100812.
    Abstract

  1840. AVINU ES, Kutah J, Akumiah PO, Opoku-Addai K, et al
    Knowledge, perception and cervical cancer screening practices among nurses and midwives: a case study of Our Lady of Grace Hospital in the Asikuma Odoben Brakwa district, Central region-Ghana.
    Afr Health Sci. 2023;23:487-497.
    Abstract

  1841. KUPAS D, Hajdu A, Kovacs I, Hargitai Z, et al
    Annotated Pap cell images and smear slices for cell classification.
    Sci Data. 2024;11:743.
    Abstract

  1842. ZHANG Y, Li H, Wei Y, Li L, et al
    Alantolactone Induced Apoptosis and DNA Damage of Cervical Cancer through ATM/CHK2 Signaling Pathway.
    Biol Pharm Bull. 2024;47:1255-1264.
    Abstract

  1843. BOAKYE EA, Gerend MA, Nair M, Khan HY, et al
    Trends in awareness of the causal link between HPV and cervical cancer in the US: 2013 to 2022.
    Am J Prev Med. 2024 Jul 5:S0749-3797(24)00225.
    Abstract

  1844. CARVALHO MFL, Calicchio CS, de Almeida BO, de Miranda LBL, et al
    Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells.
    Clinics (Sao Paulo). 2024;79:100422.
    Abstract

  1845. HARANGI B, Bogacsovics G, Toth J, Kovacs I, et al
    Pixel-wise segmentation of cells in digitized Pap smear images.
    Sci Data. 2024;11:733.
    Abstract

  1846. WESCHASAT T, Wetchasat N, Chuemchit M
    The edutainment program on knowledge, perception, and uptake of cervical cancer screening among Muslim women in Southern Thailand: a quasi experimental study.
    BMC Public Health. 2024;24:1803.
    Abstract

  1847. TRESSERRA F, Fabra G, Luque O, Castella M, et al
    Validation of digital image slides for diagnosis in cervico-vaginal cytology.
    Rev Esp Patol. 2024;57:182-189.
    Abstract

  1848. FORTEZA A, Vanrell C, Matheu G, Cortes J, et al
    Validation of immunohistochemical overexpression of p16 in the histologic diagnosis of cervical intraepithelial neoplasia grade 2.
    Rev Esp Patol. 2024;57:169-175.
    Abstract

  1849. YU M, Ni M, Xu F, Liu C, et al
    NSUN6-mediated 5-methylcytosine modification of NDRG1 mRNA promotes radioresistance in cervical cancer.
    Mol Cancer. 2024;23:139.
    Abstract

  1850. GUO F, Kong W, Li D, Zhao G, et al
    M2-type tumor-associated macrophages upregulated PD-L1 expression in cervical cancer via the PI3K/AKT pathway.
    Eur J Med Res. 2024;29:357.
    Abstract

  1851. LIU FH, Zhao XR, Zhang XL, Zhao M, et al
    Multiparametric mri-based radiomics nomogram for predicting lymph-vascular space invasion in cervical cancer.
    BMC Med Imaging. 2024;24:167.
    Abstract

  1852. BEILANKOUHI EAV, Maghsoodi MS, Sani MZ, Khosroshahi NS, et al
    miRNAs that regulate apoptosis in breast cancer and cervical cancer.
    Cell Biochem Biophys. 2024 Jul 6. doi: 10.1007/s12013-024-01405.
    Abstract

  1853. ZHANG K, Zhang Y, Wu H, Wu S, et al
    ASO Visual Abstract: Complete Laparoscopic Type C2 Radical Surgery for Cervical Stump Cancer-No-Look and No-Touch Techniques.
    Ann Surg Oncol. 2024;31:5320-5321.
    Abstract

  1854. MOORE LC, Ahern F, Li L, Kallis K, et al
    Neural network dose prediction for cervical brachytherapy: Overcoming data scarcity for applicator-specific models.
    Med Phys. 2024;51:4591-4606.
    Abstract

  1855. LUO WX, Ding XM, Cheng JM, Liu X, et al
    Nomogram based on MRI and clinical features to predict progression-free survival in patients with stage IIIC1r cervical squamous cell carcinoma: A two-center study.
    Clin Radiol. 2024;79:e1031-e1039.
    Abstract

  1856. ZHANG K, Zhang Y, Wu H, Wu S, et al
    Complete Laparoscopic Type C2 Radical Surgery for Cervical Stump Cancer: No-Look and No-Touch Techniques.
    Ann Surg Oncol. 2024;31:5111-5114.
    Abstract

  1857. YAGI A, Ueda Y, Oka E, Nakagawa S, et al
    Even though active recommendation for HPV vaccination has restarted, Japan's rates have not recovered.
    Cancer Sci. 2024;115:2410-2416.
    Abstract

  1858. SAKATA M, Mabuchi S, Maeda M, Nagata S, et al
    Extraovarian seromucinous borderline tumor: Case report and literature review.
    J Obstet Gynaecol Res. 2024;50:1263-1267.
    Abstract

  1859. GU Y, Chu C, Yuan B, Wang J, et al
    Expression and hypermethylation of JAM and EPB41L3 in cervical squamous cell carcinoma: Clinical significance and applications.
    Histol Histopathol. 2024;39:1043-1051.
    Abstract

  1860. SISIN NNT, Kong AR, Edinur HA, Jamil NIN, et al
    Silencing E6/E7 Oncoproteins in SiHa Cells Treated with siRNAs and Oroxylum indicum Extracts Induced Apoptosis by Upregulating p53/pRb Pathways.
    Appl Biochem Biotechnol. 2024;196:4234-4255.
    Abstract

  1861. JINDAKAN S, Tharavichitkul E, Watcharawipha A, Nobnop W, et al
    Improvement of treatment plan quality with modified fixed field volumetric modulated arc therapy in cervical cancer.
    J Appl Clin Med Phys. 2024 Jul 20:e14479. doi: 10.1002/acm2.14479.
    Abstract

  1862. KARTHIKA J, Anantharaju A, Koodi D, Pandya HJ, et al
    Label-free assessment of the transformation zone using multispectral diffuse optical imaging toward early detection of cervical cancer.
    J Biophotonics. 2024 Jul 20:e202400114. doi: 10.1002/jbio.202400114.
    Abstract

  1863. NARTEY Y, Amo-Antwi K, Hill PC, Dassah ET, et al
    Risk Factors for Cervical Cancer in Ghana.
    Cancer Rep (Hoboken). 2024;7:e2124.
    Abstract

  1864. TISHE ZH, Shawkat S, Popy MN, Mumu SB, et al
    Cervical cancer risk in association with TNF-alpha gene polymorphisms in Bangladeshi women.
    Tumour Biol. 2024;46:13-24.
    Abstract

  1865. NOOR MOHAMAD NA, Omar J
    Cervical cancer in Malaysia.
    J Obstet Gynaecol Res. 2024 Jul 19. doi: 10.1111/jog.16031.
    Abstract

  1866. KAMATA M, Fusegi A, Kurihara N, Abe A, et al
    Effects of tumor spillage prevention in laparoscopic radical hysterectomy for early-stage cervical cancer: a propensity score-matched analysis.
    J Gynecol Oncol. 2024 Jul 12. doi: 10.3802/jgo.2025.
    Abstract

  1867. JI C, Liu S, Wang C, Chen J, et al
    Relationship between visceral obesity and prognosis in patients with stage IVB cervical cancer receiving radiotherapy and chemotherapy.
    Cancer Pathog Ther. 2023;2:180-186.
    Abstract

  1868. WU L, Li S, Li S, Lin Y, et al
    Preoperative magnetic resonance imaging-radiomics in cervical cancer: a systematic review and meta-analysis.
    Front Oncol. 2024;14:1416378.
    Abstract

  1869. DENECKE A, Emar D, Hillemanns P, Ramachandran D, et al
    Diagnostic cervical excision in patients with HPV positivity, cytological abnormalities- and preoperative cervical stenosis.
    BMC Womens Health. 2024;24:411.
    Abstract

  1870. HE C, Zhang J, Bai X, Lu C, et al
    Lysine lactylation-based insight to understanding the characterization of cervical cancer.
    Biochim Biophys Acta Mol Basis Dis. 2024 Jul 16:167356.
    Abstract

  1871. PENG Q, Deng Y, Li G, Li J, et al
    Quantitative Proteomics Reveal the Mechanism of MiR-138-5p Suppressing Cervical Cancer via Targeting ZNF385A.
    J Proteome Res. 2024 Jul 18. doi: 10.1021/acs.jproteome.4c00349.
    Abstract

  1872. NNADI EN, Khatun N, John S
    A Rare Encounter With Unusual Metastasis: Metastatic Right Ventricular Tumor Secondary to Cervical Cancer.
    Cureus. 2024;16:e62530.
    Abstract

  1873. WANG X, Feng C, Huang M, Liu S, et al
    Cervical cancer segmentation based on medical images: a literature review.
    Quant Imaging Med Surg. 2024;14:5176-5204.
    Abstract

  1874. LI S, Gao K, Yao D
    Comprehensive Analysis of angiogenesis associated genes and tumor microenvironment infiltration characterization in cervical cancer.
    Heliyon. 2024;10:e33277.
    Abstract

  1875. GU Y, Mu Q, Cheng D
    Androgens in cervical cancer: Their role in epidemiology and biology.
    iScience. 2024;27:110155.
    Abstract

  1876. RASHEED FA, Yakasai IA, Abdurrahman A, Usman A, et al
    Human papillomavirus serotypes and determinants among women with invasive cervical cancer in Katsina state, Northwest-Nigeria: a multicentre study.
    Ecancermedicalscience. 2024;18:1714.
    Abstract

  1877. ONYANGO OE, Masinde D, Ouma C
    Improving cervical cancer screening rates among women of reproductive age in rural Kisumu County through dialogue-based community health education.
    Ecancermedicalscience. 2024;18:1713.
    Abstract

  1878. LIM L, Slee A, Lim PC
    Feasibility and early oncologic outcomes of Total Intracorporeal Robotic Radical Hysterectomy with Vaginal Cerclage (TIRRHVC) for the treatment of clinical stage IB cervical cancer: A tumor containment technique.
    Gynecol Oncol Rep. 2024;54:101437.
    Abstract

  1879. EZZELARAB S, El-Husseiny A, Nasreldin M, Ali R, et al
    Cervical cancer screening by cytology and the burden of epithelial abnormalities in low resource settings: a tertiary-center 42-year study.
    BMC Womens Health. 2024;24:405.
    Abstract

  1880. HU J, Liu G, Liu Y, Yuan M, et al
    Predicting lower limb lymphedema after cervical cancer surgery using artificial neural network and decision tree models.
    Eur J Oncol Nurs. 2024;72:102650.
    Abstract

  1881. KUNTAMUNG K, Sangthong P, Jakmunee J, Ounnunkad K, et al
    Simultaneous immunodetection of multiple cervical cancer biomarkers based on a signal-amplifying redox probes/polyethyleneimine-coated gold nanoparticles/2D tungsten disulfide/graphene oxide nanocomposite platform.
    Bioelectrochemistry. 2024;160:108780.
    Abstract

  1882. ZHU Z, Nie X, Deng L, Ding J, et al
    Regulation of cervical cancer via G15-mediated inhibition of G protein-coupled estrogen receptor.
    Anticancer Drugs. 2024 Jul 17. doi: 10.1097/CAD.0000000000001640.
    Abstract

  1883. BASHAR MA, Khan IA
    Introduction of HPV vaccine in universal immunization programme of India: A step in the right direction for the elimination of cervical cancer.
    Indian J Cancer. 2024 Jul 13. doi: 10.4103.
    Abstract

  1884. LI J, Zhang X, Yang L, Zhu Y, et al
    Corrigendum: Targeted proteomics-determined multi-biomarker profiles developed classifier for prognosis and immunotherapy responses of advanced cervical cancer.
    Front Immunol. 2024;15:1437676.
    Abstract

  1885. MWENDA V, Murage D, Kilonzo C, Bor JP, et al
    Baseline assessment of cervical cancer screening and treatment capacity in 25 counties in Kenya, 2022.
    Front Oncol. 2024;14:1371529.
    Abstract

  1886. CHI C, Tang X, Liu W, Zhou Y, et al
    Exosomal lncRNA USP30-AS1 activates the Wnt/beta-catenin signaling pathway to promote cervical cancer progression via stabilization of beta-catenin by USP30.
    Biotechnol J. 2024;19:e2300653.
    Abstract

  1887. NAKAMURA K, Kigure K, Nishimura T, Yamashita S, et al
    Questionnaire survey on cervical cancer screening and HPV awareness among patients at a local cancer center in Japan.
    BMC Womens Health. 2024;24:402.
    Abstract

  1888. HU X, Wang W, Ma T, Zhang W, et al
    Long non-coding RNA SIX1-1 promotes proliferation of cervical cancer cells via negative transcriptional regulation of RASD1.
    Hum Cell. 2024 Jul 16. doi: 10.1007/s13577-024-01104.
    Abstract

  1889. WANG F, Yue S, Huang Q, Lei T, et al
    Cellular heterogeneity and key subsets of tissue-resident memory T cells in cervical cancer.
    NPJ Precis Oncol. 2024;8:145.
    Abstract

  1890. KOUR S, Biswas I, Sheoran S, Arora S, et al
    Betulin: a novel triterpenoid anti-cancerous agent targeting cervical cancer through epigenetic proteins.
    Mol Divers. 2024 Jul 16. doi: 10.1007/s11030-024-10930.
    Abstract

  1891. OWARE J, Iddrisu M, Konlan KD, Dzansi G, et al
    Challenges and support systems of nurses caring for women with advanced cervical cancer in Accra, Ghana.
    BMC Palliat Care. 2024;23:174.
    Abstract

  1892. THAREJA G, Salvioni A, Lauzeral-Vizcaino F, Halabi N, et al
    Assessing the implications of sentinel lymph node removal in cervical cancer: an immunogenetic perspective - a SENTICOL ancillary study.
    J Immunother Cancer. 2024;12:e008734.
    Abstract

  1893. ALONSO-ESPIAS M, Gracia M, Zapardiel I
    Benefits of sentinel node detection in cervical cancer.
    Curr Opin Oncol. 2024 Jun 13. doi: 10.1097/CCO.0000000000001063.
    Abstract

  1894. SCHINDLER S, Netto E, Deminco F, Figueiredo CA, et al
    Detection of cytokines in cervicovaginal lavage in HIV-infected women and its association with high-risk human papillomavirus.
    Front Immunol. 2024;15:1416204.
    Abstract

  1895. ARANGO-BRAVO EA, Galicia-Carmona T, Cetina-Perez L, Flores-de la Torre CB, et al
    State of the art of cervical cancer treatment in rare histologies.
    Front Oncol. 2024;14:1386294.
    Abstract

  1896. FALCONER H, Norberg-Hardie A, Salehi S, Alfonzo E, et al
    Oncologic outcomes after Total Mesometrial Resection (TMMR) or treatment according to current international guidelines in FIGO (2009) stages IB1-IIB cervical cancer: an observational cohort study.
    EClinicalMedicine. 2024;73:102696.
    Abstract

  1897. WANG W, Yao S, Jiang H, Dong J, et al
    [Retracted] Upstream transcription factor 1 prompts malignancies of cervical cancer primarily by transcriptionally activating p65 expression.
    Exp Ther Med. 2024;28:342.
    Abstract

  1898. LAGU IJL, Nyamai DW, Njeru SN
    Phytochemical analysis, in-vitro and in-silico study of antiproliferative activity of ethyl acetate fraction of Launaea cornuta (Hochst. ex Oliv. & Hiern) C. Jeffrey against human cervical cancer cell line.
    Front Pharmacol. 2024;15:1399885.
    Abstract

  1899. HAN GH, Kim HR, Yun H, Chung JY, et al
    Developing a comprehensive molecular subgrouping model for cervical cancer using machine learning.
    Am J Cancer Res. 2024;14:3186-3197.
    Abstract

  1900. WEI LJ, Fu J, Yang HX, Yang X, et al
    Evaluation of pathological response to neoadjuvant chemotherapy in locally advanced cervical cancer.
    J Transl Med. 2024;22:655.
    Abstract

  1901. DULL PM, Achilles SL, Ahmed R, Barnabas RV, et al
    Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer.
    Vaccine. 2024 Jul 13:S0264-410X(24)00741-2. doi: 10.1016/j.vaccine.2024.
    Abstract

  1902. SINGH P, Gothwal M, Yadav G
    Dual-staining with P16 and Ki67 in the triaging of ASC-US and the LSIL group beneficial or added financial burden, still a diagnostic dilemma.
    Taiwan J Obstet Gynecol. 2024;63:593.
    Abstract

  1903. SRISUTTAYASATHIEN M, Kantathavorn N, Luasiripanthu T, Petchjorm S, et al
    Response to "Is it practical to add the p16/Ki67 immunohistochemical dual staining into liquid-based cytology for cervical cancer screening?".
    Taiwan J Obstet Gynecol. 2024;63:592.
    Abstract

  1904. CHIKAZAWA K, Imai K, Kuwata T, Konno R, et al
    What Is the Future of Radical Hysterectomy? Commentary on the Indication for Minimally Invasive Surgery for Cervical Cancer
    J Obstet Gynaecol Can. 2024;46:102242.
    Abstract

  1905. COURBIERE B, Miquel L, Bottin P, Provansal M, et al
    Heterotopic ovarian transplantation instead hormonal replacement therapy after radical hysterectomy for cervical cancer: case report and review of literature.
    J Assist Reprod Genet. 2024 Jul 14. doi: 10.1007/s10815-024-03196.
    Abstract

  1906. IBRAIMOVA DD, Tilekov EA, Shaimbetov BO, Bekeshova EN, et al
    [The lost years of potential life under cancer of neck of uterus in the Kyrgyz Republic].
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2024;32:462-466.
    Abstract

  1907. PEREZ-CRUZ E, Howlet-Caballero LC, Villanueva XJ
    Association of albumin, neutrophil-lymphocyte ratio and lymphocytes with clinical stage in cervical cancer patients.
    Clin Transl Oncol. 2024 Jul 13. doi: 10.1007/s12094-024-03575.
    Abstract

  1908. FLORES CEA, Falang BM, Gomez-Laguna L, Gutierrez GG, et al
    Enhancing Cervical Cancer Screening with 7-Type HPV mRNA E6/E7 Testing on Self-Collected Samples: Multicentric Insights from Mexico.
    Cancers (Basel). 2024;16:2485.
    Abstract

  1909. MURAMOTO Y, Murakami N, Okonogi N, Takatsu J, et al
    Dose Contribution to the Regional Lymph-Node Metastases and Point B from Intracavity and Interstitial Hybrid Brachytherapy in Locally Advanced Cervical Cancer.
    Cancers (Basel). 2024;16:2384.
    Abstract

  1910. LUCIC S, Spirovski M, Stojanovic D, Peter A, et al
    18F-FDG PET/CT- and MRI-Based Locally Advanced Cervical Cancer Early-Response Assessment after Concurrent Chemo- and Radiotherapy-Impact on Patient Outcomes and Survival Prediction.
    Diagnostics (Basel). 2024;14:1432.
    Abstract

  1911. VALLE-MENDIOLA A, Rocha-Zavaleta L, Maldonado-Lagunas V, Morelos-Laguna D, et al
    STAT5 Is Necessary for the Metabolic Switch Induced by IL-2 in Cervical Cancer Cell Line SiHa.
    Int J Mol Sci. 2024;25:6835.
    Abstract

  1912. TANAKA T, Nishie R, Murakami H, Tsuchihashi H, et al
    Oncologic Outcomes of Patients with Early-Stage Cervical Cancer after Minimally Invasive Radical Hysterectomy and Sentinel Lymph Node Biopsy.
    J Clin Med. 2024;13:3981.
    Abstract

  1913. VAN TRAPPEN P, Walgraeve MS, Roels S, Claes N, et al
    Robotic-Assisted Pelvic Exenteration for Cervical Cancer: A Systematic Review and Novel Insights into Compartment-Based Imaging.
    J Clin Med. 2024;13:3673.
    Abstract

  1914. NINKOVA RV, Calabrese A, Curti F, Riccardi S, et al
    The performance of the node reporting and data system 1.0 (Node-RADS) and DWI-MRI in staging patients with cervical carcinoma according to the new FIGO classification (2018).
    Radiol Med. 2024;129:1062-1075.
    Abstract

  1915. PORTOCARRERO-BONIFAZ A, Syed S, Kassel M, McKenzie GW, et al
    Dosimetric and toxicity comparison between Syed-Neblett and Fletcher-Suit-Delclos Tandem and Ovoid applicators in high dose rate cervix cancer brachytherapy.
    Brachytherapy. 2024;23:397-406.
    Abstract

  1916. DING X, Wan A, Qi X, Jiang K, et al
    ZNF695, A Potential Prognostic Biomarker, Correlates with Im mune Infiltrates in Cervical Squamous Cell Carcinoma and Endoce rvical Adenocarcinoma: Bioinformatic Analysis and Experimental Verification.
    Curr Gene Ther. 2024;24:441-452.
    Abstract

  1917. KHAOULA M, Saber Hassine A, Sirine B, Sana M, et al
    Cervix Relapses of Lymphoblastic Leukemia Type B.
    J Obstet Gynaecol Can. 2024;46:102414.
    Abstract

  1918. KUMAR N, Mangla M, Palo S, Gabbeta S, et al
    Stratified Mucin-Producing Intraepithelial Lesion of the Cervix in an HPV-16 Positive Woman: A Rare Encounter.
    Infect Disord Drug Targets. 2024;24:e290124226396.
    Abstract

  1919. CERNUSCHI T, Hall S, Malvolti S, Bloem P, et al
    Improving access to human papillomavirus vaccines: A case study in the IA2030 core principle of partnership.
    Vaccine. 2022 Dec 7:S0264-410X(22)01453-0. doi: 10.1016/j.vaccine.2022.
    Abstract

  1920. ZHAO M, Li Z, Gu X, Yang X, et al
    The role of radiomics for predicting of lymph-vascular space invasion in cervical cancer patients based on artificial intelligence: a systematic review and meta-analysis.
    J Gynecol Oncol. 2024 Jul 19. doi: 10.3802/jgo.2025.
    Abstract

  1921. DEVOTTA K, O'Campo P, Bender J, Lofters AK, et al
    Important and Feasible Actions to Address Cervical Screening Participation amongst South Asian Women in Ontario: A Concept Mapping Study with Service Users and Service Providers.
    Curr Oncol. 2024;31:4038-4051.
    Abstract

  1922. SCHELZ Z, Muddather HF, Jaski FS, Bozsity N, et al
    An In Vitro Investigation of the Antiproliferative and Antimetastatic Effects of Levosimendan: Potential Drug Repurposing for Cervical Cancer.
    Curr Issues Mol Biol. 2024;46:6566-6579.
    Abstract

  1923. KUGUYO O, Matimba A, Madziyire MG, Magwali T, et al
    Prevalence and predictors for cisplatin-induced toxicities in Zimbabwean women with cervical cancer.
    Future Oncol. 2024 Jul 26:1-16. doi: 10.1080/14796694.2024.2375959.
    Abstract


  1924. Retraction: MicroRNA-411 Inhibits Cervical Cancer Progression by Directly Targeting STAT3.
    Oncol Res. 2024;32:1371.
    Abstract

  1925. LIN X, Fang Y, Mi X, Fu J, et al
    Asiatic acid inhibits cervical cancer cell proliferation and migration via PI3K/AKT/mTOR signaling pathway.
    Heliyon. 2024;10:e34047.
    Abstract

  1926. LEE SY, Oh TJ, An S, Lee SH, et al
    Overexpression of Hypermethylated Homeobox A11 (HOXA11) Inhibits Tumor Cell Growth and Induces Apoptosis in Cervical Cancer.
    Dev Reprod. 2024;28:37-45.
    Abstract

  1927. ZHANG X, Zhang X, Chen Y, Ou T, et al
    Epidemiological trends and burden analysis of cervical cancer attributable to unsafe sex: A population-based study from 1990 to 2019.
    Public Health Nurs. 2024 Jul 25. doi: 10.1111/phn.13382.
    Abstract

  1928. LEE CY, Kim H, Degani I, Lee H, et al
    Empowering the on-site detection of nucleic acids by integrating CRISPR and digital signal processing.
    Nat Commun. 2024;15:6271.
    Abstract

  1929. ZHU Z, Wang Y, Han J, Li Y, et al
    Associations of Pap test utilisation with comorbidity and functional impairment among middle-aged non-Hispanic black women in the USA: a cross-sectional analysis of the 2018 BRFSS data.
    BMJ Open. 2024;14:e076247.
    Abstract

  1930. DECKER KM, Musto G, Bucher O, Czaykowski P, et al
    Examining the Association Between the COVID-19 Pandemic and the Rate of Diagnostic Tests for Breast, Cervical, and Colorectal Cancer in Manitoba, Canada.
    Technol Cancer Res Treat. 2024;23:15330338241263616.
    Abstract

  1931. BIRRER M, Li G, Yunokawa M, Lee JY, et al
    Bintrafusp Alfa for Recurrent or Metastatic Cervical Cancer After Platinum Failure: A Nonrandomized Controlled Trial.
    JAMA Oncol. 2024 Jul 25. doi: 10.1001/jamaoncol.2024.2145.
    Abstract

  1932. ZHANG Y, Liu T, He W
    The application of organoids in cancers associated with pathogenic infections.
    Clin Exp Med. 2024;24:168.
    Abstract

  1933. HU W, Fu R
    [Trans-YOLOv5: a YOLOv5-based prior transformer network model for automated detection of abnormal cells or clumps in cervical cytology images].
    Nan Fang Yi Ke Da Xue Xue Bao. 2024;44:1217-1226.
    Abstract

  1934. XING H, Yuan D, Zhu Y, Jiang L, et al
    A nomogram model based on SII, AFR, and NLR to predict infectious complications of laparoscopic hysterectomy for cervical cancer.
    World J Surg Oncol. 2024;22:190.
    Abstract

  1935. DAI W, Wang T, Chen L, Qiu Z, et al
    Immediate risk of cervical intraepithelial neoplasia and diagnostic value of colposcopy among cytology-negative women with oncogenic HPV: a retrospective study.
    BMC Womens Health. 2024;24:419.
    Abstract

  1936. INTIMAYTA-ESCALANTE C
    Ethnic inequalities in coverage and use of women's cancer screening in Peru.
    BMC Womens Health. 2024;24:418.
    Abstract

  1937. ZHANG T, Wang C, Wang K, Liang Y, et al
    Correction: RacGAP1 promotes the malignant progression of cervical cancer by regulating AP-1 via miR-192 and p-JNK.
    Cell Death Dis. 2024;15:528.
    Abstract

  1938. GENCTURK N, Karaahmet AY, Comert D
    The impact of herbal treatments on cervicovaginal human papillomavirus infection: a systematic review and meta-analysis.
    Rev Assoc Med Bras (1992). 2024;70:e20240141.
    Abstract

  1939. BENGTSON L, Lynch S
    Trauma, PTSD, and Self-Efficacy: Predictors of Cervical Cancer Screening in Sexual Violence Survivors.
    J Interpers Violence. 2024 Jul 24:8862605241265431.
    Abstract

  1940. BORNSTEIN J, Sacinti KG, Preti M, Billan S, et al
    Changing the paradigm: Elimination - Not only of cervical cancer.
    Gynecol Oncol Rep. 2024;54:101445.
    Abstract

  1941. MCGILL F, Fields PJ, Bahadoor-Yetman A, Manglardi ES, et al
    Investigating under-reported human papillomavirus genotypes in Grenadian women through self-sampling for cervical cancer screening.
    Rev Panam Salud Publica. 2024;48:e62.
    Abstract

  1942. ZUO J, Duan W, Zhao M, Chen Z, et al
    Efficacy, safety and biomarkers of SG001 for patients with previously treated recurrent or metastatic cervical cancer: an open-label, multicenter, phase Ib trial.
    Cancer Commun (Lond). 2024 Jul 23. doi: 10.1002/cac2.12578.
    Abstract

  1943. WIGHT AJ
    Latin America is catching up on HPV vaccination and screening.
    BMJ. 2024;386:q1553.
    Abstract

  1944. DUAN X, Ye D, Yuan J, Guan B, et al
    COL5A1 overexpression correlates with poor prognosis in human cervical cancer.
    Int J Biol Markers. 2024 Jul 23:3936155241265976. doi: 10.1177/03936155241265976
    Abstract

  1945. PETRIK AF, Rivelli JS, Firemark AJ, Johnson CA, et al
    A qualitative assessment of the acceptability of human papillomavirus self-sampling and informational materials among diverse populations.
    Cancer Med. 2024;13:e70033.
    Abstract

  1946. FENG Y, Li X, Sun F, Zhou J, et al
    Efficacy and Safety Analysis of Recombinant Human Endostatin (Endostar) Combined With Chemoradiotherapy for Locally Advanced Cervical Cancer: A 2-Center Retrospective Study.
    Technol Cancer Res Treat. 2024;23:15330338241263026.
    Abstract

  1947. LU D, Chen X, Mu Y, Kong L, et al
    Discontinuation and non-publication of randomized controlled trials on cervical cancer or precancer.
    Jpn J Clin Oncol. 2024 Jul 23:hyae096. doi: 10.1093.
    Abstract

  1948. JANOWSKI EM, Hall E, Jin R, Horton B, et al
    Impact of baseline lymphopenia on outcomes of definitive treatment for locally advanced cervical cancer.
    Gynecol Oncol Rep. 2024;54:101448.
    Abstract

  1949. FU Q, Chen X, Liu Y, Zhang J, et al
    Improvement of accumulated dose distribution in combined cervical cancer radiotherapy with deep learning-based dose prediction.
    Front Oncol. 2024;14:1407016.
    Abstract

  1950. BEAUSSIRE-TROUVAY L, Duhamel O, Perdrix A, Leveque E, et al
    Prognostic value of HPV circulating tumor DNA detection and quantification in locally advanced cervical cancer.
    Front Oncol. 2024;14:1382008.
    Abstract

  1951. WEI S, Chen H, Deng X, Jiang P, et al
    A case report of hemophagocytic lymphohistiocytosis induced by toripalimab plus chemoradiotherapy in cervical cancer.
    Heliyon. 2024;10:e33816.
    Abstract

  1952. RYAN N, Pratiwi SE, Mardhia M, Ysrafil Y, et al
    Immunoinformatics approach for design novel multiepitope prophylactic and therapeutic vaccine based on capsid proteins L1 and L2 and oncoproteins E6 and E7 of human papillomavirus 16 and human papillomavirus 18 against cervical cancer.
    Osong Public Health Res Perspect. 2024 Jul 23. doi: 10.24171/j.phrp.2024.0013.
    Abstract

  1953. KUMAR A
    Human papillomavirus-16 E6-positive cervical cancer attenuated by potent 2-(4-biphenylyl)-N-(1-ethyl-4-piperidinyl) acetamide second-generation analogs with improved binding affinity.
    Biotechnol Appl Biochem. 2024 Jul 22. doi: 10.1002/bab.2639.
    Abstract

  1954. GREANEY ML, Cohen SA, Allen JD
    Pap test recency and HPV vaccination among Brazilian immigrant women in the United States: a cross-sectional study.
    BMC Public Health. 2024;24:1954.
    Abstract

  1955. SIDAWAY P
    Tisotumab vedotin effective in recurrent cervical cancer.
    Nat Rev Clin Oncol. 2024 Jul 22. doi: 10.1038/s41571-024-00929.
    Abstract

  1956. HODNELAND E, Andersen E, Wagner-Larsen KS, Dybvik JA, et al
    Impact of MRI radiomic feature normalization for prognostic modelling in uterine endometrial and cervical cancers.
    Sci Rep. 2024;14:16826.
    Abstract

  1957. ACHARYA K, Bhattarai N, Dahal R, Bhattarai A, et al
    Examining the availability and readiness of health facilities to provide cervical cancer screening services in Nepal: a cross-sectional study using data from the Nepal Health Facility Survey.
    BMJ Open. 2024;14:e077537.
    Abstract

  1958. HUSSEIN K, Wafula F, Kassie GM, Kokwaro G, et al
    Barriers and facilitators to implementation of the Ethiopian national cancer control plan strategies: Implications for cervical cancer services in Ethiopia.
    PLOS Glob Public Health. 2024;4:e0003500.
    Abstract

  1959. GENG B, Oliveira CR, Hosier H, Sheth SS, et al
    Reduction in Unindicated Cervical Cancer Screening in Adolescents in a Large Health Care System.
    J Low Genit Tract Dis. 2024 Jul 23. doi: 10.1097/LGT.0000000000000831.
    Abstract

  1960. KAJABWANGU R, Bajunirwe F, Izudi J, Bazira J, et al
    Late Stage at Diagnosis of Cervical Cancer and Its Correlates at a Large Regional Referral Hospital in Uganda: A Cross-Sectional Study.
    Cureus. 2024;16:e62702.
    Abstract

  1961. YANG CY, Chang TC, Chou HH, Chao A, et al
    Evaluation of a novel vaginal cells self-sampling device for human papillomavirus testing in cervical cancer screening: A clinical trial assessing reliability and acceptability.
    Bioeng Transl Med. 2024;9:e10653.
    Abstract

  1962. MA NN, Wang T, Lv YN, Li SD, et al
    An MRI radiomics-based model for the prediction of invasion of the lymphovascular space in patients with cervical cancer.
    Front Oncol. 2024;14:1394427.
    Abstract

  1963. MYINT WW, Aggad R, Fan Q, Mendez SE, et al
    Factors Influencing Cervical Cancer Screening Uptake among Reproductive-Aged Filipino Women: Findings from the 2022 Philippines National Demographic and Health Survey.
    Womens Health Rep (New Rochelle). 2024;5:485-494.
    Abstract

  1964. KAJABWANGU R, Izudi J, Bazira J, Ssedyabane F, et al
    Effect of metabolic syndrome and its components on the risk and prognosis of cervical cancer: A literature review.
    Gynecol Oncol Rep. 2024;54:101438.
    Abstract

  1965. SOKALE IO, Thrift AP, Montealegre JR, Chido-Amajuoyi OG, et al
    Using Geospatial Analysis to Identify Priority Communities for Cervical Cancer Prevention in Texas.
    AJPM Focus. 2024;3:100247.
    Abstract

  1966. LU Z, Fan P, Huo W, Feng Y, et al
    Corrigendum to "Genomic profiles and their relationships with clinical characteristics and immune features in cervical cancer" [Translational Oncology 44 (2024) 1-10/101923].
    Transl Oncol. 2024;47:102037.
    Abstract

  1967. JIAN X, Zhang J, Huang Y, Duan J, et al
    Early salvage therapy with anti-PD-1 antibody Camrelizumab in patients with advanced cervical cancer: a retrospective study.
    Clin Transl Oncol. 2024 Jul 20. doi: 10.1007/s12094-024-03610.
    Abstract

  1968. WANG X, Xu L, Chen J, Jin Y, et al
    5-aminolevulinic acid photodynamic therapy inhibits the viability, invasion, and migration of cervical cancer SiHa cells by regulating the miR-152-3p/JAK1/STAT1 axis.
    Photodiagnosis Photodyn Ther. 2024 Jul 18:104283.
    Abstract

  1969. LE A, Wheeler SB, Lafata JE, Teal R, et al
    Self-Collection for HPV Testing: Potential Issues Related to Performance Measures and Quality Improvement Among Federally Qualified Health Centers.
    J Public Health Manag Pract. 2024;30:688-700.
    Abstract

  1970. CHEN R, Peng C, Wang Z, Xiao Y, et al
    Effects of vaginal microbiota on human papillomavirus infection and its related diseases.
    Microb Pathog. 2024;193:106761.
    Abstract

  1971. LI Y, Wan L, Li H, Tang X, et al
    Small molecule NMD and MDM2 inhibitors synergistically trigger apoptosis in HeLa cells.
    Mol Cells. 2024;47:100079.
    Abstract

  1972. NIAZMAND A, Nedaeinia R, Vatandoost N, Jafarpour S, et al
    The impacts of dipeptidyl- peptidase 4 (DPP-4) inhibitors on common female malignancies: A systematic review.
    Gene. 2024;927:148659.
    Abstract

  1973. VAHTERISTO M, Leinonen MK, Sarkeala T, Anttila A, et al
    Lower incidence of vaginal cancer after cervical human papillomavirus screening - long-term follow-up of Finnish randomized screening trial.
    Prev Med. 2024;185:108031.
    Abstract

  1974. TSUCHIDA K, Yoshida D, Shima S, Kusunoki T, et al
    Preliminary result of combined treatment with scanning carbon-ion radiotherapy and image-guided brachytherapy for locally advanced cervical adenocarcinoma.
    J Radiat Res. 2024;65:512-522.
    Abstract

  1975. J WHITE MP, Stevenson A, Elasifer H, Davies C, et al
    Integrity of RNA in long-term-stored cervical liquid-based cytology samples: implications for biomarker research.
    Biotechniques. 2024;76:245-253.
    Abstract

  1976. HWANG J, Risica PM, Lamy E, Goedel W, et al
    Association between the social vulnerability index and breast, cervical, and colorectal cancer screening rates in Rhode Island.
    Cancer Causes Control. 2024;35:1143-1149.
    Abstract

  1977. LI S, Li X, Yang YB, Wu SF, et al
    YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing the characteristics and Warburg effect of cancer stem cells.
    Apoptosis. 2024;29.
    Abstract

  1978. CHO HW, Jeong S, Song SH, Kim YT, et al
    A phase 1/2a, dose-escalation, safety, and preliminary efficacy study of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2.
    J Gynecol Oncol. 2024;35:e52.
    Abstract

  1979. FUSEGI A, Kanao H, Kamata M, Nishino S, et al
    Clinical implications of the superficial uterine vein pattern for the dissection of the anterior layer of the vesicouterine ligament in radical hysterectomy.
    J Gynecol Oncol. 2024;35:e50.
    Abstract

  1980. NIU G, Bi X, Kang Y, Zhao H, et al
    An Acceptor-Donor-Acceptor Structured Nano-Aggregate for NIR-Triggered Interventional Photoimmunotherapy of Cervical Cancer.
    Adv Mater. 2024 Aug 3:e2407199. doi: 10.1002/adma.202407199.
    Abstract

  1981. KARUNAKARA SH, Eswaran S, Mallya S, Suresh PS, et al
    Analysis of miR-497/195 cluster identifies new therapeutic targets in cervical cancer.
    BMC Res Notes. 2024;17:217.
    Abstract

  1982. EL-WAKIL DM, Shaker OG, Rashwan ASSA, Elesawy YF, et al
    High-risk human papillomavirus infection and cervical cytopathology: relationship with cervical nitric oxide levels.
    Virol J. 2024;21:173.
    Abstract

  1983. MERGA A, Yetwale F, Sisay B, Shumye M, et al
    Clients' satisfaction with cervical cancer screening services and influencing factors at public health facilities in Debre Markos town, Northwest Ethiopia, 2022/23: a convergent parallel mixed method.
    BMC Womens Health. 2024;24:441.
    Abstract

  1984. MANDIC A, Maksimovic T, Nadj GS, Maricic S, et al
    Neuroendocrine cervical cancer: Have we made any steps forward in its management?
    Eur J Surg Oncol. 2024 Jul 30:108570. doi: 10.1016/j.ejso.2024.108570.
    Abstract

  1985. SINDHU KJ, Nalini V, Suraishkumar GK, Karunagaran D, et al
    MiR-34b promotes oxidative stress and induces cellular senescence through TWIST1 in human cervical cancer.
    Transl Oncol. 2024;48:102063.
    Abstract

  1986. SATAPATHY P, Khatib MN, Neyazi A, Qanawezi L, et al
    Prevalence of human papilloma virus among cervical cancer patients in India: A systematic review and meta-analysis.
    Medicine (Baltimore). 2024;103:e38827.
    Abstract

  1987. CHEN YY, Huang YT
    Comparison of two platinum-containing chemotherapy regimens in the treatment of advanced cervical cancer with concurrent chemoradiotherapy.
    Ann Med. 2024;56:2371008.
    Abstract

  1988. ODEMIR I, Zaman F, Dogan Bas D, Sari U, et al
    Inhibitory effect of Curcumin on a cervical cancer cell line via the RAS/RAF signaling pathway.
    Histol Histopathol. 2024 Jul 17:18797. doi: 10.14670.
    Abstract

  1989. ZHANG Q, Yang D
    [Retracted] Allicin suppresses the migration and invasion in cervical cancer cells mainly by inhibiting NRF2.
    Exp Ther Med. 2024;28:370.
    Abstract

  1990. AZIZ AUR, Zhang J, Zhang C, Yu X, et al
    The mutual interplay between NTRK fusion genes and human papillomavirus infection in cervical cancer progression (Review).
    Mol Clin Oncol. 2024;21:67.
    Abstract

  1991. HALLIK R, Innos K, Janes J, Joers K, et al
    HPV self-sampling in organized cervical cancer screening program: A randomized pilot study in Estonia in 2021.
    J Med Screen. 2024 Aug 1:9691413241268819. doi: 10.1177/09691413241268819.
    Abstract

  1992. MEKONNEN BA, Anagaw YK, Kassahun BA, Worku MC, et al
    Evaluation of female university students' knowledge, attitudes, and practices toward human papillomavirus infection and vaccination. Multicenter cross-sectional study.
    BMC Womens Health. 2024;24:437.
    Abstract

  1993. QIU H, Wang M, Wang S, Li X, et al
    Integrating MRI-based radiomics and clinicopathological features for preoperative prognostication of early-stage cervical adenocarcinoma patients: in comparison to deep learning approach.
    Cancer Imaging. 2024;24:101.
    Abstract

  1994. DONG S, Peng YQ, Feng YN, Li XY, et al
    Based on 3D-PDU and clinical characteristics nomogram for prediction of lymph node metastasis and lymph-vascular space invasion of early cervical cancer preoperatively.
    BMC Womens Health. 2024;24:438.
    Abstract

  1995. SCHAUBERGER G, Klug SJ, Berger M
    Random forests for the analysis of matched case-control studies.
    BMC Bioinformatics. 2024;25:253.
    Abstract

  1996. CAJAS G, Ramos J, Campi Y, Ontaneda F, et al
    DYNAMICS OF HPV GENOTYPES AND THE RESULTS FOUND IN CYTOLOGICAL LESIONS OF UNIVERSITY STUDENTS: A COMPARATIVE STUDY.
    Georgian Med News. 2024;:88-94.
    Abstract

  1997. DAGGOLU J, Zakeri M, Sansgiry S
    Understanding racial disparities in health care expenditures for cervical cancer.
    J Manag Care Spec Pharm. 2024;30:873-881.
    Abstract

  1998. YE Z, Zhao Y, Chen M, Lu Q, et al
    Distribution and diagnostic value of single and multiple high-risk HPV infections in detection of cervical intraepithelial neoplasia: A retrospective multicenter study in China.
    J Med Virol. 2024;96:e29835.
    Abstract

  1999. GUO C, Zhan B, Li MY, Yue L, et al
    Association between oral contraceptives and cervical cancer: A retrospective case-control study based on the National Health and Nutrition Examination Survey.
    Front Pharmacol. 2024;15:1400667.
    Abstract

  2000. SPENCER JC, Wheeler CM
    Promise and Perils of Primary HPV Testing.
    Cancer Epidemiol Biomarkers Prev. 2024;33:982-983.
    Abstract

  2001. GOTTSCHLICH A, Smith LW, Proctor L, Ogilvie GS, et al
    HPV Extended Genotyping to Triage Abnormal Cervical Cancer Screens-Balancing the Harms and Benefits of an Additional Triage Test before Direct Colposcopy Referral.
    Cancer Epidemiol Biomarkers Prev. 2024;33:979-981.
    Abstract

  2002. DA SILVA AG, Silva TPRD, Vasconcelos NM, Santos FMD, et al
    Time trend analysis and impacts of the COVID-19 pandemic on mammography and Papanicolaou test coverage in Brazilian state capitals.
    BMC Womens Health. 2024;24:436.
    Abstract

  2003. NUER-ALLORNUVOR GF, Alolga RN, Liang S, Ling Z, et al
    GC-MS-based untargeted plasma metabolomics identifies a 2-biomarker panel for possible diagnosis of precancerous cervical intraepithelial neoplasia stages from cervical cancer.
    Sci Rep. 2024;14:17649.
    Abstract


  2004. Correction: Long non-coding RNA SPRY4-IT1 promotes epithelial-mesenchymal transition of cervical cancer by regulating the miR-101-3p/ZEB1 axis.
    Biosci Rep. 2024;44:BSR-2018-1339.
    Abstract

  2005. BARAL G, Oli L, Verma S, Rai S, et al
    Detection of Cervical Precancer Using Visual Inspection Method with Acetic Acid.
    J Nepal Health Res Counc. 2024;22:45-49.
    Abstract

  2006. BHATTARAI N, Bajracharya SL
    Knowledge, Practice and Factors associated with Utilization of Cervical Cancer Screening Services.
    J Nepal Health Res Counc. 2024;22:34-38.
    Abstract

  2007. O'LEARY K
    ADC superior to chemotherapy in recurrent cervical cancer.
    Nat Med. 2024 Jul 30. doi: 10.1038/d41591-024-00054.
    Abstract

  2008. ALI M, Sinha R, Kumar A, Karim S, et al
    HPV DNA status and clinical history of patients are supplements for accurate reporting of the cytological Pap smear.
    Sci Rep. 2024;14:17486.
    Abstract

  2009. YANG Z, Lai Y, Xiong C, Chen J, et al
    Illness perception and intimate relationships in patients with cervical cancer: the mediating role of dyadic coping.
    Support Care Cancer. 2024;32:557.
    Abstract

  2010. AGUDELO MC, Torres-Gonzalez E, Agudelo S, Ramirez AT, et al
    Comparison of Hybribio-H13 and Hybrid Capture(R) 2 human papillomavirus tests for detection of CIN2+ and CIN3.
    Biomedica. 2024;44.
    Abstract

  2011. ZHENG C, Shen Q, Zhao L, Wang Y, et al
    Utilising deep learning networks to classify ZEB2 expression images in cervical cancer.
    Br J Hosp Med (Lond). 2024;85:1-13.
    Abstract

  2012. PRETI M, Anderson K, Venturino E, Maggino T, et al
    Vulvar Inspection During Cervical Cancer Screening Procedures: The Ugly Reality.
    J Low Genit Tract Dis. 2024 Jul 30. doi: 10.1097/LGT.0000000000000832.
    Abstract

  2013. ZHAO YT, Guo S, Shang ZC, Ding HY, et al
    Study on the recovery of bladder function in patients with cervical cancer after operation by portable ultrasound combined.
    Int J Artif Organs. 2024 Jul 30:3913988241262593. doi: 10.1177/03913988241262593
    Abstract

  2014. RAMAMOORTHY T, Kulothungan V, Sathishkumar K, Tomy N, et al
    Burden of cervical cancer in India: estimates of years of life lost, years lived with disability and disability adjusted life years at national and subnational levels using the National Cancer Registry Programme data.
    Reprod Health. 2024;21:111.
    Abstract

  2015. LI R, Meng W, Zuo Y, Xu Y, et al
    The cervical cancer related distribution, coinfection and risk of 15 HPV types in Baoan, Shenzhen, in 2017-2023.
    Virol J. 2024;21:164.
    Abstract

  2016. AGENOR M, Noh M, Eiduson R, LeBlanc M, et al
    Correction: Barriers to and opportunities for advancing racial equity in cervical cancer screening in the United States.
    BMC Womens Health. 2024;24:433.
    Abstract

  2017. YI C, Yang J, Zhang T, Xie Z, et al
    lncRNA signature mediates mitochondrial permeability transition-driven necrosis in regulating the tumor immune microenvironment of cervical cancer.
    Sci Rep. 2024;14:17406.
    Abstract

  2018. SONG L, Gao Y, Wang Z, Ju X, et al
    Clinical changes in serum intercellular adhesion molecule 1 in cervical cancer patients receiving radiotherapy.
    Jpn J Radiol. 2024 Jul 29. doi: 10.1007/s11604-024-01628.
    Abstract

  2019. BRATCHENKO IA, Bratchenko LA
    Comment on "Raman spectroscopy combined with multivariate statistical algorithms for the simultaneous screening of cervical and breast cancers".
    Lasers Med Sci. 2024;39:197.
    Abstract

  2020. CHANG Y, Liang Y, Wu H, Li L, et al
    Adaptive assessment based on fractional CBCT images for cervical cancer.
    J Appl Clin Med Phys. 2024 Jul 27:e14462. doi: 10.1002/acm2.14462.
    Abstract

  2021. OJERINDE AC, Thorne SE, Howard AF, Kazanjian A, et al
    Cervical Cancer Screening Uptake and Experiences of Black African Immigrant Women in Canada.
    Glob Qual Nurs Res. 2024;11:23333936241266997.
    Abstract

  2022. ALMOGAHED M, Wang J, Wu D, Gao X, et al
    Vesicovaginal Fistula and Hydronephrosis Post-radiation for Cervical Cancer: Challenges and Strategies in Management.
    Cureus. 2024;16:e63195.
    Abstract

  2023. QU N, Meng Y, Zhai J, Griffin N, et al
    Corrigendum to "Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b+ NCR1+ NKs of tumor microenvironment" [Int. Immunopharmacol. 124(Pt B) (2023) 110967. doi: 10.1016/j.intimp.2023.110967. Epub 2023 Sep 21
    Int Immunopharmacol. 2024 Jul 28:112734. doi: 10.1016/j.intimp.2024.112734.
    Abstract

  2024. FODIL NE, Abdelhakem MM, Yahia GA, Ammar H, et al
    Evaluation of Dynamic Multi-Leaf Collimator (MLC) versus Fixed MLC for Intensity Modulated Radiotherapy (IMRT) Using the Agility 160-Leaf Collimator.
    Asian Pac J Cancer Prev. 2024;25:2467-2474.
    Abstract

  2025. SONG M, Yuan H, Zhang J, Wang J, et al
    Inhibitory effect of human interleukin-24 on the proliferation, migration, and invasion of cervical cancer cells.
    J Int Med Res. 2024;52:3000605241259655.
    Abstract

  2026. SCHERER-QUENZER AC, Beyers I, Kalisz A, Sauer ST, et al
    Evaluating the value of individualized 3D printed models for examination, diagnosis and treatment planning of cervical cancer.
    3D Print Med. 2024;10:25.
    Abstract

  2027. PISANI T, Capoluongo ED, Cenci M
    The Rare Condition of a Double Cervix: Results from the High-Risk Human Papillomavirus-Based Cervical Cancer Screening Program in the Lazio Region.
    Viruses. 2024;16:1149.
    Abstract

  2028. WEI H, Zhou Y, Ma F, Yang R, et al
    Full-Automatic High-Efficiency Mueller Matrix Microscopy Imaging for Tissue Microarray Inspection.
    Sensors (Basel). 2024;24:4703.
    Abstract

  2029. SANCHEZ-MEZA LV, Bello-Rios C, Eloy JO, Gomez-Gomez Y, et al
    Cationic Liposomes Carrying HPV16 E6-siRNA Inhibit the Proliferation, Migration, and Invasion of Cervical Cancer Cells.
    Pharmaceutics. 2024;16:880.
    Abstract

  2030. FERRARI F, Bonetti E, Oliveri G, Giannini A, et al
    Cold Knife Versus Carbon Dioxide for the Treatment of Preinvasive Cervical Lesion.
    Medicina (Kaunas). 2024;60:1056.
    Abstract

  2031. FERGUSON AL, Erwin E, Sleeth J, Symonds N, et al
    An Implementation Evaluation of the Smartphone-Enhanced Visual Inspection with Acetic Acid (SEVIA) Program for Cervical Cancer Prevention in Urban and Rural Tanzania.
    Int J Environ Res Public Health. 2024;21:878.
    Abstract

  2032. CHEPKORIR J, Guillaume D, Lee J, Duroseau B, et al
    The Role of Health Information Sources on Cervical Cancer Literacy, Knowledge, Attitudes and Screening Practices in Sub-Saharan African Women: A Systematic Review.
    Int J Environ Res Public Health. 2024;21:872.
    Abstract

  2033. BERMUDEZ Y, DeGroff A, Miller J, Kenney K, et al
    Changes in Screening Test Volume in the National Breast and Cervical Cancer Early Detection Program during the COVID-19 Pandemic, 2020-2022.
    Int J Environ Res Public Health. 2024;21:816.
    Abstract

  2034. CHEN YH, Wu JX, Yang SF, Wu YC, et al
    Molecular Mechanisms Underlying the Anticancer Properties of Pitavastatin against Cervical Cancer Cells.
    Int J Mol Sci. 2024;25:7915.
    Abstract

  2035. ANTONOULI S, Di Nisio V, Daponte N, Daponte AI, et al
    Cervical Cancer Genetic Profile through Circulating Tumor DNA: What Can We Learn from Blood?
    Biomolecules. 2024;14:825.
    Abstract

  2036. ALMOHIMEED A, Shehata M, El-Rashidy N, Mostafa S, et al
    ViT-PSO-SVM: Cervical Cancer Predication Based on Integrating Vision Transformer with Particle Swarm Optimization and Support Vector Machine.
    Bioengineering (Basel). 2024;11:729.
    Abstract

  2037. CHEN G, Sun H, Chen Y, Wang L, et al
    Perineural Invasion in Cervical Cancer: A Hidden Trail for Metastasis.
    Diagnostics (Basel). 2024;14:1517.
    Abstract

  2038. RONSINI C, Solazzo MC, Braca E, Andreoli G, et al
    Locally Advanced Cervical Cancer: Neoadjuvant Treatment versus Standard Radio-Chemotherapy-An Updated Meta-Analysis.
    Cancers (Basel). 2024;16:2542.
    Abstract

  2039. RESTAINO S, Pellecchia G, Arcieri M, Bogani G, et al
    Management for Cervical Cancer Patients: A Comparison of the Guidelines from the International Scientific Societies (ESGO-NCCN-ASCO-AIOM-FIGO-BGCS-SEOM-ESMO-JSGO).
    Cancers (Basel). 2024;16:2541.
    Abstract

  2040. LIRA GA, de Azevedo FM, Lins IGDS, Marques IL, et al
    High M2-TAM Infiltration and STAT3/NF-kappaB Signaling Pathway as a Predictive Factor for Tumor Progression and Death in Cervical Cancer.
    Cancers (Basel). 2024;16:2496.
    Abstract

  2041. HE S, Zhu G, Zhou Y, Yang B, et al
    Predictive models for personalized precision medical intervention in spontaneous regression stages of cervical precancerous lesions.
    J Transl Med. 2024;22:686.
    Abstract

  2042. EFFAH K, Tekpor E, Wormenor CM, Bosoka SA, et al
    Expanding management strategies for cervical precancerous lesions in resource-limited settings: insights from a training center in a district hospital in Ghana.
    BMC Womens Health. 2024;24:428.
    Abstract

  2043. WANG Z, Gao H, Wang X, Grzegorzek M, et al
    A multi-Task Learning based applicable AI model simultaneously predicts stage, histology, grade and LNM for cervical cancer before surgery.
    BMC Womens Health. 2024;24:425.
    Abstract

  2044. DANG TH, Rieu-Werden ML, Kobrin SC, Tiro JA, et al
    Association Between Clinician Confidence and Making Guideline-Recommended Decisions in the Management of Abnormal Cervical Cancer Screening Results.
    J Gen Intern Med. 2024 Jul 25. doi: 10.1007/s11606-024-08943.
    Abstract

  2045. ISLAM MA, Hossain MS, Hasnat S, Shuvo MH, et al
    In-silico study unveils potential phytocompounds in Andrographis paniculata against E6 protein of the high-risk HPV-16 subtype for cervical cancer therapy.
    Sci Rep. 2024;14:17182.
    Abstract

  2046. KRISTENSEN ML, Waldstrom M, Laursen ASD, Eriksen K, et al
    Cervical intraepithelial neoplasia and fecundability: a prospective cohort study.
    Hum Reprod. 2024;39:1835-1843.
    Abstract

  2047. TAGUCHI A, Yoshimoto D, Kusakabe M, Baba S, et al
    Impact of human papillomavirus types on uterine cervical neoplasia.
    J Obstet Gynaecol Res. 2024;50:1283-1288.
    Abstract

  2048. THOMAS A, Menon S, Rekhi B, Mittal N, et al
    Clear cell adenocarcinoma of the cervix and its mimickers - A series of 19 cases from a tertiary care referral centre in India.
    Indian J Pathol Microbiol. 2024;67:619-623.
    Abstract

  2049. TINELLI M, Athanasiou A, Veroniki AA, Efthimiou O, et al
    Treatment methods for cervical intraepithelial neoplasia in England: A cost-effectiveness analysis.
    BJOG. 2024;131:1411-1419.
    Abstract

  2050. TAO AS, Zuna R, Darragh TM, Grabe N, et al
    Interobserver reproducibility of cervical histology interpretation with and without p16 immunohistochemistry.
    Am J Clin Pathol. 2024;162:202-209.
    Abstract

  2051. LEE MW, Vallejo A, Furey KB, Woll SM, et al
    Racial and ethnic differences in early-death among gynecologic malignancy.
    Am J Obstet Gynecol. 2024 Mar 7:S0002-9378(24)00432.
    Abstract

  2052. YILDIRIM HC, Anik H, Ozdemir DA, Ismayilov R, et al
    Effect of hypoxia-inducible factor-1 alpha expression on survival in patients with metastatic cervical squamous cell carcinoma treated with first-line chemotherapy and bevacizumab.
    Biomol Biomed. 2024;24:998-1003.
    Abstract

  2053. ZHANG L, Yang X, Zhang Y, Wen Y, et al
    Cervical metastasis of breast cancer: A case report and literature review.
    Medicine (Baltimore). 2024;103:e39275.
    Abstract

  2054. HELMI N, Hamadi A, Al-Amer OM, Madkhali HA, et al
    Unveiling the potency of FDA-approved oxidopamine HBr for cervical cancer regulation and replication proteins.
    Med Oncol. 2024;41:223.
    Abstract

  2055. XIAO H, Han Q, Wei S, Du M, et al
    Setup errors analysis in iterative kV CBCT: A clinical study of cervical cancer treated with Volumetric Modulated Arc Therapy.
    J Appl Clin Med Phys. 2024 Aug 9:e14480. doi: 10.1002/acm2.14480.
    Abstract

  2056. SONG R, Cong L, Ni G, Chen M, et al
    [Retracted] MicroRNA?195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF.
    Oncol Lett. 2024;28:464.
    Abstract

  2057. YU H, Lin Y, Lin J, Xie N, et al
    Causes of death analysis and the prognostic model construction in neuroendocrine carcinoma of the cervix: A SEER-based study.
    Cancer Med. 2024;13:e70066.
    Abstract

  2058. KALSOOM A, Altaf A, Sarwar M, Maqbool T, et al
    GC-MS analysis, molecular docking, and apoptotic-based cytotoxic effect of Caladium lindenii Madison extracts toward the HeLa cervical cancer cell line.
    Sci Rep. 2024;14:18438.
    Abstract

  2059. ZHANG Y, Zou J, Li L, Han M, et al
    Comprehensive assessment of postoperative recurrence and survival in patients with cervical cancer.
    Eur J Surg Oncol. 2024;50:108583.
    Abstract

  2060. BERNARD L, Pond GR, Elit L, Vicus D, et al
    Safety of vaginal surgery for early-stage cervical cancer: A retrospective multicenter cohort study.
    Eur J Surg Oncol. 2024;50:108518.
    Abstract

  2061. FUADY A, Setiawan D, Man I, de Kok IMCM, et al
    Toward a Framework to Assess the Financial and Economic Burden of Cervical Cancer in Low- and Middle-Income Countries: A Systematic Review.
    JCO Glob Oncol. 2024;10:e2400066.
    Abstract

  2062. BROWN R, Holloway L, Lau A, Lim K, et al
    Potential anatomical triggers for plan adaptation of cervical cancer external beam radiotherapy.
    Phys Eng Sci Med. 2024 Aug 8. doi: 10.1007/s13246-024-01473.
    Abstract

  2063. REZA S, Anjum R, Khandoker RZ, Khan SR, et al
    Public health concern-driven insights and response of low- and middle-income nations to the World health Organization call for cervical cancer risk eradication.
    Gynecol Oncol Rep. 2024;54:101460.
    Abstract

  2064. DENG B, Kong W, Han C, Zhou C, et al
    Study of long-term effects of pelvic radiotherapy on the function of bone marrow in recurrent cervical cancer patients.
    Int J Med Sci. 2024;21:2000-2010.
    Abstract

  2065. REGINACOVA K, Pospisilova E, Kubecova M, Svobodova P, et al
    Circulating tumor cells in patients with cervical cancer undergoing chemoradiotherapy combined with brachytherapy.
    Am J Cancer Res. 2024;14:3614-3625.
    Abstract

  2066. SUN Y, Peng Q, Wang R, Yin Y, et al
    Elevated expression of Golgi Transport 1B promotes the progression of cervical cancer by activating NF-kappaB signaling pathway via interaction with TBK1.
    Carcinogenesis. 2024 Aug 8:bgae054. doi: 10.1093.
    Abstract

  2067. KANG C, Qiu L, Duo Y, Bi F, et al
    HPV18 E6/E7 activates Ca(2+) influx to promote the malignant progression of cervical cancer by inhibiting Ca(2+) binding protein 1 expression.
    Biotechnol Appl Biochem. 2024 Aug 7. doi: 10.1002/bab.2650.
    Abstract

  2068. COURSEY K, Muralidhar K, Srinivas V, Jaykrishna P, et al
    Acceptability of HPV vaccination for cervical cancer prevention amongst emerging adult women in rural Mysore, India: a mixed-methods study.
    BMC Public Health. 2024;24:2139.
    Abstract

  2069. BEYENE DA, Ayele SG, Wubneh HD, Tsige AW, et al
    Male support for cervical cancer screening in Debre Berhan City Ethiopia a community based cross sectional survey.
    Sci Rep. 2024;14:18302.
    Abstract

  2070. LIANG Y, Guo Y, Zhai Y, Zhou J, et al
    Disease trend analysis platform accurately predicts the occurrence of cervical cancer under mixed diseases.
    Methods. 2024 Aug 5:S1046-2023(24)00180-4. doi: 10.1016/j.ymeth.2024.
    Abstract

  2071. GNANAGURUSAMY J, Krishnamoorthy S, Muthusami S
    Transforming growth factor-beta micro-environment mediated immune cell functions in cervical cancer.
    Int Immunopharmacol. 2024;140:112837.
    Abstract

  2072. RAMASWAMY M, Hall B, Cejtin H, Sufrin C, et al
    Cervical Cancer Prevention in Individuals With Criminal Legal System Involvement.
    J Low Genit Tract Dis. 2024 Aug 7. doi: 10.1097/LGT.0000000000000833.
    Abstract

  2073. BRAUTIGAM K, Meier S, Koster F, Rody A, et al
    CER818: A Highly Specific and Sensitive HPV L1 High-Risk Serological Lateral Flow Rapid Test for Early Detection of Cervical Cancer and Its Precursor Lesions.
    Infect Dis Obstet Gynecol. 2024;2024:6651272.
    Abstract

  2074. HUANG X, Liu W, Liu C, Hu J, et al
    Corrigendum: CMTM6 as a candidate risk gene for cervical cancer: comprehensive bioinformatics study.
    Front Mol Biosci. 2024;11:1452740.
    Abstract

  2075. HU JP, Wang JL, Li Y, Feng Y, et al
    Prevalence and genotype distribution of human papillomavirus infection among 66000 women from 2014 to 2023 in the plateau region of Southwest China.
    Virol J. 2024;21:176.
    Abstract

  2076. MORSE RM, Brown J, Rios Lopez EJ, Prieto BA, et al
    Challenges associated with follow-up care after implementation of an HPV screen-and-treat program with ablative therapy for cervical cancer prevention.
    BMC Public Health. 2024;24:2121.
    Abstract

  2077. WANG Z, Wang B, Feng Y, Ye J, et al
    Targeting tumor-associated macrophage-derived CD74 improves efficacy of neoadjuvant chemotherapy in combination with PD-1 blockade for cervical cancer.
    J Immunother Cancer. 2024;12:e009024.
    Abstract

  2078. SARMIENTO-MEDINA MI, Velasquez-Jimenez CM, Ortiz-Hernandez N
    Experiences of a group of indigenous women from the Colombian Amazon with cervical cancer prevention screening. Qualitative study in the context of participatory research to reduce inequalities.
    Ethn Health. 2024 Aug 6:1-15. doi: 10.1080/13557858.2024.2387112.
    Abstract

  2079. DILLNER J
    [Human papillomavirus type 18 - In memoriam].
    Lakartidningen. 2024;121:24055.
    Abstract

  2080. WANG S, Qiao X, Cui Y, Liu L, et al
    NCAPH, ubiquitinated by TRIM21, promotes cell proliferation by inhibiting autophagy of cervical cancer through AKT/mTOR dependent signaling.
    Cell Death Dis. 2024;15:565.
    Abstract


  2081. [Expert consensus on p16/Ki-67 dual staining in cervical cytology].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:783-788.
    Abstract

  2082. MACHADO COLLING A, Creagh NS, Gogia N, Wyatt K, et al
    The acceptability of, and informational needs related to, self-collection cervical screening among women of Indian descent living in Victoria, Australia: A qualitative study.
    Health Expect. 2024;27:e13961.
    Abstract

  2083. ELMALI A, Guler OC, Demirhan B, Yavuz M, et al
    Long-term analysis of hematological parameters as predictors of recurrence patterns and treatment outcomes in cervical cancer patients undergoing definitive chemoradiotherapy.
    Strahlenther Onkol. 2024 Aug 5. doi: 10.1007/s00066-024-02278.
    Abstract

  2084. LIU T, Xie Q, Wang W
    Ultrasound-stimulated microbubbles enhances radiosensitivity in cervical cancer.
    Int J Radiat Biol. 2024 Aug 5:1-10. doi: 10.1080/09553002.2024.2374903.
    Abstract

  2085. MOKWENA BP, Gundo R, Mulaudzi FM
    Factors that influence the uptake of human papillomavirus vaccine among preadolescent girls in South Africa: A Scoping Review.
    Afr J Reprod Health. 2024;28:127-148.
    Abstract

  2086. DEVNATH R, Sharma K
    Government's bold initiatives: tackling cervical cancer in India with determination and commitment.
    Curr Med Res Opin. 2024 Aug 5:1-4. doi: 10.1080/03007995.2024.2388221.
    Abstract

  2087. CHEN L, Ming H, Li B, Yang C, et al
    Tumor-Specific Nano-Herb Delivery System with High L-Arginine Loading for Synergistic Chemo and Gas Therapy against Cervical Cancer.
    Small. 2024 Aug 5:e2403869. doi: 10.1002/smll.202403869.
    Abstract

  2088. EISENBLATTER R, Seifert F, Schurmann P, Beckhaus T, et al
    Validation and functional follow-up of cervical cancer risk variants at the HLA locus.
    HLA. 2024;104:e15597.
    Abstract

  2089. QIN L, Li D, Wang Z, Lan J, et al
    Comparison of multiplex PCR capillary electrophoresis assay and PCR-reverse dot blot assay for human papillomavirus DNA genotyping detection in cervical cancer tissue specimens.
    Front Public Health. 2024;12:1421774.
    Abstract

  2090. ALOHALI MA, El-Rashidy N, Alaklabi S, Elmannai H, et al
    Swin-GA-RF: genetic algorithm-based Swin Transformer and random forest for enhancing cervical cancer classification.
    Front Oncol. 2024;14:1392301.
    Abstract

  2091. PANG XY, Zhou R, Song RT, Li N, et al
    [Effect of total saponins from Panacis Majoris Rhizoma on proliferation, apoptosis and autophagy of human cervical carcinoma HeLa cells].
    Zhongguo Zhong Yao Za Zhi. 2024;49:3848-3856.
    Abstract

  2092. NGAMBI D, Ramathuba DU
    Challenges regarding the implementation of cervical cancer screening guidelines in Limpopo province, South Africa.
    Afr J Prim Health Care Fam Med. 2024;16:e1-e7.
    Abstract

  2093. NDUBUISI CC, Maphasha O, Okeke SO
    Knowledge and awareness of cervical cancer and human papillomavirus vaccination among female university students.
    S Afr Fam Pract (2004). 2024;66:e1-e8.
    Abstract

  2094. CHITRA K, Sureshkumar M, Muraleedharan A, Selvamaleeswaran P, et al
    In vitro cancer cell line luminescence-based validation of anticancer phytocompounds obtained from Leucas biflora against HELA cervical and A549 lung cancer cells.
    Luminescence. 2024;39:e4855.
    Abstract

  2095. WEI F, Georges D, Man I, Baussano I, et al
    Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature.
    Lancet. 2024;404:435-444.
    Abstract

  2096. SCHIFFMAN M, de Sanjose S
    The rational design of cervical cancer prevention strategies.
    Lancet. 2024;404:406-407.
    Abstract

  2097. LEI J, Zhang J, You C, Liu M, et al
    First-Line Treatment with Atezolizumab plus Bevacizumab and Chemotherapy for US Patients with Metastatic, Persistent, or Recurrent Cervical Cancer: A Cost-Effectiveness Analysis.
    Value Health. 2024 Aug 1:S1098-3015(24)02796-7. doi: 10.1016/j.jval.2024.
    Abstract

  2098. PANKAJ S, Rani J, Kumari P, Abhilashi K, et al
    Prevalence, risk factors and genotype distribution of human papillomavirus infection among women with and without invasive cervical cancer: Findings from a hospital-based study in Bihar, India.
    Natl Med J India. 2024;37:13-17.
    Abstract

  2099. LAI B, Yi Y, Yang X, Li X, et al
    Dynamic contrast-enhanced and diffusion-weighted MRI of cervical carcinoma: Correlations with Ki-67 proliferation status.
    Magn Reson Imaging. 2024 Jul 17:S0730-725X(24)00185.
    Abstract

  2100. LAUFER J, Scasso S, Papadia A
    Different tracers for sentinel node detection in gynecologic oncology.
    Curr Opin Oncol. 2024;36:371-375.
    Abstract

  2101. WANG Y, Song W, Wang H, Zhu G, et al
    Increased risk of subsequent primary lung cancer among female hormone-related cancer patients: A meta-analysis based on over four million cases.
    Chin Med J (Engl). 2024;137:1790-1801.
    Abstract

  2102. FAKTOR J, Henek T, Hernychova L, Singh A, et al
    Metaproteomic analysis from cervical biopsies and cytologies identifies proteinaceous biomarkers representing both human and microbial species.
    Talanta. 2024;278:126460.
    Abstract

  2103. WANG A, Zhang P, Bian C, Chen M, et al
    Laparoscopic Total Mesorectal Excision With Combined Resection of the Ureter and Ureterovesical Reimplantation for Recurrent Cervical Adenocarcinoma.
    Dis Colon Rectum. 2024;67:e1540-e1541.
    Abstract

  2104. BERCOW A, Del Carmen MG, Rauh-Hain JA, Melamed A, et al
    Role of Minimally Invasive Techniques in the Management of Early-Stage Carcinoma of the Uterine Cervix.
    J Clin Oncol. 2024;42:2731-2735.
    Abstract

  2105. XIAO ML, Fu L, Ma FH, Li YA, et al
    Comparison of MRI features among squamous cell carcinoma, adenocarcinoma and adenosquamous carcinoma, usual-type endocervical adenocarcinoma and gastric adenocarcinoma of cervix.
    Magn Reson Imaging. 2024 Jun 5:S0730-725X(24)00165.
    Abstract

  2106. QIAO R, Yuan Z, Yang M, Tang Z, et al
    Selenium-Doped Nanoheterojunctions for Highly Efficient Cancer Radiosensitization.
    Adv Sci (Weinh). 2024;11:e2402039.
    Abstract

  2107. GALE A
    Increasing Referral Acceptance for Women's Health Services Among Hispanic Women.
    Nurs Womens Health. 2024;28:296-302.
    Abstract

  2108. POLUEKTOVA O, Robertson DA, Papadopoulos A, Lunn PD, et al
    Trust in cervical screening and attributions of blame for interval cancers following a national controversy.
    Br J Health Psychol. 2024;29:788-813.
    Abstract

  2109. YONG X, Zhang Y, Tang H, Hu H, et al
    CDKN2A inhibited ferroptosis through activating JAK2/STAT3 pathway to modulate cisplatin resistance in cervical squamous cell carcinoma.
    Anticancer Drugs. 2024;35:698-708.
    Abstract

  2110. CETIN SA, Cinar D
    Determination of Opinions on HPV Infection and HPV Vaccine among Nursing Students by Focus Group Discussion.
    J Adolesc Young Adult Oncol. 2024;13:693-702.
    Abstract

  2111. DOMINONI M, Barcellini A, Pasquali MF, De Silvestri A, et al
    The Role of Neutrophil-Lymphocytes Ratio in the Prognosis of CIN2+ Recurrence after Excisional Treatment.
    Gynecol Obstet Invest. 2024;89:295-303.
    Abstract

  2112. TAN JHJ, Neesham D, Szabo RA, Khomko N, et al
    Colposcopy performance in the new primary HPV screening in Australia: How to determine colposcopy competency?
    Aust N Z J Obstet Gynaecol. 2024;64:375-382.
    Abstract

  2113. ORMANDY J, Phillips S, Campbell M, Haenga-Melvin B, et al
    'I was able to make a better decision about my health.' Wahine experiences of colposcopy at a marae-based health clinic: A qualitative study.
    Aust N Z J Obstet Gynaecol. 2024;64:368-374.
    Abstract

  2114. DEANS R, Moses D, Sach TA, Vancaillie T, et al
    Perfusion magnetic resonance imaging in Asherman syndrome.
    Aust N Z J Obstet Gynaecol. 2024;64:341-346.
    Abstract

  2115. VAN OOSTEROM MN, Diaz-Feijoo B, Santisteban MI, Sanchez-Izquierdo N, et al
    Steerable DROP-IN radioguidance during minimal-invasive non-robotic cervical and endometrial sentinel lymph node surgery.
    Eur J Nucl Med Mol Imaging. 2024;51:3089-3097.
    Abstract

  2116. LIU FY, Chen WC, Pan YB, Wang CC, et al
    Clinical factor-based risk stratification for precision therapy in locally advanced squamous cell carcinoma of the uterine cervix.
    Cancer Med. 2024;13:e6746.
    Abstract

  2117. CHEN T, Zheng W, Hu H, Luo C, et al
    A Corresponding Region Fusion Framework for Multi-Modal Cervical Lesion Detection.
    IEEE/ACM Trans Comput Biol Bioinform. 2024;21:959-970.
    Abstract

  2118. ZHANG X, Gu M, Zhu J, Gu R, et al
    Prognostic value of Naples Prognostic Score in locally advanced cervical cancer patients undergoing concurrent chemoradiotherapy.
    Biomol Biomed. 2024 Aug 15. doi: 10.17305/bb.2024.10989.
    Abstract

  2119. ZHANG X, Yin WJ, Zhang AL, Zhang XX, et al
    Meta-analysis of efficacy and safety of pembrolizumab for the treatment of advanced or recurrent cervical cancer.
    J Obstet Gynaecol. 2024;44:2390564.
    Abstract

  2120. RIJAL BM, Dawadi P
    Knowledge, attitudes and associated factors regarding cervical cancer and its screening practice among women of central Nepal.
    Heliyon. 2024;10:e34886.
    Abstract

  2121. ZHONG H, Pan W, Chen B, Gu J, et al
    A real-world, cross-sectional, and longitudinal study on high-risk human papillomavirus genotype distribution in 31,942 women in Dongguan, China.
    Front Public Health. 2024;12:1409030.
    Abstract

  2122. CORA-CRUZ MS, Martinez O, Perez S, Fang CY, et al
    Evaluating human papillomavirus (HPV) self-sampling among Latinas in the United States: A systematic review.
    Cancer Med. 2024;13:e70098.
    Abstract

  2123. MINAMITANI M, Tatemichi M, Mukai T, Katano A, et al
    Adherence to national guidelines for colorectal, breast, and cervical cancer screenings in Japanese workplaces: a survey-based classification of enterprises' practices into "overscreening," "underscreening," and "guideline-adherence screening".
    BMC Public Health. 2024;24:2223.
    Abstract

  2124. ZHU J, Yan J, Zhang J, Yu L, et al
    Automatic segmentation of high-risk clinical target volume and organs at risk in brachytherapy of cervical cancer with a convolutional neural network.
    Cancer Radiother. 2024 Aug 14:S1278-3218(24)00092.
    Abstract

  2125. MONDAL S, Pradhan R, Chakraborty A, Chatterjee S, et al
    Osseous Metaplasia of Cervix Mimicking Cervical Cancer - A Rare Case Report.
    J Midlife Health. 2024;15:122-124.
    Abstract

  2126. SHAMSUNDER S, Mishra A, Kumar A, Beriwal R, et al
    Diagnostic Efficacy of Enhanced Visual Assessment [Visual Check] for Triaging Cervical Cancer Screen Positive Women.
    J Midlife Health. 2024;15:69-74.
    Abstract

  2127. RUAN XF, Wen DT, Xu Z, Du TT, et al
    Identification and validation of ferroptosis-related prognostic gene signature in patients with cervical cancer.
    Transl Cancer Res. 2024;13:3382-3396.
    Abstract

  2128. DU L, Yuan Q, Zhang M, Ma R, et al
    Using amide proton transfer-weighted magnetic resonance imaging (MRI) in peritumor tissue to predict parametrial infiltration of cervical cancer: a case-control study.
    Quant Imaging Med Surg. 2024;14:5803-5813.
    Abstract

  2129. ZHU S, Lin L, Liu Q, Liu J, et al
    Integrating a deep neural network and Transformer architecture for the automatic segmentation and survival prediction in cervical cancer.
    Quant Imaging Med Surg. 2024;14:5408-5419.
    Abstract

  2130. QIU Q, Song JR, Zheng XQ, Zheng H, et al
    The impact of diabetes, hypercholesterolemia, and low-density lipoprotein (LDL) on the survival of cervical cancer patients.
    Discov Oncol. 2024;15:349.
    Abstract

  2131. CHEN X, Xu T, Wu J, Sun C, et al
    Exploring factors influencing awareness and knowledge of human papillomavirus in Chinese college students: A cross-sectional study.
    Hum Vaccin Immunother. 2024;20:2388347.
    Abstract

  2132. CINTRA RC, Cespedes AG, Conceicao MPF, Oliveira MVAS, et al
    Computational insights into CRISP3 downregulation in cervical cancer and its cervical lineages pattern.
    Precis Clin Med. 2024;7:pbae016.
    Abstract

  2133. KAJABWANGU R, Ngonzi J, Izudi J, Bazira J, et al
    Association between metabolic syndrome and cervical cancer among women in Southwestern Uganda: A case-control study.
    Gynecol Oncol Rep. 2024;54:101465.
    Abstract

  2134. MORETTI-MARQUES R, Franca IB, de Cillo PE, Alvarenga-Bezerra V, et al
    First birth after uterine transposition in low-volume lymph node metastasis of cervical cancer: A long journey for success.
    J Surg Oncol. 2024 Aug 13. doi: 10.1002/jso.27805.
    Abstract

  2135. LIANG ZQ, Zhang W, Zeng DT, Chen JH, et al
    Upregulation of hsa-miR-141-3p promotes uterine cervical carcinoma progression via targeting dual-specificity protein phosphatase 1.
    Funct Integr Genomics. 2024;24:137.
    Abstract

  2136. LI ML, Qi JL, Ma YQ, Shu W, et al
    National age-specific mortality trends for cervical and breast cancers in urban-rural areas of China from 2009 to 2021: a population-based analysis.
    Mil Med Res. 2024;11:55.
    Abstract

  2137. CUI X, Yang D, Zhang J, Zhao Y, et al
    Clinical value of optical coherence tomography in the early diagnosis of cervical cancer and precancerous lesions: a cross-sectional study.
    Front Oncol. 2024;14:1423128.
    Abstract

  2138. ALSHAMMARI AH, Ishii H, Hirotsu T, Hatakeyama H, et al
    Bridging the gap in cervical cancer screening for underserved communities: MCED and the promise of future technologies.
    Front Oncol. 2024;14:1407008.
    Abstract

  2139. MENSAH K, Mosquera I, Tisler A, Uuskula A, et al
    Development and pilot implementation of a novel protocol to assess capacity and readiness of health systems to adopt HPV detection-based cervical cancer screening in Europe.
    Health Res Policy Syst. 2024;22:102.
    Abstract

  2140. ORTIZ AP, Torres-Cintron CR, Santiago-Rodriguez EJ, Ramos-Cartagena JM, et al
    Recent cervical cancer incidence, stage at diagnosis, and mortality trends in Puerto Rico, 2001-2019.
    BMC Med. 2024;22:327.
    Abstract

  2141. LI Y, Dong Y
    TTI-101 targets STAT3/c-Myc signaling pathway to suppress cervical cancer progression: an integrated experimental and computational analysis.
    Cancer Cell Int. 2024;24:286.
    Abstract

  2142. TU H, Zhang L, Xu M, Zhao Z, et al
    The mediating effect of self-efficacy on social support and cancer screening behavior among Chinese women: a cross-sectional study.
    BMC Womens Health. 2024;24:454.
    Abstract

  2143. CHARLEBOIS S, Kean S
    [Not Available].
    CMAJ. 2024;196:E960-E962.
    Abstract

  2144. MANDATO VD, Torricelli F, Mastrofilippo V, Vacca I, et al
    ABO/Rh Blood Group and Cervical Cancer Survival: Results from Our Own and Other Studies.
    J Cancer. 2024;15:4777-4788.
    Abstract

  2145. DI LISA FS, Villa A, Filomeno L, Arcuri T, et al
    Breast and cervical cancer in transgender men: literature review and a case report.
    Ther Adv Med Oncol. 2024;16:17588359241259466.
    Abstract

  2146. SHANG X, Wang H, Gu J, Zhao X, et al
    Ferroptosis-related gene transferrin receptor protein 1 expression correlates with the prognosis and tumor immune microenvironment in cervical cancer.
    PeerJ. 2024;12:e17842.
    Abstract

  2147. SADEGHI MH, Sina S, Meigooni AS
    Assessing Heterogeneity Effects on Points A, B, and Organs at Risk Doses in High-dose-Rate Brachytherapy for Cervical Cancer - A Comparison of (192)Ir and (60)Co Sources Using Monte Carlo N-Particle 5.
    J Med Phys. 2024;49:294-303.
    Abstract

  2148. BALARAJ K, Roy S, Shanbhag NM, Hasnain SM, et al
    Clinical Outcomes and Treatment Efficacy in Cervical Cancer Patients in the UAE: A Retrospective Cohort Study.
    Cureus. 2024;16:e64422.
    Abstract

  2149. HAMZAOUI E, Zallez OBY, Bunay J, Leremboure M, et al
    Comparative Study of Essential Oils from Tunisian Pinus Halepensis Mill. by Hydrodistillation and Microwave-Assisted Processes: Chemical Composition and Antioxidant and Cytotoxic Potential against Prostate and Cervical Cancer Cells.
    ACS Omega. 2024;9:34128-34139.
    Abstract

  2150. RIZKALLA CN, Huang EC
    Cervical Human Papillomavirus Testing: Current and Future Impact on Patient Care.
    Surg Pathol Clin. 2024;17:431-439.
    Abstract

  2151. GULHAN I, Ozdemir R, Ileri A, Ileri H, et al
    The role of endocervical curettage in the diagnosis of cervical intraepithelial neoplasia in human papillomavirus positive patients.
    Ann Saudi Med. 2024;44:220-227.
    Abstract

  2152. SUN W, Cai H, Zhang K, Cui H, et al
    Targeting MCL1 with Sanggenon C overcomes MCL1-driven adaptive chemoresistance via dysregulation of autophagy and endoplasmic reticulum stress in cervical cancer.
    Phytomedicine. 2024;133:155935.
    Abstract

  2153. YUAN G, Qian P, Chen L, He N, et al
    Kuwanon C Inhibits Tumor Cell Proliferation and Induces Apoptosis by Targeting Mitochondria and Endoplasmic Reticulum.
    Int J Mol Sci. 2024;25:8293.
    Abstract

  2154. YUE J, Yin Y, Feng X, Xu J, et al
    Discovery of the Inhibitor Targeting the SLC7A11/xCT Axis through In Silico and In Vitro Experiments.
    Int J Mol Sci. 2024;25:8284.
    Abstract

  2155. BONIEWSKA-BERNACKA E, Panczyszyn A, Glab G, Goc A, et al
    Telomere Length, Telomerase Activity, and Vaginal Microbiome in Patients with HPV-Related Precancerous Lesions.
    Int J Mol Sci. 2024;25:8158.
    Abstract

  2156. GUSAKOV K, Kalinkovich A, Ashkenazi S, Livshits G, et al
    Nature of the Association between Rheumatoid Arthritis and Cervical Cancer and Its Potential Therapeutic Implications.
    Nutrients. 2024;16:2569.
    Abstract

  2157. MASSOBRIO R, Bianco L, Campigotto B, Attianese D, et al
    New Frontiers in Locally Advanced Cervical Cancer Treatment.
    J Clin Med. 2024;13:4458.
    Abstract

  2158. AKGOR U, Ozgul N, Gunes AC, Turkyilmaz M, et al
    Evaluation of Endocervical Curettage in Colposcopy in the Turkish Cervical Cancer Screening Program.
    J Clin Med. 2024;13:4417.
    Abstract

  2159. SZNURKOWSKI JJ, Bodnar L, Szylberg L, Zolciak-Siwinska A, et al
    The Polish Society of Gynecological Oncology Guidelines for the Diagnosis and Treatment of Cervical Cancer (v2024.0).
    J Clin Med. 2024;13:4351.
    Abstract

  2160. JEEUNNGOI J, Senawong G, Jogloy S, Prompipak J, et al
    Anticancer Potential of Valencia Peanut (Arachis hypogaea L.) Skin Extract against Cervical Cancer Cells In Vitro and in Nude Mouse Xenograft Models.
    Foods. 2024;13:2354.
    Abstract

  2161. JO JH, Lee JW, Seol KH
    Assessing the Adequacy of Traditional Vertebral Landmarks as Upper Border of Whole Pelvic Radiotherapy Field for Stage IB2-IIB Cervical Cancer.
    Cancers (Basel). 2024;16:2743.
    Abstract

  2162. KOSTOV S, Kornovski Y, Watrowski R, Yordanov A, et al
    Revisiting Querleu-Morrow Radical Hysterectomy: How to Apply the Anatomy of Parametrium and Pelvic Autonomic Nerves to Cervical Cancer Surgery?
    Cancers (Basel). 2024;16:2729.
    Abstract

  2163. AMENGUAL VILA J, Torrent Colomer A, Sampol Bas C, Quintero Duarte A, et al
    Detecting Atypical Sentinel Lymph Nodes in Early-Stage Cervical Cancer Using a Standardized Technique with a Hybrid Tracer.
    Cancers (Basel). 2024;16:2626.
    Abstract

  2164. LUO Q, Zhang H, Zeng X, Han N, et al
    HPV specificity and multiple infections and association with cervical cytology in Chongqing, China: a cross-sectional study.
    BMC Infect Dis. 2024;24:804.
    Abstract

  2165. ELANGAINESAN P, Naimer MS, Kukan S, Selk A, et al
    Are we ready for human papillomavirus testing? Assessment of patient knowledge of and preferences for cervical cancer screening in Ontario.
    Can Fam Physician. 2024;70.
    Abstract

  2166. ZHANG Q, Cai W
    The closed loop of the circCLIP2/miR-361-3p/STAT2 signaling axis regulates the progression of cervical cancer.
    Am J Med Sci. 2024 Aug 7:S0002-9629(24)01396-X. doi: 10.1016/j.amjms.2024.
    Abstract

  2167. HUANG R, Liu Z, Sun T, Zhu L, et al
    Cervicovaginal microbiome, high-risk HPV infection and cervical cancer: Mechanisms and therapeutic potential.
    Microbiol Res. 2024;287:127857.
    Abstract

  2168. ZHANG Z, Zhao H, Cheng G
    Long term clinical outcomes of cervical cancer patients who were recommended surgery but did not undergo it: A SEER database study.
    Eur J Surg Oncol. 2024;50:108572.
    Abstract

  2169. ATKINS HM, Uslu AA, Li JJ, Shearer DA, et al
    Monitoring mouse papillomavirus-associated cancer development using longitudinal Pap smear screening.
    mBio. 2024;15:e0142024.
    Abstract

  2170. FEI M, Shen Z, Song Z, Wang X, et al
    Distillation of multi-class cervical lesion cell detection via synthesis-aided pre-training and patch-level feature alignment.
    Neural Netw. 2024;178:106405.
    Abstract

  2171. GANZ EM, Brown B, Smith H, Wellisch L, et al
    The association between affordable care act implementation and the prevalence of women having ever received a Pap smear.
    J Obstet Gynaecol. 2024;44:2393359.
    Abstract

  2172. CHEN C, Xiong L, Lin Y, Li M, et al
    Super-resolution reconstruction for early cervical cancer magnetic resonance imaging based on deep learning.
    Biomed Eng Online. 2024;23:84.
    Abstract

  2173. KURITA Y, Meguro S, Kosugi I, Enomoto Y, et al
    Enhancing cervical cancer cytology screening via artificial intelligence innovation.
    Sci Rep. 2024;14:19535.
    Abstract

  2174. PRICE O, Machalek DA, Sutherland R, Gibbs D, et al
    Coverage of cervical cancer prevention interventions among people in Australia who inject drugs.
    Int J Drug Policy. 2024;132:104566.
    Abstract

  2175. SINGH N, Tanwar P, Singhal S, Mohan T, et al
    Novel Strategy of Training the Accredited Social Health Activists via Application-Based Telemedicine for Cervical Cancer Screening by Human Papillomavirus Self-Sampling: The TRACK Study.
    JCO Glob Oncol. 2024;10:e2400158.
    Abstract

  2176. TJALMA WAA
    Unlocking Japan's cervical cancer prevention deadlock.
    Cancer Sci. 2024 Aug 22. doi: 10.1111/cas.16311.
    Abstract

  2177. BARRY HC
    Scottish Screening: No Cases of Invasive Cervical Cancer in Women Who Received at Least One Dose of Bivalent HPV Vaccine at 12 or 13 Years of Age.
    Am Fam Physician. 2024;110:201-202.
    Abstract

  2178. LANIEWSKI P, Joe TR, Jimenez NR, Eddie TL, et al
    Viewing Native American Cervical Cancer Disparities through the Lens of the Vaginal Microbiome: A Pilot Study.
    Cancer Prev Res (Phila). 2024 Aug 22. doi: 10.1158/1940-6207.CAPR-24-0286.
    Abstract

  2179. KAWASAKI R, Kukimoto I, Tsukamoto T, Nishio E, et al
    Cervical mucus can be used for metabolite screening in cervical cancer.
    Cancer Sci. 2024 Aug 22. doi: 10.1111/cas.16323.
    Abstract

  2180. XIE N, Lin J, Yu H, Liu L, et al
    A Diagnostic Nomogram Incorporating Prognostic Nutritional Index for Predicting Vaginal Invasion in Stage IB - IIA Cervical Cancer.
    Cancer Control. 2024;31:10732748241278479.
    Abstract

  2181. GILLIES C, Allen-Scott LK, Nykiforuk CIJ, Belon AP, et al
    Social capital interventions for human papillomavirus (HPV) immunization and cervical cancer screening: A rapid review.
    Can Commun Dis Rep. 2024;50.
    Abstract

  2182. SCHERER-QUENZER AC, Findeis J, Herbert SL, Yokendren N, et al
    The value of endocervical curettage during large loop excision of the transformation zone in combination with endocervical surgical margin in predicting persistent/recurrent dysplasia of the uterine cervix: a retrospective study.
    BMC Womens Health. 2024;24:461.
    Abstract

  2183. ZHENG Y, Yang Y, Zhu W, Liu R, et al
    GSK3B inhibition reduced cervical cancer cell proliferation and migration by modulating the PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
    Braz J Med Biol Res. 2024;57:e13796.
    Abstract

  2184. KRAJNAKOVA B, Vybohova D, Hurta-Csizmar S, Mestanova V, et al
    Prognostic potential of PRMT5 and DSG2 proteins in pre-malignant cervical lesions.
    Pol J Pathol. 2024;75:115-125.
    Abstract

  2185. HU L, Ye X, Lin K, Gao J, et al
    Two New Phenylpropanoids and a Polyphenol with Anti-Cervical Cancer Activity from Smilax china L.
    Chem Biodivers. 2024 Aug 21:e202401467. doi: 10.1002/cbdv.202401467.
    Abstract

  2186. GUO W, Liu W, Wang J, Fan X, et al
    Extracellular vesicles and macrophages in tumor microenvironment: Impact on cervical cancer.
    Heliyon. 2024;10:e35063.
    Abstract

  2187. WANG Y, Zhu L, Wu Y
    Evaluation of the toxicity of prophylactic extended-field radiation therapy with volumetric modulated arc therapy in combination with concomitant chemoradiotherapy in patients with locally advanced stage IIIC1r cervical cancer according to the 2018 FI
    Rep Pract Oncol Radiother. 2024;29:42-50.
    Abstract

  2188. VIDAL-GUTIERREZ M, Torres-Moreno H, Arenas-Luna VM, Loredo-Mendoza ML, et al
    Tumour growth inhibitory effect of Ibervillea sonorae phytopreparations in cervical cancer xenografts.
    Nat Prod Res. 2024 Aug 21:1-9. doi: 10.1080/14786419.2024.2394095.
    Abstract

  2189. YANG Q, Xie M, Yuan M, Xia M, et al
    Application of artificial intelligence in cervical cancer screening: Enhancing accuracy and reducing misdiagnosis.
    J Clin Nurs. 2024 Aug 20. doi: 10.1111/jocn.17415.
    Abstract

  2190. POWELL A, Hodgson A, Cohen PA, Rabban TJ, et al
    Improved Risk Prediction in Human Papillomavirus-Associated Endocervical Adenocarcinoma Through Assessment of Binary Silva Pattern-based Classification: An International Multicenter Retrospective Observational Study Led by the International Society of
    Int J Gynecol Pathol. 2024;43:436-446.
    Abstract

  2191. KETCH PW, Zaharias RS, Leath CA
    Pharmacotherapy for cervical cancer: current standard of care and new perspectives.
    Expert Opin Pharmacother. 2024 Aug 20. doi: 10.1080/14656566.2024.2395379.
    Abstract

  2192. CORTES-MALAGON EM, Gariglio P, Sierra-Martinez M, Bonilla-Delgado J, et al
    Retinoids: Molecular Aspects and Treatment in Premalignant Lesions and Cervical Cancer.
    Cancer Control. 2024;31:10732748241279514.
    Abstract

  2193. AZIMI F, Moghaddam-Tabrizi F, Sharafkhani R
    The Effect of Group Counselling based on Constructive Couple Communication on Perceived Spousal Support in Uterine and Cervical Cancer Survivors: A Randomized Control Trial.
    Int J Community Based Nurs Midwifery. 2024;12:162-174.
    Abstract

  2194. MANGONE L, Marinelli F, Bisceglia I, Roncaglia F, et al
    Trends in cervical cancer: A decade?long analysis of incidence, survival and demographic disparities in a Northern Italian province.
    Mol Clin Oncol. 2024;21:71.
    Abstract

  2195. GALICIA-CARMONA T, Arango-Bravo EA, Coronel-Martinez JA, Cetina-Perez L, et al
    Advanced, recurrent, and persistent cervical cancer management: in the era of immunotherapy.
    Front Oncol. 2024;14:1392639.
    Abstract

  2196. OMI M, Tanaka YO, Kurihara N, Sugiyama Y, et al
    Preoperative diagnosis of cervical cystic lesions using magnetic resonance imaging: a retrospective study.
    BMC Womens Health. 2024;24:460.
    Abstract

  2197. WANG F, Bai Y, Wang L
    Investigating the mechanisms of ginkgetin mediated reversal of cisplatin resistance in cervical cancer through network pharmacology and molecular docking approaches.
    Asian J Surg. 2024 Aug 19:S1015-9584(24)01781.
    Abstract

  2198. GRANADOS R, Duarte JA, Lujan DR, Gutierrez-Pecharroman AM, et al
    RNA extended interventional nucleic acid longitudinal study: Clinical performance of Aptima messenger RNA HPV testing in cervical cancer screening with a 9-year follow-up.
    Cancer Cytopathol. 2024 Aug 19. doi: 10.1002/cncy.22895.
    Abstract

  2199. WANG Y, Ma Y, Zou L, Lei H, et al
    Efficacy and Safety of (125)I Seed Implantation in the Treatment of Pelvic Recurrent Cervical Cancer Following Radiotherapy: A Single-Arm Meta-Analysis of Chinese Patients.
    Cancer Rep (Hoboken). 2024;7:e2147.
    Abstract

  2200. BURGESS J, Hendry F, Bagot C, Doherty B, et al
    Catastrophic venous and arterial thrombosis in a young female with cervical cancer.
    EJHaem. 2024;5:879-880.
    Abstract

  2201. LUO Y, Niu M, Liu Y, Zhang M, et al
    Oncoproteins E6 and E7 upregulate topoisomerase I to activate the cGAS-PD-L1 pathway in cervical cancer development.
    Front Pharmacol. 2024;15:1450875.
    Abstract

  2202. SSEDYABANE F, Niyonzima N, Ngonzi J, Nambi Najjuma J, et al
    FOXP3 serum concentration; a likely predictor of CIN and cervical cancer: Secondary analysis from a case control study at a clinic in South western Uganda.
    Gynecol Oncol Rep. 2024;55:101466.
    Abstract

  2203. WANG L, Mohajer J, McNair H, Harris E, et al
    Implementing Plan of the Day for Cervical Cancer: A Comparison of Target Volume Generation Methods.
    Adv Radiat Oncol. 2024;9:101560.
    Abstract

  2204. KINJYO M, Nishie A, Kudaka R, Nakano S, et al
    A potential usefulness of ultra-high-resolution computed tomography in quality assurance of remote after-loading system for cervical cancer.
    J Radiat Res. 2024 Aug 17:rrae055. doi: 10.1093.
    Abstract

  2205. HUANG C, Xiao X, Ai W, Huang H, et al
    HPV-16 E6 mutation and viral integration related host DNA methylation implicate the development and progression of cervical cancer.
    Infect Dis (Lond). 2024 Aug 18:1-15. doi: 10.1080/23744235.2024.2391538.
    Abstract

  2206. CAI Z, Li S, Xiong Z, Lin J, et al
    Multimodal MRI-based deep-radiomics model predicts response in cervical cancer treated with neoadjuvant chemoradiotherapy.
    Sci Rep. 2024;14:19090.
    Abstract

  2207. KOKHDAN EP, Khodavandi P, Ataeyan MH, Alizadeh F, et al
    Anti-cancer activity of secreted aspartyl proteinase protein from Candida tropicalis on human cervical cancer HeLa cells.
    Toxicon. 2024;249:108073.
    Abstract

  2208. CHEN X, Jin X, Kong L, Liou Y, et al
    Triage performance of PAX1(m)/JAM3(m) in opportunistic cervical cancer screening of non?16/18 human papillomavirus-positive women: a multicenter prospective study in China.
    Clin Epigenetics. 2024;16:108.
    Abstract

  2209. LEVIN G, Ramirez PT, Wright JD, Slomovitz BM, et al
    Approach to radical hysterectomy for cervical cancer after the LACC trial and associated complications: a NSQIP study.
    Am J Obstet Gynecol. 2024 Aug 14:S0002-9378(24)00830.
    Abstract

  2210. CAMERON RL, Palmer TJ, Cuschieri K, Kavanagh K, et al
    Assessing real world vaccine effectiveness: A review of Scotland's approach to monitoring human papillomavirus (HPV) vaccine impact on HPV infection and cervical disease.
    Vaccine. 2024;42:126177.
    Abstract

  2211. CHO EH, Shin K, Park MS, Woo HY, et al
    Performance evaluation of the Allplex HPV HR Detection assay in comparison with the Cobas HPV test for high-risk HPV genotyping.
    Diagn Microbiol Infect Dis. 2024;110:116433.
    Abstract

  2212. RODRIGUEZ ER, Tonn T, Jafry M, Ahmed S, et al
    Neighborhood-level social determinants of health burden among adolescent and young adult cancer patients and impact on overall survival.
    JNCI Cancer Spectr. 2024;8:pkae062.
    Abstract

  2213. WANG ZZ, Wang HL, Xiong W, Du J, et al
    Traditional Chinese Medicine Erhuang Suppository for Treatment of Persistent High-risk Human Papillomavirus Infection and Its Impact on Transcriptome of Uterine Cervix.
    Curr Med Sci. 2024;44:841-853.
    Abstract

  2214. WANG X, Liu G, Huan T, Wang Y, et al
    Synergistic effect of chimeric antigen receptor modified with Bcl-2 on enhanced solid tumour targeting.
    Hum Cell. 2024;37:1421-1433.
    Abstract

  2215. QI W, Lv Q, Chen L, Huang S, et al
    Comparative study of photodynamic therapy (PDT) of cervical low-grade squamous intraepithelial lesion (LSIL).
    Photodiagnosis Photodyn Ther. 2024;48:104247.
    Abstract

  2216. LENTZ SE, Ranta A, Domenichini M, Fusco E, et al
    One Hundred Years of Colposcopy: Reconciling Its Auschwitz Past.
    Ann Intern Med. 2024;177:1118-1124.
    Abstract

  2217. BRENES D, Salcedo MP, Coole JB, Maker Y, et al
    Multiscale Optical Imaging Fusion for Cervical Precancer Diagnosis: Integrating Widefield Colposcopy and High-Resolution Endomicroscopy.
    IEEE Trans Biomed Eng. 2024;71:2547-2556.
    Abstract

  2218. ALWAQFI R, Gill K, Brown DN, Weigelt B, et al
    High-Risk Human Papillomavirus-Associated Mixed Intestinal-Type Mucinous Adenocarcinoma and Low-grade Neuroendocrine Tumor of the Uterine Cervix: Report of a Case Harboring Shared ARID1A and SMAD4 Mutations Between Morphologically Distinct Components.
    Int J Gynecol Pathol. 2024;43:472-473.
    Abstract

  2219. BAE BK, Bae H, Cho WK, Kim BG, et al
    Risk Factors Affecting Clinical Outcomes of Low-risk Early-stage Human Papillomavirus-Associated Endocervical Adenocarcinoma Treated by Surgery Alone: Application of Silva Pattern.
    Int J Gynecol Pathol. 2024;43:447-456.
    Abstract

  2220. RAZACK R, Butt JL, Hostein I, Velasco V, et al
    SMARCB1 (INI1) Deficient Tumours of the Uterine Cervix: Report of Two Cases, Including One Associated With an NTRK Fusion.
    Int J Gynecol Pathol. 2024;43:464-471.
    Abstract

  2221. GAO X, Wang Q, Huang T, Xu C, et al
    Cervical cancer-produced neuromedin-B reprograms Schwann cells to initiate perineural invasion.
    Cell Death Dis. 2024;15:636.
    Abstract

  2222. WU D, Kpokiri EE, Azizatunnisa' L, Rotenberg S, et al
    Equitable cervical cancer screening for women with disabilities.
    Maturitas. 2024 Aug 22:108094. doi: 10.1016/j.maturitas.2024.108094.
    Abstract

  2223. HU K, Barker MM, Herweijer E, Wang J, et al
    The role of mental illness and neurodevelopmental conditions in human papillomavirus vaccination uptake within the Swedish school-based vaccination programme: a population-based cohort study.
    Lancet Public Health. 2024;9:e674-e683.
    Abstract

  2224. ZHAO F, Lang J, Qiao Y, Zhu L, et al
    How can China achieve WHO's 2030 targets for eliminating cervical cancer?
    BMJ. 2024;386:e078641.
    Abstract

  2225. BIZZARRI N, Pedone Anchora L, Teodorico E, Certelli C, et al
    The role of diagnostic laparoscopy in locally advanced cervical cancer staging.
    Eur J Surg Oncol. 2024;50:108645.
    Abstract

  2226. SENOCAK TASCI E, Bas D, Kayak S, Anik S, et al
    Assessment of health literacy and HPV knowledge among university students: An observational study.
    Medicine (Baltimore). 2024;103:e39495.
    Abstract

  2227. DONG S, Wang Y, Ding Y
    Opportunities and challenges encountered in managing cervical cancer during the coronavirus disease 2019 pandemic.
    Infect Agent Cancer. 2024;19:41.
    Abstract

  2228. GHOSH A, Sinha A, Ghosh A, Roy S, et al
    Biological and clinical relevance of correlated expression levels of coding and long noncoding RNAs in HPV16 positive cervical cancers.
    Hum Genomics. 2024;18:91.
    Abstract

  2229. TONG X, Xiao Y, Li H, Zhang H, et al
    Treatment of secondary uterine malignancy following radiotherapy for cervical cancer: a study based on the SEER database.
    BMC Womens Health. 2024;24:475.
    Abstract

  2230. CAI X, Huang W, Huang J, Zhu X, et al
    CAPZB mRNA is a novel biomarker for cervical high-grade squamous lesions.
    Sci Rep. 2024;14:20047.
    Abstract

  2231. RAI B, Dey T, Ballari N, Singh M, et al
    Three-Dimensional Conformal Radiotherapy Versus Image-Guided Intensity Modulated External Beam Radiotherapy in Locally Advanced Cervical Cancer: A Phase III Randomized Control Study.
    Clin Oncol (R Coll Radiol). 2024 Aug 10:S0936-6555(24)00320.
    Abstract

  2232. WANG C, He L, Peng J, Lu C, et al
    Identification of Siglec-10 as a new dendritic cell checkpoint for cervical cancer immunotherapy.
    J Immunother Cancer. 2024;12:e009404.
    Abstract

  2233. AREDES MA, de Paula NS, Villaca Chaves G
    Association between body composition phenotypes and treatment toxicity in women with cervical cancer undergoing chemoradiotherapy.
    Nutrition. 2024;127:112539.
    Abstract

  2234. ONO K, Matsumoto H, Komagata Y
    Acute Kidney Injury and Ascites in a Patient with a History of Cervical Cancer.
    Kidney360. 2024;5:1226-1227.
    Abstract

  2235. STEINKASSERER L, Wesselmann S, Quaas J, Beckmann MW, et al
    Quality assurance using quality indicators for prevention and early detection of cervical cancer in certified gynaecological dysplasia units and consultancies.
    Arch Gynecol Obstet. 2024 Aug 29. doi: 10.1007/s00404-024-07694.
    Abstract

  2236. HAO X, Zhao W, Zhang X, Lu X, et al
    Mechanism of tumor-associated macrophages with PD-1 monoclonal antibodies affecting vascular generation in cervical cancer via the PD-1/IRE1alpha/SHP2/HIF1alpha signaling pathway.
    Aging (Albany NY). 2024;16.
    Abstract

  2237. YU Y, Hao J, Mohamed SB, Fu S, et al
    The prevalence of multiple or single HPV infection and genotype distribution in healthy Chinese women: A systemic review.
    J Cancer Res Ther. 2024;20:1265-1273.
    Abstract

  2238. WANG X, Jin Y, Xu L, Tao S, et al
    Integrating Single-Cell RNA-Seq and Bulk RNA-Seq to Construct a Novel gammadeltaT Cell-Related Prognostic Signature for Human Papillomavirus-Infected Cervical Cancer.
    Cancer Control. 2024;31:10732748241274228.
    Abstract

  2239. LIU T, Zhou Y, Chen L, Liu Q, et al
    Splicing Factor PTBP1 Silencing Induces Apoptosis of Human Cervical Cancer Cells via PI3K/AKT Pathway and Autophagy.
    Front Biosci (Landmark Ed). 2024;29:289.
    Abstract

  2240. XU L, Liu J, Li S, Lu X, et al
    S-Doped Hollow Multi-Metallic Prussian Blue Analogue (PBA) Nanoplatform for Enhanced Anticancer for Cervical Cancer.
    Int J Nanomedicine. 2024;19:8681-8694.
    Abstract

  2241. MOLNAR O, Mihutiu S, Ilea CD, Vesa A, et al
    Local Disease-Free Survival and Disease-Free Survival in Locally Advanced Cervical Cancer Diagnosed and Treated in Bihor County, Romania.
    Cureus. 2024;16:e65629.
    Abstract

  2242. WINATA IGS, Christyani F
    High Expression of Vascular Endothelial Growth Factor, Ki-67, and Protein 53 are Risk Factors for Poor Response of Paclitaxel-Carboplatin Neoadjuvant Chemotherapy in Stadium IB3, IIA2, and IIB Cervical Cancer.
    Asian Pac J Cancer Prev. 2024;25:2625-2631.
    Abstract

  2243. XU C, Zhang XY, Wu XC, Ming L, et al
    The value of amide proton transfer imaging combined with serum CA125 levels in predicting lymph vascular invasion in cervical cancer before surgery.
    Acta Radiol. 2024 Aug 28:2841851241273939. doi: 10.1177/02841851241273939.
    Abstract

  2244. MAUEIA C, Carulei O, Murahwa AT, Taku O, et al
    Identification of HPV16 Lineages in South African and Mozambican Women with Normal and Abnormal Cervical Cytology.
    Viruses. 2024;16:1314.
    Abstract

  2245. HAMPSON IN, Oliver AW
    Update on Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology.
    Viruses. 2024;16:1245.
    Abstract

  2246. LEE OE, Le TM, Chong GO, Cho JJ, et al
    The Mclust Analysis of Tumor Budding Unveils the Role of the Collagen Family in Cervical Cancer Progression.
    Life (Basel). 2024;14:1004.
    Abstract

  2247. LEE SJ, Kim M, Kwak YK, Kang HJ, et al
    The Clinical Course of the Late Toxicity of Definitive Radiotherapy in Cervical Cancer.
    Medicina (Kaunas). 2024;60:1364.
    Abstract

  2248. CETIN F, Kayar I, Goc G, Birge O, et al
    The Impact of Tamoxifen Usage in Breast Cancer Patients on the Development of Histopathological Lesions in the Cervix Uteri.
    Medicina (Kaunas). 2024;60:1268.
    Abstract

  2249. YORDANOV A, Damyanova P, Vasileva-Slaveva M, Hasan I, et al
    Integrated Analysis of Phagocytic and Immunomodulatory Markers in Cervical Cancer Reveals Constellations of Potential Prognostic Relevance.
    Int J Mol Sci. 2024;25:9117.
    Abstract

  2250. SU J, Zhao Y, Chen WD, Wang YD, et al
    Activation of the G Protein-Coupled Bile Acid Receptor TGR5 Modulates the HCP5/miR-139-5p/DDIT4 Axis to Antagonize Cervical Cancer Progression.
    Int J Mol Sci. 2024;25:8932.
    Abstract

  2251. ROJAS-DIAZ JM, Solorzano-Ibarra F, Garcia-Barrientos NT, Klimov-Kravtchenko K, et al
    Uncovering the Expression Pattern of the Costimulatory Receptors ICOS, 4-1BB, and OX-40 in Exhausted Peripheral and Tumor-Infiltrating Natural Killer Cells from Patients with Cervical Cancer.
    Int J Mol Sci. 2024;25:8775.
    Abstract

  2252. CHELVA M, Kaushal S, West N, Erwin E, et al
    "In the Village That She Comes from, Most of the People Don't Know Anything about Cervical Cancer": A Health Systems Appraisal of Cervical Cancer Prevention Services in Tanzania.
    Int J Environ Res Public Health. 2024;21:1059.
    Abstract

  2253. MA Z, Zhang J, Liu X, Teng X, et al
    Comparative Analysis of Repeatability in CT Radiomics and Dosiomics Features under Image Perturbation: A Study in Cervical Cancer Patients.
    Cancers (Basel). 2024;16:2872.
    Abstract

  2254. RODRIGUEZ-SARMIENTO DY, Rondon-Villarreal P, Scarpelli-Pereira PH, Bouvier M, et al
    Comprehensive Analysis of Kisspeptin Signaling: Effects on Cellular Dynamics in Cervical Cancer.
    Biomolecules. 2024;14:923.
    Abstract

  2255. LV C, Zeng Q, Qi L, Wang Y, et al
    Sodium Selenite Induces Autophagy and Apoptosis in Cervical Cancer Cells via Mitochondrial ROS-Activated AMPK/mTOR/FOXO3a Pathway.
    Antioxidants (Basel). 2024;13:1004.
    Abstract


  2256. Erratum: Imparting Knowledge to Others: A Qualitative Study Exploring How Ethiopian Women Prefer to Receive Cervical Cancer Education.
    JCO Glob Oncol. 2024;10:e2400374.
    Abstract


  2257. Erratum: If I Have the Courage...I Prefer to See a Doctor: A Qualitative Exploration of Ethiopian Women's Hesitancy to Screen for Cervical Cancer Using HPV Self-Sampling.
    JCO Glob Oncol. 2024;10:e2400375.
    Abstract

  2258. XIAO Y, Yin J, Liu P, Zhang X, et al
    Triptolide-induced cuproptosis is a novel antitumor strategy for the treatment of cervical cancer.
    Cell Mol Biol Lett. 2024;29:113.
    Abstract

  2259. ZHOU XH, Yang DN, Zou YX, Tang DD, et al
    Long-Term Survival Trend of Gynecological Cancer: A Systematic Review of Population-Based Cancer Registration Data.
    Biomed Environ Sci. 2024;37:897-921.
    Abstract

  2260. DEAR T, Chiu J, Meirovich H, Malkin A, et al
    Are outcomes of locally advanced cervical cancer associated with prebrachytherapy hemoglobin values and transfusion practice? An observational study comparing two large academic centres with divergent clinical guidelines.
    Brachytherapy. 2024 Aug 27:S1538-4721(24)00119.
    Abstract

  2261. VINK E, Antaya G, Hamula C, Holinaty C, et al
    HPV Self-Sampling for Cervical Cancer Screening in Under-Screened Saskatchewan Populations: A Pilot Study.
    Curr Oncol. 2024;31:4261-4269.
    Abstract

  2262. BENTZ JL, Barney RE, Georgantzoglou N, Manxhuka-Kerliu S, et al
    High-Risk HPV Screening Initiative in Kosovo-A Way to Optimize HPV Vaccination for Cervical Cancer.
    Diseases. 2024;12:189.
    Abstract

  2263. FULANE G, Major M, Lorenzoni C, Munguambe K, et al
    The Influence of Institutional Logics and Emotions on the Uptake of Cervical Cancer Screening: A Case Study From Xai-Xai, Mozambique.
    Health Serv Insights. 2024;17:11786329231224619.
    Abstract

  2264. XIONG Y, Xu X, Zhou X, Tong Y, et al
    Anlotinib inhibits cervical cancer cell proliferation and invasion by suppressing cytokine secretion in activated cancer-associated fibroblasts.
    Front Oncol. 2024;14:1412660.
    Abstract

  2265. ZHAO H, Wang Y, Sun Y, Wang Y, et al
    Hematological indicator-based machine learning models for preoperative prediction of lymph node metastasis in cervical cancer.
    Front Oncol. 2024;14:1400109.
    Abstract

  2266. KUMAR R, Iden M, Tsaih SW, Schmidt R, et al
    Deciphering the divergent transcriptomic landscapes of cervical cancer cells grown in 3D and 2D cell culture systems.
    Front Cell Dev Biol. 2024;12:1413882.
    Abstract

  2267. FARAJIMAKIN O
    Barriers to Cervical Cancer Screening: A Systematic Review.
    Cureus. 2024;16:e65555.
    Abstract

  2268. LIANG C, Wang W, Yang G, Xu Z, et al
    Utility of interim apparent diffusion coefficient value in predicting treatment response among patients with locally advanced cervical cancer treated with radiotherapy.
    Clin Transl Radiat Oncol. 2024;48:100827.
    Abstract

  2269. JI C, Wang Y, Jiang Y, Wang Y, et al
    Single-cell RNA-sequencing Analysis Reveals the Promoting Role of the Hedgehog Pathway in Epithelial Cells during Cervical Cancer Progression.
    Curr Med Chem. 2024 Aug 26. doi: 10.2174/0109298673333784240819063118.
    Abstract

  2270. SHAM S, Geetha SD, Kawam A, Bendari A, et al
    Malignant Pericardial Effusion from Cervical Squamous Cell Carcinoma: A Case Study.
    Am J Case Rep. 2024;25:e943013.
    Abstract

  2271. ALONSO-ESPIAS M, Gorostidi M, Garcia-Pineda V, Gracia M, et al
    Survival Impact of Sentinel Lymph Node Biopsy in Patients with Early-Stage Cervical Cancer.
    Reprod Sci. 2024 Aug 27. doi: 10.1007/s43032-024-01687.
    Abstract

  2272. GEEITHA S, Ravishankar K, Cho J, Easwaramoorthy SV, et al
    Integrating cat boost algorithm with triangulating feature importance to predict survival outcome in recurrent cervical cancer.
    Sci Rep. 2024;14:19828.
    Abstract

  2273. SMYTH SL, Jackson E, Sadeghi N, Pappa C, et al
    Efficacy and diagnostic reliability of intraoperative frozen section in the surgical management of early-stage cervical cancer.
    Gynecol Obstet Invest. 2024 Aug 27. doi: 10.1159/000541096.
    Abstract


  2274. Erratum: An Overview of the Project ECHO-Cervical Cancer Prevention in Mozambique.
    JCO Glob Oncol. 2024;10:e2400384.
    Abstract


  2275. Erratum: Distribution and Types of High-Risk Human Papillomavirus Genotypes and Associated Cervical Neoplastic Lesions in Women Living With HIV Infection in Jos Nigeria.
    JCO Glob Oncol. 2024;10:e2400381.
    Abstract

  2276. HOANG TN, Berenson AB, Shan Y, Guo F, et al
    Trends in HPV-associated cancer incidence in Texas medically underserved regions.
    Cancer Med. 2024;13:e70133.
    Abstract

  2277. SINEQUE A, Ceffa S, Parruque F, Guidotti G, et al
    Impact of STIs on cervical cancer screening: Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae in visual inspection with acetic acid (VIA) positive women in Mozambique.
    Int J STD AIDS. 2024 Aug 27:9564624241272963. doi: 10.1177/09564624241272963.
    Abstract

  2278. SUN R, He SL, Liu HY, Wang XW, et al
    Tumor Suppressor LINC02487 Inhibits the Progression of Cervical Cancer in Vitro by Regulating the PTEN/Akt/mTOR Pathway.
    Discov Med. 2024;36:1732-1742.
    Abstract

  2279. HUANG X, Li Q, Zheng X, Jiang C, et al
    TTYH3 Promotes Cervical Cancer Progression by Activating the Wnt/beta-Catenin Signaling Pathway.
    Cancer Invest. 2024 Aug 27:1-14. doi: 10.1080/07357907.2024.2395014.
    Abstract

  2280. MO B, Ye Y, Yu M, Tong X, et al
    Prevalence and genotype distribution of HPV combined with cervical pathological results in women from Sichuan, China: A cross-sectional study based on post-vaccination period 2019 to 2023.
    Cancer Med. 2024;13:e70148.
    Abstract

  2281. ZHU Y, Li Y, Tang Y, Zhang J, et al
    Comparing qSMI and qCEUS for assessing vascularization in uterine cervical cancer: operable versus non-operable group.
    Front Oncol. 2024;14:1380725.
    Abstract

  2282. SHEN H, Zhang C, Song Y, Huang Z, et al
    Assessing treatment effects with adjusted restricted mean time lost in observational competing risks data.
    BMC Med Res Methodol. 2024;24:186.
    Abstract

  2283. HUA J, Jackson K
    A Systematic Review of Interventions to Promote Cervical Cancer Screening among Immigrant Vietnamese Women.
    J Community Health. 2024 Aug 26. doi: 10.1007/s10900-024-01395.
    Abstract

  2284. NIE X
    Effects of Network-based Positive Psychological Nursing Model on Negative Emotions, Cancer-related Fatigue, and Quality of Life in Cervical Cancer Patients with Post-operative Chemotherapy.
    Ann Ital Chir. 2024;95:542-551.
    Abstract

  2285. SHU Z, Zhao W, Zhan X, Zeng J, et al
    Epidemiology and genotypes analysis of human papillomavirus infection in Huizhou, China.
    Front Public Health. 2024;12:1440480.
    Abstract

  2286. JULES M, Rahul N, Weerarathna IN, Luharia A, et al
    A Multimodality Treatment Approach for the Management of Recurrent Cervical Cancer in an Elderly Female Patient: A Case Report.
    Cureus. 2024;16:e65424.
    Abstract

  2287. MAKKAPATI BS, Challapalli S, MariappanSenthiappan A, Kilikunnel JS, et al
    Clinical and dosimetric correlation in terms of treatment response, bladder and rectal toxicities in cervical cancer patients treated with cobalt 60 high dose rate brachytherapy.
    PeerJ. 2024;12:e17759.
    Abstract

  2288. ZHANG H, Teng C, Yao Y, Bian W, et al
    MRI-based radiomics models for noninvasive evaluation of lymphovascular space invasion in cervical cancer: a systematic review and meta-analysis.
    Clin Radiol. 2024 Aug 7:S0009-9260(24)00402-1. doi: 10.1016/j.crad.2024.
    Abstract

  2289. FENG C, Wen X, Li S, Hua L, et al
    Comparison of 3D-printed multichannel non-co-planar vaginal applicators and single-channel vaginal applicators for brachytherapy with positive or close surgical margins in cervical cancer.
    Brachytherapy. 2024 Aug 24:S1538-4721(24)00102.
    Abstract

  2290. KIEBER-EMMONS AM, Hansen SE, Topmiller M, Grewal J, et al
    fRAP 2.0: a community engagement method applied to cervical cancer disparities among Hispanic women.
    Fam Med Community Health. 2024;12.
    Abstract

  2291. AKINYI I, Awandu SS, Broeck DV, Pereira AR, et al
    Prevalence and genotype distribution of potential high-risk and high-risk human papillomavirus among women attending selected reproductive health clinics in lake victoria basin-kenya: a cross-sectional study.
    BMC Womens Health. 2024;24:468.
    Abstract

  2292. WANG L, Zhang X, Chen S, Ye Q, et al
    Combining Mitomycin C with inhibition of BAD phosphorylation enhances apoptotic cell death in advanced cervical cancer.
    Transl Oncol. 2024;49:102103.
    Abstract

  2293. JI W, Jin Y, Jiang W
    Foxm1-Mediated Transcriptional Inactivation of NLRP3 Inflammasome Promotes Immunosuppression in Cervical Cancer.
    Crit Rev Eukaryot Gene Expr. 2024;34:35-45.
    Abstract

  2294. LI C, Yin Y, Yang Z, Zhang Q, et al
    Prognostic effect of the pretreatment prognostic nutritional index in cervical, ovarian, and endometrial cancer: a meta-analysis.
    BMC Womens Health. 2024;24:464.
    Abstract

  2295. HO FDV, Thaploo A, Wang K, Narayan A, et al
    Cervical cancer disparities in stage at presentation for disaggregated Asian Americans, Native Hawaiians, and Pacific Islanders.
    Am J Obstet Gynecol. 2024 Aug 21:S0002-9378(24)00867.
    Abstract

  2296. COSTA T, Bateson D, Woo YL
    Enhancing equity in cervical screening - initiatives to increase screening participation.
    Curr Opin Obstet Gynecol. 2024;36:345-352.
    Abstract

  2297. LIU P, Yang Y, Zhou Z, Zhang X, et al
    Mitochondrial targeted modification and anticancer mechanism of natural product ergosterol peroxide.
    Bioorg Chem. 2024;151:107688.
    Abstract

  2298. PEREIRA AR, Redzic N, Van Vooren S, Pelak K, et al
    Development, Validation, and Implementation of an Augmented Multiwell, Multitarget Quantitative PCR for the Analysis of Human Papillomavirus Genotyping through Software Automation, Data Science, and Artificial Intelligence.
    J Mol Diagn. 2024;26:781-791.
    Abstract

  2299. PEMPA, Dorji T, Tashi U, Choden J, et al
    Implementation of a nationwide population-level cancer screening in Bhutan: A programmatic experience.
    J Cancer Policy. 2024;41:100488.
    Abstract

  2300. MEENATCHI V, Narayanan KB, Sood A, Han SS, et al
    Formation of amygdalin/beta-cyclodextrin derivatives inclusion complexes for anticancer activity assessment in human cervical carcinoma HeLa cell line.
    Int J Pharm. 2024;662:124293.
    Abstract

  2301. LI X, Xie H, Fu Y, Zhang X, et al
    Epidemiology Characteristics and Potential Cervical Cancer Screening Value of Vulvar Human Papillomavirus in Chinese Women: A Multicenter Cross-Sectional Study.
    Arch Pathol Lab Med. 2024;148:1035-1040.
    Abstract

  2302. MA Y, Maerkeya K, Li L
    Assessment of Surgical Efficacy in Total Hysterectomy for Managing Massive Cervical Tumors: A Study of 7 Cases.
    Altern Ther Health Med. 2024;30:182-187.
    Abstract

  2303. SUN J, Chu H, Ji J, Huo G, et al
    [Retracted] Long non?coding RNA HOTAIR modulates HLA?G expression by absorbing miR?148a in human cervical cancer.
    Int J Oncol. 2024;65:97.
    Abstract

  2304. NING Y, Gao X, Kong Y, Wang Y, et al
    Adoption strategies of fertility-sparing surgery for early-stage cervical cancer patients based on clinicopathological characteristics: a large retrospective cohort study.
    Front Surg. 2024;11:1456376.
    Abstract

  2305. JIANG J, Zhao F, Hong X, Wang X, et al
    HPV vaccination strategy for 14-year-old females and economic returns for cervical cancer prevention in Wuxi City, China: a cost effectiveness analysis.
    Cost Eff Resour Alloc. 2024;22:64.
    Abstract

  2306. TEIXEIRA JC, Vale DB, Campos CS, Polegatto I, et al
    Transition from opportunistic cytological to organized screening program with DNA-HPV testing detected prevalent cervical cancers 10 years in advance.
    Sci Rep. 2024;14:20761.
    Abstract

  2307. SONG G, Thomas-Purcell K, Sealy DA, Bailey A, et al
    Cultural Shifts: An Examination of Cervical Cancer Stigma Across Age Groups in the Caribbean.
    JNCI Cancer Spectr. 2024 Sep 5:pkae075. doi: 10.1093.
    Abstract

  2308. STADLER J, Scorgie F
    Precarity and Hope at the Intersections of HIV and Cervical Cancer in a Johannesburg Clinic.
    Med Anthropol. 2024;43:495-508.
    Abstract

  2309. ADEKANMBI V, Sokale I, Guo F, Ngo J, et al
    Human Papillomavirus Vaccination and Human Papillomavirus-Related Cancer Rates.
    JAMA Netw Open. 2024;7:e2431807.
    Abstract

  2310. SADEGHI M, Abdalvand N, Mahdavi SR, Abdollahi H, et al
    Magnetic Resonance Image Radiomic Reproducibility: The Impact of Preprocessing on Extracted Features from Gross and High-Risk Clinical Tumor Volumes in Cervical Cancer Patients before Brachytherapy.
    J Med Signals Sens. 2024;14:23.
    Abstract

  2311. IGNAT RM, Fekete Z, Csutak C, Todor N, et al
    The value of contrast-enhanced ultrasound in cervical cancer assessed in comparison with magnetic resonance imaging.
    Med Pharm Rep. 2024;97:255-262.
    Abstract

  2312. MANTULA F, Toefy Y
    Exploring the Impact of COVID-19 on Cervical Cancer Screening Services: A Qualitative Study of Healthcare Providers' and Women's Perspectives and Experiences.
    Health Serv Insights. 2024;17:11786329241275883.
    Abstract

  2313. MSUNZA ZP, Kessy AT, Bakar SM
    Knowledge and Attitude Towards Cervical Cancer Screening Among Female Students in Allied Health Colleges in Shinyanga Region.
    East Afr Health Res J. 2024;8:43-51.
    Abstract

  2314. SILBERSTEIN AE, Schiff JP, Beckert R, Zhao X, et al
    Cone-Beam Computed Tomography (CBCT)-Guided Adaptive Boost Radiotherapy for a Patient With Locally Advanced Cervical Cancer Ineligible for Brachytherapy.
    Cureus. 2024;16:e66218.
    Abstract

  2315. YANG B, Xu C, Li H, Zhu X, et al
    Diagnostic value for methylation in cervical cancer based on a small-molecule fluorescent probe targeting DNMT1.
    Skin Res Technol. 2024;30:e70042.
    Abstract

  2316. IVANOVA Y, Kornovski Y, Kostov S, Slavchev S, et al
    Prognostic factors for low- and high grade squamous intraepithelial lesions in histological preparations following LLETZ procedure.
    Wiad Lek. 2024;77:1562-1568.
    Abstract

  2317. LIAO Y, Huang Q, Shen G, Muhanmode Y, et al
    Molecular subtypes and nomogram for predicting the prognosis of cervical cancer based on a matrix-immune signature.
    Discov Oncol. 2024;15:405.
    Abstract

  2318. TROMMER M, Gaasch A, Corradini S
    [Pembrolizumab and radiochemotherapy in locally advanced cervical cancer-the prospective, randomised KEYNOTE-A18 phase 3 study].
    Strahlenther Onkol. 2024 Sep 4. doi: 10.1007/s00066-024-02298.
    Abstract

  2319. AKINYI I, Ouma OJ, Ogutu S, Ogola E, et al
    HPV infection patterns and viral load distribution: implication on cervical cancer prevention in Western Kenya.
    Eur J Cancer Prev. 2024 Aug 29. doi: 10.1097/CEJ.0000000000000920.
    Abstract

  2320. PINA-CRUZ R, Molina-Pineda A, Aguila-Estrada M, Villasenor-Garcia MM, et al
    Effects of Arborvitae (Thuja plicata) Essential Oil on Cervical Cancer Cells: Insights into Molecular Mechanisms.
    Anticancer Agents Med Chem. 2024.
    Abstract

  2321. COULIBALY LL, Bayala B, Simpore J
    Molecular Activities and Mechanisms of Action of Substances and Molecules from Medicinal Plants from Sub-Saharan Africa on Prostate and Cervical Cancer Cells.
    Anticancer Agents Med Chem. 2024.
    Abstract

  2322. ZHAO R, Sanstead E, Alarid-Escudero F, Huchko M, et al
    Primary HPV screening compared with other cervical cancer screening strategies in women with HIV: a cost-effectiveness study.
    AIDS. 2024 Sep 2. doi: 10.1097/QAD.0000000000004002.
    Abstract

  2323. YANG J, Yu H, Zhang Y, Zhu M, et al
    Efficacy of PD-1 or PD-L1 inhibitors for the therapy of cervical cancer with varying PD-L1 expression levels: a single-arm meta-analysis.
    Front Oncol. 2024;14:1454372.
    Abstract

  2324. AGRAWAL S, Panneerselvam S, Ramasamy S
    A task shifting strategy for elimination of cervical cancer by 2030.
    J Family Med Prim Care. 2024;13:3467-3468.
    Abstract

  2325. STEVANATO KP, Santos LD, Pelloso FC, Borghesan DHP, et al
    Breast cancer and cervical cancer: a comparison of the period before and during the COVID-19 pandemic.
    BMC Womens Health. 2024;24:485.
    Abstract

  2326. YANG X, Wang Y, Zhang J, Yang J, et al
    A Novel Ultrasound-Based Radiomics Model for the Preoperative Prediction of Lymph Node Metastasis in Cervical Cancer.
    Ultrasound Med Biol. 2024 Sep 2:S0301-5629(24)00286.
    Abstract

  2327. ZHANG G, Chen Z, Wang Y, Huang A, et al
    Up-regulated DSG2 promotes tumor growth and reduces immune infiltration in cervical cancer.
    Pathol Res Pract. 2024;262:155554.
    Abstract

  2328. SHAO X, Bai L, Liang J, Li M, et al
    Diagnostic value and clinical significance of serum miR-4534 combined with transvaginal color Doppler ultrasound in cervical cancer.
    Discov Oncol. 2024;15:403.
    Abstract

  2329. WU CY, Yang M, Lin M, Li LP, et al
    Retraction Note: MTHFR C677T polymorphism was an ethnicity-dependent risk factor for cervical cancer development: evidence based on a meta-analysis.
    Arch Gynecol Obstet. 2024 Sep 3. doi: 10.1007/s00404-024-07725.
    Abstract

  2330. VAN VLIET-VAN DEN ENDE KM, Hoogendoorn-Mulder PG, Schokker RI, Moerland MA, et al
    Adaptive brachytherapy for cervical cancer in combined 1.5 T MR/HDR suite: Impact of repeated imaging.
    Tech Innov Patient Support Radiat Oncol. 2024;31:100262.
    Abstract

  2331. RUSS S, Kurtz R, Bennett N, Felsen C, et al
    Characterization of Cervical Cancer Screening History Among Patients with Invasive Cervical Cancer: A Population-Based Approach.
    Gynecol Oncol Rep. 2024;55:101480.
    Abstract

  2332. DELIE AM, Bogale EK, Anagaw TF, Tiruneh MG, et al
    Healthcare providers' knowledge, attitude, and practice towards cervical cancer screening in Sub-Saharan Africa: systematic review and meta-analysis.
    Front Oncol. 2024;14:1436095.
    Abstract

  2333. ZHAO F, Hong J, Zhou G, Huang T, et al
    Elucidating the role of tumor-associated ALOX5+ mast cells with transformative function in cervical cancer progression via single-cell RNA sequencing.
    Front Immunol. 2024;15:1434450.
    Abstract

  2334. TAKEKUMA M, Matsuo K, Matsuzaki S, Ishikawa M, et al
    Salvage hysterectomy for persistent residual cervical cancer: assessment of prognostic factors.
    J Gynecol Oncol. 2024 Jul 30. doi: 10.3802/jgo.2024.
    Abstract

  2335. YE Z, Zhang B, Zhang K, Mendez MJG, et al
    An assessment of ChatGPT's responses to frequently asked questions about cervical and breast cancer.
    BMC Womens Health. 2024;24:482.
    Abstract

  2336. KADAMA-MAKANGA P, Semeere A, Laker-Oketta M, Mubiru M, et al
    Usability of a smartphone-compatible, confocal micro-endoscope for cervical cancer screening in resource-limited settings.
    BMC Womens Health. 2024;24:483.
    Abstract

  2337. NIE X, Wang L, Zhao Z, Yang J, et al
    Biodegradable magnesium based metal materials inhibit the growth of cervical cancer cells.
    Sci Rep. 2024;14:19155.
    Abstract

  2338. ARAKI K, Torii T, Takeuchi K, Kinoshita N, et al
    Non-canonical olfactory pathway activation induces cell fusion of cervical cancer cells.
    Neoplasia. 2024;57:101044.
    Abstract

  2339. PORTER JE, Miller EM, Prokopiv V, Sewell L, et al
    Providing a localised cervical cancer screening course for general practice nurses.
    Aust J Prim Health. 2024;30:PY24089.
    Abstract

  2340. MUBTHASIMA PP, Singh SA, Kannan A
    Sesamol-mediated targeting of EPHA2 sensitises cervical cancer for cisplatin treatment by regulating mitochondrial dynamics, autophagy, and mitophagy.
    Mol Biol Rep. 2024;51:949.
    Abstract

  2341. TOGAMI S, Furuzono N, Mizuno M, Yanazume S, et al
    Long-term outcomes of sentinel lymph node navigation surgery for early-stage cervical cancer.
    Int J Clin Oncol. 2024 Sep 2. doi: 10.1007/s10147-024-02605.
    Abstract

  2342. JACQUIN E, Saunier M, Lepiller Q, Monnien F, et al
    The level of expression of HPV16 early transcripts is not associated with the natural history of cervical lesions.
    J Med Virol. 2024;96:e29875.
    Abstract

  2343. ARBYN M, Cuschieri K, Bonde J, Schuurman R, et al
    Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening.
    J Med Virol. 2024;96:e29881.
    Abstract

  2344. ABDEL-AZIZ HR, Mohamed NA, Elsehrawy MG
    Knowledge, Attitude, and Practice on Cervical Cancer Prevention among Female University Students in Al-Kharj, Saudi Arabia.
    SAGE Open Nurs. 2024;10:23779608241279152.
    Abstract

  2345. ZHOU X, Chen L, Lin W, Zheng W, et al
    Diagnostic and prognostic potential of the intra-tumoral microbiota profile in HPV-independent endocervical adenocarcinoma.
    Front Cell Infect Microbiol. 2024;14:1440017.
    Abstract

  2346. FAN Z, Han D, Fan X, Zeng Y, et al
    Analysis of the correlation between cervical HPV infection, cervical lesions and vaginal microecology.
    Front Cell Infect Microbiol. 2024;14:1405789.
    Abstract


  2347. Retraction: miR-181a-5p Promotes Proliferation and Invasion and Inhibits Apoptosis of Cervical Cancer Cells via Regulating Inositol Polyphosphate-5-Phosphatase A (INPP5A).
    Oncol Res. 2024;32:1539.
    Abstract

  2348. ALQARNI SS, Alshehri SM, Alkhateeb MA, Alsudias LS, et al
    Assessing Saudi women's awareness about human papillomavirus (HPV) and their susceptibility to receive the vaccine.
    Hum Vaccin Immunother. 2024;20:2395086.
    Abstract

  2349. LIANG Y, Diao W, Yang X, Tao Y, et al
    Regulator of calcineurin 3 as a novel predictor of diagnosis and prognosis in pan-cancer.
    Croat Med J. 2024;65:356-372.
    Abstract

  2350. DANKULCHAI P, Prasartseree T, Sittiwong W, Chansilpa Y, et al
    Clinical Outcome Comparison between CT-Guided Versus all MRI-Guided Scenarios in Brachytherapy for Cervical Cancer: A Single-Institute Experience.
    Clin Oncol (R Coll Radiol). 2024 Aug 10:S0936-6555(24)00322.
    Abstract

  2351. DOVER L, Dulaney C
    PROshot: Immunotherapy for Cervical Cancer, Epidermal Growth Factor Receptor-Mutated Stage III Lung Cancer, Perioperative Chemotherapy for Esophageal Cancer, Salvage Postprostatectomy Radiation and Androgen Deprivation Therapy, and Immunotherapy for H
    Pract Radiat Oncol. 2024;14:363-367.
    Abstract

  2352. RASIZADEH R, Shiri Aghbash P, Mokhtarzadeh A, Poortahmasebi V, et al
    Novel strategies in HPV?16?related cervical cancer treatment: An in vitro study of combined siRNA-E5 with oxaliplatin and ifosfamide chemotherapy.
    Gene. 2024;932:148904.
    Abstract

  2353. YE X, Xie S
    The value of human epididymal protein 4, carcinoembryonic antigen and alpha-fetoprotein in the early diagnosis of cervical cancer.
    Gynecol Obstet Invest. 2024 Aug 30. doi: 10.1159/000540855.
    Abstract

  2354. HALLQVIST D, Kormann C, Pigorsch S, Kiechle M, et al
    Bone marrow toxicity in patients with locally advanced cervical cancer undergoing multimodal treatment with VMAT/IMRT: are there dosimetric predictors for toxicity?
    Eur J Med Res. 2024;29:445.
    Abstract

  2355. YAN Z, Yu J, Wang S, Wen W, et al
    Identification of E3 ubiquitin ligase-associated prognostic genes and construction of a prediction model for uterine cervical cancer based on bioinformatics analysis.
    Discov Oncol. 2024;15:395.
    Abstract

  2356. MORICE P, Scambia G, Abu-Rustum NR, Acien M, et al
    Fertility-sparing treatment and follow-up in patients with cervical cancer, ovarian cancer, and borderline ovarian tumours: guidelines from ESGO, ESHRE, and ESGE.
    Lancet Oncol. 2024 Aug 28:S1470-2045(24)00262.
    Abstract

  2357. MANSO L, Ramchandani-Vaswani A, Romero I, Sanchez-Lorenzo L, et al
    SEOM-GEICO Clinical Guidelines on cervical cancer (2023).
    Clin Transl Oncol. 2024 Aug 31. doi: 10.1007/s12094-024-03604.
    Abstract

  2358. TEMPLETON CW, Laimins LA
    HPV induced R-loop formation represses innate immune gene expression while activating DNA damage repair pathways.
    PLoS Pathog. 2024;20:e1012454.
    Abstract

  2359. YANG T, Hu H, Li X, Meng Q, et al
    A two-stream decision fusion network for cervical pap-smear image classification tasks.
    Tissue Cell. 2024;90:102505.
    Abstract

  2360. XIAO Q, Chen W-j, Wu F, Zhang X-y, et al
    Individuality and generality of intratumoral microbiome in the three most prevalent gynecological malignancies: an observational study.
    Microbiol Spectr. 2024;12:e0100424.
    Abstract

  2361. YANG X, Shui Y, Qian Y
    A Crosstalk Analysis of high-risk human papillomavirus, microbiota and vaginal metabolome in cervicovaginal microenvironment.
    Microb Pathog. 2024;194:106826.
    Abstract

  2362. PRIYA DS, Arnav DA, Mittal DS, Pravina DP, et al
    Modified swede colposcopic index versus modified reid index in colposcopic screening for premalignant & malignant lesions of the cervix: a cross-sectional analysis.
    Cancer Treat Res Commun. 2024;40:100828.
    Abstract

  2363. DAS S, Wentzensen N, Sawaya GF, Egemen D, et al
    Primary human papillomavirus testing vs cotesting: clinical outcomes in populations with different disease prevalence.
    J Natl Cancer Inst. 2024;116:1525-1529.
    Abstract

  2364. CAI H, Zhou K, Luo L
    Mixed adenocarcinoma-neuroendocrine tumor of the uterine cervix with pulmonary metastasis: A case report and literature review.
    Asian J Surg. 2024;47:4210-4212.
    Abstract

  2365. OKOLI GN, Neilson CJ, Grossman Moon A, Kimmel Supron H, et al
    Exploration of individual socioeconomic and health-related characteristics associated with human papillomavirus vaccination initiation and vaccination series completion among adult females: A comprehensive systematic evidence review with meta-analysis
    Vaccine. 2024 May 24:S0264-410X(24)00601-7. doi: 10.1016/j.vaccine.2024.
    Abstract

  2366. LIAN J, Zhang B, Li K, Lu Y, et al
    Primary refractory diffuse large B-cell lymphoma of the uterine cervix metastasizing to the kidney: A case report.
    Asian J Surg. 2024;47:4013-4015.
    Abstract

  2367. CHEN XB, Li WL, Tan CY, Xu N, et al
    The optimal threshold for squamous-cell carcinoma antigen to predict lymph node metastasis in early-stage cervical squamous-cell carcinoma.
    Asian J Surg. 2024;47:3909-3911.
    Abstract

  2368. GIUDICI F, De Paoli A, Toffolutti F, Guzzinati S, et al
    Indicators of cure for women living after uterine and ovarian cancers: a population-based study.
    Am J Epidemiol. 2024;193:1224-1232.
    Abstract

  2369. YAGI A, Ueda Y, Kimura T
    HPV Vaccine Issues in Japan: A review of our attempts to promote the HPV vaccine and to provide effective evaluation of the problem through social-medical and behavioral-economic perspectives.
    Vaccine. 2024 Apr 13:S0264-410X(24)00407-9. doi: 10.1016/j.vaccine.2024.
    Abstract

  2370. DORJI N, Rai R, Chhetri N, Tshering S, et al
    Management of cervical cancer in pregnancy in a low resource setting: a rare case report.
    BMC Pregnancy Childbirth. 2024;24:597.
    Abstract

  2371. PINHEIRO M, Wentzensen N, Dean M, Yeager M, et al
    Somatic mutations in 3929 HPV positive cervical cells associated with infection outcome and HPV type.
    Nat Commun. 2024;15:7895.
    Abstract

  2372. LIU HY, Wang JY, Zhang HT, Huang CX, et al
    Peritoneal vaginal extension combined with psychological intervention on sexual life and quality of life in patients with early cervical cancer.
    Asian J Surg. 2024 Sep 11:S1015-9584(24)01986.
    Abstract

  2373. CHANG CW, Yang ST, Liu HH, Chang WH, et al
    Surgery-based radiation-free multimodality treatment for locally advanced cervical cancer.
    Taiwan J Obstet Gynecol. 2024;63:651-664.
    Abstract

  2374. YANG ST, Wang PH, Liu HH, Chang CW, et al
    Cervical cancer: Part II the landscape of treatment for persistent, recurrent and metastatic diseases (I).
    Taiwan J Obstet Gynecol. 2024;63:637-650.
    Abstract

  2375. SONG H, Lee HY, Oh SA, Seong J, et al
    Application of Machine Learning Algorithms for Risk Stratification and Efficacy Evaluation in Cervical Cancer Screening Among the ASCUS/LSIL Population: Evidence from the Korean HPV Cohort Study.
    Cancer Res Treat. 2024 Sep 6. doi: 10.4143/crt.2024.
    Abstract

  2376. ZHONG L, Zheng J, Wang Z, Lin L, et al
    Metabolomics and proteomics reveal the inhibitory effect of Lactobacillus crispatus on cervical cancer.
    Talanta. 2024;281:126839.
    Abstract

  2377. NAVEED M, Saad Mughal M, Aziz T, Jabeen K, et al
    The Prominence of the Broad-Spectrum Protease inhibitor gene A2ML1 as a potential biomarker in cervical cancer diagnostics using Immunotherapeutic and Multi-Omics approaches.
    Int Immunopharmacol. 2024;142.
    Abstract

  2378. JIN Y, Wu Q, Pan S, Zhou Q, et al
    Baicalein enhances cisplatin sensitivity in cervical cancer cells by promoting cuproptosis through the Akt pathway.
    Biomed Pharmacother. 2024;179:117415.
    Abstract

  2379. GOPALANI SV, Qin J, Baksa J, Thompson TD, et al
    Cervical Cancer Incidence in the US-Affiliated Pacific Islands.
    JAMA Oncol. 2024 Sep 12. doi: 10.1001/jamaoncol.2024.3675.
    Abstract

  2380. WANG Y, Ouyang Y, Cao X, Cai Q, et al
    Identifying hub genes for chemo-radiotherapy sensitivity in cervical cancer: a bi-dataset in silico analysis.
    Discov Oncol. 2024;15:434.
    Abstract

  2381. CHAUHAN P, Pramodh S, Hussain A, Elsori D, et al
    Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses.
    Front Cell Dev Biol. 2024;12:1397945.
    Abstract

  2382. CHEN Y, Zou Q, Chen Q, Wang S, et al
    Methylation-related differentially expressed genes as potential prognostic biomarkers for cervical cancer.
    Heliyon. 2024;10:e36240.
    Abstract

  2383. WANG Y, Wang J, Huang C, Ding Y, et al
    M1 macrophage-membrane-cloaked paclitaxel/beta-elemene nanoparticles targeting cervical cancer for enhanced therapy.
    Int J Pharm X. 2024;8:100276.
    Abstract

  2384. LEETANAPORN K, Chiangjong W, Roytrakul S, Molika P, et al
    Enhancing outcome prediction of concurrent chemoradiation treatment in patients with locally advanced cervical cancer through plasma extracellular vesicle proteomics.
    Heliyon. 2024;10:e36374.
    Abstract

  2385. CAPALDI DPI, Wang JY, Liu L, Sheth VR, et al
    Parametric response mapping of co-registered intravoxel incoherent motion magnetic resonance imaging and positron emission tomography in locally advanced cervical cancer undergoing concurrent chemoradiation therapy.
    Phys Imaging Radiat Oncol. 2024;31:100630.
    Abstract

  2386. ALIZAI HNK, Pasha A
    Comment on: Effect of Pap Smear Cytology, HPV Genotyping On the Concordance of Colposcopy and Conization Results.
    J Coll Physicians Surg Pak. 2024;34:1133-1134.
    Abstract

  2387. SHIMAMOTO T, Ooura H, Ono T
    [Effect of Brachytherapy Source Dwell Position on Dose Distribution in Cervical Cancer Therapy].
    Nihon Hoshasen Gijutsu Gakkai Zasshi. 2024 Sep 12. doi: 10.6009/jjrt.2024-1420.
    Abstract

  2388. CANNIZZARO NT, Mittman BS, Hahn EE, Ngo-Metzger Q, et al
    Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations.
    J Womens Health (Larchmt). 2024 Sep 11. doi: 10.1089/jwh.2023.1180.
    Abstract

  2389. ANANGWE N, Steimgrimson J, Cu-Uvin S
    Evaluation of Pathology Resources for Cervical Cancer Detection Between 2018 & 2022: a Retrospective Study at Moi Teaching and Referral Hospital, Western Kenya.
    Res Sq [Preprint]. 2024 Aug 28:rs.3.rs-4791370. doi: 10.21203/rs.3.rs-4791370.
    Abstract

  2390. FULLERTON MM, Ford C, D'Silva C, Chiang B, et al
    HPV self-sampling implementation strategies to engage under screened communities in cervical cancer screening: a scoping review to inform screening programs.
    Front Public Health. 2024;12:1430968.
    Abstract

  2391. SECK I, Soumboundou M, Ndoye SF, Sall C, et al
    Phytochemical screening, antimicrobial, antioxidant, anticancer activities on cervical cancer cell lines and aero-digestive extract of Moringa oleifera.
    Nat Prod Res. 2024 Sep 10:1-8. doi: 10.1080/14786419.2024.2400221.
    Abstract

  2392. SHOUKRY A, Yousri M
    Cervical stump leiomyomata after supracervical hysterectomy; a case report with review of literature.
    BMC Womens Health. 2024;24:500.
    Abstract

  2393. WONG HY, Wong EL
    Invitation strategy of vaginal HPV self-sampling to improve participation in cervical cancer screening: a systematic review and meta-analysis of randomized trials.
    BMC Public Health. 2024;24:2461.
    Abstract

  2394. MARFO E, Salami B, Adjei C, MacDonald S, et al
    Human papillomavirus (HPV) vaccination in a privately funded program in Ghana: A qualitative case study.
    Hum Vaccin Immunother. 2024;20:2397219.
    Abstract

  2395. GUO W, Li N, Ren R, Hu Y, et al
    Prognosis and treatment regimens for patients with different lymph node statuses in locally advanced cervical cancer.
    Eur J Surg Oncol. 2024;50:108522.
    Abstract

  2396. BONNAH J, Williams MS
    An Assessment of the Acceptability of Cervical Cancer Education Intervention Materials Among Healthcare Providers in Ghana.
    J Cancer Educ. 2024 Sep 10. doi: 10.1007/s13187-024-02501.
    Abstract

  2397. SHUKLA S, Trivedi P, Johnson D, Sharma P, et al
    Synthesis, crystal structure analysis, computational modelling and evaluation of anti-cervical cancer activity of novel 1,5-dicyclooctyl thiocarbohydrazone.
    Phys Chem Chem Phys. 2024 Sep 10. doi: 10.1039/d4cp02286.
    Abstract

  2398. ALMOBARAK F
    Bibliometric analysis of global research in palliative care for cervical cancer.
    Front Oncol. 2024;14:1432805.
    Abstract

  2399. DATTA S, Baqui Billah S, Halder A, Rahman T, et al
    Factors related to cervical cancer and human papilloma virus awareness among rural women of southern Bangladesh: A cross-sectional study.
    Gynecol Oncol Rep. 2024;55:101481.
    Abstract

  2400. FILE B, Hari A
    Discrepancy in PD-L1 expression between primary and metastatic tumors in two patients with recurrent cervical cancer.
    Gynecol Oncol Rep. 2024;55:101484.
    Abstract

  2401. ZENG Z, Zhang F, Yan J
    Moderated Hypofractionated Online Adaptive Radiotherapy in Locally Advanced Cervical Cancer: A Case Report.
    Cureus. 2024;16:e66552.
    Abstract


  2402. Dosimetry study of Auto-VMAT planning and Manual-VMAT planning based on Pinnacle3 9.10 in radiotherapy for cervical cancer: Retraction.
    Medicine (Baltimore). 2024;103:e39830.
    Abstract


  2403. A study of different minimum segment area parameters on automatic IMRT plans for cervical cancer using Pinnacle3 9.10 TPS: Retraction.
    Medicine (Baltimore). 2024;103:e39829.
    Abstract

  2404. LIU X, Fang C, Hu W, Su C, et al
    Postoperative clearance of high-risk human papillomavirus for patients with high-grade squamous intraepithelial lesion: Conization versus hysterectomy.
    Medicine (Baltimore). 2024;103:e39564.
    Abstract

  2405. GONZALEZ-FIERRO A, Dominguez-Gomez G, Chavez-Blanco A, Duenas-Gonzalez A, et al
    Pharmacokinetics and pharmacodynamics of angiogenesis inhibitors used to treat cervical cancer: current and future.
    Expert Opin Drug Metab Toxicol. 2024.
    Abstract

  2406. NAMUTUNDU J, Kiguli J, Nakku-Joloba E, Makumbi F, et al
    Barriers and facilitators of cervical cancer screening literacy among rural women with HIV attending rural public health facilities in East Central Uganda: a qualitative study using the integrated model of health literacy.
    BMC Womens Health. 2024;24:498.
    Abstract

  2407. HE J, Li T, Cheng C, Li N, et al
    The polymorphism analysis and therapy vaccine target epitopes screening of HPV-35 E6 E7 among the threaten alpha-9 HPV in Sichuan area.
    Virol J. 2024;21:213.
    Abstract

  2408. MUANGWONG P, Prukvaraporn N, Kittidachanan K, Watthanayuenyong N, et al
    Utilizing CT imaging for evaluating late gastrointestinal tract side effects of radiotherapy in uterine cervical cancer: a risk regression analysis.
    BMC Med Imaging. 2024;24:235.
    Abstract

  2409. OKYERE J, Ayebeng C, Dickson KS
    Factors associated with age at first screening for cervical cancer among adult Cape Verdean women: a cross-sectional study.
    BMC Public Health. 2024;24:2444.
    Abstract

  2410. WANG Y, Zhang Y, Liang X, Liu J, et al
    The Impact of Frailty on the Toxic Reaction of Chemotherapy in Patients With Cervical Cancer: A Longitudinal Study.
    Cancer Nurs. 2024 Sep 4. doi: 10.1097/NCC.0000000000001404.
    Abstract

  2411. WANG H, Li X, Zhou S, Guo W, et al
    Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals MMP mediated expression patterns by distinct tumor microenvironment immune profiles in cervical cancer.
    J Cancer. 2024;15:5258-5276.
    Abstract

  2412. XU F, Ye Y, Gao Y, Xu S, et al
    Dual Role of Necroptosis in Cervical Cancer: Promoting Tumor Aggression and Modulating the Immune Microenvironment via the JAK2-STAT3 Pathway.
    J Cancer. 2024;15:5288-5307.
    Abstract

  2413. KIM J, Chang HK, Paek J, Park HJ, et al
    Robotic radical hysterectomy for cervical cancer: current trends and controversies.
    J Cancer. 2024;15:5134-5139.
    Abstract

  2414. NGALLA C, Didymus J, Manjuh F, Nwufor M, et al
    Challenges faced in managing cervical cancer patients who present post-operatively with more advanced disease in LMICs: Case studies from Cameroon.
    Gynecol Oncol Rep. 2024;55:101485.
    Abstract

  2415. SHAIK N, Nerune SM, Patil VS, Jawalkar S, et al
    The Expression of Cyclooxygenase-2 in Cervical Intraepithelial Neoplasia and Cervical Cancer.
    Cureus. 2024;16:e66473.
    Abstract

  2416. HU Y, Ai J
    Development and Validation of Radiomics-Based Models for Predicting the Parametrial Invasion in Stage IB1 to IIA2 Cervical Cancer.
    Int J Gen Med. 2024;17:3813-3824.
    Abstract

  2417. JOSEPH AG, Biji M, Murali VP, Sherin DR, et al
    A comprehensive apoptotic assessment of niloticin in cervical cancer cells: a tirucallane-type triterpenoid from Aphanamixis polystachya (Wall.) Parker.
    RSC Med Chem. 2024 Aug 8. doi: 10.1039/d4md00318.
    Abstract


  2418. Correction to "Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer"Wang J, Wang S, Wang J, Huang J, Lu H, Pan B, Pan H, Song Y, Deng Q, Jin X, Shi G. Comprehensive analysis of clinical prognosis and bio
    Cancer Med. 2024;13:e70214.
    Abstract

  2419. RAHMAN MM, Rahman MS, Islam MR, Gilmour S, et al
    Regional variations and inequalities in testing for early detection of breast and cervical cancer: evidence from a nationally representative survey in India.
    J Epidemiol. 2024 Sep 7. doi: 10.2188/jea.JE20240065.
    Abstract

  2420. ZHU X, Zeng M, Dai Y, Kuang W, et al
    3D-printed individual template brachytherapy for the treatment of intractable central pelvic recurrent cervical cancer: A single institution experience.
    Brachytherapy. 2024 Sep 6:S1538-4721(24)00072.
    Abstract

  2421. KATOH Y, Kubo A, Hayashi N, Sugi T, et al
    Serum levels of stearic and dihomo-gamma-linolenic acids can be used to diagnose cervical cancer and cervical intraepithelial neoplasia.
    Sci Rep. 2024;14:20833.
    Abstract

  2422. SPACEK J, Hoffmann P, Lojik M, Gunka I, et al
    Ureteroarterial fistula - a severe manifestation of urological toxicity with possibly fatal consequences.
    Ceska Gynekol. 2024;89:293-297.
    Abstract

  2423. ZHANG Q, Song J, Sun M, Xu T, et al
    RNF113A as a poor prognostic factor promotes metastasis and invasion of cervical cancer through miR197/PRP19/P38MAPK signaling pathway.
    Arch Biochem Biophys. 2024;761:110139.
    Abstract

  2424. BORDIGONI B, Trivellato S, Pellegrini R, Meregalli S, et al
    Automated segmentation in pelvic radiotherapy: A comprehensive evaluation of ATLAS-, machine learning-, and deep learning-based models.
    Phys Med. 2024;125:104486.
    Abstract

  2425. SCHERER-QUENZER AC, Herbert SL, Schlaiss T, Wockel A, et al
    Assessment of psychological distress in patients with cervical dysplasia according to age, education, information acquisition and information level.
    Arch Gynecol Obstet. 2024;310:2173-2181.
    Abstract

  2426. SHEILA S, Adoquaye BC, Kafui AP, Lawrence E, et al
    Differential expression of host oncogenes in human papillomavirus-associated nasopharyngeal and cervical epithelial cancers.
    Kaohsiung J Med Sci. 2024;40:830-836.
    Abstract

  2427. GARCIA A, Maldonado G, Hernandez G
    Translational control of papillomavirus mRNAs in the spotlight.
    Trends Cell Biol. 2024;34:703-706.
    Abstract

  2428. KIKKAWA N, Sugawara H, Yoshida H, Kobayashi-Kato M, et al
    Characteristics of the magnetic resonance imaging findings of cervical gastric-type adenocarcinoma.
    Clin Radiol. 2024;79:e1189-e1195.
    Abstract

  2429. SHARIFIAN K, Shoja Z, Jalilvand S
    Lineage and sublineage analysis of human papillomavirus types 51 and 59 in Iranian women.
    Virus Genes. 2024;60:455-463.
    Abstract

  2430. PENG X, Liu J
    The relationship between household income and prognosis of patients with cervical adenocarcinoma in the United States: A retrospective cohort study based on the SEER database.
    Eur J Surg Oncol. 2024;50:108516.
    Abstract

  2431. MIYAGI E, Mizushima T
    Is there a need for screening of cervical HPV infections and carcinoma?
    Best Pract Res Clin Obstet Gynaecol. 2024;96:102522.
    Abstract

  2432. FONTENOT HB, Fuzzell L, Brownstein NC, Lake P, et al
    Health Care Provider Willingness to Recommend Self-collected Tests for Human Papillomavirus: A Mixed Methods Examination of Associated Factors.
    Womens Health Issues. 2024;34:506-517.
    Abstract

  2433. SOLORZANO-IBARRA F, Alejandre-Gonzalez AG, Ortiz-Lazareno PC, Bueno-Topete MR, et al
    Cataloging circulating CD3(+)CD56(+) NKT-like cells through a series of stimulating (NKG2D and DNAM-1) and inhibitory (PD-1, TIGIT, and Tim-3) immune checkpoint receptors in women diagnosed with precancerous cervical lesions or invasive cervical carci
    Immunol Lett. 2024;269:106889.
    Abstract

  2434. DANAN ER, Amundson EC, Gowdy-Jaehnig A, Friedman JK, et al
    "It Feels Like Health Care with the Patient in Mind": VA Patient and Staff Perspectives on Self-Collected HPV Testing.
    Womens Health Issues. 2024;34:518-527.
    Abstract

  2435. PATEL AG, Heller SL
    Patient-Friendly Summary of the ACR Appropriateness Criteria(R): Pretreatment Evaluation and Follow-up of Invasive Cancer of the Cervix.
    J Am Coll Radiol. 2024;21:e85.
    Abstract

  2436. ATES D, Sahin EN, Katipoglu K, Usubutun A, et al
    A Low-Risk HPV-Associated Well-Differentiated Squamous Cell Carcinoma of the Cervix with Low-Grade Squamous Intraepithelial Lesion Morphology: Clinical and Pathologic Diagnostic Difficulties and Review of the Literature.
    Turk Patoloji Derg. 2024;40:196-201.
    Abstract

  2437. MASTROGEORGIOU M, Chatzikalil E, Theocharis S, Papoudou-Bai A, et al
    The immune microenvironment of cancer of the uterine cervix.
    Histol Histopathol. 2024;39:1245-1271.
    Abstract

  2438. NA YJ, Jeong O, Seong J, Lee J, et al
    HPV vaccination status and effectiveness in Korean women with HPV16/18 infection (2010-2021): a retrospective study.
    J Gynecol Oncol. 2024;35:e56.
    Abstract

  2439. MENSAH K, Mosquera I, Tisler A, Uuskula A, et al
    Correction: Development and pilot implementation of a novel protocol to assess capacity and readiness of health systems to adopt HPV detection-based cervical cancer screening in Europe.
    Health Res Policy Syst. 2024;22:130.
    Abstract

  2440. XI Y, Zheng P, Xi W, Fu T, et al
    Exploring the impact of estrogenic endocrine disruptors on cervical cancer progression: A transcriptome analysis and prognostic model development.
    Ecotoxicol Environ Saf. 2024;285:117025.
    Abstract

  2441. SULTANOV M, van der Schans J, Koot JA, Greuter MJ, et al
    Early evaluation of a screen-and-treat strategy using high-risk HPV testing for Uganda: Implications for screening coverage and treatment.
    J Glob Health. 2024;14:04157.
    Abstract

  2442. HAN S, Wang S, Li Y, He Y, et al
    HPV-ferroptosis related genes as biomarkers to predict the prognosis of cervical cancer.
    Discov Oncol. 2024;15:468.
    Abstract

  2443. PAULO A, Oliveira MC, Cabral Campello MP, Gano L, et al
    Evaluation of a Radioiodinated G-quadruplex Binder in Cervical Cancer Models.
    ChemMedChem. 2024 Sep 20:e202400438. doi: 10.1002/cmdc.202400438.
    Abstract

  2444. LIU Z, Mao L, Wang L, Zhang H, et al
    [Retracted] miR?218 functions as a tumor suppressor gene in cervical cancer.
    Mol Med Rep. 2024;30:202.
    Abstract

  2445. DAN VM, Sanawar R, Mohan GMG, Cheriyan SP, et al
    Urdamycin V from Streptomyces sp induces p53 independent apoptosis in cervical cancer cells inconsiderate of HPV status and inhibited growth of gram-positive human pathogens.
    Nat Prod Res. 2024 Sep 20:1-5. doi: 10.1080/14786419.2024.2405862.
    Abstract

  2446. HUANG L, Shen Q, Yu K, Yang J, et al
    RBPMS-AS1 sponges miR-19a-3p to restrain cervical cancer cells via enhancing PLCL1-mediated pyroptosis.
    Biotechnol Appl Biochem. 2024 Sep 19. doi: 10.1002/bab.2667.
    Abstract

  2447. YIRSAW AN, Nigusie A, Andualem F, Getachew E, et al
    Cervical cancer screening utilization and associated factors among women living with HIV in Ethiopia, 2024: systematic review and meta-analysis.
    BMC Womens Health. 2024;24:521.
    Abstract

  2448. GU Z, Li B, OuYang L, Wu H, et al
    A study on improving cancer-related fatigue and disease-related psychological variables in patients with cervical cancer based on online mindfulness-based stress reduction: a randomized controlled trial.
    BMC Womens Health. 2024;24:525.
    Abstract

  2449. LIANG LA, Tanaka LF, Radde K, Bussas U, et al
    Population-based age- and type-specific prevalence of human papillomavirus among non-vaccinated women aged 30 years and above in Germany.
    BMC Infect Dis. 2024;24:1008.
    Abstract

  2450. AKTHER A, Millat MS, Islam MA, Chowdhury MMI, et al
    Association of HOTAIR rs7958904 Polymorphism with Cervical Cancer Risk.
    Reprod Sci. 2024 Sep 19. doi: 10.1007/s43032-024-01679.
    Abstract

  2451. MIRANDA AVSS, da Silva JL, Andrade DAP, Gomes LM, et al
    Stereotactic body radiotherapy boost as an alternative to brachytherapy for cervical cancer: a scoping review.
    Crit Rev Oncol Hematol. 2024 Sep 17:104517.
    Abstract

  2452. HUIYUN J, Yuebo Y, Xiaomao L
    Prevalence of human papillomavirus and cervical lesions among elderly women: an unignored challenge to cervical cancer prevention.
    Ann Med. 2024;56:2404548.
    Abstract

  2453. ZHAO Z, Hu B, Xu K, Jiang Y, et al
    A quantitative analysis of artificial intelligence research in cervical cancer: a bibliometric approach utilizing CiteSpace and VOSviewer.
    Front Oncol. 2024;14:1431142.
    Abstract

  2454. MAGHIAR L, Sachelarie L, Huniadi AC
    Analysis of molecular marker expression in cutaneous lesions and cervical carcinoma associated with HPV infection.
    J Med Life. 2024;17:634-638.
    Abstract

  2455. HE L, Qian H, Seyiti A, Yang C, et al
    CD133(+)/ABCC5(+) cervical cancer cells exhibit cancer stem cell properties.
    Heliyon. 2024;10:e37066.
    Abstract

  2456. HUANG R, Wang F, Zou W, Li X, et al
    Tumor endothelium-derived PODXL correlates with immunosuppressive microenvironment and poor prognosis in cervical cancer patients receiving radiotherapy or chemoradiotherapy.
    Biomark Res. 2024;12:106.
    Abstract

  2457. ASEMPAH E, Ikpebe E
    Accelerating HPV vaccination in Africa for health equity.
    Glob Health Res Policy. 2024;9:37.
    Abstract

  2458. ZHANG Z, Chen F, Deng X
    Screening and identification of susceptibility genes for cervical cancer via bioinformatics analysis and the construction of an mitophagy-related genes diagnostic model.
    J Cancer Res Clin Oncol. 2024;150:423.
    Abstract

  2459. CHEN Y, Powers J, McDougle CJ, Zurcher NR, et al
    Cervical Cancer Screening and Prevention Uptake in Females with Autism Spectrum Disorder.
    J Autism Dev Disord. 2024 Sep 18. doi: 10.1007/s10803-024-06565.
    Abstract

  2460. HELPMAN L, Bernard L, Pond G
    Reply to: Vaginal surgery for cervical cancer based on the recent results of LACC, SHAPE, SUCCOR and ConCerv trials.
    Eur J Surg Oncol. 2024 Sep 7:108656. doi: 10.1016/j.ejso.2024.108656.
    Abstract

  2461. ZHENG J, Dou M, Wu Z, Zhang C, et al
    Combined single cell and spatial transcriptome analysis reveals hedgehog pathway-related genes as potential therapeutic targets for cervical cancer.
    Cancer Treat Res Commun. 2024;41:100841.
    Abstract

  2462. YADAV P, Bandyopadhyay A, Sarkar K
    Enhancement of gold-curcumin nanoparticle mediated radiation response for improved therapy in cervical cancer: a computational approach and predictive pathway analysis.
    Discov Nano. 2024;19:153.
    Abstract

  2463. MITTAL S, Kansal Y, Singh B, Gupta V, et al
    High-risk HPV Prevalence Estimates among Older Patients: Implications for Cervical Cancer Screening Programs.
    Indian J Community Med. 2024;49:599-603.
    Abstract

  2464. TANABE S, Yutoku S, Ichida K
    Factors Influencing CRP levels in Laparoscopic and Robotic Total Hysterectomy.
    JSLS. 2024;28:e2024.
    Abstract

  2465. KAMAU SW, Ngugi MP, Mwitari PG, Njeru SN, et al
    Network pharmacology, molecular docking and experimental approaches of the anti-proliferative effects of Rhamnus prinoides ethyl-acetate extract in cervical cancer cells.
    Heliyon. 2024;10:e37324.
    Abstract

  2466. NAJAFI A, Ataee MH, Farzanehpour M, Esmaeili Guvarchin Ghaleh H, et al
    A Comparative Analysis of Computational Strategies in Multi-Epitope Vaccine Design Against Human Papillomavirus and Cervical Cancer.
    Cell J. 2024;26:403-426.
    Abstract

  2467. SAAKA SA, Hambali MG
    Factors associated with cervical cancer screening among women of reproductive age in Ghana.
    BMC Womens Health. 2024;24:519.
    Abstract

  2468. BAI B, Tuerxun G, Tuerdi A, Maimaiti R, et al
    Analysis of vaginal flora diversity and study on the role of Porphyromonas asaccharolytica in promoting IL-1beta in regulating cervical cancer.
    Sci Rep. 2024;14:21731.
    Abstract

  2469. HUNDESA FM, Ayana M, Girmaye E, Fetensa G, et al
    Uptake of Human Papilloma Virus Vaccination and Associated Factors Among Female Students Attending Secondary Schools in South West Shoa, Oromia, Ethiopia, 2022.
    Cancer Control. 2024;31:10732748241285271.
    Abstract

  2470. HE Y, Zhang X, Li J, Chen Y, et al
    Factors influencing HPV vaccine hesitancy among university students in China: A cross-sectional survey utilizing the 3Cs model.
    Hum Vaccin Immunother. 2024;20:2400750.
    Abstract

  2471. GENNIGENS C
    Hope emerging in the locally advanced cervical cancer landscape.
    Lancet. 2024 Sep 13:S0140-6736(24)01918-4. doi: 10.1016/S0140-6736(24)01918.
    Abstract

  2472. LORUSSO D, Xiang Y, Hasegawa K, Scambia G, et al
    Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-
    Lancet. 2024 Sep 13:S0140-6736(24)01808-7. doi: 10.1016/S0140-6736(24)01808.
    Abstract

  2473. IAVAZZO C, Gkegkes ID
    Vaginal surgery for cervical cancer based on the recent results of LACC, SHAPE, SUCCOR and ConCerv trials.
    Eur J Surg Oncol. 2024;50:108655.
    Abstract

  2474. SIMEK IM, Sturdza A, Knoth J, Spannbauer A, et al
    Cardiac metastasis in uterine cervical cancer : A systematic review and case study.
    Strahlenther Onkol. 2024 Sep 17. doi: 10.1007/s00066-024-02274.
    Abstract

  2475. GEBRESELASSIE KH, Adamu TA, Beyene AD
    Ureteral stenting in patients with locally advanced cervical cancer: Predictors of low success rate.
    Gynecol Oncol Rep. 2024;55:101491.
    Abstract

  2476. LI Y, Sun W, Liu S, Xia W, et al
    Effect of body contour changes on the setup and dosimetric accuracy of radiotherapy after cervical cancer surgery.
    Front Oncol. 2024;14:1392741.
    Abstract

  2477. TING WH, Chen HH, Hsieh SW, Wei MC, et al
    Comparison of clinical outcomes in women with surgically treated early primary cervical cancer: Lymphadenectomy versus sentinel lymph node biopsy.
    J Chin Med Assoc. 2024 Sep 17. doi: 10.1097/JCMA.0000000000001169.
    Abstract

  2478. GAO J, Zhang X, Xu A, Li W, et al
    Integrated analysis of N6-methyladenosine- and 5-methylcytosine-related long non-coding RNAs for predicting prognosis in cervical cancer.
    Hereditas. 2024;161:34.
    Abstract

  2479. SANTOS JP, Costa RS, Correa DG
    Urinoma as a complication of cervical cancer.
    J Bras Nefrol. 2024;46:e20240113.
    Abstract

  2480. SANLIER NT, Sacinti KG, Turkoglu I, Sanlier N, et al
    Some Polyphenolic Compounds as Potential Therapeutic Agents in Cervical Cancer: The Most Recent Advances and Future Prospects.
    Nutr Rev. 2024 Sep 16:nuae126. doi: 10.1093.
    Abstract

  2481. TAKAGAWA Y, Machida M, Seto I, Komori S, et al
    Analysis of operative duration of image-guided brachytherapy for cervical cancer.
    Strahlenther Onkol. 2024 Sep 16. doi: 10.1007/s00066-024-02297.
    Abstract

  2482. DUPPALA SK, Poleboyina PK, Kour B, Bale G, et al
    A Pilot Study Based on the Correlation Between Whole Exome and Transcriptome Reveals Potent Variants in the Indian Population of Cervical Cancer.
    Indian J Microbiol. 2024;64:1222-1245.
    Abstract

  2483. DE OLIVEIRA LIMA T, Erialdo da Silva Junior J, Aparecida Vieira Barreto G, Wellington Satiro Justino M, et al
    Time series and risk factors associated with mortality in women with cervical cancer from 2000 to 2021.
    Gynecol Oncol Rep. 2024;55:101490.
    Abstract

  2484. ZHANG X, Li Q, Liu K, Shi HY, et al
    Retrospective analysis of efficacy and safety of recombinant human Rh-endostatinstatin combined with concurrent radiotherapy for cervical cancer.
    Pak J Med Sci. 2024;40:1695-1701.
    Abstract

  2485. WITT CE, Sutton EF, Stansbury AM, Winters AN, et al
    Characterization of High-Risk-Other Human Papillomavirus Genotypes in Papanicolaou Tests, High-Grade Squamous Intraepithelial Lesions, and Cervical Cancer.
    Ochsner J. 2024;24:179-183.
    Abstract

  2486. NANDA S, Nayak B, Senapati SN, Padhy AK, et al
    Adjuvant Hysterectomy in Patients After Radiation for Locally Advanced Cervical Cancer: A Single-Center Prospective Longitudinal Study.
    J Obstet Gynaecol India. 2024;74:357-363.
    Abstract

  2487. PURANDARE CN
    Cervical Cancer Elimination. 90:70:90. Together We Can.
    J Obstet Gynaecol India. 2024;74:292-294.
    Abstract

  2488. SINGH S, Agrawal S, Seth A, Singh S, et al
    PAP Test Versus Colposcopy for Cervical Cancer Screening in HIV-Seropositive Women: A Case-Control Study.
    J Obstet Gynaecol India. 2024;74:350-356.
    Abstract

  2489. SARAIYA UB
    New Paradigms in Cervical Cancer Prevention.
    J Obstet Gynaecol India. 2024;74:295-302.
    Abstract

  2490. CHANGEDE P
    Staging of Cervical Cancer: What has Changed?
    J Obstet Gynaecol India. 2024;74:378-381.
    Abstract

  2491. LUCKSOM PG, Sherpa ML, Pradhan A, Sherpa M, et al
    Questionnaire-Based Study on the Knowledge of Cervical Cancer and Attitude and Perception Toward Self-Sampling Method of Screening, Among Women in Sikkim, India.
    J Obstet Gynaecol India. 2024;74:364-370.
    Abstract

  2492. TARIGAN VN, Rahmawati DL, Octavius GS
    Transrectal Ultrasound in Cervical Cancer: A Systematic Review of its Current Application.
    J Obstet Gynaecol India. 2024;74:303-310.
    Abstract

  2493. PATEL M
    Primary Prevention in Cervical Cancer-Current Status and Way Forward.
    J Obstet Gynaecol India. 2024;74:287-291.
    Abstract

  2494. LIAO D, Yang S, Zhao L, Ren W, et al
    ICAT-Mediated Crosstalk Between Cervical Cancer Cells and Macrophages Promotes M2-Like Macrophage Polarization to Reinforce Tumor Malignant Behaviors.
    Mol Carcinog. 2024 Sep 16. doi: 10.1002/mc.23820.
    Abstract

  2495. BOGALE AL, Ali JH, Sherif ZA
    Knowledge and Practice of Women With HIV on Cervical Cancer Prevention and Control and their Attributes to Utilize the Screening Services in Ethiopia: A Cross Sectional Study.
    Cancer Control. 2024;31:10732748241284943.
    Abstract

  2496. CAO X, Hu X, Xu X, Zhu W, et al
    Casticin suppresses self-renewal related stemness via miR-342-3p-mediated FoxM1 downregulation in cervical cancer cells.
    Phytomedicine. 2024;135:156036.
    Abstract

  2497. YANG H, Letendre A, Shea-Budgell M, Bill L, et al
    Cervical cancer screening outcomes among First Nations and non-First Nations women in Alberta, Canada.
    Cancer Epidemiol. 2024;93:102672.
    Abstract

  2498. BUELENS C, Stabel M, Wildiers A, Peremans L, et al
    Experiences and Perceptions of Cervical Cancer Screening Using Self-Sampling among Under-Screened Women in Flanders.
    Healthcare (Basel). 2024;12:1704.
    Abstract

  2499. DUSHKIN A, Afanasiev M, Afanasiev S, Grishacheva T, et al
    Subgroup Analysis of TLR2, -3, -4 and -8 in Relation to the Severity of Clinical Manifestations of Cervical HPV Infection.
    Int J Mol Sci. 2024;25:9719.
    Abstract

  2500. SHIN N, Lee HJ, Sim DY, Ahn CH, et al
    Anti-Warburg Mechanism of Ginsenoside F2 in Human Cervical Cancer Cells via Activation of miR193a-5p and Inhibition of beta-Catenin/c-Myc/Hexokinase 2 Signaling Axis.
    Int J Mol Sci. 2024;25:9418.
    Abstract

  2501. SUKHAMWANG A, Inthanon S, Dejkriengkraikul P, Semangoen T, et al
    Anti-Cancer Potential of Isoflavone-Enriched Fraction from Traditional Thai Fermented Soybean against Hela Cervical Cancer Cells.
    Int J Mol Sci. 2024;25:9277.
    Abstract

  2502. TRUJANO-CAMACHO S, Cantu-de Leon D, Perez-Yepez E, Contreras-Romero C, et al
    HOTAIR Promotes the Hyperactivation of PI3K/Akt and Wnt/beta-Catenin Signaling Pathways via PTEN Hypermethylation in Cervical Cancer.
    Cells. 2024;13:1484.
    Abstract

  2503. LAUFER J, Scasso S, Papadia A
    Impact of Indocyanine Green Dose on Sentinel Lymph Node Mapping in Cervical Cancer: A Systematic Review.
    Cancers (Basel). 2024;16:3107.
    Abstract

  2504. GABRIELE R, Campagnol M, Sapienza P, Borrelli V, et al
    Education and Information to Improve Adherence to Screening for Breast, Colorectal, and Cervical Cancer-Lessons Learned during the COVID-19 Pandemic.
    Cancers (Basel). 2024;16:3042.
    Abstract

  2505. MARINESCU SA, Toma RV, Trifanescu OG, Gales LN, et al
    Predictors of Clinical Hematological Toxicities under Radiotherapy in Patients with Cervical Cancer-A Risk Analysis.
    Cancers (Basel). 2024;16:3032.
    Abstract

  2506. ABDOUDAIM MS, Mohamed Abdellahi MV, Mohamed Baba ND, Mboumba Bouassa RS, et al
    Human Papillomavirus Genotypes Distribution in High-Grade Cervical Lesions and Invasive Cervical Carcinoma in Women Living in Mauritania: Implications for Cervical Cancer Prevention and HPV Prophylactic Vaccination.
    Diagnostics (Basel). 2024;14:1986.
    Abstract

  2507. MADDING RA, Currier JJ, Yanit K, Hedges M, et al
    HPV self-collection for cervical cancer screening among survivors of sexual trauma: a qualitative study.
    BMC Womens Health. 2024;24:509.
    Abstract

  2508. OWOKUHAISA J, Turyakira E, Ssedyabane F, Tusubira D, et al
    Barriers and facilitators of retention in care after cervical cancer screening: patients' and healthcare providers' perspectives.
    BMC Womens Health. 2024;24:516.
    Abstract

  2509. XUE X, Sun L, Liang D, Zhu J, et al
    Deep learning-based segmentation for high-dose-rate brachytherapy in cervical cancer using 3D Prompt-ResUNet.
    Phys Med Biol. 2024 Sep 13. doi: 10.1088/1361-6560.
    Abstract

  2510. NGUYEN LTP, Phan DQ, Gyan A, Nguyen HTN, et al
    Parents' Intentions of Human Papillomavirus Vaccination for Students in Vietnam: A Cross-Sectional Study.
    Cancer Control. 2024;31:10732748241284907.
    Abstract

  2511. ZHANG J, Liu G, Yang D, Cui X, et al
    Age-specific performance of human papillomavirus E6/E7 mRNA assay versus cytology for primary cervical cancer screening and triage: community-based screening in China.
    Front Cell Infect Microbiol. 2024;14:1428071.
    Abstract

  2512. DONG J, Wang M, Ni D, Zhang L, et al
    [Retracted] MicroRNA?217 functions as a tumor suppressor in cervical cancer cells through targeting Rho?associated protein kinase 1.
    Oncol Lett. 2024;28:524.
    Abstract

  2513. LIMONES-GONZALEZ JE, Aguilar Esquivel P, Vazquez-Santillan K, Castro-Oropeza R, et al
    Changes in the molecular nodes of the Notch and NRF2 pathways in cervical cancer tissues from the precursor stages to invasive carcinoma.
    Oncol Lett. 2024;28:522.
    Abstract

  2514. JASROTIA R, Kashyap I, Suri J, Chopra C, et al
    Assessing knowledge and awareness levels regarding cervical cancer and HPV vaccination in the Jammu regions.
    Iran J Microbiol. 2024;16:515-523.
    Abstract

  2515. PATAKI J, Szollosi GJ, Sarvary A, Dombradi V, et al
    Factors Associated With Cervical Cancer Screening Attendance in Hungary Based on the European Health Interview Survey.
    Int J Public Health. 2024;69:1607509.
    Abstract

  2516. MAHMOUD I, Al Eid MMA, Mohamed MA, Aladwani AJ, et al
    Human papillomavirus vaccination and Pap test uptake, awareness, and barriers among young adults in Gulf Cooperation Council countries: A comparative cross-sectional survey.
    J Infect Public Health. 2024;17:102525.
    Abstract

  2517. YANG Z, Ren X, Li L, Zhang J, et al
    Trojan-horse inspired nanoblaster: X-ray triggered spot attack on radio-resistant cancer through radiodynamic therapy.
    Biomaterials. 2025;313:122814.
    Abstract

  2518. UNGAR L, Capilna ME, Palfalvi L, Mate S, et al
    History and Perspectives of Hyperradical, Laterally Extended Parametrectomy (LEP).
    Ann Surg Oncol. 2024;31:6984-6991.
    Abstract

  2519. DENG S, Zhou Y, Lin J, Xiang Z, et al
    Survival analysis of gynecological cancers in Southeast China, 2011-2020: A population-based study.
    Cancer Epidemiol. 2024;92:102641.
    Abstract

  2520. ADCOCK R, Kang H, Castle PE, Kinney W, et al
    Population-Based Incidence of Cervical Intraepithelial Neoplasia Across 14 Years of HPV Vaccination.
    JAMA Oncol. 2024;10:1287-1290.
    Abstract

  2521. HASSAN D, Findley J, Braun A, Cheng L, et al
    Cytology-histology correlation of atypical glandular cells on cervical Papanicolaou tests: A study of 628 cases.
    J Am Soc Cytopathol. 2024;13:377-385.
    Abstract

  2522. LIU J, Hu N, Zheng X, Li H, et al
    Vaginal micro-environment disorder promotes malignant prognosis of low-grade cervical intraepithelial neoplasia: a prospective community cohort study in Shanxi Province, China.
    Clin Transl Oncol. 2024;26:2738-2748.
    Abstract

  2523. OUYANG Y, Zhao X
    A Potential Path Towards Standardized Radical Hysterectomy.
    Am J Obstet Gynecol. 2024 May 17:S0002-9378(24)00601.
    Abstract

  2524. YI H, Zhang N, Huang J, Zheng Y, et al
    Association of Levonorgestrel-Releasing Intrauterine Device with Gynecologic and Breast Cancers: National Cohort Study in Sweden.
    Am J Obstet Gynecol. 2024 May 15:S0002-9378(24)00593.
    Abstract

  2525. FEI Y, Cao D, Dong R, Li Y, et al
    The cuproptosis-related gene UBE2D2 functions as an immunotherapeutic and prognostic biomarker in pan-cancer.
    Clin Transl Oncol. 2024;26:2718-2737.
    Abstract

  2526. SONG X, Yang Y
    Analysis of the current situation and related influencing factors of cervical precancer screening under the COVID-19.
    Biotechnol Genet Eng Rev. 2023;39:1021-1033.
    Abstract

  2527. LIU J, Wu M, Yang Y, Mei X, et al
    BTN3A1 expressed in cervical cancer cells promotes Vgamma9Vdelta2 T cells exhaustion through upregulating transcription factors NR4A2/3 downstream of TCR signaling.
    Cell Commun Signal. 2024;22:459.
    Abstract

  2528. TIAN M, Xu H, Wang H, Wang H, et al
    Pretreatment Computed Tomography-Defined Sarcopenia, Treatment-Associated Muscle Loss, and Survival in Patients With Cervical Cancer: A Systematic Review and Meta-Analysis.
    Nutr Rev. 2024 Sep 28:nuae130. doi: 10.1093.
    Abstract

  2529. SHPENDI S, Norman P, Gibson-Miller J, Webster RK, et al
    Utilising the COM-B model to interpret barriers and facilitators to cervical cancer screening in young women.
    J Health Psychol. 2024 Sep 28:13591053241281405. doi: 10.1177/13591053241281405.
    Abstract

  2530. CRIPPIN T, Tounkara K, Munir H, Squibb E, et al
    Our Daughters-Ourselves: Evaluating the Impact of Paired Cervical Cancer Screening of Mothers with HPV Vaccination for Daughters to Improve HPV Vaccine Coverage in Bamako, Mali.
    Vaccines (Basel). 2024;12:1019.
    Abstract

  2531. CASTLE PE
    Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control.
    Viruses. 2024;16:1357.
    Abstract

  2532. GARCIA-ACOSTA JC, Castillo-Montoya AI, Rostro-Alonso GO, Villegas-Vazquez EY, et al
    Unrevealing Lithium Repositioning in the Hallmarks of Cancer: Effects of Lithium Salts (LiCl and Li(2)CO(3)) in an In Vitro Cervical Cancer Model.
    Molecules. 2024;29:4476.
    Abstract

  2533. WANG W, Jia Y, Liu Y, Lv X, et al
    Downregulation of RhoB Inhibits Cervical Cancer Progression and Enhances Cisplatin Sensitivity.
    Genes (Basel). 2024;15:1186.
    Abstract

  2534. SHANKAVARAM V, Shah D, Alashqar A, Sweeney J, et al
    Cornulin as a Key Diagnostic and Prognostic Biomarker in Cancers of the Squamous Epithelium.
    Genes (Basel). 2024;15:1122.
    Abstract

  2535. ASARE M, Owusu-Sekyere E, Elizondo A, Benavidez GA, et al
    Exploring Cervical Cancer Screening Uptake among Women in the United States: Impact of Social Determinants of Health and Psychosocial Determinants.
    Behav Sci (Basel). 2024;14:811.
    Abstract

  2536. ILUNO AC, Oshiname FO, Adekunle AO, Dansou J, et al
    Cervical cancer screening adoption behaviours among Nigerian women in academics: using a health belief model.
    BMC Womens Health. 2024;24:534.
    Abstract

  2537. CHEN Y, Wang X, Zhang J, Jiang Q, et al
    Split crRNA with CRISPR-Cas12a enabling highly sensitive and multiplexed detection of RNA and DNA.
    Nat Commun. 2024;15:8342.
    Abstract

  2538. KOLASSERI AE, B V
    Comparative study of machine learning and statistical survival models for enhancing cervical cancer prognosis and risk factor assessment using SEER data.
    Sci Rep. 2024;14:22203.
    Abstract

  2539. HUANG ZB, Wang LL, Xu XQ, Pylypenko D, et al
    Feasibility of using synthetic MRI to predict lymphatic vascular space invasion status in early-stage cervical cancer: added value to morphological MRI.
    Clin Radiol. 2024 Aug 23:S0009-9260(24)00488-4. doi: 10.1016/j.crad.2024.
    Abstract

  2540. LIU C, Liu G, Yu L, Hu L, et al
    The Association between Ambient PM(2.5)'s Constituents Exposure and Cervical Cancer Survival.
    Environ Res. 2024 Sep 25:119928. doi: 10.1016/j.envres.2024.119928.
    Abstract

  2541. CHEMINEAU M, Odelin N, Reitz L, Bertolotti A, et al
    [How do women in Reunion Island want to perform HPV test on vaginal sampling as part of cervical cancer screening?].
    Gynecol Obstet Fertil Senol. 2024 Sep 25:S2468-7189(24)00296.
    Abstract

  2542. LI H, Zhang H, Feng Z, Zhang X, et al
    A high biocompatible near-infrared fluorescent probe for tracking cysteine in multi-biosystem and its application in cervical cancer imaging.
    Spectrochim Acta A Mol Biomol Spectrosc. 2024;326:125185.
    Abstract

  2543. YANG B, Cheng Q, Hong X, Zhu X, et al
    Preliminary Evaluation of the Value of a Small-Molecule Probe Targeting DNMT1 in Detecting the Methylation of PAX1 in Cervical Cancer.
    Skin Res Technol. 2024;30:e70074.
    Abstract

  2544. ZOU Y, Zhu S, Kong Y, Feng C, et al
    Precision matters: the value of PET/CT and PET/MRI in the clinical management of cervical cancer.
    Strahlenther Onkol. 2024 Sep 27. doi: 10.1007/s00066-024-02294.
    Abstract

  2545. SMITH LW, Booth A, Racey CS, Smith B, et al
    Self-Screening for Cervical Cancer Offered through a Digital Platform in a Region of British Columbia with Lower Screening Rates.
    Curr Oncol. 2024;31:5399-5411.
    Abstract

  2546. KETEMA B, Addissie A, Negash S, Kantelhardt EJ, et al
    Does Prior Experience Matter? Intention to Undergo Cervical Cancer Screening among Rural Women in South-Central Ethiopia.
    Curr Oncol. 2024;31:4908-4916.
    Abstract

  2547. ZHU Y, Yang W, Wang X, Chen M, et al
    AUP1 transcriptionally activated by KDM5B reprograms lipid metabolism to promote the malignant progression of cervical cancer.
    Int J Oncol. 2024;65:107.
    Abstract

  2548. REIHANISARANSARI R, Gajjela CC, Wu X, Ishrak R, et al
    Cervical Cancer Tissue Analysis Using Photothermal Midinfrared Spectroscopic Imaging.
    Chem Biomed Imaging. 2024;2:651-658.
    Abstract

  2549. CHAN KKL, Liu SS, Lau LSK, Ngu SF, et al
    PAX1/SOX1 DNA Methylation Versus Cytology and HPV16/18 Genotyping for the Triage of High-Risk HPV-Positive Women in Cervical Cancer Screening: Retrospective Analysis of Archival Samples.
    BJOG. 2024 Sep 26. doi: 10.1111/1471-0528.17965.
    Abstract

  2550. MA Y, Shi H, Zheng W
    METTL3 Regulates the Translation of Oncogene Myc through m(6)A Modification and Promotes the Occurrence and Development of Cervical Cancer.
    Discov Med. 2024;36:1902-1910.
    Abstract

  2551. DISTELBRINK RF, Celebi E, Mom CH, Stoker J, et al
    Diffusion Weighted Imaging for the Assessment of Lymph Node Metastases in Women with Cervical Cancer: A Meta-analysis of the Apparent Diffusion Coefficient Values.
    Acad Radiol. 2024 Sep 25:S1076-6332(24)00669-X. doi: 10.1016/j.acra.2024.
    Abstract

  2552. GOULENOK T, Sacre K
    HPV Infection and Prevention in Patients With Immune-Mediated Inflammatory Diseases: A Scoping Review.
    J Clin Rheumatol. 2024;30.
    Abstract

  2553. HASEGAWA K, Takahashi S, Ushijima K, Okadome M, et al
    Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer.
    Cancer Med. 2024;13:e70236.
    Abstract

  2554. MOZEY M, Fogel J, Itzhak P
    Human Papillomavirus, Cervical Intraepithelial Neoplasia, and Quantitative Blood Loss at Delivery.
    Folia Med Cracov. 2024;64:41-50.
    Abstract

  2555. ZHANG J, Zhan J, Guan Z, Lin X, et al
    The prognostic value of Th17/Treg cell in cervical cancer: a systematic review and meta-analysis.
    Front Oncol. 2024;14:1442103.
    Abstract

  2556. XU X, Liu F, Zhao X, Wang C, et al
    The value of multiparameter MRI of early cervical cancer combined with SCC-Ag in predicting its pelvic lymph node metastasis.
    Front Oncol. 2024;14:1417933.
    Abstract

  2557. CAMARDA F, Paderno M, Cannizzaro MC, Nero C, et al
    Antibody drug conjugates in recurrent or metastatic cervical cancer: a focus on tisotumab vedotin state of art.
    Ther Adv Med Oncol. 2024;16:17588359241277647.
    Abstract

  2558. WANG J, Zhang N
    Study on the Role of EPHB6 in Inhibiting the Malignant Progression of Cervical Cancer C33A Cells by Binding to CBX7.
    Cell Biochem Biophys. 2024 Sep 26. doi: 10.1007/s12013-024-01458.
    Abstract

  2559. BEAS-LOZANO EL, Contreras S, Donald-Jaramillo MAM, Frayde-Aguilar C, et al
    Current management of cervical cancer in women living with HIV.
    Crit Rev Oncol Hematol. 2024 Sep 23:104519.
    Abstract

  2560. PENG T, Zhang H, Li L, Cao C, et al
    Plasma Cell-Free DNA Concentration and Fragmentomes Predict Neoadjuvant Chemotherapy Response in Cervical Cancer Patients.
    Adv Sci (Weinh). 2024 Sep 25:e2309422. doi: 10.1002/advs.202309422.
    Abstract

  2561. STRELOW B, Stevens J, Fink S, Cole K, et al
    Improving access to cervical cancer screening: The impact of a Saturday pap smear clinic.
    J Med Screen. 2024 Sep 25:9691413241281653. doi: 10.1177/09691413241281653.
    Abstract

  2562. ALJOHANI H JR, Alsaedi A
    Barriers and Enablers of Cervical Cancer Screening Among Saudi Women.
    Cureus. 2024;16:e67720.
    Abstract

  2563. SHIBUKI S, Saida T, Mori K, Ishiguro T, et al
    Diagnostic Imaging Performance of Dual-Energy Computed Tomography Compared with Conventional Computed Tomography and Magnetic Resonance Imaging for Uterine Cervical Cancer.
    Indian J Radiol Imaging. 2024;34:661-669.
    Abstract

  2564. TOKARSKI AO, Bernardelli RS, Bruscato JR, Lucena CR, et al
    Quality of Life Post Cervical Cancer Treatment: A Comparison Between Radical Surgery Approach and Radiotherapy and Chemotherapy.
    J Surg Oncol. 2024 Sep 24. doi: 10.1002/jso.27911.
    Abstract

  2565. HIDJO M, Mukhedkar D, Masimirembwa C, Lei J, et al
    Cervical cancer microbiome analysis: comparing HPV 16 and 18 with other HPV types.
    Sci Rep. 2024;14:22014.
    Abstract

  2566. KITAYAMA S, Takemoto K, Matsui Y, Makino T, et al
    Remission of intercellular IgG/IgA dermatosis after treatment for cervical cancer.
    J Dermatol. 2024 Sep 24. doi: 10.1111/1346-8138.17473.
    Abstract

  2567. LEHTINEN M, Gray P, Luostarinen T, Eriksson T, et al
    Head-to-head comparison of two human papillomavirus vaccines for efficacy against cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ-population-based follow-up of two cluster-randomized trials.
    Front Cell Infect Microbiol. 2024;14:1437704.
    Abstract

  2568. YADAV PK, Sharma A, Ali M, Khan N, et al
    The significance of uterine artery embolization in the treatment of utero-cervical cancer: A single case report.
    Clin Case Rep. 2024;12:e9458.
    Abstract

  2569. HASANZADEH M, Rejali M, Khalili-Tanha G, Mehramiz M, et al
    Interaction of High- and Low-Risk Human Papillomavirus Genotypes is Associated with a Reduced Risk of Developing Cervical Cancer.
    Infect Disord Drug Targets. 2024.
    Abstract

  2570. FOSMORE CL, Sullivan S, Brouwer AF, Goold SD, et al
    Strategies to Optimize Cervical Cancer Screening Rates Among Transgender and Gender-Diverse People Assigned Female at Birth.
    J Gen Intern Med. 2024 Sep 23. doi: 10.1007/s11606-024-09026.
    Abstract

  2571. HE J, Liao XH, Zhong BD, Liu AW, et al
    Association of MORC2 expression with progression-free survival in cervical cancer patients treated with concurrent chemoradiotherapy.
    Medicine (Baltimore). 2024;103:e39299.
    Abstract

  2572. XU C, Wang M, Chen C, Xu Y, et al
    Immunoprognostic analysis of indoleamine 2,3-dioxygenase 1 in patients with cervical cancer.
    Medicine (Baltimore). 2024;103:e39733.
    Abstract

  2573. ZHAO B, Liu Y, Lu H
    Roles of epidural block in combination with general anesthesia in stress response and immune function of patients after surgery for cervical cancer.
    J Mol Histol. 2024 Sep 23. doi: 10.1007/s10735-024-10266.
    Abstract

  2574. GREENMAN M, Chang YE, McNamara B, Mutlu L, et al
    Unmet needs in cervical cancer - can biological therapies plug the gap?
    Expert Opin Biol Ther. 2024 Sep 25:1-9. doi: 10.1080/14712598.2024.2408754.
    Abstract

  2575. BABU M, Thakur A, Sravyasri M, Gunjan G, et al
    Empowering Women's Health: Examining the Impact of Human Papillomavirus (HPV) Vaccination on Cervical Cancer Treatment and Beyond.
    Cureus. 2024;16:e67287.
    Abstract

  2576. EBNER F, Hartkopf A, Veselinovic K, Schochter F, et al
    A Comparison of ChatGPT and Multidisciplinary Team Meeting Treatment Recommendations in 10 Consecutive Cervical Cancer Patients.
    Cureus. 2024;16:e67458.
    Abstract

  2577. GHASEMI M, Savabi-Esfahani M, Noroozi M, Sattari M, et al
    Predicting cervical cancer screening participation using self-care behaviors among women in Iran.
    J Educ Health Promot. 2024;13:257.
    Abstract

  2578. XIE H, Tan T, Zhang H, Li Q, et al
    Dose prediction for cervical cancer in radiotherapy based on the beam channel generative adversarial network.
    Heliyon. 2024;10:e37472.
    Abstract

  2579. HU LJ, Fang HM, Lin HM, Kang X, et al
    Case report: Staged tension-reducing excision of giant acquired vulvar lymphangioma secondary to cervical cancer surgery.
    Front Oncol. 2024;14:1418829.
    Abstract

  2580. MIN FENG OOI B, Muschialli L, Kondal D, Andia G, et al
    Individual-level determinants of breast and cervical cancer screening and early testing in two regionally representative urban Indian populations.
    Prev Med Rep. 2024;46:102883.
    Abstract

  2581. CHEN X, Yan Z, Liu W, Guo L, et al
    Polymorphisms in miRNA Genes Targeting the AMPK Signaling Pathway are Associated with Cervical Cancer Susceptibility in a Han Chinese Population.
    Int J Gen Med. 2024;17:4171-4188.
    Abstract

  2582. KRUCKEL A, Saatze M, Behrens AS, Beckmann MW, et al
    Uterus didelphys and cervical cancer: A case report.
    Gynecol Oncol Rep. 2024;55:101503.
    Abstract

  2583. MA Y, Wan L, Li R, Chen X, et al
    Impact of postsurgical vaginal microbiome on high-risk HPV infection and recurrence risk in patients with cervical cancer and intraepithelial neoplasia: A retrospective study.
    Gynecol Oncol Rep. 2024;55:101506.
    Abstract

  2584. WANG S, Zhao M, Gao Z, Yang X, et al
    A survival nomogram involving nutritional-inflammatory indicators for cervical cancer patients receiving adjuvant radiotherapy.
    J Cancer. 2024;15:5773-5785.
    Abstract

  2585. GUO A, Zhong P, Wang L, Lin X, et al
    Prognosis and immunotherapeutic implications of molecular classification of cervical cancer based on immunophenoscore-related genes.
    J Biomol Struct Dyn. 2024 Sep 23:1-16. doi: 10.1080/07391102.2024.2404545.
    Abstract

  2586. LOU S, Yang W, Zhao Q, Ouyang Y, et al
    Identification of circRNA-mediated competing endogenous RNA network involved in the development of cervical cancer.
    Mol Cell Probes. 2024 Sep 20:101984. doi: 10.1016/j.mcp.2024.101984.
    Abstract

  2587. WU T, Lucas E, Zhao F, Basu P, et al
    Artificial intelligence strengthenes cervical cancer screening - present and future.
    Cancer Biol Med. 2024 Sep 19:j.issn.2095-3941.2024.0198.
    Abstract

  2588. REICH O, Regauer S, Gutierrez AL, Kashofer K, et al
    Copy Number Profiling Implicates Thin High-Grade Squamous Intraepithelial Lesions as a True Precursor of Cervical Human Papillomavirus-Induced Squamous Cell Cancer.
    Lab Invest. 2024;104:102108.
    Abstract

  2589. XU H, Jin Y, Hu E, Huang Z, et al
    Clinical Diagnosis of Cervical Lesions Combined with Programmed Death Ligand and miR-124 Detection in Peripheral Blood.
    Altern Ther Health Med. 2024;30:447-451.
    Abstract

  2590. AGUILAR-LINARES G, Marquez-Serrano M, Meneses-Navarro S, Pelcastre-Villafuerte BE, et al
    Barriers and facilitators for adherence to follow-up by HR-HPV-positive women with premalignant cervical lesions: a mixed-design study in Mexico.
    BMC Womens Health. 2024;24:550.
    Abstract

  2591. WU M, Liu R, Liu Y, Shen F, et al
    Role of HPV E7/miR-143-3p/SH2D3A pathway in regulating the occurrence and development of cervical cancer.
    J Gynecol Oncol. 2024 Sep 23. doi: 10.3802/jgo.2025.
    Abstract

  2592. ALSHAMRANI A, Aznar M, Hoskin P, Chuter R, et al
    The Current use of Adaptive Strategies for External Beam Radiotherapy in Cervical Cancer: A Systematic Review.
    Clin Oncol (R Coll Radiol). 2024 Sep 17:S0936-6555(24)00383.
    Abstract

  2593. LEE J, Ismail-Pratt I, Machalek DA, Kumarasamy S, et al
    From barriers to opportunities from COVID-19 pandemic: Stakeholder perspectives on cervical cancer screening programs in LMICs of the Asia-Pacific region.
    PLOS Glob Public Health. 2024;4:e0003768.
    Abstract

  2594. ECKRICH C, Lee B, Wang C, Light K, et al
    Evaluation of cumulative dose distributions from external beam radiation therapy using CT-to-CBCT deformable image registration (DIR) for cervical cancer patients.
    J Appl Clin Med Phys. 2024 Oct 4:e14538. doi: 10.1002/acm2.14538.
    Abstract

  2595. CHERIF A, Ovcinnikova O, Palmer C, Engelbrecht K, et al
    Cost-Effectiveness of 9-Valent HPV Vaccination for Patients Treated for High-Grade Cervical Intraepithelial Neoplasia in the UK.
    JAMA Netw Open. 2024;7:e2437703.
    Abstract

  2596. XU F, Lai J
    Commentary: Immune cell infiltration and prognostic index in cervical cancer: insights from metabolism-related differential genes.
    Front Immunol. 2024;15:1446741.
    Abstract

  2597. SHABANPOUR M, Jalali-Alhosseini P, Shoja Z, Ghafoori-Ghahdarijani F, et al
    Lineage and sublineage analysis of human papillomavirus type 58 in iranian women.
    Virol J. 2024;21:244.
    Abstract

  2598. WANG F, Xu S, Zhang X, Qian Y, et al
    Squamous cell carcinoma of the cervix associated with choriocarcinomatous differentiation: a case report and review of the literature.
    J Int Med Res. 2024;52:3000605241283632.
    Abstract

  2599. LI M, Zhang F, Shi Y, Shi K, et al
    Awareness of HPV and HPV vaccine among college students in China.
    Front Public Health. 2024;12:1451320.
    Abstract

  2600. MONEMI M, Garrosi L, Mirzaei S, Farhadi B, et al
    Identification of proteins' expression pathway and the effective miRNAs for the treatment of human papillomavirus-induced cervical cancer: in-silico analyses-experimental research.
    Ann Med Surg (Lond). 2024;86:5784-5792.
    Abstract

  2601. OU D, Cai R, Qi WX, Cui C, et al
    Toripalimab combined with definitive chemoradiotherapy for locally advanced cervical squamous cell carcinoma patients (TRACE): A single-arm, phase I/II trial.
    Cancer Immunol Immunother. 2024;73:244.
    Abstract

  2602. HAZAZI A, Khan FR, Albloui F, Arif S, et al
    Signaling pathways in HPV-induced cervical cancer: Exploring the therapeutic promise of RNA modulation.
    Pathol Res Pract. 2024;263:155612.
    Abstract

  2603. HUANG Q, Yang H, Chen L
    Recent status of cisplatin utilization in the treatment of advanced cervical cancer: A bibliometric analysis.
    Asian J Surg. 2024 Sep 30:S1015-9584(24)02190.
    Abstract

  2604. WANG H, Liu C, Jin K, Li X, et al
    Research advances in signaling pathways related to the malignant progression of HSIL to invasive cervical cancer: A review.
    Biomed Pharmacother. 2024;180:117483.
    Abstract

  2605. FERGUSON SE, Brotto LA, Kwon J, Samouelian V, et al
    Sexual Health and Quality of Life in Patients With Low-Risk Early-Stage Cervical Cancer: Results From GCIG/CCTG CX.5/SHAPE Trial Comparing Simple Versus Radical Hysterectomy.
    J Clin Oncol. 2024 Oct 1:JCO2400440. doi: 10.1200/JCO.24.00440.
    Abstract

  2606. AHMED SR, Egemen D, Befano B, Rodriguez AC, et al
    Assessing generalizability of an AI-based visual test for cervical cancer screening.
    PLOS Digit Health. 2024;3:e0000364.
    Abstract

  2607. WANG R, Harris T, Negron-Figueroa D, Lo D, et al
    Protocol for culturing patient-derived organoids of cervical cancer.
    STAR Protoc. 2024;5:103353.
    Abstract

  2608. YAN A, Wu H, Jiang W
    RACK1 inhibits ferroptosis of cervical cancer by enhancing SLC7A11 core-fucosylation.
    Glycoconj J. 2024 Oct 2. doi: 10.1007/s10719-024-10167.
    Abstract

  2609. LIU H, Lao M, Zhang Y, Chang C, et al
    Radiomics-based machine learning models for differentiating pathological subtypes in cervical cancer: a multicenter study.
    Front Oncol. 2024;14:1346336.
    Abstract

  2610. HARDER MT, Mokete M, Chammartin F, Lerotholi M, et al
    Cervical cancer screening delay and associated factors among women with HIV in Lesotho: a mixed-methods study.
    BMC Womens Health. 2024;24:543.
    Abstract

  2611. MUBTHASIMA PP, Kannan A
    Unraveling the role of EPHA2 in regulating migration and immunomodulation processes in cervical cancer: exploring the synergic effect of 17beta-estradiol on cancer progression.
    Med Oncol. 2024;41:255.
    Abstract

  2612. RAMACHANDRAN D, Mao Q, Liao D, Kamal M, et al
    Methylation, Gene Expression, and Risk Genotypes at the TERT-CLPTM1L Locus in Cervical Cancer.
    Mol Carcinog. 2024 Oct 1. doi: 10.1002/mc.23822.
    Abstract

  2613. GAO X, Kong Y, Ning Y, Tian T, et al
    The prognosis of patients with locally advanced cervical cancer undergoing surgical versus non-surgical treatment: A retrospective cohort study based on SEER database and a single-center data.
    Int J Surg. 2024 Oct 1. doi: 10.1097/JS9.0000000000002098.
    Abstract

  2614. KIGURADZE E, Skhirtladze T, Chkhartishvili N, Gogoladze T, et al
    Comparison of cervical cancer screening models based on Pap and HPV tests in Tbilisi, Georgia.
    Cent Eur J Public Health. 2024;32:166-172.
    Abstract

  2615. KRESIC T, Klaric M, Eminovic S, Kolobaric A, et al
    Prognostic Value of IMP3 Expression in Squamous Cervical Cancer.
    Appl Immunohistochem Mol Morphol. 2024;32:412-6.
    Abstract

  2616. ZENG Z, Wang W, Yan J, Liu D, et al
    Weekly Image Guidance in Patients With Cervical Cancer Treated With Intensity-Modulated Radiation Therapy: Results of a Large Cohort Study.
    Cancer Med. 2024;13:e70269.
    Abstract

  2617. ZIUKIENE GB, Liepinaitiene A
    Implementation of the cervical cancer prevention policy in one of the regions of Lithuania.
    Eur J Midwifery. 2024;8.
    Abstract

  2618. WANG M, Pan Y, Zhang X, Yang R, et al
    Exploring the impact of network depth on 3D U-Net-based dose prediction for cervical cancer radiotherapy.
    Front Oncol. 2024;14:1433225.
    Abstract

  2619. ZHAO Z, Ruan J, Fang M, Liu J, et al
    Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis.
    Front Immunol. 2024;15:1459693.
    Abstract

  2620. KUMAR A, Varshney D, Kumar S, Saha S, et al
    An Overview of the Anticancer Potential of Silver Nanostructures against Cervical Cancer.
    Pharm Nanotechnol. 2024 Sep 27. doi: 10.2174/0122117385335239240924061439.
    Abstract

  2621. JIANG W, Zhong ML, Wang SL, Chen Y, et al
    Para-aortic and pelvic lymphadenectomy in locally advanced cervical cancer with pelvic lymph node metastasis.
    World J Surg Oncol. 2024;22:262.
    Abstract

  2622. LIU Y, Ai H
    Comprehensive insights into human papillomavirus and cervical cancer: Pathophysiology, screening, and vaccination strategies.
    Biochim Biophys Acta Rev Cancer. 2024;1879:189192.
    Abstract

  2623. XIE W, Xu Z
    (Nano)biotechnological approaches in the treatment of cervical cancer: integration of engineering and biology.
    Front Immunol. 2024;15:1461894.
    Abstract

  2624. ZHANG S, Li Q, Ouyang X, Tang Y, et al
    Radiotherapy can improve overall survival in patients with lymph-node positive, high-grade neuroendocrine cervical cancer: construction of two prognostic nomograms to predict treatment outcome.
    Front Oncol. 2024;14:1450382.
    Abstract

  2625. LIU W, Huang F, Yao Y, Liang Y, et al
    Cleft lip and palate transmembrane protein 1-like is a putative regulator of tumorigenesis and sensitization of cervical cancer cells to cisplatin.
    Front Oncol. 2024;14:1440906.
    Abstract

  2626. GAM S, Kumar S, Kushari S, Dutta RS, et al
    Phytochemical Screening, HPTLC Fingerprinting and Evaluation of In Vitro Cytotoxic Activity of Stem Bark Extracts of Oroxylum indicum (L.) Vent. Against Human Cervical Cancer Cells.
    Indian J Clin Biochem. 2024;39:565-571.
    Abstract

  2627. ZHANG Y, Zhang Y, Pan C, Wang W, et al
    HPV-driven heterogeneity in cervical cancer: study on the role of epithelial cells and myofibroblasts in the tumor progression based on single-cell RNA sequencing analysis.
    PeerJ. 2024;12:e18158.
    Abstract

  2628. BRENNAN L, Adekunle T, Kasting M, Forman MR, et al
    Factors associated with clinician willingness to adopt HPV self-sampling and self-testing for cervical cancer screening.
    J Clin Transl Sci. 2024;8:e118.
    Abstract

  2629. SEBUTSOE XM, Tsotetsi NJN, Jantjies ZE, Raphela-Choma PP, et al
    Therapeutic Strategies in Advanced Cervical Cancer Detection, Prevention and Treatment.
    Onco Targets Ther. 2024;17:785-801.
    Abstract

  2630. GAO Y, Guo Q, Yu L
    m6A modification of RNA in cervical cancer: role and clinical perspectives.
    RNA Biol. 2024;21:49-61.
    Abstract


  2631. RETRACTION: CP-31398 inhibits the progression of cervical cancer through reversing the epithelial mesenchymal transition via the downregulation of PAX2s.
    J Cell Physiol. 2024 Sep 30. doi: 10.1002/jcp.31353.
    Abstract

  2632. LIU L, Zhou Y, Lin J, Xie N, et al
    Trends in incidence and mortality for gynaecological cancers in Southeastern China during 2011-2020: a retrospective analysis of registry data.
    BMJ Open. 2024;14:e083336.
    Abstract

  2633. KAGABU M, Baba T
    Enhanced immune checkpoint inhibitor therapy for advanced recurrent cervical cancer: the key to treatment efficacy and maintenance of quality of life.
    EBioMedicine. 2024;108:105386.
    Abstract

  2634. MUAFAQ SAID A, Abdulla KN, Ahmed NH, Yasin YS, et al
    Antiproliferative Impact of Linagliptin on the Cervical Cancer Cell Line.
    Asian Pac J Cancer Prev. 2024;25:3293-3300.
    Abstract

  2635. AGHILI M, Babaei M, Bayani R, Jaberi R, et al
    Short Course Brachytherapy in Locally Advanced Cervical Cancer; Safety and Response Rate.
    Asian Pac J Cancer Prev. 2024;25:3119-3124.
    Abstract

  2636. HAFIDZ F, Icanervilia AV, Rizal MF, Listiani P, et al
    Economic Evaluation of Cervical Cancer Screening by HPV DNA, VIA, and Pap smear Methods in Indonesia.
    Asian Pac J Cancer Prev. 2024;25:3015-3022.
    Abstract

  2637. LI J, Chabaytah N, Babik J, Behmand B, et al
    Relative biological effectiveness of clinically relevant photon energies for the survival of human colorectal, cervical, and prostate cancer cell lines.
    Phys Med Biol. 2024;69.
    Abstract

  2638. MATSUURA M, Tamate M, Nagao S, Akimoto T, et al
    Human papillomavirus self-sampling and urine-sampling tests and the management and short-term outcomes of cervical intraepithelial neoplasia: A prospective observational study.
    J Obstet Gynaecol Res. 2024;50:1801-1807.
    Abstract

  2639. MEHTA N, Keung MHT, Pineda E, Lynn E, et al
    Clinical validation of the Roche cobas HPV test on the Roche cobas 5800 system for the purpose of cervical screening.
    Microbiol Spectr. 2024;12:e0149324.
    Abstract

  2640. DE VASCONCELOS PC, Freitas TR, de Araujo Lopes LV, Peixoto LR, et al
    RAP1-GTPase immunostaining is altered in human precancerous and cancerous cervical lesions.
    Biomark Med. 2024;18.
    Abstract

  2641. BURKI T
    Continued suboptimal HPV vaccine coverage in the USA.
    Lancet Oncol. 2024;25:1257.
    Abstract

  2642. WU YW, Wei LJ, Yang X, Liang HY, et al
    Clinicopathological and immune characterization of mismatch repair deficient endocervical adenocarcinoma.
    Oncologist. 2024;29:e1302-e1314.
    Abstract

  2643. WEI H, Xiong M, Min L
    Abnormal vaginal microecology can indicate cervical lesions.
    Asian J Surg. 2024;47:4560-4561.
    Abstract

  2644. LAMBERTI O, Terris-Prestholt F, Bustinduy AL, Bozzani F, et al
    A health decision analytical model to evaluate the cost-effectiveness of female genital schistosomiasis screening strategies: The female genital schistosomiasis SCREEN framework.
    Trop Med Int Health. 2024 Aug 2. doi: 10.1111/tmi.14040.
    Abstract

  2645. HUANG Y, Wei X, Tu M, Lu W, et al
    CircMAN1A2_009 facilitates YBX1 nuclear localization to induce GLO1 activation for cervical adenocarcinoma cell growth.
    Cancer Sci. 2024;115:3273-3287.
    Abstract

  2646. ZHANG W, Fine JL, Pei X, Cao Y, et al
    Characteristics and utility of high-resolution optical coherence microscopy images of endocervical canal lesions.
    Am J Clin Pathol. 2024;162:392-400.
    Abstract

  2647. CHAO WR, Lee MY, Sheu GT, Lee YJ, et al
    HER2 mutations in advanced cervical neuroendocrine carcinoma: implications for trastuzumab deruxtecan therapy.
    Naunyn Schmiedebergs Arch Pharmacol. 2024;397:7615-7622.
    Abstract

  2648. XU M, Xie X, Cai L, Liu D, et al
    Preoperative scoring system for the prediction of risk of lymph node metastasis in cervical cancer.
    Sci Rep. 2024;14:23860.
    Abstract

  2649. LORUSSO D, Colombo N, Dubot C, Caceres MV, et al
    Pembrolizumab Plus Chemotherapy for Advanced and Recurrent Cervical Cancer: Final Analysis According to Bevacizumab Use in the Randomized KEYNOTE-826 Study.
    Ann Oncol. 2024 Oct 9:S0923-7534(24)04033-X. doi: 10.1016/j.annonc.2024.
    Abstract

  2650. DENG Z, Zhang L, Sun C, Liu Y, et al
    Identification of molecular subtypes, prognostic status and immunotherapy response in cervical cancer based on angiogenic signature genes.
    Heliyon. 2024;10:e38488.
    Abstract

  2651. XIAO H, Guo Q, Ma J, Chen J, et al
    A Personalized Anisotropic Margin for Cervical Cancer Radiation Therapy Under the Guidance of Daily Iterative Cone-Beam Computed Tomography (iCBCT).
    Cureus. 2024;16:e69029.
    Abstract

  2652. APOORVA, Handa V, Batra S, Arora V, et al
    Advancing epigenetic profiling in cervical cancer: machine learning techniques for classifying DNA methylation patterns.
    3 Biotech. 2024;14:264.
    Abstract

  2653. YE H, Ding X, Lv X, Du Y, et al
    KLF14 directly downregulates the expression of GPX4 to exert antitumor effects by promoting ferroptosis in cervical cancer.
    J Transl Med. 2024;22:923.
    Abstract

  2654. DIAS GONCALVES LIMA F, Molina MA
    Uncovering the HPV types causing cervical cancer.
    Nat Microbiol. 2024 Oct 10. doi: 10.1038/s41564-024-01835.
    Abstract

  2655. JIANG A, Chen Y, Ning Y, Yu B, et al
    MRI grading for informed clinical decision-making in Peutz-Jeghers syndrome patients with cervical lesions.
    Sci Rep. 2024;14:23731.
    Abstract

  2656. CHEN X, Liu Y, Luo X, Pan T, et al
    HPV16 E6-induced M2 macrophage polarization in the cervical microenvironment via exosomal miR-204-5p.
    Sci Rep. 2024;14:23725.
    Abstract

  2657. XIAO X, Wang W, Bai P, Chen Y, et al
    Genomic imprinting biomarkers for cervical cancer risk stratification.
    Cancer Commun (Lond). 2024 Oct 10. doi: 10.1002/cac2.12617.
    Abstract

  2658. KUMAR A
    C-71980262, a novel small molecule against human papilloma virus-16 E6 (HPV-16 E6) with anticancer potency against cervical cancer: A computational guided in vitro approach.
    Iran J Basic Med Sci. 2024;27:1389-1396.
    Abstract

  2659. WANG Y, Zhen H, Hu K, Yu L, et al
    A phase I clinical trial evaluating the application of hydrogel in reducing rectal dose during cervical cancer brachytherapy.
    Clin Transl Radiat Oncol. 2024;49:100867.
    Abstract

  2660. JIANG D, Hu X, Qi X, Liu Y, et al
    Assessment of the Incidence and Risk Factors of Stress Urinary Incontinence in Women after Cervical Cancer Surgery: A Single-Centre Retrospective Study.
    Arch Esp Urol. 2024;77:921-927.
    Abstract

  2661. DRUEL V, Delpierre C, Ouanhnon L, Bugat MR, et al
    General practitioners may improve cervical screening equality in France.
    BMC Public Health. 2024;24:2748.
    Abstract

  2662. XAVIER SP, da Silva KM, Galvao ND, das Neves MAB, et al
    Time to death from cervical cancer and its predictors in hospitalized patients: a survival approach study in Mato Grosso, Brazil.
    World J Surg Oncol. 2024;22:269.
    Abstract

  2663. MURAKAMI A, Nomura H, Abe A, Fusegi A, et al
    Influence of COVID-19 on the clinical characteristics of patients with uterine cervical cancer in Japan: A single-center retrospective study.
    J Obstet Gynaecol Res. 2024 Oct 9. doi: 10.1111/jog.16119.
    Abstract

  2664. ZENG Q, Lv C, Qi L, Wang Y, et al
    Sodium selenite inhibits cervical cancer progression via ROS-mediated suppression of glucose metabolic reprogramming.
    Life Sci. 2024;357:123109.
    Abstract

  2665. NING Y, Chen Y, Tian T, Gao X, et al
    S100A7 Orchestrates Neutrophil Chemotaxis and Drives Neutrophil Extracellular Traps (NETs) Formation to Facilitate Lymph Node Metastasis in Cervical Cancer Patients.
    Cancer Lett. 2024 Oct 7:217288. doi: 10.1016/j.canlet.2024.217288.
    Abstract

  2666. RADCLIFFE BA, Kim Y, Raffi J, Ayala-Peacock DN, et al
    Retrospective assessment of HDR brachytherapy dose calculation methods in locally advanced cervical cancer patients: AcurosBV vs. AAPM TG43 formalism.
    J Appl Clin Med Phys. 2024 Oct 9:e14549. doi: 10.1002/acm2.14549.
    Abstract

  2667. JU M, Pan B, Huang Y, Zhou Y, et al
    The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer.
    Cancer Med. 2024;13:e70204.
    Abstract

  2668. YONEDA JY, Santiago AE, Teixeira JC, Machado HC, et al
    The top hat procedure does not impact the management of women treated by LEEP in cervical cancer screening.
    Rev Bras Ginecol Obstet. 2024;46:e-rbgo44.
    Abstract

  2669. ROTELI-MARTINS CM, Maranhao AGK, Fialho SCAV, da Silva-Filho AL, et al
    The importance of the quadrivalent HPV vaccine in the elimination of cervical cancer in Brazil.
    Rev Bras Ginecol Obstet. 2024;46:e-rbgoedt4.
    Abstract

  2670. AL-RAWI RA
    Early detection of cervical tumor cell of origin through Oncogene-induced senescent HPV-positive cells.
    Cell Mol Biol (Noisy-le-grand). 2024;70:129-135.
    Abstract

  2671. BLOOM A, Springer R, Angier H, Heintzman J, et al
    Association Between a Mother's Cervical Cancer Screening and Child's Human Papillomavirus (HPV) Vaccination Status.
    Matern Child Health J. 2024 Oct 8. doi: 10.1007/s10995-024-03998.
    Abstract

  2672. HARASANI K, Vasileva-Slaveva M, Yordanov A, Tripac I, et al
    Systematic review of cost-effectiveness studies on cervical cancer screening across Europe.
    Eur J Surg Oncol. 2024 Oct 4:108742. doi: 10.1016/j.ejso.2024.108742.
    Abstract

  2673. KIM G, Viswanathan AN, Bhatia R, Landman Y, et al
    Dual convolution-transformer UNet (DCT-UNet) for organs at risk and clinical target volume segmentation in MRI for cervical cancer brachytherapy.
    Phys Med Biol. 2024 Oct 8. doi: 10.1088/1361-6560.
    Abstract

  2674. TIAN Y, Zhang S, Ni F
    Targeting glucose metabolism for HPV-associated cervical cancer: A sweet poison.
    Biomed Pharmacother. 2024;180:117519.
    Abstract

  2675. HUO W, Huang Y, Tian B, Chen X, et al
    Unraveling the mechanisms of RECQL4-mediated cervical cancer progression through the PI3K/AKT pathway.
    Transl Oncol. 2024;50:102146.
    Abstract

  2676. OLIVER K, Shaw J, Suryadevara M, Stephens A, et al
    Optimizing Protection Against HPV-Related Cancer: Unveiling the Benefits and Overcoming Challenges of HPV Vaccination.
    Pediatr Ann. 2024;53:e372-e377.
    Abstract

  2677. MODI AD, Zahid H, Southerland AC, Modi DM, et al
    Epitranscriptomics and cervical cancer: the emerging role of m(6)A, m(5)C and m(1)A RNA modifications.
    Expert Rev Mol Med. 2024;26:e20.
    Abstract

  2678. SOOD T, Khandnor P, Bhatia R
    Enhancing pap smear image classification: integrating transfer learning and attention mechanisms for improved detection of cervical abnormalities.
    Biomed Phys Eng Express. 2024;10.
    Abstract

  2679. ALGHALYINI B, Zaidi ARZ, Meo SA, Faroog Z, et al
    Awareness and knowledge of human papillomavirus, vaccine acceptability and cervical cancer among college students in Saudi Arabia.
    Hum Vaccin Immunother. 2024;20:2403844.
    Abstract

  2680. GLEASON EG, Saris DH, Tubridy EA, Brensinger CM, et al
    Racial disparities in receipt of radiation and brachytherapy in cervical cancer patients: Do they exist in a SEER-Medicare population?
    Gynecol Oncol Rep. 2024;55:101505.
    Abstract

  2681. YASIN S, Ferede A, Tafa M
    Cervical cancer screening service utilisation and related factors among women on antiretroviral therapy in public health facilities of Asella town, Ethiopia, cross-sectional study.
    BMC Infect Dis. 2024;24:1115.
    Abstract

  2682. GUO W, Hu Z, Yan J, Shen X, et al
    Epidemiological study of human papillomavirus infection in 105,679 women in Wuhan, China.
    BMC Infect Dis. 2024;24:1111.
    Abstract

  2683. LIU YY, Xia M, Chen ZB, Liao YD, et al
    HNRNPC mediates lymphatic metastasis of cervical cancer through m6A-dependent alternative splicing of FOXM1.
    Cell Death Dis. 2024;15:732.
    Abstract

  2684. RAJKHOWA P, Mathew M, Fadra R, Saha S, et al
    A scoping review of evidence on routine cervical cancer screening in South Asia: investigating factors affecting adoption and implementation.
    Cancer Causes Control. 2024 Oct 7. doi: 10.1007/s10552-024-01923.
    Abstract

  2685. TANG D, Fu P, Zhao LH
    [HER2 amplification and PD-L1 expression in invasive stratified mucin-producing carcinoma of the cervix: a clinicopathological analysis of eighteen cases].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:1018-1023.
    Abstract

  2686. DROLET M, Laprise JF, Chamberland E, Sauvageau C, et al
    Switching from a 2-dose to a 1-dose program of gender-neutral routine vaccination against human papillomavirus in Canada: a mathematical modelling analysis.
    CMAJ. 2024;196:E1136-E1143.
    Abstract

  2687. CHEN H, Chen Y, Zheng A, Tan X, et al
    Clinical Outcomes Between Completion and Abandonment of Radical Hysterectomy in Early-Stage Cervical Cancer Patients with Lymph Nodal Involvement Identified During Surgery: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2024 Oct 7. doi: 10.1245/s10434-024-16326.
    Abstract

  2688. KJAER SK, Falkenthal TEH, Sundstrom K, Munk C, et al
    Long-term effectiveness of the nine-valent human papillomavirus vaccine: Interim results after 12 years of follow-up in Scandinavian women.
    Hum Vaccin Immunother. 2024;20:2377903.
    Abstract

  2689. SOYDAL C, Baltacioglu MH, Araz M, Demir B, et al
    Prognostic Importance of (18)F-FDG Positron Emission Tomography in Uterine Cervical Cancer.
    Mol Imaging Radionucl Ther. 2024;33:167-173.
    Abstract

  2690. YESHE P, Li F
    Clinical efficacy and safety of neoadjuvant chemotherapy with paclitaxel and cisplatin in combination with concurrent chemoradiotherapy for locally advanced cervical cancer: a systematic review and meta-analysis.
    J Radiat Res. 2024 Oct 5:rrae073. doi: 10.1093.
    Abstract

  2691. XU J, Yang W, Xie X, Gu C, et al
    Identification of 10 differentially expressed genes involved in the tumorigenesis of cervical cancer via next-generation sequencing.
    PeerJ. 2024;12:e18157.
    Abstract

  2692. CAO C, Cai D, Liu H, Zhang X, et al
    Causal relationship between genetic-predicted uric acid and cervical cancer risk: evidence for nutritional intervention on cervical cancer prevention.
    Front Nutr. 2024;11:1464046.
    Abstract

  2693. SOROKIN P, Kulikova S, Nikiforchin A, Ulrikh E, et al
    Impact of Various Treatment Modalities on Long-Term Quality of Life in Cervical Cancer Survivors.
    Cureus. 2024;16:e68642.
    Abstract

  2694. BRECHER AC, Handorf EA, Tan Y, Rhee J, et al
    A Community-Based Cervical Cancer Education and Navigation Program for Korean American Women.
    Asian Am J Psychol. 2024;15:196-204.
    Abstract

  2695. NING K, Gong J, Li X, He L, et al
    Analysis of high-risk human papillomavirus infections and cervical intraepithelial neoplasia: factors influencing awareness among women of childbearing age in southwest China.
    Prim Health Care Res Dev. 2024;25:e41.
    Abstract

  2696. HU S, Meng Y, Guo L, Xu X, et al
    A novel strategy to enhance inhibition of Hela cervical cancer by combining Lentinus beta-glucan and autophagic flux blockage.
    Int J Biol Macromol. 2024;281.
    Abstract

  2697. JIN S, Xu H, Dong Y, Wang X, et al
    Ranking attention multiple instance learning for lymph node metastasis prediction on multicenter cervical cancer MRI.
    J Appl Clin Med Phys. 2024 Oct 6:e14547. doi: 10.1002/acm2.14547.
    Abstract

  2698. LAL BK, Bhatta GK, Adhikari R, Karn A, et al
    Cervical Cancer Screening Services in Nepal: A Descriptive Crosssectional Study.
    JNMA J Nepal Med Assoc. 2024;62:439-445.
    Abstract

  2699. LIN Y, Liu N, Yang C, Tan H, et al
    Oncolytic activity of a coxsackievirus B3 strain in patient-derived cervical squamous cell carcinoma organoids and synergistic effect with paclitaxel.
    Virol J. 2024;21:245.
    Abstract

  2700. TENG X, Chen H, Yang H, Liu H, et al
    Pre-clinical study of IR808 dye for cervical cancer in vitro and in vivo imaging.
    Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct 5. doi: 10.1007/s00210-024-03508.
    Abstract

  2701. LIAO D, He Y, He B, Zeng S, et al
    Inhibiting SNX10 induces autophagy to suppress invasion and EMT and inhibits the PI3K/AKT pathway in cervical cancer.
    Clin Transl Oncol. 2024 Oct 5. doi: 10.1007/s12094-024-03715.
    Abstract

  2702. SUN F, Zhao T
    KIF18A promotes cervical squamous cell carcinoma progression by activating the PI3K/AKT pathway through upregulation of CENPE.
    Cancer Biomark. 2024;41:165-178.
    Abstract

  2703. EL-ZEIN M, Franco EL
    Will methylation assays be part of a full molecular strategy to improve clinical management of cervical neoplasia?
    Epigenomics. 2024;16:1197-1201.
    Abstract

  2704. ZHANG X, McCluggage WG, Howitt BE, Hirsch MS, et al
    SOX17 expression in mesonephric-like adenocarcinomas and mesonephric remnants/hyperplasia of the female genital tract: Expanding its utility as a Mullerian biomarker.
    Histopathology. 2024;85:820-825.
    Abstract

  2705. SATO S, Rancourt A, Satoh MS
    Cell fate simulation reveals cancer cell features in the tumor microenvironment.
    J Biol Chem. 2024;300:107697.
    Abstract

  2706. YAMADA S, Orisaka M, Kurokawa T, Onuma T, et al
    Combination therapy with paclitaxel and trastuzumab for human epidermal growth factor receptor 2-positive recurrent serous carcinoma of the uterine cervix: A case report.
    J Obstet Gynaecol Res. 2024;50:1748-1752.
    Abstract

  2707. FURUNO A, Sukegawa A, Ohshige K, Suzuki Y, et al
    Three-year questionnaire study on human papillomavirus vaccination targeting new female college school students: Follow-up to a 2021 report to reveal the impact of a policy change in Japan.
    J Obstet Gynaecol Res. 2024;50:1640-1648.
    Abstract

  2708. TAKAHASHI N, Seki T, Sasaki K, Machida R, et al
    High cost of chemotherapy for gynecologic malignancies.
    Jpn J Clin Oncol. 2024;54:1078-1083.
    Abstract

  2709. TAMURA S, Yamanoi K, Inayama Y, Kurata Y, et al
    Investigation of the clinical implications of anterior cervical invasion in locally advanced cervical squamous cell carcinoma.
    J Obstet Gynaecol Res. 2024;50:1581-1590.
    Abstract

  2710. ZOU K, Ou J
    A predictive study of genes related to lactic acid metabolism in cervical carcinoma.
    J Obstet Gynaecol Res. 2024;50:1552-1565.
    Abstract

  2711. YUJING L, Sijing L, Chengli N
    Regarding "Symptomatic Lymphocele After Robot-Assisted Pelvic Lymphadenectomy as Part of the Primary Surgical Treatment for Cervical and Endometrial Cancer: A Retrospective Cohort Study".
    J Minim Invasive Gynecol. 2024;31:890-891.
    Abstract

  2712. POHLERS M, Gies S, Taenzer T, Stroeder R, et al
    Th17 cells target the metabolic miR-142-5p-succinate dehydrogenase subunit C/D (SDHC/SDHD) axis, promoting invasiveness and progression of cervical cancers.
    Mol Oncol. 2024;18:2157-2178.
    Abstract

  2713. YANG C, Tan Z, Wang Y, Bi R, et al
    SwinUNeCCt: bidirectional hash-based agent transformer for cervical cancer MRI image multi-task learning.
    Sci Rep. 2024;14:24621.
    Abstract

  2714. TISLER A, Vork A, Tammemagi M, Ojavee SE, et al
    Nationwide study on development and validation of a risk prediction model for CIN3+ and cervical cancer in Estonia.
    Sci Rep. 2024;14:24589.
    Abstract

  2715. WU X, Sun Y, Yang H, Wang J, et al
    Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China.
    Lancet. 2024 Oct 15:S0140-6736(24)02135-4. doi: 10.1016/S0140-6736(24)02135.
    Abstract

  2716. SUN C, Ma D
    Embracing more treatment choices for metastatic, recurrent, or persistent cervical cancer.
    Lancet. 2024 Oct 15:S0140-6736(24)02196-2. doi: 10.1016/S0140-6736(24)02196.
    Abstract

  2717. WEN M, Yi N, Mijiti B, Zhao S, et al
    N(6)-methyladenosine (m(6)A) reader HNRNPA2B1 accelerates the cervical cancer cells aerobic glycolysis.
    J Bioenerg Biomembr. 2024 Oct 19. doi: 10.1007/s10863-024-10042.
    Abstract

  2718. VERBERCKMOES B, De Paepe E, De Vestele J, Gama A, et al
    Barriers and facilitators to cervical cancer screening among under- and neverscreened women in Flanders, Belgium - a qualitative study on community and healthcare providers' perspectives.
    BMC Public Health. 2024;24:2870.
    Abstract

  2719. MELO MS, Lima SVMA, Dos Santos AD, Ribeiro CJN, et al
    Temporal trends, spatial and spatiotemporal clusters of cervical cancer mortality in Brazil from 2000 to 2021.
    Sci Rep. 2024;14:24436.
    Abstract

  2720. GUO Y, Bai Y, Wang L, Xu Z, et al
    METTL3 facilitates the progression of cervical cancer by m6A modification-mediated up-regulation of NEK2.
    Sci Rep. 2024;14:24469.
    Abstract

  2721. PRETET JL, Baraquin A, Chung PYJ, Puget L, et al
    The Sansure(R) Human Papillomavirus DNA Diagnostic Kit offers excellent reproducibility performance for the detection of high-risk HPV.
    J Med Virol. 2024;96:e29961.
    Abstract

  2722. TAN D, Zhou C, Han S, Hou X, et al
    [Corrigendum] MicroRNA?378 enhances migration and invasion in cervical cancer by directly targeting autophagy?related protein 12.
    Mol Med Rep. 2025;31:1.
    Abstract

  2723. AKOLO M, Gelmon L, Musembi H, Mutwiri B, et al
    Uptake of cervical cancer screening among sex workers living with HIV in Nairobi, Kenya: a cross-sectional study.
    Ther Adv Infect Dis. 2024;11:20499361241284238.
    Abstract

  2724. MUNJOMA M, Gudukeya S, Mavudze J, Chipfumbu C, et al
    Acceptability and feasibility of implementing thermal ablation as a preventive cervical cancer treatment and the comparison of treatment outcome with cryotherapy in Zimbabwe.
    Ecancermedicalscience. 2024;18:1736.
    Abstract

  2725. GUL OZTAS H, Isik K
    The Effect of Cervical Cancer Education Given to Women in Turkey on Knowledge, Attitudes, and Health Beliefs: A Randomized Controlled Study.
    Public Health Nurs. 2024 Oct 17. doi: 10.1111/phn.13456.
    Abstract

  2726. IZADI N, Strmiskova J, Anton M, Hausnerova J, et al
    LAMP-based electrochemical platform for monitoring HPV genome integration at the mRNA level associated with higher risk of cervical cancer progression.
    J Med Virol. 2024;96:e70008.
    Abstract

  2727. TARATULA-LYONS M, Hill MC
    Young women's perceptions of cervical screening in the UK: a qualitative study.
    Prim Health Care Res Dev. 2024;25:e49.
    Abstract

  2728. MCCORMACK M, Eminowicz G, Gallardo D, Diez P, et al
    Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial.
    Lancet. 2024;404:1525-1535.
    Abstract

  2729. DUSKA LR, Randall LM
    Progress in the treatment paradigms for locally advanced cervical cancer.
    Lancet. 2024;404:1494-1496.
    Abstract

  2730. DUZOVA US, Kaplan Serin E, Mutlu A, Ocal N, et al
    The Effect of Cervical Cancer and Human Papillomavirus Vaccine Education on Vaccination Perception in University Students: A Quasi-Experimental Controlled Educational Intervention.
    J Adolesc Young Adult Oncol. 2024 Oct 17. doi: 10.1089/jayao.2024.0121.
    Abstract

  2731. MOURA EL, Santos IFD, Freitas PP, Silva DMD, et al
    Influence of polymorphisms on the phenotype of TLR1, TLR4 and TLR9 genes and their association with cervical cancer: Bioinformatics prediction analysis and a case-control study.
    Cancer Genet. 2024;288-289:59-67.
    Abstract

  2732. QI Y, Qi P, Yao Q, Sun X, et al
    Coinactivation of the Switch/Sucrose Nonfermenting Complex SMARCA4/BRG1 and SMARCB1/INI1 in a Cervical Mixed Carcinoma: A Case Report.
    Int J Gynecol Pathol. 2024;43:646-651.
    Abstract

  2733. WANG X, Jiang C, Li Q
    Serinc2 Drives the Progression of Cervical Cancer Through Regulating Myc Pathway.
    Cancer Med. 2024;13:e70296.
    Abstract

  2734. WANG L, Wang Y, Yang K, Hu X, et al
    Roles of microRNA-486-5p in the diagnosis and the association with clinical symptoms of cervical cancer.
    Biomark Med. 2024 Oct 17:1-8. doi: 10.1080/17520363.2024.2400963.
    Abstract

  2735. XU XS, Ma YS, Dai RH, Zhang HL, et al
    Identification of novel genomic hotspots and tumor-relevant genes via comprehensive analysis of HPV integration in Chinese patients of cervical cancer.
    Am J Cancer Res. 2024;14:4665-4682.
    Abstract

  2736. XING C, Ji G, Zhang D, Qin X, et al
    Construction of nomogram prediction model using heart rate and pulse perfusion variability index as predictors for hypotension in cervical cancer patients with spinal epidural anesthesia.
    Am J Cancer Res. 2024;14:4398-4410.
    Abstract

  2737. WANG L, Wang Q, Zhou X, Liu H, et al
    Women's knowledge, attitude, and practice regarding cervical precancerous lesions: a cross-sectional study in Beijing, China.
    Front Public Health. 2024;12:1433718.
    Abstract

  2738. LU Z, Pu T, Boning L, Ling X, et al
    Risk-stratified management of cervical high-grade squamous intraepithelial lesion based on machine learning.
    J Med Virol. 2024;96:e70016.
    Abstract

  2739. MENSAH NA, Mensah YB, Dedey F
    Navigating the challenging storms of cancer management in a national cancer centre: perspectives of female patients.
    BMC Public Health. 2024;24:2856.
    Abstract

  2740. ALSAIARI AA, Almufarriji FM, Hazazi A, Almarghalani DA, et al
    Multitargeted docking approach reveals droxidopa against DNA replication and repair-related protein of cervical cancer.
    Sci Rep. 2024;14:24301.
    Abstract

  2741. LIAO Y, Ye L, Cai Q, Song H, et al
    Status and influencing factors of knowledge, attitudes and practices relating to screening for breast and cervical cancer among rural women aged 40-65 years in China: a cross-sectional study.
    BMJ Open. 2024;14:e080945.
    Abstract

  2742. TEIGNE D, Banaszuk AS, Grimault C, Lebon A, et al
    Organized cervical cancer screening: A randomized controlled trial assessing the effect of sending invitation letters.
    Prev Med. 2024;189:108150.
    Abstract

  2743. SAHU B, Thakur M, Shapeti SS
    Anxiety and depression among those experiencing cervical cancer in India: A neglected theme for research.
    J Cancer Res Ther. 2024;20:1664-1665.
    Abstract

  2744. OPPONG AF, Nwozichi CU, Boakye EO, Kyei EF, et al
    Characterizing the Patterns of Cervical Cancer Symptom Recognition, Symptom Response, and Associated Factors Among Patients Treated in a Teaching Hospital in Ghana.
    Cancer Nurs. 2024 Oct 11. doi: 10.1097/NCC.0000000000001411.
    Abstract

  2745. GARG M, Bhati P, Balaji G, Sasidharan A, et al
    Hematological Parameters at Baseline: A Novel Prognostic Factor for Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy in South India.
    Cureus. 2024;16:e69461.
    Abstract

  2746. SHAO Y, Shah PT, Su Q, Li S, et al
    Recombinant adenoviruses expressing HPV16/18 E7 upregulate the HDAC6 and DNMT3B genes in C33A cells.
    Front Cell Infect Microbiol. 2024;14:1459572.
    Abstract

  2747. HAN L, Chen Y, Zheng A, Tan X, et al
    Stage migration and survival outcomes in patients with cervical cancer at Stage IIIC according to the 2018 FIGO staging system: a systematic review and meta-analysis.
    Front Oncol. 2024;14:1460543.
    Abstract

  2748. TOZZI R, Bigardi S, Spagnol G, Ferrari F, et al
    Nerve-Sparing Laparoscopic Radical Hysterectomy (nsLRH) without Adjuvant Therapy in FIGO Stage IB3 Cervical Cancer Patients: Surgical Technique and Survival Outcomes.
    Cancers (Basel). 2024;16:3355.
    Abstract

  2749. GAXIOLA-RUBIO A, Jave-Suarez LF, Hernandez-Silva CD, Ramirez-de-Arellano A, et al
    The G-Protein-Coupled Estrogen Receptor Agonist G-1 Mediates Antitumor Effects by Activating Apoptosis Pathways and Regulating Migration and Invasion in Cervical Cancer Cells.
    Cancers (Basel). 2024;16:3292.
    Abstract

  2750. PANDEY P, Ramniwas S, Pandey S, Lakhanpal S, et al
    Review to Elucidate the Correlation between Cuproptosis-Related Genes and Immune Infiltration for Enhancing the Detection and Treatment of Cervical Cancer.
    Int J Mol Sci. 2024;25:10604.
    Abstract

  2751. PUTRA AD, Andrijono, Winarto H, Prijanti AR, et al
    miR-21 and miR-145 as Prognostic Biomarkers for Radiotherapy Responses in Cervical Cancer Patients: A Preliminary Study.
    Int J Mol Sci. 2024;25:10545.
    Abstract

  2752. PAVONE G, Marino A, Fisicaro V, Motta L, et al
    Entangled Connections: HIV and HPV Interplay in Cervical Cancer-A Comprehensive Review.
    Int J Mol Sci. 2024;25:10358.
    Abstract

  2753. LUO J, He L, Guo Y, Wang J, et al
    MCPIP1 Elicits a Therapeutic Effect on Cervical Cancer by Facilitating XIAP mRNA Decay via Its Endoribonuclease Activity.
    Int J Mol Sci. 2024;25:10285.
    Abstract

  2754. RANTSHABENG PS, Tsima BM, Ndlovu AK, Motlhatlhedi K, et al
    High-risk human papillomavirus diversity among indigenous women of western Botswana with normal cervical cytology and dysplasia.
    BMC Infect Dis. 2024;24:1163.
    Abstract

  2755. JIN K, Zhao D, Zhou J, Zhang X, et al
    Pulsed electromagnetic fields inhibit IL-37 to alleviate CD8(+) T cell dysfunction and suppress cervical cancer progression.
    Apoptosis. 2024 Oct 15. doi: 10.1007/s10495-024-02006.
    Abstract

  2756. WANG R, Zhang Y
    RecQ protein-like 4 drives cisplatin chemosensitivity of cervical cancer cells by modulating annexin A2.
    Drug Dev Res. 2024;85:e70003.
    Abstract

  2757. LESTARI DPO, Wellere AI, Brill IK, Sari NLPEK, et al
    The Impact of an Educational Program on Cervical Cancer Knowledge Among HIV-Positive Women in Bali, Indonesia.
    Int J Womens Health. 2024;16:1677-1685.
    Abstract

  2758. NI H, Huang C, Ran Z, Li S, et al
    Targeting HPV for the prevention, diagnosis, and treatment of Cervical Cancer.
    J Mol Cell Biol. 2024 Oct 14:mjae046. doi: 10.1093.
    Abstract

  2759. WU Z, Wang D, Xu C, Peng S, et al
    Clinical target volume (CTV) automatic delineation using deep learning network for cervical cancer radiotherapy: A study with external validation.
    J Appl Clin Med Phys. 2024 Oct 14:e14553. doi: 10.1002/acm2.14553.
    Abstract

  2760. CHENG L, Wang R, Yan J
    A review of urinary HPV testing for cervical cancer management and HPV vaccine surveillance: rationale, strategies, and limitations.
    Eur J Clin Microbiol Infect Dis. 2024 Oct 14. doi: 10.1007/s10096-024-04963.
    Abstract

  2761. YANG LL, Zhang XK, Cao Y, Shi LY, et al
    PARP1 acetylation at K119 is essential in regulating the progression and proliferation of cervical cancer cells.
    Med Oncol. 2024;41:273.
    Abstract

  2762. OLTHOF EMG, Kaljouw S, van Kemenade FJ, Uyterlinde AM, et al
    Cost-Effectiveness of Computer-Assisted Cytology in a Primary hrHPV-Based Cervical Cancer Screening Programme.
    Cancer Med. 2024;13:e70299.
    Abstract

  2763. BALAMOU C, Zysman K, Olicard C, Garnier A, et al
    Prevalence and Description of High-Grade Intraepithelial Lesions of Cervical Mucosa Cells in a Screening Programme for Cervical Cancer in Isere, France.
    Cancer Med. 2024;13:e70259.
    Abstract

  2764. NUSSBAUM L, Brown J, Meza-Sanchez G, Soto S, et al
    Catalyzing Change: Assessing Inner Setting Context of Cervical Cancer Prevention Efforts in Loreto, Peru, Prior to Transition from VIA to HPV Screen-and-Treat.
    Res Sq [Preprint]. 2024 Sep 27:rs.3.rs-4992569. doi: 10.21203/rs.3.rs-4992569.
    Abstract

  2765. CETINA-PEREZ L, Medina-Contreras O
    Editorial: Cervical cancer: updates from the Mexican national consensus.
    Front Oncol. 2024;14:1493334.
    Abstract

  2766. LEDWABA L, Saidu R, Malila B, Kuhn L, et al
    Automated analysis of digital medical images in cervical cancer screening: A systematic review.
    medRxiv [Preprint]. 2024 Sep 27:2024.09.27.24314466.
    Abstract

  2767. NISHINO S, Yunokawa M, Matsuura Y, Fusegi A, et al
    Secondary spontaneous pneumothorax during chemotherapy with bevacizumab for cervical cancer: a case report and literature review.
    Int Cancer Conf J. 2024;13:395-400.
    Abstract

  2768. OKPALANWAKA IF, Anazodo FI, Chike-Aliozor ZL, Ekweozor C, et al
    Bridging the Gap: Immune Checkpoint Inhibitor as an Option in the Management of Advanced and Recurrent Cervical Cancer in Sub-Saharan Africa.
    Cureus. 2024;16:e69136.
    Abstract

  2769. GANDHI R, Patel A, Patel M, Sojitra SA, et al
    Cervical Cancer Prevention Among Rural Women in Gujarat, India: A Mixed Methods Study on Risk Factors and KAP (Knowledge, Attitude and Practice).
    Cureus. 2024;16:e69169.
    Abstract

  2770. LIU D, Chu J
    Analysis of effectiveness in an artificial intelligent film reading system combined with liquid based cytology examination for cervical cancer screening.
    Am J Transl Res. 2024;16:4979-4987.
    Abstract

  2771. OKABA E
    Knowledge, Attitude and Practice Concerning Cervical Cancer Screening Among Reproductive Age Group Women in Low-Resource Settings Yenagoa Bayelsa State.
    Niger Med J. 2024;65:512-523.
    Abstract

  2772. LI MY, Liu JQ, Chen DP, Li ZY, et al
    [Retracted] p68 prompts the epithelial?mesenchymal transition in cervical cancer cells by transcriptionally activating the TGF?beta1 signaling pathway.
    Oncol Lett. 2024;28:575.
    Abstract

  2773. MOMBO-MAGANGA C, Mangala C, Mabika-Obanda AKF, Maulot-Bangola D, et al
    Prevalence of high-risk human papillomavirus genotypes and viral load correlated with squamous cell inflammation among women in Gabon.
    BMC Womens Health. 2024;24:561.
    Abstract

  2774. THRALL MJ, McCarthy E, Mito JK, Rao J, et al
    Triage options for positive high-risk HPV results from HPV-based cervical cancer screening: a review of the potential alternatives to Papanicolaou test cytology.
    J Am Soc Cytopathol. 2024 Sep 19:S2213-2945(24)00213.
    Abstract

  2775. TAMANG P, Gupta M, Thatal A
    Digital colposcopy image analysis techniques requirements and their role in clinical diagnosis: a systematic review.
    Expert Rev Med Devices. 2024;21:955-969.
    Abstract

  2776. SYED KHAJA AS, Saleem M, Zafar M, Moursi S, et al
    Association between pelvic inflammatory disease and risk of ovarian, uterine, cervical, and vaginal cancers-a meta-analysis.
    Arch Gynecol Obstet. 2024;310:2577-2585.
    Abstract

  2777. GOODMAN E, Reuschenbach M, Viering T, Luzak A, et al
    The impact of Germany's human papillomavirus immunization program on HPV-related anogenital diseases: a retrospective analysis of claims data from statutory health insurances.
    Arch Gynecol Obstet. 2024;310:2639-2646.
    Abstract

  2778. PANJI Z, Nadoushan MJ, Fekrirad Z, Rasooli I, et al
    Modulation with anti-Oma87 antibodies of cytotoxicity, adherence, and internalization of Acinetobacter baumannii in human cervical carcinoma epithelial cells.
    APMIS. 2024;132:843-858.
    Abstract

  2779. FERNANDEZ-DEAZA G, Negrete-Tobar G, Caicedo M, Tellez N, et al
    Cervical precancer and invasive cancer among women living with HIV in Latin America: A systematic review and meta-analysis.
    Int J STD AIDS. 2024;35:1008-1018.
    Abstract

  2780. QIN J, He Y, Liang Y, Kang L, et al
    Cell comparative learning: A cervical cytopathology whole slide image classification method using normal and abnormal cells.
    Comput Med Imaging Graph. 2024;117:102427.
    Abstract

  2781. ZHANG C, Yuan L, Wen W, Shao C, et al
    LNMAC Promotes Cervical Squamous Cell Carcinoma Lymphatic Metastasis via Epigenetic Regulation of FGF2-Induced Lymphangiogenesis.
    Adv Sci (Weinh). 2024;11:e2404645.
    Abstract

  2782. YANG J, Peng Y, Ding Y, Liu Y, et al
    The Clinicopathological and Molecular Characteristics of Endocervical Gastric-Type Adenocarcinoma and the Use of Claudin18.2 as a Potential Therapeutic Target.
    Mod Pathol. 2024;37:100569.
    Abstract

  2783. ALTMANN J, Kubiak K, Sehouli J, Roser E, et al
    Fertility-sparing strategy in a rare case of highly malignant Dicer-1-associated sarcoma of the cervix.
    Arch Gynecol Obstet. 2024;310:2617-2621.
    Abstract

  2784. CHEN Y, He H, Wang X, Ye Y, et al
    Influence of cervical treatment methods on subsequent vaginal lesions: A study of HPV-related neoplasia.
    Biomol Biomed. 2024;24:1595-1605.
    Abstract

  2785. DAVIES JC, Sargent A, Pinggera E, Carter S, et al
    Urine high-risk human papillomavirus testing as an alternative to routine cervical screening: A comparative diagnostic accuracy study of two urine collection devices using a randomised study design trial.
    BJOG. 2024;131:1456-1464.
    Abstract

  2786. GAGRANI V, Kabara J, Shukla A, Rathore NK, et al
    A comparative study between two different dose fractionation schedules of cobalt-60-based HDR intracavitary brachytherapy in carcinoma cervix stages IIB-IIIC1.
    J Cancer Res Ther. 2024;20:1551-1556.
    Abstract

  2787. YEARY KHK, Willis DE, Yu H, Johnson B, et al
    Self-reported Racial Discrimination and Healthy Behaviors in Black Adults Residing in Rural Persistent Poverty Areas.
    J Racial Ethn Health Disparities. 2024;11:2756-2765.
    Abstract

  2788. GARCIA E, Ayoub N, Tewari KS
    Erratum: Recent breakthroughs in the management of locally advanced and recurrent/metastatic cervical cancer.
    J Gynecol Oncol. 2024 Oct 18. doi: 10.3802/jgo.2024.
    Abstract

  2789. KWON JS, McTaggart-Cowan H, Ferguson SE, Samouelian V, et al
    Cost-effectiveness analysis of simple hysterectomy compared to radical hysterectomy for early cervical cancer: analysis from the GCIG/CCTG CX.5/SHAPE trial.
    J Gynecol Oncol. 2024 Oct 18. doi: 10.3802/jgo.2024.
    Abstract

  2790. SO YL, He MY, Hui SK, Yu EL, et al
    Clinical trial comparing the use of Orcellex((R)) Brush versus Cervex-Brush((R)) on vaginal vault smear cytology adequacy rate in patients treated with radiotherapy for cervical cancer.
    J Gynecol Oncol. 2024 Oct 22. doi: 10.3802/jgo.2025.
    Abstract

  2791. PEREZ S
    Progress and Challenges in Canada's Path Toward the Elimination of Cervical Cancer.
    Curr Oncol. 2024;31:5850-5861.
    Abstract

  2792. MOHAMMED FA, Tune KK, Mohammed JA, Wassu TA, et al
    Early Cervical Cancer Diagnosis with SWIN-Transformer and Convolutional Neural Networks.
    Diagnostics (Basel). 2024;14:2286.
    Abstract

  2793. SALAMI BO, Kalenga CZ, Olukotun M, Renzaho AMN, et al
    Ethnic and racialized disparities in the use of screening services for pap smears and mammograms in Canada.
    Cancer Med. 2024;13:e70021.
    Abstract

  2794. WANG M, Chen H, Wong MCS, Huang J, et al
    Effects of screening coverage and screening quality assurance on cervical cancer mortality: Implication for integrated framework to monitor global implementation of cervical cancer screening programmes.
    J Glob Health. 2024;14:04189.
    Abstract

  2795. MASEKO TN, Tsoka-Gwegweni JM, Dlamini X
    "A Man With a Loving Heart": A Systematic Review of Male Involvement in Cervical Cancer Screening in Africa.
    Int J Public Health. 2024;69:1607447.
    Abstract

  2796. YU T, Gao S, Jin F, Yan B, et al
    Characteristics of the vaginal microbiota and vaginal metabolites in women with cervical dysplasia.
    Front Cell Infect Microbiol. 2024;14:1457216.
    Abstract

  2797. WANG C, Cai Y, Feng P
    Case report: A case of sintilimab-induced recurrent diabetic ketoacidosis and thyroid dysfunction in a patient with advanced cervical carcinoma.
    Front Immunol. 2024;15:1405856.
    Abstract


  2798. Retraction: long noncoding RNA ANRIL promotes cervical cancer development by acting as a sponge of miR-186.
    Oncol Res. 2024;32:1817.
    Abstract

  2799. YAN Q, Wu M, Zhang J, Yang J, et al
    MRI radiomics and nutritional-inflammatory biomarkers: a powerful combination for predicting progression-free survival in cervical cancer patients undergoing concurrent chemoradiotherapy.
    Cancer Imaging. 2024;24:144.
    Abstract

  2800. CENA SE, Olivero F, Martini S, Gianello L, et al
    External beam radiotherapy followed by image-guided adaptive brachytherapy in locally advanced cervical cancer: a multicenter retrospective analysis.
    Radiol Med. 2024 Oct 24. doi: 10.1007/s11547-024-01899.
    Abstract

  2801. HERNANDEZ ND, Wilson N, Abah T, Contreras O, et al
    Unveiling Cervical Cancer Inequities Among Georgia Immigrant Latinas: A Robust Qualitative Examination of the Facilitators and Barriers to Prevention, with Emphasis on the Impact of Community-Based Organizations.
    J Cancer Educ. 2024 Oct 25. doi: 10.1007/s13187-024-02532.
    Abstract

  2802. STRAATHOF R, van Vliet-Perez SM, Kolkman-Deurloo IK, Wauben LSGL, et al
    Automated planning of curved needle channels in 3D printed patient-tailored applicators for cervical cancer brachytherapy.
    Phys Med Biol. 2024 Oct 24. doi: 10.1088/1361-6560.
    Abstract

  2803. MA Z, Xiang X, Chai Y, Wang J, et al
    The application value of low-risk human papillomavirus testing in cervical cancer prevention and treatment in low- and middle-resource areas.
    Public Health. 2024;237:205-211.
    Abstract

  2804. REITER PL, Shoben AB, Cooper S, Ashcraft AM, et al
    A Mail-Based HPV Self-Collection Program to Increase Cervical Cancer Screening in Appalachia: Results of a Group Randomized Trial.
    Cancer Epidemiol Biomarkers Prev. 2024.
    Abstract

  2805. YANG Y, Zhang L, Hartwig S, Jiang P, et al
    Post-marketing study design to evaluate the effectiveness of the 9-valent and 4-valent HPV vaccines on serious HPV-related cervical disease in China.
    Hum Vaccin Immunother. 2024;20:2418168.
    Abstract

  2806. HUNTINGTON S, Smith JS, Nuttall D, Polokaova A, et al
    Evidence from Europe on implementation, participation and performance of self-collection for cervical cancer screening.
    Future Oncol. 2024 Oct 24:1-12. doi: 10.1080/14796694.2024.2409625.
    Abstract

  2807. LOU J, Guo F
    The characteristics of high-risk HPV-negative cervical cancer: a systematic review and meta-analysis.
    Front Oncol. 2024;14:1452834.
    Abstract

  2808. SHAO L, Liu W, Zhang C, Ma W, et al
    The Role and Function of Secretory Protein Matrix Metalloproteinase-3 (MMP3) in Cervical Cancer.
    Iran J Public Health. 2024;53:855-866.
    Abstract

  2809. WHITE LL, Goldberg SR, Escobar AG, Hixon B, et al
    Cervical Cancer Screening: Patient Perspectives on Transitioning to Primary High-Risk Human Papillomavirus Testing Alone.
    Perm J. 2024 Oct 24:1-8. doi: 10.7812.
    Abstract

  2810. CORAZZELLI G, Zanuttini L, Balestrini D, Quercia S, et al
    Strategic insights and survival outcomes: a systematic review of CNS metastases in uterine cervical cancer.
    Br J Neurosurg. 2024 Oct 23:1-14. doi: 10.1080/02688697.2024.2418490.
    Abstract

  2811. ZHANG H, Li X, Yang Z, Gao R, et al
    Influence of COVID-19 pandemic on prevalence and genotype distribution of HPV in cervical cancer screening population.
    Virol J. 2024;21:261.
    Abstract

  2812. VAN WELL EB, Showalter TN, Giannouli S, Nioutsikou E, et al
    The effect of one-room CT guided brachytherapy on procedure time and cost in the treatment of cervical cancer.
    Brachytherapy. 2024 Oct 22:S1538-4721(24)00390.
    Abstract

  2813. FENG Y, Sun Z, Zhang H, Wang Z, et al
    Plasma-based proteomic and metabolomic characterization of lung and lymph node metastases in cervical cancer patients.
    J Pharm Biomed Anal. 2024;253:116521.
    Abstract

  2814. CHEN JJ, Sarkar IN, Hsu E, Dizon DS, et al
    An Intersectional Approach to Cervical Cancer Screening Disparities by Race/Ethnicity and Immigrant Status.
    J Womens Health (Larchmt). 2024 Oct 23. doi: 10.1089/jwh.2024.0251.
    Abstract

  2815. TER-MINASYAN V
    EVALUATION OF KNOWLEDGE AND ATTITUDE REGARDING CERVICAL CANCER SCREENING PRACTICE: A MULTICENTER REGIONAL STUDY.
    Georgian Med News. 2024;.
    Abstract

  2816. SOLDAN K, Falcaro M, Sasieni P
    HPV vaccination has dramatically reduced inequalities in cervical cancer, but the most deprived groups remain at highest risk.
    BMJ. 2024;387:q2296.
    Abstract

  2817. JIA X, Jiang M, Zhou J, Ma C, et al
    Trends in high-risk human papillomavirus infection and cervical cytology of women in Karamay City, 2012-2021.
    Sex Health. 2024;21:SH24057.
    Abstract

  2818. WILLIAMS C, Goulbourne E, Gyansa E, Hashi A, et al
    Initiatives to increase breast and cervical cancer-related knowledge, screening, and health behaviours among Black women.
    Can J Public Health. 2024 Oct 22. doi: 10.17269/s41997-024-00953.
    Abstract

  2819. DAI W, Guo C, Yang Q, Zhang Y, et al
    Validation of the 2019 American Society of Colposcopy and Cervical Pathology Online Cervical Cancer Screening Program via 9 Large-Cohort Data of Chinese Women.
    J Low Genit Tract Dis. 2024 Oct 22. doi: 10.1097/LGT.0000000000000852.
    Abstract

  2820. AL-HINDAWI MM
    Prevalence of cervical dysplastic lesions in cervical smears from Baghdad city: a single centre study.
    J Pak Med Assoc. 2024;74.
    Abstract

  2821. MEDA ZC, Hien H, Traore TI, Ouattara CA, et al
    Factors associated with positive human papillomavirus (HPV) test results in cervical precancer screening: a cross-sectional study at Souro Sanou National Teaching Hospital (SSNTH) in Bobo Dioulasso, Burkina Faso.
    BMC Public Health. 2024;24:2900.
    Abstract

  2822. FOURIE L, Christowitz C, Eksteen C, van der Merwe H, et al
    Inflammation and thrombotic risk in late-stage cervical cancer: An exploratory study of coagulation and cytokine profiles in a South African cohort.
    Cytokine. 2024;184:156782.
    Abstract

  2823. ALSHAHRANI NZ, Alshahrani JA, Almushari BS, Alshammri FM, et al
    Parental Perspectives on Human Papillomavirus (HPV) Vaccination in Gulf Cooperation Council Countries: A systematic review.
    Medicine (Baltimore). 2024;103:e40124.
    Abstract

  2824. SHI Y, Xu Y, Li M, Zheng W, et al
    Cervical angiofibroma of soft tissue: A rare case report with literature review.
    Medicine (Baltimore). 2024;103:e40200.
    Abstract

  2825. KALANI M, Mirzaei F, Keyghobadi H, Keighobadi G, et al
    Comparing the distribution of common human papillomavirus genotypes among the population of Fars province in southwest Iran with the genotypes included in the available HPV vaccines.
    Mol Biol Rep. 2024;51:1083.
    Abstract

  2826. ETEMAD S, Asghari Baghalan AM, Naeimi B, Mehrzad S, et al
    Prevalence of Human Papillomavirus (HPV) Infection and its Association With Pap Smear Findings Among Women Attending a Gynecology Clinic in Khorasan Razavi-Iran.
    J Res Health Sci. 2024;24:e00629.
    Abstract

  2827. HAO Q, Feng L, Chen D, Fan X, et al
    Application of WeChat-based cognitive behavioural stress management for early-stage cervical cancer patients: a randomised controlled study.
    J Obstet Gynaecol. 2024;44:2410858.
    Abstract

  2828. SON J, Cain KE, Marten CA, Dwyer KW, et al
    Tisotumab vedotin extravasation injury in a patient with recurrent cervical cancer.
    Gynecol Oncol Rep. 2024;56:101525.
    Abstract

  2829. GYMAH GYAMFI H
    Impact of gender and education on cervical cancer knowledge amongst students: implications for health policies and public health strategies in Wiesbaden, Germany.
    J Prev Med Hyg. 2024;65:E227-E231.
    Abstract

  2830. MAHAJAN I, Kadam A, McCann L, Ghose A, et al
    Early adoption of innovation in HPV prevention strategies: closing the gap in cervical cancer.
    Ecancermedicalscience. 2024;18:1762.
    Abstract

  2831. DIAZ JFR
    Hemoglobin level and survival in cervical cancer with chemoradiotherapy at high altitude, 2020-2022.
    Ecancermedicalscience. 2024;18:1767.
    Abstract

  2832. HONG R, Luo L, Xu X, Huang K, et al
    The treatment response evaluation through the combination of contrast-enhanced ultrasound and squamous cell carcinoma antigen in cervical cancer.
    Quant Imaging Med Surg. 2024;14:7587-7599.
    Abstract

  2833. SU Y, Zeng K, Yan Z, Yang X, et al
    Predicting the Ki-67 proliferation index in cervical cancer: a preliminary comparative study of four non-Gaussian diffusion-weighted imaging models combined with histogram analysis.
    Quant Imaging Med Surg. 2024;14:7484-7495.
    Abstract

  2834. MA C, Zhou J
    First Application of Demand-Triggered Online Adaptive Radiotherapy in the Treatment of Cervical Cancer: A Clinical Report.
    Cureus. 2024;16:e69703.
    Abstract

  2835. KASHYAP VK, Nagesh PKB, Singh AK, Massey A, et al
    Curcumin attenuates smoking and drinking activated NF-kappaB/IL-6 inflammatory signaling axis in cervical cancer.
    Cancer Cell Int. 2024;24:343.
    Abstract

  2836. CHEN L, Wu L, Huang Q
    Exploring the effectiveness of Neoadjuvant chemotherapy in cervical cancer: A bibliometric approach.
    Asian J Surg. 2024 Oct 19:S1015-9584(24)02294.
    Abstract

  2837. PAN CH, Xu XQ, Wen TM, Wang MY, et al
    [Evaluation of the 10-year protective effect and immunogenicity of quadrivalent HPV vaccination].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2024;58:1508-1513.
    Abstract

  2838. LI L, Su Y
    Mediation Effects of Self-Care Self-Efficacy and Health-Promoting Behaviors on Fear of Cancer Recurrence and Posttraumatic Growth in Postoperative Patients with Cervical Cancer: A Cross-Sectional Study.
    Asian Nurs Res (Korean Soc Nurs Sci). 2024 Oct 18:S1976-1317(24)00110.
    Abstract

  2839. GONZALEZ PENA T, Huang M
    Genetic Predisposition for Gynecologic Cancers.
    Clin Obstet Gynecol. 2024;67:660-665.
    Abstract

  2840. LI C, Liu S, He Y, Yao H, et al
    Toripalimab combined with bevacizumab plus chemotherapy as first-line treatment for refractory recurrent or metastatic cervical cancer: a single-arm, open-label, phase II study (JS001-ISS-CO214).
    J Gynecol Oncol. 2024 Oct 25. doi: 10.3802/jgo.2025.
    Abstract

  2841. LI H, Wu J, Xu Q, Chen Y, et al
    Different surgical methods for FIGO stage IVB cervical cancer patients receiving chemotherapy: a population-based study.
    J Gynecol Oncol. 2024 Oct 22. doi: 10.3802/jgo.2025.
    Abstract

  2842. HONG MK, Wang JH, Li MH, Su CC, et al
    Progesterone receptor isoform B in the stroma of squamous cervical carcinoma: An independent favorable prognostic marker correlating with hematogenous metastasis.
    Taiwan J Obstet Gynecol. 2024;63:853-860.
    Abstract

  2843. MARIYA T, Nishikawa A, Umemoto M, Ogawa S, et al
    Impact of colposcopy-guided carbon dioxide laser vaporization therapy on peripheral cervical intraepithelial neoplasia lesions.
    Taiwan J Obstet Gynecol. 2024;63:846-852.
    Abstract

  2844. LIU C, Xiu C, Zou Y, Wu W, et al
    Cervical cancer diagnosis model using spontaneous Raman and Coherent anti-Stokes Raman spectroscopy with artificial intelligence.
    Spectrochim Acta A Mol Biomol Spectrosc. 2024;327:125353.
    Abstract

  2845. LIU X, Ning L, Fan W, Jia C, et al
    Electronic Health Interventions and Cervical Cancer Screening: Systematic Review and Meta-Analysis.
    J Med Internet Res. 2024;26:e58066.
    Abstract

  2846. GUO X, Song J, Tian S, Li W, et al
    A retrospective study on the effect of surgical approaches and uterine manipulators on the prognosis of cervical cancer.
    Arch Gynecol Obstet. 2024 Oct 30. doi: 10.1007/s00404-024-07746.
    Abstract

  2847. BAEK S, Noh KW, Zhao Y, Schoemig-Markiefka B, et al
    Neoadjuvant Chemotherapy With the Angiogenesis Inhibitor Bevacizumab for Locally Advanced Cervical Cancer.
    In Vivo. 2024;38:3068-3077.
    Abstract

  2848. KUM SJ, Choi S, Kim HS
    Liquid-based Cytological Features of Adenocarcinoma Not Otherwise Specified, Extrauterine Adenocarcinoma, and Other Malignant Neoplasms of The Uterine Cervix: A 5-year Single-institutional Experience With 30 Consecutive Patients.
    In Vivo. 2024;38:2740-2751.
    Abstract

  2849. KIM H, Han B, Kim H, Choi S, et al
    Clinical Outcomes of Pleomorphic High-grade Squamous Intraepithelial Lesions of the Uterine Cervix: A Single-institutional Experience of 44 Cases.
    In Vivo. 2024;38:3050-3058.
    Abstract

  2850. LENZ C, Gesemann L, Al-Baldawi Y, Pusken M, et al
    Accuracy of Preoperative Magnet Resonance Imaging to Predict Pathologic T-Stage in Patients With Cervical Cancer.
    Anticancer Res. 2024;44:5081-5085.
    Abstract

  2851. NA JM, Kim HS
    Comprehensive Clinicopathological and Immunohistochemical Analysis of Human Papillomavirus-independent Squamous Cell Carcinoma and Adenosquamous Carcinoma of the Uterine Cervix.
    Anticancer Res. 2024;44:4969-4981.
    Abstract

  2852. SIN J, Kiosea M, Mahdavi K, Akbarpour F, et al
    Investigation of the Efficacy of Nowarta110 in the Treatment of HPV-16 and HPV-18 Oncogenically-transformed Human Cells and Cancer-implanted Animal Models.
    Anticancer Res. 2024;44:4723-4728.
    Abstract

  2853. LEE J, Chi SA, Choi S, Kim HS, et al
    Invasive Stratified Mucin-producing Carcinoma of the Uterine Cervix: Comparison of Its Clinicopathological Characteristics and Programmed Death-ligand 1 Expression Status With Those of Other Endocervical Adenocarcinomas.
    Anticancer Res. 2024;44:5007-5022.
    Abstract

  2854. LUCKETT R, Zhang BX, Gompers A, George J, et al
    High-grade cervical disease and cervical cancer in women aged 50 years and older compared with younger women: examining prevalence by HIV status in two large prospective cohorts in Botswana.
    BMJ Open. 2024;14:e089375.
    Abstract

  2855. NEGESSE SIMEGN Y, Wossen Samuel A, Gebresilasie Kelelew R, Mohammed LA, et al
    Knowledge and acceptability of the human papillomavirus vaccine and associated factors among adolescent girls in public primary schools in Dessie Town, South Wollo, Northeast Ethiopia, 2020: A cross-sectional study.
    BMJ Open. 2024;14:e083397.
    Abstract

  2856. WEI Q, Yang Y, Li C, Wang H, et al
    ZC3H13-induced the m6A modification of hsa_circ_0081723 promotes cervical cancer progression via AMPK/p53 pathway.
    J Obstet Gynaecol Res. 2024 Oct 30. doi: 10.1111/jog.16140.
    Abstract

  2857. ZHU Y, Fu C, Du J, Jin Y, et al
    Prediction of Cervical Cancer Lymph Node Metastasis via a Multimodal Transfer Learning Approach.
    Br J Hosp Med (Lond). 2024;85:1-14.
    Abstract

  2858. KANG G, Du W, Zeng S, Wu X, et al
    Advances in systemic treatment for recurrent metastatic cervical cancer.
    Br J Hosp Med (Lond). 2024;85:1-10.
    Abstract

  2859. LAREYRE O, Mollevi C, Broc G, Caspar MN, et al
    An outreach strategy to increase uptake of vaginal self-sampling for cervical cancer screening in older French women: The RIDECA interventional research protocol.
    Womens Health (Lond). 2024;20:17455057241292693.
    Abstract

  2860. CHIKAMATSU H, Taki M, Kitamura S, Sunada M, et al
    Vaginal Cuff Infection Caused by Ureaplasma parvum After Hysterectomy for Uterine Cervical Cancer: A Case Report.
    Case Rep Infect Dis. 2024;2024:4114954.
    Abstract

  2861. LI Y, Na J, Wang X, Han S, et al
    Robot-assisted Mullerian compartment resection for cervical cancer.
    Front Oncol. 2024;14:1466921.
    Abstract

  2862. MORISADA T
    Latest findings in chemotherapy.
    J Obstet Gynaecol Res. 2024;50 Suppl 1:79-83.
    Abstract

  2863. GUPTA K, Mandal R, Chatterjee P
    Navigating the landscape of cervical cancer in India: Epidemiology, prevention, current status, and emerging solutions.
    J Obstet Gynaecol Res. 2024;50 Suppl 1:55-64.
    Abstract

  2864. BABA T
    Trends of minimally invasive surgery in the primary treatment of cervical cancer.
    J Obstet Gynaecol Res. 2024;50 Suppl 1:72-78.
    Abstract

  2865. TSE KY, Tan AL, Subedi K, Pervin S, et al
    The AOFOG recommendations on human papillomavirus vaccination in the Asia-Pacific region.
    J Obstet Gynaecol Res. 2024;50 Suppl 1:95-102.
    Abstract

  2866. PADOLINA CS, Toral JAB
    Asia Oceania Federation of Obstetrics and Gynecology (AOFOG)'s efforts in the cervical cancer elimination program in the Asia-Pacific.
    J Obstet Gynaecol Res. 2024;50 Suppl 1:42-48.
    Abstract

  2867. JALIL DM, Al-Mahdawi TT, Jameel MG, Talal M, et al
    In Vitro Evaluate the Antiproliferative Impact of Cnicus Benedictus L. Leaves Methanolic Extract on Cervical Cancer.
    Asian Pac J Cancer Prev. 2024;25:3643-3649.
    Abstract

  2868. FEITOSA PSF, Fernandes FL, Pereira TP, Almeida DRQ, et al
    Alterations in miRNA Expression and Their Role in the Pathogenesis of Cervical Cancer.
    Asian Pac J Cancer Prev. 2024;25:3533-3541.
    Abstract

  2869. PUROHIT R, Singh S, Vaishampayan D, Sane Y, et al
    A Systematic Review of Cervical Cancer Mobile Applications and a Future Directions for Developers.
    Asian Pac J Cancer Prev. 2024;25:3429-3437.
    Abstract

  2870. YIN Y, Li Y, Zhang Y, Jia Q, et al
    CXCL8 may serve as a potential biomarker for predicting the prognosis and immune response in cervical cancer.
    Discov Oncol. 2024;15:601.
    Abstract

  2871. EMERSON A, Dogan M, Hawes E, Wilson K, et al
    Correction: Cervical cancer screening barriers and facilitators from the perspectives of women with a history of criminal-legal system involvement and substance use.
    Health Justice. 2024;12:41.
    Abstract

  2872. LIU A, Yang M, Zou H, Gong X, et al
    Cytologic features of gastric-type endocervical adenocarcinoma: Three cases report and literature review.
    Medicine (Baltimore). 2024;103:e40149.
    Abstract

  2873. SANCHEZ MAYORCA I, Gomez Forero AM, Gallo Roa R, Garzon Sarmiento CA, et al
    Prevalence of unexpected malignant disease in the histopathology of hysterectomy indicated for benign condition.
    Rev Colomb Obstet Ginecol. 2024;75.
    Abstract

  2874. NI J, Dong X, Shou H, Xu Q, et al
    Second-line monotherapy with a PD-1/CTLA-4 inhibitor effectively treated multiple brain and lung metastases of cervical cancer: a case report.
    Front Immunol. 2024;15:1434697.
    Abstract

  2875. DOU Z, Ai C, Zhang J, Li K, et al
    The intra-tumoral microbiome as a potential biomarker of response to external beam radiation therapy in cervical cancer.
    J Transl Med. 2024;22:972.
    Abstract

  2876. ZHU Y, Shi F, Lin H, Cao Y, et al
    Cost-effectiveness analysis of atezolizumab plus bevacizumab and chemotherapy for the treatment of metastatic, persistent, or recurrent cervical cancer (BEATcc).
    Expert Rev Pharmacoecon Outcomes Res. 2024.
    Abstract

  2877. SHAO N
    Research progress on human papillomavirus-negative cervical cancer: A review.
    Medicine (Baltimore). 2024;103:e39957.
    Abstract

  2878. OMENAI SA, Ajani MA
    The interplay between programmed death ligand 1 (PD-L1) expression and human papillomavirus (HPV) genotypes in cervical carcinomas: findings of a Nigerian Tertiary Hospital.
    Pan Afr Med J. 2024;48:90.
    Abstract

  2879. MURUGAN Y, Bhavana BM, Ekka A, Gandhi R, et al
    Knowledge, attitudes, practices, and sociocultural factors influencing cervical cancer screening and vaccination among women in rural communities of Gujarat: A mixed-methods study.
    J Family Med Prim Care. 2024;13:3988-3994.
    Abstract

  2880. PAL A, Verma P, Paul S, Majumder I, et al
    Editorial Expression of Concern: Two species of Ulva inhibits the progression of cervical cancer cells SiHa by means of autophagic cell death induction.
    3 Biotech. 2024;14:279.
    Abstract

  2881. GOLDSTEIN A, Gersh M, Skovronsky G, Moss C, et al
    The Future of Cervical Cancer Screening.
    Int J Womens Health. 2024;16:1715-1731.
    Abstract

  2882. SMALLEY TB, Nicolaci A, Tran KC, Lokhandwala J, et al
    Targeted degradation of the HPV oncoprotein E6 reduces tumor burden in cervical cancer.
    bioRxiv [Preprint]. 2024 Oct 17:2024.10.17.618959.
    Abstract

  2883. BULIC M, Nikolic I, Mitrovic M, Muskinja J, et al
    Four newly synthesized enones induce mitochondrial-mediated apoptosis and G2/M cell cycle arrest in colorectal and cervical cancer cells.
    RSC Adv. 2024;14:33987-34004.
    Abstract

  2884. GLASS-RIVEROS E, Baumann K, Craemer K, Geller S, et al
    The Acceptability and Feasibility of Self-Collected HPV Testing for Cervical Cancer Screening Among Black and Latinx Women in Chicago: Perspectives from the Community.
    Womens Health Rep (New Rochelle). 2024;5:735-743.
    Abstract

  2885. XIAO JJ, Sun YX, Wang Q, Sui L, et al
    [Clinical effect of secondary LEEP combined with transcervical resection of endocervical tissue for cervical precancerous lesions with positive internal margin after the first LEEP].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:786-793.
    Abstract

  2886. CHENG X, Chai R, Zhang T, Chen Y, et al
    A novel methylation-detection panel for HPV associated high-grade squamous intraepithelial lesion and cervical cancer screening.
    Sci Rep. 2024;14:25556.
    Abstract

  2887. MAKGOO L, Mosebi S, Mbita Z
    Susceptibility of HPV-18 Cancer Cells to HIV Protease Inhibitors.
    Viruses. 2024;16:1622.
    Abstract

  2888. MRUZEK H, Kacperczyk-Bartnik J, Danska-Bidzinska A, Ciebiera M, et al
    Early-Stage and Locally Advanced Cervical Cancer during Pregnancy: Clinical Presentation, Diagnosis and Treatment.
    Medicina (Kaunas). 2024;60:1700.
    Abstract

  2889. SANTOS MPSD, Ramos BRA, Oliveira MLCS, Tristao ADR, et al
    Prevalence of Trichomonas vaginalis Infection in Women Screened for Precursor Lesions of Cervical Cancer in a Brazilian Population.
    Microorganisms. 2024;12:2032.
    Abstract

  2890. GULYAEVA L
    Special Issue: "Molecular Signatures of Gynecological Cancers-Breast Cancer, Ovarian Cancer, Cervical Cancer, and Endometrial Cancer 2.0".
    Int J Mol Sci. 2024;25:11275.
    Abstract

  2891. CLAYTON AHA
    Phase-Sensitive Fluorescence Image Correlation Spectroscopy.
    Int J Mol Sci. 2024;25:11165.
    Abstract

  2892. ILIC I, Babic G, Dimitrijevic A, Sipetic Grujicic S, et al
    Psychosocial Burden of Women Who Are to Undergo Additional Diagnostic Procedures Due to Positive Screening for Cervical Cancer.
    Cancers (Basel). 2024;16:3541.
    Abstract

  2893. SCHONICKE T, Koch R, Vogt I, Falke I, et al
    Retrospective Evaluation of GEC-ESTRO Constraints for Definitive Radiochemotherapy with Brachytherapy and Correlation with Oncologic Outcome in Cervical Cancer: A Monocenter Study.
    Cancers (Basel). 2024;16:3495.
    Abstract

  2894. HUANG Q, Tan LY
    Exploring Factors Influencing Cervical Cancer Screening Participation among Singaporean Women: A Social Ecological Approach.
    Cancers (Basel). 2024;16:3475.
    Abstract

  2895. ROMERO D
    Cadonilimab is effective and safe in recurrent cervical cancer.
    Nat Rev Clin Oncol. 2024 Oct 25. doi: 10.1038/s41571-024-00962.
    Abstract

  2896. HUANG H, Pan Y, Mai Q, Zhang C, et al
    Targeting CDCP1 boost CD8+ T cells-mediated cytotoxicity in cervical cancer via the JAK/STAT signaling pathway.
    J Immunother Cancer. 2024;12:e009416.
    Abstract

  2897. YANG C, Wu M, Zhang J, Qian H, et al
    Radiomics based on MRI in predicting lymphovascular space invasion of cervical cancer: a meta-analysis.
    Front Oncol. 2024;14:1425078.
    Abstract

  2898. PAN X, Guo X, Wang J, Yang C, et al
    Improved outcomes of palliative radiotherapy combined with immune checkpoint inhibitors in recurrent or metastatic cervical cancers.
    Int Immunopharmacol. 2024;143.
    Abstract

  2899. SUN X, Ye G, Li J, Yuan L, et al
    The tumor suppressor Parkin exerts anticancer effects through regulating mitochondrial GAPDH activity.
    Oncogene. 2024;43:3215-3226.
    Abstract

  2900. SURMELI ZG, Ibrahim RHM, Alkhalfan N, Mahmood Z, et al
    Cisplatin-induced bone marrow failure in an adult patient with Fanconi anemia.
    J Oncol Pharm Pract. 2024;30:1274-1277.
    Abstract

  2901. LE GAC M, Benoit L, Koual M, Bentivegna E, et al
    Exploring uterine involvement in hysterectomy samples following conization for adenocarcinoma in situ of the uterine cervix: Insights from a multicenter study by the FRANCOGYN group.
    J Gynecol Obstet Hum Reprod. 2024;53:102826.
    Abstract

  2902. KAWAKAMI F, Yanai H, Teramoto N, Miyama Y, et al
    Concordance Between Biopsy and Resection Diagnoses of Uterine Cervical Adenocarcinoma According to the Updated World Health Organization 2020 Classification: A Multi-Institutional Study Elucidating Real-World Practice in Japan.
    Arch Pathol Lab Med. 2024;148:1218-1225.
    Abstract

  2903. YOSEF T, Birhanu B, Shifera N, Bekele BB, et al
    Determinants of cervical cancer screening uptake among reproductive-age women in southwest Ethiopia: a case-control study.
    Front Oncol. 2024;14:1424810.
    Abstract

  2904. REZAEI F, Mazidimoradi A, Pasokh Z, Mobasheri F, et al
    Global trend of cervical cancer among women aged 55 and older from 2010 to 2019: An analysis by socio-demographic index and geographic regions.
    Aging Med (Milton). 2024;7:614-635.
    Abstract

  2905. ZHANG X, Yu H, Chen K, Ding B, et al
    Definite Treatment Delay With Neoadjuvant Chemotherapy and Longitudinal Monitoring by Circulating Tumor DNA for Advanced Cervical Cancer During Pregnancy: A Case Series and Literature Review.
    Cancer Rep (Hoboken). 2024;7:e70021.
    Abstract

  2906. CHEN X, Li J, Zeng Q, Huang W, et al
    Construction of a nomogram for personalized prediction of lower limb lymphedema risk after cervical cancer surgery.
    BMC Womens Health. 2024;24:593.
    Abstract

  2907. PENG H, Liu T, Li P, Yang F, et al
    Automatic delineation of cervical cancer target volumes in small samples based on multi-decoder and semi-supervised learning and clinical application.
    Sci Rep. 2024;14:26937.
    Abstract

  2908. RAJAWAT J, Banerjee M
    Poly(ADP-ribose) polymerase1 (PARP1) and PARP inhibitors: New frontiers in cervical cancer.
    Biochem Biophys Res Commun. 2024;738:150943.
    Abstract

  2909. HUANG C, Xue L, Lin X, Shen Y, et al
    Histone Lactylation-Driven GPD2 Mediates M2 Macrophage Polarization to Promote Malignant Transformation of Cervical Cancer Progression.
    DNA Cell Biol. 2024 Nov 6. doi: 10.1089/dna.2024.0122.
    Abstract

  2910. SMITH PJ, Wallington SF
    Disparities in Cervical Cancer Knowledge and Trust in Information Sources Among Diverse American Women.
    J Cancer Educ. 2024 Nov 6. doi: 10.1007/s13187-024-02534.
    Abstract

  2911. RASHEED Z
    MicroRNA-183-5p negatively regulates interleukin-8 expression in cervical cancer cells.
    Int J Health Sci (Qassim). 2024;18:25-30.
    Abstract

  2912. WANG Y, Chen F, Qu W, Gong Y, et al
    Alternative splicing in the genome of HPV and its regulation.
    Front Cell Infect Microbiol. 2024;14:1443868.
    Abstract

  2913. PERERA K, Mapitigama KN, Abeysena H
    Prevalence of vaginal and cervical HPV infection among 35-year age cohort ever-married women in Kalutara district of Sri Lanka and the validity of vaginal HPV/DNA specimen as a cervical cancer screening tool: a cross-sectional study.
    BMC Infect Dis. 2024;24:1249.
    Abstract

  2914. KHAN MJ, Kannan P, Sayma, Winser SJ, et al
    Population-based cross-sectional survey of cervical cancer screening prevalence and socio-demographic correlates in Bangladeshi women.
    Res Health Serv Reg. 2024;3:17.
    Abstract

  2915. MONK BJ, van Mens S, Hale O, Boer J, et al
    Cost-Effectiveness of Pembrolizumab as First-Line Treatment in Patients with Persistent, Recurrent, or Metastatic Cervical Cancer in the United States.
    Oncol Ther. 2024 Nov 5. doi: 10.1007/s40487-024-00311.
    Abstract

  2916. FENG FX, Birdsong GG, Wei J, Dababneh MN, et al
    Retrospective analysis of HPV infection: Cotesting and HPV genotyping in cervical cancer screening within a large academic health care system.
    Cancer Cytopathol. 2024 Nov 5. doi: 10.1002/cncy.22916.
    Abstract

  2917. GHAFOURI M, Miller S, Burmeister J, Boggula R, et al
    Adaptive Approach to Treating Cervical Cancer in a Patient With Dramatic Uterine Movement.
    Cureus. 2024;16:e72938.
    Abstract

  2918. CAI H, Fang L, Lin J, Zheng Z, et al
    Atezolizumab plus bevacizumab and chemotherapy versus bevacizumab plus chemotherapy for metastatic cervical cancer: a cost-effectiveness analysis.
    Front Pharmacol. 2024;15:1476256.
    Abstract

  2919. YE M, Liu T, Miao L, Ji H, et al
    Cisplatin-encapsulated TRAIL-engineered exosomes from human chorion-derived MSCs for targeted cervical cancer therapy.
    Stem Cell Res Ther. 2024;15:396.
    Abstract

  2920. SOLIMAN AS
    The Changing Landscape of Cervical Cancer in Africa: Opportunities for Patient, Public, and Professional Education.
    J Cancer Educ. 2024 Nov 5. doi: 10.1007/s13187-024-02528.
    Abstract

  2921. USHIO E, Mizushima T, Sukegawa A, Saigusa Y, et al
    Risk factors for positive cervical cytology during early pregnancy screening and awareness of positive cytological results in Japan: a report from the Pregnant Women Health Initiative.
    J Int Med Res. 2024;52:3000605241285548.
    Abstract

  2922. FALLATAH DI, Khalil MA, Abd ElHafeez S, Gouda S, et al
    Factors influencing human papillomavirus vaccine uptake among parents and teachers of schoolgirls in Saudi Arabia: a cross-sectional study.
    Front Public Health. 2024;12:1403634.
    Abstract

  2923. SHAKIL R, Islam S, Akter B
    A precise machine learning model: Detecting cervical cancer using feature selection and explainable AI.
    J Pathol Inform. 2024;15:100398.
    Abstract

  2924. TATAR O, Haward B, Perez S, Zhu P, et al
    On the path toward cervical cancer elimination in Canada: a national survey of factors influencing women's intentions to participate in human papillomavirus test-based primary cervical screening.
    Lancet Reg Health Am. 2024;39:100901.
    Abstract

  2925. ADEBISI AA, Onobun DE, Orji C, Ononye R, et al
    Barriers to the Completion of Radiation Therapy in Cervical Cancer Treatment in Nigeria: A Review of Socioeconomic, Geographical, and Psychosocial Factors.
    Cureus. 2024;16:e70747.
    Abstract

  2926. PETRE I, Negru S, Dragomir R, Bordianu A, et al
    Artificial Intelligence Algorithms in Predictive Factors for Hematologic Toxicities During Concurrent Chemoradiation for Cervical Cancer.
    Cureus. 2024;16:e70665.
    Abstract

  2927. OTORKPA OJ, Onifade AA, Otorkpa CO
    The Surge in Human Papillomavirus Vaccine Rejection in Nigeria.
    Cancer Prev Res (Phila). 2024;17:497-498.
    Abstract

  2928. PANDEY P, Ramniwas S, Pandey S, Lakhanpal S, et al
    Elucidating the anticancerous efficacy of genistein via modulating HPV (E7 and E6) oncogenes expression and apoptotic induction in cervical cancer cells.
    Biotechnol Appl Biochem. 2024 Nov 3. doi: 10.1002/bab.2691.
    Abstract

  2929. BROOKE G, Wendel S, Banerjee A, Wallace N, et al
    Opportunities to Advance Cervical Cancer Prevention and Care.
    Tumour Virus Res. 2024 Oct 25:200292. doi: 10.1016/j.tvr.2024.200292.
    Abstract

  2930. PING Q, Chen Q, Li N
    Identification of m(6)A-related lncRNAs prognostic signature for predicting immunotherapy response in cervical cancer.
    SLAS Technol. 2024 Oct 26:100210. doi: 10.1016/j.slast.2024.100210.
    Abstract

  2931. ZHAO X, Liu Z, Qin H, Liu Y, et al
    T cell receptor repertoire characteristics and therapeutic potential of tumor infiltrating lymphocytes (TILs) derived from metastatic lymph node in cervical cancer.
    Mol Biomed. 2024;5:51.
    Abstract

  2932. LUO X, Jian M, Wu P, Wu Y, et al
    STIM1 promotes cervical cancer progression through autophagy activation via TFEB nuclear translocation.
    Cell Signal. 2024;125:111500.
    Abstract

  2933. YANG X, Gao X, Xu C, Ni T, et al
    Cryoablation synergizes with anti-PD-1 immunotherapy induces an effective abscopal effect in murine model of cervical cancer.
    Transl Oncol. 2024;51:102175.
    Abstract

  2934. LU Z, Zhu G, Qiu Z, Guo H, et al
    3D-printed brachytherapy in patients with cervical cancer: improving efficacy and safety outcomes.
    Radiat Oncol. 2024;19:152.
    Abstract

  2935. NAKOV I
    Quality of food intake and spontaneous clearance of Human papillomavirus in women.
    Bratisl Lek Listy. 2024;125:719-723.
    Abstract

  2936. BLINOV DV, Solopova AG, Gameeva EV, Badalov NG, et al
    [Impact of various rehabilitation programs on anxiety and depression after surgery of early-stage cervical cancer].
    Vopr Kurortol Fizioter Lech Fiz Kult. 2024;101:40-44.
    Abstract

  2937. WANG J, Elfstrom KM, Dillner J
    Human papillomavirus-based cervical screening and long-term cervical cancer risk: a randomised health-care policy trial in Sweden.
    Lancet Public Health. 2024;9:e886-e895.
    Abstract

  2938. ALMONTE M, Hernandez ML, Adsul P
    Implementation efforts to support transition to HPV-based cervical cancer screening.
    Lancet Public Health. 2024;9:e838-e839.
    Abstract

  2939. GOLD RS, Williams M, Wainstein HM
    Cervical cancer screening in high-risk patients: Clinical challenges in primary care.
    Cleve Clin J Med. 2024;91:693-703.
    Abstract

  2940. BRENNAN KJ, Reay JL
    Emotional barriers pose the greatest threat to cervical cancer screening for young adult women in the United Kingdom.
    Prev Med. 2024;189:108160.
    Abstract

  2941. CORTES-HERNANDEZ U, Lizardi-Aguilera TM, Noriega-Mejia BJ, Gonzalez-Macias J, et al
    Prostaglandin E(2) suppresses KCNH1 gene expression and inhibits the proliferation of CaSki cervical cells through its four prostanoid PTGER subtypes.
    Gene. 2025;933:148997.
    Abstract

  2942. CAMPRODON G, Gabro A, El Ayachi Z, Chopra S, et al
    Personalized strategies for brachytherapy of cervix cancer.
    Cancer Radiother. 2024;28.
    Abstract

  2943. ZHANG J, Liu Y, Guan Y, Zhang Y, et al
    A single-injection vaccine providing protection against two HPV types.
    J Mater Chem B. 2024;12:11237-11250.
    Abstract

  2944. LI J, Cui N, Wang Y, Li W, et al
    Prediction of preoperative lymph-vascular space invasion and survival outcomes of cervical squamous cell carcinoma by utilizing 18F-FDG PET/CT imaging at early stage.
    Nucl Med Commun. 2024 Oct 2. doi: 10.1097/MNM.0000000000001909.
    Abstract

  2945. ANDO H, Katoh Y, Kobayashi O, Ikeda Y, et al
    Low CD86 expression is a predictive biomarker for clinical response to the therapeutic human papillomavirus vaccine IGMKK16E7: results of a post hoc analysis.
    JNCI Cancer Spectr. 2024;8:pkae091.
    Abstract

  2946. TSUNEMATSU R, Mariya T, Umemoto M, Ogawa S, et al
    Microbiological investigation of pregnancies following vaginal radical trachelectomy using 16S rRNA sequencing of FFPE placental specimens.
    FEBS Open Bio. 2024;14:1825-1836.
    Abstract

  2947. GURDAL Y, Ilhan N
    Health beliefs and associated factors related to HPV and HPV vaccination in a sample of Turkish women: A cross-sectional study.
    Public Health Nurs. 2024;41:1342-1352.
    Abstract

  2948. ZENG X, Starr D, Li J, Bi X, et al
    AICyte-alone capabilities as an independent screener for triaging cervical cytology using a 50% negative cutoff value.
    Cancer Cytopathol. 2024;132:723-730.
    Abstract

  2949. KUCUKKAYA B, Cangol Sogut S, Cangol E
    The relationship between HPV testing attitudes and beliefs, knowledge, and vaccination attitudes: A cross-sectional study.
    Public Health Nurs. 2024;41:1466-1479.
    Abstract

  2950. ADEGBOYEGA A, Kang J, Aroh A, Williams LB, et al
    Perceived Barriers to Pap Screening Influence Adherence to Screening Recommendations Among Black Women.
    J Womens Health (Larchmt). 2024;33:1482-1491.
    Abstract

  2951. TERMRUNGRUANGLERT W, Khemapech N, Vasuratna A, Havanond P, et al
    Cost-effectiveness analysis of single-dose or 2-dose of bivalent, quadrivalent, or nonavalent HPV vaccine in a low/middle-income country setting.
    J Gynecol Oncol. 2024;35:e85.
    Abstract

  2952. GRAY T, Cherian S, Amarnath S, Guo B, et al
    Method to assess the need for re-planning HDR brachytherapy tandem and ring treatments.
    Med Dosim. 2024;49:298-306.
    Abstract

  2953. ZHAO Y, Xu L, Peng C, Deng J, et al
    Clinical and prognostic significance of Hec1 expression in patients with Cervical Cancer.
    Front Oncol. 2024;14:1438734.
    Abstract

  2954. NANDAKUMAR V, Ramasamy SS, Adhigaman K, Arumugam D, et al
    Investigating the Antiproliferative Activity of Novel 4-Chloro-8-Nitro-1,2-Dihydro-3-Quinoline Acylhydrazones on Human Cervical Cancer Cell Lines.
    Chem Biodivers. 2024 Nov 14:e202401636. doi: 10.1002/cbdv.202401636.
    Abstract

  2955. PODDAR A, Rao SR
    Overcoming Barriers of Cervical Cancer Elimination in India: A Practice to Policy Level Advocacy.
    J Cancer Policy. 2024 Nov 12:100521. doi: 10.1016/j.jcpo.2024.100521.
    Abstract

  2956. TONY-OKEKE TO, Zoakah JH, Odoh AF, Nnorom OC, et al
    KNOWLEDGE AND PERCEPTION OF HUMAN PAPILLOMAVIRUS VACCINE AMONG ADOLESCENTS AND CAREGIVERS IN JOS METROPOLIS, PLATEAU STATE, NIGERIA.
    West Afr J Med. 2024;41.
    Abstract

  2957. PI R, Li T, Zhang H, Zhou H, et al
    The Distribution of HR-HPV E6/E7 DNA and mRNA by Histological Grade and the Clinical Performance for Detection of Cervical Cancer and Precancer.
    J Med Virol. 2024;96:e70026.
    Abstract

  2958. PEI J, Yu J, Ge P, Bao L, et al
    Constructing a Classification Model for Cervical Cancer Tumor Tissue and Normal Tissue Based on CT Radiomics.
    Technol Cancer Res Treat. 2024;23:15330338241298554.
    Abstract

  2959. GEBREMARIAM GT, Gebretekle GB, Tigneh W, Gashawbeza B, et al
    The psychometric properties of the amharic version of EuroQoL five-dimensions-five level among Ethiopian cervical cancer patients.
    Health Qual Life Outcomes. 2024;22:98.
    Abstract

  2960. SHERIDAN L, Pocobelli G, Anderson M, Li CI, et al
    Cervical cancer screening rates in females living with HIV at three healthcare settings in the United States, 2010-2019.
    Cancer Causes Control. 2024 Nov 13. doi: 10.1007/s10552-024-01937.
    Abstract

  2961. PROCHAZKA V, Skopelidou V, Romanova M, Klat J, et al
    Spontaneous and post-interventional regression of cervical HPV infection.
    Ceska Gynekol. 2024;89:400-404.
    Abstract

  2962. HU Z, Liu W, Liu J, Zhou H, et al
    The anti-tumor efficacy of a recombinant oncolytic herpes simplex virus mediated CRISPR/Cas9 delivery targeting in HPV16-positive cervical cancer.
    Antiviral Res. 2024 Nov 11:106035. doi: 10.1016/j.antiviral.2024.106035.
    Abstract

  2963. ABRAR SS, Azmel Mohd Isa S, Mohd Hairon S, Yaacob NM, et al
    Prognostic Factors for Cervical Cancer in Asian Populations: A Scoping Review of Research From 2013 to 2023.
    Cureus. 2024;16:e71359.
    Abstract

  2964. LI Q, Zhao N, Ding X, Zhao J, et al
    METTL14-mediated m6A modification upregulates HOXB13 expression to activate NF-kappaB and exacerbate cervical cancer progression.
    Mol Cell Oncol. 2024;11:2423986.
    Abstract

  2965. FONSECA FV, de Carvalho NS, Maestri CA, Martins MF, et al
    The role of HIV as an independent risk factor to cervical HSIL recurrence.
    Rev Bras Ginecol Obstet. 2024;46:e-rbgo85.
    Abstract

  2966. CHATTERJEE K, Mukherjee S, Vanmanen J, Banerjee P, et al
    Corrigendum: Dietary polyphenols, resveratrol and pterostilbene exhibit antitumor activity on an HPV E6-positive cervical cancer model: an in vitro and in vivo analysis.
    Front Oncol. 2024;14:1483410.
    Abstract

  2967. BERTA DM, Teketelew BB, Chane E, Bayleyegn B, et al
    Hematological changes in women with cervical cancer before and after cancer treatment: retrospective cohort study.
    Sci Rep. 2024;14:27630.
    Abstract

  2968. KAUR G, Garg P, Dangwal VK, Singh B, et al
    Tumor Control and Normal Tissue Complications in High-dose-rate Brachytherapy for Cervical Cancer Patients Using Ir-192 Radioactive Source.
    J Med Phys. 2024;49:363-369.
    Abstract

  2969. ZOU J, Liu S, Long J
    Up-regulation of MSMO1 was associated with poor survival in cervical cancer.
    Transl Cancer Res. 2024;13:5316-5327.
    Abstract

  2970. ZHANG Y, Meng YP, Xu XF, Shi Q, et al
    Prognostic nomograms for locally advanced cervical cancer based on the SEER database: Integrating Cox regression and competing risk analysis.
    Medicine (Baltimore). 2024;103:e40408.
    Abstract

  2971. RENDLE KA, Ramogola-Masire D, Grover S
    Thibang Diphatlha: a sequential multiple assignment randomized trial designed to increase timely adoption of cervical cancer treatment in Botswana.
    Implement Sci Commun. 2024;5:128.
    Abstract

  2972. TALIENTO C, Scutiero G, Battello G, Sala A, et al
    Reproductive, obstetrical and oncological outcomes of fertility-sparing treatment for cervical cancer according to the FIGO 2018 staging system: A systematic review.
    Eur J Surg Oncol. 2024;51:109359.
    Abstract

  2973. FAN J, Li W, Cheng M, Wang Z, et al
    Nomograms combining clinical factors and apparent diffusion coefficient to predict downstaging and progression-free survival after concurrent chemoradiotherapy in patients with cervical cancer.
    Acta Radiol. 2024;65:1430-1439.
    Abstract

  2974. YAN S, Gong X, Liu R, Jia X, et al
    Prognostic significance of systemic pan-immune-inflammation value in locally advanced cervical cancer.
    Front Oncol. 2024;14:1492251.
    Abstract

  2975. BRISSON M, Laprise JF, Drolet M, Chamberland E, et al
    Population-level impact of switching to 1-dose human papillomavirus vaccination in high-income countries: examining uncertainties using mathematical modeling.
    J Natl Cancer Inst Monogr. 2024;2024:387-399.
    Abstract

  2976. BURGER EA, Laprise JF, Portnoy A, Spencer JC, et al
    Population-level health impact of hypothetical waning 1-dose human papillomavirus vaccination and 2-dose mitigation strategies in a high cervical cancer burden setting.
    J Natl Cancer Inst Monogr. 2024;2024:379-386.
    Abstract

  2977. MAN I, Georges D, Basu P, Baussano I, et al
    Leveraging single-dose human papillomavirus vaccination dose-efficiency to attain cervical cancer elimination in resource-constrained settings.
    J Natl Cancer Inst Monogr. 2024;2024:400-409.
    Abstract

  2978. CAMPOS NG, Lowy DR, de Sanjose S, Schiffman M, et al
    A cervical cancer control strategy for lower-resource settings: interventions to complement one-dose HPV vaccination.
    J Natl Cancer Inst Monogr. 2024;2024:417-423.
    Abstract

  2979. UMUTESI G, Weiner BJ, Oluoch L, Bukusi E, et al
    Acceptability of single-dose HPV vaccination schedule among health-care professionals in Kenya: a mixed-methods study.
    J Natl Cancer Inst Monogr. 2024;2024:358-370.
    Abstract

  2980. SLAVKOVSKY R, Mvundura M, Debellut F, Naddumba T, et al
    Evaluating potential program cost savings with a single-dose HPV vaccination schedule: a modeling study.
    J Natl Cancer Inst Monogr. 2024;2024:371-378.
    Abstract

  2981. SCHUIND AE, Balaji KA, Du A, Yuan Y, et al
    Human papillomavirus prophylactic vaccines: update on new vaccine development and implications for single-dose policy.
    J Natl Cancer Inst Monogr. 2024;2024:410-416.
    Abstract

  2982. MALVI SG, Esmy PO, Muwonge R, Joshi S, et al
    A prospective cohort study comparing efficacy of 1 dose of quadrivalent human papillomavirus vaccine to 2 and 3 doses at an average follow up of 12 years postvaccination.
    J Natl Cancer Inst Monogr. 2024;2024:317-328.
    Abstract

  2983. KREIMER AR, Watson-Jones D, Kim JJ, Dull P, et al
    Single-dose human papillomavirus vaccination: an update.
    J Natl Cancer Inst Monogr. 2024;2024:313-316.
    Abstract

  2984. CARAULEANU A, Mogos RA, Solomon-Condriuc IP, Costea CF, et al
    Conservative management of cervical intraepithelial neoplasia 2 and prediction of its progression - a retrospective study.
    Rom J Morphol Embryol. 2024;65:443-447.
    Abstract

  2985. WANG Z, Gao H, Wang X, Grzegorzek M, et al
    Correction: A multi-task learning based applicable AI model simultaneously predicts stage, histology, grade and LNM for cervical cancer before surgery.
    BMC Womens Health. 2024;24:602.
    Abstract

  2986. MONDAL A, Das B, Karmakar S, Pani S, et al
    Modulatory Role of Pantropic Cell Signaling Pathways in the Antimigratory and Antiproliferative Action of Triazole Chelated Iridium(III) Complexes in Cervical Cancer Cells.
    J Med Chem. 2024 Nov 11. doi: 10.1021/acs.jmedchem.4c01997.
    Abstract

  2987. COFIE LE, Whitt O, Bhagat N
    Personal Networks and Cervical Cancer Screening among Black Immigrant Women.
    J Racial Ethn Health Disparities. 2024 Nov 11. doi: 10.1007/s40615-024-02231.
    Abstract

  2988. BATISTA I, Nogueira A
    Letter to Editor-"Exploring the Correlation Between Health Literacy and Knowledge of Cervical Cancer and Radiotherapy Among Japanese Women: A Web-Based Survey".
    J Cancer Educ. 2024 Nov 11. doi: 10.1007/s13187-024-02523.
    Abstract

  2989. OKAN Y, Stone ER, Petrova D, Bruine de Bruin W, et al
    Communicating Probabilities of Cervical Cancer Screening Results with Icon Arrays or Tree Diagrams: A Longitudinal Experiment.
    Health Commun. 2024 Nov 11:1-13. doi: 10.1080/10410236.2024.2421612.
    Abstract

  2990. ADACHI T, Matsui T, Okata-Karigane U, Takahashi C, et al
    Delayed and immediate cutaneous adverse events during pembrolizumab combination chemotherapy against cervical cancer: Case series.
    J Dermatol. 2024 Nov 11. doi: 10.1111/1346-8138.17521.
    Abstract

  2991. GUO Y, Han Y, Zhang J, Zhou Y, et al
    Identification and Experimental Validation of Prognostic miRNA Signature and Ferroptosis-Related Key Genes in Cervical Squamous Cell Carcinoma.
    Cancer Med. 2024;13:e70415.
    Abstract

  2992. LIU Y, He P, Ma X, Tian Y, et al
    The combination of SLC7A11 inhibitor and oridonin synergistically inhibits cervical cancer cell growth by decreasing the NADPH/NADP(+) ratio.
    Genes Dis. 2024;12:101265.
    Abstract

  2993. DUAN Z, Li D, Li N, Lin S, et al
    CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer.
    Mol Ther Oncol. 2024;32:200892.
    Abstract

  2994. TESFAYE S, Price AR, Litwin TR
    Disparities in cervical cancer screening rates and electronic health record completeness among All of Us Research Program participants.
    Am J Epidemiol. 2024 Nov 7:kwae427. doi: 10.1093.
    Abstract

  2995. BOLIO A, Waheed DE, Mugo N, Garland SM, et al
    Overview of CHIC symposia series: Summary of Africa and South Asia symposia.
    Vaccine. 2024;42 Suppl 2:S9-S15.
    Abstract

  2996. BURDIER FR, Bolio A, Abraham P, Pimple S, et al
    Case studies on the progress of cervical cancer screening programs in Bhutan, India, and Turkiye.
    Vaccine. 2024;42 Suppl 2:S49-S53.
    Abstract

  2997. NDIAYE C, Kyesi F, Masupha T, Ranyali M, et al
    Integrating HPV vaccine service delivery with adolescent health programmes - Experiences and perspectives from selected countries in Africa.
    Vaccine. 2024;42 Suppl 2:S45-S48.
    Abstract

  2998. WAHEED DE, Bolio A, Kyesi F, Miano CW, et al
    Routine HPV vaccination: Reflection on delivery strategies based on countries' experiences.
    Vaccine. 2024;42 Suppl 2:S37-S40.
    Abstract

  2999. WAHEED DE, Mumba M, Alfred D, Bogale M, et al
    Identifying key challenges and optimizing approaches for training of health care professionals for HPV vaccination programmes.
    Vaccine. 2024;42 Suppl 2:S22-S26.
    Abstract

  3000. BORDA H, Bloem P, Akaba H, Guillaume D, et al
    Status of HPV disease and vaccination programmes in LMICs: Introduction to special issue.
    Vaccine. 2024;42 Suppl 2:S1-S8.
    Abstract

  3001. BONLOKKE S, Stougaard M, Blaakaer J, Bertelsen J, et al
    HPV is an essential driver in recurrence of cervical cancer.
    Pathol Res Pract. 2024;264:155672.
    Abstract

  3002. SHANSHAN C, Jing C, Tao X
    HPV infection status among women of all ages in Jinshan District, Shanghai.
    J Int Med Res. 2024;52:3000605241291754.
    Abstract

  3003. LOGEL M, Tope P, El-Zein M, Gonzalez E, et al
    A Narrative Review of the Putative Etiologic Role and Diagnostic Utility of the Cervicovaginal Microbiome in Human Papillomavirus-Associated Cervical Carcinogenesis.
    J Med Virol. 2024;96:e70027.
    Abstract

  3004. AIMAGAMBETOVA G, Bapayeva G, Ukybassova T, Kamzayeva N, et al
    Risks of Cervical Cancer Recurrence After Fertility-Sparing Surgery and the Role of Human Papillomavirus Infection Types.
    J Clin Med. 2024;13:6318.
    Abstract

  3005. CHONG Y, Zhang K, Zeng Y, Chen Q, et al
    ZNF281 Facilitates the Invasion of Cervical Cancer Cell Both In Vivo and In Vitro (dagger).
    Cancers (Basel). 2024;16:3717.
    Abstract

  3006. BAETEN IGT, Hoogendam JP, Stathonikos N, Gerestein CG, et al
    Artificial Intelligence-Based Sentinel Lymph Node Metastasis Detection in Cervical Cancer.
    Cancers (Basel). 2024;16:3619.
    Abstract

  3007. MA C, Xu X, Qin S, Zhou J, et al
    Screening of biomarkers in acute radiation enteritis based on microbiome and clustering methods.
    BMC Microbiol. 2024;24:463.
    Abstract

  3008. XIAO F, Sui L
    Evaluation of a real-time optoelectronic method for the detection of cervical intraepithelial neoplasia and cervical cancer in patients with different transformation zone types.
    Sci Rep. 2024;14:27220.
    Abstract

  3009. LOU S, Lv H, Zhang L
    Identification of Vesicle-Mediated Transport-Related Genes for Predicting Prognosis, Immunotherapy Response, and Drug Screening in Cervical Cancer.
    Immun Inflamm Dis. 2024;12:e70052.
    Abstract

  3010. YIN M, Weng Y, Qi T
    PLOD2 exacerbates cervical squamous cell carcinoma by suppressing p53 by binding to YAP1.
    Mol Med Rep. 2025;31:23.
    Abstract

  3011. GUPTA C, Sherpa ML, Lucksom PG, Pradhan A, et al
    Evaluating different samples & techniques for hr-HPV DNA genotyping to improve the efficiency of risk profiling for oral & cervical cancers in Sikkim, India.
    Indian J Med Res. 2024;160:226-235.
    Abstract

  3012. ZHANG Y, Shu P, Wang X, Ouyang G, et al
    Comparison of Survival Between Different Histological Subtypes in Cervical Cancer Patients: A Retrospective and Propensity Score-matched Analysis.
    J Cancer. 2024;15:6326-6335.
    Abstract

  3013. TSUI TL, Ho YC, Ueng KC, Liao PL, et al
    The lower incidence of cervical cancer in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitors utilization.
    J Cancer. 2024;15:6196-6203.
    Abstract

  3014. HATEFI-SHOGAE S, Emadi-Baygi M, Ghaedi-Heydari R
    Analysis of Human Papillomavirus-Associated Cervical Cancer Differentially Expressed Genes and Identification of Prognostic Factors using Integrated Bioinformatics Approaches.
    Adv Biomed Res. 2024;13:78.
    Abstract

  3015. NAMUGGA J, Wong J, Nakisige C, Okoth A, et al
    Feasibility of neoadjuvant chemotherapy for bulky early stage to stage IIIB cervical cancer in Uganda.
    Gynecol Oncol Rep. 2024;56:101533.
    Abstract

  3016. RUSCHUKOVA DN, Momchilova TD, Vladimirova MS, Nikolova ZI, et al
    Attitudes and awareness related to cervical cancer vaccine.
    Folia Med (Plovdiv). 2024;66:707-716.
    Abstract

  3017. LIU Y, Li R, Li C, Liu Z, et al
    Photodynamic therapy compared with loop electrosurgical excision procedure in patients with cervical high-grade squamous intraepithelial lesion.
    Sci Rep. 2024;14:27090.
    Abstract

  3018. TAN W, Chen G, Ci Q, Deng Z, et al
    Elevated ITGA3 expression serves as a novel prognostic biomarker and regulates tumor progression in cervical cancer.
    Sci Rep. 2024;14:27063.
    Abstract

  3019. OOMMEN AM, Ashfaq M, Cherian AG, Colling AM, et al
    Strategies and implementation outcomes of HPV-based cervical screening studies to prevent cervical cancer in India: A systematic review.
    J Cancer Policy. 2024;42:100513.
    Abstract

  3020. AREGA S, Dey S, Pani S, Dash SR, et al
    Determining the effect of long non-coding RNA maternally expressed gene 3 (lncRNA MEG3) on the transcriptome profile in cervical cancer cell lines.
    Genomics. 2024;116:110957.
    Abstract

  3021. RUSSO L, D'Erme L, Bottazzi S, Amerighi A, et al
    MRI-based assessment of residual disease after neoadjuvant chemotherapy in pregnant women with cervical cancer.
    Eur J Radiol. 2024;181:111766.
    Abstract

  3022. GONG J, Gu D, Dong S, Shen W, et al
    Effects of Message Framing on Human Papillomavirus Vaccination: Systematic Review.
    J Med Internet Res. 2024;26:e52738.
    Abstract

  3023. CHONGSUWAT T, Decker ER, Wilde M, Fitzpatrick MB, et al
    Development of Cervical Cancer Prevention Workshops for Hmong and Karenni Women Through a Community-Academic Partnership.
    WMJ. 2024;123:339-343.
    Abstract

  3024. SHUKLA S, Deo BS, Nemichand, Singh P, et al
    Spatially Resolved Fibre-Optic Probe for Cervical Precancer Detection Using Fluorescence Spectroscopy and PCA-ANN-Based Classification Algorithm: An In Vitro Study.
    J Biophotonics. 2024;17:e202400284.
    Abstract

  3025. ZHANG R, Zhang L, Wu L, You S, et al
    Rapid detection of HPV16 utilizing recombinase polymerase amplification with the employment of an extremely low concentration of the probe.
    Anal Methods. 2024;16:7557-7566.
    Abstract

  3026. WANG F, Xiao J, Wang Q, Zhen H, et al
    Identifying low muscle mass and monitoring body composition changes in newly diagnosed cancer patients: Agreement between multifrequency bioelectrical impedance analysis and computed tomography.
    Nutrition. 2024;128:112526.
    Abstract

  3027. ADEN D, Zaheer S, Khan S, Jairajpuri ZS, et al
    Navigating the landscape of HPV-associated cancers: From epidemiology to prevention.
    Pathol Res Pract. 2024;263:155574.
    Abstract

  3028. REAVES S, Hall KC, Stewart MW, Wentzensen N, et al
    Evaluation of follow-up colposcopy procedures after abnormal cervical screening result across a statewide study in Mississippi.
    Cancer Causes Control. 2024;35:1487-1496.
    Abstract

  3029. KIM SK, Kornides M, Chittams J, Waas R, et al
    Pilot Randomized Controlled Trial of an Intervention to Promote HPV Uptake Among Young Women Who Attend Subsidized Clinics.
    J Obstet Gynecol Neonatal Nurs. 2024;53:607-617.
    Abstract

  3030. CHEN M, Li J, Abudousalamu Z, Yuan L, et al
    A Reinterpretation of Paracolpium in Radical Hysterectomy: New Insights into Its Surgical Implication.
    J Minim Invasive Gynecol. 2024;31:908.
    Abstract

  3031. JONGEN VW, van Dongen N, Sohn AH
    Human papillomavirus infection among adolescents living with HIV: a focus on prevention.
    Curr Opin HIV AIDS. 2024;19:361-367.
    Abstract

  3032. DRYSDALE K, Creagh NS, Nightingale C, Whop LJ, et al
    Inclusive language in health policy - a timely case (study) of cervical screening in Australia.
    Health Sociol Rev. 2024;33:325-341.
    Abstract

  3033. KSIRRI R, Bhanukiran K, Maity S, Maiti P, et al
    Evaluation of anticancer activity of Gmelina asiatica leaves, in-vitro and in-silico studies.
    J Biomol Struct Dyn. 2024;42:11690-11705.
    Abstract

  3034. AREKLETT EW, Hagen BI, Stubberud J, Fagereng E, et al
    Digital goal management training for cognitive impairment in cervical cancer survivors-a randomized comparison study.
    J Cancer Surviv. 2024 Nov 22. doi: 10.1007/s11764-024-01701.
    Abstract

  3035. EBADI M, Kavousi M, Farahmand M
    Investigation of the Apoptotic and Anti-metastatic Effects of Nano-niosomes Containing the Plant extract Anabasis setifera on HeLa: in Vitro Cervical Cancer Study.
    Chem Biodivers. 2024 Nov 22:e202402599. doi: 10.1002/cbdv.202402599.
    Abstract

  3036. MKUU R, Hungu C, Makokha F, Harvey I, et al
    "It was not normal, and I had to find a doctor and tell him." Kenyan Women's Response to Cervical Cancer Symptoms.
    J Patient Exp. 2024;11:23743735241283200.
    Abstract

  3037. WANG C, Zhang T, Zhang C
    LncRNA AFAP1-AS1 exhibits oncogenic characteristics and promotes gemcitabine-resistance of cervical cancer cells through miR-7-5p/EGFR axis.
    Oncol Res. 2024;32:1867-1879.
    Abstract

  3038. CHEN C, Zhang M, Tang J, Pu K, et al
    Cost-effectiveness of robotic surgery compared to conventional laparoscopy for the management of early-stage cervical cancer: a model-based economic evaluation in China.
    BMJ Open. 2024;14:e087113.
    Abstract

  3039. MIGNOT S, Naiditch N, Llorens J, Fritel X, et al
    Adherence to cervical cancer screening in France: factors influencing the healthcare professionals' decisions-a qualitative study.
    BMJ Open. 2024;14:e084795.
    Abstract

  3040. LI L, Hu R, Zhang X, Liu G, et al
    Carboxylesterase-activatable multi-in-one nanoplatform for near-infrared fluorescence imaging guided chemo/photodynamic/sonodynamic therapy toward cervical cancer.
    Int J Biol Macromol. 2024 Nov 19:137899. doi: 10.1016/j.ijbiomac.2024.137899.
    Abstract

  3041. MITRA T, Prusty M, Elangovan S
    Identification and validation of miR-21 key genes in cervical cancer through an integrated bioinformatics approach.
    Comput Biol Chem. 2024;113:108280.
    Abstract

  3042. VILLANUEVA-DUQUE JA, Castro-Valdes IC, Garcia-Cervantes N
    [Obstetric-gynecological and social factors for the development of cervical intraepithelial neoplasia].
    Rev Med Inst Mex Seguro Soc. 2024;62:1-7.
    Abstract

  3043. VILLANUEVA-DUQUE JA, Castro-Valdes IC, Garcia-Cervantes N
    [Obstetric-gynecological and social factors for the development of cervical intraepithelial neoplasia].
    Rev Med Inst Mex Seguro Soc. 2024;62:1-7.
    Abstract

  3044. ALARID-ESCUDERO F, Gracia V, Wolf M, Zhao R, et al
    State-level disparities in cervical cancer prevention and outcomes in the U.S.: a modeling study.
    J Natl Cancer Inst. 2024 Nov 21:djae298. doi: 10.1093.
    Abstract

  3045. CHAISRI P, Laoprom N, Buranrat B
    Ethanolic Fruit Extract of Piper retrofractum Induced Cell Cycle Arrest, Apoptosis, Increased Reactive Oxygen Species Production, and Mitochondrial Dysfunction in Human Cervical Cancer.
    Chem Biodivers. 2024 Nov 21:e202402353. doi: 10.1002/cbdv.202402353.
    Abstract

  3046. ZHANG B, Liu L, Meng D, Kue CS, et al
    Development of a radiomic model for cervical cancer staging based on pathologically verified, retrospective metastatic lymph node data.
    Acta Radiol. 2024 Nov 21:2841851241291931. doi: 10.1177/02841851241291931.
    Abstract

  3047. NYGARD S, Falkenthal T, Sture T, Lynge E, et al
    Impact of multi-cohort HPV vaccination on cervical cancer in women below 30 years of age: Lessons learned from the Scandinavian countries.
    J Infect Dis. 2024 Nov 21:jiae584. doi: 10.1093.
    Abstract

  3048. YANG X, Ren H, Li Z, Fu J, et al
    Brachytherapy for cervical cancer: from intracavitary to interstitial technique.
    Front Oncol. 2024;14:1442712.
    Abstract

  3049. CAPRIFICO AE, Vaghi L, Spearman P, Calabrese G, et al
    In vitro detection of cancer cells using a novel fluorescent choline derivative.
    BMC Med Imaging. 2024;24:316.
    Abstract

  3050. ZHANG J, Maimaiti A, Chang X, Sun P, et al
    DDR1 promotes metastasis of cervical cancer and downstream phosphorylation signal via binding GRB2.
    Cell Death Dis. 2024;15:849.
    Abstract

  3051. TIRADO-REYES RJ, Huape-Abad N, Simental-Gomez NI, Mascareno-Castro SY, et al
    [Validity of visual inspection with acetic acid versus cervical cytology].
    Rev Med Inst Mex Seguro Soc. 2024;62:1-10.
    Abstract

  3052. MAO S, Fang Z, Xu Y, Yang K, et al
    [The role of tumor-associated macrophages in the development and progression of cervical cancer].
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2024;40:1029-1034.
    Abstract

  3053. WANG Y, Zhang Y, Liang X, Liu J, et al
    The impact of frailty on chemotherapy intolerance in patients with cervical cancer: A longitudinal study.
    Eur J Oncol Nurs. 2024;74:102725.
    Abstract

  3054. JI L, Yao Y, Yu D, Chen W, et al
    Performance of a Full-Coverage Cervical Cancer Screening Program Using on an Artificial Intelligence- and Cloud-Based Diagnostic System: Observational Study of an Ultralarge Population.
    J Med Internet Res. 2024;26:e51477.
    Abstract

  3055. DENG Z, Li W, Tang X, Zhao B, et al
    Vulvar Skin Metastasis From Cervical Adenocarcinoma.
    Am J Dermatopathol. 2024;46:852-854.
    Abstract

  3056. SHENG S, Xu J, Hu D, Qian W, et al
    Paeonol regulates glycolytic metabolism by downregulating BACH1 to ameliorate stemness, angiogenesis, and EMT in SiHa cervical cancer cells.
    Histol Histopathol. 2024 Nov 5:18844. doi: 10.14670.
    Abstract

  3057. SUYUSAL IH, Konuk AO, Diremsizoglu U, Ari O, et al
    Avoiding Packing When an External Fixator Is Used in Cervical Cancer Brachytherapy: The Rationale for Vaginal Gauze Packing on Rectum and Bladder.
    Cureus. 2024;16:e71936.
    Abstract

  3058. LIN J, Winer RL, Barsness CB, Desai J, et al
    Design of a pragmatic trial integrating human papillomavirus (HPV) self-sampling into primary care to reduce cervical cancer screening disparities in Somali American individuals: The Isbaar project.
    Contemp Clin Trials. 2024 Nov 17:107754. doi: 10.1016/j.cct.2024.107754.
    Abstract

  3059. YU Y, Zhao JD, Yang H
    Retraction Note: MiR-299-3p inhibits proliferation and invasion of cervical cancer cell via targeting TCF4.
    Eur Rev Med Pharmacol Sci. 2024;28:4490.
    Abstract

  3060. ERIKS-HOOGLAND I, Veseli-Abazi M, Muller L, Abazi C, et al
    Breast and cervical cancer screening in females with spinal cord injury: A systematic review and meta-analysis.
    J Spinal Cord Med. 2024 Nov 19:1-21. doi: 10.1080/10790268.2024.2408056.
    Abstract

  3061. CAO J, Guo F, Jiang H, Liu C, et al
    Selenium-containing metallodrug overcomes cervical cancer radioresistance through physical-chemical dual sensitization.
    Dalton Trans. 2024 Nov 19. doi: 10.1039/d4dt02643.
    Abstract

  3062. DZOBO M, Dzinamarira T, Strauss M, Mashamba-Thompson T, et al
    Rural women's preferences for cervical cancer screening via HPV self-sampling: a discrete choice experiment study in chidamoyo, Hurungwe District, Zimbabwe.
    AJOG Glob Rep. 2024;4:100414.
    Abstract

  3063. ALOSAIMI B, Fallatah DI, Abd ElHafeez S, Saleeb M, et al
    Predictors of Human Papillomavirus (HPV) Vaccine Acceptability Among Physicians, Their Knowledge on Cervical Cancer, and Factors Influencing Their Decision to Recommend It.
    J Multidiscip Healthc. 2024;17:5177-5188.
    Abstract

  3064. FENG X, Shu L
    The methyltransferase KIAA1429 potentiates cervical cancer tumorigenesis via modulating LARP1 mRNA m6A modification and stability.
    Histol Histopathol. 2024 Nov 4:18843. doi: 10.14670.
    Abstract

  3065. ZHANG X, Yan W, Jin H, Yu B, et al
    Transcriptional and post-transcriptional regulation of CARMN and its anti-tumor function in cervical cancer through autophagic flux blockade and MAPK cascade inhibition.
    J Exp Clin Cancer Res. 2024;43:305.
    Abstract

  3066. LIU Y, Li R, Li C, Shang J, et al
    Hiporfin-photodynamic therapy for high-grade squamous intraepithelial lesions of the endocervical canal in young women.
    Sci Rep. 2024;14:28423.
    Abstract

  3067. XIONG J, He L, Chai X, Zhang Y, et al
    YTHDF1 boosts the lactate accumulation to potentiate cervical cancer cells immune escape.
    Cell Death Dis. 2024;15:843.
    Abstract

  3068. ALEMAYEHU R, Stroetmann CY, Wondimagegnehu A, Rabe F, et al
    Barriers to adherence of posttreatment follow-up after positive primary cervical cancer screening in Ethiopia: a mixed-methods study.
    Oncologist. 2024 Nov 18:oyae305. doi: 10.1093.
    Abstract

  3069. ZHOU J, Guo Z, Peng X, Wu B, et al
    Chrysotoxine regulates Ferroptosis and the PI3K/AKT/mTOR pathway to prevent cervical cancer.
    J Ethnopharmacol. 2024 Nov 16:119126. doi: 10.1016/j.jep.2024.119126.
    Abstract

  3070. XU S, Zhang W, Zhang Y
    Beyond health: exploring women's socio-cultural motivations for HPV vaccination.
    Int J Qual Stud Health Well-being. 2024;19:2424494.
    Abstract

  3071. WU H, Huang L, Chen X, OuYang Y, et al
    Establishment of a Novel Risk Stratification System Integrating Clinical and Pathological Parameters for Prognostication and Clinical Decision-Making in Early-Stage Cervical Cancer.
    Cancer Med. 2024;13:e70394.
    Abstract

  3072. LI J, Chen Q, Liu Z, Xu Y, et al
    Predictive value of bowel dose-volume for severe radiation-induced lymphopenia and survival in cervical cancer.
    Front Immunol. 2024;15:1459206.
    Abstract

  3073. ZHAO Q
    Application and clinical efficacy of comprehensive nursing intervention in pelvic floor and bladder function recovery post-cervical cancer surgery.
    Pak J Med Sci. 2024;40:2287-2292.
    Abstract

  3074. CHEN Q, Chen Q, Yang H, Dai S, et al
    Efficacy of total laparoscopic hysterectomy without uterine manipulators in patient with early-stage cervical cancer.
    Pak J Med Sci. 2024;40:2428-2431.
    Abstract

  3075. FIAGBEDZI E, Atuwo-Ampoh VD, Ofori IN, Nyarko S, et al
    Access to brachytherapy treatment for cervical cancer management in Africa.
    Clin Transl Radiat Oncol. 2024;50:100880.
    Abstract

  3076. DING S, Piao Z, Chen M, Li F, et al
    MRI guided online adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion in patients with cervical cancer.
    Clin Transl Radiat Oncol. 2024;50:100881.
    Abstract

  3077. TAMATE M, Matsuura M, Someya M, Mariya T, et al
    Successful Outcome of Stage IB3 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Vaginal Radical Trachelectomy: A Case Report.
    Cureus. 2024;16:e71626.
    Abstract

  3078. LOU PJ, Phongsamart W, Sukarom I, Wu YH, et al
    Systematic literature review on the clinical and economic burden of human papillomavirus-related diseases in select areas in the Asia-Pacific region.
    Hum Vaccin Immunother. 2024;20:2425535.
    Abstract

  3079. MEIRELLES I, Pinto M, Barros L, Russomano F, et al
    Systematic review of economic evaluations of triage tests for women with atypical squamous cells of undetermined significance (ASC-US) or low-grade squamous intraepithelial lesions (LSIL).
    Int J Technol Assess Health Care. 2024;40:e58.
    Abstract

  3080. GOSSELIN G, Blais P, Smith N, Brassard P, et al
    Cervical cancer screening preference among Inuit women in Nunavik, Quebec.
    Int J Circumpolar Health. 2024;83:2429860.
    Abstract

  3081. JACOB S, Gabriel G, Yap ML, Vinod S, et al
    Comparison of Epidemiology, Demography, Treatment (Surgery and Radiotherapy), and Survival Between Aboriginal and Torres Strait Islander and Non-Indigenous Women With Cervical Cancer in NSW, Australia in 2009-2018.
    Asia Pac J Clin Oncol. 2024 Nov 17. doi: 10.1111/ajco.14140.
    Abstract

  3082. SANTOS-TELES M, Modugu G, Silva IC, Bandera EV, et al
    Survivorship care plans and adherence to breast and cervical cancer screening guidelines among cancer survivors in a national sample.
    Support Care Cancer. 2024;32:798.
    Abstract

  3083. LIU Y, Zhou J, Liu W, Le Y, et al
    The E3 ubiquitin ligase RNF6 facilitates the progression of cervical cancer by inhibiting the Hippo/Yap pathway.
    Cell Div. 2024;19:32.
    Abstract

  3084. AHMED SM, Laha S, Ifthikar MA, Das R, et al
    MCM10: A potential biomarker for cervical cancer and precancerous lesions.
    Gene. 2024 Nov 15:149103. doi: 10.1016/j.gene.2024.149103.
    Abstract

  3085. SUDHA B, Kumar NS, Sumathi S
    Women's ignorance and misperception of cervical cancer: Evidence-based analysis from low- and middle-income countries.
    Curr Probl Cancer. 2024;54:101157.
    Abstract

  3086. NOWROZI H, Tehrani FR, Soleimanidodaran M, Hamedi D, et al
    Validity of Mehrviru((R)) and Sacace((R)) in molecular detection of HPV: a latent class analysis.
    BMC Infect Dis. 2024;24:1309.
    Abstract

  3087. CHEN R, Hou Y, Chen J, Dong F, et al
    PLAC1 augments the malignant phenotype of cervical cancer through the mTOR/HIF-1alpha/Snail signaling pathway.
    Life Sci. 2024;359:123242.
    Abstract

  3088. MEYER M, Fourie C, van der Merwe H, Botha H, et al
    Targeting treatment resistance in cervical cancer: A new avenue for senolytic therapies.
    Adv Med Sci. 2024 Nov 14:S1896-1126(24)00062-2. doi: 10.1016/j.advms.2024.
    Abstract

  3089. LI Y, Guo L, Xie P, Liu Y, et al
    Systemic immune-related spleen radiomics predict progression-free survival in patients with locally advanced cervical cancer underwent definitive chemoradiotherapy.
    BMC Med Imaging. 2024;24:310.
    Abstract

  3090. FIELDS EC, Bosch WR, Albuquerque KV, Bhatia R, et al
    Consensus Guidelines for Delineation of Clinical Target Volumes for Intensity-Modulated Radiotherapy for Intact Cervical Cancer: An Update.
    Pract Radiat Oncol. 2024 Nov 13:S1879-8500(24)00305.
    Abstract

  3091. GAUTAM S, Osman AFI, Richeson D, Gholami S, et al
    Attention 3D UNET for dose distribution prediction of high-dose-rate brachytherapy of cervical cancer: Intracavitary applicators.
    J Appl Clin Med Phys. 2024 Nov 15:e14568. doi: 10.1002/acm2.14568.
    Abstract

  3092. MUNDAGOWA PT, Tapera O, Guzha B, Fitzpatrick MB, et al
    Determinants of Cervical Cancer Screening Among Rural Women in Zimbabwe.
    Public Health Nurs. 2024 Nov 15. doi: 10.1111/phn.13490.
    Abstract

  3093. ACHMAD AB, Proboningrat A, Ansori ANM, Fadholly A, et al
    Stem bark ethanolic extract of Pinus merkusii induces caspase 9-mediated apoptosis in HeLa cells.
    Open Vet J. 2024;14:2628-2633.
    Abstract

  3094. MARTINS TR, Witkin SS, Ferreira ADS, Viscondi JYK, et al
    A critical evaluation of the status of HPV vaccination in Sao Paulo State, Brazil.
    Clinics (Sao Paulo). 2024;79:100526.
    Abstract

  3095. HEIMBECKER V, Bordini SC, Rodrigues AC, de Alencar NM, et al
    Gender Differences on the Awareness of Human Papillomavirus Infection and Vaccination.
    J Cancer Educ. 2024;39:611-617.
    Abstract

  3096. YACOUTI A, Baddou R, Bourissi H, Ez-Zaouy S, et al
    Human PapillomaVirus Vaccine Uptake: Attitudes and Practices Among Moroccan Physicians.
    J Cancer Educ. 2024;39:588-596.
    Abstract

  3097. ZHU L, Du Z, Xiong J, Li H, et al
    Phototheranostic LPP-QDs-IR-820 Nanocomposites for Specific NIR-II Imaging of Lymphatic and Photothermal Therapy of Cervical Tumors.
    Adv Healthc Mater. 2024;13:e2401358.
    Abstract

  3098. VERLINGUE L, Italiano A, Prenen H, Guerra Alia EM, et al
    Phase 2 study of the antitumour activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in patients with recurrent and/or metastatic cervical squamous cell carcinoma.
    EBioMedicine. 2024;109:105374.
    Abstract

  3099. LUGO-SALAZAR D, Lopez-Lopez L, Bernal-Lopera C, Vanegas JM, et al
    Conventional cytology scheme: adherence and associated factors.
    Public Health. 2024;236:459-465.
    Abstract

  3100. ZHANG J, Dong Z, Xu L, Han X, et al
    An Injection Molded SlipChip with Self-Sampling for Integrated Point-of-Care Testing of Human Papilloma Virus.
    Adv Sci (Weinh). 2024;11:e2406367.
    Abstract

  3101. NOGUEIRA MC, Guerra MR, Bustamante-Teixeira MT, Azevedo E Silva G, et al
    Mortality due to cervical and breast cancer in health regions of Brazil: impact of public policies on cancer care.
    Public Health. 2024;236:239-246.
    Abstract

  3102. BADDOU R, Yacouti A, Guennouni M, Got AE, et al
    Study of Knowledge, Attitudes, Acceptability and Preference of Home-based HPV Self-Sampling Among a Population of Moroccan Women.
    J Cancer Educ. 2024;39:597-604.
    Abstract

  3103. PUSCHEL K, Rioseco A, Soto M, Paz S, et al
    Implementation of cancer prevention practices in primary care: results of a cohort study in Chile 2018-2022.
    Public Health. 2024;236:168-174.
    Abstract

  3104. COHEN O, Kargar S, Woo S, Vargas A, et al
    DCE-Qnet: deep network quantification of dynamic contrast enhanced (DCE) MRI.
    MAGMA. 2024;37:1077-1090.
    Abstract

  3105. LANDER ME, Feldman K, Perlman B, Greenberg P, et al
    The effect of carbomer versus noncarbomer lubricant on the adequacy of cervical cytology specimens.
    J Am Soc Cytopathol. 2024;13:444-450.
    Abstract

  3106. SUN Y, Wang T, Zhong F, Starr D, et al
    Genotype profile of HPV in ASC-H cytology and histologic follow-up-prevalence, distribution, and risk: A retrospective study of 1414 cases.
    Cancer Cytopathol. 2024;132:588-598.
    Abstract

  3107. ACHARI RB, Chakraborty S, Ray S, Mahata A, et al
    18F-fluorodeoxyglucose PET-CT-guided pelvic chemoradiation therapy using helical tomotherapy for locally advanced carcinoma cervix without para-aortic nodal disease: Clinical and patient-reported outcomes from a prospective phase 2 study.
    J Med Imaging Radiat Oncol. 2024;68:624-634.
    Abstract

  3108. YE J, Qi X
    Vaginal microecology and its role in human papillomavirus infection and human papillomavirus associated cervical lesions.
    APMIS. 2024;132:928-947.
    Abstract

  3109. VO TN, Nguyen L, Nguyen PN
    Modified abdominal radical trachelectomy used to spare fertility during surgery for early-stage cervical cancer: a case report.
    J Med Case Rep. 2024;18:586.
    Abstract

  3110. TUNGU M, Luoga P, Anaeli A, Nyamhanga T, et al
    Correlates associated with health insurance on cervical cancer screening in Tanzania: a comparison between the insured and uninsured women using demographic and health survey 2022.
    BMC Health Serv Res. 2024;24:1512.
    Abstract

  3111. CAO Y, Qin Y, Cheng Q, Zhong J, et al
    Bifunctional nanomaterial enabled high-specific isolation of urinary exosomes for cervical cancer metabolomics analysis and biomarker discovery.
    Talanta. 2024;285:127280.
    Abstract

  3112. ZUO Y, Yang K, Zhang J, Liu X, et al
    Factors influencing postoperative urinary retention after radical hysterectomy for cervical cancer: development and validation of a predictive model in a prospective cohort study in Southwest China.
    BMJ Open. 2024;14:e086706.
    Abstract

  3113. RIA T, Roy R, Mandal US, Sk UH, et al
    Prospects of nano-theranostic approaches against breast and cervical cancer.
    Biochim Biophys Acta Rev Cancer. 2024 Nov 27:189227.
    Abstract

  3114. POHANKOVA D, Sirak I, Hodek M, Kasaova L, et al
    Pattern of pelvic recurrence in MRI-only adaptive brachytherapy for locally advanced cervical cancer.
    Brachytherapy. 2024 Nov 28:S1538-4721(24)00444.
    Abstract

  3115. PAN Y, Fan Z, Yu S, Xia L, et al
    ROS-responsive supramolecular antimicrobial peptides-based nanoprodrugs for cervical cancer therapy.
    Colloids Surf B Biointerfaces. 2024;247:114411.
    Abstract

  3116. LIANG Y, Ma A
    Cost-effectiveness analysis of immune checkpoint inhibitors combined with targeted therapy and chemotherapy for HPV/HIV-related cervical cancer.
    Medicine (Baltimore). 2024;103:e40678.
    Abstract

  3117. ANDREW A, Kima J, Rahul C, Letendre A, et al
    Barriers to and facilitators of breast, cervical and colorectal cancer screening and cancer screening histories of Metis people in Alberta, Canada.
    Int J Circumpolar Health. 2024;83:2368766.
    Abstract

  3118. QADERI S, Shah J, Qaderi F, Bachmann GA, et al
    The Hidden Burden: Unveiling the Cervical Cancer Burden Among Recent Afghan Women Immigrants in the United States.
    J Immigr Minor Health. 2024 Nov 29. doi: 10.1007/s10903-024-01655.
    Abstract

  3119. GRACA AV, Brollo LCS
    Regional Disparities in the Impact of Human Papillomavirus-Induced Lesions after 10 Years of HPV Vaccination Program in Brazil.
    Asian Pac J Cancer Prev. 2024;25:3755-3759.
    Abstract

  3120. XU M, Cao C, Wu P, Huang X, et al
    Advances in cervical cancer: current insights and future directions.
    Cancer Commun (Lond). 2024 Nov 29. doi: 10.1002/cac2.12629.
    Abstract

  3121. MIRANDA-FALCONI P, Flores-Pena G, Jimenez-Trejo MF, Torres-Paz YE, et al
    Pioneering molecular screening for cervical precursor lesions and cervical cancer in sera.
    Front Oncol. 2024;14:1483882.
    Abstract

  3122. JIANG D, Yang C, Sun S, Wang D, et al
    First implementation and results of online adaptive radiotherapy for cervical cancer based on CT-Linac combination.
    Front Oncol. 2024;14:1399468.
    Abstract

  3123. LI X, You Q
    Sanguinarine identified as a natural dual inhibitor of AURKA and CDK2 through network pharmacology and bioinformatics approaches.
    Sci Rep. 2024;14:29608.
    Abstract

  3124. WANG B, Liang Y, Wu Y, Li Q, et al
    Sintilimab plus HPV vaccine for recurrent or metastatic cervical cancer.
    J Immunother Cancer. 2024;12:e009898.
    Abstract

  3125. KRISHNAN B B S, Vijayakumar S, Dhakshanamoorthy R, Baskaran A, et al
    3-Dimensional multicellular aggregates of human cervical cancer cell line SiHa - getting to the core of their morphologies.
    Pathol Res Pract. 2024;265:155740.
    Abstract

  3126. KUIPERS SC, Godart J, Negenman EM, Corbeau A, et al
    Margin and robustness settings for a library-of-plans IMPT strategy for locally advanced cervical cancer.
    Phys Med Biol. 2024 Nov 28. doi: 10.1088/1361-6560/ad9882.
    Abstract

  3127. SEGEL JE, Chetlen A, Ramos M, Zaorsky NG, et al
    Individual and Catchment Area Factors Associated With Breast and Cervical Cancer Screening Within the Military Health System.
    Mil Med. 2024 Nov 28:usae525. doi: 10.1093.
    Abstract

  3128. OKEOMA CM, Naushad W, Okeoma BC, Islam HK, et al
    Berberine: A dual anti-HIV and anti- cervical cancer compound.
    Res Sq [Preprint]. 2024 Nov 21:rs.3.rs-5479739. doi: 10.21203/rs.3.rs-5479739.
    Abstract


  3129. RETRACTION: Long noncoding RNA ZNF667-AS1 reduces tumor invasion and metastasis in cervical cancer by counteracting microRNA-93-3p-dependent PEG3 downregulation.
    Mol Oncol. 2024 Nov 27. doi: 10.1002/1878-0261.13777.
    Abstract

  3130. MEHEDI MHK, Khandaker M, Ara S, Alam MA, et al
    A lightweight deep learning method to identify different types of cervical cancer.
    Sci Rep. 2024;14:29446.
    Abstract

  3131. YANG C, Hassan HA, Omar NF, Soo TH, et al
    The value of amide proton transfer imaging in predicting parametrial invasion and lymph-vascular space invasion of cervical cancer.
    Magn Reson Imaging. 2024 Nov 25:110282. doi: 10.1016/j.mri.2024.110282.
    Abstract

  3132. XU H, Dong C, Xiang T, Shentu X, et al
    Microplastic changes during the development of cervical cancer and its effects on the metabolomic profiles of cancer tissues.
    J Hazard Mater. 2024;483:136656.
    Abstract

  3133. LEE M, Lee EJ, Kang J, Lee KH, et al
    Roles of cancer histology type and HPV genotype in HPV ctDNA detection at baseline in cervical cancer: Implications for tumor burden assessment.
    Pathobiology. 2024 Nov 27:1-21. doi: 10.1159/000542638.
    Abstract

  3134. DORALI P, Damgacioglu H, Clarke MA, Wentzensen N, et al
    Cervical Cancer Mortality Among US Women Younger Than 25 Years, 1992-2021.
    JAMA. 2024 Nov 27. doi: 10.1001/jama.2024.22169.
    Abstract

  3135. ZOU Y, Zhu S, Kong Y, Feng C, et al
    Correction to: Precision matters: the value of PET/CT and PET/MRI in the clinical management of cervical cancer.
    Strahlenther Onkol. 2024 Nov 27. doi: 10.1007/s00066-024-02330.
    Abstract

  3136. MBULAWA ZZA, Kondlo S, Toni S, Faye LM, et al
    Prevalence, Characteristics, and Distribution of Human Papillomavirus According to Age and HIV Status in Women of Eastern Cape Province, South Africa.
    Viruses. 2024;16:1751.
    Abstract

  3137. ZHANG Y, Liu Y, Xing X, Liu H, et al
    Genome-Wide Analysis of p53 Targets Reveals SCN2A as a Novel Player in p53-Induced Cell Arrest in HPV-Positive Cells.
    Viruses. 2024;16:1725.
    Abstract

  3138. BLANCO R, Munoz JP
    HPV and HCMV in Cervical Cancer: A Review of Their Co-Occurrence in Premalignant and Malignant Lesions.
    Viruses. 2024;16:1699.
    Abstract

  3139. MALENKOVIC G, Malenkovic J, Tomic S, Sljivo A, et al
    Comparative Diagnostic Value of 18F-FDG-PET-CT and Intraoperative Examination in Cervical Cancer Staging.
    Medicina (Kaunas). 2024;60:1758.
    Abstract

  3140. PRUSKI D, Millert-Kalinska S, Lis A, Pelc E, et al
    Evaluation of the Use of Methylation as a New Tool for the Diagnostics and Progression of Squamous Intraepithelial Lesions.
    Int J Mol Sci. 2024;25:11863.
    Abstract

  3141. LENKOVA K, Khusainova R, Minyazeva R, Zaripova A, et al
    Germline Variants in Proto-Oncogenes and Tumor Suppressor Genes in Women with Cervical Cancer.
    Biomedicines. 2024;12:2454.
    Abstract

  3142. CEPERO A, Yang Y, Young L, Huang J, et al
    Longitudinal FDG-PET Radiomics for Early Prediction of Treatment Response to Chemoradiation in Locally Advanced Cervical Cancer: A Pilot Study.
    Cancers (Basel). 2024;16:3813.
    Abstract

  3143. MUKSIMOVA S, Umirzakova S, Shoraimov K, Baltayev J, et al
    Novelty Classification Model Use in Reinforcement Learning for Cervical Cancer.
    Cancers (Basel). 2024;16:3782.
    Abstract

  3144. SAGLAM B, Akkus O, Akcaoz-Alasar A, Ceylan C, et al
    An Investigation of RNA Methylations with Biophysical Approaches in a Cervical Cancer Cell Model.
    Cells. 2024;13:1832.
    Abstract

  3145. UMUTESI G, Hathaway CL, Heitner J, Jackson R, et al
    The Potential Impact of a Single-Dose HPV Vaccination Schedule on Cervical Cancer Outcomes in Kenya: A Mathematical Modelling and Health Economic Analysis.
    Vaccines (Basel). 2024;12:1248.
    Abstract

  3146. JEONG H, Choi K, Hwang D, Park S, et al
    miR-29a Downregulates PIK3CA Expression and Inhibits Cervical Cancer Cell Dynamics: A Comparative Clinical Analysis.
    Curr Issues Mol Biol. 2024;46:12704-12717.
    Abstract

  3147. BAEK S, Mairinger FD, Borchert S, Zhao Y, et al
    Comparative Analysis of Digital Transcriptomics Between Pre- and Post-Treatment Samples of Patients with Locally Advanced Cervical Cancer: A Preliminary Study.
    Curr Issues Mol Biol. 2024;46:12075-12087.
    Abstract

  3148. DEVOTTA KA, O'Campo P, Bender JL, Lofters AK, et al
    Addressing Underscreening for Cervical Cancer among South Asian Women: Using Concept Mapping to Compare Service Provider and Service User Perspectives of Cervical Screening in Ontario, Canada.
    Curr Oncol. 2024;31:6749-6766.
    Abstract

  3149. GARLAND J, Hussain S, Rai R, Kennedy AL, et al
    Targeting HSP70-E7 Interaction With SHetA2: A Novel Therapeutic Strategy for Cervical Cancer.
    J Med Virol. 2024;96:e70088.
    Abstract

  3150. GIUBBI C, Martinelli M, Latsuzbaia A, Cuschieri K, et al
    Clinical Performance of OncoPredict HPV Screening Assay on Self-Collected Vaginal and Urine Specimens Within the VALHUDES Framework.
    J Med Virol. 2024;96:e70079.
    Abstract

  3151. HE S, Niu H, Zhang L, Tao Z, et al
    Synergy Effects of HPV E6-E7 Encoding mRNA and Nucleic Acid Immunostimulators Improve Therapeutic Potential in TC-1 Graft Tumor.
    J Med Virol. 2024;96:e70075.
    Abstract

  3152. DESHMUKH VN, Patil S, Hinge DD
    The Burden and Prevention of Human Papillomavirus (HPV) Infections and Cervical Cancer in India: A Literature Review.
    Cureus. 2024;16:e72435.
    Abstract

  3153. DHEUR A, Kakkos A, Danthine D, Delbecque K, et al
    Lymph node assessment in cervical cancer: current approaches.
    Front Oncol. 2024;14:1435532.
    Abstract

  3154. SHEN Z, Li M, Zhu H, Song T, et al
    TBP activates DCBLD1 transcription to promote cell cycle progression in cervical cancer.
    Funct Integr Genomics. 2024;24:221.
    Abstract

  3155. YANG J, Xue F
    Research Progress of Immune Mechanisms Related to Persistent HPV Infection in CIN after Cervical Conization.
    Iran J Allergy Asthma Immunol. 2024;23:467-475.
    Abstract

  3156. ALIZADEH MH, Namazi H
    Core-shell structured magnetite carboxymethyl cellulose for cervical cancer treatment by maintaining methotrexate serum concentration.
    Int J Biol Macromol. 2024;284.
    Abstract

  3157. HE Y, Qiu Y, Yang X, Lu G, et al
    Remodeling of tumor microenvironment by cellular senescence and immunosenescence in cervical cancer.
    Semin Cancer Biol. 2024;108:17-32.
    Abstract

  3158. LIU Y, Wu R, Li C, Li M, et al
    Hiporfin photodynamic therapy for early-stage cervical cancer: A case report.
    Photodiagnosis Photodyn Ther. 2024 Nov 23:104422.
    Abstract

  3159. KHAMTO N, Utama K, Chawapun P, Siriphong S, et al
    Discovery of amino acid-conjugated dimethylcardamonin analogues as potent anti-cervical cancer agents on SiHa cells targeting p53 signalling pathway.
    Biomed Pharmacother. 2024;181:117705.
    Abstract

  3160. LIU X, Zhao Y, Niu N, Li L, et al
    [A fluorescence immunochromatography method for detection of human papillomavirus type 16 E6 and L1 proteins].
    Sheng Wu Gong Cheng Xue Bao. 2024;40:4266-4276.
    Abstract

  3161. ABRAHAM C
    Call to Action: Advocating for Alternatives to Cervical Cytology.
    J Health Care Poor Underserved. 2024;35:1343-1350.
    Abstract

  3162. JI X, Hao M, Wang Y, Pan Z, et al
    HPV self-sampling for cervical cancer screening in China: A multi-center study.
    Heliyon. 2024;10:e39544.
    Abstract

  3163. SHARMIN S, Jamiruddin M, Jamiruddin MR, Islam ABMMK, et al
    Detection of Protein Markers From Blood Samples of Cervical Cancer Patients.
    Cureus. 2024;16:e72365.
    Abstract

  3164. GUAN L, Xu X, Xu J, Xu G, et al
    Analysis of Lymphovascular Infiltration and Tumor-Associated Macrophages in Cervical Cancer Immunoescape.
    Onco Targets Ther. 2024;17:1117-1136.
    Abstract

  3165. TADLAOUI KA, Sosse SA, Tiabi I, Aqerrout M, et al
    Screening for proline?rich protein 11 gene expression in cervical cancer: Use as a novel diagnostic biomarker and poor prognostic factor.
    Med Int (Lond). 2024;5:3.
    Abstract

  3166. KAARIA F, Odhiambo FB, Okenyoru DS, Murugi L, et al
    Religious leaders' willingness to promote the uptake of human papillomavirus vaccine among their congregants in Mavoko Sub-County, Machakos County, Kenya.
    Pan Afr Med J. 2024;48:141.
    Abstract

  3167. ZHANG XY, Xu C, Wu XC, Qu QQ, et al
    Evaluation of Amide Proton Transfer Imaging Combined With Serum Squamous Cell Carcinoma Antigen for Grading Cervical cancer.
    J Comput Assist Tomogr. 2024 Nov 14. doi: 10.1097/RCT.0000000000001699.
    Abstract

  3168. ZHANG L, Meng FT, Wu JN, Sui L, et al
    [Value of laser therapy, photodynamic therapy, and follow-up observation in the management of cervical low-grade squamous intraepithelial lesions: a prospective cohort study].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:848-855.
    Abstract

  3169. SHINGHAL A, Pradhan S, Chopra S, Kapoor AR, et al
    Study protocol of Elective Para-aortic and pelvic versus Pelvic only Irradiation in pelvic node positive Cervical cancer: a multicentric open labelled phase III randomised controlled trial (EPIC Study).
    BMJ Open. 2024;14:e088223.
    Abstract

  3170. YANG T, Chen X, Hua K, Li C, et al
    Association Between Adenomyosis and Cervical Cancer: A Retrospective Cohort Study.
    J Invest Surg. 2024;37:2430707.
    Abstract

  3171. LIN B, Wang Q, Wang X, Wei H, et al
    Expression of variant isoforms of the tyrosine kinase SYK differentially regulates cervical cancer progression through PI3K/AKT pathway.
    Sci Rep. 2024;14:29080.
    Abstract

  3172. SHANDILYA G, Gupta S, Almogren A, Bharany S, et al
    Enhancing advanced cervical cell categorization with cluster-based intelligent systems by a novel integrated CNN approach with skip mechanisms and GAN-based augmentation.
    Sci Rep. 2024;14:29040.
    Abstract

  3173. AGYEIWAA J, Kusi-Amponsah Diji A, Amoo SA, Asare H, et al
    Experiences of women living with cervical cancer in Ghana: challenges and coping strategies.
    BMC Womens Health. 2024;24:621.
    Abstract

  3174. HAILU AM, Kassie FY, Damtew BS, Mihret MS, et al
    Correction: Clients' satisfaction with cervical cancer screening services and influencing factors at public health facilities in Debre Markos town, Northwest Ethiopia, 2022/23: a convergent parallel mixed method.
    BMC Womens Health. 2024;24:622.
    Abstract

  3175. LIU S, Wei Z, Ding H
    The role of the SOX2 gene in cervical cancer: focus on ferroptosis and construction of a predictive model.
    J Cancer Res Clin Oncol. 2024;150:509.
    Abstract

  3176. LORUSSO D, Yamada K, Li K, Cerrotta A, et al
    Pembrolizumab for locally advanced cervical cancer - Authors' reply.
    Lancet. 2024;404:2051-2052.
    Abstract

  3177. DONG B, Lu Y, Wang Y, Sun P, et al
    Pembrolizumab for locally advanced cervical cancer.
    Lancet. 2024;404:2050.
    Abstract

  3178. SCHMID MP, Petric P, Mahantshetty U, Kirisits C, et al
    Pembrolizumab for locally advanced cervical cancer.
    Lancet. 2024;404:2050-2051.
    Abstract

  3179. KAMRAVA M, Beriwal S
    Pembrolizumab for locally advanced cervical cancer.
    Lancet. 2024;404:2049.
    Abstract

  3180. MURAKAMI N, Okonogi N, Terao Y, Shikama N, et al
    Pembrolizumab for locally advanced cervical cancer.
    Lancet. 2024;404:2049-2050.
    Abstract

  3181. CHEN Z, Li X, Tian D, Liu J, et al
    Study on the clinical characteristics, persistent infection capability and viral load of human papillomavirus type 26 single infection.
    Virol J. 2024;21:301.
    Abstract

  3182. YU J, Gui X, Zou Y, Liu Q, et al
    A proteogenomic analysis of cervical cancer reveals therapeutic and biological insights.
    Nat Commun. 2024;15:10114.
    Abstract

  3183. GUPTA B, Sridevi P
    Knowledge, Attitude and Practices towards Cervical Cancer and its Screening Among Women from Tribal Population of Anuppur District.
    J Prev (2022). 2024 Nov 23. doi: 10.1007/s10935-024-00813.
    Abstract

  3184. DOMINONI M, Inzani FS, Gritti A, Pasquali MF, et al
    The role of programmed death-ligand 1 (PDL-1) in high-grade cervical intraepithelial neoplasia (CIN2+) development and recurrence: A systematic review of literature about HPV-CIN2+-PDL-1 axis.
    Pathol Res Pract. 2024;264:155712.
    Abstract

  3185. SEKAR S, Budithi S, Fernando S
    Trends in the incidence and mortality of cervical, ovarian, and corpus uteri cancers in Wales, UK: A joinpoint regression analysis from 2002 to 2021.
    Cancer Epidemiol. 2024;93:102660.
    Abstract

  3186. CHENG L, Yan C, Yang Y, Hong F, et al
    Exploring the Clinical Signatures of Cervical Dysplasia Patients and Their Association With Vaginal Microbiota.
    Cancer Med. 2024;13:e70440.
    Abstract

  3187. MA YM, Cheng SX, Zhang MC, Zhang HY, et al
    An early combination of concurrent chemoradiotherapy with immune checkpoint inhibitors for cervical cancer is superior to a late combination: a propensity-score matching analysis.
    Front Oncol. 2024;14:1429176.
    Abstract

  3188. WANG P, Sun X, Tang L, Li N, et al
    CaCO(3)-encircled hollow CuS nanovehicles to suppress cervical cancer through enhanced calcium overload-triggered mitochondria damage.
    Asian J Pharm Sci. 2024;19:100989.
    Abstract

  3189. LI Q, Kaidong L, Tian Z, Diao W, et al
    Association of Inflammatory Factors with Cervical Cancer: A Bidirectional Mendelian Randomization.
    J Inflamm Res. 2024;17:10119-10130.
    Abstract

  3190. YOSHIIZUMI E, Onuki M, Kukimoto I, Takahashi F, et al
    Declining Prevalence of Human Papillomavirus Co-Infections Among Young Japanese Women With Cervical Cancer and Its Precursors.
    J Med Virol. 2024;96:e70096.
    Abstract

  3191. AZIZ H, Mehmood H, Arif S, Afzal K, et al
    Distribution of HPV Types in Cervical Cancer in Pakistan: Implications for Screening and Vaccination Programs.
    J Clin Lab Anal. 2024 Dec 5:e25130. doi: 10.1002/jcla.25130.
    Abstract

  3192. ZHAO Z, Qin Y, Shao K, Liu Y, et al
    Radiomics Harmonization in Ultrasound Images for Cervical Cancer Lymph Node Metastasis Prediction Using Cycle-GAN.
    Technol Cancer Res Treat. 2024;23:15330338241302237.
    Abstract

  3193. KHIARI H, Makni K, Meddeb K, Jaidane O, et al
    Cost-effectiveness of human papillomavirus (HPV) vaccination in Tunisia: a modelling study.
    BMJ Open. 2024;14:e085462.
    Abstract

  3194. FERRAZ BEPL, Filho RCS, Carvalho LRB, Almeida MS, et al
    Neoadjuvant chemotherapy with carboplatin and paclitaxel in pregnant women with advanced stage cervical cancer: maternal and perinatal outcomes.
    J Gynecol Obstet Hum Reprod. 2024 Dec 3:102890. doi: 10.1016/j.jogoh.2024.102890
    Abstract

  3195. SHIRI AGHBASH P, Rasizadeh R, Sadri Nahand J, Bannazadeh Baghi H, et al
    The role of immune cells and inflammasomes in Modulating cytokine responses in HPV-Related cervical cancer.
    Int Immunopharmacol. 2024;145:113625.
    Abstract

  3196. TAKATSU J, Chiba T, Murakami N, Iijima K, et al
    Optimizing the planning process in computed tomography-based image-guided adaptive brachytherapy for cervical cancer using a spreadsheet-based daily dose management system.
    Radiol Phys Technol. 2024 Dec 5. doi: 10.1007/s12194-024-00867.
    Abstract

  3197. LIU Q, Chen X, Zhang W, Shang W, et al
    The predictive value of miR-29b-2-5p on the prognosis of cervical cancer and its inhibitory effect on cervical cancer progression.
    Int J Biol Markers. 2024;39:319-327.
    Abstract

  3198. MENG F, Yan Y, Zhou L, Zhao S, et al
    Targeting autophagy promotes the antitumor effect of radiotherapy on cervical cancer cells.
    Cancer Biol Ther. 2024;25:2431136.
    Abstract

  3199. WANG W, Bi X, Feng Y, Ming X, et al
    Efficacy and Safety of Immune Checkpoint Inhibitors on Advanced Cervical Cancer: A Systematic Review and Meta-analysis.
    J Immunother. 2024 Dec 5. doi: 10.1097/CJI.0000000000000545.
    Abstract

  3200. ZHAO Z, Ruan J, Fang M, Liu J, et al
    Corrigendum: Efficacy and safety of chemoradiotherapy plus immune checkpoint inhibitors for the treatment of locally advanced cervical cancer: a systematic review and meta-analysis.
    Front Immunol. 2024;15:1524791.
    Abstract

  3201. YARI AH, Aghbash PS, Bayat M, Lahouti S, et al
    Novel bioinformatic approaches show the role of driver genes in the progression of cervical cancer: An in-silico study.
    Heliyon. 2024;10:e40179.
    Abstract

  3202. GARCIA MUENTES GD, Abdul Latif F, Beltran Rodriguez CC, Medina Gonzalez S, et al
    High frequency of HPV high-risk preventable genotypes in Ecuadorian women with invasive cervical cancer.
    Rev Panam Salud Publica. 2024;48:e128.
    Abstract

  3203. OLUBODUN T, Ogunsola EA, Coker MO, Olayinka SA, et al
    HPV vaccine knowledge, attitude, and programme satisfaction among parents and caregivers of vaccine recipients in Ogun state Nigeria.
    Reprod Health. 2024;21:179.
    Abstract

  3204. HU J, Duan R, Zhang H, Zhao X, et al
    Awareness, attendance, and attitudes toward cervical cancer screening among HIV-positive Chinese women in Yunnan province: a cross-sectional study.
    BMC Womens Health. 2024;24:636.
    Abstract

  3205. DUAN Q, Wang W, Xiong H, Xiao J, et al
    JAK2/ULK1 axis promotes cervical cancer progression by autophagy induction and SRPK1 phosphorylation.
    Oncogene. 2024 Dec 4. doi: 10.1038/s41388-024-03246.
    Abstract

  3206. DHINU K, Fernandez S, Gupta A, Elangbam V, et al
    Effect of health education on acceptance of human papilloma virus vaccine among parents of adolescent girls of Bishnupur, Manipur: A quasi-experimental study.
    Indian J Med Res. 2024;160.
    Abstract

  3207. MAO Y, Xu Q, Zhang J, Chou S, et al
    Aetiology and Prognostic Significance of Postoperative Urinary Tract Infections in Patients with Cervical Cancer.
    Arch Esp Urol. 2024;77:1070-1077.
    Abstract

  3208. MABUCHI S, Maeda M, Sakata M, Matsuzaki S, et al
    Robotic salvage radical hysterectomy for locally recurrent cervical cancer: A comparison with open surgery in a single-surgeon series.
    J Obstet Gynaecol Res. 2024 Dec 4. doi: 10.1111/jog.16142.
    Abstract

  3209. ZHANG P, Liu H, Yu Y, Peng S, et al
    Terpenoids mediated cell apoptotsis in cervical cancer: Mechanisms, advances and prospects.
    Fitoterapia. 2024 Dec 2:106323. doi: 10.1016/j.fitote.2024.106323.
    Abstract

  3210. KUTAKOVA L, Reckova M, Brazinova A
    Cancer epidemiology in Slovakia.
    Bratisl Lek Listy. 2024;125:829-834.
    Abstract

  3211. DEWAN M, Shukla D, Shrivastav G, Diwan P, et al
    Knowledge and attitude towards HPV infection, HPV vaccination and cervical cancer among middle- and high-school students in Gwalior.
    J Family Med Prim Care. 2024;13:4382-4387.
    Abstract

  3212. LARRAURI-RODRIGUEZ KA, Leon-Chavez BA, Vallejo-Ruiz V, Pena LM, et al
    Interplay between reactive oxygen species and ERK activation in cervical cancer cells.
    Front Cell Dev Biol. 2024;12:1465729.
    Abstract

  3213. RAJ S, Prasad RR, Ranjan A
    Incidence of vaginal toxicities following definitive chemoradiation in intact cervical cancer: A meta-analysis.
    J Contemp Brachytherapy. 2024;16:241-256.
    Abstract

  3214. DANKULCHAI P, Thanamitsomboon N, Sittiwong W, Kosaisawe N, et al
    Pre-treatment T2-weighted magnetic resonance radiomics for prediction of loco-regional recurrence after image-guided adaptive brachytherapy for locally advanced cervical cancer.
    J Contemp Brachytherapy. 2024;16:193-201.
    Abstract

  3215. CHOI E, Kim B, Byun SJ, Kim JH, et al
    MRI-guided brachytherapy for cervical cancer treatment: The significance of bladder morphology in dose distribution planning.
    J Contemp Brachytherapy. 2024;16:184-192.
    Abstract

  3216. WU N, Bu M, Jiang H, Mu X, et al
    Dose-effect relationship in external beam radiotherapy combined with brachytherapy for cervical cancer: A systematic review.
    J Contemp Brachytherapy. 2024;16:232-240.
    Abstract

  3217. NGEMA F, Mdhluli B, Mmileng P, Shungube P, et al
    A bibliometric review of predictive modelling for cervical cancer risk.
    Front Res Metr Anal. 2024;9:1493944.
    Abstract

  3218. JOSEPH AG, Biji M, Murali VP, Sherin DR, et al
    Correction: A comprehensive apoptotic assessment of niloticin in cervical cancer cells: a tirucallane-type triterpenoid from Aphanamixis polystachya (Wall.) Parker.
    RSC Med Chem. 2024 Dec 2. doi: 10.1039/d4md90049.
    Abstract

  3219. SHARMA DN, Kumar P, Subramani V, Giridhar P, et al
    Low-dose-rate, high-dose-rate, and pulsed-dose-rate intra-cavitary brachytherapy for cervical cancer: The very first comparison study.
    J Contemp Brachytherapy. 2024;16:273-278.
    Abstract

  3220. CHO Y, Kim HS
    Immunohistochemical Expression and Significance of Preferentially Expressed Antigen in Melanoma (PRAME) in Gynecological Tumors: A Single-institution Retrospective Analysis.
    Anticancer Res. 2024;44:5515-5524.
    Abstract

  3221. KULKARNI A, Ahsan MD, LaRosa T, Webster E, et al
    Bridging Gaps in Cervical Cancer Care: A Web-Based Intervention to Improve Knowledge and Follow-up.
    J Low Genit Tract Dis. 2024 Dec 3. doi: 10.1097/LGT.0000000000000856.
    Abstract

  3222. ULMER KK, Wilson PL, Petereit MA, Sargent M, et al
    Cervical Cancer 2010-2019: An Upper Midwest Catchment of 40,000 Square Miles.
    J Low Genit Tract Dis. 2024 Dec 3. doi: 10.1097/LGT.0000000000000853.
    Abstract

  3223. WEI J, Feng Q, Liu H, Zheng H, et al
    18F-AlF-NOTA-FAPI-04 Superior to 18F-FDG PET/CT in Detecting Primary Tumor and Metastatic Lymph Nodes in a Cervical Cancer Patient.
    Clin Nucl Med. 2024 Dec 2. doi: 10.1097/RLU.0000000000005601.
    Abstract

  3224. XU C, Liu J
    Influence of vitamin D supplementation and the vaginal microenvironment on human papillomavirus infection.
    Afr J Reprod Health. 2024;28:88-98.
    Abstract

  3225. TENG F, Zhao L
    Nimotuzumab and irinotecan synergistically induce ROS-mediated apoptosis by endoplasmic reticulum stress and mitochondrial-mediated pathway in cervical cancer.
    Biotechnol Appl Biochem. 2024 Dec 3. doi: 10.1002/bab.2693.
    Abstract

  3226. CHEN Z, Nie S, Ran J, Wang Y, et al
    Study on the Clinical Characteristics, Persistent Infection Ability and Viral Load of Human Papillomavirus Type 73 Single Infection.
    J Med Virol. 2024;96:e70097.
    Abstract

  3227. NGU SF, Cheung ANY, Jong KK, Law JYP, et al
    2024 Hong Kong College of Obstetricians and Gynaecologists Guidelines for cervical cancer prevention and screening.
    Hong Kong Med J. 2024 Dec 3. doi: 10.12809/hkmj2411547.
    Abstract

  3228. HRABAL V, Stenckova M, Zavadil Kokas F, Muller P, et al
    TAp73 and DeltaTAp73 isoforms show cell-type specific distributions and alterations in cancer.
    Sci Rep. 2024;14:29949.
    Abstract

  3229. DANG C, Liu M, Liu P, Liu J, et al
    Causal relationship between inflammatory factors and gynecological cancer: a Bayesian Mendelian randomization study.
    Sci Rep. 2024;14:29868.
    Abstract

  3230. KEYES S, Chai B, Ingledew PA
    Evaluating Online YouTube Videos for Cervical Cancer Brachytherapy Patient Education.
    J Cancer Educ. 2024 Dec 2. doi: 10.1007/s13187-024-02546.
    Abstract

  3231. LI Z, Cheng Y, Dong J, Han L, et al
    The impact of setup errors on dose distribution in cervical cancer radiotherapy and the margin from CTV to PTV.
    J Cancer Res Clin Oncol. 2024;150:516.
    Abstract

  3232. FENG Y, Feng L, Wang B, Zhang T, et al
    Therapeutic Potential of IL-37 in Cervical Cancer: Suppression of Tumour Progression and Enhancement of CD47-Mediated Macrophage Phagocytosis.
    Mol Carcinog. 2024 Dec 2. doi: 10.1002/mc.23855.
    Abstract

  3233. SHARIF A
    The Paradox of Poor Cervical Cancer Screening Uptake for Kidney Transplant Recipients.
    Cancer Epidemiol Biomarkers Prev. 2024;33:1544-1546.
    Abstract

  3234. EGAWA N
    [Development and Implementation of HPV Vaccination].
    Uirusu. 2024;74:9-16.
    Abstract

  3235. SHIRO R, Tsunoda I
    [HPV vaccinations and cervical cancer in Japan: Flaws in alleged experimental evidence for molecular mimicry and animal models of HPV vaccine-induced "adverse reactions "].
    Uirusu. 2024;74:17-28.
    Abstract

  3236. TSEGAYE AT, Winer RL, Cole A, Szpiro AA, et al
    Modeling HPV self-sampling impact on cervical cancer in East African immigrants.
    Am J Prev Med. 2024 Nov 29:S0749-3797(24)00406.
    Abstract

  3237. HARVEY N, Nallathambi J, Kaushik S
    Post-radical hysterectomy ovarian torsion-A gynecological emergency: a case series.
    J Med Case Rep. 2024;18:580.
    Abstract

  3238. HUANG L, Li Y, Li R, Zuo H, et al
    Cervical cancer with patent foramen ovale metastasis to the left ventricle: a case report.
    World J Surg Oncol. 2024;22:322.
    Abstract

  3239. GONG Y, Gou F, Qin Q, Tian W, et al
    Construction and validation of prognostic models for young cervical cancer patients: age stratification based on restricted cubic splines.
    Sci Rep. 2024;14:29808.
    Abstract

  3240. WANG B, Zhu Y, Zhang Y, Ru Z, et al
    Hyperactivity of the IL-33-ILC2s-IL-13-M-MDSCs axis promotes cervical cancer progression.
    Int Immunopharmacol. 2024;144:113693.
    Abstract

  3241. EL AYACHI Z, Gabro A, Camprodon G, Chopra S, et al
    Transformative clinical trials in gynaecologic radiation oncology in 2023-2024: Shaping modern treatment practices.
    Cancer Radiother. 2024;28:719-726.
    Abstract

  3242. WANG Q, Xiong Y, Zhu H, Mu X, et al
    Cervical OCT image classification using contrastive masked autoencoders with Swin Transformer.
    Comput Med Imaging Graph. 2024;118:102469.
    Abstract

  3243. SHITOVA AA, Filimonova MV, Soldatova OV, Volkova IK, et al
    In Vitro and In Vivo Antitumor Activities of Isothiourea and Cinnamic Acid Derivative with NOS/MCT Inhibitory Effect.
    Bull Exp Biol Med. 2024;178:68-74.
    Abstract

  3244. FURUZONO N, Togami S, Kitazono I, Nishikawa T, et al
    Malignant peripheral nerve sheath tumor of the cervix in an adolescent with neurofibromatosis type 1: A case report and review of literature.
    J Obstet Gynaecol Res. 2024;50:2372-2376.
    Abstract

  3245. STOKHOLM RN, Kirkegaard P, Larsen MB, Lauridsen HH, et al
    Perspectives of international experts and the Danish citizens on the 'relevant knowledge' that citizens need for making informed choices about participation in cancer screening: Qualitative study.
    Patient Educ Couns. 2025;130:108479.
    Abstract

  3246. RAO D, Meng L, Sheng X, Yu W, et al
    Construction of a hydrophilic porphyrin-based MOF@COF hybrid via post-synthetic modification for N-glycopeptides analysis in human serum.
    Anal Methods. 2024;16:8188-8193.
    Abstract

  3247. PETITPIERRE G, Otandault A, Neumann-Michel E, Olivier E, et al
    Co-construction of an instructional module to improve the understanding of cancer screening by people with intellectual disabilities: Strategic choices.
    Patient Educ Couns. 2025;130:108471.
    Abstract

  3248. MOKRESH ME, Alomari O, Varda A, Akdag G, et al
    Safety and efficacy of tisotumab vedotin with cervical cancers: A systematic review and meta-analysis.
    J Obstet Gynaecol Res. 2024;50:2195-2210.
    Abstract

  3249. CHENG L, Wang Z, Li R, Qiang M, et al
    The global burden, trends and cross-country inequalities of female breast and gynaecologic cancers: A population based study.
    BJOG. 2025;132:55-63.
    Abstract

  3250. FERRAZ DLF, Dos Santos ES, Pedroso CM, Silva BSF, et al
    Histopathological risk assessment in multisite epithelial dysplasia: A meta-analysis.
    Oral Dis. 2024;30:4821-4829.
    Abstract

  3251. KICONCO A, Kabanda R, Ronald A, Beyer KMM, et al
    Correction: Correlates of intention to screen for cervical cancer among adult women in Kyotera District, Central Uganda: a community based cross-sectional study.
    BMC Womens Health. 2024;24:659.
    Abstract

  3252. BURMEISTER CA, Khan SF, Prince S
    Drugs and Drug Targets for the treatment of HPV-Positive Cervical Cancer.
    Tumour Virus Res. 2024 Dec 19:200309. doi: 10.1016/j.tvr.2024.200309.
    Abstract

  3253. WANG Y, Qi L, Guo S, Jia Y, et al
    Sodium selenite inhibits the growth of cervical cancer cells through the PI3K/AKT pathway.
    J Trace Elem Med Biol. 2024;87:127582.
    Abstract

  3254. LI Y, Lee Wong JC, Ou S, Yang F, et al
    Intimate partner violence and its associated psychosocial factors among women with breast and/or cervical cancer in China: A cross-sectional study.
    Eur J Oncol Nurs. 2024;74:102759.
    Abstract

  3255. NOWAKOWSKI A, Prusaczyk A, Szenborn L, Ludwikowska K, et al
    The HPV prevention and control program in Poland: progress and the way forward.
    Acta Dermatovenerol Alp Pannonica Adriat. 2024;33:189-197.
    Abstract

  3256. ZHAO T, Li Y, Liu H, Tong C, et al
    Geneticsbiologiesingle cell and expression analysis for erectile dysfunction and cervical cancer targets.
    Discov Oncol. 2024;15:820.
    Abstract

  3257. GRANGE A, Mouton V, Roojee M, Rosec S, et al
    [Human papillomaviruses : origin, oncogenic factors and markers for cervical cancer screening].
    Virologie (Montrouge). 2024;28:357-368.
    Abstract

  3258. SUROV A, Borggrefe J, Hohn AK, Meyer HJ, et al
    Associations between ADC histogram analysis values and tumor-micro milieu in uterine cervical cancer.
    Cancer Imaging. 2024;24:170.
    Abstract

  3259. CAI C, Xiao JF, Cai R, Ou D, et al
    Longitudinal dynamic MRI radiomic models for early prediction of prognosis in locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Radiat Oncol. 2024;19:181.
    Abstract

  3260. ASOUDEH-FARD A, Beygi MY, Parsaei A, Mohkam M, et al
    Postbiotic metabolites derived from lactobacillus fermentum as potent antiproliferative bioresources on HeLa cells with promising biocompatibility.
    BMC Complement Med Ther. 2024;24:420.
    Abstract

  3261. YANG Q, Yan W, Wang N, Xu P, et al
    Thyroid metastases from cervical carcinoma: unusual implications for clinicians-case report.
    BMC Endocr Disord. 2024;24:273.
    Abstract

  3262. ANUSHA T, Brahman PK, Sesharamsingh B, Lakshmi A, et al
    Electrochemical detection of cervical cancer biomarkers.
    Clin Chim Acta. 2024;567:120103.
    Abstract

  3263. TANG S, Yen A, Wang K, Albuquerque K, et al
    Progression-Free Survival Prediction for Locally Advanced Cervical Cancer After Chemoradiotherapy With MRI-based Radiomics.
    Clin Oncol (R Coll Radiol). 2024;38:103702.
    Abstract

  3264. ZHAO Z, Zhao X, Guo R, Xu T, et al
    Cervical cancer screening by biomarker-free Serum-SERS technique: A three-principal-substrate approach.
    Biosens Bioelectron. 2024;271:117070.
    Abstract

  3265. MOHAMMED E, Taye G, Assefa M, Aman H, et al
    Cervical Cancer Screening Utilization and Barriers to Uptake in Ethiopia: An Umbrella Review.
    Cancer Control. 2024;31:10732748241310575.
    Abstract

  3266. PRESTON M, Richards A
    Risk of High-Grade Cervical Dysplasia in Older Patients With a Positive Human Papillomavirus Cervical Screening Test.
    J Low Genit Tract Dis. 2025;29:55-59.
    Abstract

  3267. CARRERAS-DIEGUEZ N, Torras I, Marti C, Matas I, et al
    Endocervical Brush Cytology After Cervical Conization as a Predictor of Treatment Failure: A Prospective Cohort Study.
    J Low Genit Tract Dis. 2025;29:42-47.
    Abstract

  3268. JENNETT CJ, Smith MA, Machalek DA, Sultana F, et al
    How Does Transitioning to Primary Human Papillomavirus Screening Impact Colposcopy Services? Lessons From an Australian National Program.
    J Low Genit Tract Dis. 2025;29:13-22.
    Abstract

  3269. CRANE L, Fitzpatrick MB, Sutton E, Conageski C, et al
    Evaluation of a Self-collected Device for Human Papillomavirus Screening to Increase Cervical Cancer Screening.
    J Low Genit Tract Dis. 2025;29:1-5.
    Abstract

  3270. WANHAINEN KM, Berkseth M, Sando N, Golden L, et al
    Effect of External Beam Radiation Therapy and Brachytherapy on Circulating Myeloid-Derived Suppressor Cell Populations in Patients Treated Definitively for Cervical Cancer.
    Adv Radiat Oncol. 2024;10:101677.
    Abstract

  3271. BAO X, Chen Y, Zhang J, Zhang X, et al
    Case report: Multiphenotypic cervical cancer resembling human papillomavirus-related multiphenotypic sinonasal carcinoma.
    Front Med (Lausanne). 2024;11:1507736.
    Abstract

  3272. LIU S, Ai Z, Hu Y, Ren G, et al
    Ginseng glucosyl oleanolate inhibit cervical cancer cell proliferation and angiogenesis via PI3K/AKT/HIF-1alpha pathway.
    NPJ Sci Food. 2024;8:105.
    Abstract

  3273. LI Q, Su M, Wang Y, Li Z, et al
    Association between TAB2 genetic polymorphisms and the susceptibility to cervical cancer: a case-control study.
    Cancer Cell Int. 2024;24:413.
    Abstract

  3274. BAO L, Wu Y, Ren Z, Huang Y, et al
    Comprehensive pan-cancer analysis indicates UCHL5 as a novel cancer biomarker and promotes cervical cancer progression through the Wnt signaling pathway.
    Biol Direct. 2024;19:139.
    Abstract

  3275. GNANAGURUSAMY J, Krishnamoorthy S, Muruganatham B, Nagarajan S, et al
    Analysing the relevance of TGF-beta and its regulators in cervical cancer to identify therapeutic and diagnostic markers.
    Gene. 2024 Dec 17:149166. doi: 10.1016/j.gene.2024.149166.
    Abstract

  3276. MBOINEKI JF, Chen C
    Preparing patient navigators and assessing the impact of patient navigation in promoting cervical cancer screening uptake, knowledge, awareness, intention, and health beliefs: a protocol for a randomized controlled trial.
    Front Glob Womens Health. 2024;5:1209441.
    Abstract

  3277. NING W, Liu J, Lu Y, Zhu B, et al
    Trends in the Disease Burden and Risk Factors of Women's Cancers in China From 1990 to 2019.
    Int J Public Health. 2024;69:1607245.
    Abstract

  3278. ZHOU X, Han T, Guo T, Liu Y, et al
    Cervical intraepithelial neoplasia and cervical cancer in Hunan Province, China, 2020-2023.
    Front Oncol. 2024;14:1480983.
    Abstract

  3279. FENG M, Wu H, Zhu L, Gao J, et al
    Triptolide Promotes Ferroptosis in Cervical Cancer Cell via NRF2/xCT/GPX4.
    Phytother Res. 2024 Dec 19. doi: 10.1002/ptr.8398.
    Abstract

  3280. MAO Y, Li H, Xu G, Tian J, et al
    Alpha-lipoic acid targets KLF7 expression to inhibit cervical cancer progression.
    Acta Biochim Biophys Sin (Shanghai). 2024 Dec 18. doi: 10.3724/abbs.2024212.
    Abstract

  3281. ZHANG X, Xu W, Wang Z, Liu J, et al
    Cross-talk between cuproptosis and ferroptosis to identify immune landscape in cervical cancer for mRNA vaccines development.
    Eur J Med Res. 2024;29:602.
    Abstract

  3282. WANG H, Li Z, Shi D, Yin P, et al
    Assessing intra- and interfraction motion and its dosimetric impacts on cervical cancer adaptive radiotherapy based on 1.5T MR-Linac.
    Radiat Oncol. 2024;19:176.
    Abstract

  3283. QIU Y, Han S, Ji Y, Lu Z, et al
    Development of a thrombin-antithrombin complex detection kit and study in venous thromboembolism complicated by cervical cancer.
    BMC Biotechnol. 2024;24:103.
    Abstract

  3284. SUMIEC EG, Yim ZY, Mohy-Eldin H, Nedjai B, et al
    The current state of DNA methylation biomarkers in self-collected liquid biopsies for the early detection of cervical cancer: a literature review.
    Infect Agent Cancer. 2024;19:62.
    Abstract

  3285. FOKOM DOMGUE J, Dille I, Gnangnon F, Kapambwe S, et al
    Utility of colposcopy for the screening and management of cervical cancer in Africa: a cross-sectional analysis of providers' training and practices.
    BMC Health Serv Res. 2024;24:1619.
    Abstract

  3286. MYERS L, Perry N, Anderson L, Ireland M, et al
    Understanding the mechanisms underlying the socioeconomic disparities in cancer screening among Australian women.
    BMC Public Health. 2024;24:3437.
    Abstract

  3287. SOBOH S, Vorontsova A, Farhoud M, Barash U, et al
    Tumor- and host-derived heparanase-2 (Hpa2) attenuates tumorigenicity: role of Hpa2 in macrophage polarization and BRD7 nuclear localization.
    Cell Death Dis. 2024;15:894.
    Abstract

  3288. FENG T, Xu X, Wang X, Tang W, et al
    PGRN protects against serum deprivation-induced cell death by promoting the ROS scavenger system in cervical cancer.
    Cell Death Dis. 2024;15:889.
    Abstract

  3289. PROKOPOVICH K, Beard F, Buchanan T, Stanoevska B, et al
    Supporting equitable cervical cancer elimination for Australia's culturally and linguistically diverse communities: A call for intersectoral action.
    Health Promot J Austr. 2025;36:e933.
    Abstract

  3290. TANNE JH
    Cervical cancer: US taskforce recommends HPV tests for screening, in updated guidelines.
    BMJ. 2024;387:q2840.
    Abstract

  3291. ALOBAIDA A, Abouzied AS, Taslim Ahmed A, Huwaimel B, et al
    Potential VEGFR2 inhibitors for managing metastatic cervical cancer: insights from molecular dynamics and free energy landscape studies.
    Mol Divers. 2024 Dec 18. doi: 10.1007/s11030-024-11080.
    Abstract

  3292. CAO C, Zhang H, Zhang T, Nie C, et al
    Circular RNA NINL accelerates the malignant progression of cervical cancer.
    Discov Oncol. 2024;15:766.
    Abstract

  3293. CHEN B, Wang L, Li X, Ren C, et al
    FTO Facilitates Cervical Cancer Malignancy Through Inducing m6A-Demethylation of PIK3R3 mRNA.
    Cancer Med. 2024;13:e70507.
    Abstract

  3294. XIONG L, Wei Y, Si H, Li Z, et al
    Development of the Curcumin Analog CA7 Liposome and Its Evaluation for Efficacy Against Cervical Cancer in vitro and in vivo.
    Int J Nanomedicine. 2024;19:13411-13428.
    Abstract

  3295. WU F, Xu Y
    Immunogenic cell death-related cancer-associated fibroblast clusters and prognostic risk model in cervical cancer.
    APL Bioeng. 2024;8:046114.
    Abstract

  3296. LUO D, Huang H, Chen X, Chen X, et al
    [Primary uterine hepatoid adenocarcinoma: Clinicopathological analysis of 2 cases and literature review].
    Beijing Da Xue Xue Bao Yi Xue Ban. 2024;56:1126-1131.
    Abstract

  3297. LI YF, Yin J, Kuang XF, Wu T, et al
    [Proportion of adenocarcinoma and the distribution of HPV genotypes in China: a meta-analysis].
    Zhonghua Zhong Liu Za Zhi. 2024;46:1209-1217.
    Abstract

  3298. CHEN J, Shi JM, Cao YJ, Li C, et al
    [A prospective phase ? clinical trial of toripalimab combined with platinum-based concurrent chemoradiotherapy and consolidation chemotherapy in patients with locally advanced cervical cancer].
    Zhonghua Yi Xue Za Zhi. 2024;104:4402-4408.
    Abstract

  3299. WANG P, Chen L, Xi H, Yang B, et al
    Correlation between HPV-16 integration status and cervical intraepithelial neoplasia and cervical cancer in patients infected with HIV.
    Bull Cancer. 2024 Dec 16:S0007-4551(24)00461.
    Abstract

  3300. ARRIGHETTI G, Carrozzini A, Gatti C, De Michele F, et al
    [Not Available].
    Recenti Prog Med. 2024;115:608-609.
    Abstract

  3301. CHEN Y, Cui F, Wu X, Zhao W, et al
    The expression and clinical significance of serum exosomal-long non-coding RNA DLEU1 in patients with cervical cancer.
    Ann Med. 2025;57:2442537.
    Abstract

  3302. KARDAVA IV, Barinova IV, Fattakhov AR, Trishhenkova OV, et al
    [Clinical morphology of cervical conization variants for high-grade squamous intraepithelial lesions].
    Arkh Patol. 2024;86:43-48.
    Abstract

  3303. MALENKOVIC G, Malenkovic J, Tomic S, Sljivo A, et al
    Assessing the Efficacy of 18F FDG PET-CT in Preoperative Staging of Early-Stage Cervical Cancer in Novi Sad, Serbia-A Pilot Study.
    J Clin Med. 2024;13:7445.
    Abstract

  3304. CHEHAB R, Abboud R, Bou Zeidan M, Eid C, et al
    The Impact of a Randomized Community-Based Intervention on the Awareness of Women Residing in Lebanon Toward Breast Cancer, Cervical Cancer, and Intimate Hygiene.
    Healthcare (Basel). 2024;12:2422.
    Abstract

  3305. PALOMINO-VIZCAINO G, Banuelos-Villegas EG, Alvarez-Salas LM
    The Natural History of Cervical Cancer and the Case for MicroRNAs: Is Human Papillomavirus Infection the Whole Story?
    Int J Mol Sci. 2024;25:12991.
    Abstract

  3306. PULLIERO A, Cassatella G, Astuni P, Khalid Z, et al
    The Role of microRNA Expression and DNA Methylation in HPV-Related Cervical Cancer: A Systematic Review.
    Int J Mol Sci. 2024;25:12714.
    Abstract

  3307. KIM N, Yang C
    Butyrate as a Potential Modulator in Gynecological Disease Progression.
    Nutrients. 2024;16:4196.
    Abstract

  3308. MOLIKA P, Leetanaporn K, Chiangjong W, Choochuen P, et al
    Proteomic Analysis Reveals Cadherin, Actin, and Focal Adhesion Molecule-Mediated Formation of Cervical Cancer Spheroids.
    Cells. 2024;13:2004.
    Abstract

  3309. CHIEREGHIN A, Pizzi L, Buriani C, Sanna T, et al
    Addressing COVID-19 Screening Delays: The Impact of HPV Self-Sampling on Non-Attenders in a Cervical Cancer Screening Program.
    Cancers (Basel). 2024;16:4071.
    Abstract

  3310. MEIXNER E, Wermes L, Hoeltgen L, von Diest LA, et al
    Hematologic Toxicity Profiles and the Impact of Hemoglobin Nadir and Transfusion on Oncologic Outcome in Definitive Radiochemotherapy for Cervical Cancer.
    Cancers (Basel). 2024;16:3986.
    Abstract

  3311. RATNAPARKHI R, Ismail A, Krebill H, Cook I, et al
    Utilization and outcomes of serial cervical cancer screening in a National Breast and Cervical Cancer Early Detection Program (NBCCEDP) in a non-Medicaid expansion state.
    Cancer Causes Control. 2024 Dec 16. doi: 10.1007/s10552-024-01948.
    Abstract

  3312. ZHAO H, Zou L, Xu J, Zhou X, et al
    Let-7c-5p Targeting CHD7 Hinders Cervical Cancer Migration and Invasion by Regulating Cell Adhesion.
    Biochem Genet. 2024 Dec 16. doi: 10.1007/s10528-024-10993.
    Abstract

  3313. WANG T, Wei J, Jiang L, Huang L, et al
    Risk Factor Analysis and Prediction of Para-Aortic Lymph Node Metastases in Locally Advanced Cervical Cancer.
    Cancer Med. 2024;13:e70492.
    Abstract

  3314. MBADHI A, Aboua YG, Akai LA, Omoruyi BE, et al
    Cervical Inspection With AAVI and Cryotherapy on HPV-Diagnosed Women in Windhoek, Namibia.
    Inquiry. 2024;61:469580241290041.
    Abstract

  3315. BETTI E, Nappo V, Anghinoni E, Ballotari P, et al
    [The CCM Project "Guidelines for the Social Reporting of Screening Programmes"].
    Epidemiol Prev. 2024;48:449-455.
    Abstract

  3316. ZENG C, Ji J, Huang Y, Peng Y, et al
    A Novel Scoring System to Predict Acute Radiation Enteritis Recovery in Cervical Cancer Patients Undergoing Concurrent Chemoradiotherapy: A Southwest China Cohort Study.
    Int J Gen Med. 2024;17:5907-5919.
    Abstract

  3317. HU J, Shi Q, Gong X, You T, et al
    Establishment of a prognostic nomogram based on the clinical and inflammatory parameters as well as acute radiation enteritis for patients with cervical cancer receiving radiotherapy.
    Front Oncol. 2024;14:1453837.
    Abstract

  3318. WU X, You Y, Guan Z, Ban Y, et al
    A correlation study between cervical cancer and sex hormones.
    Front Oncol. 2024;14:1475052.
    Abstract

  3319. OTIENO JA, Were L, Nyanchoka M, Olwanda E, et al
    Human papillomavirus self-sampling versus provider-sampling in low- and middle-income countries: a scoping review of accuracy, acceptability, cost, uptake, and equity.
    Front Public Health. 2024;12:1439164.
    Abstract

  3320. HAMDIUI N, Boer M, van Steenbergen J, van den Muijsenbergh M, et al
    Exploring Different Sampling Strategies: A Description of Our Success in Reaching Hard-to-Reach Turkish and Moroccan Immigrant Women in The Netherlands.
    Health Expect. 2024;27:e70105.
    Abstract

  3321. CHEN Y, Xue G, Hu Y, Da M, et al
    Exploring the role of NAT10 in regulating EMT and JAK2/STAT3 pathway activation in cervical cancer progression.
    Asian J Surg. 2024 Dec 14:S1015-9584(24)02836.
    Abstract

  3322. KNUDSEN AS, Randrup TH, Kesmodel US, Booth B, et al
    Assessment of a colposcopic scoring system (Swedescore) to reduce the number of cervical biopsies: a protocol for a clinical multicentre non-randomised intervention study in Denmark.
    BMJ Open. 2024;14:e085382.
    Abstract

  3323. TAYLOR SE, Behr S, Cooper KL, Mahdi H, et al
    Dose finding, bioavailability, and PK-PD of oral triapine with concurrent chemoradiation for locally advanced cervical cancer and vaginal cancer (ETCTN 9892).
    Cancer Chemother Pharmacol. 2024;95:4.
    Abstract

  3324. MANSOUR MBL, Crone MR, van Weert HC, Chavannes NH, et al
    A stop-smoking strategy after cervical cancer screening: Results of a cluster-randomised controlled trial in Dutch general practice.
    Nicotine Tob Res. 2024 Nov 30:ntae285. doi: 10.1093.
    Abstract

  3325. XIE H, Li L, Zhu T, Zhou H, et al
    Genome-integrated Human Papilloma Viruses Testing: A Complement to Colposcopy-guided Biopsy for Cervical Cancer Screening.
    Curr Med Sci. 2024 Dec 14. doi: 10.1007/s11596-024-2947.
    Abstract

  3326. ROBINSON E, Rodriguez I, Argueta V, Xie Y, et al
    Analysis of the progression of cervical cancer in a low-and-middle-income country: From pre-malignancy to invasive disease.
    Tumour Virus Res. 2024;19:200299.
    Abstract

  3327. CHITMANEE P, Sampaongen T, Klomjit N
    Factors Affecting D90 High-risk Clinical Target Volumes (HR-CTV dose) of Intracavitary and Interstitial Brachytherapy in Locally Advanced Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2024;37:103701.
    Abstract

  3328. PORTELANCE L, Asher D, Llorente R, Mellon E, et al
    Potential to reduce margins and Shrink targets in patients with intact cervical cancer treated on An MRI guided radiation therapy (MRgRT) system.
    Phys Med. 2024;129:104869.
    Abstract

  3329. HUMPHREY P, Dures E, Hoskin P, Johnston J, et al
    Development and refinement of patient care recommendations in brachytherapy for locally advanced cervical cancer using nominal group technique workshops.
    Support Care Cancer. 2024;33:24.
    Abstract

  3330. CHEN Y, Li Y, Xue L, Xu M, et al
    Concordance analysis between Human Papillomavirus genotyping assay and PCR-reverse spot hybridization for the detection of Human Papillomavirus infection.
    J Med Microbiol. 2024;73.
    Abstract

  3331. KARAMOUSOULI E, Sabale U, Valente S, Morosan F, et al
    Readiness assessment for cervical cancer elimination and prevention of human papillomavirus (HPV)-related cancers in Europe - are we winning the RACE?
    Expert Rev Vaccines. 2025;24:11-26.
    Abstract

  3332. GUARE LA, Das J, Caruth L, Setia-Verma S, et al
    Social Determinants of Health and Lifestyle Risk Factors Modulate Genetic Susceptibility for Women's Health Outcomes.
    Pac Symp Biocomput. 2025;30:296-313.
    Abstract

  3333. TANG Y, Pang Y, Tang J, Sun X, et al
    Predicting grade II-IV bone marrow suppression in patients with cervical cancer based on radiomics and dosiomics.
    Front Oncol. 2024;14:1493926.
    Abstract

  3334. VENTURA PM, Guimaraes ICCDV, Velarde LGC, Fialho SCAV, et al
    Analysis of vaginal microbiota before and after treatment of high-grade squamous intraepithelial lesions of the uterine cervix.
    Rev Bras Ginecol Obstet. 2024;46:e-rbgo86.
    Abstract

  3335. FLOWER E, Busuttil G, Cosgriff E, Thiruthaneeswaran N, et al
    Evaluation of plan quality, safety, and toxicity of brachytherapy for locally advanced cervical cancer in an Australian setting following changes in prescription and applicator design.
    J Med Imaging Radiat Oncol. 2024 Dec 12. doi: 10.1111/1754-9485.13811.
    Abstract

  3336. POLI UR, Gudlavalleti AG, Bharadwaj Y J, Pant HB, et al
    Development and Clinical Validation of Visual Inspection With Acetic Acid Application-Artificial Intelligence Tool Using Cervical Images in Screen-and-Treat Visual Screening for Cervical Cancer in South India: A Pilot Study.
    JCO Glob Oncol. 2024;10:e2400146.
    Abstract

  3337. GEORGE IA, Sambath J, Dhawale RE, Singh M, et al
    Phosphoproteomics guides low dose drug combination of cisplatin and silmitasertib against concurrent chemoradiation resistant cervical cancer.
    Mol Omics. 2024 Dec 12. doi: 10.1039/d4mo00147.
    Abstract

  3338. LU Z, Zhu G, Feng X, Xiang Y, et al
    Exploring the therapeutic potency of cryptotanshinone in cervical cancer: a multi-omics and network pharmacology approach.
    Front Genet. 2024;15:1435132.
    Abstract

  3339. LIN Y, Li C, Wang C, Chen J, et al
    Atezolizumab plus bevacizumab and chemotherapy as first-line therapy for cervical cancer: a cost-effectiveness analysis in the US.
    Front Immunol. 2024;15:1481584.
    Abstract

  3340. TANAKA Y, Higami S, Ishii T, Shiki Y, et al
    Adjuvant Chemotherapy versus Concurrent Chemoradiotherapy for Surgically Treated T1b Uterine Cervical Cancer: A Propensity Score Matched Analysis of the JSOG Nationwide Data.
    Ann Surg Oncol. 2024 Dec 11. doi: 10.1245/s10434-024-16638.
    Abstract

  3341. QU N, Li Z, Wei J, Yang Y, et al
    Bevacizumab increases cisplatin efficacy by inhibiting epithelial-mesenchymal transition via ALDH1 in cervical carcinoma.
    Int Immunopharmacol. 2025;145:113736.
    Abstract

  3342. ROY R, Mandal S, Chakrabarti J, Saha P, et al
    Retraction Note: Downregulation of Hyaluronic acid-CD44 signaling pathway in cervical cancer cell by natural polyphenols Plumbagin, Pongapin and Karanjin.
    Mol Cell Biochem. 2024 Dec 11. doi: 10.1007/s11010-024-05183.
    Abstract

  3343. KUZMINSKI C, Podczerwinska A, Rowinski D, Baran J, et al
    Assessment of the level of knowledge on cervical cancer prevention among women visiting a private gynecological practice in Krakow - a pilot study.
    Przegl Epidemiol. 2024;78:273-286.
    Abstract

  3344. GUPTA R, Singh S, Gupta S
    Performance characteristics of the point-of-care tests for HPV-based cervical cancer screening: a systematic review and meta-analysis.
    J Public Health (Oxf). 2024 Dec 11:fdae306. doi: 10.1093.
    Abstract

  3345. YU H, Lin J, Chen J, Chen L, et al
    A surprising complete response to cadonilimab in a primary metastatic cervical cancer: a case report.
    Front Immunol. 2024;15:1494138.
    Abstract

  3346. HAPPEL AU, Budiawan E, Onono M, Innes S, et al
    Natural History of High-Risk Human Papillomavirus in Kenyan and South African Women: Implications for Vaccination Campaigns and Cervical Cancer Screening Programs.
    Open Forum Infect Dis. 2024;11:ofae690.
    Abstract

  3347. ARRIVILLAGA M, Bermudez PC, Garcia-Cifuentes JP, Vargas-Cardona HD, et al
    Designing CITOBOT: A portable device for cervical cancer screening using human-centered design, smart prototyping, and artificial intelligence.
    Comput Struct Biotechnol J. 2024;24:739-745.
    Abstract


  3348. RETRACTION: Long Noncoding RNA HCG11 Inhibited Growth and Invasion in Cervical Cancer by Sponging miR-942-5p and Targeting GFI1.
    Cancer Med. 2024;13:e70465.
    Abstract

  3349. FULANE G, Major M, Lorenzoni C
    Living in the Minds of Others: How Pudor and Social Judgements Affect Women's Cervical Cancer Screening Uptake in Mozambique?
    Int J Health Plann Manage. 2024 Dec 10. doi: 10.1002/hpm.3881.
    Abstract

  3350. ASGEDOM YS, Kassie GA, Habte A, Ketema DB, et al
    Socioeconomic inequality in cervical cancer screening uptake among women in sub-Saharan Africa: a decomposition analysis of Demographic and Health Survey data.
    BMJ Open. 2024;14:e088753.
    Abstract

  3351. KULKARNI T, Fitch A
    Navigating the challenge of high-grade cervical lesions (CIN3) in pregnancy: a near miss.
    BMJ Case Rep. 2024;17:e261808.
    Abstract

  3352. PARANITHARAN N, Kataria S, Arumugam VA, Hsieh HL, et al
    Integrin alpha1 upregulation by TF:FVIIa complex promotes cervical cancer migration through PAR2-dependent MEK1/2 activation.
    Biochem Biophys Res Commun. 2025;742:151151.
    Abstract

  3353. GULLE BT, Kiran P, Celik SG, Varol ZS, et al
    Awareness and acceptance of human papillomavirus vaccine in the Middle East: A systematic review, meta-analysis, and meta-regression of 159 studies.
    Epidemiol Infect. 2024;152:e165.
    Abstract

  3354. SASIVIMOLRATTANA T, Gunawan A, Wattanathavorn W, Pholpong C, et al
    Upregulation of HPV16E1 and E7 expression and FOXO3a mRNA downregulation in high-grade cervical neoplasia.
    PeerJ. 2024;12:e18601.
    Abstract

  3355. BI XY, Pan ZW, Liu SL, Chen XM, et al
    A feasibility study of DNA ploidy analysis, HPV, and TCT for screening of cervical cancer: A retrospective study.
    Medicine (Baltimore). 2024;103:e40038.
    Abstract

  3356. CUI Y, Zhao Y, Shen G, Lv Q, et al
    Corrigendum to "CDYL loss promotes cervical cancer aggression by increasing PD-L1 expression via the suppression of IRF2BP2 transcription" [Transl Oncol. 2024 Sep;47:102038 /PMID: 38991463].
    Transl Oncol. 2025;51:102219.
    Abstract

  3357. MAKONI M
    Africa renews commitment to an accelerated plan to end cervical cancer by 2030.
    Lancet Oncol. 2024 Dec 6:S1470-2045(24)00711.
    Abstract

  3358. KUMAR A
    Amentoflavone, a biflavonoid with potential anticancer properties against viral oncoprotein E6 in Human papilloma virus-16 (HPV-16) positive cervical cancer cells.
    Nat Prod Res. 2024 Dec 9:1-10. doi: 10.1080/14786419.2024.2438273.
    Abstract

  3359. BAWAZIR WA, Ahmed NS, Abd El-Karim SS, El-Sayed AF, et al
    New thiazolidin-4-ones as anti-cervical cancer agents targeting EGFR: design, synthesis, and computational studies.
    Future Med Chem. 2024 Dec 9:1-17. doi: 10.1080/17568919.2024.2437976.
    Abstract

  3360. SRIRAM S
    Supply-Side Barriers in Accessing Human Papillomavirus Screening for Cervical Cancer Prevention in Rural India: Evidence From a Cross-Sectional Study.
    Cureus. 2024;16:e73145.
    Abstract

  3361. WANG R, Deng J, Zhang M, Wang Z, et al
    Overexpression of HYOU1 is associated with cisplatin resistance and may depend on m(6)A modification in patients with cervical cancer.
    Oncol Lett. 2024;29:77.
    Abstract

  3362. ROSTAMI VARNOSFADERANI M, Khoshnazar Z, Ghotb Tahriri I, Azimiyan S, et al
    25th National and 11th International Annual Congress, Urmia, Iran, September 5-7, 2024.
    Iran Biomed J. 2024;28:9.
    Abstract

  3363. ZHANG CN, Zhou H, Dai Y, Zhang X, et al
    [Association between invasive stratified mucinous carcinoma of the cervix and human papillomavirus genotypes].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:1244-1247.
    Abstract

  3364. CHOPRA S, Samanta A, Nagar A, Mittal P, et al
    Clinical outcomes of abbreviated high dose-rate brachytherapy in locally advanced cervical cancer: lessons from the COVID pandemic for high dose-rate fractionation.
    Brachytherapy. 2024 Dec 6:S1538-4721(24)00441.
    Abstract

  3365. GAUTAM S, Flower E, Richeson D, Sangha I, et al
    Improving plan quality in cervical cancer brachytherapy using knowledge-based planning for direction modulated brachytherapy tandem applicator.
    Brachytherapy. 2024 Dec 6:S1538-4721(24)00452.
    Abstract

  3366. CHENG K, To S, Liu Z, Han HR, et al
    Clinical and dosimetric outcomes of a 3-fraction high-dose-rate brachytherapy boost for the treatment of locally advanced cervical cancer in a safety net hospital.
    Brachytherapy. 2024 Dec 6:S1538-4721(24)00453.
    Abstract

  3367. XIA Z, Zhang L, Zhou H, Ran W, et al
    LncRNA-FGD5-AS1 promotes 5-Fu resistance of cervical cancer cells through modulating the miR-130a-3p-YTHDF2 axis.
    J Chemother. 2024 Dec 6:1-13. doi: 10.1080/1120009X.2024.2436803.
    Abstract

  3368. MCKINNISH TR, Kuroki LM, Schwarz JK, Mazul AL, et al
    Trends in Cervical and Anal Cancer Incidence and Mortality in the United States.
    J Low Genit Tract Dis. 2025;29:48-54.
    Abstract

  3369. ZHANG M, Jiang H, Chen L, Ren J, et al
    Efficacy and Safety of Focused Ultrasound Treatment for High-risk Human Papillomavirus Infection-related Cervical Intraepithelial Neoplasia Grade 2 in Nulligravidae Women: A Retrospective Study.
    Ultrasound Med Biol. 2025;51:341-347.
    Abstract

  3370. SHANAZAROV N, Grishacheva T, Aitkaliyev A, Salmaganbetova Z, et al
    Assessment of systemic reaction to inflammation induced by photodynamic therapy in cervical intraepithelial neoplasia.
    Photodiagnosis Photodyn Ther. 2024;50:104416.
    Abstract

  3371. SHIRLEY M
    Enlonstobart: First Approval.
    Drugs. 2024;84:1659-1663.
    Abstract

  3372. DESRAVINES N, Tran C, Wethington S, Williams-Brown MY, et al
    Contemporary Review of Adenocarcinoma of the Cervix.
    Curr Treat Options Oncol. 2024;25:1538-1549.
    Abstract

  3373. KADERLY RASMUSSEN EL, Lindquist S, Baandrup L, Hansen T, et al
    Human papillomavirus-associated cancers, precancers, and genital warts in Denmark, 2000-2022 - Current burden of disease and population impact of multi-cohort HPV vaccination.
    Prev Med. 2024;189:108165.
    Abstract

  3374. ROHR I, Skof AS, Heinrich-Rohr M, Weiss F, et al
    Impact of HIV infection on cervical intraepithelial neoplasia detection in pregnant and non-pregnant women in Germany: a cross-sectional study.
    Arch Gynecol Obstet. 2024;310:3099-3110.
    Abstract

  3375. WANG L, Zhang J, Sun A, Yin Y, et al
    Placental extracellular vesicles promoted cervical tumour tissue undergoing death.
    Placenta. 2024;158:223-230.
    Abstract

  3376. TRUGILO KP, Cebinelli GCM, Castilha EP, da Silva MR, et al
    The role of transforming growth factor beta in cervical carcinogenesis.
    Cytokine Growth Factor Rev. 2024;80:12-23.
    Abstract

  3377. BEHRENS AS, Dietl AK, Adler W, Geppert C, et al
    Evaluation of endocervical curettage (ECC) in colposcopy for detecting cervical intraepithelial lesions.
    Arch Gynecol Obstet. 2024;310:3037-3045.
    Abstract

  3378. TASKIN T, Roncancio AM, Cano MA, Valente M, et al
    Cancer fatalism is associated with HPV vaccine uptake among Hispanic emerging adult women in the US.
    Vaccine. 2024;42:126417.
    Abstract

  3379. POOROLAJAL J, Doosti-Irani A, Karami AM, Fattahi-Darghlou M, et al
    A dose-response meta-analysis of the relationship between number of pregnancies and risk of gynecological cancers.
    Arch Gynecol Obstet. 2024;310:2783-2790.
    Abstract

  3380. YE Z, Cui X, Wang H, Chen M, et al
    The Distribution of Cervical Transformation Zone and Its Impact on Colposcopic Diagnosis: A Multicenter Study in China.
    J Low Genit Tract Dis. 2025;29:6-12.
    Abstract

  3381. MOUCHERAUD C, Ochieng E, Ogutu V, Chang LC, et al
    Intervention-amenable factors associated with lack of HPV vaccination in Kenya: Results from a large national phone survey.
    Vaccine. 2024;42:126410.
    Abstract

  3382. GARLAND SM, Bhatla N, Woo YL
    IPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets.
    Vaccine. 2024;42:126400.
    Abstract

  3383. MAH SJ, Brotto LA, Bryce M, Keast S, et al
    A Parallel-Group, Randomized Trial Examining Impact of Colposcopy Results Delivery by a Nurse Liaison on Patient-Reported Outcomes and Adherence.
    J Obstet Gynaecol Can. 2024;46:102668.
    Abstract

  3384. SUN H, Sun X, Li J, Zhu J, et al
    Pseudo-CT synthesis in adaptive radiotherapy based on a stacked coarse-to-fine model: Combing diffusion process and spatial-frequency convolutions.
    Med Phys. 2024;51:8979-8998.
    Abstract

  3385. GLINSKA P, Macios A, Jaworski R, Bobinski M, et al
    Baseline data on distribution of human papillomavirus (HPV) genotypes in cervical samples of gynecological patients before implementation of population-based HPV vaccination program in Poland.
    Ginekol Pol. 2024;95:870-878.
    Abstract

  3386. WISNIAK A, Yakam V, Bolo SE, Moukam A, et al
    Fertility and Miscarriage Incidence After Cervical Intraepithelial Neoplasia Treatment by Thermal Ablation: A Cohort Study.
    BJOG. 2025;132:167-177.
    Abstract

  3387. KOCIC J, Zecevic N, Jagodic J, Ardalic D, et al
    Exploring serum trace element shifts: Implications for cervical intraepithelial neoplasia.
    J Trace Elem Med Biol. 2024;86:127531.
    Abstract

  3388. LU LH, Chen YQ, Li J, Shao SS, et al
    [Clinicopathological features and prognostic analysis of synchronous mucinous metaplasia and neoplasia of the female genital tract].
    Zhonghua Zhong Liu Za Zhi. 2024;46:1195-1208.
    Abstract

  3389. MOLANO M, Machalek DA, Phillips S, Tan G, et al
    DNA methylation at individual CpG-sites of EPB41L3, HTERT and FAM19A4 are useful for detection of cervical high-grade squamous intraepithelial lesions (HSIL) or worse: Analysis of individual CpG-sites outperforms averaging.
    Tumour Virus Res. 2024;18:200288.
    Abstract

  3390. HORN LC, Brambs CE, Aktas B, Dannenmann A, et al
    Human Papilloma Virus-Independent/p53abnormal Keratinizing Squamous Cell Carcinoma of the Uterine Cervix Associated With Uterine Prolapse.
    Int J Gynecol Pathol. 2025;44:2-14.
    Abstract

  3391. KARKAS R, Abdullah KSA, Kaizer L, Urmos A, et al
    LINE-1 ORF1p is a Promising Biomarker in Cervical Intraepithelial Neoplasia Degree Assessment.
    Int J Gynecol Pathol. 2025;44:22-30.
    Abstract

  3392. DANG JHT, Chen S, Hall S, Campbell JE, et al
    Association Between COVID-19 and Planned and Postponed Cancer Screenings Among American Indian Adults Residing in California and Oklahoma, March-December 2020.
    Public Health Rep. 2025;140:57-66.
    Abstract

  3393. AL-HUSSAINI M, Talia KL, McCluggage WG
    Napsin A Immunoreactivity in "Hobnail" Epithelium in Benign Endometrial and Endocervical Polyps.
    Int J Gynecol Pathol. 2025;44:31-36.
    Abstract

  3394. GUERRISI A, Miseo L, Falcone I, Messina C, et al
    Quantitative ultrasound radiomics analysis to evaluate lymph nodes in patients with cancer: a systematic review.
    Ultraschall Med. 2024;45:586-596.
    Abstract

  3395. ORUMAA M, Lahlum EJ, Gulla M, Tota J, et al
    Quadrivalent HPV vaccine effectiveness against cervical intraepithelial lesion grade 2 or worse in Norway: A registry-based study of 0,9 million Norwegian women.
    J Infect Dis. 2024 Apr 25:jiae209. doi: 10.1093.
    Abstract

  3396. DUTTA G, Chinnaiyan SK, Palaniyandi T, Sugumaran A, et al
    Biogenic synthesized CuO nanoparticles and 5-fluorouracil loaded anticancer gel for HeLa cervical cancer cells.
    Discov Nano. 2024;19:217.
    Abstract

  3397. SHAHZAD A, Ur Rehman A, Naz T, Rasool MF, et al
    Addition of Bevacizumab to Chemotherapy and Its Impact on Clinical Efficacy in Cervical Cancer: A Systematic Review and Meta-Analysis.
    Pharmacy (Basel). 2024;12:180.
    Abstract

  3398. WDOWIAK K, Drab A, Filipek P, Religioni U, et al
    The Assessment of Knowledge About Cervical Cancer, HPV Vaccinations, and Screening Programs Among Women as an Element of Cervical Cancer Prevention in Poland.
    J Pers Med. 2024;14:1139.
    Abstract

  3399. VAHABI M, Hynes J, Wong JP, Kithulegoda N, et al
    Breaking Barriers: Empowering Cervical Cancer Screening with HPV Self-Sampling for Sex Workers and Formerly Incarcerated Women in Toronto.
    Curr Oncol. 2024;31:7994-8009.
    Abstract

  3400. CAI Z, Wu Q, Yang X, Qin Q, et al
    Application value of personalized 3D printing vaginal model for the Image-guided adaptive brachytherapy of cervical cancer.
    J Gynecol Oncol. 2024 Nov 27. doi: 10.3802/jgo.2025.
    Abstract

  3401. HUSSAIN SA, Dore M, Van Bokkem K, Whittington JR, et al
    Cervical Cancer Screening in the United States Military Health System During the COVID-19 Pandemic.
    Cureus. 2024;16:e74510.
    Abstract

  3402. FEI J, Zhai L, Wang J, Zhu X, et al
    Evaluating PAX1/JAM3 methylation for triage in HPV 16/18-infected women.
    Clin Epigenetics. 2024;16:190.
    Abstract

  3403. WEI KN, Fu XD, Wang MY, Wang LX, et al
    Two cases of mixed large cell neuroendocrine carcinoma and adenocarcinoma of the cervix: case report and review of the literature.
    Diagn Pathol. 2024;19:166.
    Abstract

  3404. SARMA P, Barmon D, Rai AK, Kataki AC, et al
    CareHPV, Papanicolaou Positivity Status, and Their Association With Behavioral Risk Factors in Rural Women of Kamrup District, Assam, India.
    Cancer Rep (Hoboken). 2024;7:e70097.
    Abstract

  3405. VENKAT PS, Smick AH, Salani R
    Current opinions: updates on the changing landscape in the management of cervical cancer.
    Curr Opin Obstet Gynecol. 2024 Sep 27. doi: 10.1097/GCO.0000000000000999.
    Abstract

  3406. ORIGA M, Kayiira A, Ghebre R, Bollinger L, et al
    Views on cervical cancer screening among female caregivers at the Uganda cancer Institute.
    Gynecol Oncol Rep. 2024;57:101654.
    Abstract

  3407. BHALERAO V, Gotarkar S, Muneshwar K
    The Impact of HPV Vaccination on Cervical Cancer in adolescent females: A narrative review.
    J Family Med Prim Care. 2024;13:4775-4782.
    Abstract

  3408. NOREEN K, Naeem Khalid S, Murad MA, Baig M, et al
    Uptake and determinants of HPV vaccination in South Asia: a systematic review and meta-analysis.
    Front Public Health. 2024;12:1453704.
    Abstract

  3409. FOYA JA, Kumwenda MJ, Amour KO, Masana JJ, et al
    Evaluation of dose distribution to the tumor and organs at risk for cervical cancer patients treated using HDR-ICBT without central tandem applicator: A single center based experience.
    Brachytherapy. 2024 Dec 24:S1538-4721(24)00450.
    Abstract

  3410. SAMBANDAM T, Karuppasamy G, Perumal G, Rajasingh EC, et al
    Liquid phase preparation and characterization of MgO nanoparticles and their butchery activities against dental bacterial pathogens and human cervical cancer cell line.
    J Photochem Photobiol B. 2024;262:113084.
    Abstract

  3411. ZU YE, Wang SF, Peng XX, Wen YC, et al
    New cheaper human papilloma virus mass screening strategy reduces cervical cancer incidence in Changsha city: A clinical trial.
    World J Clin Oncol. 2024;15:1491-1500.
    Abstract

  3412. NEGA BG, Yadita ZS, Misker AD, Ebrahim AB, et al
    Cervical Cancer Screening Practice and Associated Factors Among School Teachers in Bahir Dar City, North West Ethiopia: A Cross-Sectional Study.
    Health Sci Rep. 2024;7:e70295.
    Abstract

  3413. CONDE TORO AM, Velez Figueroa AC, Baez Cruz A, Grau Rodriguez M, et al
    Disparities in Cervical Cancer Among LHS+ Women: A Primer for Medical Students.
    MedEdPORTAL. 2024;20:11482.
    Abstract

  3414. HE M, Zhao H, Zhang Y, Zhang N, et al
    Freiburg flap used as vaginal applicator with/without free-hand interstitial needles in three-dimensional high-dose-rate brachytherapy for vaginal stump recurrence of cervical cancer.
    J Contemp Brachytherapy. 2024;16:344-351.
    Abstract

  3415. POJANI E, Bozo S, Capparelli E, Hoxha B, et al
    Cervical Cancer and HPV vaccination: Insights into knowledge, attitudes, and practices among Albanian women.
    Vaccine X. 2024;22:100594.
    Abstract

  3416. EBU ENYAN NI, Raouna A, King-Okoye M, Ken-Amoah S, et al
    Understanding cervical cancer prevention in Africa: a qualitative systematic review of the role of men.
    BMJ Open. 2024;14:e080416.
    Abstract

  3417. SUN Y, Wang M, Ling J, Wu Q, et al
    Curzerenone inactivates the nuclear factor-kappa B signaling to suppress malignancy and immune evasion in cervical cancer by targeting CSNK2B.
    Hum Cell. 2024;38:35.
    Abstract

  3418. LIN Y, Bian L, Zhu G, Zhang B, et al
    Vitronectin promotes proliferation and metastasis of cervical cancer cells via the epithelial-mesenchymal transition.
    Front Oncol. 2024;14:1466264.
    Abstract

  3419. ZHANG T, Yan P, Huang Z, Liu L, et al
    Interrelation between dyadic coping and psychological resilience among cervical cancer couples in Northwest China: An Actor-Partner interdependence model.
    Asia Pac J Oncol Nurs. 2024;11:100615.
    Abstract

  3420. LI Y, Hou X, Liu S, Chen Z, et al
    Synthesis and Activity Study of Gefitinib Derivatives Inducing Mitochondrial Apoptosis in Hela Cells.
    Chem Biol Drug Des. 2024;104:e70035.
    Abstract

  3421. SUBRAMANIAN S, Ekwueme DU, Heffernan N, Blackburn N, et al
    Role of Community-Clinical Partnerships to Promote Cancer Screening: Lessons Learned From the National Breast and Cervical Cancer Early Detection Program.
    Health Promot Pract. 2024 Dec 23:15248399241303891.
    Abstract

  3422. OVESTAD IT, Dalen I, Soreng K, Akbari S, et al
    Gene expression levels associated with impaired immune response and increased proliferation could serve as biomarkers for women following cervical cancer screening programmes.
    Front Immunol. 2024;15:1507193.
    Abstract

  3423. ZHANG X, Shen J, Huang M, Li R, et al
    Efficacy and safety of adding immune checkpoint inhibitors to first-line standard therapy for recurrent or advanced cervical cancer: a meta-analysis of phase 3 clinical trials.
    Front Immunol. 2024;15:1507977.
    Abstract

  3424. BLUM AC, Tessema R, Nussbaum L, Hidalgo C, et al
    "The problem is not detection, it is treatment": Exploring Why Women Needing Pre-Cervical Cancer Care are Lost to Follow-Up at the Hospital in Iquitos, Peru.
    Res Sq [Preprint]. 2024 Dec 13:rs.3.rs-5059371. doi: 10.21203/rs.3.rs-5059371.
    Abstract

  3425. BONNAH J, Awuah B, Williams MS
    The Role of Healthcare Providers in Shared Decision Making for Cervical Cancer Prevention in Ghana: A Qualitative Study.
    Res Sq [Preprint]. 2024 Dec 13:rs.3.rs-5436571. doi: 10.21203/rs.3.rs-5436571.
    Abstract

  3426. SONG R, Ma M, Yang N, Chen C, et al
    A meta-analysis comparing open and minimally invasive cervical tumor surgery wound infection and postoperative complications.
    BMC Surg. 2024;24:413.
    Abstract

  3427. LUBEYA MK, Sinyani A, Mukosha M, Lindsay B, et al
    Self-Reported Cervical Cancer Screening Uptake Among Women of Reproductive Age in Zambia: Evidence from the 2021 Zambia Population-Based HIV Impact Assessment (ZAMPHIA) Survey.
    Cancer Control. 2024;31:10732748241307361.
    Abstract

  3428. COSTA T, Bateson D, Broutet N, Saville M, et al
    Eliminating cervical cancer: tackling inequity through human papillomavirus (HPV) test self-sampling.
    BMJ Sex Reprod Health. 2024 Dec 22:bmjsrh-2024-202536.
    Abstract

  3429. ZHU Y, Lv Y, Yao H, Chen Z, et al
    Qiu's Cervical Prescription inhibit the invasion and growth of cervical cancer through LncRNA ATB/miR-126 pathway.
    Pathol Res Pract. 2024;266:155784.
    Abstract

  3430. BANEGAS MP, O'Malley J, Kaufmann J, Marino M, et al
    Social risk factors and cancer prevention care among patients in community health-care settings.
    JNCI Cancer Spectr. 2024;8:pkae115.
    Abstract

  3431. BENAVIDEZ GA, Sedani AE, Felder TM, Asare M, et al
    Rural-urban disparities and trends in cancer screening: an analysis of Behavioral Risk Factor Surveillance System data (2018-2022).
    JNCI Cancer Spectr. 2024;8:pkae113.
    Abstract

  3432. LI Y, Wang W, Xu D, Liang H, et al
    PIWIL2/PDK1 Axis Promotes the Progression of Cervical Epithelial Lesions via Metabolic Reprogramming to Maintain Tumor-Initiating Cell Stemness.
    Adv Sci (Weinh). 2024;11:e2410756.
    Abstract

  3433. ARCIUOLO D, Scaglione G, Travaglino A, D'Alessandris N, et al
    Morphological and immunohistochemical evaluation in distinguishing post-radiotherapy serous-like endometrial change (PoRSEC) and serous endometrial intraepithelial carcinoma (SEIC).
    Virchows Arch. 2024;485:989-994.
    Abstract

  3434. UCAK R, Dilbaz OF, Polat N
    Analysis of the Differences between Bethesda Groups according to Conventional Smear and Liquid-Based Cytology Methods in Cervicovaginal Cytology: A Single-Center Experience with 165,915 Cases.
    Acta Cytol. 2024;68:54-59.
    Abstract

  3435. GAO Y, Zi D, Liang W, Qiu F, et al
    PAX1 and SOX1 Gene Methylation as a Detection and Triage Method for Cervical Intraepithelial Neoplasia Diagnosis.
    Acta Cytol. 2024;68:137-144.
    Abstract

  3436. ELGERT PA
    The Founding Pioneer Cytotechnologists: The Women Who Assisted George N. Papanicolaou, M.D., Ph.D. develop the Pap Test for Cervical Cancer Prevention.
    Acta Cytol. 2024 May 30. doi: 10.1159/000539566.
    Abstract

  3437. VRDOLJAK-MOZETIC D, Stemberger-Papic S, Versa Ostojic D, Rubesa R, et al
    Pitfalls in Gynecological Cytology: Review of the Common and Less Frequent Entities in Pap Test.
    Acta Cytol. 2024;68:281-298.
    Abstract

  3438. TANDON A, Kaur K, Shah M, Trivedi P, et al
    Role of Pap Smear Cervical Cytology in the Diagnosis of Extrauterine Malignancies: Largest Study of 104 Cases from Tertiary Care Cancer Centre in India.
    Acta Cytol. 2024;68:319-326.
    Abstract

  3439. LINDROTH Y, Pedersen L, Alssamaray J, Berglund T, et al
    Cervix cytology samples revealed increased methylation of the human markers FAM19A4/miR124-2 up to 8 years before adenocarcinoma.
    Acta Obstet Gynecol Scand. 2024;103:378-386.
    Abstract

  3440. BOHLIN KS, Brannstrom M, Dahm-Kahler P
    Gynecological cancer during pregnancy-From a gyne-oncological perspective.
    Acta Obstet Gynecol Scand. 2024 Jan 6. doi: 10.1111/aogs.14763.
    Abstract

  3441. HARRIS CA, Mandelbaum RS, Rau AR, Song BB, et al
    Contraception and sterilization selection at delivery among pregnant patients with malignancy.
    Acta Obstet Gynecol Scand. 2023 Aug 14. doi: 10.1111/aogs.14654.
    Abstract

  3442. FOTHERINGHAM P, Safi N, Li Z, Anazodo A, et al
    Pregnancy-associated gynecological cancer in New South Wales, Australia 1994-2013: A population-based historical cohort study.
    Acta Obstet Gynecol Scand. 2023 Mar 13. doi: 10.1111/aogs.14530.
    Abstract

  3443. CASSANI C, Dominoni M, Pasquali MF, Gardella B, et al
    The role of multiple high-risk human papillomavirus infection on the persistence recurrence of high-grade cervical lesions after standard treatment: A systematic review and a meta-analysis.
    Acta Obstet Gynecol Scand. 2024;103:1028-1035.
    Abstract

  3444. LINDQUIST S, Kjaer SK, Frederiksen K, Ornskov D, et al
    Clinical performance of human papillomavirus based cervical cancer screening algorithm: The result of a large Danish implementation study.
    Acta Obstet Gynecol Scand. 2024 Jul 16. doi: 10.1111/aogs.14915.
    Abstract

  3445. ERIKSEN DO, Randrup TH, Lycke KD, Damgaard RK, et al
    Time trends in the clinical management of cervical intraepithelial neoplasia grade 2: A Danish register-based study.
    Acta Obstet Gynecol Scand. 2024;103:1771-1780.
    Abstract

  3446. RANDRUP TH, Leeson S, Ciavattini A, Eldib A, et al
    Reproducibility of colposcopy quality indicators-A survey among members of the European Federation for Colposcopy.
    Acta Obstet Gynecol Scand. 2024;103:1745-1752.
    Abstract

  3447. BONDE J, Hammer A
    Discontinuation of cervical cancer screening for HPV-vaccinated women?
    Acta Obstet Gynecol Scand. 2024 Sep 24. doi: 10.1111/aogs.14978.
    Abstract

  3448. ZHANG J, Lian Z, Xue X, Li J, et al
    Does HPV vaccination during periconceptional or gestational period increase the risk of adverse pregnancy outcomes?-An updated systematic review and meta-analysis based on timing of vaccination.
    Acta Obstet Gynecol Scand. 2024 Aug 6. doi: 10.1111/aogs.14881.
    Abstract

  3449. TALIA KL, McCluggage WG
    Cervical Adenoid Basal Carcinoma With High-grade Squamous Component: True Mixed Carcinoma or Colonization of Adenoid Basal Carcinoma by High-grade Squamous Intraepithelial Lesion?
    Am J Surg Pathol. 2024;48:238-246.
    Abstract

  3450. RUIZ F, Tjendra Y, Millan N, Gomez-Fernandez C, et al
    Trichorhinophalangeal Syndrome Type 1 Immunohistochemical Expression in Carcinomas of Gynecologic Origin.
    Am J Surg Pathol. 2024 Feb 15. doi: 10.1097/PAS.0000000000002193.
    Abstract

  3451. DOWNHAM L, Jaafar I, Rol ML, Nyawira Nyaga V, et al
    Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
    Br J Cancer. 2023 Nov 16. doi: 10.1038/s41416-023-02490.
    Abstract

  3452. WANG Y, He M, He T, Ouyang X, et al
    Integrated genomic and transcriptomic analysis reveals the activation of PI3K signaling pathway in HPV-independent cervical cancers.
    Br J Cancer. 2024 Jan 22. doi: 10.1038/s41416-023-02555.
    Abstract

  3453. PORTNOY A, Pedersen K, Kim JJ, Burger EA, et al
    Vaccination and screening strategies to accelerate cervical cancer elimination in Norway: a model-based analysis.
    Br J Cancer. 2024 Apr 20. doi: 10.1038/s41416-024-02682.
    Abstract

  3454. REBOLJ M, Brentnall AR, Cuschieri K
    Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.
    Br J Cancer. 2024;130:1733-1743.
    Abstract

  3455. HIRAHARA Y, Shimizu K, Yamasaki S, Iyoda T, et al
    Crucial immunological roles of the invasion front in innate and adaptive immunity in cervical cancer.
    Br J Cancer. 2024 Oct 29. doi: 10.1038/s41416-024-02877.
    Abstract


  3456. New test for detecting cervical adenocarcinoma.
    Cancer. 2024;130:10.
    Abstract

  3457. BYTNAR JA, McGlynn KA, Nealeigh MD, Shriver CD, et al
    Cancer incidence in the US military: An updated analysis.
    Cancer. 2024;130:96-106.
    Abstract

  3458. KNISELY A, Ahmed J, Stephen B, Piha-Paul SA, et al
    Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies.
    Cancer. 2023 Oct 21. doi: 10.1002/cncr.35063.
    Abstract

  3459. MICHEL AD, Fontenot HB, Fuzzell L, Brownstein NC, et al
    Attitudes toward the American Cancer Society's 2020 cervical cancer screening guidelines: A qualitative study of a national sample of US clinicians.
    Cancer. 2024 Mar 4. doi: 10.1002/cncr.35269.
    Abstract

  3460. NIERENGARTEN MB
    Promising new treatment approaches for locally advanced cervical cancer.
    Cancer. 2024;130:1192.
    Abstract

  3461. MEGHANI K, Puri P, Bazzett-Matabele L, Vuylsteke P, et al
    Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
    Cancer. 2024 Mar 26. doi: 10.1002/cncr.35289.
    Abstract

  3462. LEE H, Baeker Bispo J, Pal Choudhury P, Wiese D, et al
    Factors contributing to differences in cervical cancer screening in rural and urban community health centers.
    Cancer. 2024 Mar 25. doi: 10.1002/cncr.35265.
    Abstract

  3463. DUSKA LR, Podwika SE, Randall LM
    Top advances of the year: Cervical cancer.
    Cancer. 2024 Apr 23. doi: 10.1002/cncr.35334.
    Abstract

  3464. STERPETTI AV, Gabriele R, Iannone I, Dimarzo L, et al
    National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough.
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35335.
    Abstract

  3465. RUAN Y, Heer E, Brenner DR
    Reply to "National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough".
    Cancer. 2024 Apr 20. doi: 10.1002/cncr.35339.
    Abstract

  3466. ISSAKA RB, Ibekwe LN, Todd KW, Burnett-Hartman AN, et al
    Association between racial residential segregation and screening uptake for colorectal and cervical cancer among Black and White patients in five US health care systems.
    Cancer. 2024 Aug 9. doi: 10.1002/cncr.35514.
    Abstract

  3467. MEGHANI K, Grover S
    Reply to "Assessing the impact of HIV status on cervical cancer treatment outcomes in Botswana: A commentary".
    Cancer. 2024 Sep 10. doi: 10.1002/cncr.35553.
    Abstract

  3468. JEYARAJ G
    Assessing the impact of HIV status on cervical cancer treatment outcomes in Botswana: A commentary.
    Cancer. 2024 Sep 10. doi: 10.1002/cncr.35545.
    Abstract

  3469. HENDRIX EL, Chollette VY, Wentzensen N, Loukissas JK, et al
    Federal Cervical Cancer Collaborative: Improving cervical cancer prevention through vaccination, screening, and management in safety-net settings of care.
    Cancer. 2024 Dec 11. doi: 10.1002/cncr.35655.
    Abstract

  3470. OAKNIN A, Ghamande SA, Kasamatsu Y, Gil-Martin M, et al
    Phase 1 trial of first-line bintrafusp alfa in patients with locally advanced or persistent/recurrent/metastatic cervical cancer.
    Clin Cancer Res. 2024 Jan 2. doi: 10.1158/1078-0432.CCR-23-1829.
    Abstract

  3471. LUKOVIC J, Pintilie M, Han K, Fyles AW, et al
    An immune gene expression risk score for distant metastases after radiotherapy for cervical cancer.
    Clin Cancer Res. 2024 Jan 5. doi: 10.1158/1078-0432.CCR-23-2085.
    Abstract

  3472. LOU H, Cai H, Huang X, Li G, et al
    Cadonilimab combined with chemotherapy with or without bevacizumab as first-line treatment in recurrent or metastatic cervical cancer (COMPASSION-13): a phase 2 study.
    Clin Cancer Res. 2024 Feb 19. doi: 10.1158/1078-0432.CCR-23-3162.
    Abstract

  3473. SIVARS L, Jylha C, Crona Guterstam Y, Zupancic M, et al
    Cell-free human papillomavirus (HPV) DNA is a sensitive biomarker for prognosis and for early detection of relapse in locally advanced cervical cancer.
    Clin Cancer Res. 2024 Apr 26. doi: 10.1158/1078-0432.CCR-23-3941.
    Abstract

  3474. CHAMBERS L, Haight P, Chalif J, Mehra Y, et al
    Bridging the Gap from Bench to Bedside: A Call for In Vivo Preclinical Models to Advance Endometrial Cancer and Cervical Cancer Immuno-Oncology Research.
    Clin Cancer Res. 2024 Apr 25. doi: 10.1158/1078-0432.CCR-23-2570.
    Abstract

  3475. SHETH SS, Oh JE, Bellone S, Siegel ER, et al
    Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
    Clin Cancer Res. 2024;30:1768-1777.
    Abstract

  3476. BONFILL-TEIXIDOR E, Neva-Alejo A, Arias A, Cuartas I, et al
    Cervical Cancer Evades the Host Immune System Through the Inhibition of Type I Interferon and CXCL9 by LIF.
    Clin Cancer Res. 2024 Jul 30. doi: 10.1158/1078-0432.CCR-24-0385.
    Abstract

  3477. SEO A, Xiao W, Gjyshi O, Yoshida-Court K, et al
    Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Cervical Cancer Patients Undergoing Definitive Chemoradiation.
    Clin Cancer Res. 2024 Dec 16. doi: 10.1158/1078-0432.CCR-24-2343.
    Abstract

  3478. GUPTA N, Jain V, Srinivasan R, Singh T, et al
    Tall-columnar glandular cells in SurePath liquid-based cytology Pap sample: Learning from mimics/pitfalls.
    Cytopathology. 2024;35:510-514.
    Abstract

  3479. CIANFRINI F, d'Amati A, Arciuolo D, Travaglino A, et al
    Atypical glandular cells and predictive features of malignancy in Pap smears: A retrospective monocentric study.
    Cytopathology. 2024;35:473-480.
    Abstract

  3480. KOYANAGI T, Fujiwara H, Yamamoto K, Suzuki M, et al
    Cervical cancer screening efficacy using SurePath, ThinPrep and conventional cytology: A large data set analysis from the Japan Cancer Society.
    Cytopathology. 2024 Aug 8. doi: 10.1111/cyt.13431.
    Abstract

  3481. GOKKAYA M, Alci A, Aytekin O, Unsal M, et al
    Does HPV-18 co-infection increase the risk of cervical pathology in individuals with HPV-16?
    Cytopathology. 2024;35:757-760.
    Abstract

  3482. LEE KH, Kim NI, Nam JH, Kim SS, et al
    Gastric-type adenocarcinoma of the uterine cervix presenting in urine cytology specimens: A case report and literature review.
    Diagn Cytopathol. 2023 Dec 22. doi: 10.1002/dc.25268.
    Abstract

  3483. MAHAJAN P, Kaur P
    Improving cervical cancer classification in PAP smear images with enhanced segmentation and deep progressive learning-based techniques.
    Diagn Cytopathol. 2024 Mar 22. doi: 10.1002/dc.25295.
    Abstract

  3484. ALY FZ, Irhayyim A, Jordan R, Mukhtar F, et al
    Prevalence of non 16/18 high risk human papilloma virus as a quality metric in gynecological cytology.
    Diagn Cytopathol. 2024 Apr 23. doi: 10.1002/dc.25327.
    Abstract

  3485. YAVUZ O, Karaca I
    Letter to "Correlation of immediate prevalence of cervical squamous cell precancers and cancers with HPV genotype and age in women with LSIL cytology".
    Diagn Cytopathol. 2024;52:400.
    Abstract

  3486. CHEN L, Niu S, Zhou F
    Letter to "Correlation of immediate prevalence of cervical squamous cell precancers and cancers with HPV genotype and age in women with LSIL cytology".
    Diagn Cytopathol. 2024;52:401.
    Abstract

  3487. FASANYA-MAKU H, Petty D, Knapik J, Leon M, et al
    A case of metastatic HPV-related cervical small cell neuroendocrine carcinoma with varying cytomorphology found in cytological specimens of a solid organ transplant recipient.
    Diagn Cytopathol. 2024;52:E202-E207.
    Abstract

  3488. NEGRI G, Tauber M, Pinamonti M, Golinelli L, et al
    Diagnostic Agreement in Whole Slide Digital Images of Cervical Cytology and Cell Blocks.
    Diagn Cytopathol. 2025;53:43-47.
    Abstract

  3489. WOO CG, Son SM, Hwang HK, Bae JS, et al
    Sensitivity, Specificity, and Cost-Benefit Effect Between Primary Human Papillomavirus Testing, Primary Liquid-Based Cytology, and Co-Testing Algorithms for Cervical Lesions.
    Diagn Cytopathol. 2025;53:35-42.
    Abstract

  3490. GAFEER MM, Alperstein S, Appleby R, Carniello JS, et al
    Unsatisfactory Pap Test Results: A Critical Patient Management Problem Pre-Analytically Addressed by the Cytopathology Laboratory.
    Diagn Cytopathol. 2025;53:10-17.
    Abstract

  3491. TANAKA LF, Schoffer O, Schriefer D, Schauberger G, et al
    An audit of 1632 routinely collected cervical cancer screening smears from 398 women in Germany: Results from the TeQaZ Study.
    Eur J Cancer. 2024;201:113915.
    Abstract

  3492. TUNINETTI V, Virano E, Salutari V, Ricotti A, et al
    Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study.
    Eur J Cancer. 2024;203:114039.
    Abstract

  3493. BIZZARRI N, Querleu D, Ramirez PT, Dostalek L, et al
    Survival associated with the use of sentinel lymph node in addition to lymphadenectomy in early-stage cervical cancer treated with surgery alone: A sub-analysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study.
    Eur J Cancer. 2024;211:114310.
    Abstract

  3494. WENZEL HHB, Schnack TH, Van der Aa MA, Jensen PT, et al
    Risk factors for lymph node metastasis in women with FIGO 2018 IA cervical cancer with a horizontal spread of > 7 mm.
    Eur J Cancer. 2024;212:115063.
    Abstract

  3495. WU J, Wang R, Chen W, Wu Y, et al
    Immunohistochemical markers Ki67 and P16 help predict prognosis in locally advanced cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;294:210-216.
    Abstract

  3496. COLONETTI T, Rodrigues Uggioni ML, Meller Dos Santos AL, Michels Uggioni N, et al
    Self-sampling for HPV testing in cervical cancer screening: A scoping review.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:20-51.
    Abstract

  3497. ALVES FIRMEZA M, de Vasconcelos Oliveira NM, Mendes Alves F, Teixeira Moreira Vasconcelos C, et al
    Urinary symptoms and sexual function after hysterectomy secondary to cervical cancer: A prospective, cohort study.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:208-214.
    Abstract

  3498. ASHMORE AA, Abdul S, Phillips A, Bali A, et al
    Regular follow-up with cervical cytology is of questionable value following surgical treatment of microinvasive cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:307-310.
    Abstract

  3499. CEA GARCIA J, Rodriguez Jimenez I, Marquez Maraver F, Rios-Pena L, et al
    Quality of life in long-term cervical cancer survivors compared with healthy women and women with benign gynecological disorders.
    Eur J Obstet Gynecol Reprod Biol. 2024;297:78-85.
    Abstract

  3500. LUO Y, Ma X
    Construction and efficacy test of a survival prediction model for locally advanced cervical cancer based on anti-angiogenesis.
    Eur J Obstet Gynecol Reprod Biol. 2024;297:72-77.
    Abstract

  3501. LIU S, Zhang W, Wang W, Zheng J, et al
    Topical delivery of drugs in the treatment of high-grade cervical squamous intraepithelial lesions: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;296:131-139.
    Abstract

  3502. WANG D, Fang X
    Meta-analysis of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2024;297:202-208.
    Abstract

  3503. TJALMA WAA, Konno R, van Heerden J
    The deadlock on HPV vaccination in Japan is almost broken!
    Eur J Obstet Gynecol Reprod Biol. 2024;297:267-269.
    Abstract

  3504. GARCIA JC, Maraver FM, Rodriguez Jimenez I, Rios-Pena L, et al
    Female sexual function in long-term cervical cancer survivors compared with healthy women and women affected by benign gynecological disorders.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:43-53.
    Abstract

  3505. LIU N, Ma S
    A case of cervical rhabdomyosarcoma in a 17-year-old woman and literature review.
    Eur J Obstet Gynecol Reprod Biol. 2024;298:210-211.
    Abstract

  3506. WANG ZY, Li R, Li RZ, Pei KG, et al
    Prognostic value of human papillomavirus cell-free DNA in cervical cancer patients: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;300:211-218.
    Abstract

  3507. ABU-ZAID A, Baradwan S, Alyafi M, Al Baalharith M, et al
    Association between polycystic ovary syndrome and the risk of malignant gynecologic cancers (ovarian, endometrial, and cervical): A population-based study from the U.S.A. National Inpatient Sample 2016-2019.
    Eur J Obstet Gynecol Reprod Biol. 2024;299:283-288.
    Abstract

  3508. ZHAO C, Yu W, Yang L
    Letter to editor regarding the article "Brachytherapy and surgery versus surgery alone for IB2 (FIGO 2018) cervical cancers: A FRANCOGYN study".
    Eur J Obstet Gynecol Reprod Biol. 2024 Aug 3:S0301-2115(24)00423.
    Abstract

  3509. REUSCHENBACH M, Valente S, Takyar J, Dhawan A, et al
    Treatment characteristics, HPV genotype distribution and risk of subsequent disease among women with high-grade cervical intraepithelial neoplasia in Europe: A systematic literature review.
    Eur J Obstet Gynecol Reprod Biol. 2024;300:129-140.
    Abstract

  3510. SEPODES B, Rebelo T, Santos F, Oliveira D, et al
    Optimization of HPV-positive women triage with p16/Ki67 dual staining cytology in an organized cervical cancer screening program in the center region of Portugal.
    Eur J Obstet Gynecol Reprod Biol. 2024;302:111-115.
    Abstract

  3511. VALANTIN L, Bertolotti A, Chirpaz E, Ah Pine F, et al
    High risk human papillomavirus prevalence and genotype distribution in Reunion Island.
    Eur J Obstet Gynecol Reprod Biol. 2024;301:114-119.
    Abstract

  3512. MCGEE AE, Hawco S, Bhattacharya S, Hanley SJB, et al
    Alternatives to surveillance for persistent human papillomavirus after a positive cervical screen: A systematic review and meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;302:332-338.
    Abstract

  3513. COBBINAH P, Zheng Zheng S, Oklah F, Yuyang Z, et al
    Comparative analysis of Paiteling a traditional Chinese medicine (TCM) and CO2 laser therapy for high-risk HPV-associated with LSIL (CIN1) lesions.
    Eur J Obstet Gynecol Reprod Biol. 2024;302:81-86.
    Abstract

  3514. ACCORSI GS, Zanon JR, Santos MHD, Ubinha ACF, et al
    Cervical cancer in young women: Does age impact survival in cervical cancer?
    Eur J Obstet Gynecol Reprod Biol. 2024;305:67-74.
    Abstract

  3515. HALLE MK, Bozickovic O, Forsse D, Wagner-Larsen KS, et al
    Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer.
    Gynecol Oncol. 2023;181:110-117.
    Abstract

  3516. RIVES TA, Orellana TJ, Mumford BS, Sukumvanich P, et al
    The role of obesity in treatment planning for early-stage cervical cancer.
    Gynecol Oncol. 2023;181:60-67.
    Abstract

  3517. TJIOE KC, Miranda-Galvis M, Johnson MS, Agrawal G, et al
    The interaction between social determinants of health and cervical cancer survival: A systematic review.
    Gynecol Oncol. 2023;181:141-154.
    Abstract

  3518. FRIEDMAN CF, D'Souza A, Bello Roufai D, Tinker AV, et al
    Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.
    Gynecol Oncol. 2024;181:162-169.
    Abstract

  3519. MANNING-GEIST B, Grace MA, Sonoda Y
    Trachelectomy and fertility-sparing procedures for early-stage cervical cancer: A state of the science review.
    Gynecol Oncol. 2024;181:179-182.
    Abstract

  3520. LEE SS, Gold HT, Kwon SC, Pothuri B, et al
    Guideline concordant care for patients with locally advanced cervical cancer by disaggregated Asian American and Native Hawaiian/Pacific Islander groups: A National Cancer Database Analysis.
    Gynecol Oncol. 2024;182:132-140.
    Abstract

  3521. DORISMOND VG, Saraiya M, Gopalani SV, Soman A, et al
    Variation in cervical cancer screening test utilization and results in a United States-based program.
    Gynecol Oncol. 2024;184:96-102.
    Abstract

  3522. BEFANO B, Wentzensen N, Lorey T, Poitras N, et al
    Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California.
    Gynecol Oncol. 2024;184:89-95.
    Abstract

  3523. KUCERA CW, Chappell NP, Tian C, Richardson MT, et al
    Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
    Gynecol Oncol. 2024;184:224-235.
    Abstract

  3524. DINICU AI, Dioun S, Wang Y, Huang Y, et al
    Survival rates in Hispanic/Latinx subpopulations with cervical cancer associated with disparities in guideline-concordant care.
    Gynecol Oncol. 2024;184:214-223.
    Abstract

  3525. ROOF KA, Wichmann HK, Carlton LJ, Nguyen ML, et al
    Factors associated with loss to follow up after abnormal cervical cancer screening in pregnancy.
    Gynecol Oncol. 2024;185:46-50.
    Abstract

  3526. NASIOUDIS D, Gysler S, Latif N, Cory L, et al
    Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions.
    Gynecol Oncol. 2023;180:1-5.
    Abstract

  3527. PELTECU G
    Eugen Bogdan Aburel, a pioneer of fertility sparing surgery.
    Gynecol Oncol. 2024;181:40-45.
    Abstract

  3528. ROSS DH, Gomez K, Harmon G, Mysz ML, et al
    Evaluating outcomes and toxicities for a newly implemented MRI-based brachytherapy program for cervical cancer.
    Gynecol Oncol. 2024;183:33-38.
    Abstract

  3529. GASS P, Thiel FC, Haberle L, Ackermann S, et al
    Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer.
    Gynecol Oncol. 2024;183:25-32.
    Abstract

  3530. CHOI KH, Lee HC, Kim YS, Park W, et al
    Diagnostic assessments and treatment results of well-differentiated gastric-type adenocarcinoma of the uterine cervix (Adenoma malignum): A multicenter retrospective analysis of KROG 22-03 study.
    Gynecol Oncol. 2024;182:45-50.
    Abstract

  3531. VESZTERGOM D, Teglas G, Bahrehmand K, Torok A, et al
    Reducing radicality in fertility-sparing surgery is associated with improved in vitro fertilization outcome in early-stage cervical cancer: A national retrospective study.
    Gynecol Oncol. 2024;186:35-41.
    Abstract

  3532. CHIBA Y, Kojima Y, Yazaki S, Yoshida H, et al
    Trop-2 expression and the tumor immune microenvironment in cervical cancer.
    Gynecol Oncol. 2024;187:51-57.
    Abstract

  3533. HUNSBERGER KS, Treiman S, Monk BJ, Tewari KS, et al
    A systematic review of stage IVA cervical cancer treatment: Challenges in the management of an understudied group.
    Gynecol Oncol. 2024;187:120-127.
    Abstract

  3534. PERSSON J, Luhrs O, Geppert B, Ekdahl L, et al
    A prospective study evaluating an optimized sentinel node algorithm in early stage cervical cancer: The PROSACC-study.
    Gynecol Oncol. 2024;187:178-183.
    Abstract

  3535. WALKER CA, Edwards C, McIntire D, Makepeace L, et al
    Predicting VTE and utility of thromboprophylaxis in metastatic and recurrent cervical cancer.
    Gynecol Oncol. 2024;188:22-26.
    Abstract

  3536. CHALIF J, Kistenfeger Q, Fulton J, Morton M, et al
    Diagnosis and management of gastric-type endocervical adenocarcinoma: A case report and review of the literature.
    Gynecol Oncol. 2024;185:165-172.
    Abstract

  3537. NICA A, Benseler A, Parbhakar A, Fortin LT, et al
    Robotic versus vaginal radical trachelectomy for reproductive-aged patients with early-stage cervical carcinoma: A multi-center cohort study.
    Gynecol Oncol. 2024;185:95-100.
    Abstract

  3538. MACCHIA G, Cilla S, Pezzulla D, Campitelli M, et al
    Efficacy of stereotactic body radiotherapy and response prediction using artificial intelligence in oligometastatic gynaecologic cancer.
    Gynecol Oncol. 2024;184:16-23.
    Abstract

  3539. KA K, Cordoba A, Cagetti LV, Schiappa R, et al
    Preoperative brachytherapy of early-stage cervical cancer: A multicenter study by the SFRO brachytherapy group.
    Gynecol Oncol. 2024;188:90-96.
    Abstract

  3540. KOCIAN R, Kohler C, Bajsova S, Jarkovsky J, et al
    Sentinel lymph node pathological ultrastaging: Final outcome of the Sentix prospective international study in patients with early-stage cervical cancer.
    Gynecol Oncol. 2024;188:83-89.
    Abstract

  3541. O'CONNOR RM, Huang DS, Rimel BJ, Kim KH, et al
    Unmet financial needs among patients crowdfunding to support gynecologic cancer care.
    Gynecol Oncol. 2024;186:199-203.
    Abstract

  3542. BERGSTEIN A, Huang Y, Hershman DL, Xu X, et al
    Impact of medicaid expansion on cervical cancer screening: A state-specific difference in difference analysis.
    Gynecol Oncol. 2024;189:49-55.
    Abstract

  3543. DA COSTA AABA, Souza RP, Pandolfi NC, de Souza Castro F, et al
    Should we consider progression-free survival benefits enough for drug approvals in locally advanced cervical cancer?
    Gynecol Oncol. 2024;189:109-110.
    Abstract

  3544. ADOLPH L, Mann A, Liu XQ, Roberts L, et al
    Follow-up of women with cervical adenocarcinoma in situ treated by conization: A single centre clinical experience.
    Gynecol Oncol. 2024;187:74-79.
    Abstract

  3545. FROEDING LP, Jensen PT
    Commentary on "Simple versus radical hysterectomy in women with low-risk cervical cancer" by Plante M. et al. published in The New England Journal of Medicine.
    Gynecol Oncol. 2024;189:137.
    Abstract

  3546. WAGAR MK, Patel UJ, Bharucha K, Heisler CA, et al
    Postoperative urinary retention by void trial methodology following radical hysterectomy for cervical cancer.
    Gynecol Oncol. 2024;190:90-95.
    Abstract

  3547. MILLER EA, Chowdhary B, Chapman-Davis E
    Beyond the decision: Reproductive justice and cervical cancer care in a post-Dobbs era.
    Gynecol Oncol. 2024;190:186-188.
    Abstract

  3548. FRICOVA L, Kommoss S, Scambia G, Ferron G, et al
    Reproductive outcomes after fertility-sparing surgery for cervical cancer - results of the multicenter FERTISS study.
    Gynecol Oncol. 2024;190:179-185.
    Abstract

  3549. CHUK E, Conway JL, Hanuschak J, Han K, et al
    Patient-reported sexual health outcomes of cervical cancer patients treated with definitive chemoradiation and MRI-guided brachytherapy.
    Gynecol Oncol. 2024;190:153-159.
    Abstract

  3550. LIM H, Kim SI, Kim MK, Yoon SH, et al
    Initial sarcopenia and body composition changes as prognostic factors in cervical cancer patients treated with concurrent chemoradiation: An artificial intelligence-based volumetric study.
    Gynecol Oncol. 2024;190:200-208.
    Abstract

  3551. MONK BJ, Tewari KS, Randall LM, Pothuri B, et al
    Immunotherapy in locally advanced cervix cancer: A critical appraisal of the FDA indication based on ENGOT-CX11/GOG-3047/KEYNOTE-A18.
    Gynecol Oncol. 2024;188:81-82.
    Abstract

  3552. NGUYEN L, Chung TH, Le YL, Reygaerts H, et al
    Hispanic individuals' cervical cancer screening disparities amidst the COVID-19 pandemic.
    Gynecol Oncol. 2024;190:243-249.
    Abstract

  3553. FULLERTON R, Martell K, Khanolkar R, Phan T, et al
    Impact of immune, inflammatory and nutritional indices on outcome in patients with locally advanced cervical cancer treated with definitive (chemo)radiotherapy.
    Gynecol Oncol. 2024;190:291-297.
    Abstract

  3554. LINDQUIST S, Kjaer SK, Frederiksen K, Ornskov D, et al
    Comparative analysis of HPV testing versus cytology in Danish cervical cancer screening: Insights from a large-scale implementation study.
    Gynecol Oncol. 2024;191:45-55.
    Abstract

  3555. YANG X, Li C, Li Z, Du D, et al
    The clinical value of ultrasound-guided sacral anesthesia in Intracavitary and/or interstitial brachytherapy for cervical Cancer.
    Gynecol Oncol. 2024;191:31-36.
    Abstract

  3556. NG ZY, Manchanda R, Lopez A, Obermair A, et al
    The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN study.
    Gynecol Oncol. 2024;191:95-99.
    Abstract

  3557. LI G, Li X, Yin R, Feng M, et al
    Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer.
    Gynecol Oncol. 2024;191:165-171.
    Abstract

  3558. ELAYAPILLAI SP, Dogra S, Lausen J, Parker M, et al
    ATR inhibition increases reliance on PARP-mediated DNA repair revealing an improved therapeutic strategy for cervical cancer.
    Gynecol Oncol. 2024;191:182-193.
    Abstract

  3559. HUNSBERGER KS, Tewari KS, Monk BJ, Chase DM, et al
    Standard of care treatment for stage IVB cervical cancer: A systematic review and meta-analysis.
    Gynecol Oncol. 2024;191:259-264.
    Abstract

  3560. JAIN D, Zaeim F, Wahidi M, Smith WJ, et al
    Cervical squamous cell carcinoma outcomes across continents: A retrospective study.
    Gynecol Oncol. 2024;190:272-282.
    Abstract

  3561. CHOI YK, Lee JH, Kim YS, Wee CW, et al
    Mid-treatment MRI-based tumor response assessment for tumor recurrence and patient survival in locally advanced adenocarcinoma of the cervix: A retrospective multicenter study of KROG 23-03.
    Gynecol Oncol. 2024;190:222-229.
    Abstract

  3562. NONZEE NJ, Thiel de Bocanegra H, Navarro S, Bastani R, et al
    Impact of management guidelines for abnormal cervical cytology on colposcopy procedure rates among young women.
    Gynecol Oncol. 2024;190:160-166.
    Abstract

  3563. DE JAEGHERE EA, Hamerlinck H, Tuyaerts S, Lippens L, et al
    Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial.
    Gynecol Oncol. 2024;191:275-286.
    Abstract

  3564. WONG TY, Adzibolosu NK, Mattei LH, Speak AC, et al
    Disparities in contemporary human papilloma virus vaccination uptake among adult women living in the United States: An All of Us Research Program study.
    Gynecol Oncol. 2024;191:100-105.
    Abstract

  3565. CHOUCHANE-MLIK O, Oniga A, Latouche A, Halladjian M, et al
    Systematic assessment of tumor necrosis at baseline in cervical cancer - An independent factor associated with poor outcome.
    Hum Pathol. 2023;143:62-70.
    Abstract

  3566. DASHTI NK, Swanson AA, Bentz J, Xing D, et al
    DICER1-sarcomas of GYN tract: Expanding on an emerging entity.
    Hum Pathol. 2024;152:105636.
    Abstract

  3567. LEHTINEN M, Bruni L, Elfstrom M, Gray P, et al
    Scientific approaches toward improving cervical cancer elimination strategies.
    Int J Cancer. 2024 Jan 9. doi: 10.1002/ijc.34839.
    Abstract

  3568. AMBOREE TL, Damgacioglu H, Sonawane K, Adsul P, et al
    Recent trends in cervical cancer incidence, stage at diagnosis, and mortality according to county-level income in the United States, 2000-2019.
    Int J Cancer. 2024 Jan 25. doi: 10.1002/ijc.34860.
    Abstract

  3569. PORTNOY A, Pedersen K, Sy S, Trope A, et al
    Cost-effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model-based analysis.
    Int J Cancer. 2024;154:1073-1081.
    Abstract

  3570. LI N, Yi H, Sun W, Sundquist J, et al
    Revealing genes associated with cervical cancer in distinct immune cells: A comprehensive Mendelian randomization analysis.
    Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34911.
    Abstract

  3571. STERPETTI AV, Gabriele R, Iannone I, Sapienza P, et al
    Reduced adherence to cervical cancer screening. The importance of information and education for women with low education and low-income.
    Int J Cancer. 2024 Mar 6. doi: 10.1002/ijc.34907.
    Abstract

  3572. OLTHOF EMG, Aitken CA, Siebers AG, van Kemenade FJ, et al
    The impact of loss to follow-up in the Dutch organised HPV-based cervical cancer screening programme.
    Int J Cancer. 2024 Mar 4. doi: 10.1002/ijc.34902.
    Abstract

  3573. DOWNHAM L, Rol ML, Forestier M, Romero P, et al
    Field experience with the 8-HPV-type oncoprotein test for cervical cancer screening among HPV-positive women living with and without HIV in LMICs.
    Int J Cancer. 2024 Apr 11. doi: 10.1002/ijc.34953.
    Abstract

  3574. WEN TM, Xu XQ, Zhao XL, Pan CH, et al
    Efficacy and immunogenicity of AS04-HPV-16/18 vaccine in females with existing cervical HR-HPV infection at first vaccination: A pooled analysis of four large clinical trials worldwide.
    Int J Cancer. 2024 Feb 17. doi: 10.1002/ijc.34882.
    Abstract

  3575. GILHAM C, Nedjai B, Scibior-Bentkowska D, Reuter C, et al
    Long-term prediction by DNA methylation of high-grade cervical intraepithelial neoplasia: Results of the ARTISTIC cohort.
    Int J Cancer. 2024;155:81-92.
    Abstract

  3576. LINDQUIST S, Frederiksen K, Petersen LK, Kjaer SK, et al
    The risk of vaginal, vulvar and anal precancer and cancer according to high-risk HPV status in cervical cytology samples.
    Int J Cancer. 2024 Feb 28. doi: 10.1002/ijc.34896.
    Abstract

  3577. HANSEN BT, Nygard M, Castle PE, Burger EA, et al
    Sociodemographic characteristics associated with cervical cancer screening participation by send-to-all and opt-in HPV self-sampling: Who benefits? Results from a randomized controlled trial among long-term non-attending women in Norway.
    Int J Cancer. 2024 May 15. doi: 10.1002/ijc.34989.
    Abstract

  3578. LOBIN C, Orang'o EO, Were E, Muthoka K, et al
    Cost-effectiveness analysis of alternative screening strategies for the detection of cervical cancer among women in rural areas of Western Kenya.
    Int J Cancer. 2024 May 27. doi: 10.1002/ijc.35036.
    Abstract

  3579. FUJITA M, Nagashima K, Shimazu M, Suzuki M, et al
    Effectiveness of self-sampling human papillomavirus test on precancer detection and screening uptake in Japan: The ACCESS randomized controlled trial.
    Int J Cancer. 2024;155:905-915.
    Abstract

  3580. BUDUKH A, Dora T, Sancheti S, Singh V, et al
    Outcome of early detection approach in control of breast, cervical, and oral cancer: Experience from a rural cancer center in India.
    Int J Cancer. 2024 Apr 20. doi: 10.1002/ijc.34966.
    Abstract

  3581. LYNGE E, Bennekou Schroll J, Andersen B, Balasubramaniam K, et al
    Cervical cancer incidence in Denmark: Disentangling determinants of time trend.
    Int J Cancer. 2024 Jul 14. doi: 10.1002/ijc.35081.
    Abstract

  3582. CUI M, Song L, Mao R, Lyu Y, et al
    Exposure to polycyclic aromatic hydrocarbons promotes the progression of low-grade cervical intraepithelial neoplasia: A population-based cohort study in China.
    Int J Cancer. 2024;155:1162-1171.
    Abstract

  3583. SCHAAFSMA M, van den Helder R, Mom CH, Steenbergen RDM, et al
    Recurrent cervical cancer detection using DNA methylation markers in self-collected samples from home.
    Int J Cancer. 2024 Aug 22. doi: 10.1002/ijc.35143.
    Abstract

  3584. CHEN J, Shi J, Cao Y, Li C, et al
    A new treatment approach of toripalimab in combination with concurrent platinum-based chemoradiotherapy for locally advanced cervical cancer: A phase II clinical trial.
    Int J Cancer. 2024 Sep 28. doi: 10.1002/ijc.35206.
    Abstract

  3585. OSTRBENK VALENCAK A, Kroon KR, Fabjan D, Mlakar J, et al
    Clinically validated HPV assays offer comparable long-term safety in primary cervical cancer screening: A 9-year follow-up of a population-based screening cohort.
    Int J Cancer. 2024 Sep 24. doi: 10.1002/ijc.35200.
    Abstract

  3586. MISHRA GA, Pimple SA, Anand KV, Kulkarni VY, et al
    Acceptability and validity of HPV self-sampling for cervical cancer screening among women living in different ecological settings in India.
    Int J Cancer. 2024 Oct 16. doi: 10.1002/ijc.35222.
    Abstract

  3587. LEHTINEN M, Elfstrom M, Vanska S, Dillner J, et al
    Elimination of cervical cancer by refined vaccination and screening.
    Int J Cancer. 2024 Oct 25. doi: 10.1002/ijc.35228.
    Abstract

  3588. KOKEMULLER L, Ramachandran D, Schurmann P, Geffers R, et al
    Germline variants of homology-directed repair or mismatch repair genes in cervical cancer.
    Int J Cancer. 2024 Oct 23. doi: 10.1002/ijc.35221.
    Abstract

  3589. DESCAMPS P, Bosch Jose FX, Monsonego J, Neisingh O, et al
    Cervical cancer screening: Sharing best practices and addressing common challenges in cervical cancer screening programs.
    Int J Cancer. 2024 Oct 26. doi: 10.1002/ijc.35220.
    Abstract

  3590. LOUVANTO K, Verhoef L, Pimenoff V, Eriksson T, et al
    Low methylation marker levels among human papillomavirus-vaccinated women with cervical high-grade squamous intraepithelial lesions.
    Int J Cancer. 2024;155:1549-1557.
    Abstract

  3591. LIU H, Zou M, Shen M, Kamarulzaman A, et al
    HPV vaccination is highly effective and cost-effective for cervical cancer prevention in women living with HIV in China: A cost-effectiveness analysis.
    Int J Cancer. 2024 Nov 17. doi: 10.1002/ijc.35242.
    Abstract

  3592. ARROYO MUHR LS, Wang J, Hassan SS, Yilmaz E, et al
    Nationwide registry-based trial of risk-stratified cervical screening.
    Int J Cancer. 2025;156:379-388.
    Abstract

  3593. MORO F, Ciancia M, Zace D, Vagni M, et al
    Role of artificial intelligence applied to ultrasound in gynecology oncology: A systematic review.
    Int J Cancer. 2024 Jul 11. doi: 10.1002/ijc.35092.
    Abstract

  3594. DEBEAUDRAP P, Kabore FN, Setha L, Tegbe J, et al
    Performance of visual inspection, partial genotyping, and their combination for the triage of women living with HIV who are screen positive for human papillomavirus: Results from the AIMA-CC ANRS 12375 multicentric screening study.
    Int J Cancer. 2024 Sep 25. doi: 10.1002/ijc.35190.
    Abstract

  3595. TANG X, Zhang X, Ding Y, Zhang Y, et al
    A long-term retrospective analysis of management of cervical cancer during pregnancy.
    Int J Gynaecol Obstet. 2023 Dec 27. doi: 10.1002/ijgo.15314.
    Abstract

  3596. MARINO-NOYA A, Magallanes-Pelaez N, Puga-Gonzalez N, Conde-Ferreiros M, et al
    Cervical carcinosarcoma, report of some cases and a literature review.
    Int J Gynaecol Obstet. 2024;164:795-796.
    Abstract

  3597. JIA L, Wang L, Zheng J, Lu J, et al
    Ureter metastasis from a primary cervical malignancy 3 years after initial treatment.
    Int J Gynaecol Obstet. 2024;164:793-794.
    Abstract

  3598. SABEENA S, Ravishankar N, Kalpana MM
    Implementation strategies of cervical cancer screening in South Asia: A systematic review.
    Int J Gynaecol Obstet. 2024 Jan 24. doi: 10.1002/ijgo.15366.
    Abstract

  3599. XU JY, Hu M, Wu SG, Zhou J, et al
    Local treatment strategies in Stage IVB cervical squamous cell carcinoma and adenocarcinoma.
    Int J Gynaecol Obstet. 2024;164:1053-1063.
    Abstract

  3600. STRATULAT V, Melamed N, Barrett J, Ladhani NNN, et al
    Cervical assessment certification and its impact on performance quality in the context of universal cervical screening.
    Int J Gynaecol Obstet. 2024;164:951-958.
    Abstract

  3601. PATEL A, Suneja A, Malik R, Gupta B, et al
    Chromocolposcopy with fluorescein sodium for detection of premalignant and malignant lesions of the cervix: A cross-sectional study.
    Int J Gynaecol Obstet. 2024;165:169-175.
    Abstract

  3602. LUCKETT R, Ramogola-Masire D, Gompers A, Moraka N, et al
    Triage of HPV positivity in a high HIV prevalence setting: A prospective cohort study comparing visual triage methods and HPV genotype restriction in Botswana.
    Int J Gynaecol Obstet. 2023 Nov 10. doi: 10.1002/ijgo.15225.
    Abstract

  3603. HILL SK, Bempong-Ahun N, Okolo ID, Lalla AT, et al
    Improving access to safe, quality surgical care for gynecologic cancers through capacity-building interventions in low- and middle-income countries: A scoping review.
    Int J Gynaecol Obstet. 2023 Nov 5. doi: 10.1002/ijgo.15156.
    Abstract

  3604. ALFAREH M, Obeid D, Alhoshan H, Basri R, et al
    Low uptake of Pap test as a cervical cancer screen among Saudi women: Findings from a national survey.
    Int J Gynaecol Obstet. 2024 Apr 19. doi: 10.1002/ijgo.15532.
    Abstract

  3605. MWANDACHA N, Dau H, AboMoslim M, Naguti P, et al
    Investigating the healthcare-seeking behaviors of mobile phone users to improve cervical cancer screening in rural Uganda.
    Int J Gynaecol Obstet. 2024 May 4. doi: 10.1002/ijgo.15577.
    Abstract

  3606. YANG ST, Liu HH, Liu CH, Wang LW, et al
    Bevacizumab is associated with a higher gastrointestinal/genitourinary fistula or perforation risk in cervical cancer patients undergoing pelvic radiotherapy.
    Int J Gynaecol Obstet. 2024 May 15. doi: 10.1002/ijgo.15609.
    Abstract

  3607. WANG R, Ma L, Xiao Y, Jiang H, et al
    A case of postoperative non-invasive mucosal implantation of early-stage cervical adenocarcinoma to the clitoris.
    Int J Gynaecol Obstet. 2024;165:1295-1297.
    Abstract

  3608. DESCAMPS P, Dixon S, Bosch Jose FX, Kyrgiou M, et al
    Turning the tide-Recommendations to increase cervical cancer screening among women who are underscreened.
    Int J Gynaecol Obstet. 2024;166 Suppl 1:3-21.
    Abstract

  3609. ALIABADI AR, Wilailak S, McNally O, Berek JS, et al
    Contraceptive strategies for reducing the risk of reproductive cancers.
    Int J Gynaecol Obstet. 2024 May 9. doi: 10.1002/ijgo.15567.
    Abstract

  3610. LIANG C, Su G, Sun L, Zhao H, et al
    Comparison of the clinical outcomes of patients with stage IA-IIA2 cervical adenocarcinoma and squamous cell carcinoma after radical hysterectomy: A propensity score-matched real-world analysis.
    Int J Gynaecol Obstet. 2024 Jan 29. doi: 10.1002/ijgo.15388.
    Abstract

  3611. YURTCU E, Ozvural S, Keyif B
    Analyzing the performance of ChatGPT in answering inquiries about cervical cancer.
    Int J Gynaecol Obstet. 2024 Aug 16. doi: 10.1002/ijgo.15861.
    Abstract

  3612. HERNANDEZ JA, Rodriguez J, Rendon G, Trujillo LM, et al
    Pelvic lymph node involvement and risk of recurrence in HPV-associated endocervical adenocarcinoma stage IA2-IB1 according to Silva's system in two Colombian cancer centers.
    Int J Gynaecol Obstet. 2024 Mar 28. doi: 10.1002/ijgo.15482.
    Abstract

  3613. DEGENNARO V JR, Henderson RR, Petterson C, Wilson C, et al
    Working towards health: A model of cervical cancer screening and treatment for factory employees in Haiti.
    Int J Gynaecol Obstet. 2024 Sep 27. doi: 10.1002/ijgo.15940.
    Abstract

  3614. SADAT R, Sacinti KG, Topcu EG, Saeed S, et al
    Overcoming barriers to cervical cancer prevention in Afghanistan: The imperative for an HPV vaccination and screening program.
    Int J Gynaecol Obstet. 2024 Oct 16. doi: 10.1002/ijgo.15956.
    Abstract

  3615. WU T, Sun R, Sun J, Tao X, et al
    Circulating tumor HPV DNA as a specific biomarker for cervical cancer.
    Int J Gynaecol Obstet. 2024 Nov 8. doi: 10.1002/ijgo.16011.
    Abstract

  3616. LYU YH, Liu HX, Han X, Yuan P, et al
    Clinicopathologic characteristics and prognostic factors of patients with surgically treated high-grade neuroendocrine carcinoma of the cervix: A multicenter retrospective study.
    Int J Gynaecol Obstet. 2024;167:1055-1065.
    Abstract

  3617. LIU Y, Yang S, Ma Y, Gong Y, et al
    HPV E6/E7 mRNA screening alone can be used as a screening method for cervical cancer in premenopausal women in China: A retrospective study.
    Int J Gynaecol Obstet. 2024 Nov 25. doi: 10.1002/ijgo.16043.
    Abstract

  3618. LAAN J, van Lonkhuijzen L, Hinnen K, Pieters B, et al
    Malnutrition is associated with poor survival in women receiving radiotherapy for cervical cancer.
    Int J Gynecol Cancer. 2024 Jan 17:ijgc-2023-005024.
    Abstract

  3619. BIZZARRI N, Obermair A, Hsu HC, Chacon E, et al
    Consensus on surgical technique for sentinel lymph node dissection in cervical cancer.
    Int J Gynecol Cancer. 2024 Feb 20:ijgc-2023-005151.
    Abstract

  3620. FOTOPOULOU C, Eriksson AG, Planchamp F, Morice P, et al
    European Society of Gynaecological Oncology expanded quality indicators and accreditation for cervical cancer management.
    Int J Gynecol Cancer. 2024 Feb 23:ijgc-2024-005293.
    Abstract

  3621. JAYRAJ AS, Singhal S
    The beginning of the end for cervical cancer in India.
    Int J Gynecol Cancer. 2024 Mar 7:ijgc-2024-005420. doi: 10.1136/ijgc-2024-005420
    Abstract

  3622. VIVEROS-CARRENO D, Pareja R, Plante M
    De-escalation of surgical radicality for non-fertility preserving management in patients with early-stage cervical cancer: a systematic review.
    Int J Gynecol Cancer. 2024;34:386-392.
    Abstract

  3623. PETERS I, Marchetti C, Scambia G, Fagotti A, et al
    New windows of surgical opportunity for gynecological cancers in the era of targeted therapies.
    Int J Gynecol Cancer. 2024;34:352-362.
    Abstract

  3624. WESS B, Kohler C, Plaikner A, El-Safadi S, et al
    Comparative study using indocyanine green and patent blue dye for sentinel lymph node biopsy in patients with early-stage cervical cancer.
    Int J Gynecol Cancer. 2024 Mar 14:ijgc-2023-005206.
    Abstract

  3625. DEL M, Illac C, Morisseau M, Angeles MA, et al
    Intraepithelial tumor-infiltrating lymphocytes shape loco-regional PET/CT spread of locally advanced cervical cancer.
    Int J Gynecol Cancer. 2024 Mar 12:ijgc-2023-004677.
    Abstract

  3626. HANEY K, Ismail-Pratt I, Ng JS, Schmeler KM, et al
    The International Gynecologic Cancer Society Preinvasive Certificate Program: building a skilled workforce for the detection and treatment of cervical pre-cancer.
    Int J Gynecol Cancer. 2024;34:637-638.
    Abstract

  3627. KEMAH BL, Bhagat N, Pandya A, Sullivan R, et al
    Training the gynecologic oncologists of the future - challenges and opportunities.
    Int J Gynecol Cancer. 2024;34:619-626.
    Abstract

  3628. KOHLER C, Plaikner A, Siegler K, Hertel H, et al
    Radical vaginal trachelectomy: long-term oncologic and fertility outcomes in patients with early cervical cancer.
    Int J Gynecol Cancer. 2024 Apr 10:ijgc-2024-005274.
    Abstract

  3629. VAZQUEZ-VICENTE D, Boria F, Castellanos T, Gutierrez M, et al
    SUCCOR morbidity: complications in minimally invasive versus open radical hysterectomy in early cervical cancer.
    Int J Gynecol Cancer. 2024;34:203-208.
    Abstract

  3630. CHARNALIA M, Chopra S, Mulani J, Popat P, et al
    RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials.
    Int J Gynecol Cancer. 2024 Apr 22:ijgc-2024-005336.
    Abstract

  3631. ROSATI A, Certelli C, Ferrandina G, Fanfani F, et al
    Minimally invasive adrenalectomy: a personalized surgical approach in recurrent cervical cancer.
    Int J Gynecol Cancer. 2024 Apr 22:ijgc-2023-005241.
    Abstract

  3632. SHI V, Grover S, Huang Y, Thaker PH, et al
    Accuracy of surveillance serum squamous cell carcinoma antigen for cervical cancer recurrence after definitive chemoradiation.
    Int J Gynecol Cancer. 2024 Apr 29:ijgc-2024-005303.
    Abstract

  3633. NISTOR SI, El Tawab S, Zouridis A, Ferrari F, et al
    Minimally invasive surgery in the management of early stage cervical cancer after the publication of SHAPE trial.
    Int J Gynecol Cancer. 2024 May 31:ijgc-2024-005724.
    Abstract

  3634. PAREJA R
    Vaginal radical trachelectomy: is now the end of an era?
    Int J Gynecol Cancer. 2024;34:806-807.
    Abstract

  3635. SALANI R, McCormack M, Kim YM, Ghamande S, et al
    A non-comparative, randomized, phase II trial of atezolizumab or atezolizumab plus tiragolumab for programmed death-ligand 1-positive recurrent cervical cancer (SKYSCRAPER-04).
    Int J Gynecol Cancer. 2024 Jun 10:ijgc-2024-005588.
    Abstract

  3636. DIGGS A, Huang Y, Melamed A, Szamreta E, et al
    Patterns of use of primary and first-line chemotherapy for recurrence among patients with cervical cancer.
    Int J Gynecol Cancer. 2024 Jun 8:ijgc-2023-004860. doi: 10.1136/ijgc-2023-004860
    Abstract

  3637. AGUSTI N, Viveros-Carreno D, Melamed A, Pareja R, et al
    Adjuvant external beam radiotherapy combined with brachytherapy for intermediate-risk cervical cancer.
    Int J Gynecol Cancer. 2024 Jun 25:ijgc-2024-005570.
    Abstract

  3638. GUO XM, Roman LD, Matsuo K
    Considerations for route of hysterectomy in low-risk cervical cancer.
    Int J Gynecol Cancer. 2024 Jun 23:ijgc-2024-005745.
    Abstract

  3639. VAN DEN BERG MC, Berg HF, Stokowy T, Hoivik EA, et al
    Expression patterns of mismatch repair proteins in cervical cancer uncover independent prognostic value of MSH-2.
    Int J Gynecol Cancer. 2024;34:993-1000.
    Abstract

  3640. FRUHAUF F, Cibula D, Kocian R, Zikan M, et al
    Diagnostic performance of ultrasonography in pre-operative assessment of lymph nodes in patients with cervical cancer.
    Int J Gynecol Cancer. 2024;34:985-992.
    Abstract

  3641. AKYILDIZ A, Gultekin M, Yigit E, Demir E, et al
    Efficacy of cumulative cisplatin dose on survival in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy: multicenter study by Turkish Oncology Group.
    Int J Gynecol Cancer. 2024 Jun 30:ijgc-2024-005419.
    Abstract

  3642. LINDEGAARD JC, Petric P, Tan LT, Hoskin P, et al
    Are we making progress in curing advanced cervical cancer-again?
    Int J Gynecol Cancer. 2024 Jul 10:ijgc-2024-005572.
    Abstract

  3643. LEE ST, Lee YL, Chung CH, Chien WC, et al
    Cervical cancer and risk of dementia: real-world insights from a nationwide cohort study in Taiwan.
    Int J Gynecol Cancer. 2024 Jul 23:ijgc-2024-005408.
    Abstract

  3644. CARUSO G, Wagar MK, Hsu HC, Hoegl J, et al
    Cervical cancer: a new era.
    Int J Gynecol Cancer. 2024 Aug 7:ijgc-2024-005579. doi: 10.1136/ijgc-2024-005579
    Abstract

  3645. ZAMBRANO HARVEY AR, Galvis-Catano LM, Bonilla-Escobar FJ, Zapata Izquierdo MA, et al
    Intercultural dialogues and multilevel strategies for cervical cancer prevention for the Arhuacos indigenous community in Colombia.
    Int J Gynecol Cancer. 2024 Aug 7:ijgc-2024-005871. doi: 10.1136/ijgc-2024-005871
    Abstract

  3646. MATSUO K, Shimada M, Matsuzaki S, Machida H, et al
    Assessment of postoperative therapy de-escalation for early-stage, intermediate-risk cervical cancer.
    Int J Gynecol Cancer. 2024 Aug 6:ijgc-2024-005597. doi: 10.1136/ijgc-2024-005597
    Abstract

  3647. PEREZ VILLENA JF, Sanchez Salcedo M, Montoya Guivin A, Villoslada Terrones V, et al
    First workshop on cervix cancer surgery in Latin America: a hands-on experience from Lima, Peru.
    Int J Gynecol Cancer. 2024;34:1294-1295.
    Abstract

  3648. KANG WD, Ju UC, Kim SM
    Human papillomavirus genotyping for predicting disease progression in women with biopsy-negative or cervical intraepithelial neoplasia grade 1 of low-grade intraepithelial lesion cytology.
    Int J Gynecol Cancer. 2024;34:12-18.
    Abstract

  3649. DELLINO M, Cerbone M, Fortunato F, Capursi T, et al
    Incidence of pre-neoplastic and neoplastic lesions of the cervix before and after the COVID-19 pandemic.
    Int J Gynecol Cancer. 2024;34:224-228.
    Abstract

  3650. KHURANA N, Frumovitz M, Flores Legarreta A, Ramalingam P, et al
    Impact of pelvic radiation therapy in patients with early neuroendocrine cervical carcinoma and no residual disease in the radical hysterectomy specimen: a NeCTuR study.
    Int J Gynecol Cancer. 2024;34:209-215.
    Abstract

  3651. FITCH K, Bohn JA, Emerson JB, Boniface ER, et al
    Acceptability of human papillomavirus self-collection and the role of telehealth: a prospective, randomized study stratified by menopausal status.
    Int J Gynecol Cancer. 2024;34:19-27.
    Abstract

  3652. FERNANDEZ MA, Clark HD, Iniesta MD, Munsell MF, et al
    Sentinel lymph node mapping with indocyanine green using SPY-PHI in open radical hysterectomy or trachelectomy.
    Int J Gynecol Cancer. 2024;34:28-34.
    Abstract

  3653. DOSTALEK L, Freitag P, Slovackova M, Zima T, et al
    HPV testing as an effective triage strategy in the follow-up after fertility-sparing treatment for glandular lesions of the uterine cervix.
    Int J Gynecol Cancer. 2024;34:216-223.
    Abstract

  3654. BIZZARRI N, Abu-Rustum NR, Plante M, Ramirez PT, et al
    Assessing minimally invasive simple hysterectomy in low risk cervical cancer: set up for the LASH trial.
    Int J Gynecol Cancer. 2024 Aug 28:ijgc-2024-005941.
    Abstract

  3655. GAO H, Wu H, Zhang Y, Li X, et al
    Long-term survival in patients with para-aortic metastatic cervical cancer receiving simultaneous integrated boost chemoradiation to positive lymph nodes: a single-center experience.
    Int J Gynecol Cancer. 2024 Aug 28:ijgc-2024-005664.
    Abstract

  3656. MANNING-GEIST BL, Mueller JJ
    Raising the bar on collaborative science: the SENECA study and sentinel lymph node mapping.
    Int J Gynecol Cancer. 2024;34:1322-1323.
    Abstract

  3657. ZHANG L, Zhang X, Sui L, Cong Q, et al
    Risk factors for vaginal squamous intra-epithelial lesions in women with high-grade cervical lesions.
    Int J Gynecol Cancer. 2024;34:1344-1348.
    Abstract

  3658. EL HAJJ H, Hemida R, Taumberger N, Friko I, et al
    Advancing cervical cancer prevention in Africa: ESGO's strategic initiatives and collaborative efforts.
    Int J Gynecol Cancer. 2024 Sep 18:ijgc-2024-006059.
    Abstract

  3659. CHAMBULE S, Rangeiro R, Batman S, Lathrop E, et al
    Scaling cervical cancer screening in Mozambique: analysis of loop electrosurgical excision procedure (LEEP) specimens.
    Int J Gynecol Cancer. 2024 Sep 25:ijgc-2024-005827.
    Abstract

  3660. DITTO A, Martinelli F, Dri M, Maggiore ULR, et al
    Fertility-sparing treatment with conization versus radical hysterectomy in patients with early-stage cervical cancer: inverse propensity score weighted analysis.
    Int J Gynecol Cancer. 2024 Sep 23:ijgc-2024-005418.
    Abstract

  3661. SILVA FILHO ALD, Reis Romualdo G, Pinhati MES, Neves GL, et al
    Exploring cervical cancer mortality in Brazil: an ecological study on socioeconomic and healthcare factors.
    Int J Gynecol Cancer. 2024 Oct 4:ijgc-2024-005738. doi: 10.1136/ijgc-2024-005738
    Abstract

  3662. GOLIA D'AUGE T, Caruso G, Laudani ME, Nazzaro L, et al
    Para-aortic lymph node recurrence in surgically treated early-stage cervical cancer without para-aortic lymph node surgical staging.
    Int J Gynecol Cancer. 2024 Oct 8:ijgc-2024-005950. doi: 10.1136/ijgc-2024-005950
    Abstract

  3663. GOUVEIA MC, Graziano LM, Leis LV, Scaranti M, et al
    The evolving landscape of locally advanced cervical cancer treatment.
    Int J Gynecol Cancer. 2024 Oct 7:ijgc-2024-006128. doi: 10.1136/ijgc-2024-006128
    Abstract

  3664. PAN TL, Pareja R, Chiva L, Rodriguez J, et al
    Accuracy of pre-operative tumor size assessment compared to final pathology and frequency of adjuvant treatment in patients with FIGO 2018 stage IB2 cervical cancer.
    Int J Gynecol Cancer. 2024 Oct 23:ijgc-2024-005986.
    Abstract

  3665. AFROZE L, Rahman MS
    Community-based interventions to reduce cervical cancer in low- and middle-income countries: a call to action.
    Int J Gynecol Cancer. 2024 Oct 21:ijgc-2024-006188.
    Abstract

  3666. MEKURIA SF, Biazin H, Abebe T, Borgfeldt C, et al
    Comparing visual inspection with acetic acid, with and without Lugol's Iodine for triage of HPV self-sample positive women in Ethiopia: a randomized controlled trial.
    Int J Gynecol Cancer. 2024;34:1691-1697.
    Abstract

  3667. CHEN M, Han L, Wang Y, Chen Y, et al
    Association between Silva pattern-based classification and endocervical adenocarcinoma: a systematic review and meta-analysis.
    Int J Gynecol Cancer. 2024;34:1704-1710.
    Abstract

  3668. MORETTI-MARQUES R, Alvarenga-Bezerra V, de Cillo PE, Akaishi DY, et al
    First robotic radical trachelectomy for cervical cancer using the Hugo RAS platform.
    Int J Gynecol Cancer. 2024 Nov 13:ijgc-2024-005895.
    Abstract

  3669. ALVARENGA-BEZERRA V, Santia MC, Meschini T, Deavers M, et al
    Challenges in differentiating between primary cervical cancer versus stage II endometrial cancer.
    Int J Gynecol Cancer. 2024;34:1976-1979.
    Abstract

  3670. NASIOUDIS D, Latif NA, Gysler S, Giuntoli RL 2nd, et al
    Premature adoption of adjuvant chemotherapy for locally advanced cervical carcinoma before the OUTBACK trial: cautionary tale on outcomes.
    Int J Gynecol Cancer. 2024;34:1874-1880.
    Abstract

  3671. HUMPHREY P, Dures E, Hoskin P, Cramp F, et al
    Patient experiences of brachytherapy for locally advanced cervical cancer: hearing the patient voice through qualitative interviews.
    Int J Radiat Oncol Biol Phys. 2023 Dec 26:S0360-3016(23)08253.
    Abstract

  3672. KASSICK M, Taunk NK
    Pelvic Nodal Recurrence in Uterine Cancer: Novel Management and a Radiation Riddle.
    Int J Radiat Oncol Biol Phys. 2024;118:318.
    Abstract

  3673. FIELDS EC, Erickson B, Hubbard A, Chino J, et al
    Erratum to: Fields EC, Erickson B, Hubbard A, Chino J, Small C, Weiner A, Petereit D, Mayadev JS, Yashar CM, Joyner M. Tipping the Balance: Adding Resources for Cervical Cancer Brachytherapy. Int J Radiat Oncol Biol Phys 2023;117:1138-1142.
    Int J Radiat Oncol Biol Phys. 2024;118:869.
    Abstract

  3674. MEI X, Kok HP, Rodermond HM, van Bochove GGW, et al
    Radiosensitization by Hyperthermia Critically Depends on the Time Interval.
    Int J Radiat Oncol Biol Phys. 2024;118:817-828.
    Abstract

  3675. CHOW Z, Fabian D
    Cervical Cancer With Vaginal Recurrence and Prior Pelvic Radiation.
    Int J Radiat Oncol Biol Phys. 2024;118:886-887.
    Abstract

  3676. GEORGE J, Tuli S, Patel PP, Monare B, et al
    Delays in cervical cancer treatment initiation for patients living with or without HIV in Botswana: An observational cohort analysis (2015-2019).
    Int J Radiat Oncol Biol Phys. 2024 Mar 8:S0360-3016(24)00354.
    Abstract

  3677. COLSON-FEARON D, Han K, Roumeliotis MB, Viswanathan AN, et al
    Updated Trends in Cervical Cancer Brachytherapy Utilization and Disparities in the United States From 2004 to 2020.
    Int J Radiat Oncol Biol Phys. 2024;119:154-162.
    Abstract

  3678. ZHU J, Li X, Huang M, Zhu H, et al
    Application of Recombinant Human Superoxide Dismutase in Radical Concurrent Chemoradiotherapy for Cervical Cancer to Prevent and Treat Radiation-induced Acute Rectal Injury: A Multi-center, Randomized, Open-label, Prospective Trial.
    Int J Radiat Oncol Biol Phys. 2024 May 3:S0360-3016(24)00611.
    Abstract

  3679. CHUK E, Yu C, Scott AA, Liu ZA, et al
    Clinical outcomes of three vs four fractions of MRI-guided brachytherapy in cervical cancer.
    Int J Radiat Oncol Biol Phys. 2024 Jun 25:S0360-3016(24)00745.
    Abstract

  3680. HUANG J, Gao J, Zhang F, Gu F, et al
    Pelvic Bone Marrow Sparing Intensity Modulated Radiotherapy Reduces the Bone Mineral Density Loss of Cervical Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2024 Jul 27:S0360-3016(24)03140.
    Abstract

  3681. CHOPRA S, Bosse T, Horeweg N, Deodhar K, et al
    Biomarker expression and impact on clinical outcomes in an international study of chemoradiation and MRI-based image-guided brachytherapy for locally advanced cervical cancer: BIOEMBRACE.
    Int J Radiat Oncol Biol Phys. 2024 Jul 25:S0360-3016(24)03141.
    Abstract

  3682. KIRCHHEINER K, Zaharie A, Smet S, Spampinato S, et al
    Association between the regular use of vaginal dilators and/or sexual activity and vaginal morbidity in locally advanced cervical cancer survivors - An EMBRACE-I study report.
    Int J Radiat Oncol Biol Phys. 2024 Sep 13:S0360-3016(24)03370.
    Abstract

  3683. HERRERA TD, Oden J, Lorenzo Polo A, Crezee J, et al
    Thermoradiotherapy Optimization Strategies Accounting for Hyperthermia Delivery Uncertainties.
    Int J Radiat Oncol Biol Phys. 2024;120:1435-1447.
    Abstract

  3684. LIU Q, Zhang T, Chen L, Zhou X, et al
    Correlation of immediate prevalence of cervical precancers and cancers with HPV genotype and age in women with ASC-US/hrHPV+: a retrospective analysis of 2292 cases.
    J Clin Pathol. 2023 Jan 18:jcp-2022-208580. doi: 10.1136/jcp-2022-208580.
    Abstract

  3685. OSTRBENK VALENCAK A, Cuschieri K, Connor L, Zore A, et al
    Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening.
    J Clin Virol. 2024;170:105638.
    Abstract

  3686. YILMAZ E, Eklund C, Lagheden C, Robertsson KD, et al
    Corrigendum to "First international proficiency study on human papillomavirus testing in cervical cancer screening" [J Clin Virol. 2023 Oct;167:105581].
    J Clin Virol. 2024;171:105660.
    Abstract

  3687. PRETET JL, Arroyo Muhr LS, Cuschieri K, Fellner MD, et al
    Human papillomavirus negative high grade cervical lesions and cancers: Suggested guidance for HPV testing quality assurance.
    J Clin Virol. 2024;171:105657.
    Abstract

  3688. HEIDEMAN DAM, Berkhof J, Verhoef L, Ouwerkerk C, et al
    Validation of the clinical performance and reproducibility of the NeuMoDx HPV assay self-sample workflow.
    J Clin Virol. 2024;171:105649.
    Abstract

  3689. POLJAK M, Ostrbenk Valencak A, Cuschieri K, Bohinc KB, et al
    2023 global inventory of commercial molecular tests for human papillomaviruses (HPV).
    J Clin Virol. 2024;172:105671.
    Abstract

  3690. LATSUZBAIA A, Martinelli M, Giubbi C, Cuschieri K, et al
    Clinical accuracy of OncoPredict HPV Quantitative Typing (QT) assay on self-samples.
    J Clin Virol. 2024;175:105737.
    Abstract

  3691. FORSON W, Bhatia R, Currie H, Elasifer H, et al
    High-risk HPV mRNA testing on self-samples offered to those who do not attend for organised cervical screening - real world data from the Dumfries and Galloway region in Scotland.
    J Clin Virol. 2024;175:105734.
    Abstract

  3692. TROISI R, Bertrand K, Hatch EE, Strohsnitter WC, et al
    An Update on Prenatal Diethylstilbestrol Exposure and High-Grade Squamous Intraepithelial Lesions of the Lower Genital Tract.
    Obstet Gynecol. 2024;143:603-606.
    Abstract

  3693. LARISH A, Long ME
    Diagnosis and Management of Cervical Squamous Intraepithelial Lesions in Pregnancy and Postpartum.
    Obstet Gynecol. 2024 Mar 29. doi: 10.1097/AOG.0000000000005566.
    Abstract

  3694. WANG M, Maimaitiming M, Bi Y, Jin Y, et al
    Compliance Rate With Triage Test and Treatment for Participants Screening Positive in Cervical Cancer Screening Programs: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2024 Sep 12. doi: 10.1097/AOG.0000000000005723.
    Abstract

  3695. VIVEROS-CARRENO D, Agusti N, Wu CF, Melamed A, et al
    Survival After Simple Compared With Radical Hysterectomy for Patients With Early-Stage Cervical Cancer.
    Obstet Gynecol. 2024 Sep 26. doi: 10.1097/AOG.0000000000005743.
    Abstract

  3696. BRENNER SE, Modesitt S, Bednarczyk RA, Dilley SE, et al
    Human Papillomavirus Vaccination in the Postpartum Period: A Systematic Review.
    Obstet Gynecol. 2024;144:782-789.
    Abstract

  3697. SHI C, Zhang Z
    [Retracted] MicroRNA?362 is downregulated in cervical cancer and inhibits cell proliferation, migration and invasion by directly targeting SIX1.
    Oncol Rep. 2024;51:54.
    Abstract

  3698. LI W, Liang J, Zhang Z, Lou H, et al
    [Retracted] MicroRNA?329?3p targets MAPK1 to suppress cell proliferation, migration and invasion in cervical cancer.
    Oncol Rep. 2024;51:86.
    Abstract

  3699. ZHOU Y, Xie Y, Luo Y, Wang S, et al
    SNAI2 enhances HPV?negative cervical cancer cell dormancy by modulating u?PAR expression and the activity of the ERK/p38 signaling pathway in vitro.
    Oncol Rep. 2024;52:104.
    Abstract

  3700. HUI C, Ewongwo A, Mendoza MG, Kozak MM, et al
    Less than whole uterus irradiation for patients with locally advanced cervical cancer.
    Radiother Oncol. 2024 Mar 2:110199. doi: 10.1016/j.radonc.2024.110199.
    Abstract

  3701. KUIPERS SC, Godart J, Corbeau A, Breedveld S, et al
    Dosimetric impact of bone marrow sparing for robustly optimized IMPT for locally advanced cervical cancer.
    Radiother Oncol. 2024 Mar 10:110222. doi: 10.1016/j.radonc.2024.110222.
    Abstract

  3702. SKIPAR K, Hompland T, Lund KV, Lindemann K, et al
    Mri-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy.
    Radiother Oncol. 2024 Mar 29:110263. doi: 10.1016/j.radonc.2024.110263.
    Abstract

  3703. AI Y, Zhu X, Zhang Y, Li W, et al
    MRI radiomics nomogram integrating postoperative adjuvant treatments in recurrence risk prediction for patients with early-stage cervical cancer.
    Radiother Oncol. 2024;197:110328.
    Abstract

  3704. NI R, Han K, Haibe-Kains B, Rink A, et al
    Generalizability of deep learning in organ-at-risk segmentation: A transfer learning study in cervical brachytherapy.
    Radiother Oncol. 2024;197:110332.
    Abstract

  3705. MARSILLA J, Weiss J, Ye XY, Welch M, et al
    A T2-weighted MRI-based radiomic signature for disease-free survival in locally advanced cervical cancer following chemoradiation: An international, multicentre study.
    Radiother Oncol. 2024;199:110463.
    Abstract

  3706. LIU Y, Chen Z, Zhou Q, Shang X, et al
    A feasibility study of dose-band prediction in radiation therapy: Predicting a spectrum of plan dose.
    Radiother Oncol. 2025;202:110593.
    Abstract

  3707. KAIZILEGE GK, Ndaboine E, Chuma C, Mujuni F, et al
    Unraveling cervical cancer screening dilemmas: histopathological insights from VIA and LEEP at bugando medical centre, Mwanza.
    BMC Cancer. 2024;24:66.
    Abstract

  3708. KUSSIA B, Shewangizaw M, Abebe S, Alemu H, et al
    Health care seeking behaviour towards cervical cancer screening among women aged 30-49 years in Arbaminch town, Southern Ethiopia, 2023.
    BMC Cancer. 2024;24:38.
    Abstract

  3709. YU JH, Tong CJ, Huang QD, Ye YL, et al
    Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.
    BMC Cancer. 2024;24:88.
    Abstract

  3710. PAN XB, Lu Y, Wei YS, Yao DS, et al
    Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
    BMC Cancer. 2024;24:106.
    Abstract

  3711. CETINA-PEREZ L, Luvian-Morales J, Delgadillo-Gonzalez M, Castro-Eguiluz D, et al
    Sociodemographic characteristics and their association with survival in women with cervical cancer.
    BMC Cancer. 2024;24:161.
    Abstract

  3712. LIU H, Cui Y, Chang C, Zhou Z, et al
    Development and validation of a (18)F-FDG PET/CT radiomics nomogram for predicting progression free survival in locally advanced cervical cancer: a retrospective multicenter study.
    BMC Cancer. 2024;24:150.
    Abstract

  3713. XIAO L, Dong X, Sun J, Zhang X, et al
    Focused ultrasound versus the loop electrosurgical excision procedure to treat women with cervical high-grade squamous intraepithelial lesions under 40: a retrospective study.
    BMC Cancer. 2024;24:169.
    Abstract

  3714. ZHONG ML, Liu YC, Yang JT, Wang YN, et al
    Treatment for locally resectable stage IIIC1r cervical cancer: surgery or chemoradiotherapy?
    BMC Cancer. 2024;24:217.
    Abstract

  3715. NAKIGOZI H, Ndejjo R, Bazeyo W, Nabaggala A, et al
    Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
    BMC Cancer. 2024;24:243.
    Abstract

  3716. CORREDOR C, Pineros M, Wiesner C, de Vries E, et al
    Using administrative registries as a source for population-based cancer incidence and mortality.
    BMC Cancer. 2024;24:232.
    Abstract

  3717. BONLOKKE S, Blaakaer J, Steiniche T, Iachina M, et al
    Social factors and age play a significant role in cervical cancer and advanced-stage disease among Danish women.
    BMC Cancer. 2024;24:259.
    Abstract

  3718. KHANNA D, Sharma P, Budukh A, Vishwakarma R, et al
    Rural-urban disparity in cancer burden and care: findings from an Indian cancer registry.
    BMC Cancer. 2024;24:308.
    Abstract

  3719. ZHANG Y, Liu S, Chen M, Ou Q, et al
    Preimmunization with Listeria-vectored cervical cancer vaccine candidate strains can establish specific T-cell immune memory and prevent tumorigenesis.
    BMC Cancer. 2024;24:288.
    Abstract

  3720. CUI X, Wang H, Chen M, Seery S, et al
    Assessing colposcopy competencies in medically underserved communities: a multi-center study in China.
    BMC Cancer. 2024;24:349.
    Abstract

  3721. GHASEMI M, Savabi-Esfahani M, Noroozi M, Satari M, et al
    Prediction of cervical cancer screening: application of the information-motivation-behavioral skills model.
    BMC Cancer. 2024;24:351.
    Abstract

  3722. LI X, Zhao Y, Xiang F, Zhang X, et al
    Evaluation of the diagnostic performance of colposcopy in the detection of cervical high-grade squamous intraepithelial lesions among women with transformation zone type 3.
    BMC Cancer. 2024;24:381.
    Abstract

  3723. NAKIGOZI H, Ategyeka PM, Nabadda S, Ndejjo R, et al
    Positivity rates, trends and experiences of health workers on human papillomavirus screened using genexpert in Uganda: a three-year retrospective cohort study.
    BMC Cancer. 2024;24:375.
    Abstract

  3724. LI Z, Zhou G, Jiang L, Wang M, et al
    Analysis of related factors for pathological upgrading of cervical biopsy from CIN3 to cancer after conical resection.
    BMC Cancer. 2024;24:401.
    Abstract

  3725. NAKISIGE C, de Fouw M, Nakalembe M, Orem J, et al
    Baseline knowledge on risk factors, symptoms and intended behavior of women and men towards screening and treatment of cervical cancer in rural Uganda: a cross-sectional study.
    BMC Cancer. 2024;24:450.
    Abstract

  3726. GU Z, Yang C, Zhang K, Wu H, et al
    Development and validation of a nomogram for predicting sever cancer-related fatigue in patients with cervical cancer.
    BMC Cancer. 2024;24:492.
    Abstract

  3727. ADAM JA, Poel E, van Eck Smit BLF, Mom CH, et al
    [(18)F]FDG-PET/CT-based risk stratification in women with locally advanced uterine cervical cancer.
    BMC Cancer. 2024;24:513.
    Abstract

  3728. ZHOU Y, Wang W, Tang J, Hu K, et al
    Comparison of outcomes between early-stage cervical cancer patients without high-risk factors undergoing adjuvant concurrent chemoradiotherapy and radiotherapy alone after radical surgery.
    BMC Cancer. 2024;24:548.
    Abstract

  3729. LEI L, Zhang L, Zheng Y, Ma W, et al
    Clinical analysis of 314 patients with high-grade squamous intraepithelial lesion who underwent total hysterectomy directly: a multi-center, retrospective cohort study.
    BMC Cancer. 2024;24:575.
    Abstract

  3730. ZHAO A, Pan Y, Gao Y, Zhi Z, et al
    MUC1 promotes cervical squamous cell carcinoma through ERK phosphorylation-mediated regulation of ITGA2/ITGA3.
    BMC Cancer. 2024;24:559.
    Abstract

  3731. LYONNAIS E, Vigoureux S, Blondel B, Wylomanski S, et al
    Women's country of birth and failure to catch up an overdue cervical cancer cytological screening participation during pregnancy in France, an observational study based on survey sources.
    BMC Cancer. 2024;24:595.
    Abstract

  3732. WU Y, Jiang P, Chen Z, Li W, et al
    Efficacy and safety of different chemotherapy regimens concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
    BMC Cancer. 2024;24:589.
    Abstract

  3733. BUYUKBAYRAM ME, Hannarici Z, Turhan A, Caglar AA, et al
    A novel prognostic biomarker in progression free survival for patients with cervical cancer, glucose to c-reactive protein ratio (GCR).
    BMC Cancer. 2024;24:626.
    Abstract

  3734. AZIZ MA, Chowdhury S, Jafrin S, Barek MA, et al
    Genetic association of Interleukin-17A polymorphism in Bangladeshi patients with breast and cervical cancer: a case-control study with functional analysis.
    BMC Cancer. 2024;24:660.
    Abstract

  3735. PAN XB, Lu Y, Wei YS, Yao DS, et al
    Neoadjuvant chemotherapy followed by surgery versus concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma: a retrospective cohort study.
    BMC Cancer. 2024;24:655.
    Abstract

  3736. ALI B, Galbarczyk A, Jasienska G, Ba-Break M, et al
    Factors related to knowledge, attitudes, and behaviors regarding cervical cancer among Yemeni women.
    BMC Cancer. 2024;24:695.
    Abstract

  3737. FEREDE YA, Tassew WC, Zeleke AM
    Precancerous cervical lesion and associated factors among HIV-infected women in Ethiopia: systematic review and meta- analysis.
    BMC Cancer. 2024;24:678.
    Abstract

  3738. LI J, Yang Z, Wang T, Li M, et al
    Causal relationship between lipid-lowering drugs and ovarian cancer, cervical cancer: a drug target mendelian randomization study.
    BMC Cancer. 2024;24:667.
    Abstract

  3739. HOSKIN P, Lee M, Dunkley D, Danh M, et al
    Dose escalation of tolinapant (ASTX660) in combination with standard radical chemoradiotherapy in cervical cancer : a study protocol for a phase 1b TiTE-CRM clinical trial (CRAIN) in UK secondary care centres.
    BMC Cancer. 2024;24:702.
    Abstract

  3740. OKUNADE KS, Adejimi AA, Adekanye TV, Allsop MJ, et al
    Impact of mobile health technologies on human papillomavirus vaccination uptake among mothers of unvaccinated girls aged 9-14 years in Lagos, Nigeria (mHealth-HPVac): study protocol of a randomised controlled trial.
    BMC Cancer. 2024;24:751.
    Abstract

  3741. SIFER SD
    Survival status and predictors of mortality among cervical cancer patients at oncologic centers in Addis Ababa, Ethiopia: a follow up study.
    BMC Cancer. 2024;24:750.
    Abstract

  3742. YANG W, Jin X, Huang L, Jiang S, et al
    Clinical evaluation of an artificial intelligence-assisted cytological system among screening strategies for a cervical cancer high-risk population.
    BMC Cancer. 2024;24:776.
    Abstract

  3743. QIN L, Zhang L
    The predictive value of serum inflammatory markers for the severity of cervical lesions.
    BMC Cancer. 2024;24:780.
    Abstract

  3744. SERMAN F, Lisembard G, Sahraoui M, Berkhout C, et al
    A transversal cross-sectional study of factors related to HPV vaccination status and cancer screening participation among French women aged 25-40.
    BMC Cancer. 2024;24:807.
    Abstract

  3745. CONG H, Yang X, Li Z, Li Z, et al
    Salvage radiotherapy for locally recurrent cervical and endometrial carcinoma: clinical outcomes and toxicities.
    BMC Cancer. 2024;24:871.
    Abstract

  3746. DE LA CRUZ-LOPEZ KG, Alvarado-Ortiz E, Valencia-Gonzalez HA, Beltran-Anaya FO, et al
    Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines.
    BMC Cancer. 2024;24:853.
    Abstract

  3747. YOU J, Yuan Y, Gu X, Wang W, et al
    Pegylated recombinant human granulocyte colony-stimulating factor for primary prophylaxis of neutropenia in patients with cervical cancer receiving concurrent chemoradiotherapy: a prospective study.
    BMC Cancer. 2024;24:833.
    Abstract

  3748. BOUSKILL K, Wagner GJ, Gizaw M, Matovu JK, et al
    Understanding women's and men's perspectives on cervical cancer screening in Uganda: a qualitative study.
    BMC Cancer. 2024;24:933.
    Abstract

  3749. HUANG M, Wang T, Li M, Qin M, et al
    Evaluating PAX1 methylation for cervical cancer screening triage in non-16/18 hrHPV-positive women.
    BMC Cancer. 2024;24:913.
    Abstract

  3750. ANABA EA, Alor SK, Badzi CD, Mbuwir CB, et al
    Drivers of breast cancer and cervical cancer screening among women of reproductive age: insights from the Ghana Demographic and Health Survey.
    BMC Cancer. 2024;24:920.
    Abstract

  3751. YANG X, Zhou M, Luan Y, Li K, et al
    Identification of key genes associated with cervical cancer based on bioinformatics analysis.
    BMC Cancer. 2024;24:897.
    Abstract

  3752. YE Y, Lian R, Li Z, Chen X, et al
    Predictive value of number of metastatic lymph nodes and lymph node ratio for prognosis of patients with FIGO 2018 stage IIICp cervical cancer: a multi-center retrospective study.
    BMC Cancer. 2024;24:1005.
    Abstract

  3753. ARROSSI S, Straw C, Sanchez Antelo V, Paolino M, et al
    Implementation of WHO guidelines for cervical cancer screening, diagnosis and treatment: knowledge and perceptions of health providers from Argentina.
    BMC Cancer. 2024;24:996.
    Abstract

  3754. MON HM, Robb KA, Demou E
    Effectiveness of workplace cancer screening interventions: a systematic review.
    BMC Cancer. 2024;24:999.
    Abstract

  3755. LAKEW G, Yirsaw AN, Berhie AY, Belayneh AG, et al
    Cervical cancer screening practice and associated factors among female health care professionals in Ethiopia 2024: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:986.
    Abstract

  3756. TAO H, Chen Z, Yao B, Ren X, et al
    Galaxamide alleviates cisplatin-induced premature ovarian insufficiency via the PI3K signaling pathway in HeLa tumor-bearing mice.
    BMC Cancer. 2024;24:1060.
    Abstract

  3757. HAILEGEBIREAL AH, Bizuayehu HM, Tirore LL
    Far behind 90-70-90's screening target: the prevalence and determinants of cervical cancer screening among Sub-Saharan African women: evidence from Demographic and Health Survey.
    BMC Cancer. 2024;24:1050.
    Abstract

  3758. DABOUS E, Alalem M, Awad AM, Elawdan KA, et al
    Regulation of KLRC and Ceacam gene expression by miR-141 supports cell proliferation and metastasis in cervical cancer cells.
    BMC Cancer. 2024;24:1091.
    Abstract

  3759. FU J, Xu X, Tian M, Wang H, et al
    The controlling nutritional status score as a new prognostic predictor in patients with cervical cancer receiving radiotherapy: a propensity score matching analysis.
    BMC Cancer. 2024;24:1093.
    Abstract

  3760. ZHAO YC, Li YF, Qiu L, Jin SZ, et al
    SQLE-a promising prognostic biomarker in cervical cancer: implications for tumor malignant behavior, cholesterol synthesis, epithelial-mesenchymal transition, and immune infiltration.
    BMC Cancer. 2024;24:1133.
    Abstract

  3761. LUO H, Lian Y, Tao H, Zhao Y, et al
    Relationship between p16/ki67 immunoscores and PAX1/ZNF582 methylation status in precancerous and cancerous cervical lesions in high-risk HPV-positive women.
    BMC Cancer. 2024;24:1171.
    Abstract

  3762. FANG C, Liu S, Xia J, Wu X, et al
    Clinical significance of intensity-modulated radiotherapy (IMRT) to the distant metastatic lymph nodes for metastatic cervical cancer.
    BMC Cancer. 2024;24:1170.
    Abstract

  3763. PENG L, Ai C, Dou Z, Li K, et al
    Altered microbial diversity and composition of multiple mucosal organs in cervical cancer patients.
    BMC Cancer. 2024;24:1154.
    Abstract

  3764. FENG L, Shi Q, Wang S, Zhao Y, et al
    The outcome of advanced and recurrent cervical cancer patients treated with first-line platinum and paclitaxel with or without indication for immune checkpoint inhibitors: the comparative study.
    BMC Cancer. 2024;24:1267.
    Abstract

  3765. LI M, Xu T, Yang R, Wang X, et al
    Exploring MPC1 as a potential ferroptosis-linked biomarker in the cervical cancer tumor microenvironment: a comprehensive analysis.
    BMC Cancer. 2024;24:1258.
    Abstract

  3766. RASEKHI KAZERUNI A, Babaei N, Esmaeili Gouvarchin Ghaleh H, Doosti A, et al
    Newcastle disease virus enhances the antitumor efficacy of Doxorubicin in a cervical cancer mouse model.
    BMC Cancer. 2024;24:1253.
    Abstract

  3767. YIRSAW AN, Tefera M, Bogale EK, Anagaw TF, et al
    Applying the Health Belief Model to cervical cancer screening uptake among women in Ethiopia: a systematic review and meta-analysis.
    BMC Cancer. 2024;24:1294.
    Abstract

  3768. TURNA M, Rzazade R, Kucukmorkoc E, Kucuk N, et al
    Dose escalation with stereotactic body radiotherapy for cervical cancer treatment.
    BMC Cancer. 2024;24:1281.
    Abstract

  3769. MEKONEN EG, Gebrehana DA, Tamir TT
    Determinants of cervical cancer screening among women of childbearing age in four sub-Saharan African countries: insights from large population surveys.
    BMC Cancer. 2024;24:1304.
    Abstract

  3770. REMMEL ML, Suija K, Raudne R, Tisler A, et al
    Women's perspectives on the acceptability of risk-based cervical cancer screening.
    BMC Cancer. 2024;24:1314.
    Abstract

  3771. DEDEY F, Nsaful J, Nartey E, Labi J, et al
    Assessing the impact of cervical cancer education in two high schools in Ghana.
    BMC Cancer. 2024;24:1359.
    Abstract

  3772. TAO H, Yu F, Yang L, Pei X, et al
    Comparing the performance of DeoxyriboNucleic Acid methylation analysis and cytology for detecting cervical (pre)cancer in women with high-risk human papillomavirus-positive status in a gynecologic outpatient population.
    BMC Cancer. 2024;24:1352.
    Abstract

  3773. CHEN H, Ma Y, Wang D, Wu H, et al
    The efficacy and safety of the prophylactic application of PEG-rhG-CSF in radiotherapy with weekly concurrent chemotherapy for cervical cancer.
    BMC Cancer. 2024;24:1405.
    Abstract

  3774. CHEN X, Jiang H, Xu H, Wang L, et al
    Cervical cancer screening: efficacy of PAX1 and JAM3 methylation assay in the triage of atypical squamous cell of undetermined significance (ASC-US).
    BMC Cancer. 2024;24:1385.
    Abstract

  3775. EFFAH K, Tekpor E, Wormenor CM, Allotey J, et al
    Cervical precancer screening using self-sampling, HPV DNA testing, and mobile colposcopy in a hard-to-reach community in Ghana: a pilot study.
    BMC Cancer. 2024;24:1367.
    Abstract

  3776. ITO H, Yokoyama Y, Kyo S, Mandai M, et al
    Interim analysis of robot-assisted radical hysterectomy in Japan: a multicenter, prospective interventional single-arm clinical trial.
    BMC Cancer. 2024;24:1360.
    Abstract

  3777. AHMED HAA, Abbas MH, Hussein HA, Nasr RSF, et al
    Cervical cancer screening uptake in Arab countries: a systematic review with meta-analysis.
    BMC Cancer. 2024;24:1438.
    Abstract

  3778. AHMED HAA, Abbas MH, Hussein HA, Nasr RSF, et al
    Correction: Cervical cancer screening uptake in Arab countries: a systematic review with meta-analysis.
    BMC Cancer. 2024;24:1478.
    Abstract

  3779. CHEN C, Zhu B, Wang Y, Zhao Y, et al
    Incidence and risk factor of blood transfusion after abdominal radical hysterectomy for cervical cancer: a 10-year retrospective study of the US nationwide inpatient sample.
    BMC Cancer. 2024;24:1454.
    Abstract

  3780. LIU Q, Zhu J, Abulizi G, Hasim A, et al
    Metabolism and spatial transcription resolved heterogeneity of glutamine metabolism in cervical carcinoma.
    BMC Cancer. 2024;24:1504.
    Abstract

  3781. XIA W, Dai X, Hu Y, Yang S, et al
    Value of intraoperative post-conisation human papillomavirus testing in predicting residual or recurrence after treatment with a loop electrosurgical excision procedure in women with HR-HPV positive and cervical high-grade squamous intraepithelial les
    BMC Cancer. 2024;24:1496.
    Abstract

  3782. SUN D, Shu C, Zeng F, Xu D, et al
    The performance of JAM3/PAX1 methylation in the diagnosis of high-grade squamous intraepithelial lesions for women with high-risk HPV infection.
    BMC Cancer. 2024;24:1514.
    Abstract

  3783. STUART RM, Cohen JA, Kerr CC, Mathur P, et al
    HPVsim: An agent-based model of HPV transmission and cervical disease.
    PLoS Comput Biol. 2024;20:e1012181.
    Abstract

  3784. HERWEIJER E, Hu K, Wang J, Lu D, et al
    Incidence of oncogenic HPV infection in women with and without mental illness: A population-based cohort study in Sweden.
    PLoS Med. 2024;21:e1004372.
    Abstract

  3785. HELGESTAD ADL, Larsen MB, Njor S, Tranberg M, et al
    Increasing coverage in cervical and colorectal cancer screening by leveraging attendance at breast cancer screening: A cluster-randomised, crossover trial.
    PLoS Med. 2024;21:e1004431.
    Abstract

  3786. LEI J, Cuschieri K, Patel H, Lawrence A, et al
    Human papillomavirus genotype and cycle threshold value from self-samples and risk of high-grade cervical lesions: A post hoc analysis of a modified stepped-wedge implementation feasibility trial.
    PLoS Med. 2024;21:e1004494.
    Abstract

  3787. ALJREES T
    Improving prediction of cervical cancer using KNN imputer and multi-model ensemble learning.
    PLoS One. 2024;19:e0295632.
    Abstract

  3788. MUNSHI RM
    Novel ensemble learning approach with SVM-imputed ADASYN features for enhanced cervical cancer prediction.
    PLoS One. 2024;19:e0296107.
    Abstract

  3789. YU C, Wu X, Zhang S, Zhang L, et al
    Prognostic model for survival in patients with neuroendocrine carcinomas of the cervix: SEER database analysis and a single-center retrospective study.
    PLoS One. 2024;19:e0296446.
    Abstract

  3790. GUILLAUME D, Waheed DE, Schleiff M, Muralidharan KK, et al
    Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries.
    PLoS One. 2024;19:e0291990.
    Abstract

  3791. SARMIENTO-MEDINA MI, de Amaya MP, Villamizar-Gomez L, Gonzalez-Coba AC, et al
    High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.
    PLoS One. 2024;19:e0297579.
    Abstract

  3792. KANG SW, Kang OJ, Lee JY, Kim H, et al
    Evaluation of the anti-cancer efficacy of lipid nanoparticles containing siRNA against HPV16 E6/E7 combined with cisplatin in a xenograft model of cervical cancer.
    PLoS One. 2024;19:e0298815.
    Abstract

  3793. MANGENAH C, Sibanda EL, Maringwa G, Sithole J, et al
    Provider and female client economic costs of integrated sexual and reproductive health and HIV services in Zimbabwe.
    PLoS One. 2024;19:e0291082.
    Abstract

  3794. MUNSHI RM
    Correction: Novel ensemble learning approach with SVM-imputed ADASYN features for enhanced cervical cancer prediction.
    PLoS One. 2024;19:e0298980.
    Abstract

  3795. VARON ML, Geng Y, Fellman BM, Troisi C, et al
    Interventions to increase follow-up of abnormal cervical cancer screening results: A systematic literature review and meta-analysis.
    PLoS One. 2024;19:e0291931.
    Abstract

  3796. YAO B, Peng J, Song W, Yang L, et al
    Real-world effectiveness of cytology and HPV-based screening strategy in cervical cancer screening: A cross-sectional population-based study in Chengdu, China.
    PLoS One. 2024;19:e0299651.
    Abstract

  3797. SUN J, Frick KD, Liang H, Chow CM, et al
    Examining cancer screening disparities by race/ethnicity and insurance groups: A comparison of 2008 and 2018 National Health Interview Survey (NHIS) data in the United States.
    PLoS One. 2024;19:e0290105.
    Abstract

  3798. ZHANG J, Yuan J, Zhang D, Yang Y, et al
    Short video platforms as sources of health information about cervical cancer: A content and quality analysis.
    PLoS One. 2024;19:e0300180.
    Abstract

  3799. CAROZZI FM, Royder Yanez R, Paganini I, Sani C, et al
    Cervical cancer prevention: Feasibility of self-sampling and HPV testing in rural and urban areas of Bolivia: An observational study.
    PLoS One. 2024;19:e0292605.
    Abstract

  3800. LIU Z, Fan T, Mo X, Kan J, et al
    Association between multiple sclerosis and cancer risk: A two-sample Mendelian randomization study.
    PLoS One. 2024;19:e0298271.
    Abstract

  3801. LIN Y, Long Y, He J, Yi Q, et al
    The residual rate of HPV and the recurrence rate of CIN after LEEP with negative margins: A meta-analysis.
    PLoS One. 2024;19:e0298520.
    Abstract

  3802. OOMMEN AM, Isaac R, Paul B, Weller D, et al
    Strategies for primary HPV test-based cervical cancer screening programme in resource-limited settings in India: Results from a quasi-experimental pragmatic implementation trial.
    PLoS One. 2024;19:e0301385.
    Abstract

  3803. LEMLEM SB, Gary RA, Yeager KA, Sisay MM, et al
    Psychometric properties of a modified health belief model for cervical cancer and visual inspection with acetic acid among healthcare professionals in Ethiopia.
    PLoS One. 2024;19:e0295905.
    Abstract

  3804. KHUMALO PG, Carey M, Mackenzie L, Sanson-Fisher R, et al
    Cervical cancer screening knowledge and associated factors among Eswatini women: A cross-sectional study.
    PLoS One. 2024;19:e0300763.
    Abstract

  3805. DUA R, Bhardwaj T, Ahmad I, Somvanshi P, et al
    Investigating the potential of Juglans regia phytoconstituents for the treatment of cervical cancer utilizing network biology and molecular docking approach.
    PLoS One. 2024;19:e0287864.
    Abstract

  3806. ZEBER-LUBECKA N, Kulecka M, Dabrowska M, Baginska-Drabiuk K, et al
    Cervical microbiota dysbiosis associated with high-risk Human Papillomavirus infection.
    PLoS One. 2024;19:e0302270.
    Abstract

  3807. XU F, Carlson SA, Greenlund KJ
    Understanding primary care providers' attitudes towards preventive screenings to patients with inflammatory bowel disease.
    PLoS One. 2024;19:e0299890.
    Abstract

  3808. MOSHI JM, Ummelen M, Smedts F, Ramaekers FCS, et al
    Inhibition of cytosine 5-hydroxymethylation during progression of cancer precursor lesions in the uterine cervix.
    PLoS One. 2024;19:e0297008.
    Abstract

  3809. TIRKASO BH, Bayisa TH, Desta TW
    Histopathologic patterns and factors associated with cervical lesions at Jimma Medical Center, Jimma, Southwest Ethiopia: A two-year cross-sectional study.
    PLoS One. 2024;19:e0301559.
    Abstract

  3810. WANG QL, Gong C, Meng XY, Fu M, et al
    TPP1 is associated with risk of advanced precursors and cervical cancer survival.
    PLoS One. 2024;19:e0298118.
    Abstract

  3811. SHIMELS T, Gashawbeza B, Fenta TG
    Validation of the Amharic version of perceived access to healthcare services for patients with cervical cancer in Ethiopia: A second-order confirmatory factor analysis.
    PLoS One. 2024;19:e0300815.
    Abstract

  3812. ILIKA CP, Eleje GU, Chiemeka ME, Ilika FN, et al
    Effects of speculum lubrication on cervical smears for cervical cancer screening: A double blind randomized clinical trial.
    PLoS One. 2024;19:e0292207.
    Abstract

  3813. BROSHKEVITCH CJ, Barnabas RV, Liu G, Palanee-Phillips T, et al
    Enhanced cervical cancer and HIV interventions reduce the disproportionate burden of cervical cancer cases among women living with HIV: A modeling analysis.
    PLoS One. 2024;19:e0301997.
    Abstract

  3814. HUSSEIN K, Kokwaro G, Wafula F, Kassie GM, et al
    Assessing the influence of the health system on access to cervical cancer prevention, screening, and treatment services at public health centers in Addis Ababa, Ethiopia.
    PLoS One. 2024;19:e0300152.
    Abstract

  3815. AGYARE GYANE F, Modey E, Maya E, Bonney EY, et al
    Prevalence and risk factors associated with high-risk human papillomavirus infection among women living with HIV (WLWH) at a tertiary health facility in Accra, Ghana.
    PLoS One. 2024;19:e0303535.
    Abstract

  3816. KIM JY, Jung JH, Jung S, Lee S, et al
    Glyoxalase 1: Emerging biomarker and therapeutic target in cervical cancer progression.
    PLoS One. 2024;19:e0299345.
    Abstract

  3817. WANG Q, Xu M, Zhou H, Li Y, et al
    Prevalence characteristics of cervical human papillomavirus infection in Chengdu and Aba District, Sichuan Province, China.
    PLoS One. 2024;19:e0304760.
    Abstract

  3818. TONG Y, Jia L, Li M, Li H, et al
    Identification of exosomal circSLC26A4 as a liquid biopsy marker for cervical cancer.
    PLoS One. 2024;19:e0305050.
    Abstract

  3819. TSIMA BM, Motlhatlhedi K, Sharma K, Rantshabeng P, et al
    The association between smoking and cervical human papillomavirus infection among women from indigenous communities in western Botswana.
    PLoS One. 2024;19:e0302153.
    Abstract

  3820. NONBOE MH, Napolitano GM, Kann C, Andersen B, et al
    Screening outcome of HPV-vaccinated women: Data from the Danish Trial23 cohort study.
    PLoS One. 2024;19:e0306044.
    Abstract

  3821. GONG S, Li G, Li D, Liu Y, et al
    The risk for subsequent primary lung cancer after cervical carcinoma: A quantitative analysis based on 864,627 cases.
    PLoS One. 2024;19:e0305670.
    Abstract

  3822. QI J, Li J, Zhu X, Zhao S, et al
    Endothelial cell specific molecule 1 promotes epithelial-mesenchymal transition of cervical cancer via the E-box binding homeobox 1.
    PLoS One. 2024;19:e0304597.
    Abstract

  3823. JIN S, Lin F, Yang L, Zhang Q, et al
    Association between dietary folate intake and HPV infection: NHANES 2005-2016.
    PLoS One. 2024;19:e0306636.
    Abstract

  3824. CASTELLANO T, ElHabr AK, Washington C, Ting J, et al
    Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US.
    PLoS One. 2024;19:e0307282.
    Abstract

  3825. BALQIS-ALI NZ, Anis-Syakira J, Fun WH, Mohd Said Z, et al
    Achieving cervical cancer elimination: The simulated impacts of HPV vaccination and transitioning from liquid-based cytology to HPV-based screening test.
    PLoS One. 2024;19:e0307880.
    Abstract


  3826. Retraction: Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis.
    PLoS One. 2024;19:e0308113.
    Abstract

  3827. MUCHAILI L, Simushi P, Mweene BC, Mwakyoma T, et al
    Prevalence and correlates of Human Papillomavirus infection in females from Southern Province, Zambia: A cross-sectional study.
    PLoS One. 2024;19:e0299963.
    Abstract

  3828. LORDELO MV, Oliveira CZ, Aguirre Buexm L, Vieira Reis RM, et al
    Randomized experimental population-based study to evaluate the acceptance and completion of and preferences for cervical cancer screening.
    PLoS One. 2024;19:e0306130.
    Abstract

  3829. NAZRUL N, de Fouw M, Beltman JJ, de Zeeuw J, et al
    Understanding cervical cancer awareness in hard-to-reach areas of Bangladesh: A cross-sectional study involving women and household decisionmakers.
    PLoS One. 2024;19:e0304396.
    Abstract

  3830. GOLALIPOUR A, Mohammadi A, Hosseinzadeh S, Soltani A, et al
    Synergistic cytotoxicity of olive leaf extract-loaded lipid nanocarriers combined with Newcastle disease virus against cervical cancer cells.
    PLoS One. 2024;19:e0308599.
    Abstract

  3831. HARIPRASAD R, Bagepally BS, Kumar S, Pradhan S, et al
    Cost-utility analysis of primary HPV testing through home-based self-sampling in comparison to visual inspection using acetic acid for cervical cancer screening in East district, Sikkim, India, 2023.
    PLoS One. 2024;19:e0300556.
    Abstract

  3832. GOMES FC, Galhardo DDR, Navegante ACG, Santos GSD, et al
    Bioinformatics analysis to identify the relationship between human papillomavirus-associated cervical cancer, toll-like receptors and exomes: A genetic epidemiology study.
    PLoS One. 2024;19:e0305760.
    Abstract

  3833. ROMLI R, Mohamad EMW, Abd Rahman R, Chew KT, et al
    Validation and usability of SeDAR e-health video for enhancing cervical cancer screening.
    PLoS One. 2024;19:e0310555.
    Abstract

  3834. ROBLEDO-CADENA DX, Pacheco-Velazquez SC, Vargas-Navarro JL, Padilla-Flores JA, et al
    Synergistic celecoxib and dimethyl-celecoxib combinations block cervix cancer growth through multiple mechanisms.
    PLoS One. 2024;19:e0308233.
    Abstract

  3835. DANTAS DM, de Souza ATB, de Araujo Santos Camargo JD, Costa APF, et al
    Efficacy and safety of pembrolizumab in cervical cancer: Protocol for systematic review and meta-analysis of randomized clinical trials.
    PLoS One. 2024;19:e0312004.
    Abstract

  3836. TWABI HH, Msosa TC, Meja SJ, Mukoka M, et al
    Spatial distribution and characteristics of women reporting cervical cancer screening in Malawi: An analysis of the 2020 to 2021 Malawi Population-based HIV Impact Assessment survey data.
    PLoS One. 2024;19:e0309053.
    Abstract

  3837. SUTHERLAND EK, Smith JD, Ofori-Boateng M, Kushitor SB, et al
    Study protocol for the development of a real-time interface showing the availability of breast and cervical cancer services in Ghana.
    PLoS One. 2024;19:e0312150.
    Abstract

  3838. RONG Y, Yang Y, Zhang X, Zhou X, et al
    Pain scores reduction with the use of ultrasound-guided paracervical nerve block in patients with cervical cancer undergoing intracavitary brachytherapy: A randomized controlled trial.
    PLoS One. 2024;19:e0310238.
    Abstract

  3839. SULTANOV M, Koot JAR, de Bock GH, Greuter MJW, et al
    High-risk human papillomavirus testing for cervical cancer screening in Uganda: Considering potential harms and benefits in a low-resource setting.
    PLoS One. 2024;19:e0312295.
    Abstract

  3840. LAHOLE BK, Woldamlak M, Kussia W
    Determinants of cervical cancer screening intention among reproductive age women in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0312449.
    Abstract

  3841. ILIC I, Babic G, Dimitrijevic A, Grujicic SS, et al
    Detecting the impact of diagnostic procedures in Pap-positive women on anxiety using artificial neural networks.
    PLoS One. 2024;19:e0312870.
    Abstract

  3842. BIRARA M, Urgie T, Sium AF
    Locally advanced cervical cancer: Neoadjuvant chemotherapy plus radical surgery an alternative approach to chemo-radiation in a low-income setting: A descriptive study.
    PLoS One. 2024;19:e0310457.
    Abstract

  3843. CAMPUZANO TMF, Borba MACSM, de Mendonca Batista P, Nadalin M, et al
    Real world data on cervical cancer treatment patterns, healthcare access and resource utilization in the Brazilian public healthcare system.
    PLoS One. 2024;19:e0312757.
    Abstract

  3844. AREVALOS A, Valenzuela A, Mongelos P, Barrios H, et al
    Genital infections in high-risk human papillomavirus positive Paraguayan women aged 30-64 with and without cervical lesions.
    PLoS One. 2024;19:e0312947.
    Abstract

  3845. BAWALLE AA, Nguyen TXT, Khan MSR, Kadoya Y, et al
    Impact of financial literacy and education on breast and cervical cancer screening participation in Japan.
    PLoS One. 2024;19:e0313687.
    Abstract

  3846. PLISKO O, Zodzika J, Jermakova I, Pcolkina K, et al
    Prediction of high-grade cervical precancerous abnormalities: The role of personal factors, vaginal microflora, sexually transmitted infections, and high-risk human papillomavirus.
    PLoS One. 2024;19:e0313004.
    Abstract

  3847. ABDULL RAHIM U, Mustapa M, Mohamed Shakrin NNS, Nurdin A, et al
    Current evidence and future direction on evaluating the anticancer effects of curcumin, gingerols, and shogaols in cervical cancer: A systematic review.
    PLoS One. 2024;19:e0314280.
    Abstract

  3848. DANIELS V, Saxena K, Patterson-Lomba O, Gomez-Lievano A, et al
    Modeling the health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination program in adolescents in low/middle-income countries: An analysis of Indonesia.
    PLoS One. 2024;19:e0310591.
    Abstract

  3849. OWARE J, Iddrisu M, Konlan KD, Dzansi G, et al
    Personal and workplace factors influencing the resilience of nurses caring for women with cervical cancer in a resource-constrained setting in Ghana.
    PLoS One. 2024;19:e0314764.
    Abstract

  3850. WANG J, Lu Y, Li F, Yao D, et al
    Preserving circumflex iliac lymph nodes to reduce the incidence of lower limb lymphedema following lymphadenectomy in cervical and endometrial cancers: A prospective randomized controlled trial.
    PLoS One. 2024;19:e0311144.
    Abstract

  3851. ASGEDOM YS, Hailegebireal AH, Woldegeorgis BZ, Koyira MM, et al
    Towards 90-70-90 targets: Individual and community level factors associated with cervical cancer screening among women of reproductive age in Tanzania: A multi-level analysis based on 2022 Tanzania demographic and health survey.
    PLoS One. 2024;19:e0315438.
    Abstract

  3852. CHAKRABORTY S, Nessa A, Ferdous NE, Rahman MM, et al
    Prevalence and genotypic distribution of high-risk human papillomavirus (HPV) among ever-married women in coastal regions of Bangladesh.
    PLoS One. 2024;19:e0313396.
    Abstract

  3853. LIM C, Seo YJ, Lee JY, Jung ES, et al
    Evaluation of the cervical liquid-based cytology sample as a microbiome resource for dual diagnosis.
    PLoS One. 2024;19:e0308985.
    Abstract

  3854. LOWY DR
    Harald zur Hausen (1936 to 2023): Discoverer of human papillomavirus infection as the main cause of cervical cancer.
    Proc Natl Acad Sci U S A. 2024;121:e2400517121.
    Abstract

  3855. BELLONE S, Jeong K, Halle MK, Krakstad C, et al
    Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.
    Proc Natl Acad Sci U S A. 2024;121:e2321898121.
    Abstract

  3856. ZHAI G, Niu Z, Jiang Z, Zhao F, et al
    DPF2 reads histone lactylation to drive transcription and tumorigenesis.
    Proc Natl Acad Sci U S A. 2024;121:e2421496121.
    Abstract


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;